id
stringlengths 7
10
| query
stringlengths 559
87.6k
| answer
stringlengths 16
1.58k
| text
stringlengths 288
87.3k
|
|---|---|---|---|
edtsum1802 | You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text.
Text: MONETT, Mo., Jan. 8, 2021 /PRNewswire/ --Jack Henry & Associates, Inc. (NASDAQ: JKHY) is a leading provider of technology solutions and payment processing services primarily for the financial services industry. Jack Henry Lendinghas expanded its Paycheck Protection Program (PPP) loan solution with a borrower-facing digital interface to capture the application and supporting documents. The company is also providing an additional broker option for institutions that make the strategic decision to refer PPP loans, allowing them to meet their community's needs by accepting loan requests online that are then decisioned and funded through a trusted Jack Henry lender without any exchange of funds or fees. The upcoming stimulus round will provide an additional $284 billion in PPP funding to help small businesses survive prolonged economic challenges stemming from the pandemic. Jack Henry's new self-service interface makes it easy and convenient for small business borrowers to enter and upload required information online. The solution then streamlines the information directly through the SBA and a financial institution's core, saving time and eliminating the need for redundant data entry. The comprehensive, end-to-end PPP offering also features built-in fraud and risk controls. Terry Renoux, group president of Jack Henry Lending, stated, "The pandemic's impact on small businesses is long lasting; this latest round of PPP loans is necessary to help many businesses survive. At Jack Henry, we're committed to helping banks and credit unions deliver these funds to those in need, and to making the experience as seamless as possible. Our expanded PPP lending offering delivers an automated, digital approach that allows financial institutions to more quickly and efficiently manage large volumes. And, we can now help bankers who want to provide for their local communities but are not in a position to manage the loans themselves." Last year, Jack Henry supported approximately 400 banks and credit unions in facilitating more than 70,000 loan applications with a total of $6.5 billion in requests for small businesses seeking assistance through the PPP. With this updated offering, banks and credit unions will be able to continue to meet the needs in their communities with even greater efficiencies and improved digital experiences. Visit the Jack Henry Lending CARES Act Support Pageto learn more. About Jack Henry & Associates, Inc. Jack Henry (NASDAQ:JKHY) is a leading provider of technology solutions primarily for the financial services industry. We are a S&P 500 company that serves approximately 8,700 clients nationwide through three divisions: Jack Henry Banking supports banks ranging from community banks to multi-billion-dollar institutions; Symitar provides industry-leading solutions to credit unions of all sizes; and ProfitStars offers highly specialized solutions to financial institutions of every asset size, as well as diverse corporate entities outside of the financial services industry. With a heritage that has been dedicated to openness, partnership, and user centricity for more than 40 years, we are well-positioned as a driving market force in future-ready digital solutions and payment processing services. We empower our clients and consumers with the human-centered, tech-forward, and insights-driven solutions that will get them where they want to go. Are you future ready? Additional information is available at www.jackhenry.com. Statements made in this news release that are not historical facts are forward-looking information. Actual results may differ materially from those projected in any forward-looking information.Specifically, there are a number of important factors that could cause actual results to differ materially from those anticipated by any forward-looking information. Additional information on these and other factors, which could affect the Company's financial results, are included in its Securities and Exchange Commission (SEC) filings on Form 10-K, and potential investors should review these statements. Finally, there may be other factors not mentioned above or included in the Company's SEC filings that may cause actual results to differ materially from any forward-looking information. SOURCE Jack Henry & Associates, Inc. Related Links http://www.jackhenry.com
Answer: | Jack Henry Enhances Paycheck Protection Program Lending Solution, Helps Banks and Credit Unions Support Local Businesses Borrower-focused improvements enhance experience, new broker option provides flexibility and meets community needs | MONETT, Mo., Jan. 8, 2021 /PRNewswire/ --Jack Henry & Associates, Inc. (NASDAQ: JKHY) is a leading provider of technology solutions and payment processing services primarily for the financial services industry. Jack Henry Lendinghas expanded its Paycheck Protection Program (PPP) loan solution with a borrower-facing digital interface to capture the application and supporting documents. The company is also providing an additional broker option for institutions that make the strategic decision to refer PPP loans, allowing them to meet their community's needs by accepting loan requests online that are then decisioned and funded through a trusted Jack Henry lender without any exchange of funds or fees. The upcoming stimulus round will provide an additional $284 billion in PPP funding to help small businesses survive prolonged economic challenges stemming from the pandemic. Jack Henry's new self-service interface makes it easy and convenient for small business borrowers to enter and upload required information online. The solution then streamlines the information directly through the SBA and a financial institution's core, saving time and eliminating the need for redundant data entry. The comprehensive, end-to-end PPP offering also features built-in fraud and risk controls. Terry Renoux, group president of Jack Henry Lending, stated, "The pandemic's impact on small businesses is long lasting; this latest round of PPP loans is necessary to help many businesses survive. At Jack Henry, we're committed to helping banks and credit unions deliver these funds to those in need, and to making the experience as seamless as possible. Our expanded PPP lending offering delivers an automated, digital approach that allows financial institutions to more quickly and efficiently manage large volumes. And, we can now help bankers who want to provide for their local communities but are not in a position to manage the loans themselves." Last year, Jack Henry supported approximately 400 banks and credit unions in facilitating more than 70,000 loan applications with a total of $6.5 billion in requests for small businesses seeking assistance through the PPP. With this updated offering, banks and credit unions will be able to continue to meet the needs in their communities with even greater efficiencies and improved digital experiences. Visit the Jack Henry Lending CARES Act Support Pageto learn more. About Jack Henry & Associates, Inc. Jack Henry (NASDAQ:JKHY) is a leading provider of technology solutions primarily for the financial services industry. We are a S&P 500 company that serves approximately 8,700 clients nationwide through three divisions: Jack Henry Banking supports banks ranging from community banks to multi-billion-dollar institutions; Symitar provides industry-leading solutions to credit unions of all sizes; and ProfitStars offers highly specialized solutions to financial institutions of every asset size, as well as diverse corporate entities outside of the financial services industry. With a heritage that has been dedicated to openness, partnership, and user centricity for more than 40 years, we are well-positioned as a driving market force in future-ready digital solutions and payment processing services. We empower our clients and consumers with the human-centered, tech-forward, and insights-driven solutions that will get them where they want to go. Are you future ready? Additional information is available at www.jackhenry.com. Statements made in this news release that are not historical facts are forward-looking information. Actual results may differ materially from those projected in any forward-looking information.Specifically, there are a number of important factors that could cause actual results to differ materially from those anticipated by any forward-looking information. Additional information on these and other factors, which could affect the Company's financial results, are included in its Securities and Exchange Commission (SEC) filings on Form 10-K, and potential investors should review these statements. Finally, there may be other factors not mentioned above or included in the Company's SEC filings that may cause actual results to differ materially from any forward-looking information. SOURCE Jack Henry & Associates, Inc. Related Links http://www.jackhenry.com |
edtsum1803 | You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text.
Text: DUBAI, United Arab Emirates--(BUSINESS WIRE)--Pacific Prime, a global employee benefits and health insurance specialist, is pleased to announce that they have received two accolades from Cigna Middle East in 2020: "Individual Broker of the Year" and "Innovative Broker of the Year". The awards were presented to the team at Pacific Prime's Dubai office on 4 April, 2021. When asked why Pacific Prime received the awards, Jerome Droesch, CEO at Cigna MEA and SEA, stated: Our partnership with Pacific Prime, the leading global insurance consultancy, has been a mutually rewarding one. We are pleased to recognize the company as Cignas Innovative Broker of the Year and Individual Broker of the Year." "Over the course of our long-term synergy, Pacific Primes knowledge, professionalism, and dedication have supported our sustained endeavors to innovate and tailor our offerings to deliver the highest quality of care to our customers. We look forward to continuing our collaboration and bringing to market advanced solutions that enhance our customers' quality of life in the years to come." David Hayes, Regional CEO at Pacific Prime Dubai, was one of the recipients who received the accolades on behalf of Pacific Prime. He said: "It's truly an honor to receive such prestigious industry recognition. These awards are a testament of our innovative approach and dedication to simplifying insurance for individual and corporate clients. We look forward to continuing our partnership and achieving mutually beneficial results." Nageen Sattar, Director of Regional Client Services at Pacific Prime Dubai, commented: "We've worked with Cigna for many years, and I'm delighted to see our strong partnership recognized with the Individual Broker of the Year and Innovative Broker of the Year awards - the former demonstrating our unwavering commitment to the individual business category, and the latter recognizing our SME expertise and feedback, which the insurer took into account when designing their new Smart Care Regional SME plan." About Pacific Prime Founded in Hong Kong in 2000, Pacific Prime is an award-winning insurance brokerage with a strong focus on 'simplifying insurance' for individual and corporate clients around the world. The company acquired the brokerage arms of CXA Group in January 2021 to bolster the support and offerings available to Pacific Prime's clients. To learn more about the insurance brokerage, visit: https://www.pacificprime.com/corporate About Cigna Middle East With more than 15 years of experience in the region, Cigna Middle East combines the insurer's global expertise and local knowledge to create flexible insurance plans. Visit https://www.cigna-me.com/ to learn more about Cigna Middle East.
Answer: | Pacific Prime Named Cigna Middle East's "Individual Broker of the Year" and "Innovative Broker of the Year" in 2020 | DUBAI, United Arab Emirates--(BUSINESS WIRE)--Pacific Prime, a global employee benefits and health insurance specialist, is pleased to announce that they have received two accolades from Cigna Middle East in 2020: "Individual Broker of the Year" and "Innovative Broker of the Year". The awards were presented to the team at Pacific Prime's Dubai office on 4 April, 2021. When asked why Pacific Prime received the awards, Jerome Droesch, CEO at Cigna MEA and SEA, stated: Our partnership with Pacific Prime, the leading global insurance consultancy, has been a mutually rewarding one. We are pleased to recognize the company as Cignas Innovative Broker of the Year and Individual Broker of the Year." "Over the course of our long-term synergy, Pacific Primes knowledge, professionalism, and dedication have supported our sustained endeavors to innovate and tailor our offerings to deliver the highest quality of care to our customers. We look forward to continuing our collaboration and bringing to market advanced solutions that enhance our customers' quality of life in the years to come." David Hayes, Regional CEO at Pacific Prime Dubai, was one of the recipients who received the accolades on behalf of Pacific Prime. He said: "It's truly an honor to receive such prestigious industry recognition. These awards are a testament of our innovative approach and dedication to simplifying insurance for individual and corporate clients. We look forward to continuing our partnership and achieving mutually beneficial results." Nageen Sattar, Director of Regional Client Services at Pacific Prime Dubai, commented: "We've worked with Cigna for many years, and I'm delighted to see our strong partnership recognized with the Individual Broker of the Year and Innovative Broker of the Year awards - the former demonstrating our unwavering commitment to the individual business category, and the latter recognizing our SME expertise and feedback, which the insurer took into account when designing their new Smart Care Regional SME plan." About Pacific Prime Founded in Hong Kong in 2000, Pacific Prime is an award-winning insurance brokerage with a strong focus on 'simplifying insurance' for individual and corporate clients around the world. The company acquired the brokerage arms of CXA Group in January 2021 to bolster the support and offerings available to Pacific Prime's clients. To learn more about the insurance brokerage, visit: https://www.pacificprime.com/corporate About Cigna Middle East With more than 15 years of experience in the region, Cigna Middle East combines the insurer's global expertise and local knowledge to create flexible insurance plans. Visit https://www.cigna-me.com/ to learn more about Cigna Middle East. |
edtsum1807 | You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text.
Text: FORT WORTH, Texas, March 30, 2020 /PRNewswire/ --GDC Technics, a global aerospace company and industry leader in multiple aircraft services, announces it will begin voluntary production of N95 compliant face masks to be donated to local Fort Worth hospitals to combat the ongoing COVID-19 pandemic as part of its GDC Cares initiative. GDC Technics begin voluntary production of N95 compliant face masks to be donated to local Fort Worth hospitals. The GDC Technics US operations is recognized by the Federal Government Department of Defense as an Essential Operation and continues to operate at full capacity in order to provide customers with consistent and high-quality services. All GDC Technics workshops remain in operation, including its Upholstery shops, in both Fort Worth and San Antonio which have been focused on the production of face masks. The company has pledged to produce and donate a minimum of one thousand N95 compliant face masks per week to local hospitals while maintaining its normal operations. "Our top priority is the safety and well-being of our employees, customers, and our community," said Brad Foreman, GDC Technics CEO. "We, at GDC, are doing everything we can to continue our operations while keeping our employees and their families safe by ensuring we follow the recommendations and regulations issued by all local authorities, the Center for Disease Control, and the World Health Organization." Foreman added, "We recognize that this is a difficult time for many and our employees want to do everything possible to support our country. We offer this commitment of face mask donations to bring help to our community and further unite us against the spread of COVID-19." GDC Cares is the company's community outreach initiative that shows the commitment of GDC Technics to the community where it lives and works. GDC Technics firmly believes that community involvement is a great way to give back to the people as well as to its company's ripening culture. As a world-wide company, GDC Technics is proud to be thinking globally and acting locally and hopes its efforts will continue to spread inspiration in both its colleagues and community alike.GDC Technics will donate all of the produced face masks to Fort Worth hospitals as there is currently a high demand for face masks within healthcare organizations. N95 compliant face masks are a type of personal protective equipment that can be used to protect the wearer from airborne particles and to keep liquids from contaminating the wearer's face. Healthcare professionals use face masks to help prevent the contraction and spread of the virus.GDC Technics is also evaluating its ability to help manufacture ventilators as we realize that this is also a critical need at this time.About GDC Technics. GDC Technics is a global aerospace company with extensive expertise in Engineering & Technical services, Modifications, Electronic Systems, R&D, and MRO services. GDC Technics is headquartered in Fort Worth, Texas with multiple worldwide locations across North America, Europe, Asia, and Africa. For more information, see www.gdctechnics.com.SOURCE GDC Technics Related Links http://www.gdctechnics.com/
Answer: | GDC Technics Announces Commencement Of Face Mask Production As Part Of GDC Cares Initiative | FORT WORTH, Texas, March 30, 2020 /PRNewswire/ --GDC Technics, a global aerospace company and industry leader in multiple aircraft services, announces it will begin voluntary production of N95 compliant face masks to be donated to local Fort Worth hospitals to combat the ongoing COVID-19 pandemic as part of its GDC Cares initiative. GDC Technics begin voluntary production of N95 compliant face masks to be donated to local Fort Worth hospitals. The GDC Technics US operations is recognized by the Federal Government Department of Defense as an Essential Operation and continues to operate at full capacity in order to provide customers with consistent and high-quality services. All GDC Technics workshops remain in operation, including its Upholstery shops, in both Fort Worth and San Antonio which have been focused on the production of face masks. The company has pledged to produce and donate a minimum of one thousand N95 compliant face masks per week to local hospitals while maintaining its normal operations. "Our top priority is the safety and well-being of our employees, customers, and our community," said Brad Foreman, GDC Technics CEO. "We, at GDC, are doing everything we can to continue our operations while keeping our employees and their families safe by ensuring we follow the recommendations and regulations issued by all local authorities, the Center for Disease Control, and the World Health Organization." Foreman added, "We recognize that this is a difficult time for many and our employees want to do everything possible to support our country. We offer this commitment of face mask donations to bring help to our community and further unite us against the spread of COVID-19." GDC Cares is the company's community outreach initiative that shows the commitment of GDC Technics to the community where it lives and works. GDC Technics firmly believes that community involvement is a great way to give back to the people as well as to its company's ripening culture. As a world-wide company, GDC Technics is proud to be thinking globally and acting locally and hopes its efforts will continue to spread inspiration in both its colleagues and community alike.GDC Technics will donate all of the produced face masks to Fort Worth hospitals as there is currently a high demand for face masks within healthcare organizations. N95 compliant face masks are a type of personal protective equipment that can be used to protect the wearer from airborne particles and to keep liquids from contaminating the wearer's face. Healthcare professionals use face masks to help prevent the contraction and spread of the virus.GDC Technics is also evaluating its ability to help manufacture ventilators as we realize that this is also a critical need at this time.About GDC Technics. GDC Technics is a global aerospace company with extensive expertise in Engineering & Technical services, Modifications, Electronic Systems, R&D, and MRO services. GDC Technics is headquartered in Fort Worth, Texas with multiple worldwide locations across North America, Europe, Asia, and Africa. For more information, see www.gdctechnics.com.SOURCE GDC Technics Related Links http://www.gdctechnics.com/ |
edtsum1811 | You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text.
Text: LONDON--(BUSINESS WIRE)-- Xtrackers (IE) plc Investment Company with Variable Capital Registered Office: 78 Sir John Rogerson's Quay, Dublin 2, Ireland Registration number: 393802 (the Company) Registered in Dublin as an open-ended variable capital umbrella investment company with limited liability and as an umbrella fund with segregated liability between sub-funds. Regulated by the Central Bank of Ireland. Registration Number 393802. Registered Office as above. Directors: Tom Murray (Irish), Michael Whelan (Irish), Alex McKenna (UK), Gerry Grimes (Irish), Manooj Mistry (UK) NOTICE TO SHAREHOLDERS OF THE SUB-FUNDS LISTED ON THE LONDON STOCK EXCHANGE Dublin, 25 February 2021 This announcement is to inform the shareholders of the sub-funds listed in the table below (each a Sub-Fund, and together the Sub-Funds) (the Shareholders) on behalf of the board of directors of the Company (the Board of Directors) of the applicable net asset value (the NAV) in respect of each Sub-Fund for the below stated Dealing Day: Sub-Fund ISIN Outstanding Shares Currency Dealing Day NAV LEI Xtrackers (IE) plc ESG USD Corporate Bond UCITS ETF 1C IE00BL58LJ19 465,000 USD 25-Feb-2021 44.5097 254900YQ6CUXP95AXP64 Xtrackers (IE) plc FTSE All-World ex UK UCITS ETF 1C IE00BM67HJ62 543,392 GBP 25-Feb-2021 69.9026 549300Z2SIL2X411X235 Xtrackers (IE) plc iBoxx USD Corporate Bond Yield Plus UCITS ETF 1D IE00BF8J5974 2,441,495 USD 25-Feb-2021 20.5299 549300QIFH7Y0VUSB550 Xtrackers (IE) plc JPX-Nikkei 400 UCITS ETF 1D IE00BPVLQD13 10,503,505 JPY 25-Feb-2021 1825.5285 549300DIT7F25Z1MYN06 Xtrackers (IE) plc JPX-Nikkei 400 UCITS ETF 2D - GBP Hedged IE00BPVLQF37 792,829 GBP 25-Feb-2021 17.5687 549300DIT7F25Z1MYN06 Xtrackers (IE) plc JPX-Nikkei 400 UCITS ETF 4C - USD Hedged IE00BTGD1B38 524,281 USD 25-Feb-2021 20.5584 549300DIT7F25Z1MYN06 Xtrackers (IE) plc MSCI AC World UCITS ETF 1C IE00BGHQ0G80 28,350,000 EUR 25-Feb-2021 25.5772 549300T1PSHCUYSNHE68 Xtrackers (IE) plc MSCI Emerging Markets ESG UCITS ETF 1C IE00BG370F43 20,780,000 USD 25-Feb-2021 63.0277 54930068DSSGNFYYVR85 Xtrackers (IE) plc MSCI Emerging Markets UCITS ETF 1C IE00BTJRMP35 67,948,000 USD 25-Feb-2021 66.3718 5493002C2LG0TVRY4T35 Xtrackers (IE) plc MSCI EMU ESG UCITS ETF 1C IE00BNC1G699 206,000 EUR 25-Feb-2021 55.221 254900OARN1CRQBI4D27 Xtrackers (IE) plc MSCI Europe ESG UCITS ETF 1C IE00BFMNHK08 8,250,000 EUR 25-Feb-2021 22.2766 549300I5MYV9MCPQD952 Xtrackers (IE) plc MSCI GCC Select Swap UCITS ETF 1C IE00BQXKVQ19 1,204,621 USD 25-Feb-2021 18.9305 5493003PO25H4G3SSF64 Xtrackers (IE) plc MSCI Japan ESG UCITS ETF 1C IE00BG36TC12 71,960,000 USD 25-Feb-2021 23.0797 549300VT3CD217Z7Q476 Xtrackers (IE) plc MSCI Nordic UCITS ETF 1D IE00B9MRHC27 9,929,224 EUR 25-Feb-2021 42.8061 5493007KGDIVBDEQHM64 Xtrackers (IE) plc MSCI USA Banks UCITS ETF 1D IE00BDVPTJ63 27,175,000 USD 25-Feb-2021 22.9948 254900P9QIPJGCJR6N80 Xtrackers (IE) plc MSCI USA Communication Services UCITS ETF 1D IE00BNC1G707 63,000 USD 25-Feb-2021 51.0972 2549005LD5ZIQ8C4LL08 Xtrackers (IE) plc MSCI USA Consumer Discretionary UCITS ETF 1D IE00BGQYRR35 1,236,157 USD 25-Feb-2021 65.6501 549300E63DJSRCJZ6614 Xtrackers (IE) plc MSCI USA Consumer Staples UCITS ETF 1D IE00BGQYRQ28 2,280,000 USD 25-Feb-2021 35.6645 54930096GV0MTBBDYV48 Xtrackers (IE) plc MSCI USA Energy UCITS ETF 1D IE00BCHWNS19 600,000 USD 25-Feb-2021 25.756 5493008L9YO5GRO3ZN19 Xtrackers (IE) plc MSCI USA ESG UCITS ETF 1C IE00BFMNPS42 51,700,000 USD 25-Feb-2021 39.1195 549300GV7ND6DPBVN624 Xtrackers (IE) plc MSCI USA Financials UCITS ETF 1D IE00BCHWNT26 26,460,000 USD 25-Feb-2021 24.0207 549300M68RNPQMXLBB25 Xtrackers (IE) plc MSCI USA Health Care UCITS ETF 1D IE00BCHWNW54 9,611,246 USD 25-Feb-2021 46.6509 549300IH60G2OJH57P83 Xtrackers (IE) plc MSCI USA Industrials UCITS ETF 1D IE00BCHWNV48 53,000 USD 25-Feb-2021 58.0109 549300L0LMLRSZ26QR72 Xtrackers (IE) plc MSCI USA Information Technology UCITS ETF 1D IE00BGQYRS42 11,313,272 USD 25-Feb-2021 60.1325 549300M6JAZI5LWML141 Xtrackers (IE) plc MSCI USA Minimum Volatility UCITS ETF 1D IE00BDB7J586 115,000 USD 25-Feb-2021 42.3387 5493000I1N60EFHBLR44 Xtrackers (IE) plc MSCI USA UCITS ETF 1C IE00BJ0KDR00 51,124,425 USD 25-Feb-2021 108.771 549300J9YPZW8OQXLF38 Xtrackers (IE) plc MSCI World Communication Services UCITS ETF 1C IE00BM67HR47 12,095,797 USD 25-Feb-2021 18.7869 549300RZO14LB1V7K773 Xtrackers (IE) plc MSCI World Consumer Discretionary UCITS ETF 1C IE00BM67HP23 8,737,672 USD 25-Feb-2021 50.3076 549300OF256895TPBN07 Xtrackers (IE) plc MSCI World Consumer Staples UCITS ETF 1C IE00BM67HN09 7,141,417 USD 25-Feb-2021 39.1734 549300SWTOHJYCRTIU71 Xtrackers (IE) plc MSCI World Energy UCITS ETF 1C IE00BM67HM91 9,154,918 USD 25-Feb-2021 27.1399 549300PD0M2UW0Y2XV93 Xtrackers (IE) plc MSCI World ESG UCITS ETF 1C IE00BZ02LR44 50,886,399 USD 25-Feb-2021 29.6158 549300KBPMH7CRUHUW62 Xtrackers (IE) plc MSCI World Financials UCITS ETF 1C IE00BM67HL84 36,765,753 USD 25-Feb-2021 22.2052 54930037UOCTZSIPKX79 Xtrackers (IE) plc MSCI World Health Care UCITS ETF 1C IE00BM67HK77 26,235,527 USD 25-Feb-2021 42.7296 549300J9P50W4IOBWS91 Xtrackers (IE) plc MSCI World High Dividend Yield UCITS ETF 1D IE00BCHWNQ94 4,164,000 USD 25-Feb-2021 20.0384 5493000MMCBYY20QMC86 Xtrackers (IE) plc MSCI World Industrials UCITS ETF 1C IE00BM67HV82 10,722,073 USD 25-Feb-2021 45.0094 549300749B86R75HG635 Xtrackers (IE) plc MSCI World Information Technology UCITS ETF 1C IE00BM67HT60 36,683,748 USD 25-Feb-2021 52.3722 549300CM6KL5NIENK841 Xtrackers (IE) plc MSCI World Materials UCITS ETF 1C IE00BM67HS53 6,762,173 USD 25-Feb-2021 51.7106 5493001RFO47M71FEX43 Xtrackers (IE) plc MSCI World Minimum Volatility UCITS ETF 1C IE00BL25JN58 18,900,000 USD 25-Feb-2021 35.3285 54930014T94RHSFQFQ97 Xtrackers (IE) plc MSCI World Momentum UCITS ETF 1C IE00BL25JP72 10,150,000 USD 25-Feb-2021 49.4673 549300JTUIN0HTFEH791 Xtrackers (IE) plc MSCI World Quality UCITS ETF 1C IE00BL25JL35 7,050,000 USD 25-Feb-2021 48.6911 549300IILXM4ST526335 Xtrackers (IE) plc MSCI World UCITS ETF 1C IE00BJ0KDQ92 81,607,086 USD 25-Feb-2021 82.3969 549300ZPCMJ0UKSMRS71 Xtrackers (IE) plc MSCI World UCITS ETF 1D IE00BK1PV551 14,893,147 USD 25-Feb-2021 74.7674 549300ZPCMJ0UKSMRS71 Xtrackers (IE) plc MSCI World UCITS ETF 2D - GBP Hedged IE00BZ1BS790 3,315,577 GBP 25-Feb-2021 17.6075 549300ZPCMJ0UKSMRS71 Xtrackers (IE) plc MSCI World Utilities UCITS ETF 1C IE00BM67HQ30 2,158,433 USD 25-Feb-2021 28.4528 5493005SK6V4E5KRXN82 Xtrackers (IE) plc MSCI World Value UCITS ETF 1C IE00BL25JM42 16,175,000 USD 25-Feb-2021 35.466 5493003ZC4YBJJRSAX18 Xtrackers (IE) plc NASDAQ 100 UCITS ETF 1C IE00BMFKG444 429,000 USD 25-Feb-2021 29.0357 254900B3YYIAXJ1WEN66 Xtrackers (IE) plc Russell 2000 UCITS ETF 1C IE00BJZ2DD79 6,246,157 USD 25-Feb-2021 310.9473 549300RDZXTM5DJWDC22 Xtrackers (IE) plc Russell Midcap UCITS ETF 1C IE00BJZ2DC62 3,490,808 USD 25-Feb-2021 32.7695 5493001R2VWIV9D4XH46 Xtrackers (IE) plc S&P 500 Equal Weight UCITS ETF 1C IE00BLNMYC90 54,623,226 USD 25-Feb-2021 69.7738 549300K5EREWUG10PC82 Xtrackers (IE) plc S&P 500 UCITS ETF 2C - GBP Hedged IE00BM67HX07 4,395,619 GBP 25-Feb-2021 63.5565 549300NZCAJCKZWK5644 Xtrackers (IE) plc S&P Europe ex UK UCITS ETF 1D IE00BGV5VM45 8,840,000 EUR 25-Feb-2021 57.6295 254900AV94BB0XCLC120 Xtrackers (IE) plc US Treasuries Ultrashort Bond UCITS ETF 1C IE00BM97MR69 170,371 USD 25-Feb-2021 53.574 254900OSQHTSXUWQKZ28 Xtrackers (IE) plc USD Corporate Bond UCITS ETF 1D IE00BZ036H21 56,588,080 USD 25-Feb-2021 16.2502 549300TN3252QWI8QN78 Xtrackers (IE) plc USD High Yield Corporate Bond UCITS ETF 1D IE00BDR5HM97 27,631,303 USD 25-Feb-2021 15.3552 549300XH6DDPBRY7P527 Xtrackers (IE) plc Xtrackers ESG USD Emerging Markets Bond Quality Weighted UCITS ETF 1D IE00BD4DX952 7,070,987 USD 25-Feb-2021 13.6303 549300BQBF21JCBVKV46 This announcement is for information purposes only. Shareholders are not required to take any action. Capitalised terms used in this notice shall have the same meaning ascribed to them in the latest version of the prospectus of the Company (the Prospectus) unless the context otherwise requires. Any further information in relation to the Sub-Funds may be obtained by contacting the x-trackers ETF hotline on +44 (20) 7547 1747 or +49 (69) 910 30549 or by sending an email to [email protected]. Xtrackers (IE) plc Board of directors Contact information Xtrackers (IE) plc 78 Sir John Rogerson's Quay Dublin 2
Answer: | Net Asset Value(s) | LONDON--(BUSINESS WIRE)-- Xtrackers (IE) plc Investment Company with Variable Capital Registered Office: 78 Sir John Rogerson's Quay, Dublin 2, Ireland Registration number: 393802 (the Company) Registered in Dublin as an open-ended variable capital umbrella investment company with limited liability and as an umbrella fund with segregated liability between sub-funds. Regulated by the Central Bank of Ireland. Registration Number 393802. Registered Office as above. Directors: Tom Murray (Irish), Michael Whelan (Irish), Alex McKenna (UK), Gerry Grimes (Irish), Manooj Mistry (UK) NOTICE TO SHAREHOLDERS OF THE SUB-FUNDS LISTED ON THE LONDON STOCK EXCHANGE Dublin, 25 February 2021 This announcement is to inform the shareholders of the sub-funds listed in the table below (each a Sub-Fund, and together the Sub-Funds) (the Shareholders) on behalf of the board of directors of the Company (the Board of Directors) of the applicable net asset value (the NAV) in respect of each Sub-Fund for the below stated Dealing Day: Sub-Fund ISIN Outstanding Shares Currency Dealing Day NAV LEI Xtrackers (IE) plc ESG USD Corporate Bond UCITS ETF 1C IE00BL58LJ19 465,000 USD 25-Feb-2021 44.5097 254900YQ6CUXP95AXP64 Xtrackers (IE) plc FTSE All-World ex UK UCITS ETF 1C IE00BM67HJ62 543,392 GBP 25-Feb-2021 69.9026 549300Z2SIL2X411X235 Xtrackers (IE) plc iBoxx USD Corporate Bond Yield Plus UCITS ETF 1D IE00BF8J5974 2,441,495 USD 25-Feb-2021 20.5299 549300QIFH7Y0VUSB550 Xtrackers (IE) plc JPX-Nikkei 400 UCITS ETF 1D IE00BPVLQD13 10,503,505 JPY 25-Feb-2021 1825.5285 549300DIT7F25Z1MYN06 Xtrackers (IE) plc JPX-Nikkei 400 UCITS ETF 2D - GBP Hedged IE00BPVLQF37 792,829 GBP 25-Feb-2021 17.5687 549300DIT7F25Z1MYN06 Xtrackers (IE) plc JPX-Nikkei 400 UCITS ETF 4C - USD Hedged IE00BTGD1B38 524,281 USD 25-Feb-2021 20.5584 549300DIT7F25Z1MYN06 Xtrackers (IE) plc MSCI AC World UCITS ETF 1C IE00BGHQ0G80 28,350,000 EUR 25-Feb-2021 25.5772 549300T1PSHCUYSNHE68 Xtrackers (IE) plc MSCI Emerging Markets ESG UCITS ETF 1C IE00BG370F43 20,780,000 USD 25-Feb-2021 63.0277 54930068DSSGNFYYVR85 Xtrackers (IE) plc MSCI Emerging Markets UCITS ETF 1C IE00BTJRMP35 67,948,000 USD 25-Feb-2021 66.3718 5493002C2LG0TVRY4T35 Xtrackers (IE) plc MSCI EMU ESG UCITS ETF 1C IE00BNC1G699 206,000 EUR 25-Feb-2021 55.221 254900OARN1CRQBI4D27 Xtrackers (IE) plc MSCI Europe ESG UCITS ETF 1C IE00BFMNHK08 8,250,000 EUR 25-Feb-2021 22.2766 549300I5MYV9MCPQD952 Xtrackers (IE) plc MSCI GCC Select Swap UCITS ETF 1C IE00BQXKVQ19 1,204,621 USD 25-Feb-2021 18.9305 5493003PO25H4G3SSF64 Xtrackers (IE) plc MSCI Japan ESG UCITS ETF 1C IE00BG36TC12 71,960,000 USD 25-Feb-2021 23.0797 549300VT3CD217Z7Q476 Xtrackers (IE) plc MSCI Nordic UCITS ETF 1D IE00B9MRHC27 9,929,224 EUR 25-Feb-2021 42.8061 5493007KGDIVBDEQHM64 Xtrackers (IE) plc MSCI USA Banks UCITS ETF 1D IE00BDVPTJ63 27,175,000 USD 25-Feb-2021 22.9948 254900P9QIPJGCJR6N80 Xtrackers (IE) plc MSCI USA Communication Services UCITS ETF 1D IE00BNC1G707 63,000 USD 25-Feb-2021 51.0972 2549005LD5ZIQ8C4LL08 Xtrackers (IE) plc MSCI USA Consumer Discretionary UCITS ETF 1D IE00BGQYRR35 1,236,157 USD 25-Feb-2021 65.6501 549300E63DJSRCJZ6614 Xtrackers (IE) plc MSCI USA Consumer Staples UCITS ETF 1D IE00BGQYRQ28 2,280,000 USD 25-Feb-2021 35.6645 54930096GV0MTBBDYV48 Xtrackers (IE) plc MSCI USA Energy UCITS ETF 1D IE00BCHWNS19 600,000 USD 25-Feb-2021 25.756 5493008L9YO5GRO3ZN19 Xtrackers (IE) plc MSCI USA ESG UCITS ETF 1C IE00BFMNPS42 51,700,000 USD 25-Feb-2021 39.1195 549300GV7ND6DPBVN624 Xtrackers (IE) plc MSCI USA Financials UCITS ETF 1D IE00BCHWNT26 26,460,000 USD 25-Feb-2021 24.0207 549300M68RNPQMXLBB25 Xtrackers (IE) plc MSCI USA Health Care UCITS ETF 1D IE00BCHWNW54 9,611,246 USD 25-Feb-2021 46.6509 549300IH60G2OJH57P83 Xtrackers (IE) plc MSCI USA Industrials UCITS ETF 1D IE00BCHWNV48 53,000 USD 25-Feb-2021 58.0109 549300L0LMLRSZ26QR72 Xtrackers (IE) plc MSCI USA Information Technology UCITS ETF 1D IE00BGQYRS42 11,313,272 USD 25-Feb-2021 60.1325 549300M6JAZI5LWML141 Xtrackers (IE) plc MSCI USA Minimum Volatility UCITS ETF 1D IE00BDB7J586 115,000 USD 25-Feb-2021 42.3387 5493000I1N60EFHBLR44 Xtrackers (IE) plc MSCI USA UCITS ETF 1C IE00BJ0KDR00 51,124,425 USD 25-Feb-2021 108.771 549300J9YPZW8OQXLF38 Xtrackers (IE) plc MSCI World Communication Services UCITS ETF 1C IE00BM67HR47 12,095,797 USD 25-Feb-2021 18.7869 549300RZO14LB1V7K773 Xtrackers (IE) plc MSCI World Consumer Discretionary UCITS ETF 1C IE00BM67HP23 8,737,672 USD 25-Feb-2021 50.3076 549300OF256895TPBN07 Xtrackers (IE) plc MSCI World Consumer Staples UCITS ETF 1C IE00BM67HN09 7,141,417 USD 25-Feb-2021 39.1734 549300SWTOHJYCRTIU71 Xtrackers (IE) plc MSCI World Energy UCITS ETF 1C IE00BM67HM91 9,154,918 USD 25-Feb-2021 27.1399 549300PD0M2UW0Y2XV93 Xtrackers (IE) plc MSCI World ESG UCITS ETF 1C IE00BZ02LR44 50,886,399 USD 25-Feb-2021 29.6158 549300KBPMH7CRUHUW62 Xtrackers (IE) plc MSCI World Financials UCITS ETF 1C IE00BM67HL84 36,765,753 USD 25-Feb-2021 22.2052 54930037UOCTZSIPKX79 Xtrackers (IE) plc MSCI World Health Care UCITS ETF 1C IE00BM67HK77 26,235,527 USD 25-Feb-2021 42.7296 549300J9P50W4IOBWS91 Xtrackers (IE) plc MSCI World High Dividend Yield UCITS ETF 1D IE00BCHWNQ94 4,164,000 USD 25-Feb-2021 20.0384 5493000MMCBYY20QMC86 Xtrackers (IE) plc MSCI World Industrials UCITS ETF 1C IE00BM67HV82 10,722,073 USD 25-Feb-2021 45.0094 549300749B86R75HG635 Xtrackers (IE) plc MSCI World Information Technology UCITS ETF 1C IE00BM67HT60 36,683,748 USD 25-Feb-2021 52.3722 549300CM6KL5NIENK841 Xtrackers (IE) plc MSCI World Materials UCITS ETF 1C IE00BM67HS53 6,762,173 USD 25-Feb-2021 51.7106 5493001RFO47M71FEX43 Xtrackers (IE) plc MSCI World Minimum Volatility UCITS ETF 1C IE00BL25JN58 18,900,000 USD 25-Feb-2021 35.3285 54930014T94RHSFQFQ97 Xtrackers (IE) plc MSCI World Momentum UCITS ETF 1C IE00BL25JP72 10,150,000 USD 25-Feb-2021 49.4673 549300JTUIN0HTFEH791 Xtrackers (IE) plc MSCI World Quality UCITS ETF 1C IE00BL25JL35 7,050,000 USD 25-Feb-2021 48.6911 549300IILXM4ST526335 Xtrackers (IE) plc MSCI World UCITS ETF 1C IE00BJ0KDQ92 81,607,086 USD 25-Feb-2021 82.3969 549300ZPCMJ0UKSMRS71 Xtrackers (IE) plc MSCI World UCITS ETF 1D IE00BK1PV551 14,893,147 USD 25-Feb-2021 74.7674 549300ZPCMJ0UKSMRS71 Xtrackers (IE) plc MSCI World UCITS ETF 2D - GBP Hedged IE00BZ1BS790 3,315,577 GBP 25-Feb-2021 17.6075 549300ZPCMJ0UKSMRS71 Xtrackers (IE) plc MSCI World Utilities UCITS ETF 1C IE00BM67HQ30 2,158,433 USD 25-Feb-2021 28.4528 5493005SK6V4E5KRXN82 Xtrackers (IE) plc MSCI World Value UCITS ETF 1C IE00BL25JM42 16,175,000 USD 25-Feb-2021 35.466 5493003ZC4YBJJRSAX18 Xtrackers (IE) plc NASDAQ 100 UCITS ETF 1C IE00BMFKG444 429,000 USD 25-Feb-2021 29.0357 254900B3YYIAXJ1WEN66 Xtrackers (IE) plc Russell 2000 UCITS ETF 1C IE00BJZ2DD79 6,246,157 USD 25-Feb-2021 310.9473 549300RDZXTM5DJWDC22 Xtrackers (IE) plc Russell Midcap UCITS ETF 1C IE00BJZ2DC62 3,490,808 USD 25-Feb-2021 32.7695 5493001R2VWIV9D4XH46 Xtrackers (IE) plc S&P 500 Equal Weight UCITS ETF 1C IE00BLNMYC90 54,623,226 USD 25-Feb-2021 69.7738 549300K5EREWUG10PC82 Xtrackers (IE) plc S&P 500 UCITS ETF 2C - GBP Hedged IE00BM67HX07 4,395,619 GBP 25-Feb-2021 63.5565 549300NZCAJCKZWK5644 Xtrackers (IE) plc S&P Europe ex UK UCITS ETF 1D IE00BGV5VM45 8,840,000 EUR 25-Feb-2021 57.6295 254900AV94BB0XCLC120 Xtrackers (IE) plc US Treasuries Ultrashort Bond UCITS ETF 1C IE00BM97MR69 170,371 USD 25-Feb-2021 53.574 254900OSQHTSXUWQKZ28 Xtrackers (IE) plc USD Corporate Bond UCITS ETF 1D IE00BZ036H21 56,588,080 USD 25-Feb-2021 16.2502 549300TN3252QWI8QN78 Xtrackers (IE) plc USD High Yield Corporate Bond UCITS ETF 1D IE00BDR5HM97 27,631,303 USD 25-Feb-2021 15.3552 549300XH6DDPBRY7P527 Xtrackers (IE) plc Xtrackers ESG USD Emerging Markets Bond Quality Weighted UCITS ETF 1D IE00BD4DX952 7,070,987 USD 25-Feb-2021 13.6303 549300BQBF21JCBVKV46 This announcement is for information purposes only. Shareholders are not required to take any action. Capitalised terms used in this notice shall have the same meaning ascribed to them in the latest version of the prospectus of the Company (the Prospectus) unless the context otherwise requires. Any further information in relation to the Sub-Funds may be obtained by contacting the x-trackers ETF hotline on +44 (20) 7547 1747 or +49 (69) 910 30549 or by sending an email to [email protected]. Xtrackers (IE) plc Board of directors Contact information Xtrackers (IE) plc 78 Sir John Rogerson's Quay Dublin 2 |
edtsum1820 | You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text.
Text: NEW YORK andMANALAPAN TOWNSHIP, N.J., Sept. 30, 2020 /PRNewswire/ -- Neurotrope, Inc. (Nasdaq: NTRP) and Metuchen Pharmaceuticals, L.L.C.,a privately held biopharmaceutical company focused on innovative therapeutics for men's health conditions ("Metuchen"), today announced that they have entered into an amendment to their definitive merger agreement ("Amended Merger Agreement") under which the consideration due to Neurotrope stockholders will increase to 49% of the combined companyon a pro forma basis and based upon the final Neurotrope common stock share count at close (Under terms of the Merger Agreement dated July 23, 2020, Neurotrope stockholders were to own approximately 22.5% of the combined company.) Neurotrope and Metuchen previously announced their intent to merge in an all-stock transaction resulting to form a NASDAQ-traded holding company to be named Petros Pharmaceuticals, Inc. ("Petros"). As part of the Amended Merger Agreement, Neurotrope shareholders currently representing 34% of the Company's outstanding shares have signed a shareholder rights agreement in support of the merger. Consistent with the original Merger Agreement, under terms of the Amended Merger Agreement, upon closing of the transaction, Neurotrope Bioscience Inc.'s ("NBI") current lead asset, Bryostatin-1 to treat neurodegeneration, and substantially all of its existing assets, operations and liabilities, except for cash retained by Petros in accordance with the terms of the Amended Merger Agreement, will be spun-out into a new, separately traded company. The Amended Merger Agreement has been approved by the boards of directors of both companies. "With this amendment, Neurotrope investors are being offered nearly half ownership in Petros while retaining full interest in NBI, with both companies expected to be publicly traded," said Mr. Silverman. "We believe this provides a far more compelling stake in two distinct opportunities, one continuing the exciting clinical development of Bryostatin-1 in an NIH-supported study in Alzheimer's disease, and the other building on a commercial asset in Stendra with substantial upside potential." As part of the strategy of enhancing value to its existing drug portfolio, Petros will be led by a streamlined management team and will focus on its two core assets: Stendra, a phosphodiesterase-5 (PDE-5) inhibitor and the only oral, patented erectile disfunction (ED) product on the market, as well as H-100, an innovative, non-invasive topical treatment candidate for Peyronie's disease (PD). Petros will be led by Fady Boctor, Chief Commercial Officer of Metuchen, who will be named President and CCO. Mr. Boctor has extensive industry experience in men's health, particularly in the areas of ED and PD. A new board of directors will be installed and John Shulman, Founder and Managing Partner of Juggernaut Capital Partners ("JCP"), a leading private equity firm with over $1 billion in capital commitments, will become Executive Chairman of the Board. In line withPetros' more focused strategy, Charles S. Ryan, J.D., Ph.D., Neurotrope's Chief Executive Officer, will transition to a senior consulting role to Petros. Petros will explore the potential to convert Stendra from prescription-only status to non-prescription status. Stendra is a distinct oral prescription therapeutic that may be taken as early as approximately 15 minutes prior to intimate engagement, with or without food, and has a clinically proven safety profile, including a discontinuation rate due to adverse events comparable to placebo. Petros will partnerwith Foundation Consumer Healthcare ("FCH") in this effort. FCH is a long-time portfolio investment of JCP and is one of the largest pure-play Over-the-Counter ("OTC") companies in the U.S. FCH is dedicated to improving consumers' lives by developing and growing a portfolio of differentiated OTC products, including the single highest selling SKU in the OTC category: Plan B One Step. The company is led by President and CEO Greg Bradley, who has deep industry experience within the OTC healthcare landscape in senior roles at GlaxoSmithKline Consumer Healthcare (GSK) and other organizations. "Erectile dysfunction is a condition that affects 30 million men in the U.S., and yet only 25% of men have accessed ED therapies," said Mr. Boctor. "OTC availability has a long track record of increasing access to well-tolerated and effective medicines. We look forward to exploring this opportunity for Stendra together with Foundation Consumer Healthcare." Neurotrope plans to hold a special meeting of stockholders to approve the pending transaction mid-fourth quarter 2020. The transaction is expected to close shortly thereafter, subject to customary closing conditions, including approval of the amended Merger Agreement by Neurotrope stockholders. Lead Asset Stendra(avanafil) Stendra(avanafil), originally launched by Auxilium Pharmaceuticals prior to that company's sale to Endo Pharmaceuticals, is an oral phosphodiesterase 5 (PDE5) inhibitor for the treatment of ED that can be dosed as early as ~15 minutes before sexual activity, can be taken with or without food, and is well tolerated, with a rate of discontinuation (2.0%) comparable to placebo (1.7%) in clinical trials. Stendrawas designed and developed expressly for erectile dysfunction. Metuchen recently undertook a relaunch of Stendra, following Juggernaut's acquisition of a majority position in Metuchen in 2018, generating gross revenues of approximately $30 million in 2019. Upon closing of the merger, Petros intends to accelerate the relaunch of Stendrawith a well-funded commercial organization and refocused strategy. Currently, Stendrais covered for 75% of commercially insured lives, with a co-pay as low as $0. Lead Pipeline Program H100 Metuchen's lead pipeline program includes the recently in-licensed drug candidate H-100, a non-invasive, compounded, topical treatment for Peyronie's disease (PD). In its current formulation, H-100 demonstrated positive efficacy and tolerability in a 22 patient prospective, randomized, double-blind, placebo-controlled study in patients with PD. Metuchen intends to optimize manufacturing and the patented formulation of H-100, then seek FDA guidance on the studies necessary to achieve approval and labeling of the product. PD is a progressive, wound-healing disorder of the penis involving the formation of plaques and the subsequent development of penile curvature or indentations. The current non-surgical standard of care in PD, an injectable, was granted Orphan Designation by the FDA in 1996. "As a topical treatment, we believe H-100 can have a transformative effect on the management of a disease that causes pain, anxiety and psychological distress," said Fady Boctor, Chief Commercial Officer of Metuchen. "Our goal is to deliver on this promise rapidly and cost effectively with a proprietary, clinically validated therapeutic." About STENDRA(avanafil) STENDRA(avanafil) is approved in the U.S. by the FDA for the treatment of erectile dysfunction. Metuchen Pharmaceuticals LLC has exclusive marketing rights to STENDRAin the U.S., Canada, South America and India. STENDRAis available through retail and mail order pharmacies. For more information about STENDRA, please visitwww.STENDRA.com. Important Safety Information STENDRA(avanafil) is prescribed to treat erectile dysfunction (ED). Do not take STENDRAif you take nitrates, often prescribed for chest pain, as this may cause a sudden, unsafe drop in blood pressure. Discuss your general health status with your healthcare provider to ensure that you are healthy enough to engage in sexual activity. If you experience chest pain, nausea, or any other discomforts during sex, seek immediate medical help. STENDRAmay affect the way other medicines work. Tell your healthcare provider if you take any of the following; medicines called HIV protease inhibitors, such as ritonavir (Norvir), indinavir (Crixivan), saquinavir (Fortavase or Invirase) or atazanavir (Reyataz); some types of oral antifungal medicines, such as ketoconazole (Nizoral), and itraconazole (Sporanox); or some types of antibiotics, such as clarithromycin (Biaxin), telithromycin (Ketek), or erythromycin. In the rare event of an erection lasting more than 4 hours, seek immediate medical help to avoid long-term injury. In rare instances, men taking PDE5 inhibitors (oral erectile dysfunction medicines, including STENDRA) reported a sudden decrease or loss of vision. It is not possible to determine whether these events are related directly to these medicines or to other factors. If you experience sudden decrease or loss of vision, stop taking PDE5 inhibitors, including STENDRA, and call a doctor right away. Sudden decrease or loss of hearing has been rarely reported in people taking PDE5 inhibitors, including STENDRA. It is not possible to determine whether these events are related directly to the PDE5 inhibitors or to other factors. If you experience sudden decrease or loss of hearing, stop taking STENDRAand contact a doctor right away. If you have prostate problems or high blood pressure for which you take medicines called alpha blockers or other anti-hypertensives, your doctor may start you on a lower dose of STENDRA. Drinking too much alcohol when taking STENDRAmay lead to headache, dizziness, and lower blood pressure. STENDRAin combination with other treatments for ED is not recommended. STENDRAdoes not protect against sexually transmitted diseases, including HIV. The most common side effects of STENDRAare headache, flushing, runny nose and congestion. Please see full patient prescribing information for STENDRA(50 mg, 100 mg, 200 mg) tablets. About Neurotrope Bioscience, Inc. NBI is a clinical-stage biopharmaceutical company that has historically worked to develop novel therapies for neurodegenerative diseases. NBI has conducted clinical and preclinical studies of its lead therapeutic candidate, Bryostatin-1, in Alzheimer's disease, and preclinical studies for rare diseases and brain injury, including Fragile X syndrome, multiple sclerosis, stroke, Niemann-Pick Type C disease, Rett syndrome, and traumatic brain injury. The FDA has granted Orphan Drug Designation to NBI for Bryostatin-1 as a treatment for Fragile X syndrome. Bryostatin-1 has already undergone testing in more than 1,500 people in cancer studies, thus creating a large safety data base that will further inform clinical trial designs. Additional information about Neurotrope may be found on its website:www.neurotrope.com. About Metuchen Pharmaceuticals Metuchen pharmaceuticals is committed to becoming the world's leading men's health company by identifying, developing, acquiring, and commercializing innovative therapeutics for men's health issues including, but not limited to erectile dysfunction, endothelial dysfunction, psychosexual and psychosocial ailments, Peyronie's disease (acute and chronic), hormone health and substance use disorders. No Offer or Solicitation This communication shall not constitute an offer to sell or the solicitation of an offer to sell or the solicitation of an offer to buy any securities, nor shall there be any sale of securities in any jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such jurisdiction. No public offer of securities shall be made except by means of a prospectus meeting the requirements of Section 10 of the Securities Act of 1933, as amended. Important Additional Information Will be Filed with the SEC In connection with the proposed transaction between Petros, Neurotrope and Metuchen, Petros intends to file relevant materials with the SEC, including a registration statement that will contain a proxy statement and prospectus. BEFORE MAKING ANY VOTING OR INVESTMENT DECISION, INVESTORS AND STOCKHOLDERS ARE URGED TO READ THE PROXY STATEMENT/PROSPECTUS (INCLUDING ANY AMENDMENTS OR SUPPLEMENTS THERETO) AND ANY OTHER RELEVANT DOCUMENTS THAT NEUROTROPE MAY FILE WITH THE SEC WHEN THEY BECOME AVAILABLE BECAUSE THEY WILL CONTAIN IMPORTANT INFORMATION ABOUT THE PROPOSED TRANSACTIONS. Stockholders may obtain, free of charge, copies of the definitive proxy statement/prospectus and any other documents filed by Petros with the SEC in connection with the proposed transactions at the SEC's website (www.sec.gov), at Neurotrope's website:www.neurotrope.com, or by directing written request to: Neurotrope, Inc.,1185 Avenue of the Americas, 3rd Floor, New York, New York 10036, Attention: Robert Weinstein. Participants in the Solicitation Petros, Neurotrope, Metuchen and their respective directors and executive officers may be deemed to be participants in the solicitation of proxies from the stockholders of Neurotrope in connection with the proposed transaction. Information regarding the special interests of these directors and executive officers in the merger will be included in the proxy statement/prospectus referred to above. Additional information regarding the directors and executive officers of Neurotrope is also included in Neurotrope's Annual Report on Form 10-K for the year ended December 31, 2019, filed with the SEC on March 13, 2020. This document is available free of charge at the SEC web site (www.sec.gov), at Neurotrope's website, or by directing a written request to Neurotrope as described above. Cautionary Note Regarding Forward-Looking Statements Any statements contained in this press release that do not describe historical facts may constitute forward-looking statements. These forward-looking statements include statements regarding Petros, Neurotrope, Metuchen, the combined company, the proposed transaction and other matters. Such forward-looking statements are subject to risks and uncertainties and other influences, many of which Neurotrope has no control over. Actual results and the timing of certain events and circumstances may differ materially from those described by the forward-looking statements as a result of these risks and uncertainties, including, without limitation: the risk that the conditions to the closing of the proposed transactions are not satisfied, including the failure to obtain stockholder approval for the proposed transactions in a timely manner or at all; uncertainties as to the timing of the consummation of the proposed transactions and the ability of each of Petros, Neurotrope and Metuchen to consummate the proposed transactions; risks related to Petros' initial listing on The Nasdaq Capital Market at the closing of the proposed transactions; risks related to Neurotrope's ability to correctly estimate its operating expenses and its expenses associated with the proposed transactions; the ability of Neurotrope or Metuchen to protect their respective intellectual property rights; competitive responses to the transaction; unexpected costs, charges or expenses resulting from the proposed transactions; potential adverse reactions or changes to business relationships resulting from the announcement or completion of the proposed transactions; and legislative, regulatory, political and economic developments; expectations regarding the industry and business operations of Petros. The foregoing review of important factors that could cause actual events to differ from expectations should not be construed as exhaustive and should be read in conjunction with statements that are included herein and elsewhere, including Neurotrope's filings with the Securities and Exchange Commission, including Neurotrope's Annual Report on Form 10-K for the year ended December 31, 2019, Quarterly Reports on Form 10-Q and Current Reports on Form 8-K filed with the SEC. Neurotrope can give no assurance that the conditions to the proposed transactions will be satisfied. Except as required by applicable law, Neurotrope does not undertake to update these forward-looking statements. Contact information: Investors and MediaLisa SherArgot Partners[emailprotected] 212-600-1902 Juggernaut/MetuchenDeirdre WalshAbernathy MacGregor[emailprotected] 212-371-5999 SOURCE Neurotrope, Inc. Related Links https://neurotrope.com/
Answer: | Neurotrope Shareholders to Own 49 Percent of Petros Under Revised Merger Agreement with Metuchen | NEW YORK andMANALAPAN TOWNSHIP, N.J., Sept. 30, 2020 /PRNewswire/ -- Neurotrope, Inc. (Nasdaq: NTRP) and Metuchen Pharmaceuticals, L.L.C.,a privately held biopharmaceutical company focused on innovative therapeutics for men's health conditions ("Metuchen"), today announced that they have entered into an amendment to their definitive merger agreement ("Amended Merger Agreement") under which the consideration due to Neurotrope stockholders will increase to 49% of the combined companyon a pro forma basis and based upon the final Neurotrope common stock share count at close (Under terms of the Merger Agreement dated July 23, 2020, Neurotrope stockholders were to own approximately 22.5% of the combined company.) Neurotrope and Metuchen previously announced their intent to merge in an all-stock transaction resulting to form a NASDAQ-traded holding company to be named Petros Pharmaceuticals, Inc. ("Petros"). As part of the Amended Merger Agreement, Neurotrope shareholders currently representing 34% of the Company's outstanding shares have signed a shareholder rights agreement in support of the merger. Consistent with the original Merger Agreement, under terms of the Amended Merger Agreement, upon closing of the transaction, Neurotrope Bioscience Inc.'s ("NBI") current lead asset, Bryostatin-1 to treat neurodegeneration, and substantially all of its existing assets, operations and liabilities, except for cash retained by Petros in accordance with the terms of the Amended Merger Agreement, will be spun-out into a new, separately traded company. The Amended Merger Agreement has been approved by the boards of directors of both companies. "With this amendment, Neurotrope investors are being offered nearly half ownership in Petros while retaining full interest in NBI, with both companies expected to be publicly traded," said Mr. Silverman. "We believe this provides a far more compelling stake in two distinct opportunities, one continuing the exciting clinical development of Bryostatin-1 in an NIH-supported study in Alzheimer's disease, and the other building on a commercial asset in Stendra with substantial upside potential." As part of the strategy of enhancing value to its existing drug portfolio, Petros will be led by a streamlined management team and will focus on its two core assets: Stendra, a phosphodiesterase-5 (PDE-5) inhibitor and the only oral, patented erectile disfunction (ED) product on the market, as well as H-100, an innovative, non-invasive topical treatment candidate for Peyronie's disease (PD). Petros will be led by Fady Boctor, Chief Commercial Officer of Metuchen, who will be named President and CCO. Mr. Boctor has extensive industry experience in men's health, particularly in the areas of ED and PD. A new board of directors will be installed and John Shulman, Founder and Managing Partner of Juggernaut Capital Partners ("JCP"), a leading private equity firm with over $1 billion in capital commitments, will become Executive Chairman of the Board. In line withPetros' more focused strategy, Charles S. Ryan, J.D., Ph.D., Neurotrope's Chief Executive Officer, will transition to a senior consulting role to Petros. Petros will explore the potential to convert Stendra from prescription-only status to non-prescription status. Stendra is a distinct oral prescription therapeutic that may be taken as early as approximately 15 minutes prior to intimate engagement, with or without food, and has a clinically proven safety profile, including a discontinuation rate due to adverse events comparable to placebo. Petros will partnerwith Foundation Consumer Healthcare ("FCH") in this effort. FCH is a long-time portfolio investment of JCP and is one of the largest pure-play Over-the-Counter ("OTC") companies in the U.S. FCH is dedicated to improving consumers' lives by developing and growing a portfolio of differentiated OTC products, including the single highest selling SKU in the OTC category: Plan B One Step. The company is led by President and CEO Greg Bradley, who has deep industry experience within the OTC healthcare landscape in senior roles at GlaxoSmithKline Consumer Healthcare (GSK) and other organizations. "Erectile dysfunction is a condition that affects 30 million men in the U.S., and yet only 25% of men have accessed ED therapies," said Mr. Boctor. "OTC availability has a long track record of increasing access to well-tolerated and effective medicines. We look forward to exploring this opportunity for Stendra together with Foundation Consumer Healthcare." Neurotrope plans to hold a special meeting of stockholders to approve the pending transaction mid-fourth quarter 2020. The transaction is expected to close shortly thereafter, subject to customary closing conditions, including approval of the amended Merger Agreement by Neurotrope stockholders. Lead Asset Stendra(avanafil) Stendra(avanafil), originally launched by Auxilium Pharmaceuticals prior to that company's sale to Endo Pharmaceuticals, is an oral phosphodiesterase 5 (PDE5) inhibitor for the treatment of ED that can be dosed as early as ~15 minutes before sexual activity, can be taken with or without food, and is well tolerated, with a rate of discontinuation (2.0%) comparable to placebo (1.7%) in clinical trials. Stendrawas designed and developed expressly for erectile dysfunction. Metuchen recently undertook a relaunch of Stendra, following Juggernaut's acquisition of a majority position in Metuchen in 2018, generating gross revenues of approximately $30 million in 2019. Upon closing of the merger, Petros intends to accelerate the relaunch of Stendrawith a well-funded commercial organization and refocused strategy. Currently, Stendrais covered for 75% of commercially insured lives, with a co-pay as low as $0. Lead Pipeline Program H100 Metuchen's lead pipeline program includes the recently in-licensed drug candidate H-100, a non-invasive, compounded, topical treatment for Peyronie's disease (PD). In its current formulation, H-100 demonstrated positive efficacy and tolerability in a 22 patient prospective, randomized, double-blind, placebo-controlled study in patients with PD. Metuchen intends to optimize manufacturing and the patented formulation of H-100, then seek FDA guidance on the studies necessary to achieve approval and labeling of the product. PD is a progressive, wound-healing disorder of the penis involving the formation of plaques and the subsequent development of penile curvature or indentations. The current non-surgical standard of care in PD, an injectable, was granted Orphan Designation by the FDA in 1996. "As a topical treatment, we believe H-100 can have a transformative effect on the management of a disease that causes pain, anxiety and psychological distress," said Fady Boctor, Chief Commercial Officer of Metuchen. "Our goal is to deliver on this promise rapidly and cost effectively with a proprietary, clinically validated therapeutic." About STENDRA(avanafil) STENDRA(avanafil) is approved in the U.S. by the FDA for the treatment of erectile dysfunction. Metuchen Pharmaceuticals LLC has exclusive marketing rights to STENDRAin the U.S., Canada, South America and India. STENDRAis available through retail and mail order pharmacies. For more information about STENDRA, please visitwww.STENDRA.com. Important Safety Information STENDRA(avanafil) is prescribed to treat erectile dysfunction (ED). Do not take STENDRAif you take nitrates, often prescribed for chest pain, as this may cause a sudden, unsafe drop in blood pressure. Discuss your general health status with your healthcare provider to ensure that you are healthy enough to engage in sexual activity. If you experience chest pain, nausea, or any other discomforts during sex, seek immediate medical help. STENDRAmay affect the way other medicines work. Tell your healthcare provider if you take any of the following; medicines called HIV protease inhibitors, such as ritonavir (Norvir), indinavir (Crixivan), saquinavir (Fortavase or Invirase) or atazanavir (Reyataz); some types of oral antifungal medicines, such as ketoconazole (Nizoral), and itraconazole (Sporanox); or some types of antibiotics, such as clarithromycin (Biaxin), telithromycin (Ketek), or erythromycin. In the rare event of an erection lasting more than 4 hours, seek immediate medical help to avoid long-term injury. In rare instances, men taking PDE5 inhibitors (oral erectile dysfunction medicines, including STENDRA) reported a sudden decrease or loss of vision. It is not possible to determine whether these events are related directly to these medicines or to other factors. If you experience sudden decrease or loss of vision, stop taking PDE5 inhibitors, including STENDRA, and call a doctor right away. Sudden decrease or loss of hearing has been rarely reported in people taking PDE5 inhibitors, including STENDRA. It is not possible to determine whether these events are related directly to the PDE5 inhibitors or to other factors. If you experience sudden decrease or loss of hearing, stop taking STENDRAand contact a doctor right away. If you have prostate problems or high blood pressure for which you take medicines called alpha blockers or other anti-hypertensives, your doctor may start you on a lower dose of STENDRA. Drinking too much alcohol when taking STENDRAmay lead to headache, dizziness, and lower blood pressure. STENDRAin combination with other treatments for ED is not recommended. STENDRAdoes not protect against sexually transmitted diseases, including HIV. The most common side effects of STENDRAare headache, flushing, runny nose and congestion. Please see full patient prescribing information for STENDRA(50 mg, 100 mg, 200 mg) tablets. About Neurotrope Bioscience, Inc. NBI is a clinical-stage biopharmaceutical company that has historically worked to develop novel therapies for neurodegenerative diseases. NBI has conducted clinical and preclinical studies of its lead therapeutic candidate, Bryostatin-1, in Alzheimer's disease, and preclinical studies for rare diseases and brain injury, including Fragile X syndrome, multiple sclerosis, stroke, Niemann-Pick Type C disease, Rett syndrome, and traumatic brain injury. The FDA has granted Orphan Drug Designation to NBI for Bryostatin-1 as a treatment for Fragile X syndrome. Bryostatin-1 has already undergone testing in more than 1,500 people in cancer studies, thus creating a large safety data base that will further inform clinical trial designs. Additional information about Neurotrope may be found on its website:www.neurotrope.com. About Metuchen Pharmaceuticals Metuchen pharmaceuticals is committed to becoming the world's leading men's health company by identifying, developing, acquiring, and commercializing innovative therapeutics for men's health issues including, but not limited to erectile dysfunction, endothelial dysfunction, psychosexual and psychosocial ailments, Peyronie's disease (acute and chronic), hormone health and substance use disorders. No Offer or Solicitation This communication shall not constitute an offer to sell or the solicitation of an offer to sell or the solicitation of an offer to buy any securities, nor shall there be any sale of securities in any jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such jurisdiction. No public offer of securities shall be made except by means of a prospectus meeting the requirements of Section 10 of the Securities Act of 1933, as amended. Important Additional Information Will be Filed with the SEC In connection with the proposed transaction between Petros, Neurotrope and Metuchen, Petros intends to file relevant materials with the SEC, including a registration statement that will contain a proxy statement and prospectus. BEFORE MAKING ANY VOTING OR INVESTMENT DECISION, INVESTORS AND STOCKHOLDERS ARE URGED TO READ THE PROXY STATEMENT/PROSPECTUS (INCLUDING ANY AMENDMENTS OR SUPPLEMENTS THERETO) AND ANY OTHER RELEVANT DOCUMENTS THAT NEUROTROPE MAY FILE WITH THE SEC WHEN THEY BECOME AVAILABLE BECAUSE THEY WILL CONTAIN IMPORTANT INFORMATION ABOUT THE PROPOSED TRANSACTIONS. Stockholders may obtain, free of charge, copies of the definitive proxy statement/prospectus and any other documents filed by Petros with the SEC in connection with the proposed transactions at the SEC's website (www.sec.gov), at Neurotrope's website:www.neurotrope.com, or by directing written request to: Neurotrope, Inc.,1185 Avenue of the Americas, 3rd Floor, New York, New York 10036, Attention: Robert Weinstein. Participants in the Solicitation Petros, Neurotrope, Metuchen and their respective directors and executive officers may be deemed to be participants in the solicitation of proxies from the stockholders of Neurotrope in connection with the proposed transaction. Information regarding the special interests of these directors and executive officers in the merger will be included in the proxy statement/prospectus referred to above. Additional information regarding the directors and executive officers of Neurotrope is also included in Neurotrope's Annual Report on Form 10-K for the year ended December 31, 2019, filed with the SEC on March 13, 2020. This document is available free of charge at the SEC web site (www.sec.gov), at Neurotrope's website, or by directing a written request to Neurotrope as described above. Cautionary Note Regarding Forward-Looking Statements Any statements contained in this press release that do not describe historical facts may constitute forward-looking statements. These forward-looking statements include statements regarding Petros, Neurotrope, Metuchen, the combined company, the proposed transaction and other matters. Such forward-looking statements are subject to risks and uncertainties and other influences, many of which Neurotrope has no control over. Actual results and the timing of certain events and circumstances may differ materially from those described by the forward-looking statements as a result of these risks and uncertainties, including, without limitation: the risk that the conditions to the closing of the proposed transactions are not satisfied, including the failure to obtain stockholder approval for the proposed transactions in a timely manner or at all; uncertainties as to the timing of the consummation of the proposed transactions and the ability of each of Petros, Neurotrope and Metuchen to consummate the proposed transactions; risks related to Petros' initial listing on The Nasdaq Capital Market at the closing of the proposed transactions; risks related to Neurotrope's ability to correctly estimate its operating expenses and its expenses associated with the proposed transactions; the ability of Neurotrope or Metuchen to protect their respective intellectual property rights; competitive responses to the transaction; unexpected costs, charges or expenses resulting from the proposed transactions; potential adverse reactions or changes to business relationships resulting from the announcement or completion of the proposed transactions; and legislative, regulatory, political and economic developments; expectations regarding the industry and business operations of Petros. The foregoing review of important factors that could cause actual events to differ from expectations should not be construed as exhaustive and should be read in conjunction with statements that are included herein and elsewhere, including Neurotrope's filings with the Securities and Exchange Commission, including Neurotrope's Annual Report on Form 10-K for the year ended December 31, 2019, Quarterly Reports on Form 10-Q and Current Reports on Form 8-K filed with the SEC. Neurotrope can give no assurance that the conditions to the proposed transactions will be satisfied. Except as required by applicable law, Neurotrope does not undertake to update these forward-looking statements. Contact information: Investors and MediaLisa SherArgot Partners[emailprotected] 212-600-1902 Juggernaut/MetuchenDeirdre WalshAbernathy MacGregor[emailprotected] 212-371-5999 SOURCE Neurotrope, Inc. Related Links https://neurotrope.com/ |
edtsum1823 | You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text.
Text: LONDON--(BUSINESS WIRE)-- DB ETC plc COMPANY ANNOUNCEMENT Immediate Release 20 April 2021 DB ETC plc (the Issuer) (Incorporated and registered in Jersey under the Companies (Jersey) Law 1991 (as amended) with registered number 103781) Re: Buy-Back of ETC Securities Announcement The Issuer has agreed to buy back the ETC Securities for the following Series as set out in the table below. Series Number of Securities to be bought back Trade Date Settlement Date ISIN: Series 08 - Xtrackers Physical Palladium EUR Hedged ETC 47,000 16 April 2021 20 April 2021 DE000A1EK3B8 Series 09 - Xtrackers Physical Gold ETC (EUR) 70,000 16 April 2021 20 April 2021 DE000A1E0HR8 Series 13 - Xtrackers Physical Gold GBP Hedged ETC 1,100,000 16 April 2021 20 April 2021 GB00B68FL050 Following the buy-back of the ETC Securities described above, the total number DB ETC plc ETC Securities in issue in relation to this Series will be: Series 08 - Xtrackers Physical Palladium EUR Hedged ETC 170,927 Series 09 - Xtrackers Physical Gold ETC (EUR) 19,084,997 Series 13 - Xtrackers Physical Gold GBP Hedged ETC 16,595,345 Issuer Name LEI DB ETC plc 549300SNVSPBXF55RX28 Enquiries to: [email protected] DB ETC plc
Answer: | Buy-Back of Securities | LONDON--(BUSINESS WIRE)-- DB ETC plc COMPANY ANNOUNCEMENT Immediate Release 20 April 2021 DB ETC plc (the Issuer) (Incorporated and registered in Jersey under the Companies (Jersey) Law 1991 (as amended) with registered number 103781) Re: Buy-Back of ETC Securities Announcement The Issuer has agreed to buy back the ETC Securities for the following Series as set out in the table below. Series Number of Securities to be bought back Trade Date Settlement Date ISIN: Series 08 - Xtrackers Physical Palladium EUR Hedged ETC 47,000 16 April 2021 20 April 2021 DE000A1EK3B8 Series 09 - Xtrackers Physical Gold ETC (EUR) 70,000 16 April 2021 20 April 2021 DE000A1E0HR8 Series 13 - Xtrackers Physical Gold GBP Hedged ETC 1,100,000 16 April 2021 20 April 2021 GB00B68FL050 Following the buy-back of the ETC Securities described above, the total number DB ETC plc ETC Securities in issue in relation to this Series will be: Series 08 - Xtrackers Physical Palladium EUR Hedged ETC 170,927 Series 09 - Xtrackers Physical Gold ETC (EUR) 19,084,997 Series 13 - Xtrackers Physical Gold GBP Hedged ETC 16,595,345 Issuer Name LEI DB ETC plc 549300SNVSPBXF55RX28 Enquiries to: [email protected] DB ETC plc |
edtsum1830 | You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text.
Text: NEW YORK, March 9, 2021 /PRNewswire/ --Today, Sony Music Publishing announced the promotion of Tom Foley to Senior Vice President, Worldwide Portfolio Management and Analysis. Based in the company's Nashville office, Foley reports to Sony Music Publishing Global Chief Financial Officer, Tom Kelly.In his new role, Tom is responsible for providing analysis on the performance of the company's investments around the world and working with regional and local management teams to maximize investment returns. (PRNewsfoto/Sony Music Publishing) Sony Music Publishing Global Chief Financial Officer, Tom Kelly said "Tom has been a vital and dedicated member of our team since he began at EMI Music Publishing in 1998 his knowledge and expertise have helped us adapt to the industry's ever-changing landscape and I'm confident he will create more growth opportunities for our roster in this new role." Tom Foley said, "I am very excited to continue working with Tom and Jon, who have guided and mentored me throughout my career. I look forward to helping them deliver for Sony Music Publishing and its songwriters the greatest value for their catalogues in an ever growing and evolving music marketplace."Previously, Tom held the position of Vice President, North American Royalty Administration in Nashville, where he helped his team implement several new technologies, such as Real-Time Foreign accounting and Cash Out. He first joined Sony from EMI in 2013 as Vice President of Financial Planning and Analysis, where he led the department during period of rapid expansion after the EMI Music Publishing acquisition. He originally began working at EMI Music Publishing in 1998, holding various roles in royalties and finance. Tom is a graduate of Georgetown University with a degree in business administration.SOURCE Sony Music Publishing
Answer: | Sony Music Publishing Promotes Tom Foley to SVP, Worldwide Portfolio Management and Analysis | NEW YORK, March 9, 2021 /PRNewswire/ --Today, Sony Music Publishing announced the promotion of Tom Foley to Senior Vice President, Worldwide Portfolio Management and Analysis. Based in the company's Nashville office, Foley reports to Sony Music Publishing Global Chief Financial Officer, Tom Kelly.In his new role, Tom is responsible for providing analysis on the performance of the company's investments around the world and working with regional and local management teams to maximize investment returns. (PRNewsfoto/Sony Music Publishing) Sony Music Publishing Global Chief Financial Officer, Tom Kelly said "Tom has been a vital and dedicated member of our team since he began at EMI Music Publishing in 1998 his knowledge and expertise have helped us adapt to the industry's ever-changing landscape and I'm confident he will create more growth opportunities for our roster in this new role." Tom Foley said, "I am very excited to continue working with Tom and Jon, who have guided and mentored me throughout my career. I look forward to helping them deliver for Sony Music Publishing and its songwriters the greatest value for their catalogues in an ever growing and evolving music marketplace."Previously, Tom held the position of Vice President, North American Royalty Administration in Nashville, where he helped his team implement several new technologies, such as Real-Time Foreign accounting and Cash Out. He first joined Sony from EMI in 2013 as Vice President of Financial Planning and Analysis, where he led the department during period of rapid expansion after the EMI Music Publishing acquisition. He originally began working at EMI Music Publishing in 1998, holding various roles in royalties and finance. Tom is a graduate of Georgetown University with a degree in business administration.SOURCE Sony Music Publishing |
edtsum1832 | You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text.
Text: LOS ANGELES, Dec. 1, 2020 /PRNewswire/ -- Entertainment law firmRamo Law PCannounced today that the firm is included in theLos Angeles Business Journal's 2020 list of 'Most Admired Law Firms.' The journal's Publisher and CEO Josh Schimmels says the list of LA's top firms to work for is comprised of "particularly outstanding law firms who are consciously working towards creating diverse, positive, and supportive environments to help dive the success of their attorneys." "It's an honor to receive this recognition surrounding such an important topic," said Founding Partner Elsa Ramo. "We strive to create an inclusive environment for allour attorneys, our administrative professionals and our clients." According to the publication, the factors considered in establishing the list included diversity and women's initiatives, company culture, employee compensation, benefits, programs, and work-life balance. Ramo Law is a boutique firm comprised of people of different race, gender and socioeconomic backgrounds with a common passion and goal of providing the best quality service in the entertainment industry. "Employees understand the competitive nature of the industry and treat each call, e-mail and interaction with care to ensure the firm retains its reputation as one of the best in the business," says the feature. "The culture of the firm is that its people work hard but know how to laugh and play hard as well. Historically (pre-COVID), Ramo Law sponsored Pizza Fridays; brought in manicurists and a barber for an appreciation event; rented out a cabin at Sundance so the firm could celebrate their projects, network and ski together; did an Escape Room competition to celebrate two senior associate promotions; and for the past 14 years the firm has thrown an epic holiday party with over 500 clients, colleagues and friends." Ramo founded the firm in 2005 on the Universal Studios backlot after several clients approached her to handle their independent productions. Now as managing partner to the firm, she handles client matters as well as manages the firm's attorneys and packaging and sales department. The firm's original concentration was for traditionally financed independent films, but this past year the firm has handled financing, production and distribution legal for a variety of projects. 2020 transformed the firm's practice further to include representation of various forms of content providers who are negotiating deals with all subscription services including Disney+, Netflix, Apple and HBO Max. In 2020, Ramo Law was featured by the Daily Journal in its list of 'Top Boutique Law Firms.' The firm's three partners were named to Variety's "Legal Impact Report" in both 2020 and 2019 and this year Ramo was recognized as a nominee for the Los Angeles Business Journal's "Women's Leadership Award" and "Leaders in Law Award". To read the firm's profile in the Los Angeles Business Journal's Most Admired Law Firms special edition, visit here. With offices in Los Angeles and New York City, Ramo Law PC provides comprehensive legal services to its clients in the entertainment industry with a specialized focus in representing financiers, producers, and production entities in film, television and digital content. The firm provides experienced legal services to optimize its clients' financial, legal and business position in the financing, production and exploitation of their content. For more information, visit RamoLaw.com. SOURCE Ramo Law PC Related Links https://www.ramolawpc.com/
Answer: | Ramo Law Named to the Los Angeles Business Journal's List of Most Admired Law Firms | LOS ANGELES, Dec. 1, 2020 /PRNewswire/ -- Entertainment law firmRamo Law PCannounced today that the firm is included in theLos Angeles Business Journal's 2020 list of 'Most Admired Law Firms.' The journal's Publisher and CEO Josh Schimmels says the list of LA's top firms to work for is comprised of "particularly outstanding law firms who are consciously working towards creating diverse, positive, and supportive environments to help dive the success of their attorneys." "It's an honor to receive this recognition surrounding such an important topic," said Founding Partner Elsa Ramo. "We strive to create an inclusive environment for allour attorneys, our administrative professionals and our clients." According to the publication, the factors considered in establishing the list included diversity and women's initiatives, company culture, employee compensation, benefits, programs, and work-life balance. Ramo Law is a boutique firm comprised of people of different race, gender and socioeconomic backgrounds with a common passion and goal of providing the best quality service in the entertainment industry. "Employees understand the competitive nature of the industry and treat each call, e-mail and interaction with care to ensure the firm retains its reputation as one of the best in the business," says the feature. "The culture of the firm is that its people work hard but know how to laugh and play hard as well. Historically (pre-COVID), Ramo Law sponsored Pizza Fridays; brought in manicurists and a barber for an appreciation event; rented out a cabin at Sundance so the firm could celebrate their projects, network and ski together; did an Escape Room competition to celebrate two senior associate promotions; and for the past 14 years the firm has thrown an epic holiday party with over 500 clients, colleagues and friends." Ramo founded the firm in 2005 on the Universal Studios backlot after several clients approached her to handle their independent productions. Now as managing partner to the firm, she handles client matters as well as manages the firm's attorneys and packaging and sales department. The firm's original concentration was for traditionally financed independent films, but this past year the firm has handled financing, production and distribution legal for a variety of projects. 2020 transformed the firm's practice further to include representation of various forms of content providers who are negotiating deals with all subscription services including Disney+, Netflix, Apple and HBO Max. In 2020, Ramo Law was featured by the Daily Journal in its list of 'Top Boutique Law Firms.' The firm's three partners were named to Variety's "Legal Impact Report" in both 2020 and 2019 and this year Ramo was recognized as a nominee for the Los Angeles Business Journal's "Women's Leadership Award" and "Leaders in Law Award". To read the firm's profile in the Los Angeles Business Journal's Most Admired Law Firms special edition, visit here. With offices in Los Angeles and New York City, Ramo Law PC provides comprehensive legal services to its clients in the entertainment industry with a specialized focus in representing financiers, producers, and production entities in film, television and digital content. The firm provides experienced legal services to optimize its clients' financial, legal and business position in the financing, production and exploitation of their content. For more information, visit RamoLaw.com. SOURCE Ramo Law PC Related Links https://www.ramolawpc.com/ |
edtsum1833 | You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text.
Text: SANTA ANA, Calif., March 29, 2021 /PRNewswire/ --Inc. magazine this month revealed that SkillsetGroup, a dynamic staffing company focusing on manufacturing, engineering, IT and technical staffing is not only the fastest-growing staffing company in California for a fourth year running, but its high on the list of fastest-growing companies in the state, overall. Inc. places SkillSet at 36 on its second annual Inc. 5000 Regionals: California, a list of the most prestigious of the fastest-growing California-based private companies. Born of the annual Inc. 5000 franchise, this regional list represents a unique look at the most successful companies within the California economy's most dynamic segmentits independent small businesses. "We're proud of our SkillsetGroup team members, who have outperformed themselves year after year," said founder and CEO Clint Armstrong. "While many businesses were decimated or shuttered by the COVID-19 pandemic, we thrived as our mission of creating a culture of long-term retention helped stabilize our revenues and grow our customer base. We opened a new office in Riverside in 2020. This year, we're poised to occupy a new, local headquarters and expand out-of-state to Texas and Nevada." The companies on the Inc. list show stunning rates of growth across all industries in California. Between 2017 and 2019, these 250 private companies had an average growth rate of 535 percent and, in 2019 alone, they employed more than 40,000 people and added nearly $7 billion to the California economy. SkillsetGroup nearly doubled its revenue from $24 million in 2019 to $47 million in 2020, despite economic pressures of the pandemic. This year, the company predicts revenues reaching $68 million, Armstrong said. Complete results of the Inc. 5000 Regionals: California, including company profiles and an interactive database that can be sorted by industry, metro area, and other criteria, can be found at https://www.inc.com/inc5000/regionals/california About SkillsetGroup: Founded in Orange County in 2013 and headquartered in Santa Ana, Skillset has locations in Commerce, Riverside, Santa Fe Springs and Paramount with nearly 100 internal employees. From accounting to aerospace, from executive search to unskilled labor, Skillset can serve all your staffing and HR/payroll outsourcing needs, no matter what skillset the job requires. SOURCE SkillsetGroup Related Links https://skillsetgroup.com/
Answer: | 'Fastest-Growing' California Staffing Firm SkillsetGroup Nearly Doubles Revenue | SANTA ANA, Calif., March 29, 2021 /PRNewswire/ --Inc. magazine this month revealed that SkillsetGroup, a dynamic staffing company focusing on manufacturing, engineering, IT and technical staffing is not only the fastest-growing staffing company in California for a fourth year running, but its high on the list of fastest-growing companies in the state, overall. Inc. places SkillSet at 36 on its second annual Inc. 5000 Regionals: California, a list of the most prestigious of the fastest-growing California-based private companies. Born of the annual Inc. 5000 franchise, this regional list represents a unique look at the most successful companies within the California economy's most dynamic segmentits independent small businesses. "We're proud of our SkillsetGroup team members, who have outperformed themselves year after year," said founder and CEO Clint Armstrong. "While many businesses were decimated or shuttered by the COVID-19 pandemic, we thrived as our mission of creating a culture of long-term retention helped stabilize our revenues and grow our customer base. We opened a new office in Riverside in 2020. This year, we're poised to occupy a new, local headquarters and expand out-of-state to Texas and Nevada." The companies on the Inc. list show stunning rates of growth across all industries in California. Between 2017 and 2019, these 250 private companies had an average growth rate of 535 percent and, in 2019 alone, they employed more than 40,000 people and added nearly $7 billion to the California economy. SkillsetGroup nearly doubled its revenue from $24 million in 2019 to $47 million in 2020, despite economic pressures of the pandemic. This year, the company predicts revenues reaching $68 million, Armstrong said. Complete results of the Inc. 5000 Regionals: California, including company profiles and an interactive database that can be sorted by industry, metro area, and other criteria, can be found at https://www.inc.com/inc5000/regionals/california About SkillsetGroup: Founded in Orange County in 2013 and headquartered in Santa Ana, Skillset has locations in Commerce, Riverside, Santa Fe Springs and Paramount with nearly 100 internal employees. From accounting to aerospace, from executive search to unskilled labor, Skillset can serve all your staffing and HR/payroll outsourcing needs, no matter what skillset the job requires. SOURCE SkillsetGroup Related Links https://skillsetgroup.com/ |
edtsum1834 | You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text.
Text: EDISON, N.J.--(BUSINESS WIRE)--Seven and Eight Biopharmaceuticals Inc., a clinical stage biotechnology company focused on developing proprietary novel immuno-oncology therapies to activate the immune system against cancer, today announced the acceptance of an abstract for a poster discussion presentation at the 2021 American Society of Clinical Oncology (ASCO) Annual Meeting. The abstract details additional interim safety and efficacy results for a phase 1 study of BDB001, an intravenously administered toll-like receptor 7 and 8 (TLR7/8) agonist, in combination with pembrolizumab in advanced solid tumors (NCT03486301). We are excited to share additional information about BDB001 in combination with pembrolizumab at the 2021 ASCO Annual Meeting, said Dr. Robert H.I. Andtbacka, Chief Medical Officer, Seven and Eight Biopharma. This builds upon the promising monotherapy data we reported on recently and helps illustrate the potential for BDB001 in combination with anti-PD-(L)1 therapies in difficult to treat tumors. The ASCO Annual Meeting will be held virtually on June 4-8, 2021 and showcases innovative scientific research in clinical oncology and advancements in cancer therapy. Details on Seven and Eight Biopharmas poster discussion presentation: Abstract Title: BDB001, an intravenously administered toll-like receptor 7 and 8 (TLR7/8) agonist, in combination with pembrolizumab in advanced solid tumors: Phase 1 safety and efficacy results. Session Title: Poster Discussion Session, Developmental TherapeuticsImmunotherapy On-Demand Session Release Date and Time: 6/4/2021, 9:00 AM-10:00 AM Abstract Number for Publication: 2512 This year, ASCO reviewed more than 5,400 abstracts for the 2021 ASCO Annual Meeting. More information about the meeting may be accessed at https://meetings.asco.org/am/ . According to ASCOs Embargo Policy, abstracts will be released to the public on ASCOs Meeting Library at 5:00 p.m. ET on May 19, 2021. About Seven and Eight Biopharma Seven and Eight Biopharmaceuticals Inc. is an Edison, New Jersey based, clinical stage biotechnology company focused on the development and commercialization of novel immunotherapies for cancer. The company specializes in TLR7/8 programs to treat cancer and has built a comprehensive global intellectual property portfolio in the category of toll-like receptor modulators. Managed by a seasoned team of professionals, the company is progressing a proprietary pipeline of cancer therapeutics in the U.S., with the lead product BDB001 in Phase I clinical trials in monotherapy and in combination with both anti-PD-1 and anti-PD-L1 monoclonal antibodies. For more information, please visit www.7and8biopharma.com
Answer: | Seven and Eight Biopharmaceuticals Announces Acceptance of BDB001 in Combination with Pembrolizumab Interim Data to be Presented in a Poster Discussion at the 2021 ASCO Annual Meeting | EDISON, N.J.--(BUSINESS WIRE)--Seven and Eight Biopharmaceuticals Inc., a clinical stage biotechnology company focused on developing proprietary novel immuno-oncology therapies to activate the immune system against cancer, today announced the acceptance of an abstract for a poster discussion presentation at the 2021 American Society of Clinical Oncology (ASCO) Annual Meeting. The abstract details additional interim safety and efficacy results for a phase 1 study of BDB001, an intravenously administered toll-like receptor 7 and 8 (TLR7/8) agonist, in combination with pembrolizumab in advanced solid tumors (NCT03486301). We are excited to share additional information about BDB001 in combination with pembrolizumab at the 2021 ASCO Annual Meeting, said Dr. Robert H.I. Andtbacka, Chief Medical Officer, Seven and Eight Biopharma. This builds upon the promising monotherapy data we reported on recently and helps illustrate the potential for BDB001 in combination with anti-PD-(L)1 therapies in difficult to treat tumors. The ASCO Annual Meeting will be held virtually on June 4-8, 2021 and showcases innovative scientific research in clinical oncology and advancements in cancer therapy. Details on Seven and Eight Biopharmas poster discussion presentation: Abstract Title: BDB001, an intravenously administered toll-like receptor 7 and 8 (TLR7/8) agonist, in combination with pembrolizumab in advanced solid tumors: Phase 1 safety and efficacy results. Session Title: Poster Discussion Session, Developmental TherapeuticsImmunotherapy On-Demand Session Release Date and Time: 6/4/2021, 9:00 AM-10:00 AM Abstract Number for Publication: 2512 This year, ASCO reviewed more than 5,400 abstracts for the 2021 ASCO Annual Meeting. More information about the meeting may be accessed at https://meetings.asco.org/am/ . According to ASCOs Embargo Policy, abstracts will be released to the public on ASCOs Meeting Library at 5:00 p.m. ET on May 19, 2021. About Seven and Eight Biopharma Seven and Eight Biopharmaceuticals Inc. is an Edison, New Jersey based, clinical stage biotechnology company focused on the development and commercialization of novel immunotherapies for cancer. The company specializes in TLR7/8 programs to treat cancer and has built a comprehensive global intellectual property portfolio in the category of toll-like receptor modulators. Managed by a seasoned team of professionals, the company is progressing a proprietary pipeline of cancer therapeutics in the U.S., with the lead product BDB001 in Phase I clinical trials in monotherapy and in combination with both anti-PD-1 and anti-PD-L1 monoclonal antibodies. For more information, please visit www.7and8biopharma.com |
edtsum1843 | You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text.
Text: VANCOUVER, B.C.--(BUSINESS WIRE)--Absolute Software (NASDAQ: ABST) (TSX: ABST), a leader in Endpoint Resilience solutions, today announced that the Absolute Resilience platform has been awarded a Cyber Catalyst designation following an independent evaluation of over 90 solutions by leading cyber insurers. The designation emphasizes Absolutes critical capabilities to address todays top cyber risks most notably, privacy regulation and data management and offer the highest level of protection. Now heading into its third year, the Cyber Catalyst by Marsh program brings together insurers Allianz Global Corporate & Specialty (AGCS); AXA XL, a division of AXA; AXIS; Beazley; CFC; Munich Re; Sompo International; and Zurich North America to evaluate cybersecurity solutions and award the Cyber Catalyst designation to those they believe can have a meaningful impact on cyber risk. Today, many businesses are facing new challenges amid an acceleration of remote work and increasingly sophisticated cybersecurity threats, said Ameer Karim, EVP of Product Management at Absolute Software. This recognition is a testament to Absolutes commitment to empowering businesses across verticals to effectively detect and respond to security risks. By deploying Absolute Resilience, our customers receive complete endpoint visibility and control, and actionable intelligence. The Absolute Resilience platform provides organizations with a secure connection to every device, even off the corporate network, using its patented Persistence technology embedded in the firmware of over 500 million endpoints. With its unbreakable connection and self-healing capabilities, Absolutes Resilience platform enables devices and security controls to recover from any incident to its original healthy state, autonomously. To achieve the designation, the Absolute Resilience platform was evaluated against six criteria: reduction of cyber risk, key performance metrics, viability, efficiency, flexibility, and differentiation. Quotes from participating insurers who conducted the evaluation include: The capacity to provide visibility to all endpoints and look for sensitive information across those endpoints on or off the network really gives an enhanced level of control. In high risk sectors such as banking and financial services, pharmaceuticals, and manufacturing, this level of control is highly desirable. A very comprehensive and interesting endpoint solution: it tackles the issue of dark endpoints, quite topical now with so many people working remotely. Intuitive dashboards with valuable reporting metrics out of the box. I like the feature that protects and reinstalls business critical applications. The admin GUI seems easy to use; I like that it cannot be removed from the device because its embedded in the firmware itself. Other strong features are the ability to freeze an asset and display a message; easy tracking of where assets are; software able to delete software, data, and remotely wipe a machine not in your possession. For more information about the Absolute Resilience platform being named a 2020 Cyber Catalyst designated solution, visit here. To learn more about how Absolutes undeletable defense platform enables always-connected visibility and Self-Healing Endpoint security, visit www.absolute.com. About Absolute Software Absolute Software is a leader in Endpoint Resilience solutions and the industrys only undeletable defense platform embedded in over a half-billion devices. Enabling a permanent digital tether between the endpoint and the enterprise who distributed it, Absolute provides IT and Security organizations with complete connectivity, visibility, and control, whether a device is on or off the corporate network and empowers them with Self-Healing Endpoint security to ensure mission-critical apps remain healthy and deliver intended value. For the latest information, visit www.absolute.com and follow us on LinkedIn or Twitter. 2021 Absolute Software Corporation. All rights reserved. ABSOLUTE, the ABSOLUTE logo, ABSOLUTE RESILIENCE, and PERSISTENCE are registered trademarks of Absolute Software Corporation in the United States and/or other countries. Other names or logos mentioned herein may be the trademarks of Absolute or their respective owners. The absence of the symbols and in proximity to each trademark, or at all, herein is not a disclaimer of ownership of the related trademark.
Answer: | Absolute Resilience Awarded 2020 Cyber Catalyst Designation Leading cyber insurers acknowledge Absolute Softwares unique capabilities to help customers reduce cybersecurity risks | VANCOUVER, B.C.--(BUSINESS WIRE)--Absolute Software (NASDAQ: ABST) (TSX: ABST), a leader in Endpoint Resilience solutions, today announced that the Absolute Resilience platform has been awarded a Cyber Catalyst designation following an independent evaluation of over 90 solutions by leading cyber insurers. The designation emphasizes Absolutes critical capabilities to address todays top cyber risks most notably, privacy regulation and data management and offer the highest level of protection. Now heading into its third year, the Cyber Catalyst by Marsh program brings together insurers Allianz Global Corporate & Specialty (AGCS); AXA XL, a division of AXA; AXIS; Beazley; CFC; Munich Re; Sompo International; and Zurich North America to evaluate cybersecurity solutions and award the Cyber Catalyst designation to those they believe can have a meaningful impact on cyber risk. Today, many businesses are facing new challenges amid an acceleration of remote work and increasingly sophisticated cybersecurity threats, said Ameer Karim, EVP of Product Management at Absolute Software. This recognition is a testament to Absolutes commitment to empowering businesses across verticals to effectively detect and respond to security risks. By deploying Absolute Resilience, our customers receive complete endpoint visibility and control, and actionable intelligence. The Absolute Resilience platform provides organizations with a secure connection to every device, even off the corporate network, using its patented Persistence technology embedded in the firmware of over 500 million endpoints. With its unbreakable connection and self-healing capabilities, Absolutes Resilience platform enables devices and security controls to recover from any incident to its original healthy state, autonomously. To achieve the designation, the Absolute Resilience platform was evaluated against six criteria: reduction of cyber risk, key performance metrics, viability, efficiency, flexibility, and differentiation. Quotes from participating insurers who conducted the evaluation include: The capacity to provide visibility to all endpoints and look for sensitive information across those endpoints on or off the network really gives an enhanced level of control. In high risk sectors such as banking and financial services, pharmaceuticals, and manufacturing, this level of control is highly desirable. A very comprehensive and interesting endpoint solution: it tackles the issue of dark endpoints, quite topical now with so many people working remotely. Intuitive dashboards with valuable reporting metrics out of the box. I like the feature that protects and reinstalls business critical applications. The admin GUI seems easy to use; I like that it cannot be removed from the device because its embedded in the firmware itself. Other strong features are the ability to freeze an asset and display a message; easy tracking of where assets are; software able to delete software, data, and remotely wipe a machine not in your possession. For more information about the Absolute Resilience platform being named a 2020 Cyber Catalyst designated solution, visit here. To learn more about how Absolutes undeletable defense platform enables always-connected visibility and Self-Healing Endpoint security, visit www.absolute.com. About Absolute Software Absolute Software is a leader in Endpoint Resilience solutions and the industrys only undeletable defense platform embedded in over a half-billion devices. Enabling a permanent digital tether between the endpoint and the enterprise who distributed it, Absolute provides IT and Security organizations with complete connectivity, visibility, and control, whether a device is on or off the corporate network and empowers them with Self-Healing Endpoint security to ensure mission-critical apps remain healthy and deliver intended value. For the latest information, visit www.absolute.com and follow us on LinkedIn or Twitter. 2021 Absolute Software Corporation. All rights reserved. ABSOLUTE, the ABSOLUTE logo, ABSOLUTE RESILIENCE, and PERSISTENCE are registered trademarks of Absolute Software Corporation in the United States and/or other countries. Other names or logos mentioned herein may be the trademarks of Absolute or their respective owners. The absence of the symbols and in proximity to each trademark, or at all, herein is not a disclaimer of ownership of the related trademark. |
edtsum1844 | You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text.
Text: PHILADELPHIA, Jan. 12, 2021 /PRNewswire/ -- Berger Montague is investigating potential securities fraud claims against CD Projekt S.A. ("CD Projekt" or the "Company") on behalf of investors who purchased CD Projekt securities (OTC: OTGLY, OTGLF) between January 16, 2020 and December 17, 2020 (the "Class Period"). If you purchased CD Projekt securities during the Class Period, have questions concerning your rights or interests, or would like to discuss Berger Montague's investigation, please contact attorneys Andrew Abramowitz at [emailprotected]or (215) 875-3015, or Donnell Much at [emailprotected]or (215) 875-4667, or contact us at www.bergermontague.com/cd-projekt. A recently filed lawsuit accuses the Company of misleading investors about the fact that its highly anticipated videogame, Cyberpunk 2077, was virtually unplayable on th e current-generation Xbox or PlayStation systems due to an overwhelming number of bugs, and thus it was reasonably foreseeable that Sony would remove Cyberpunk 2077 from the PlayStation store, and vendors would be forced to offer full refunds for the game. On January 16, 2020, CD Projekt announced a five-month delay in the launch of Cyberpunk 2077, from April 2020 to September 2020, and represented that the "game is complete and playable." After subsequent delays, the game was finally released on December 10, 2020, and immediately, players reported a host of bugs and issues that rendered the game unplayable. On December 18, 2020, Bloomberg reported that Sony had announced it was pulling Cyberpunk 2077 from its PlayStation store and was offering full refunds to players. In a Twitter post the same day, the Company advised that "following [its] discussion with PlayStation, a decision was made to temporarily suspend digital distribution" of the game. Market Insider also quoted the Company's CEO Adam Kicinski as stating during an analyst call that, "[a]fter three delays, we were too focused on releasing the game," and "[w]e ignored signals about the need for additional time to refine the game on the base last-gen consoles." Following this news, the price of CD Projekt's American Depository Receipts (ADRs) price fell precipitously, with OTGLY declining $3.44 per ADR (16%) to close at $18.50, and OTGLF declining $9.20 per ADR (10%) to close at $78.80 on December 18, 2020. If you purchased CD Projekt securities, including ADRs, during the Class Period, you may seek Court appointment as lead plaintiff to represent other injured investors in a class action. The lead plaintiff appointment deadline is February 22, 2021. You do not need to be a lead plaintiff to share in any potential Class recovery. Whistleblowers:Persons with non-public information regarding CD Projekt are encouraged to confidentially assist Berger Montague's investigation or take advantage of the SEC Whistleblower program. Under this program, whistleblowers who provide original information may receive rewards totaling up to thirty percent (30%) of recoveries obtained by the SEC. For more information, contact us. Berger Montague, with offices in Philadelphia, Minneapolis, Washington, D.C., and San Diego, has been a pioneer in securities class action litigation since its founding in 1970. Berger Montague has represented individual and institutional investors for five decades and serves as lead counsel in courts throughout the United States. Contacts: Andrew Abramowitz, Senior CounselBerger Montague(215) 875-3015[emailprotected] Donnell Much, AssociateBerger Montague(215) 875-4667[emailprotected] SOURCE Berger Montague Related Links http://www.bergermontague.com
Answer: | Berger Montague Investigates Alleged Securities Fraud Claims Against CD Projekt S.A. (OTC: OTGLY, OTGLF); Lead Plaintiff Deadline is February 22, 2021 | PHILADELPHIA, Jan. 12, 2021 /PRNewswire/ -- Berger Montague is investigating potential securities fraud claims against CD Projekt S.A. ("CD Projekt" or the "Company") on behalf of investors who purchased CD Projekt securities (OTC: OTGLY, OTGLF) between January 16, 2020 and December 17, 2020 (the "Class Period"). If you purchased CD Projekt securities during the Class Period, have questions concerning your rights or interests, or would like to discuss Berger Montague's investigation, please contact attorneys Andrew Abramowitz at [emailprotected]or (215) 875-3015, or Donnell Much at [emailprotected]or (215) 875-4667, or contact us at www.bergermontague.com/cd-projekt. A recently filed lawsuit accuses the Company of misleading investors about the fact that its highly anticipated videogame, Cyberpunk 2077, was virtually unplayable on th e current-generation Xbox or PlayStation systems due to an overwhelming number of bugs, and thus it was reasonably foreseeable that Sony would remove Cyberpunk 2077 from the PlayStation store, and vendors would be forced to offer full refunds for the game. On January 16, 2020, CD Projekt announced a five-month delay in the launch of Cyberpunk 2077, from April 2020 to September 2020, and represented that the "game is complete and playable." After subsequent delays, the game was finally released on December 10, 2020, and immediately, players reported a host of bugs and issues that rendered the game unplayable. On December 18, 2020, Bloomberg reported that Sony had announced it was pulling Cyberpunk 2077 from its PlayStation store and was offering full refunds to players. In a Twitter post the same day, the Company advised that "following [its] discussion with PlayStation, a decision was made to temporarily suspend digital distribution" of the game. Market Insider also quoted the Company's CEO Adam Kicinski as stating during an analyst call that, "[a]fter three delays, we were too focused on releasing the game," and "[w]e ignored signals about the need for additional time to refine the game on the base last-gen consoles." Following this news, the price of CD Projekt's American Depository Receipts (ADRs) price fell precipitously, with OTGLY declining $3.44 per ADR (16%) to close at $18.50, and OTGLF declining $9.20 per ADR (10%) to close at $78.80 on December 18, 2020. If you purchased CD Projekt securities, including ADRs, during the Class Period, you may seek Court appointment as lead plaintiff to represent other injured investors in a class action. The lead plaintiff appointment deadline is February 22, 2021. You do not need to be a lead plaintiff to share in any potential Class recovery. Whistleblowers:Persons with non-public information regarding CD Projekt are encouraged to confidentially assist Berger Montague's investigation or take advantage of the SEC Whistleblower program. Under this program, whistleblowers who provide original information may receive rewards totaling up to thirty percent (30%) of recoveries obtained by the SEC. For more information, contact us. Berger Montague, with offices in Philadelphia, Minneapolis, Washington, D.C., and San Diego, has been a pioneer in securities class action litigation since its founding in 1970. Berger Montague has represented individual and institutional investors for five decades and serves as lead counsel in courts throughout the United States. Contacts: Andrew Abramowitz, Senior CounselBerger Montague(215) 875-3015[emailprotected] Donnell Much, AssociateBerger Montague(215) 875-4667[emailprotected] SOURCE Berger Montague Related Links http://www.bergermontague.com |
edtsum1849 | You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text.
Text: CAMPBELL, Calif.--(BUSINESS WIRE)--Tigo Energy, Inc., the worldwide leader in Flex-MLPE (Module Level Power Electronics) today announced it has received UL PVRSS (Photovoltaic Rapid Shutdown System) certifications for approximately 30 inverter models, bringing its certified inverter total to more than 200 inverters from 17 different companies. Tigo already had the largest network of certified inverters for customers to choose from and this adds even more options to the rapidly growing list. This is by far the biggest variety of certified inverters that are available for use with rapid shutdown devices anywhere, said Sarah Ozga, Product Manager for Tigo. Our customers want the freedom to choose the inverter and capacity that they want, and we are delivering it for them. The certified inverters range from 2.5 kW, single phase for small residential installations to 100 kW, three-phase for large commercial arrays. It also includes newly introduced residential hybrid inverters, which are designed for easy integration with energy storage systems. In order to receive certification, every inverter family was independently tested with Tigos TS4 family of rapid shutdown devices accordingly to UL standards. ULs rapid shutdown testing is the most rigid testing standard available, proving functionality, reliability and safety of rapid shutdown systems rather than basic function. We have certified our rapid shutdown solutions with essentially every major string inverter manufacturer, added Ozga. This is an amazing accomplishment and Im very proud of our team. The certified inverters include the following brands: The UL PVRSS certification fulfills a necessary safety requirement for PV Rapid Shutdown in the US National Electrical Code, whereby both the inverter and the rapid shutdown device must be tested as a system. Rapid shutdown devices are now required with rooftop PV installations across the vast majority of the United States. Similar requirements are being adopted and discussed throughout the world. Customers can view the entire list of inverters that are certified with Tigo devices here. For inquiries, contact: [email protected] About Tigo Tigo is the worldwide leader in Flex-MLPE (Module Level Power Electronics) with innovative solutions that significantly enhance safety, increase energy production, and decrease operating costs of photovoltaic (PV) systems. Tigos TS4 platform maximizes the benefit of PV systems and provides customers with the most scalable, versatile, and reliable MLPE solution available. Tigo was founded in Silicon Valley in 2007 to accelerate the adoption of solar energy worldwide. Tigo systems operate on 7 continents and produce gigawatt hours of reliable, clean, affordable and safe solar energy daily. Tigo's global team is dedicated to making the best MLPE on earth so more people can enjoy the benefits of solar. Visit us at www.tigoenergy.com.
Answer: | Tigo Adds to Expansive List of PV Rapid Shutdown System Certified Inverters Tigo devices are certified with more than 200 inverters from 17 different companies | CAMPBELL, Calif.--(BUSINESS WIRE)--Tigo Energy, Inc., the worldwide leader in Flex-MLPE (Module Level Power Electronics) today announced it has received UL PVRSS (Photovoltaic Rapid Shutdown System) certifications for approximately 30 inverter models, bringing its certified inverter total to more than 200 inverters from 17 different companies. Tigo already had the largest network of certified inverters for customers to choose from and this adds even more options to the rapidly growing list. This is by far the biggest variety of certified inverters that are available for use with rapid shutdown devices anywhere, said Sarah Ozga, Product Manager for Tigo. Our customers want the freedom to choose the inverter and capacity that they want, and we are delivering it for them. The certified inverters range from 2.5 kW, single phase for small residential installations to 100 kW, three-phase for large commercial arrays. It also includes newly introduced residential hybrid inverters, which are designed for easy integration with energy storage systems. In order to receive certification, every inverter family was independently tested with Tigos TS4 family of rapid shutdown devices accordingly to UL standards. ULs rapid shutdown testing is the most rigid testing standard available, proving functionality, reliability and safety of rapid shutdown systems rather than basic function. We have certified our rapid shutdown solutions with essentially every major string inverter manufacturer, added Ozga. This is an amazing accomplishment and Im very proud of our team. The certified inverters include the following brands: The UL PVRSS certification fulfills a necessary safety requirement for PV Rapid Shutdown in the US National Electrical Code, whereby both the inverter and the rapid shutdown device must be tested as a system. Rapid shutdown devices are now required with rooftop PV installations across the vast majority of the United States. Similar requirements are being adopted and discussed throughout the world. Customers can view the entire list of inverters that are certified with Tigo devices here. For inquiries, contact: [email protected] About Tigo Tigo is the worldwide leader in Flex-MLPE (Module Level Power Electronics) with innovative solutions that significantly enhance safety, increase energy production, and decrease operating costs of photovoltaic (PV) systems. Tigos TS4 platform maximizes the benefit of PV systems and provides customers with the most scalable, versatile, and reliable MLPE solution available. Tigo was founded in Silicon Valley in 2007 to accelerate the adoption of solar energy worldwide. Tigo systems operate on 7 continents and produce gigawatt hours of reliable, clean, affordable and safe solar energy daily. Tigo's global team is dedicated to making the best MLPE on earth so more people can enjoy the benefits of solar. Visit us at www.tigoenergy.com. |
edtsum1858 | You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text.
Text: IRVINE, Calif., May 7, 2020 /PRNewswire/ --Edwards Lifesciences Corporation (NYSE: EW), the global leader in patient-focused innovations for structural heart disease and critical care monitoring, today announced updates from its annual meeting, in which Edwards' stockholders voted with the board's recommendations on all proxy proposals. During the meeting, held earlier today, the company also announced changes to the company's board of directors. Wes von Schack, who has been a director since 2010, has retired from the board and Edwards' stockholders approved the appointment of Ramona Sequeira to the board. Sequeira is president of Takeda Pharmaceuticals USA, Inc., and also leads Takeda's global portfolio commercialization efforts. "I'd like to take this opportunity to express my sincere appreciation and gratitude to Wes, who has retired after serving on Edwards' board for 10 years," said Michael A. Mussallem, Edwards' chairman and CEO. "Wes was a substantial contributor to our board, utilizing his decades of experience as a CEO and board chairman. His engagement and guidance during a period of significant growth and progress at Edwards have been valued and admired. We thank Wes for his leadership, service and contributions." During von Schack's tenure with the board, he served as presiding director and then lead independent director. Martha Marsh, a board member since 2015, assumed the role of lead independent director. Marsh served the healthcare industry for more than 30 years in a variety of leadership positions, including as president and CEO of Stanford Hospital and Clinics and CEO of the University of California Davis Medical Center. "Also today, we welcome Ramona to Edwards' board of directors, and we look forward to her insights as an experienced lifesciences executive, working around the world to help deliver important therapies to patients," said Mussallem. "Ramona has a passion for healthcare innovation and patient access that aligns with the values and strategy of our company, and we are confident she will further strengthen our talented and engaged board." During her more than 20-year career in the pharmaceutical industry, Sequeira has held leadership roles with Takeda Pharmaceutical Company and previously with Eli Lilly and Company in the U.S., Europe and Canada. Currently, she serves as treasurer on the board of directors of the Pharmaceutical Research and Manufacturers of America (PhRMA), which represents biopharmaceutical research companies. Also at today's annual meeting, stockholders approved the company's plan to execute a 3-for-1 stock split. The split of the company's outstanding shares of common stock will be effected in the form of a stock dividend of two shares of common stock to the holders of record of each share of Edwards' common stock as of the close of business on May 18, 2020. The additional shares will be distributed on May 29, 2020. The stock split will increase the number of common shares outstanding from approximately 212 million shares to approximately 636 million shares. The company's last stock split occurred in December 2015; this will be the company's third since it went public in April 2000. About Edwards Lifesciences Edwards Lifesciences, based inIrvine, Calif., is the global leader of patient-focused medical innovations for structural heart disease and critical care monitoring. We are driven by a passion for patients, dedicated to improving and enhancing lives through partnerships with clinicians and stakeholders across the global healthcare landscape. For more information, visit Edwards.com and follow us on Facebook, Instagram, LinkedIn, Twitter and YouTube. This news release includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. These forward-looking statements include, but are not limited to execution of the stock split. Forward-looking statements are based on estimates and assumptions made by management of the company and are believed to be reasonable, though they are inherently uncertain and difficult to predict. Our forward-looking statements speak only as of the date on which they are made and we do not undertake any obligation to update any forward-looking statement to reflect events or circumstances after the date of the statement. Statements of past performance, efforts, or results about which inferences or assumptions may be made can also be forward-looking statements and are not indicative of future performance or results; these statements can be identified by the use of words such as "continued," "transform," "develop," "preliminary," "initial," diligence," "industry-leading," "compliant," "indications," or "early feedback" or other forms of these words or similar words or expressions or the negative thereof. Investors are cautioned not to unduly rely on such forward-looking statements. Forward-looking statements involve risks and uncertainties that could cause results to differ materially from those expressed or implied by the forward-looking statements based on a number of factors as detailed in the company's filings with the Securities and Exchange Commission including its Annual Report on Form 10-K for the year ended December 31, 2019 and the Quarterly Report on Form 10-Q for the quarter ended March 31, 2020. These filings, along with important safety information about our products, may be found at edwards.com. Edwards, Edwards Lifesciences and the stylized E logo are trademarks of Edwards Lifesciences Corporation and its affiliates. All other trademarks are the property of their respective owners.This statement is made on behalf of Edwards Lifesciences Corporation and its subsidiaries. SOURCE Edwards Lifesciences Corporation Related Links http://www.edwards.com
Answer: | Edwards Announces Updates From Annual Meeting Stockholders Approve Board Recommendations, Including Stock Split | IRVINE, Calif., May 7, 2020 /PRNewswire/ --Edwards Lifesciences Corporation (NYSE: EW), the global leader in patient-focused innovations for structural heart disease and critical care monitoring, today announced updates from its annual meeting, in which Edwards' stockholders voted with the board's recommendations on all proxy proposals. During the meeting, held earlier today, the company also announced changes to the company's board of directors. Wes von Schack, who has been a director since 2010, has retired from the board and Edwards' stockholders approved the appointment of Ramona Sequeira to the board. Sequeira is president of Takeda Pharmaceuticals USA, Inc., and also leads Takeda's global portfolio commercialization efforts. "I'd like to take this opportunity to express my sincere appreciation and gratitude to Wes, who has retired after serving on Edwards' board for 10 years," said Michael A. Mussallem, Edwards' chairman and CEO. "Wes was a substantial contributor to our board, utilizing his decades of experience as a CEO and board chairman. His engagement and guidance during a period of significant growth and progress at Edwards have been valued and admired. We thank Wes for his leadership, service and contributions." During von Schack's tenure with the board, he served as presiding director and then lead independent director. Martha Marsh, a board member since 2015, assumed the role of lead independent director. Marsh served the healthcare industry for more than 30 years in a variety of leadership positions, including as president and CEO of Stanford Hospital and Clinics and CEO of the University of California Davis Medical Center. "Also today, we welcome Ramona to Edwards' board of directors, and we look forward to her insights as an experienced lifesciences executive, working around the world to help deliver important therapies to patients," said Mussallem. "Ramona has a passion for healthcare innovation and patient access that aligns with the values and strategy of our company, and we are confident she will further strengthen our talented and engaged board." During her more than 20-year career in the pharmaceutical industry, Sequeira has held leadership roles with Takeda Pharmaceutical Company and previously with Eli Lilly and Company in the U.S., Europe and Canada. Currently, she serves as treasurer on the board of directors of the Pharmaceutical Research and Manufacturers of America (PhRMA), which represents biopharmaceutical research companies. Also at today's annual meeting, stockholders approved the company's plan to execute a 3-for-1 stock split. The split of the company's outstanding shares of common stock will be effected in the form of a stock dividend of two shares of common stock to the holders of record of each share of Edwards' common stock as of the close of business on May 18, 2020. The additional shares will be distributed on May 29, 2020. The stock split will increase the number of common shares outstanding from approximately 212 million shares to approximately 636 million shares. The company's last stock split occurred in December 2015; this will be the company's third since it went public in April 2000. About Edwards Lifesciences Edwards Lifesciences, based inIrvine, Calif., is the global leader of patient-focused medical innovations for structural heart disease and critical care monitoring. We are driven by a passion for patients, dedicated to improving and enhancing lives through partnerships with clinicians and stakeholders across the global healthcare landscape. For more information, visit Edwards.com and follow us on Facebook, Instagram, LinkedIn, Twitter and YouTube. This news release includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. These forward-looking statements include, but are not limited to execution of the stock split. Forward-looking statements are based on estimates and assumptions made by management of the company and are believed to be reasonable, though they are inherently uncertain and difficult to predict. Our forward-looking statements speak only as of the date on which they are made and we do not undertake any obligation to update any forward-looking statement to reflect events or circumstances after the date of the statement. Statements of past performance, efforts, or results about which inferences or assumptions may be made can also be forward-looking statements and are not indicative of future performance or results; these statements can be identified by the use of words such as "continued," "transform," "develop," "preliminary," "initial," diligence," "industry-leading," "compliant," "indications," or "early feedback" or other forms of these words or similar words or expressions or the negative thereof. Investors are cautioned not to unduly rely on such forward-looking statements. Forward-looking statements involve risks and uncertainties that could cause results to differ materially from those expressed or implied by the forward-looking statements based on a number of factors as detailed in the company's filings with the Securities and Exchange Commission including its Annual Report on Form 10-K for the year ended December 31, 2019 and the Quarterly Report on Form 10-Q for the quarter ended March 31, 2020. These filings, along with important safety information about our products, may be found at edwards.com. Edwards, Edwards Lifesciences and the stylized E logo are trademarks of Edwards Lifesciences Corporation and its affiliates. All other trademarks are the property of their respective owners.This statement is made on behalf of Edwards Lifesciences Corporation and its subsidiaries. SOURCE Edwards Lifesciences Corporation Related Links http://www.edwards.com |
edtsum1859 | You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text.
Text: The firm hires two top-performing brokers to launch its presence in the market and deepen its industrial and office leasing and sales capabilities across Western Canada EDMONTON, AB, April 13, 2021 /PRNewswire/ --Savills is continuing the firm's expansion throughout North America with the opening of a new office in Edmonton, Alberta. The firm welcomes Alex Heintz as corporate managing director and Kyle Bartkus as managing director, who join from Lizotte and Associate Real Estate Inc. and will specialize in office and industrial leasing and commercial sales. Savills is continuing the firms expansion throughout North America with the opening of a new office in Edmonton, Alberta. The firm welcomes Alex Heintz as corporate managing director and Kyle Bartkus as managing director. "Savills is continuing its strategic advancement throughout North America and the opening in Edmonton increases our presence in Western Canada," said Vice Chairman and Market Lead for the Mountain-Northwest region Rick Schuham. "Alberta remains the center for a multitude of industries and Edmonton is home to a well-diversified industrial base, which has proven to be a resilient sector throughout the pandemic. Adding Alex and Kyle to Savills extends our global industrial services platform and our ability to deliver local expertise throughout Alberta." Heintz and Bartkus will work from a new space located in the 124th Street submarket at 10406 124 St. NW. The two bring 20 years of combined experience in commercial sales and leasing in the Alberta region. The team has executed transactions on behalf of prominent companies including Above and Beyond Compression, Allied Fitting Canada, Ampak, Bird Construction, HESCO, OK Tire, Parkland Fuel, The Brick, and Wood Wyant Canada. Heintz is a noted perennial top performer having successfully completed more than $200 million in transactions, totaling over 2 million square feet. His in-depth knowledge of the market and commitment to innovative thinking has enabled him to provide clients with insightful solutions to build and execute their real estate strategy.Bartkus focuses on both the industrial and investment markets and he has completed sale and lease transactions in multiple asset classes. Over his career, Bartkus has executed over 1.2 million square feet of commercial leases, with values totaling more than $125 million.The Edmonton office will work closely with Savills Calgary location led by Senior Managing Director Josh Hamilland Vice President Adam Stewart. Since its September 2019 opening, the Calgary office has relocated to a new, downtown space and steadily increased its staffing, most recently adding tenant representation expert Steve Bermanas managing director. Hamill and Stewart will also oversee the Western Canada operations and drive growth for Edmonton."Alberta features a thriving tech sector and burgeoning industries in life sciences, petrochemical, and agriculture," said Hamill. "Many of the leading energy, service, logistics, and manufacturing companies currently reside in Edmonton, making it an ideal extension to our growing practice in Calgary. We are looking forward to collaborating with Alex and Kyle's team as we continue to build Savills' services and solutions throughout Canada."With more than 35 offices and over 900 employees in North America, Savills provides local and international clients with a comprehensive and cohesive suite of services and solutions encompassing tenant representation, workplace strategy, capital markets, workforce and incentives strategy, labor analytics, and project management and additional areas of commercial real estate.About Savills Inc.Savills helps organizations find the right solutions that ensure employee success. Sharply skilled and fiercely dedicated, the firm's integrated teams of consultants and brokers are experts in better real estate. With services in tenant representation, workforce and incentives strategy, workplace strategy and occupant experience, project management, and capital markets, Savills has elevated the potential of workplaces around the corner, and around the world, for 160 years and counting.For more information, please visitSavills.usand follow us on LinkedIn, Twitter, Instagramand Facebook.SOURCE Savills Related Links http://www.savills-studley.com
Answer: | Savills Continues North American Expansion with New Office in Edmonton, Alberta | The firm hires two top-performing brokers to launch its presence in the market and deepen its industrial and office leasing and sales capabilities across Western Canada EDMONTON, AB, April 13, 2021 /PRNewswire/ --Savills is continuing the firm's expansion throughout North America with the opening of a new office in Edmonton, Alberta. The firm welcomes Alex Heintz as corporate managing director and Kyle Bartkus as managing director, who join from Lizotte and Associate Real Estate Inc. and will specialize in office and industrial leasing and commercial sales. Savills is continuing the firms expansion throughout North America with the opening of a new office in Edmonton, Alberta. The firm welcomes Alex Heintz as corporate managing director and Kyle Bartkus as managing director. "Savills is continuing its strategic advancement throughout North America and the opening in Edmonton increases our presence in Western Canada," said Vice Chairman and Market Lead for the Mountain-Northwest region Rick Schuham. "Alberta remains the center for a multitude of industries and Edmonton is home to a well-diversified industrial base, which has proven to be a resilient sector throughout the pandemic. Adding Alex and Kyle to Savills extends our global industrial services platform and our ability to deliver local expertise throughout Alberta." Heintz and Bartkus will work from a new space located in the 124th Street submarket at 10406 124 St. NW. The two bring 20 years of combined experience in commercial sales and leasing in the Alberta region. The team has executed transactions on behalf of prominent companies including Above and Beyond Compression, Allied Fitting Canada, Ampak, Bird Construction, HESCO, OK Tire, Parkland Fuel, The Brick, and Wood Wyant Canada. Heintz is a noted perennial top performer having successfully completed more than $200 million in transactions, totaling over 2 million square feet. His in-depth knowledge of the market and commitment to innovative thinking has enabled him to provide clients with insightful solutions to build and execute their real estate strategy.Bartkus focuses on both the industrial and investment markets and he has completed sale and lease transactions in multiple asset classes. Over his career, Bartkus has executed over 1.2 million square feet of commercial leases, with values totaling more than $125 million.The Edmonton office will work closely with Savills Calgary location led by Senior Managing Director Josh Hamilland Vice President Adam Stewart. Since its September 2019 opening, the Calgary office has relocated to a new, downtown space and steadily increased its staffing, most recently adding tenant representation expert Steve Bermanas managing director. Hamill and Stewart will also oversee the Western Canada operations and drive growth for Edmonton."Alberta features a thriving tech sector and burgeoning industries in life sciences, petrochemical, and agriculture," said Hamill. "Many of the leading energy, service, logistics, and manufacturing companies currently reside in Edmonton, making it an ideal extension to our growing practice in Calgary. We are looking forward to collaborating with Alex and Kyle's team as we continue to build Savills' services and solutions throughout Canada."With more than 35 offices and over 900 employees in North America, Savills provides local and international clients with a comprehensive and cohesive suite of services and solutions encompassing tenant representation, workplace strategy, capital markets, workforce and incentives strategy, labor analytics, and project management and additional areas of commercial real estate.About Savills Inc.Savills helps organizations find the right solutions that ensure employee success. Sharply skilled and fiercely dedicated, the firm's integrated teams of consultants and brokers are experts in better real estate. With services in tenant representation, workforce and incentives strategy, workplace strategy and occupant experience, project management, and capital markets, Savills has elevated the potential of workplaces around the corner, and around the world, for 160 years and counting.For more information, please visitSavills.usand follow us on LinkedIn, Twitter, Instagramand Facebook.SOURCE Savills Related Links http://www.savills-studley.com |
edtsum1860 | You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text.
Text: RIVERDALE, Md., Dec. 7, 2020 /PRNewswire/ --The Troops First Foundation today urged the incoming Biden administration and members of Congress to promote a national suicide prevention effort specifically aimed at reaching veterans and service members who may be dangerously disconnected from others. In an open letter, the Foundation said: "Leaders in the military community are deeply concerned that the grinding pandemic could exacerbate a troubling trend of suicides among active duty military personnel and veterans. As such, we write you today to urge your participation in and promotion of an ongoing national effort "Warrior Call" to increase connectivity among our military community and in turn save lives." Far more emphasis must be placed on reaching vets and service memberswho are perilously disconnected from others. Tweet this The letter was signed by Frank Larkin and Leroy Petry, the Warrior Call co-chairs. Larkin is a former Navy SEAL, 40thUS Senate Sergeant at Arms and father of a Navy SEAL son who committed suicide. Petry is a 2011 recipient of the Medal of Honor, the nation's highest military honor. The text of their open letter follows:Dear Incoming Officials of the Biden Administration and Members of Congress:The holiday season, coupled with the public health crisis posed by the coronavirus pandemic, creates a toxic brew of isolation for many Americans your constituents. This is especially true for our bravest men and women who are wearing or have worn the uniform to protect and serve the United States.Leaders in the military community are deeply concerned that the grinding pandemic could exacerbate a troubling trend of suicides among active duty military personnel and veterans. As such, we write you today to urge your participation in and promotion of an ongoing national effort "Warrior Call" to increase connectivity among our military community and in turn save lives."The premise is simple. We are asking active duty servicepeople and veterans to connect with former battle buddies and let them know they care. We want them to make a call and have an honest conversation and steer them to resources, if necessary.The reason is all too clear. Far more emphasis must be placed on reaching those vets and service members who don't raise their hands, who are suffering in silence, whose physical or psychological injuries have left them perilously disconnected from others and who don't avail themselves of state or federal services. Sen. Mark Warner, D-Virginia, puts his finger on the issue."What we found is that two-thirds of these veterans who take their own lives have had no contact with the VA," he said.As leaders of this country, you have a unique opportunity to promote the Warrior Call initiative and help get these disconnected heroes re-connected. The most recent data surrounding military suicide certainly underscores the need for connecting with veterans: The rate of suicide among veterans ticked upwards in recent years despite increased public attention and funding on the problem, according to anew reportreleased byDepartment of Veterans Affairs . After adjusting for sex and age, veterans suicide was 27.5 per 100,000 individuals in 2018, up from 25.8 per 100,000 in 2016. By comparison, among all U.S. adults, the suicide rate per 100,000 was 18.3. We recognize that phone calls are no panacea, but they are a starting point for connecting with people who might be spiraling into an abyss. The Troops First Foundation is seeking to have at least 50,000 current service members and vets pick up the phone, make a Warrior Call and connect with another by the end of the year. To members of Congress, we ask for your help in specific ways, such as: sharing the Warrior Call pledge on your social media channels or in your constituent newsletters; addressing this issue in relevant committees and/or during floor time; encouraging your constituents to take the pledge and participate in Warrior Call; and/or reaching out to military facilities in your district or state to apprise them of Warrior Call. To the new administration, in addition to sharing the Warrior Call pledge on your social media channels, we ask that you prioritize those Veterans Affairs programs that help reach these warriors who are disconnected. To both the new administration and Congress, we ask that you consider making Warrior Call a national day, recognized by Congress and commemorated across America as a key tool for suicide prevention among those who wear or who have worn the unform.Saving our service members and veterans from suicide surely transcends politics and party affiliation. It is a tragic problem that should move us all to action, united as Americans. Thank you for your time and consideration.Sincerely,Frank Larkin and Leroy PetryCo-Chairs, Warrior CallSOURCE Warrior Call Related Links https://warriorcall.org/
Answer: | In Open Letter To Biden Administration And Congress, Foundation Calls For National 'Warrior Call' Suicide Prevention Effort | RIVERDALE, Md., Dec. 7, 2020 /PRNewswire/ --The Troops First Foundation today urged the incoming Biden administration and members of Congress to promote a national suicide prevention effort specifically aimed at reaching veterans and service members who may be dangerously disconnected from others. In an open letter, the Foundation said: "Leaders in the military community are deeply concerned that the grinding pandemic could exacerbate a troubling trend of suicides among active duty military personnel and veterans. As such, we write you today to urge your participation in and promotion of an ongoing national effort "Warrior Call" to increase connectivity among our military community and in turn save lives." Far more emphasis must be placed on reaching vets and service memberswho are perilously disconnected from others. Tweet this The letter was signed by Frank Larkin and Leroy Petry, the Warrior Call co-chairs. Larkin is a former Navy SEAL, 40thUS Senate Sergeant at Arms and father of a Navy SEAL son who committed suicide. Petry is a 2011 recipient of the Medal of Honor, the nation's highest military honor. The text of their open letter follows:Dear Incoming Officials of the Biden Administration and Members of Congress:The holiday season, coupled with the public health crisis posed by the coronavirus pandemic, creates a toxic brew of isolation for many Americans your constituents. This is especially true for our bravest men and women who are wearing or have worn the uniform to protect and serve the United States.Leaders in the military community are deeply concerned that the grinding pandemic could exacerbate a troubling trend of suicides among active duty military personnel and veterans. As such, we write you today to urge your participation in and promotion of an ongoing national effort "Warrior Call" to increase connectivity among our military community and in turn save lives."The premise is simple. We are asking active duty servicepeople and veterans to connect with former battle buddies and let them know they care. We want them to make a call and have an honest conversation and steer them to resources, if necessary.The reason is all too clear. Far more emphasis must be placed on reaching those vets and service members who don't raise their hands, who are suffering in silence, whose physical or psychological injuries have left them perilously disconnected from others and who don't avail themselves of state or federal services. Sen. Mark Warner, D-Virginia, puts his finger on the issue."What we found is that two-thirds of these veterans who take their own lives have had no contact with the VA," he said.As leaders of this country, you have a unique opportunity to promote the Warrior Call initiative and help get these disconnected heroes re-connected. The most recent data surrounding military suicide certainly underscores the need for connecting with veterans: The rate of suicide among veterans ticked upwards in recent years despite increased public attention and funding on the problem, according to anew reportreleased byDepartment of Veterans Affairs . After adjusting for sex and age, veterans suicide was 27.5 per 100,000 individuals in 2018, up from 25.8 per 100,000 in 2016. By comparison, among all U.S. adults, the suicide rate per 100,000 was 18.3. We recognize that phone calls are no panacea, but they are a starting point for connecting with people who might be spiraling into an abyss. The Troops First Foundation is seeking to have at least 50,000 current service members and vets pick up the phone, make a Warrior Call and connect with another by the end of the year. To members of Congress, we ask for your help in specific ways, such as: sharing the Warrior Call pledge on your social media channels or in your constituent newsletters; addressing this issue in relevant committees and/or during floor time; encouraging your constituents to take the pledge and participate in Warrior Call; and/or reaching out to military facilities in your district or state to apprise them of Warrior Call. To the new administration, in addition to sharing the Warrior Call pledge on your social media channels, we ask that you prioritize those Veterans Affairs programs that help reach these warriors who are disconnected. To both the new administration and Congress, we ask that you consider making Warrior Call a national day, recognized by Congress and commemorated across America as a key tool for suicide prevention among those who wear or who have worn the unform.Saving our service members and veterans from suicide surely transcends politics and party affiliation. It is a tragic problem that should move us all to action, united as Americans. Thank you for your time and consideration.Sincerely,Frank Larkin and Leroy PetryCo-Chairs, Warrior CallSOURCE Warrior Call Related Links https://warriorcall.org/ |
edtsum1865 | You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text.
Text: DUBLIN, April 7, 2020 /PRNewswire/ -- The "Traction Transformers Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2020-2025" report has been added to ResearchAndMarkets.com's offering. The global traction transformers market is currently witnessing a healthy growth. Looking forward, the publisher expects the market to expand at a CAGR of 4.5% during 2020-2025.The growth of the high-speed rail sector and significant advancements in railway infrastructure are among the key factors driving the growth of the market. Furthermore, the rapid electrification of rail networks is expected to increase the demand for traction transformers across the globe.The governments of emerging nations are implementing favorable policies to improve the existing transportation facilities and optimize rail systems. Widespread adoption of traction transformers in both traditional and next-generation locomotives to support faster-commuting networks, the rapidly increasing number of passengers and diversifying travel routes are further driving the product demand. In addition to this, growing awareness regarding the utilization of energy-efficient products for reducing the environmental damage caused by outdated technologies is resulting in the increasing adoption of AC transformers worldwide. Also, since these transformers are not dependent on conventional sources of energy, such as crude oil and coal, they offer an eco-friendly and convenient solution.Other factors, including innovations to develop equipment with minimal noise, carbon emissions, power losses and operating costs, are projected to create a positive outlook for the market.The competitive landscape of the industry has also been examined with some of the key players being ABB Ltd., Alstom SA, EMCO Limited, Hind Rectifiers Ltd., International Electric Co., Ltd., JST Transformateurs, Schneider Electric SA, Setrans Holding AS, Siemens AG, Wilson Transformer Company, etc.Key Questions Answered How has the global traction transformer market performed so far and how will it perform in the coming years? What are the key regional markets? What is the breakup of the market based on the type? What is the breakup of the market based on the rolling stock? What is the breakup of the market based on the mounting position? What is the breakup of the market based on the overhead line voltage? What are the various stages in the value chain of the industry? What are the key driving factors and challenges in the market? What is the structure of the global traction transformer market and who are the key players? What is the degree of competition in the market? Key Topics Covered 1 Preface2 Scope and Methodology3 Executive Summary4 Introduction4.1 Overview4.2 Key Industry Trends5 Global Traction Transformer Market5.1 Market Overview5.2 Market Performance5.3 Market Forecast6 Market Breakup by Type6.1 Tap Changing6.2 Tapped6.3 Rectifier7 Market Breakup by Rolling Stock7.1 Electric Locomotives7.2 High-Speed Trains7.3 Metros7.4 Others8 Market Breakup by Mounting Position8.1 Underframe8.2 Machine Room8.3 Roof9 Market Breakup by Overhead Line Voltage9.1 Alternative Current (AC) Systems9.2 Direct Current (DC) Systems10 Market Breakup by Region10.1 North America10.2 Europe10.3 Asia Pacific10.4 Latin America10.5 Middle East and Africa11 SWOT Analysis11.1 Overview11.2 Strengths11.3 Weaknesses11.4 Opportunities11.5 Threats12 Value Chain Analysis13 Porters Five Forces Analysis13.1 Overview13.2 Bargaining Power of Buyers13.3 Bargaining Power of Suppliers13.4 Degree of Competition13.5 Threat of New Entrants13.6 Threat of Substitutes14 Price Indicators15 Competitive Landscape15.1 Market Structure15.2 Key Players15.3 Profiles of Key Players15.3.1 ABB Ltd.15.3.1.1 Company Overview15.3.1.2 Product Portfolio 15.3.1.3 Financials15.3.1.4 SWOT Analysis15.3.2 Alstom SA15.3.3 EMCO Limited15.3.4 Hind Rectifiers Limited15.3.5 International Electric Co. Ltd.15.3.6 JST Transformateurs15.3.7 Schneider Electric SA15.3.8 Setrans Holding AS15.3.9 Siemens AG15.3.10 Wilson Transformer CompanyFor more information about this report visit https://www.researchandmarkets.com/r/52d2nd Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research. Media Contact: Research and Markets Laura Wood, Senior Manager [emailprotected]dmarkets.com For E.S.T Office Hours Call +1-917-300-0470 For U.S./CAN Toll Free Call +1-800-526-8630 For GMT Office Hours Call +353-1-416-8900 U.S. Fax: 646-607-1907 Fax (outside U.S.): +353-1-481-1716 SOURCE Research and Markets Related Links http://www.researchandmarkets.com
Answer: | The Future of the Traction Transformers Market, 2025 - High-Speed Rail Sector Growth, Significant Advancements in Railway Infrastructure | DUBLIN, April 7, 2020 /PRNewswire/ -- The "Traction Transformers Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2020-2025" report has been added to ResearchAndMarkets.com's offering. The global traction transformers market is currently witnessing a healthy growth. Looking forward, the publisher expects the market to expand at a CAGR of 4.5% during 2020-2025.The growth of the high-speed rail sector and significant advancements in railway infrastructure are among the key factors driving the growth of the market. Furthermore, the rapid electrification of rail networks is expected to increase the demand for traction transformers across the globe.The governments of emerging nations are implementing favorable policies to improve the existing transportation facilities and optimize rail systems. Widespread adoption of traction transformers in both traditional and next-generation locomotives to support faster-commuting networks, the rapidly increasing number of passengers and diversifying travel routes are further driving the product demand. In addition to this, growing awareness regarding the utilization of energy-efficient products for reducing the environmental damage caused by outdated technologies is resulting in the increasing adoption of AC transformers worldwide. Also, since these transformers are not dependent on conventional sources of energy, such as crude oil and coal, they offer an eco-friendly and convenient solution.Other factors, including innovations to develop equipment with minimal noise, carbon emissions, power losses and operating costs, are projected to create a positive outlook for the market.The competitive landscape of the industry has also been examined with some of the key players being ABB Ltd., Alstom SA, EMCO Limited, Hind Rectifiers Ltd., International Electric Co., Ltd., JST Transformateurs, Schneider Electric SA, Setrans Holding AS, Siemens AG, Wilson Transformer Company, etc.Key Questions Answered How has the global traction transformer market performed so far and how will it perform in the coming years? What are the key regional markets? What is the breakup of the market based on the type? What is the breakup of the market based on the rolling stock? What is the breakup of the market based on the mounting position? What is the breakup of the market based on the overhead line voltage? What are the various stages in the value chain of the industry? What are the key driving factors and challenges in the market? What is the structure of the global traction transformer market and who are the key players? What is the degree of competition in the market? Key Topics Covered 1 Preface2 Scope and Methodology3 Executive Summary4 Introduction4.1 Overview4.2 Key Industry Trends5 Global Traction Transformer Market5.1 Market Overview5.2 Market Performance5.3 Market Forecast6 Market Breakup by Type6.1 Tap Changing6.2 Tapped6.3 Rectifier7 Market Breakup by Rolling Stock7.1 Electric Locomotives7.2 High-Speed Trains7.3 Metros7.4 Others8 Market Breakup by Mounting Position8.1 Underframe8.2 Machine Room8.3 Roof9 Market Breakup by Overhead Line Voltage9.1 Alternative Current (AC) Systems9.2 Direct Current (DC) Systems10 Market Breakup by Region10.1 North America10.2 Europe10.3 Asia Pacific10.4 Latin America10.5 Middle East and Africa11 SWOT Analysis11.1 Overview11.2 Strengths11.3 Weaknesses11.4 Opportunities11.5 Threats12 Value Chain Analysis13 Porters Five Forces Analysis13.1 Overview13.2 Bargaining Power of Buyers13.3 Bargaining Power of Suppliers13.4 Degree of Competition13.5 Threat of New Entrants13.6 Threat of Substitutes14 Price Indicators15 Competitive Landscape15.1 Market Structure15.2 Key Players15.3 Profiles of Key Players15.3.1 ABB Ltd.15.3.1.1 Company Overview15.3.1.2 Product Portfolio 15.3.1.3 Financials15.3.1.4 SWOT Analysis15.3.2 Alstom SA15.3.3 EMCO Limited15.3.4 Hind Rectifiers Limited15.3.5 International Electric Co. Ltd.15.3.6 JST Transformateurs15.3.7 Schneider Electric SA15.3.8 Setrans Holding AS15.3.9 Siemens AG15.3.10 Wilson Transformer CompanyFor more information about this report visit https://www.researchandmarkets.com/r/52d2nd Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research. Media Contact: Research and Markets Laura Wood, Senior Manager [emailprotected]dmarkets.com For E.S.T Office Hours Call +1-917-300-0470 For U.S./CAN Toll Free Call +1-800-526-8630 For GMT Office Hours Call +353-1-416-8900 U.S. Fax: 646-607-1907 Fax (outside U.S.): +353-1-481-1716 SOURCE Research and Markets Related Links http://www.researchandmarkets.com |
edtsum1878 | You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text.
Text: LONDON--(BUSINESS WIRE)--The biopolymers market is expected to grow by 620.37 thousand tons during 2020-2024, according to Technavio. The report offers a detailed analysis of the impact of the COVID-19 pandemic on the biopolymers market in optimistic, probable, and pessimistic forecast scenarios. Get a Free Sample Report Delivered Instantly to know more The biopolymers market will witness a neutral impact during the forecast period owing to the widespread growth of the COVID-19 pandemic. As per Technavios pandemic-focused market research, market growth is likely to increase in 2020 as compared to 2019. The biopolymers market is driven by volatility in crude oil prices. In addition, factors such as strict environmental regulations and policies and increased demand for environment-friendly and sustainable packaging solutions are expected to trigger the biopolymers market toward witnessing a CAGR of over almost 3% during the forecast period. With the continuing spread of the novel coronavirus pandemic, organizations across the globe are gradually flattening their recessionary curve by leveraging technology. Many businesses will go through response, recovery, and renewal phases. Building business resilience and enabling agility will aid organizations to move forward in their journey out of the COVID-19 crisis and towards the Next Normal. This post-pandemic business planning research will aid clients to: Develop Smart Strategies for Your Business: Get a Free Sample Report Now! Key Considerations for Market Forecast: Subscribe to World-Class Market Intelligence and gain instant access to 17,000+ market research reports and connect with expert analysts Related Report on Materials Include: Global Advanced Polymer Composites Market - Global advanced polymer composites market segmentation by fiber type (glass, carbon, and aramide), end-user (aerospace, automotive, energy, marine, and others), and Region (APAC, Europe, MEA, North America, and South America). Click Here to Get an Exclusive Free Sample Report Global Polymer Foam Market - Global polymer foam market segmentation by type (PU, PS, PVC, phenolic, and others), application (packaging, building and construction, furniture and bedding, transportation, and others), and geography (APAC, North America, Europe, MEA, and South America). Click Here to Get an Exclusive Free Sample Report Major Three Biopolymers Market Participants: Archer Daniels Midland Co. Archer Daniels Midland Co. operates its business through segments such as Ag Services and Oilseeds, Carbohydrate Solutions, and Nutrition. The company produces corn and wheat starches and cellulose, soy protein and xanthan bio-polymers. Arkema SA Arkema SA operates its business through segments such as High Performance Materials, Industrial Specialties, and Coating Solutions. The company offers biopolymer impact modifiers under the brand, Biostrength. BASF SE BASF SE operates its business through segments such as Agricultural Solutions and Other. The company offers biopolymers under the brand, ecoflex. Give Your Business a Head Start for 2021: Download Our Free Sample Report Biopolymers Market 2020-2024: Segmentation Biopolymers market is segmented as below: Based on the end-user, the market witnessed maximum demand from the packaging and foodservice sector in 2019. The market growth in the segment will be significant over the forecast period. In 2019, APAC dominated the market with a 33% share. The region will continue to offer several growth opportunities for market players over the forecast period. China and Japan are the key markets for biopolymers in APAC. Get more insights about the global trends impacting the future of the biopolymers market, Request Free Sample Report @ https://www.technavio.com/talk-to-us?report=IRTNTR45591 Market Drivers Market Challenges Market Trends Vendor Landscape About Us Technavio is a leading global technology research and advisory company. Their research and analysis focuses on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions. With over 500 specialized analysts, Technavios report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavios comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.
Answer: | Biopolymers Market will Grow Over 620 Thousand Tons During 2020-2024| Key Vendor Insights and Business Continuity Plan for New Normal | Technavio Shape strategic responses through the phases of industry recovery Archer Daniels Midland Co., Arkema SA, and BASF SE will emerge as major biopolymers market participants during 2020-2024 | LONDON--(BUSINESS WIRE)--The biopolymers market is expected to grow by 620.37 thousand tons during 2020-2024, according to Technavio. The report offers a detailed analysis of the impact of the COVID-19 pandemic on the biopolymers market in optimistic, probable, and pessimistic forecast scenarios. Get a Free Sample Report Delivered Instantly to know more The biopolymers market will witness a neutral impact during the forecast period owing to the widespread growth of the COVID-19 pandemic. As per Technavios pandemic-focused market research, market growth is likely to increase in 2020 as compared to 2019. The biopolymers market is driven by volatility in crude oil prices. In addition, factors such as strict environmental regulations and policies and increased demand for environment-friendly and sustainable packaging solutions are expected to trigger the biopolymers market toward witnessing a CAGR of over almost 3% during the forecast period. With the continuing spread of the novel coronavirus pandemic, organizations across the globe are gradually flattening their recessionary curve by leveraging technology. Many businesses will go through response, recovery, and renewal phases. Building business resilience and enabling agility will aid organizations to move forward in their journey out of the COVID-19 crisis and towards the Next Normal. This post-pandemic business planning research will aid clients to: Develop Smart Strategies for Your Business: Get a Free Sample Report Now! Key Considerations for Market Forecast: Subscribe to World-Class Market Intelligence and gain instant access to 17,000+ market research reports and connect with expert analysts Related Report on Materials Include: Global Advanced Polymer Composites Market - Global advanced polymer composites market segmentation by fiber type (glass, carbon, and aramide), end-user (aerospace, automotive, energy, marine, and others), and Region (APAC, Europe, MEA, North America, and South America). Click Here to Get an Exclusive Free Sample Report Global Polymer Foam Market - Global polymer foam market segmentation by type (PU, PS, PVC, phenolic, and others), application (packaging, building and construction, furniture and bedding, transportation, and others), and geography (APAC, North America, Europe, MEA, and South America). Click Here to Get an Exclusive Free Sample Report Major Three Biopolymers Market Participants: Archer Daniels Midland Co. Archer Daniels Midland Co. operates its business through segments such as Ag Services and Oilseeds, Carbohydrate Solutions, and Nutrition. The company produces corn and wheat starches and cellulose, soy protein and xanthan bio-polymers. Arkema SA Arkema SA operates its business through segments such as High Performance Materials, Industrial Specialties, and Coating Solutions. The company offers biopolymer impact modifiers under the brand, Biostrength. BASF SE BASF SE operates its business through segments such as Agricultural Solutions and Other. The company offers biopolymers under the brand, ecoflex. Give Your Business a Head Start for 2021: Download Our Free Sample Report Biopolymers Market 2020-2024: Segmentation Biopolymers market is segmented as below: Based on the end-user, the market witnessed maximum demand from the packaging and foodservice sector in 2019. The market growth in the segment will be significant over the forecast period. In 2019, APAC dominated the market with a 33% share. The region will continue to offer several growth opportunities for market players over the forecast period. China and Japan are the key markets for biopolymers in APAC. Get more insights about the global trends impacting the future of the biopolymers market, Request Free Sample Report @ https://www.technavio.com/talk-to-us?report=IRTNTR45591 Market Drivers Market Challenges Market Trends Vendor Landscape About Us Technavio is a leading global technology research and advisory company. Their research and analysis focuses on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions. With over 500 specialized analysts, Technavios report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavios comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios. |
edtsum1883 | You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text.
Text: COSTA MESA, Calif., Oct. 22, 2020 /PRNewswire/ --CareCredit,a Synchrony (NYSE:SYF) solution and a leading provider of promotional financing for patients, is now integrated into Open Dental practice management software version 20.3. The new integration is designed to help practice teams save time, increase productivity and provide patients with a financing option in order to make it easier for them to move forward with recommended treatment. CareCredit is now integrated into Open Dental practice management software. This integration is designed save time, increase productivity, and provide patients with a financing option in order to make it easier to move forward with recommended treatment. The integration features CareCredit's Quickscreen, which enables teams to easily identify patients who are pre-approved or that already have an existing CareCredit credit card directly from the Calendar or Family Module even before they visit the office. Knowing who is already approved for CareCredit and who already has a card, can help make the financial conversation easier. Additionally, practices can now process transactions directly from the Patient Account Screen and have them automatically post back to the ledger, helping to save time and minimize human error. Helping patients apply for CareCredit is also easier. When a patient wants to apply, the patient information is automatically transferred to the CareCredit application, so all the team has to do is complete a few fields of information from the patient and click "submit" to receive a credit decision within seconds. "Providing solutions that can help practices streamline processes, enhance productivity and help patients move forward with care, is imperative especially in today's environment" said Doug Hammond, SVP & GM of CareCredit. "CareCredit's integration into Open Dental practice management software is an important part of our ongoing commitment to respond to the needs of the dental community by giving practices easy access to a financing solution that helps remove barriers to recommended care." "As practices continue their efforts to ramp up and address the needs of their patients, CareCredit's integration into the latest version of Open Dental software simply made sense" said Nathan Sparks, CEO of Open Dental. "We know providers rely on our practice management software to effectively manage their business and service their patients. Being able to access CareCredit directly in their Open Dental software helps them to achieve that goal."Practice teams who accept CareCredit and use Open Dental practice management software can watch a demo video of the integration at https://youtu.be/owhEAk6TIdI, learn more at https://www.opendental.com/manual/carecredit.html, or call +1 503-363-5432. Practices not currently accepting CareCredit but are interested in helping maximize treatment acceptance by becoming a part of the CareCredit network should call 800 859-9975 or visit https://www.carecredit.com/providercenter/ to learn more or enroll. About CareCreditCareCredit, a Synchrony solution, is a leading provider of promotional financing to consumers for health, veterinary and personal care procedures, services and products. For more than 30 years, CareCredit has helped millions of people by offering special financing options with convenient monthly payments. CareCredit is accepted at more than 240,000 locations for a wide variety of health and wellness procedures, treatments, products and services.About SynchronySynchrony (NYSE: SYF) is a premier consumer financial services company delivering customized financing programs across key industries including retail, health, auto, travel and home, along with award-winning consumer banking products. With more than $149 billion in sales financed and 75 million active accounts, Synchrony brings deep industry expertise, actionable data insights, innovative solutions and differentiated digital experiences to improve the success of every business we serve and the quality of each life we touch. More information can be found at www.synchrony.com and through Twitter: @Synchrony.CONTACTS:CareCredit: Jeanne DeLeonardo (203) 585-6551 or [emailprotected]2020 Synchrony BankSOURCE Synchrony Financial Related Links http://www.synchrony.com
Answer: | CareCredit Is Now Integrated Into Open Dental Practice Management Software New Integration Makes It Easier To Help More Patients Get Care | COSTA MESA, Calif., Oct. 22, 2020 /PRNewswire/ --CareCredit,a Synchrony (NYSE:SYF) solution and a leading provider of promotional financing for patients, is now integrated into Open Dental practice management software version 20.3. The new integration is designed to help practice teams save time, increase productivity and provide patients with a financing option in order to make it easier for them to move forward with recommended treatment. CareCredit is now integrated into Open Dental practice management software. This integration is designed save time, increase productivity, and provide patients with a financing option in order to make it easier to move forward with recommended treatment. The integration features CareCredit's Quickscreen, which enables teams to easily identify patients who are pre-approved or that already have an existing CareCredit credit card directly from the Calendar or Family Module even before they visit the office. Knowing who is already approved for CareCredit and who already has a card, can help make the financial conversation easier. Additionally, practices can now process transactions directly from the Patient Account Screen and have them automatically post back to the ledger, helping to save time and minimize human error. Helping patients apply for CareCredit is also easier. When a patient wants to apply, the patient information is automatically transferred to the CareCredit application, so all the team has to do is complete a few fields of information from the patient and click "submit" to receive a credit decision within seconds. "Providing solutions that can help practices streamline processes, enhance productivity and help patients move forward with care, is imperative especially in today's environment" said Doug Hammond, SVP & GM of CareCredit. "CareCredit's integration into Open Dental practice management software is an important part of our ongoing commitment to respond to the needs of the dental community by giving practices easy access to a financing solution that helps remove barriers to recommended care." "As practices continue their efforts to ramp up and address the needs of their patients, CareCredit's integration into the latest version of Open Dental software simply made sense" said Nathan Sparks, CEO of Open Dental. "We know providers rely on our practice management software to effectively manage their business and service their patients. Being able to access CareCredit directly in their Open Dental software helps them to achieve that goal."Practice teams who accept CareCredit and use Open Dental practice management software can watch a demo video of the integration at https://youtu.be/owhEAk6TIdI, learn more at https://www.opendental.com/manual/carecredit.html, or call +1 503-363-5432. Practices not currently accepting CareCredit but are interested in helping maximize treatment acceptance by becoming a part of the CareCredit network should call 800 859-9975 or visit https://www.carecredit.com/providercenter/ to learn more or enroll. About CareCreditCareCredit, a Synchrony solution, is a leading provider of promotional financing to consumers for health, veterinary and personal care procedures, services and products. For more than 30 years, CareCredit has helped millions of people by offering special financing options with convenient monthly payments. CareCredit is accepted at more than 240,000 locations for a wide variety of health and wellness procedures, treatments, products and services.About SynchronySynchrony (NYSE: SYF) is a premier consumer financial services company delivering customized financing programs across key industries including retail, health, auto, travel and home, along with award-winning consumer banking products. With more than $149 billion in sales financed and 75 million active accounts, Synchrony brings deep industry expertise, actionable data insights, innovative solutions and differentiated digital experiences to improve the success of every business we serve and the quality of each life we touch. More information can be found at www.synchrony.com and through Twitter: @Synchrony.CONTACTS:CareCredit: Jeanne DeLeonardo (203) 585-6551 or [emailprotected]2020 Synchrony BankSOURCE Synchrony Financial Related Links http://www.synchrony.com |
edtsum1886 | You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text.
Text: BOISE, Idaho--(BUSINESS WIRE)--Kount, the leader in fraud prevention and identity trust, today announced new research that finds the upcoming 2020 holiday season is either a lifetime opportunity or existential threat for many eCommerce companies, as the pandemic has impacted both typical commerce models and consumers spending habits. Of businesses engaged in digital commerce, 84% say that compared to last year, the upcoming holiday season is critical to their business for recovery or survival, with nearly half of respondents saying they will need to catch up on sales in order to recover from the economic downturn. This new research gives the first 360-degree view of eCommerce and fraud prevention this holiday season from the perspective of both eCommerce providers as well as shoppers. The consumer survey of 1,008 adults in the U.S. revealed the driving factors that motivate or disincentivize online shoppers. The business survey, which focused on mid-to-large online retail and eCommerce entities, surveyed 501 employees who were at the manager level and above, revealing major risks and opportunities. Permanent Change in Consumer Shopping Behavior Drives Economic Shift and Digital Acceleration These opportunities, risks and trends in digital acceleration mean businesses need to focus on five key things: Securing and controlling inventory. Supply shortages and the importance of on-time delivery to consumers make it especially important to protect inventory levels. Protecting new and existing eCommerce models. Contactless and convenient options, such as Buy Online, Pick Up in Store (BOPIS); Click-and-Pick and same-day shipping, can make up for reduced in-store sales. Eliminating chargebacks and manual reviews. An increase in eCommerce transaction volumes can correspond to an increase in payment fraud, friendly fraud and chargebacks. Bad actors know that overwhelming volumes and new channels will be key this season, and theyre looking to take advantage. Protecting digital accounts. As shoppers turn to online experiences, many will expect to have loyalty accounts, stored value and saved information readily available. All of these are targets of fraud, and consumers and businesses are thinking about data breaches. Reducing friction can drive conversions and loyalty. With stiff competition for digital business, fast and exceptional customer experiences will be key. Switching costs are low for shoppers, and businesses need to create every advantage to keep them on their site. Unprecedented may be said a lot this year, but this upcoming holiday shopping season truly brings unknowns. Businesses are faced with high stakes and the need to make up for lost revenue, and they must also be scaling and protecting digital commerce, said Brad Wiskirchen, CEO of Kount. Now is the time to be reviewing, analyzing and implementing the resources needed to address the accelerated shift to eCommerce, which is sure to continue beyond this season. Kount has created resources to help businesses navigate this season, as well as provided additional research results, at kount.com/holiday. About Kount Kounts Identity Trust Global Network delivers real-time fraud prevention and account protection and enables personalized customer experiences for more than 9,000 leading brands and payment providers. Linked by Kounts award-winning AI, the Identity Trust Global Network analyzes signals from 32 billion annual interactions to personalize user experiences across the spectrum of trustfrom frictionless experiences to blocking fraud. Quick and accurate identity trust decisions deliver safe payment, account creation and login events while reducing digital fraud, chargebacks, false positives and manual reviews. Kount.com
Answer: | New Research Reveals 84% of eCommerce Providers Consider the 2020 Holiday Season Essential to Recovery or Survival Two parallel Kount surveys of merchants and consumers uncover a divide in perceptions of the 2020 holiday season between lifetime opportunity and existential threat | BOISE, Idaho--(BUSINESS WIRE)--Kount, the leader in fraud prevention and identity trust, today announced new research that finds the upcoming 2020 holiday season is either a lifetime opportunity or existential threat for many eCommerce companies, as the pandemic has impacted both typical commerce models and consumers spending habits. Of businesses engaged in digital commerce, 84% say that compared to last year, the upcoming holiday season is critical to their business for recovery or survival, with nearly half of respondents saying they will need to catch up on sales in order to recover from the economic downturn. This new research gives the first 360-degree view of eCommerce and fraud prevention this holiday season from the perspective of both eCommerce providers as well as shoppers. The consumer survey of 1,008 adults in the U.S. revealed the driving factors that motivate or disincentivize online shoppers. The business survey, which focused on mid-to-large online retail and eCommerce entities, surveyed 501 employees who were at the manager level and above, revealing major risks and opportunities. Permanent Change in Consumer Shopping Behavior Drives Economic Shift and Digital Acceleration These opportunities, risks and trends in digital acceleration mean businesses need to focus on five key things: Securing and controlling inventory. Supply shortages and the importance of on-time delivery to consumers make it especially important to protect inventory levels. Protecting new and existing eCommerce models. Contactless and convenient options, such as Buy Online, Pick Up in Store (BOPIS); Click-and-Pick and same-day shipping, can make up for reduced in-store sales. Eliminating chargebacks and manual reviews. An increase in eCommerce transaction volumes can correspond to an increase in payment fraud, friendly fraud and chargebacks. Bad actors know that overwhelming volumes and new channels will be key this season, and theyre looking to take advantage. Protecting digital accounts. As shoppers turn to online experiences, many will expect to have loyalty accounts, stored value and saved information readily available. All of these are targets of fraud, and consumers and businesses are thinking about data breaches. Reducing friction can drive conversions and loyalty. With stiff competition for digital business, fast and exceptional customer experiences will be key. Switching costs are low for shoppers, and businesses need to create every advantage to keep them on their site. Unprecedented may be said a lot this year, but this upcoming holiday shopping season truly brings unknowns. Businesses are faced with high stakes and the need to make up for lost revenue, and they must also be scaling and protecting digital commerce, said Brad Wiskirchen, CEO of Kount. Now is the time to be reviewing, analyzing and implementing the resources needed to address the accelerated shift to eCommerce, which is sure to continue beyond this season. Kount has created resources to help businesses navigate this season, as well as provided additional research results, at kount.com/holiday. About Kount Kounts Identity Trust Global Network delivers real-time fraud prevention and account protection and enables personalized customer experiences for more than 9,000 leading brands and payment providers. Linked by Kounts award-winning AI, the Identity Trust Global Network analyzes signals from 32 billion annual interactions to personalize user experiences across the spectrum of trustfrom frictionless experiences to blocking fraud. Quick and accurate identity trust decisions deliver safe payment, account creation and login events while reducing digital fraud, chargebacks, false positives and manual reviews. Kount.com |
edtsum1890 | You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text.
Text: NEW YORK, March 29, 2021 /PRNewswire/ --Significantly strengthening its capital markets capabilities and enhancing its position as a global Fintech leader, Broadridge Financial Solutions, Inc. (NYSE:BR), today announced it has signed a definitive agreement to acquire Itiviti Holding AB ("Itiviti"), a leading provider of trading and connectivity technology to the capital markets industry, in an all-cash transaction valued at 2.143 billion (approximately $2.5 billion) from Nordic Capital. "The acquisition of Itiviti enhances Broadridge's position as a global Fintech leader," said Tim Gokey, Broadridge's Chief Executive Officer. "By extending our capabilities into the front office and deepening our multi-asset class solutions, Itiviti significantly strengthens our Capital Markets franchise and better enables Broadridge to help financial institutions adapt to a rapidly evolving marketplace. Itiviti's well-developed footprint in APAC and EMEA will increase our scale outside North America and strengthen our ability to serve our global clients. "The acquisition is also expected to deliver value to our shareholders in the form of stronger recurring revenue growth, higher margins and higher Adjusted EPS. This incremental revenue and earnings growth positions us well to deliver at the higher end of our three-year growth objectives for recurring revenue and Adjusted EPS growth," Mr. Gokey added. Itiviti is a leading global capital markets technology service provider offering highly scalable solutions that financial institutions use to consolidate their trading infrastructure, driving significant cost savings. With offices in 16 countries, Itiviti serves 24 of the top 25 global investment banks and over 2,000 leading brokers, trading firms and asset managers across 50 countries. Itiviti's suite of Trading and Connect solutions offer comprehensive tools to support both connectivity and adaptivity to changing market dynamics and regulatory demands. The solutions and services offered provide financial institutions the flexibility and functionality to serve any trading style across asset classes. Itiviti CEO Rob Mackay stated, "Joining Broadridge represents an exciting next chapter for our business and team by creating a leading front-to-back capital markets technology and operations provider. The combination of our technology, solutions and people will unlock significant value for our clients and drive long-term growth for our combined business." With a focus on front-office trade order and execution management systems, FIX connectivity and network offerings, Itiviti is highly complementary to Broadridge's industry-leading post-trade product suite and other capital markets capabilities. This combination is expected to drive significant value to clients by enabling them to streamline their front-to-back technology stacks, increasing efficiencies, reducing risk and optimizing balance sheet utilization across equities, fixed income, exchange-traded derivatives, and other asset classes. With more than $900 million in combined calendar 2020 revenues, Broadridge's Capital Markets franchise will be even better positioned to help its clients adapt to increasing electronification and algo-driven trading and to mutualize non-differentiating functions to reduce their total cost of ownership. In addition, Itiviti's strong presence in APAC and EMEA will significantly expand Broadridge's revenues outside of North America and enhance Broadridge's international footprint in key markets. Itiviti's blue-chip client base should also provide significant cross-sell opportunities across Broadridge's product portfolio, further enhancing its long-term growth. Itiviti generated recurring revenues of approximately 210 million in calendar year 2020. Its subscription-like revenue model delivers growing and high-quality recurring revenues. Upon closing, Itiviti will become part of Broadridge's Global Technology and Operations segment and its senior management team, led by CEO Rob Mackay, will remain with the company to drive future growth. "Itiviti has experienced a journey of growth and transformation during Nordic Capital's ownership to become a world leading capital markets technology and infrastructure provider," said Fredrik Nslund, partner at Nordic Capital Advisers. "We are immensely proud of the Itiviti team and it's now time for them to take the next step with Broadridge, who is the ideal company to help capitalize on its next-generation technology platform and achieve even further growth and expansion." The acquisition is subject to customary closing conditions and regulatory approval and is expected to close in the fourth quarter of Fiscal Year 2021. Broadridge Positioned to Achieve Higher End of Three-Year Growth Objectives Broadridge is financing the acquisition through a new $2.55 billion term credit agreement. Following the closing, Broadridge expects to maintain an investment grade credit rating and intends to reduce its leverage over the next two years. The Company plans to continue to follow its historical capital allocation priorities, including internal investments, funding a growing dividend, and pursuing additional tuck-in M&A. The acquisition of Itiviti is expected to be accretive to Adjusted EPS in the first full year after closing and generate attractive financial returns for Broadridge's shareholders. In addition, the acquisition is expected to contribute 2.5-3 points to Broadridge's recurring revenue compound annual growth rate ("CAGR") and 2 points to its Adjusted EPS CAGR over the fiscal year 2020-2023 time period. As a result, the Company believes it is well-positioned to achieve the higher end of the three-year 7-9% recurring revenue growth and 8-12% Adjusted EPS growth CAGRs that it presented at its December 2020 Investor Day. Conference Call An analyst conference call will be held today, March 29, 2021 at 8:00 a.m. ET. A live webcast of the call will be available to the public on a listen-only basis. To listen to the live event and access the slide presentation, visit Broadridge's Investor Relations website at www.broadridge-ir.comprior to the start of the webcast. To listen to the call, investors may also dial 1-877-328-2502 within the United States and international callers may dial 1-412-317-5419. A replay of the webcast will be available and can be accessed in the same manner as the live webcast at the Broadridge Investor Relations site. Through April 12, 2021, the recording will also be available by dialing 1-877-344-7529 passcode: 10153707 within the United States or 1-412-317-0088 passcode: 10153707 for international callers. Advisors Houlihan Lokey Inc. and J.P. Morgan Securities LLC acted as financial advisors to Broadridge on this transaction. In addition, Squire Patton Boggs, Roschier Advokatbyr, and Covington & Burling provided legal advice to Broadridge on the acquisition, and Cahill Gordon & Reindel LLP provided legal advice to Broadridge on the financing transaction. Credit Suisse and Morgan Stanley acted as joint financial advisors to Nordic Capital on this transaction. About Broadridge Broadridge Financial Solutions (NYSE: BR), a global Fintech leader with over $4.5 billion in revenues, provides the critical infrastructure that powers investing, corporate governance and communications to enable better financial lives. We deliver technology-driven solutions to banks, broker-dealers, asset and wealth managers and public companies. Broadridge's infrastructure serves as a global communications hub enabling corporate governance by linking thousands of public companies and mutual funds to tens of millions of individual and institutional investors around the world. In addition, Broadridge's technology and operations platforms underpin the daily trading of on average more than U.S. $10 trillion of equities, fixed income and other securities globally. A certified Great Place to Work, Broadridge is a part of the S&P 500 Index, employing over 12,000 associates in 17 countries. For more information about us and what we can do for you, please visit broadridge.com. About Itiviti Itiviti is a leading global capital markets technology service provider offering highly scalable solutions that deliver significant cost savings for financial institutions by enabling them to consolidate their trading infrastructure. The company's modular OEMS (order execution management systems) support multi-asset class, global trading across both principal and agency trading operations. Itiviti's Connect and Trade solution portfolios offer comprehensive tools to support both connectivity, reflective of the growing importance of FIX as the financial markets' universal language, and adaptivity to changing market dynamics and regulatory demands. Headquartered in Stockholm, Sweden, with offices in 16 countries, the company serves over 2,000 customers across 50 countries, including several top-tier banks, brokers, trading firms and asset managers. For more information please visit itiviti.com. About Nordic Capital Nordic Capital is a leading private equity investor with a resolute commitment to creating stronger, sustainable businesses through operational improvement and transformative growth. Nordic Capital focuses on selected regions and sectors where it has deep experience and a long history. Focus sectors are Healthcare, Technology & Payments, Financial Services, and selectively, Industrial & Business Services. Key regions are Europe and globally for Healthcare and Technology & Payments investments. Since inception in 1989, Nordic Capital has invested more than EUR 17 billion in close to 120 investments. The most recent fund is Nordic Capital Fund X with EUR 6.1 billion in committed capital, principally provided by international institutional investors such as pension funds. Nordic Capital Advisors have local offices in Sweden, Denmark, Finland, Norway, Germany, the UK and the US. For further information about Nordic Capital, please visit www.nordiccapital.com. Broadridge Investors:W. Edings ThibaultInvestor Relations(516) 472-5129 Media: Linda NamiasCorporate Communications[emailprotected] (631) 254-7711 Forward-Looking Statements This press release and other written or oral statements made from time to time by representatives of Broadridge may contain "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Statements that are not historical in nature, and which may be identified by the use of words such as "expects," "assumes," "projects," "anticipates," "estimates," "we believe," "could be" and other words of similar meaning, are forward-looking statements. These statements are based on management's expectations and assumptions and are subject to risks and uncertainties that may cause actual results to differ materially from those expressed. These risks and uncertainties include those risk factors discussed in Part I, "Item 1A. Risk Factors" of our Annual Report on Form 10-K for the fiscal year ended June 30, 2020 (the "2020 Annual Report"), as they may be updated in any future reports filed with the Securities and Exchange Commission.All forward-looking statements speak only as of the date of this press release and are expressly qualified in their entirety by reference to the factors discussed in the 2020 Annual Report. These statements are based on management's expectations and assumptions and are subject to risks and uncertainties that may cause actual results to differ materially from those expressed. Factors related to the transactions discussed in this release that could cause actual results to differ materially from those contemplated by the forward-looking statements include: uncertainties as to the timing to consummate the potential transaction; the risk that a condition to closing the potential transaction may not be satisfied; the risk that regulatory approvals are not obtained or are obtained subject to conditions that are not anticipated by the parties; potential litigation relating to the potential transaction that could be instituted; the effects of disruption to Broadridge's or Itiviti's respective businesses; the impact of transaction costs; Broadridge's ability to achieve the benefits from the proposed transaction; Broadridge's ability to effectively integrate the acquired operations into its own operations; the ability of Broadridge to retain and hire key Itiviti personnel; the effects of any unknown liabilities; the diversion of management time on transaction-related issues; and the failure to obtain any financing necessary to complete the acquisition. Factors that could cause actual results to differ materially from those contemplated by the forward-looking statements include: the potential impact and effects of the Covid-19 pandemic ("Covid-19") on the business of Broadridge, Broadridge's results of operations and financial performance, any measures Broadridge has and may take in response to Covid-19 and any expectations Broadridge may have with respect thereto; the success of Broadridge in retaining and selling additional services to its existing clients and in obtaining new clients; Broadridge's reliance on a relatively small number of clients, the continued financial health of those clients, and the continued use by such clients of Broadridge's services with favorable pricing terms; a material security breach or cybersecurity attack affecting the information of Broadridge's clients; changes in laws and regulations affecting Broadridge's clients or the services provided by Broadridge; declines in participation and activity in the securities markets; the failure of Broadridge's key service providers to provide the anticipated levels of service; a disaster or other significant slowdown or failure of Broadridge's systems or error in the performance of Broadridge's services; overall market and economic conditions and their impact on the securities markets; Broadridge's failure to keep pace with changes in technology and the demands of its clients; Broadridge's ability to attract and retain key personnel; the impact of new acquisitions and divestitures; and competitive conditions. There may be other factors that may cause our actual results to differ materially from the forward-looking statements. Our actual results, performance or achievements could differ materially from those expressed in, or implied by, the forward-looking statements. We can give no assurances that any of the events anticipated by the forward-looking statements will occur or, if any of them do, what impact they will have on our results of operations and financial condition. You should carefully read the factors described in the "Risk Factors" section of the 2020 Annual Report for a description of certain risks that could, among other things, cause our actual results to differ from these forward-looking statements. Explanation and Reconciliation of the Company's Use of Non-GAAP Financial Measures This release includes certain Non-GAAP financial measures including Adjusted earnings per share ("EPS"). These Non-GAAP financial measures are not calculated in accordance with U.S. generally accepted accounting principles ("GAAP") and should be viewed in addition to, and not as a substitute for, the Company's reported results. Broadridge believes these Non-GAAP financial measures help investors understand how management plans, measures and evaluates the Company's business performance. Management believes that Non-GAAP measures provide consistency in its financial reporting and facilitates investors' understanding of the Company's operating results and trends by providing an additional basis for comparison. Management uses these Non-GAAP financial measures to, among other things, evaluate our ongoing operations, and for internal planning and forecasting purposes. In addition, and as a consequence of the importance of these Non-GAAP financial measures in managing our business, the Company's Compensation Committee of the Board of Directors incorporates Non-GAAP financial measures in the evaluation process for determining management compensation. Adjusted EPS Non-GAAP measure excludes the impact of certain costs, expenses, gains and losses and other specified items from Broadridge's GAAP results, the exclusion of which management believes provides insight regarding our ongoing operating performance. For purposes of discussing the projected impact of the Itivitiacquisition, certain forecasted results are included. A reconciliation of Non-GAAP forward-looking information to the corresponding GAAP measures cannot be provided without unreasonable efforts due to the inherent difficulty in quantifying certain amounts due to a variety of factors, including the unpredictability in the movement in foreign currency rates, Broadridge's effective tax rate as well as expenses related to the acquisition. SOURCE Broadridge Financial Solutions, Inc. Related Links http://www.broadridge.com
Answer: | Broadridge Extends Capital Markets Franchise with Acquisition of Itiviti | NEW YORK, March 29, 2021 /PRNewswire/ --Significantly strengthening its capital markets capabilities and enhancing its position as a global Fintech leader, Broadridge Financial Solutions, Inc. (NYSE:BR), today announced it has signed a definitive agreement to acquire Itiviti Holding AB ("Itiviti"), a leading provider of trading and connectivity technology to the capital markets industry, in an all-cash transaction valued at 2.143 billion (approximately $2.5 billion) from Nordic Capital. "The acquisition of Itiviti enhances Broadridge's position as a global Fintech leader," said Tim Gokey, Broadridge's Chief Executive Officer. "By extending our capabilities into the front office and deepening our multi-asset class solutions, Itiviti significantly strengthens our Capital Markets franchise and better enables Broadridge to help financial institutions adapt to a rapidly evolving marketplace. Itiviti's well-developed footprint in APAC and EMEA will increase our scale outside North America and strengthen our ability to serve our global clients. "The acquisition is also expected to deliver value to our shareholders in the form of stronger recurring revenue growth, higher margins and higher Adjusted EPS. This incremental revenue and earnings growth positions us well to deliver at the higher end of our three-year growth objectives for recurring revenue and Adjusted EPS growth," Mr. Gokey added. Itiviti is a leading global capital markets technology service provider offering highly scalable solutions that financial institutions use to consolidate their trading infrastructure, driving significant cost savings. With offices in 16 countries, Itiviti serves 24 of the top 25 global investment banks and over 2,000 leading brokers, trading firms and asset managers across 50 countries. Itiviti's suite of Trading and Connect solutions offer comprehensive tools to support both connectivity and adaptivity to changing market dynamics and regulatory demands. The solutions and services offered provide financial institutions the flexibility and functionality to serve any trading style across asset classes. Itiviti CEO Rob Mackay stated, "Joining Broadridge represents an exciting next chapter for our business and team by creating a leading front-to-back capital markets technology and operations provider. The combination of our technology, solutions and people will unlock significant value for our clients and drive long-term growth for our combined business." With a focus on front-office trade order and execution management systems, FIX connectivity and network offerings, Itiviti is highly complementary to Broadridge's industry-leading post-trade product suite and other capital markets capabilities. This combination is expected to drive significant value to clients by enabling them to streamline their front-to-back technology stacks, increasing efficiencies, reducing risk and optimizing balance sheet utilization across equities, fixed income, exchange-traded derivatives, and other asset classes. With more than $900 million in combined calendar 2020 revenues, Broadridge's Capital Markets franchise will be even better positioned to help its clients adapt to increasing electronification and algo-driven trading and to mutualize non-differentiating functions to reduce their total cost of ownership. In addition, Itiviti's strong presence in APAC and EMEA will significantly expand Broadridge's revenues outside of North America and enhance Broadridge's international footprint in key markets. Itiviti's blue-chip client base should also provide significant cross-sell opportunities across Broadridge's product portfolio, further enhancing its long-term growth. Itiviti generated recurring revenues of approximately 210 million in calendar year 2020. Its subscription-like revenue model delivers growing and high-quality recurring revenues. Upon closing, Itiviti will become part of Broadridge's Global Technology and Operations segment and its senior management team, led by CEO Rob Mackay, will remain with the company to drive future growth. "Itiviti has experienced a journey of growth and transformation during Nordic Capital's ownership to become a world leading capital markets technology and infrastructure provider," said Fredrik Nslund, partner at Nordic Capital Advisers. "We are immensely proud of the Itiviti team and it's now time for them to take the next step with Broadridge, who is the ideal company to help capitalize on its next-generation technology platform and achieve even further growth and expansion." The acquisition is subject to customary closing conditions and regulatory approval and is expected to close in the fourth quarter of Fiscal Year 2021. Broadridge Positioned to Achieve Higher End of Three-Year Growth Objectives Broadridge is financing the acquisition through a new $2.55 billion term credit agreement. Following the closing, Broadridge expects to maintain an investment grade credit rating and intends to reduce its leverage over the next two years. The Company plans to continue to follow its historical capital allocation priorities, including internal investments, funding a growing dividend, and pursuing additional tuck-in M&A. The acquisition of Itiviti is expected to be accretive to Adjusted EPS in the first full year after closing and generate attractive financial returns for Broadridge's shareholders. In addition, the acquisition is expected to contribute 2.5-3 points to Broadridge's recurring revenue compound annual growth rate ("CAGR") and 2 points to its Adjusted EPS CAGR over the fiscal year 2020-2023 time period. As a result, the Company believes it is well-positioned to achieve the higher end of the three-year 7-9% recurring revenue growth and 8-12% Adjusted EPS growth CAGRs that it presented at its December 2020 Investor Day. Conference Call An analyst conference call will be held today, March 29, 2021 at 8:00 a.m. ET. A live webcast of the call will be available to the public on a listen-only basis. To listen to the live event and access the slide presentation, visit Broadridge's Investor Relations website at www.broadridge-ir.comprior to the start of the webcast. To listen to the call, investors may also dial 1-877-328-2502 within the United States and international callers may dial 1-412-317-5419. A replay of the webcast will be available and can be accessed in the same manner as the live webcast at the Broadridge Investor Relations site. Through April 12, 2021, the recording will also be available by dialing 1-877-344-7529 passcode: 10153707 within the United States or 1-412-317-0088 passcode: 10153707 for international callers. Advisors Houlihan Lokey Inc. and J.P. Morgan Securities LLC acted as financial advisors to Broadridge on this transaction. In addition, Squire Patton Boggs, Roschier Advokatbyr, and Covington & Burling provided legal advice to Broadridge on the acquisition, and Cahill Gordon & Reindel LLP provided legal advice to Broadridge on the financing transaction. Credit Suisse and Morgan Stanley acted as joint financial advisors to Nordic Capital on this transaction. About Broadridge Broadridge Financial Solutions (NYSE: BR), a global Fintech leader with over $4.5 billion in revenues, provides the critical infrastructure that powers investing, corporate governance and communications to enable better financial lives. We deliver technology-driven solutions to banks, broker-dealers, asset and wealth managers and public companies. Broadridge's infrastructure serves as a global communications hub enabling corporate governance by linking thousands of public companies and mutual funds to tens of millions of individual and institutional investors around the world. In addition, Broadridge's technology and operations platforms underpin the daily trading of on average more than U.S. $10 trillion of equities, fixed income and other securities globally. A certified Great Place to Work, Broadridge is a part of the S&P 500 Index, employing over 12,000 associates in 17 countries. For more information about us and what we can do for you, please visit broadridge.com. About Itiviti Itiviti is a leading global capital markets technology service provider offering highly scalable solutions that deliver significant cost savings for financial institutions by enabling them to consolidate their trading infrastructure. The company's modular OEMS (order execution management systems) support multi-asset class, global trading across both principal and agency trading operations. Itiviti's Connect and Trade solution portfolios offer comprehensive tools to support both connectivity, reflective of the growing importance of FIX as the financial markets' universal language, and adaptivity to changing market dynamics and regulatory demands. Headquartered in Stockholm, Sweden, with offices in 16 countries, the company serves over 2,000 customers across 50 countries, including several top-tier banks, brokers, trading firms and asset managers. For more information please visit itiviti.com. About Nordic Capital Nordic Capital is a leading private equity investor with a resolute commitment to creating stronger, sustainable businesses through operational improvement and transformative growth. Nordic Capital focuses on selected regions and sectors where it has deep experience and a long history. Focus sectors are Healthcare, Technology & Payments, Financial Services, and selectively, Industrial & Business Services. Key regions are Europe and globally for Healthcare and Technology & Payments investments. Since inception in 1989, Nordic Capital has invested more than EUR 17 billion in close to 120 investments. The most recent fund is Nordic Capital Fund X with EUR 6.1 billion in committed capital, principally provided by international institutional investors such as pension funds. Nordic Capital Advisors have local offices in Sweden, Denmark, Finland, Norway, Germany, the UK and the US. For further information about Nordic Capital, please visit www.nordiccapital.com. Broadridge Investors:W. Edings ThibaultInvestor Relations(516) 472-5129 Media: Linda NamiasCorporate Communications[emailprotected] (631) 254-7711 Forward-Looking Statements This press release and other written or oral statements made from time to time by representatives of Broadridge may contain "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Statements that are not historical in nature, and which may be identified by the use of words such as "expects," "assumes," "projects," "anticipates," "estimates," "we believe," "could be" and other words of similar meaning, are forward-looking statements. These statements are based on management's expectations and assumptions and are subject to risks and uncertainties that may cause actual results to differ materially from those expressed. These risks and uncertainties include those risk factors discussed in Part I, "Item 1A. Risk Factors" of our Annual Report on Form 10-K for the fiscal year ended June 30, 2020 (the "2020 Annual Report"), as they may be updated in any future reports filed with the Securities and Exchange Commission.All forward-looking statements speak only as of the date of this press release and are expressly qualified in their entirety by reference to the factors discussed in the 2020 Annual Report. These statements are based on management's expectations and assumptions and are subject to risks and uncertainties that may cause actual results to differ materially from those expressed. Factors related to the transactions discussed in this release that could cause actual results to differ materially from those contemplated by the forward-looking statements include: uncertainties as to the timing to consummate the potential transaction; the risk that a condition to closing the potential transaction may not be satisfied; the risk that regulatory approvals are not obtained or are obtained subject to conditions that are not anticipated by the parties; potential litigation relating to the potential transaction that could be instituted; the effects of disruption to Broadridge's or Itiviti's respective businesses; the impact of transaction costs; Broadridge's ability to achieve the benefits from the proposed transaction; Broadridge's ability to effectively integrate the acquired operations into its own operations; the ability of Broadridge to retain and hire key Itiviti personnel; the effects of any unknown liabilities; the diversion of management time on transaction-related issues; and the failure to obtain any financing necessary to complete the acquisition. Factors that could cause actual results to differ materially from those contemplated by the forward-looking statements include: the potential impact and effects of the Covid-19 pandemic ("Covid-19") on the business of Broadridge, Broadridge's results of operations and financial performance, any measures Broadridge has and may take in response to Covid-19 and any expectations Broadridge may have with respect thereto; the success of Broadridge in retaining and selling additional services to its existing clients and in obtaining new clients; Broadridge's reliance on a relatively small number of clients, the continued financial health of those clients, and the continued use by such clients of Broadridge's services with favorable pricing terms; a material security breach or cybersecurity attack affecting the information of Broadridge's clients; changes in laws and regulations affecting Broadridge's clients or the services provided by Broadridge; declines in participation and activity in the securities markets; the failure of Broadridge's key service providers to provide the anticipated levels of service; a disaster or other significant slowdown or failure of Broadridge's systems or error in the performance of Broadridge's services; overall market and economic conditions and their impact on the securities markets; Broadridge's failure to keep pace with changes in technology and the demands of its clients; Broadridge's ability to attract and retain key personnel; the impact of new acquisitions and divestitures; and competitive conditions. There may be other factors that may cause our actual results to differ materially from the forward-looking statements. Our actual results, performance or achievements could differ materially from those expressed in, or implied by, the forward-looking statements. We can give no assurances that any of the events anticipated by the forward-looking statements will occur or, if any of them do, what impact they will have on our results of operations and financial condition. You should carefully read the factors described in the "Risk Factors" section of the 2020 Annual Report for a description of certain risks that could, among other things, cause our actual results to differ from these forward-looking statements. Explanation and Reconciliation of the Company's Use of Non-GAAP Financial Measures This release includes certain Non-GAAP financial measures including Adjusted earnings per share ("EPS"). These Non-GAAP financial measures are not calculated in accordance with U.S. generally accepted accounting principles ("GAAP") and should be viewed in addition to, and not as a substitute for, the Company's reported results. Broadridge believes these Non-GAAP financial measures help investors understand how management plans, measures and evaluates the Company's business performance. Management believes that Non-GAAP measures provide consistency in its financial reporting and facilitates investors' understanding of the Company's operating results and trends by providing an additional basis for comparison. Management uses these Non-GAAP financial measures to, among other things, evaluate our ongoing operations, and for internal planning and forecasting purposes. In addition, and as a consequence of the importance of these Non-GAAP financial measures in managing our business, the Company's Compensation Committee of the Board of Directors incorporates Non-GAAP financial measures in the evaluation process for determining management compensation. Adjusted EPS Non-GAAP measure excludes the impact of certain costs, expenses, gains and losses and other specified items from Broadridge's GAAP results, the exclusion of which management believes provides insight regarding our ongoing operating performance. For purposes of discussing the projected impact of the Itivitiacquisition, certain forecasted results are included. A reconciliation of Non-GAAP forward-looking information to the corresponding GAAP measures cannot be provided without unreasonable efforts due to the inherent difficulty in quantifying certain amounts due to a variety of factors, including the unpredictability in the movement in foreign currency rates, Broadridge's effective tax rate as well as expenses related to the acquisition. SOURCE Broadridge Financial Solutions, Inc. Related Links http://www.broadridge.com |
edtsum1891 | You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text.
Text: CHICAGO, March 31, 2021 /PRNewswire/ --Opportunity Financial, LLC ("OppFi"), a leading financial technology platform that powers banks to help the everyday consumer gain access to credit, announced today that it has entered into an agreement with financial care platformBrightside to provide small dollar loans to non-prime borrowers at prime rates via OppFi's new loan product, SalaryTap. SalaryTap is a multiyear small dollar installment loan product offered through employers that ranges from $2,000 to $6,000, extending prime pricing to non-prime consumers, and is repaid via payroll deduction. The product is fully transparent with no additional fees or charges levied on borrowers, and loan amounts are based on each borrower's income as a means of assessing loan affordability. The agreement with Brightside is the first publicly announced arrangement for SalaryTap as OppFi expands this offering to a growing number of employers and distribution channels. Through this arrangement, OppFi believes SalaryTap will directly reach thousands of consumers working in industries ranging from healthcare and telecom to retail and manufacturing. "We are excited to work with Brightside to expand access to credit for the everyday consumer with products that support our mission to build financial inclusion," said Jared Kaplan, chief executive officer of OppFi. "As we expand our offering for the 60 million consumers locked out of traditional options, we believe working with companies like Brightside will create a win-win proposition with more credit options for more consumers who need them." "We focus on improving outcomes for working families and their employers by reducing financial stress, using a holistic and innovative Financial Care approach and a suite of partners that provide real solutions for working families." said Tom Spann, CEO of Brightside. "OppFi is creatively solving the credit access issue for those who need it most and we are proud to deliver its innovative and transparent solutions to employees via our platform." Other early-stage SalaryTap pilots performed directly with employers have been underway since November 2020. The most common uses of funds for SalaryTap have been car repair, family needs, housing costs, and medical bills. A national roll-out for SalaryTap is planned for the second quarter of 2021. On February 9, 2021, OppFi and FG New America Acquisition Corp. (NYSE: FGNA), a special purpose acquisition corporation, entered into a definitive agreement for a business combination that would result in OppFi becoming a public company. About OppFi OppFi a leading financial technology platform that powers banks to help the everyday consumer gain access to credit. Through its unwavering commitment to customer service, OppFi helps consumers who are turned away by traditional providers build a better financial path. OppFi has facilitated the issuance of more than 1.5 million loans. The company has been ranked as an Inc. 5000 company for five straight years and was named the eighth fastest-growing Chicagoland company in 2020 by Crain's Chicago Business. The company was also named on Forbes America 2021 list of America's Best Startup Employers and Built In's 2021 Best Places to Work in Chicago. The company maintains an A+ rating from the Better Business Bureau (BBB) and maintains a 4.9/5 star rating with more than 14,000 online customer reviews, making it one of the top customer-rated financial platforms online. For more information, please visit www.oppfi.com. About FGNA FG New America Acquisition Corp., (NYSE: FGNA), is a NYSE-listed blank check company formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses. For more information, please visit www.fgnewamerica.com. About Brightside Founded in 2017, Brightside is the first employer-based financial care platform to drive meaningful ROI for employers by making paychecks go farther for the 72% of Americans who are not financially healthy.1With a combination of expert Financial Assistants, a proprietary rules engine, and innovative financial products, Brightside delivers an average of $1,200 savings annually to each of the thousands of families it serves. In addition, employers experience improved productivity, retention, diversity, and lower healthcare costs. Brightside is backed by Andreessen Horowitz (a16z), Trinity Ventures, and Comcast Ventures. For more information, please visit:https://www.gobrightside.com. Contact: [emailprotected] 1https://finhealthnetwork.org/research/u-s-financial-health-pulse-2018-baseline-survey-results/ Forward-Looking Statements This press release includes "forward-looking statements" within the meaning of the "safe harbor" provisions of the Private Securities Litigation Reform Act of 1995. OppFi's actual results may differ from its beliefs, expectations, estimates and projections and consequently, you should not rely on these forward-looking statements as predictions of future events. Words such as "expect," "estimate," "project," "budget," "forecast," "anticipate," "intend," "plan," "may," "will," "could," "should," "believes," "predicts," "potential," "continue," and similar expressions are intended to identify such forward-looking statements. These forward-looking statements include, without limitation, OppFi's beliefs regarding SalaryTap and SalaryTap's market and performance. These forward-looking statements involve significant risks and uncertainties that could cause the actual results to differ materially from the expected results. Most of these factors are outside OppFi's control and are difficult to predict. Factors that may cause such differences include, but are not limited to: (1) the occurrence of any event, change or other circumstances that could give rise to the termination of the definitive business combination agreement (the "Agreement") relating to the proposed business combination between FG New America Acquisition Corp. ("FGNA") and OppFi; (2) the outcome of any legal proceedings that may be instituted against FGNA and OppFi following the announcement of the Agreement and the transactions contemplated therein; (3) the inability to complete the proposed business combination, including due to failure to obtain approval of the stockholders of FGNA, certain regulatory approvals or satisfy other conditions to closing in the Agreement, including with respect to the levels of FGNA stockholder redemptions; (4) the occurrence of any event, change or other circumstance that could give rise to the termination of the Agreement or could otherwise cause the transaction to fail to close; (5) the impact of COVID-19 on OppFi's business or Brightside's business and/or the ability of FGNA and OppFi to complete the proposed business combination; (6) the inability to obtain or maintain the listing of the combined company's shares of common stock on the New York Stock Exchange following the proposed business combination; (7) the risk that the proposed business combination disrupts OppFi's current plans and operations, including with respect to SalaryTap, as a result of the announcement and consummation of the proposed business combination; (8) the ability to recognize the anticipated benefits of the proposed business combination, which may be affected by, among other things, competition, the ability of OppFi to grow and manage growth profitably and retain its key employees; (9) costs related to the proposed business combination; (10) changes in applicable laws or regulations; (11) the possibility that OppFi, Brightside or FGNA may be adversely affected by other economic, business, and/or competitive factors; and (12) other risks and uncertainties indicated from time to time in the proxy statement filed by FGNA, including those under "Risk Factors" included therein, and in FGNA's other filings with the SEC. The foregoing list of factors is not exclusive. OppFi cautions readers not to place undue reliance upon any forward-looking statements, which speak only as of the date made. None of OppFi, Brightside or FGNA undertake or accept any obligation or undertaking to release publicly any updates or revisions to any forward-looking statements to reflect any change in its expectations or any change in events, conditions or circumstances on which any such statement is based. Important Information and Where to Find It In connection with the proposed business combination, FGNA filed a preliminary proxy statement and will file a definitive proxy statement with the SEC. FGNA's stockholders and other interested persons are advised to read the preliminary proxy statement and the amendments thereto and, when available, the definitive proxy statement and documents incorporated by reference therein filed in connection with the proposed business combination, as these materials contain important information about OppFi, FGNA and the proposed business combination. When available, the definitive proxy statement and other relevant materials for the proposed business combination will be mailed to stockholders of FGNA as of the record dateestablished for voting on the proposed business combination. Stockholders will also be able to obtain copies of the preliminary proxy statement, the definitive proxy statement and other documents filed with the SEC that will be incorporated by reference therein, without charge, once available, at the SEC's web site at www.sec.gov, or by directing a request to: FG New America Acquisition Corp., Attention: Hassan Baqar, Chief Financial Officer, 105 S. Maple Street, Itasca, Illinois 60143. Participants in the Solicitation FGNA and its directors and executive officers may be deemed participants in the solicitation of proxies from FGNA's stockholders with respect to the business combination. A list of the names of those directors and executive officers and a description of their interests in FGNA was filed in the preliminary proxy statement for the proposed business combination and is available at www.sec.gov. Additional information regarding the interests of such participants will be contained in the definitive proxy statement for the proposed business combination when available. OppFi and its directors and executive officers may also be deemed to be participants in the solicitation of proxies from the stockholders of FGNA in connection with the business combination. A list of the names of such directors and executive officers and information regarding their interests in the proposed business combination was included in the preliminary proxy statement for the proposed business combination. Additional information regarding the interests of such participants will be contained in the definitive proxy statement for the proposed business combination when available. Non-Solicitation This press release shall not constitute a solicitation of a proxy, consent or authorization with respect to any securities or in respect of the proposed business combination. This press release shall also not constitute an offer to sell or the solicitation of an offer to buy any securities, nor shall there be any sale of securities in any states or jurisdictions in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such jurisdiction. No offering of securities shall be made except by means of a prospectus meeting the requirements of Section 10 of the Securities Act of 1933, as amended. SOURCE OppFi
Answer: | OppFi Announces Agreement with Brightside to Leverage Payroll Deduction for Non-Prime Borrowers | CHICAGO, March 31, 2021 /PRNewswire/ --Opportunity Financial, LLC ("OppFi"), a leading financial technology platform that powers banks to help the everyday consumer gain access to credit, announced today that it has entered into an agreement with financial care platformBrightside to provide small dollar loans to non-prime borrowers at prime rates via OppFi's new loan product, SalaryTap. SalaryTap is a multiyear small dollar installment loan product offered through employers that ranges from $2,000 to $6,000, extending prime pricing to non-prime consumers, and is repaid via payroll deduction. The product is fully transparent with no additional fees or charges levied on borrowers, and loan amounts are based on each borrower's income as a means of assessing loan affordability. The agreement with Brightside is the first publicly announced arrangement for SalaryTap as OppFi expands this offering to a growing number of employers and distribution channels. Through this arrangement, OppFi believes SalaryTap will directly reach thousands of consumers working in industries ranging from healthcare and telecom to retail and manufacturing. "We are excited to work with Brightside to expand access to credit for the everyday consumer with products that support our mission to build financial inclusion," said Jared Kaplan, chief executive officer of OppFi. "As we expand our offering for the 60 million consumers locked out of traditional options, we believe working with companies like Brightside will create a win-win proposition with more credit options for more consumers who need them." "We focus on improving outcomes for working families and their employers by reducing financial stress, using a holistic and innovative Financial Care approach and a suite of partners that provide real solutions for working families." said Tom Spann, CEO of Brightside. "OppFi is creatively solving the credit access issue for those who need it most and we are proud to deliver its innovative and transparent solutions to employees via our platform." Other early-stage SalaryTap pilots performed directly with employers have been underway since November 2020. The most common uses of funds for SalaryTap have been car repair, family needs, housing costs, and medical bills. A national roll-out for SalaryTap is planned for the second quarter of 2021. On February 9, 2021, OppFi and FG New America Acquisition Corp. (NYSE: FGNA), a special purpose acquisition corporation, entered into a definitive agreement for a business combination that would result in OppFi becoming a public company. About OppFi OppFi a leading financial technology platform that powers banks to help the everyday consumer gain access to credit. Through its unwavering commitment to customer service, OppFi helps consumers who are turned away by traditional providers build a better financial path. OppFi has facilitated the issuance of more than 1.5 million loans. The company has been ranked as an Inc. 5000 company for five straight years and was named the eighth fastest-growing Chicagoland company in 2020 by Crain's Chicago Business. The company was also named on Forbes America 2021 list of America's Best Startup Employers and Built In's 2021 Best Places to Work in Chicago. The company maintains an A+ rating from the Better Business Bureau (BBB) and maintains a 4.9/5 star rating with more than 14,000 online customer reviews, making it one of the top customer-rated financial platforms online. For more information, please visit www.oppfi.com. About FGNA FG New America Acquisition Corp., (NYSE: FGNA), is a NYSE-listed blank check company formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses. For more information, please visit www.fgnewamerica.com. About Brightside Founded in 2017, Brightside is the first employer-based financial care platform to drive meaningful ROI for employers by making paychecks go farther for the 72% of Americans who are not financially healthy.1With a combination of expert Financial Assistants, a proprietary rules engine, and innovative financial products, Brightside delivers an average of $1,200 savings annually to each of the thousands of families it serves. In addition, employers experience improved productivity, retention, diversity, and lower healthcare costs. Brightside is backed by Andreessen Horowitz (a16z), Trinity Ventures, and Comcast Ventures. For more information, please visit:https://www.gobrightside.com. Contact: [emailprotected] 1https://finhealthnetwork.org/research/u-s-financial-health-pulse-2018-baseline-survey-results/ Forward-Looking Statements This press release includes "forward-looking statements" within the meaning of the "safe harbor" provisions of the Private Securities Litigation Reform Act of 1995. OppFi's actual results may differ from its beliefs, expectations, estimates and projections and consequently, you should not rely on these forward-looking statements as predictions of future events. Words such as "expect," "estimate," "project," "budget," "forecast," "anticipate," "intend," "plan," "may," "will," "could," "should," "believes," "predicts," "potential," "continue," and similar expressions are intended to identify such forward-looking statements. These forward-looking statements include, without limitation, OppFi's beliefs regarding SalaryTap and SalaryTap's market and performance. These forward-looking statements involve significant risks and uncertainties that could cause the actual results to differ materially from the expected results. Most of these factors are outside OppFi's control and are difficult to predict. Factors that may cause such differences include, but are not limited to: (1) the occurrence of any event, change or other circumstances that could give rise to the termination of the definitive business combination agreement (the "Agreement") relating to the proposed business combination between FG New America Acquisition Corp. ("FGNA") and OppFi; (2) the outcome of any legal proceedings that may be instituted against FGNA and OppFi following the announcement of the Agreement and the transactions contemplated therein; (3) the inability to complete the proposed business combination, including due to failure to obtain approval of the stockholders of FGNA, certain regulatory approvals or satisfy other conditions to closing in the Agreement, including with respect to the levels of FGNA stockholder redemptions; (4) the occurrence of any event, change or other circumstance that could give rise to the termination of the Agreement or could otherwise cause the transaction to fail to close; (5) the impact of COVID-19 on OppFi's business or Brightside's business and/or the ability of FGNA and OppFi to complete the proposed business combination; (6) the inability to obtain or maintain the listing of the combined company's shares of common stock on the New York Stock Exchange following the proposed business combination; (7) the risk that the proposed business combination disrupts OppFi's current plans and operations, including with respect to SalaryTap, as a result of the announcement and consummation of the proposed business combination; (8) the ability to recognize the anticipated benefits of the proposed business combination, which may be affected by, among other things, competition, the ability of OppFi to grow and manage growth profitably and retain its key employees; (9) costs related to the proposed business combination; (10) changes in applicable laws or regulations; (11) the possibility that OppFi, Brightside or FGNA may be adversely affected by other economic, business, and/or competitive factors; and (12) other risks and uncertainties indicated from time to time in the proxy statement filed by FGNA, including those under "Risk Factors" included therein, and in FGNA's other filings with the SEC. The foregoing list of factors is not exclusive. OppFi cautions readers not to place undue reliance upon any forward-looking statements, which speak only as of the date made. None of OppFi, Brightside or FGNA undertake or accept any obligation or undertaking to release publicly any updates or revisions to any forward-looking statements to reflect any change in its expectations or any change in events, conditions or circumstances on which any such statement is based. Important Information and Where to Find It In connection with the proposed business combination, FGNA filed a preliminary proxy statement and will file a definitive proxy statement with the SEC. FGNA's stockholders and other interested persons are advised to read the preliminary proxy statement and the amendments thereto and, when available, the definitive proxy statement and documents incorporated by reference therein filed in connection with the proposed business combination, as these materials contain important information about OppFi, FGNA and the proposed business combination. When available, the definitive proxy statement and other relevant materials for the proposed business combination will be mailed to stockholders of FGNA as of the record dateestablished for voting on the proposed business combination. Stockholders will also be able to obtain copies of the preliminary proxy statement, the definitive proxy statement and other documents filed with the SEC that will be incorporated by reference therein, without charge, once available, at the SEC's web site at www.sec.gov, or by directing a request to: FG New America Acquisition Corp., Attention: Hassan Baqar, Chief Financial Officer, 105 S. Maple Street, Itasca, Illinois 60143. Participants in the Solicitation FGNA and its directors and executive officers may be deemed participants in the solicitation of proxies from FGNA's stockholders with respect to the business combination. A list of the names of those directors and executive officers and a description of their interests in FGNA was filed in the preliminary proxy statement for the proposed business combination and is available at www.sec.gov. Additional information regarding the interests of such participants will be contained in the definitive proxy statement for the proposed business combination when available. OppFi and its directors and executive officers may also be deemed to be participants in the solicitation of proxies from the stockholders of FGNA in connection with the business combination. A list of the names of such directors and executive officers and information regarding their interests in the proposed business combination was included in the preliminary proxy statement for the proposed business combination. Additional information regarding the interests of such participants will be contained in the definitive proxy statement for the proposed business combination when available. Non-Solicitation This press release shall not constitute a solicitation of a proxy, consent or authorization with respect to any securities or in respect of the proposed business combination. This press release shall also not constitute an offer to sell or the solicitation of an offer to buy any securities, nor shall there be any sale of securities in any states or jurisdictions in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such jurisdiction. No offering of securities shall be made except by means of a prospectus meeting the requirements of Section 10 of the Securities Act of 1933, as amended. SOURCE OppFi |
edtsum1893 | You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text.
Text: CHICAGO, March 25, 2020 /PRNewswire/ --Starting today, companies with fleets that are tasked with moving goods to meet the COVID-19 demand can register for free Uptake predictive maintenance software. With the help of AI-enabled predictive maintenance tools, vehicles transporting food, personal wellness, and medical supplies will be less likely to break down, ensuring our hospitals and communities receive necessities in a timely manner. As COVID-19 spreads throughout our world, consumers continue to pack their carts in response to the pandemic. Grocery store shelves are empty, Target and Walmart shelves are bare of everyday items, and Amazon is suspending shipments of all nonessential products to its warehouses. The headline across the globe has become: Demand is high, supply is low. The delivery of supplies and the restocking of shelves is crucial, which is dependent on the trucks and vehicles that transport those goods into each community. There are an estimated 3.5 million Class 8 trucks on American roads todayand over 5.7 million commercial drivers. Roadside truck breakdowns occur every 10,000 miles. With the current COVID-19 pandemic, these breakdowns must be reduced to ensure the on-time delivery of essential goods and critical supplies. "Uptake has worked with some of the largest fleets in America to reduce on-road breakdowns by 20%. Given the current environment, we want our software to be available to fleet operators who are responsible for delivering essential items to our nation's communities," shares Braden Pastalaniec, VP of Transportation for Uptake. "Our technology is uniquely capable of helping in today's climate and we are pleased to make it available for free to those who might benefit." Uptake can immediately start working with fleets of any size that currently utilize a Geotab telematics device and have either a Pro or ProPlus rate package. Once vehicle data is securely obtained, maintenance recommendations will be delivered within days, allowing fleet maintenance operators to turn mountains of data and hundreds of notifications into actionable insights. The COVID-19 demand calls for the trucking industry to optimize how maintenance is conducted, shifting simple preventive schedules into full predictive strategies. LEARN MORE AND SIGNUP FOR FREE PREDICTIVE MAINTENANCE SOFTWARE, EMAIL:[emailprotected]VP of Transportation for Uptake ABOUT UPTAKEUptake is the intelligence system for industrial assets. Providing an AI-driven asset management solution that bridges the gap between industrial assets and front-line workers, Uptake gives all departmentsincluding maintenance, operations, finance and salesa single, shared view of every asset in an operation. With the power of machine learning (ML) and artificial intelligence (AI), Uptake helps customers monitor and increase the availability of assets, improve asset reliability, and streamline operations. Recognized for leadership in industrial IoT (IIoT) by the World Economic Forum, CNBC and Forbes, Uptake is headquartered in Chicago with presence in Canada, South America, and Australia. To stay up-to-date on what we're doing, visit us at www.uptake.com and follow us on Twitter and LinkedIn. MEDIA CONTACTMorgan Scott, Director of Communications (312) 465-6345[emailprotected] SOURCE Uptake Related Links http://www.uptake.com
Answer: | Uptake Offers Free Predictive Maintenance Software to Fleet Operators During COVID-19 To ensure the reliability of trucks that move essential goods, Uptake is offering its AI-enabled software during the global pandemic | CHICAGO, March 25, 2020 /PRNewswire/ --Starting today, companies with fleets that are tasked with moving goods to meet the COVID-19 demand can register for free Uptake predictive maintenance software. With the help of AI-enabled predictive maintenance tools, vehicles transporting food, personal wellness, and medical supplies will be less likely to break down, ensuring our hospitals and communities receive necessities in a timely manner. As COVID-19 spreads throughout our world, consumers continue to pack their carts in response to the pandemic. Grocery store shelves are empty, Target and Walmart shelves are bare of everyday items, and Amazon is suspending shipments of all nonessential products to its warehouses. The headline across the globe has become: Demand is high, supply is low. The delivery of supplies and the restocking of shelves is crucial, which is dependent on the trucks and vehicles that transport those goods into each community. There are an estimated 3.5 million Class 8 trucks on American roads todayand over 5.7 million commercial drivers. Roadside truck breakdowns occur every 10,000 miles. With the current COVID-19 pandemic, these breakdowns must be reduced to ensure the on-time delivery of essential goods and critical supplies. "Uptake has worked with some of the largest fleets in America to reduce on-road breakdowns by 20%. Given the current environment, we want our software to be available to fleet operators who are responsible for delivering essential items to our nation's communities," shares Braden Pastalaniec, VP of Transportation for Uptake. "Our technology is uniquely capable of helping in today's climate and we are pleased to make it available for free to those who might benefit." Uptake can immediately start working with fleets of any size that currently utilize a Geotab telematics device and have either a Pro or ProPlus rate package. Once vehicle data is securely obtained, maintenance recommendations will be delivered within days, allowing fleet maintenance operators to turn mountains of data and hundreds of notifications into actionable insights. The COVID-19 demand calls for the trucking industry to optimize how maintenance is conducted, shifting simple preventive schedules into full predictive strategies. LEARN MORE AND SIGNUP FOR FREE PREDICTIVE MAINTENANCE SOFTWARE, EMAIL:[emailprotected]VP of Transportation for Uptake ABOUT UPTAKEUptake is the intelligence system for industrial assets. Providing an AI-driven asset management solution that bridges the gap between industrial assets and front-line workers, Uptake gives all departmentsincluding maintenance, operations, finance and salesa single, shared view of every asset in an operation. With the power of machine learning (ML) and artificial intelligence (AI), Uptake helps customers monitor and increase the availability of assets, improve asset reliability, and streamline operations. Recognized for leadership in industrial IoT (IIoT) by the World Economic Forum, CNBC and Forbes, Uptake is headquartered in Chicago with presence in Canada, South America, and Australia. To stay up-to-date on what we're doing, visit us at www.uptake.com and follow us on Twitter and LinkedIn. MEDIA CONTACTMorgan Scott, Director of Communications (312) 465-6345[emailprotected] SOURCE Uptake Related Links http://www.uptake.com |
edtsum1898 | You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text.
Text: SALT LAKE CITY--(BUSINESS WIRE)--As the economy slows under the COVID-19 pandemic, the Women Tech Council (WTC), a national organization focused on the economic impact of women in technology, is strengthening the workforce and technology economy by joining other key organizations to launch the Women Tech Talent Pipeline Alliance. The alliance will focus on programs that create activation into technology and STEM careers for women of color, moms and women returning to the workforce, refugees and immigrants. With the pandemic impacting women significantly more than men in the workforce, it has never been more important to focus on increasing the number of women in tech, said Cydni Tetro, president of WTC. By uniting these organizations to expand the talent pipeline and include more of these women, we will change the trajectories of their careers and families, strengthen our economy, and increase the impact of women in tech at this critical time. The Alliance brings together WTC, the Governor's Office of Economic Development, Code in Color, Latinas in Tech Utah (LiT), the Department of Workforce Services, United Way and RizeNext Tech-Moms. Together, these organizations will increase access to resources and opportunities, and provide support through role models and mentors for more women, especially women of color and women returning to the workforce. Ultimately, adding these women to the technology workforce will positively impact them and their families, provide tech companies needed talent and bolster the long-term health and growth of the economy. "We are thrilled to be a part of this exciting initiative to bring women in the technology workforce, said Mary Cardon, director of the Utah Industry and Innovation Center at the Governors Office of Economic Development. The Alliance will help our state become stronger and more diverse and allow women and the companies they work for to reach their highest potential. Its imperative that the tech industry continue to make strides toward a more equitable and inclusive industry, and I am pleased to take this important step toward change alongside Women Tech Council, Latinas In Tech Utah and other phenomenal organizations, said Karen Rodriguez La Paz, founder and CEO of Code In Color. By banding together, we will enter a new chapter of transformational growth, leadership and change, and continue to bring education and financial wealth to the black and brown women who rightfully deserve a seat at the table. "At LiT, our mission is to connect, support and empower Latina women working in tech. This alliance with Women Tech Council, Code in Color, RizeNext Tech-Moms and other great organizations is going to help us bridge the gap and break the stigma of Latina women working in the tech ecosystem," said Donnaly Crull, chair of the Latinas in Tech Utah Chapter. "With a larger pool of resources to offer to our community, such as education through mentorship, community connections and the ability to access a wide network of potential career opportunities, we can empower more Latina women into the tech workforce. Our team is ready to get the work started. "As part of our Department of Labor Apprenticeship State Expansion grant, Workforce Services seeks to diversify the candidate pool for apprentices in tech to include women, veterans and people of color. We believe that being part of this alliance and leveraging the efforts and resources of these great partners will help us to meet these diversity goals and will begin to change the landscape of what Utah's tech workforce looks like, while meeting the demand of the business community," said Melisa Stark, Commissioner of Apprenticeship Programs. "United Way of Utah County is thrilled to be a part of this Alliance to strengthen and increase access to technology in our community," said Bill Hulterstrom, president and CEO of United Way of Utah County. "United Way sees digital inclusion as a way to elevate our community. Providing technology education and access to equipment creates community members who are active participants in our economy and our health and education systems." At RizeNext, our Tech-Moms program fills an untapped resource in the talent pipeline that is currently underserved in Utah and nationally, said Trina Limpert, founder and CEO of RizeNext. By joining this Alliance, we can continue to build upon our work and our partners shared vision and efforts to bring more women into the tech industry. About Women Tech Council: Founded in 2007, the Women Tech Council (WTC) focuses on the economic impact of women in driving growth for the technology sector. WTC builds programs that amplify and create tech talent to support more women in technology careers from high school to the board room. Through these programs, WTC offers mentoring, visibility, opportunities and networking to more than 10,000 women and men working in technology, has activated more than 17,000 girls to pursue STEM fields, and helps organizations create business environments focused on high performance, not just diversity, where men and women can succeed. These efforts propel individual careers and the talent pipeline by ensuring a strong, diverse, and entrepreneurial technology workforce. For more information on Women Tech Council, visit: www.womentechcouncil.org.
Answer: | Technology and Workforce Organizations Unite to Pathway More Women, Women of Color and Women Returning To The Workforce Into Tech Jobs Women Tech Talent Pipeline Alliance to provide resources, support and opportunities for tech careers | SALT LAKE CITY--(BUSINESS WIRE)--As the economy slows under the COVID-19 pandemic, the Women Tech Council (WTC), a national organization focused on the economic impact of women in technology, is strengthening the workforce and technology economy by joining other key organizations to launch the Women Tech Talent Pipeline Alliance. The alliance will focus on programs that create activation into technology and STEM careers for women of color, moms and women returning to the workforce, refugees and immigrants. With the pandemic impacting women significantly more than men in the workforce, it has never been more important to focus on increasing the number of women in tech, said Cydni Tetro, president of WTC. By uniting these organizations to expand the talent pipeline and include more of these women, we will change the trajectories of their careers and families, strengthen our economy, and increase the impact of women in tech at this critical time. The Alliance brings together WTC, the Governor's Office of Economic Development, Code in Color, Latinas in Tech Utah (LiT), the Department of Workforce Services, United Way and RizeNext Tech-Moms. Together, these organizations will increase access to resources and opportunities, and provide support through role models and mentors for more women, especially women of color and women returning to the workforce. Ultimately, adding these women to the technology workforce will positively impact them and their families, provide tech companies needed talent and bolster the long-term health and growth of the economy. "We are thrilled to be a part of this exciting initiative to bring women in the technology workforce, said Mary Cardon, director of the Utah Industry and Innovation Center at the Governors Office of Economic Development. The Alliance will help our state become stronger and more diverse and allow women and the companies they work for to reach their highest potential. Its imperative that the tech industry continue to make strides toward a more equitable and inclusive industry, and I am pleased to take this important step toward change alongside Women Tech Council, Latinas In Tech Utah and other phenomenal organizations, said Karen Rodriguez La Paz, founder and CEO of Code In Color. By banding together, we will enter a new chapter of transformational growth, leadership and change, and continue to bring education and financial wealth to the black and brown women who rightfully deserve a seat at the table. "At LiT, our mission is to connect, support and empower Latina women working in tech. This alliance with Women Tech Council, Code in Color, RizeNext Tech-Moms and other great organizations is going to help us bridge the gap and break the stigma of Latina women working in the tech ecosystem," said Donnaly Crull, chair of the Latinas in Tech Utah Chapter. "With a larger pool of resources to offer to our community, such as education through mentorship, community connections and the ability to access a wide network of potential career opportunities, we can empower more Latina women into the tech workforce. Our team is ready to get the work started. "As part of our Department of Labor Apprenticeship State Expansion grant, Workforce Services seeks to diversify the candidate pool for apprentices in tech to include women, veterans and people of color. We believe that being part of this alliance and leveraging the efforts and resources of these great partners will help us to meet these diversity goals and will begin to change the landscape of what Utah's tech workforce looks like, while meeting the demand of the business community," said Melisa Stark, Commissioner of Apprenticeship Programs. "United Way of Utah County is thrilled to be a part of this Alliance to strengthen and increase access to technology in our community," said Bill Hulterstrom, president and CEO of United Way of Utah County. "United Way sees digital inclusion as a way to elevate our community. Providing technology education and access to equipment creates community members who are active participants in our economy and our health and education systems." At RizeNext, our Tech-Moms program fills an untapped resource in the talent pipeline that is currently underserved in Utah and nationally, said Trina Limpert, founder and CEO of RizeNext. By joining this Alliance, we can continue to build upon our work and our partners shared vision and efforts to bring more women into the tech industry. About Women Tech Council: Founded in 2007, the Women Tech Council (WTC) focuses on the economic impact of women in driving growth for the technology sector. WTC builds programs that amplify and create tech talent to support more women in technology careers from high school to the board room. Through these programs, WTC offers mentoring, visibility, opportunities and networking to more than 10,000 women and men working in technology, has activated more than 17,000 girls to pursue STEM fields, and helps organizations create business environments focused on high performance, not just diversity, where men and women can succeed. These efforts propel individual careers and the talent pipeline by ensuring a strong, diverse, and entrepreneurial technology workforce. For more information on Women Tech Council, visit: www.womentechcouncil.org. |
edtsum1906 | You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text.
Text: TINTON FALLS, N.J., April 21, 2020 /PRNewswire/ -- Commvault (NASDAQ: CVLT), a recognized global enterprise software leader in data management across cloud and on-premises environments, today filed lawsuits in federal court in Delaware alleging Cohesity, Inc. and Rubrik, Inc. collectively infringe seven Commvault patents relating to data management technologies including cloud, data deduplication, snapshots, search, security and virtualization. Commvault has invested more than $1 billion in research and development, yielding nearly 900 patents worldwide, with 350 patent applications pending. Commvault's lawsuits allege that Rubrik and Cohesity have impermissibly appropriated Commvault-patented inventions in their products to short-circuit the development process and minimize the investment necessary for them to have competitive products. Commvault is pursuing a judgment finding that Rubrik and Cohesity have infringed and are infringing its United States patents and seeks injunctive relief, as well as monetary damages for past and ongoing infringement. "Commvault is not a litigious company but given this clear patent infringement by Cohesity and Rubrik, we have a responsibility to file these lawsuits we must stand up for our innovation and intellectual property," said Commvault Vice President and General Counsel Warren Mondschein. The lawsuit alleges that Cohesity has infringed and continues to infringe at least one claim of U.S. Patent Nos. 7,725,671, 7,840,533, 8,762,335, 9,740,723, 10,210,048, and 10,248,657 and Rubrik has infringed and continues to infringe at least one claim of U.S. Patent Nos. 7,725,671, 7,840,533, 8,447,728, 9,740,723, 10,210,048, and 10,248,657. About CommvaultCommvault believes in data readiness.Commvault helps organizations of all sizes intelligently manage data through solutions that store, protect, manage and use their most critical asset their data. Commvault software, solutions and services are available from the company and through a global ecosystem of trusted partners. Commvault employs more than 2,300 highly-skilled individuals across markets worldwide, is publicly traded on NASDAQ (CVLT), and is headquartered in Tinton Falls, New Jersey in the United States. To learn more about Commvault visitwww.commvault.com SOURCE Commvault Related Links www.commvault.com
Answer: | Commvault Initiates Patent Infringement Litigation Against Cohesity and Rubrik | TINTON FALLS, N.J., April 21, 2020 /PRNewswire/ -- Commvault (NASDAQ: CVLT), a recognized global enterprise software leader in data management across cloud and on-premises environments, today filed lawsuits in federal court in Delaware alleging Cohesity, Inc. and Rubrik, Inc. collectively infringe seven Commvault patents relating to data management technologies including cloud, data deduplication, snapshots, search, security and virtualization. Commvault has invested more than $1 billion in research and development, yielding nearly 900 patents worldwide, with 350 patent applications pending. Commvault's lawsuits allege that Rubrik and Cohesity have impermissibly appropriated Commvault-patented inventions in their products to short-circuit the development process and minimize the investment necessary for them to have competitive products. Commvault is pursuing a judgment finding that Rubrik and Cohesity have infringed and are infringing its United States patents and seeks injunctive relief, as well as monetary damages for past and ongoing infringement. "Commvault is not a litigious company but given this clear patent infringement by Cohesity and Rubrik, we have a responsibility to file these lawsuits we must stand up for our innovation and intellectual property," said Commvault Vice President and General Counsel Warren Mondschein. The lawsuit alleges that Cohesity has infringed and continues to infringe at least one claim of U.S. Patent Nos. 7,725,671, 7,840,533, 8,762,335, 9,740,723, 10,210,048, and 10,248,657 and Rubrik has infringed and continues to infringe at least one claim of U.S. Patent Nos. 7,725,671, 7,840,533, 8,447,728, 9,740,723, 10,210,048, and 10,248,657. About CommvaultCommvault believes in data readiness.Commvault helps organizations of all sizes intelligently manage data through solutions that store, protect, manage and use their most critical asset their data. Commvault software, solutions and services are available from the company and through a global ecosystem of trusted partners. Commvault employs more than 2,300 highly-skilled individuals across markets worldwide, is publicly traded on NASDAQ (CVLT), and is headquartered in Tinton Falls, New Jersey in the United States. To learn more about Commvault visitwww.commvault.com SOURCE Commvault Related Links www.commvault.com |
edtsum1909 | You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text.
Text: HOUSTON, May 19, 2020 /PRNewswire/ -- Today, NanoVapor Biotech, a division of NanoVapor Inc., announces a newly formed Executive Advisory team to address innovation in pandemic mitigation using nanotechnology on an industrial scale. Dr. Russell Chew Chairman and Chief Executive Officer. Dr. Chew holds a Doctoral Degree from University of Southern California with undergraduate studies from Stanford University.His prior positions include President and Chief Operating Office for JetBlue Airlines, Chief Operating Officer for the Federal Aviation Administration, Managing Director of System Operations for American Airlines, and Managing Partner at NEXA Capital Partners. Dr. Maurizio Miglietta Clinical Medical Director. Dr. Miglietta is a Regional Dean and Professor of Surgery at Touro College of Osteopathic Medicine. He is the former Chief of Acute Care Surgery at the New York-Presbyterian Hospital. Dr. Miglietta founded and serves as Director of the Homeland Security Mobile Trauma Unit. From 2004 - 2014, he served as Physician Advisor to the United States Secret Service and continues to support various federal agencies with medical support. Dr. Miglietta has authored and co-authored more than thirty peer-reviewed publications and is dual board certified in Surgery and Critical Care. Dr. Emmanuel Fombu Clinical Director of Nanotechnology.Dr. Fombu currently serves as Vice President on the Biopharma team at Locust Walk. Prior to Locust Walk, Dr. Fombu held multiple senior leadership roles in drug development, medical affairs, business development and Licensing and digital innovation at some of the world's largest pharmaceutical companies where he successfully launched drugs in multiple therapeutic areas like CNA, Cardiovascular, Immunology, Oncology and Gene Therapy. Dr. Fombu serves as an external advisory board member at the Massachusetts Institute of Technology's nanotechnology "MIT.nano" project. Dorottya Nagy-Szakal- Clinical Director of Microbiology.Dr. Dora received her Doctor of Medicine and Doctor of Philosophy degree's from Semmelweis University School of Medicine, Budapest, Hungary. Dr. Nagy-Szakal currently holds a Research Assistant Professor position at the Department of Cell Biology, College of Medicine, SUNY Downstate Health Sciences University and the Chief Medical Officer for Biotia Inc., where she is responsible for the clinical molecular diagnostics lab that uses advanced DNA/RNA sequencing techniques and AI-powered reporting for clinical interpretation and pandemic response. She has a strong background as a clinical physician and impressive experience in microbiology, infectious disease and translational medicine as a post-doctoral research scientist at Texas Children's Hospital and Columbia University's Center for Infection and Immunity in New York. Her industry expertise is deep rooted in academic and translational research with 25+ peer reviewed publications and 2 book chapters in the fields of Microbiome, Neuroscience, Clinical Microbiology and Infectious Diseases and Public Health. Dr. Nagy-Szakal has been a UN invited panelist and speaker, President of the New York Hungarian Scientific Society, Director of Community and Partnerships/Co-founder of the Hungarian Idea Exchange. About NanoVapor BiotechNanoVapor Inc. is a Texas company focusing on delivering practical solutions to real-world problems using nanotechnologies for the Energy, Marine, Aviation and Biotech industries. The patented NanoVapor Vapor System dramatically reduces greenhouse gas and carbon vapor emissions. NanoVapor Biotech, a division of NanoVapor Inc., has developed the Microbial Suppression System which creates a submicroscopic molecular coating inhibiting the growth of microorganisms and helps prevent the growth and spread of bacteria. This durable nano-coating, 1000 times thinner than a sheet of paper, can continue to provide lasting antimicrobial protection that can keep surfaces mold-free for months.General information can be found athttps://www.nanovapor.com/ SOURCE NanoVapor Biotech Related Links https://www.nanovapor.com
Answer: | Highlights: NanoVapor Biotech forms Executive Advisory team to address pandemic mitigation | HOUSTON, May 19, 2020 /PRNewswire/ -- Today, NanoVapor Biotech, a division of NanoVapor Inc., announces a newly formed Executive Advisory team to address innovation in pandemic mitigation using nanotechnology on an industrial scale. Dr. Russell Chew Chairman and Chief Executive Officer. Dr. Chew holds a Doctoral Degree from University of Southern California with undergraduate studies from Stanford University.His prior positions include President and Chief Operating Office for JetBlue Airlines, Chief Operating Officer for the Federal Aviation Administration, Managing Director of System Operations for American Airlines, and Managing Partner at NEXA Capital Partners. Dr. Maurizio Miglietta Clinical Medical Director. Dr. Miglietta is a Regional Dean and Professor of Surgery at Touro College of Osteopathic Medicine. He is the former Chief of Acute Care Surgery at the New York-Presbyterian Hospital. Dr. Miglietta founded and serves as Director of the Homeland Security Mobile Trauma Unit. From 2004 - 2014, he served as Physician Advisor to the United States Secret Service and continues to support various federal agencies with medical support. Dr. Miglietta has authored and co-authored more than thirty peer-reviewed publications and is dual board certified in Surgery and Critical Care. Dr. Emmanuel Fombu Clinical Director of Nanotechnology.Dr. Fombu currently serves as Vice President on the Biopharma team at Locust Walk. Prior to Locust Walk, Dr. Fombu held multiple senior leadership roles in drug development, medical affairs, business development and Licensing and digital innovation at some of the world's largest pharmaceutical companies where he successfully launched drugs in multiple therapeutic areas like CNA, Cardiovascular, Immunology, Oncology and Gene Therapy. Dr. Fombu serves as an external advisory board member at the Massachusetts Institute of Technology's nanotechnology "MIT.nano" project. Dorottya Nagy-Szakal- Clinical Director of Microbiology.Dr. Dora received her Doctor of Medicine and Doctor of Philosophy degree's from Semmelweis University School of Medicine, Budapest, Hungary. Dr. Nagy-Szakal currently holds a Research Assistant Professor position at the Department of Cell Biology, College of Medicine, SUNY Downstate Health Sciences University and the Chief Medical Officer for Biotia Inc., where she is responsible for the clinical molecular diagnostics lab that uses advanced DNA/RNA sequencing techniques and AI-powered reporting for clinical interpretation and pandemic response. She has a strong background as a clinical physician and impressive experience in microbiology, infectious disease and translational medicine as a post-doctoral research scientist at Texas Children's Hospital and Columbia University's Center for Infection and Immunity in New York. Her industry expertise is deep rooted in academic and translational research with 25+ peer reviewed publications and 2 book chapters in the fields of Microbiome, Neuroscience, Clinical Microbiology and Infectious Diseases and Public Health. Dr. Nagy-Szakal has been a UN invited panelist and speaker, President of the New York Hungarian Scientific Society, Director of Community and Partnerships/Co-founder of the Hungarian Idea Exchange. About NanoVapor BiotechNanoVapor Inc. is a Texas company focusing on delivering practical solutions to real-world problems using nanotechnologies for the Energy, Marine, Aviation and Biotech industries. The patented NanoVapor Vapor System dramatically reduces greenhouse gas and carbon vapor emissions. NanoVapor Biotech, a division of NanoVapor Inc., has developed the Microbial Suppression System which creates a submicroscopic molecular coating inhibiting the growth of microorganisms and helps prevent the growth and spread of bacteria. This durable nano-coating, 1000 times thinner than a sheet of paper, can continue to provide lasting antimicrobial protection that can keep surfaces mold-free for months.General information can be found athttps://www.nanovapor.com/ SOURCE NanoVapor Biotech Related Links https://www.nanovapor.com |
edtsum1917 | You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text.
Text: CULVER CITY, Calif.--(BUSINESS WIRE)--NantHealth, Inc. (NASDAQ-GS: NH), a provider of enterprise solutions that help transform complex data into actionable insights, today reported financial results for its fourth quarter and full year ended December 31, 2020. While managing our business through the challenges associated with COVID-19 for most of the past year, we advanced our goal of expanding and diversifying NantHealth's software portfolio and services offerings with the acquisition of OpenNMS, continued to invest in our data solutions and AI capabilities, and delivered expanded capabilities on our NaviNet and Eviti SaaS products, said Ron Louks, Chief Operating Officer, NantHealth. In addition, as part of our NantHealth Cares initiative, we supported healthcare providers and medical staff by offering, at no cost for the entire month of May, our NaviNet AllPayer platform to providers. I am pleased to report that even with a month of free access, AllPayer revenues grew in 2020 and added more than 1,500 providers to its network." Software and Services Q4 Highlights: Network Monitoring and Management (OpenNMS) Precision Medicine and Artificial Intelligence - Highlights: Business and Financial Highlights For the 2020 fourth quarter: For the 2020 full year: At December 31, 2020, cash and cash equivalents totaled $22.8 million. Conference Call Information and Forward-Looking Statements Later today, the company will host a conference call at 1:30 p.m. PT (4:30 p.m. ET) to review its results of operations for the fourth quarter and full year ended December 31, 2020. The conference call will be available to interested parties by dialing 844-309-3709 from the U.S. or Canada, or 281-962-4864 from international locations, passcode 9786375. The call will be broadcast via the Internet at www.nanthealth.com. Listeners are encouraged to visit the website at least 10 minutes prior to the start of the scheduled presentation to register, download and install any necessary audio software. A playback of the call will be archived and accessible on the same website for at least three months. Discussion during the conference call may include forward-looking statements regarding topics such as the companys financial status and performance, regulatory and operational developments, and other comments the company may make about its future plans or prospects in response to questions from participants on the conference call. Use of Non-GAAP Financial Measures This news release contains references to Non-GAAP financial measures, including adjusted net loss and adjusted net loss per share, which are financial measures that are not prepared in conformity with United States generally accepted accounting principles (U.S. GAAP). The Companys management believes that the presentation of Non-GAAP financial measures provides useful supplementary information regarding operational performance, because it enhances an investors overall understanding of the financial results for the Companys core business. Additionally, it provides a basis for the comparison of the financial results for the Companys core business between current, past and future periods. Other companies may define these measures in different ways. Non-GAAP financial measures should be considered only as a supplement to, and not as a substitute for or as a superior measure to, financial measures prepared in accordance with U.S. GAAP. Non-GAAP per share numbers are calculated based on one class of common stock and do not incorporate the effects, if any, of using the two-class method. About NantHealth, Inc. NantHealth, a member of the NantWorks ecosystem of companies, provides enterprise solutions that help businesses transform complex data into actionable insights. By offering efficient ways to move, interpret, and visualize complex and highly sensitive information, NantHealth enables customers in healthcare, life sciences, logistics, telecommunications and other industries to automate, understand and act on data while keeping it secure and scalable. NantHealths product portfolio comprises the latest technology in payer/provider collaboration platforms for real-time coverage decision support (Eviti and NaviNet), molecular analysis (GPS Cancer), and data solutions that provide multi-data analysis, reporting and professional services offerings (Quadris). OpenNMS, a NantHealth subsidiary, helps businesses monitor and manage network health and performance. For more information, visit nanthealth.com, follow us on Twitter, Facebook and LinkedIn, and subscribe to our blog. This news release contains certain statements of a forward-looking nature relating to future events or future business performance. Forward-looking statements can be identified by the words expects, anticipates, believes, intends, estimates, plans, will, outlook and similar expressions. Forward-looking statements are based on managements current plans, estimates, assumptions and projections, and speak only as of the date they are made. Risks and uncertainties include, but are not limited to: our ability to successfully integrate our systems and solutions to address a wide range of healthcare issues; our ability to successfully amass the requisite data to achieve maximum network effects; appropriately allocating financial and human resources across a broad array of product and service offerings; raising additional capital as necessary to fund our operations; achieving significant commercial market acceptance for our solutions; establishing relationships with key thought leaders or key decision makers in order to attract, retain and renew partners and clients and obtain reimbursement for our sequencing and molecular analysis solutions; our ability to grow the market for our solutions; successfully enhancing our solutions to achieve market acceptance and keep pace with technological developments; customer concentration; competition; security breaches; data loss or corruption due to failures or errors in our systems and service disruptions at our data centers; bandwidth limitations; our ability to use, disclose, de-identify or license data and to integrate third-party technologies; our use of open source software; our ability to continue our relationship with NantOmics; our ability to obtain regulatory approvals; dependence upon senior management; the need to comply with and meet applicable laws and regulations; unexpected adverse events; clinical adoption and market acceptance of our molecular sequencing and analysis solutions; and anticipated cost savings. We undertake no obligation to update any forward-looking statement in light of new information or future events, except as otherwise required by law. Forward-looking statements involve inherent risks and uncertainties, most of which are difficult to predict and are generally beyond our control. Actual results or outcomes may differ materially from those implied by the forward-looking statements as a result of the impact of a number of factors, many of which are discussed in more detail in our reports filed with the Securities and Exchange Commission.. NantHealth, Inc. Consolidated Balance Sheets (Dollars in thousands, except per share amounts) (Unaudited) December 31, 2020 2019 Assets Current assets Cash and cash equivalents $ 22,787 $ 5,243 Accounts receivable, net 3,273 6,179 Related party receivables, net 1,031 823 Prepaid expenses and other current assets 3,504 19,341 Current assets of discontinued operations 6,327 Total current assets 30,595 37,913 Property, plant, and equipment, net 13,102 14,985 Goodwill 98,333 97,307 Intangible assets, net 47,969 51,848 Investment in related party 31,702 Related party receivable, net of current 823 1,108 Operating lease right-of-use assets 7,539 8,470 Other assets 1,927 1,818 Noncurrent assets of discontinued operations 21,336 Total assets $ 200,288 $ 266,487 Liabilities and Stockholders' Equity Current liabilities Accounts payable $ 5,122 $ 3,377 Accrued and other current liabilities 13,975 31,988 Deferred revenue 1,166 7,098 Related party payables, net 4,238 4,120 Notes payable 268 238 Related party convertible note, net 9,411 Convertible notes, net 90,578 Current liabilities of discontinued operations 10,680 Total current liabilities 124,758 57,501 Deferred revenue, net of current 393 1,129 Related party liabilities 31,091 24,227 Related party promissory note 112,666 112,666 Related party convertible note, net 8,864 Convertible notes, net 84,648 Deferred income taxes, net 1,853 1,669 Operating lease liabilities 8,170 9,728 Other liabilities 32,757 21,542 Noncurrent liabilities of discontinued operations 1,649 Total liabilities 311,688 323,623 Stockholders' deficit Common stock, $0.0001 par value per share, 750,000,000 shares authorized; 111,284,733 and 110,619,678 shares issued and outstanding at December 31, 2020 and 2019, respectively 11 11 Additional paid-in capital 891,583 889,955 Accumulated deficit (1,003,210) (946,884) Accumulated other comprehensive loss (168) (218) Total NantHealth stockholders' deficit (111,784) (57,136) Noncontrolling interests 384 Total stockholders' deficit (111,400) (57,136) Total liabilities and stockholders' deficit $ 200,288 $ 266,487 NantHealth, Inc. Consolidated Statements of Operations (Dollars in thousands, except per share amounts) (Unaudited) Three Months Ended December 31, Year Ended December 31, 2020 2019 2020 2019 Revenue Software-as-a-service related $ 18,201 $ 18,410 $ 72,198 $ 72,831 Maintenance 378 677 Professional services 24 86 Total software-related revenue 18,603 18,410 72,961 72,831 Sequencing and molecular analysis 39 152 211 1,733 Home health care services 2,863 Total net revenue 18,642 18,562 73,172 77,427 Cost of Revenue Software-as-a-service related 5,504 6,096 23,056 23,100 Maintenance 230 69 361 357 Professional services 1 16 Amortization of developed technologies 1,247 1,143 4,755 4,662 Total software-related cost of revenue 6,982 7,308 28,188 28,119 Sequencing and molecular analysis 211 480 1,038 4,546 Home health care services 1,471 Total cost of revenue 7,193 7,788 29,226 34,136 Gross Profit 11,449 10,774 43,946 43,291 Operating Expenses Selling, general and administrative 11,670 12,752 48,534 55,595 Research and development 4,828 3,431 17,274 13,934 Amortization of acquisition-related assets 985 1,054 3,676 4,216 Impairment of intangible assets, including internal-use software 729 729 3,977 Total operating expenses 18,212 17,237 70,213 77,722 Loss from operations (6,763) (6,463) (26,267) (34,431) Interest expense, net (4,908) (4,601) (19,199) (18,044) Other expense, net (8,274) (585) (10,824) (5,607) Loss from related party equity method investment (1,916) (31,702) (8,317) Loss from continuing operations before income taxes (19,945) (13,565) (87,992) (66,399) Provision for (benefit from) income taxes 273 (359) 447 (1,018) Net loss from continuing operations (20,218) (13,206) (88,439) (65,381) Income from discontinued operations, net of tax attributable to NantHealth 38 1,457 31,993 2,619 Net loss (20,180) (11,749) (56,446) (62,762) Net loss attributable to noncontrolling interests (78) (120) Net loss attributable to NantHealth $ (20,102) $ (11,749) $ (56,326) $ (62,762) Basic and diluted net loss per share attributable to NantHealth: Continuing operations - common stock $ (0.18) $ (0.12) $ (0.80) $ (0.59) Discontinued operations - common stock $ $ 0.01 $ 0.29 $ 0.02 Total net loss per share - common stock $ (0.18) $ (0.11) $ (0.51) $ (0.57) Weighted average shares outstanding Basic and diluted - common stock 111,238,540 110,619,780 110,954,858 110,351,638 NantHealth, Inc. Non-GAAP Net Loss from Continuing Operations Attributable to NantHealth and Non-GAAP Net Loss Per Share from Continuing Operations Attributable to NantHealth (Dollars in thousands, except per share amounts) (Unaudited) Three Months Ended December 31, Year Ended December 31, 2020 2019 2020 2019 Net loss from continuing operations attributable to NantHealth $ (20,140) $ (13,206) $ (88,319) $ (65,381) Adjustments to GAAP net loss from continuing operations attributable to NantHealth: Loss from related party equity method investment 1,916 31,702 8,317 Stock-based compensation expense from continuing operations 961 1,566 2,722 2,842 Change in fair value of derivatives liability (3) 4 Change in fair value of Bookings Commitment 8,098 372 11,168 5,036 Noncash interest expense related to convertible notes 1,698 1,495 6,477 5,702 Intangible amortization from continuing operations 2,212 2,197 8,395 8,878 Impairment of intangible assets, including internal-use software 729 729 3,977 Loss on sale of business 582 Securities litigation costs 28 (103) 528 Tax provision (benefit) resulting from certain noncash tax items 244 (51) 228 (570) Total adjustments to GAAP net loss from continuing operations attributable to NantHealth 13,939 7,523 61,322 35,292 Net loss from continuing operations attributable to NantHealth - Non-GAAP $ (6,201) $ (5,683) $ (26,997) $ (30,089) Weighted average basic common shares outstanding 111,238,540 110,619,780 110,954,858 110,351,638 Net loss per common share from continuing operations attributable to NantHealth - Non-GAAP $ (0.06) $ (0.05) $ (0.24) $ (0.27) Reconciliation of Net Loss per Common Share from Continuing Operations Attributable to NantHealth to Net Loss per Common Share from Continuing Operations Attributable to NantHealth - Non-GAAP (Unaudited): Three Months Ended December 31, Year Ended December 31, 2020 2019 2020 2019 Net loss per common share from continuing operations attributable to NantHealth $ (0.18) $ (0.12) $ (0.80) $ (0.59) Adjustments to GAAP net loss per common share from continuing operations attributable to NantHealth: Loss from related party equity method investment 0.03 0.29 0.07 Stock-based compensation expense from continuing operations 0.01 0.01 0.02 0.03 Change in fair value of derivatives liability Change in fair value of Bookings Commitment 0.07 0.10 0.05 Noncash interest expense related to convertible notes 0.01 0.01 0.06 0.05 Intangible amortization from continuing operations 0.02 0.02 0.08 0.08 Impairment of intangible assets, including internal-use software 0.01 0.01 0.04 Loss on sale of business 0.01 Securities litigation costs Tax provision (benefit) resulting from certain noncash tax items (0.01) Total adjustments to GAAP net loss per common share from continuing operations attributable to NantHealth 0.12 0.07 0.56 0.32 Net loss per common share from continuing operations attributable to NantHealth - Non-GAAP $ (0.06) $ (0.05) $ (0.24) $ (0.27)
Answer: | NantHealth Reports 2020 Fourth-Quarter, Full-Year Financial Results Q4 Financial Highlights 2020 vs 2019: Total revenue was $18.6 million Total software-related revenue was $18.6 million, up from $18.4 million Total gross margin increased to 61% from 58% Full-Year Financial Highlights 2020 vs 2019: Total revenue was $73.2 million vs $77.4 million Total software-related revenue was $73.0 million, up from $72.8 million Total gross margin increased to 60% from 56% Completed sale of Connected Care Business for $47.25 million in February 2020 Acquired The OpenNMS Group, an open source network monitoring company, in July 2020 | CULVER CITY, Calif.--(BUSINESS WIRE)--NantHealth, Inc. (NASDAQ-GS: NH), a provider of enterprise solutions that help transform complex data into actionable insights, today reported financial results for its fourth quarter and full year ended December 31, 2020. While managing our business through the challenges associated with COVID-19 for most of the past year, we advanced our goal of expanding and diversifying NantHealth's software portfolio and services offerings with the acquisition of OpenNMS, continued to invest in our data solutions and AI capabilities, and delivered expanded capabilities on our NaviNet and Eviti SaaS products, said Ron Louks, Chief Operating Officer, NantHealth. In addition, as part of our NantHealth Cares initiative, we supported healthcare providers and medical staff by offering, at no cost for the entire month of May, our NaviNet AllPayer platform to providers. I am pleased to report that even with a month of free access, AllPayer revenues grew in 2020 and added more than 1,500 providers to its network." Software and Services Q4 Highlights: Network Monitoring and Management (OpenNMS) Precision Medicine and Artificial Intelligence - Highlights: Business and Financial Highlights For the 2020 fourth quarter: For the 2020 full year: At December 31, 2020, cash and cash equivalents totaled $22.8 million. Conference Call Information and Forward-Looking Statements Later today, the company will host a conference call at 1:30 p.m. PT (4:30 p.m. ET) to review its results of operations for the fourth quarter and full year ended December 31, 2020. The conference call will be available to interested parties by dialing 844-309-3709 from the U.S. or Canada, or 281-962-4864 from international locations, passcode 9786375. The call will be broadcast via the Internet at www.nanthealth.com. Listeners are encouraged to visit the website at least 10 minutes prior to the start of the scheduled presentation to register, download and install any necessary audio software. A playback of the call will be archived and accessible on the same website for at least three months. Discussion during the conference call may include forward-looking statements regarding topics such as the companys financial status and performance, regulatory and operational developments, and other comments the company may make about its future plans or prospects in response to questions from participants on the conference call. Use of Non-GAAP Financial Measures This news release contains references to Non-GAAP financial measures, including adjusted net loss and adjusted net loss per share, which are financial measures that are not prepared in conformity with United States generally accepted accounting principles (U.S. GAAP). The Companys management believes that the presentation of Non-GAAP financial measures provides useful supplementary information regarding operational performance, because it enhances an investors overall understanding of the financial results for the Companys core business. Additionally, it provides a basis for the comparison of the financial results for the Companys core business between current, past and future periods. Other companies may define these measures in different ways. Non-GAAP financial measures should be considered only as a supplement to, and not as a substitute for or as a superior measure to, financial measures prepared in accordance with U.S. GAAP. Non-GAAP per share numbers are calculated based on one class of common stock and do not incorporate the effects, if any, of using the two-class method. About NantHealth, Inc. NantHealth, a member of the NantWorks ecosystem of companies, provides enterprise solutions that help businesses transform complex data into actionable insights. By offering efficient ways to move, interpret, and visualize complex and highly sensitive information, NantHealth enables customers in healthcare, life sciences, logistics, telecommunications and other industries to automate, understand and act on data while keeping it secure and scalable. NantHealths product portfolio comprises the latest technology in payer/provider collaboration platforms for real-time coverage decision support (Eviti and NaviNet), molecular analysis (GPS Cancer), and data solutions that provide multi-data analysis, reporting and professional services offerings (Quadris). OpenNMS, a NantHealth subsidiary, helps businesses monitor and manage network health and performance. For more information, visit nanthealth.com, follow us on Twitter, Facebook and LinkedIn, and subscribe to our blog. This news release contains certain statements of a forward-looking nature relating to future events or future business performance. Forward-looking statements can be identified by the words expects, anticipates, believes, intends, estimates, plans, will, outlook and similar expressions. Forward-looking statements are based on managements current plans, estimates, assumptions and projections, and speak only as of the date they are made. Risks and uncertainties include, but are not limited to: our ability to successfully integrate our systems and solutions to address a wide range of healthcare issues; our ability to successfully amass the requisite data to achieve maximum network effects; appropriately allocating financial and human resources across a broad array of product and service offerings; raising additional capital as necessary to fund our operations; achieving significant commercial market acceptance for our solutions; establishing relationships with key thought leaders or key decision makers in order to attract, retain and renew partners and clients and obtain reimbursement for our sequencing and molecular analysis solutions; our ability to grow the market for our solutions; successfully enhancing our solutions to achieve market acceptance and keep pace with technological developments; customer concentration; competition; security breaches; data loss or corruption due to failures or errors in our systems and service disruptions at our data centers; bandwidth limitations; our ability to use, disclose, de-identify or license data and to integrate third-party technologies; our use of open source software; our ability to continue our relationship with NantOmics; our ability to obtain regulatory approvals; dependence upon senior management; the need to comply with and meet applicable laws and regulations; unexpected adverse events; clinical adoption and market acceptance of our molecular sequencing and analysis solutions; and anticipated cost savings. We undertake no obligation to update any forward-looking statement in light of new information or future events, except as otherwise required by law. Forward-looking statements involve inherent risks and uncertainties, most of which are difficult to predict and are generally beyond our control. Actual results or outcomes may differ materially from those implied by the forward-looking statements as a result of the impact of a number of factors, many of which are discussed in more detail in our reports filed with the Securities and Exchange Commission.. NantHealth, Inc. Consolidated Balance Sheets (Dollars in thousands, except per share amounts) (Unaudited) December 31, 2020 2019 Assets Current assets Cash and cash equivalents $ 22,787 $ 5,243 Accounts receivable, net 3,273 6,179 Related party receivables, net 1,031 823 Prepaid expenses and other current assets 3,504 19,341 Current assets of discontinued operations 6,327 Total current assets 30,595 37,913 Property, plant, and equipment, net 13,102 14,985 Goodwill 98,333 97,307 Intangible assets, net 47,969 51,848 Investment in related party 31,702 Related party receivable, net of current 823 1,108 Operating lease right-of-use assets 7,539 8,470 Other assets 1,927 1,818 Noncurrent assets of discontinued operations 21,336 Total assets $ 200,288 $ 266,487 Liabilities and Stockholders' Equity Current liabilities Accounts payable $ 5,122 $ 3,377 Accrued and other current liabilities 13,975 31,988 Deferred revenue 1,166 7,098 Related party payables, net 4,238 4,120 Notes payable 268 238 Related party convertible note, net 9,411 Convertible notes, net 90,578 Current liabilities of discontinued operations 10,680 Total current liabilities 124,758 57,501 Deferred revenue, net of current 393 1,129 Related party liabilities 31,091 24,227 Related party promissory note 112,666 112,666 Related party convertible note, net 8,864 Convertible notes, net 84,648 Deferred income taxes, net 1,853 1,669 Operating lease liabilities 8,170 9,728 Other liabilities 32,757 21,542 Noncurrent liabilities of discontinued operations 1,649 Total liabilities 311,688 323,623 Stockholders' deficit Common stock, $0.0001 par value per share, 750,000,000 shares authorized; 111,284,733 and 110,619,678 shares issued and outstanding at December 31, 2020 and 2019, respectively 11 11 Additional paid-in capital 891,583 889,955 Accumulated deficit (1,003,210) (946,884) Accumulated other comprehensive loss (168) (218) Total NantHealth stockholders' deficit (111,784) (57,136) Noncontrolling interests 384 Total stockholders' deficit (111,400) (57,136) Total liabilities and stockholders' deficit $ 200,288 $ 266,487 NantHealth, Inc. Consolidated Statements of Operations (Dollars in thousands, except per share amounts) (Unaudited) Three Months Ended December 31, Year Ended December 31, 2020 2019 2020 2019 Revenue Software-as-a-service related $ 18,201 $ 18,410 $ 72,198 $ 72,831 Maintenance 378 677 Professional services 24 86 Total software-related revenue 18,603 18,410 72,961 72,831 Sequencing and molecular analysis 39 152 211 1,733 Home health care services 2,863 Total net revenue 18,642 18,562 73,172 77,427 Cost of Revenue Software-as-a-service related 5,504 6,096 23,056 23,100 Maintenance 230 69 361 357 Professional services 1 16 Amortization of developed technologies 1,247 1,143 4,755 4,662 Total software-related cost of revenue 6,982 7,308 28,188 28,119 Sequencing and molecular analysis 211 480 1,038 4,546 Home health care services 1,471 Total cost of revenue 7,193 7,788 29,226 34,136 Gross Profit 11,449 10,774 43,946 43,291 Operating Expenses Selling, general and administrative 11,670 12,752 48,534 55,595 Research and development 4,828 3,431 17,274 13,934 Amortization of acquisition-related assets 985 1,054 3,676 4,216 Impairment of intangible assets, including internal-use software 729 729 3,977 Total operating expenses 18,212 17,237 70,213 77,722 Loss from operations (6,763) (6,463) (26,267) (34,431) Interest expense, net (4,908) (4,601) (19,199) (18,044) Other expense, net (8,274) (585) (10,824) (5,607) Loss from related party equity method investment (1,916) (31,702) (8,317) Loss from continuing operations before income taxes (19,945) (13,565) (87,992) (66,399) Provision for (benefit from) income taxes 273 (359) 447 (1,018) Net loss from continuing operations (20,218) (13,206) (88,439) (65,381) Income from discontinued operations, net of tax attributable to NantHealth 38 1,457 31,993 2,619 Net loss (20,180) (11,749) (56,446) (62,762) Net loss attributable to noncontrolling interests (78) (120) Net loss attributable to NantHealth $ (20,102) $ (11,749) $ (56,326) $ (62,762) Basic and diluted net loss per share attributable to NantHealth: Continuing operations - common stock $ (0.18) $ (0.12) $ (0.80) $ (0.59) Discontinued operations - common stock $ $ 0.01 $ 0.29 $ 0.02 Total net loss per share - common stock $ (0.18) $ (0.11) $ (0.51) $ (0.57) Weighted average shares outstanding Basic and diluted - common stock 111,238,540 110,619,780 110,954,858 110,351,638 NantHealth, Inc. Non-GAAP Net Loss from Continuing Operations Attributable to NantHealth and Non-GAAP Net Loss Per Share from Continuing Operations Attributable to NantHealth (Dollars in thousands, except per share amounts) (Unaudited) Three Months Ended December 31, Year Ended December 31, 2020 2019 2020 2019 Net loss from continuing operations attributable to NantHealth $ (20,140) $ (13,206) $ (88,319) $ (65,381) Adjustments to GAAP net loss from continuing operations attributable to NantHealth: Loss from related party equity method investment 1,916 31,702 8,317 Stock-based compensation expense from continuing operations 961 1,566 2,722 2,842 Change in fair value of derivatives liability (3) 4 Change in fair value of Bookings Commitment 8,098 372 11,168 5,036 Noncash interest expense related to convertible notes 1,698 1,495 6,477 5,702 Intangible amortization from continuing operations 2,212 2,197 8,395 8,878 Impairment of intangible assets, including internal-use software 729 729 3,977 Loss on sale of business 582 Securities litigation costs 28 (103) 528 Tax provision (benefit) resulting from certain noncash tax items 244 (51) 228 (570) Total adjustments to GAAP net loss from continuing operations attributable to NantHealth 13,939 7,523 61,322 35,292 Net loss from continuing operations attributable to NantHealth - Non-GAAP $ (6,201) $ (5,683) $ (26,997) $ (30,089) Weighted average basic common shares outstanding 111,238,540 110,619,780 110,954,858 110,351,638 Net loss per common share from continuing operations attributable to NantHealth - Non-GAAP $ (0.06) $ (0.05) $ (0.24) $ (0.27) Reconciliation of Net Loss per Common Share from Continuing Operations Attributable to NantHealth to Net Loss per Common Share from Continuing Operations Attributable to NantHealth - Non-GAAP (Unaudited): Three Months Ended December 31, Year Ended December 31, 2020 2019 2020 2019 Net loss per common share from continuing operations attributable to NantHealth $ (0.18) $ (0.12) $ (0.80) $ (0.59) Adjustments to GAAP net loss per common share from continuing operations attributable to NantHealth: Loss from related party equity method investment 0.03 0.29 0.07 Stock-based compensation expense from continuing operations 0.01 0.01 0.02 0.03 Change in fair value of derivatives liability Change in fair value of Bookings Commitment 0.07 0.10 0.05 Noncash interest expense related to convertible notes 0.01 0.01 0.06 0.05 Intangible amortization from continuing operations 0.02 0.02 0.08 0.08 Impairment of intangible assets, including internal-use software 0.01 0.01 0.04 Loss on sale of business 0.01 Securities litigation costs Tax provision (benefit) resulting from certain noncash tax items (0.01) Total adjustments to GAAP net loss per common share from continuing operations attributable to NantHealth 0.12 0.07 0.56 0.32 Net loss per common share from continuing operations attributable to NantHealth - Non-GAAP $ (0.06) $ (0.05) $ (0.24) $ (0.27) |
edtsum1925 | You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text.
Text: LONDON--(BUSINESS WIRE)-- FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the Code) 1. KEY INFORMATION (a) Full name of discloser: Millennium International Management LP (b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named. (c) Name of offeror/offeree in relation to whose relevant securities this form relates: Use a separate form for each offeror/offeree Signature Aviation plc (d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree: (e) Date position held/dealing undertaken: For an opening position disclosure, state the latest practicable date prior to the disclosure 4th May 2021 (f) In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer? If it is a cash offer or possible cash offer, state N/A No 2. POSITIONS OF THE PERSON MAKING THE DISCLOSURE If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security. (a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any) Class of relevant security: 37p ordinary (GB00BKDM7X41) Interests Short positions Number % Number % (1) Relevant securities owned and/or controlled: - - - - (2) Cash-settled derivatives: 21,068,292 2.542% 29,165 0.004% (3) Stock-settled derivatives (including options) and agreements to purchase/sell: - - - - TOTAL: 21,068,292 2.542% 29,165 0.004% All interests and all short positions should be disclosed. Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions). (b) Rights to subscribe for new securities (including directors and other employee options) Class of relevant security in relation to which subscription right exists: Details, including nature of the rights concerned and relevant percentages: 3. DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in. The currency of all prices and other monetary amounts should be stated. (a) Purchases and sales Class of relevant security Purchase/sale Number of securities Price per unit (b) Cash-settled derivative transactions Class of relevant security Product description e.g. CFD Nature of dealing e.g. opening/closing a long/short position, increasing/reducing a long/short position Number of reference securities Price per unit GB00BKDM7X41 Equity Swap Reducing a long position 31 4.04 GBP GB00BKDM7X41 Equity Swap Increasing a long position 6,709 4.03 GBP GB00BKDM7X41 Equity Swap Reducing a long position 124 4.03 GBP GB00BKDM7X41 Equity Swap Increasing a long position 448 5.59 USD (c) Stock-settled derivative transactions (including options) (i) Writing, selling, purchasing or varying Class of relevant security Product description e.g. call option Writing, purchasing, selling, varying etc. Number of securities to which option relates Exercise price per unit Type e.g. American, European etc. Expiry date Option money paid/ received per unit (ii) Exercise Class of relevant security Product description e.g. call option Exercising/ exercised against Number of securities Exercise price per unit (d) Other dealings (including subscribing for new securities) Class of relevant security Nature of dealing e.g. subscription, conversion Details Price per unit (if applicable) 4. OTHER INFORMATION (a) Indemnity and other dealing arrangements Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer: Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state none NONE (b) Agreements, arrangements or understandings relating to options or derivatives Details of any agreement, arrangement or understanding, formal or informal, between the person making the disclosure and any other person relating to: (i) the voting rights of any relevant securities under any option; or (ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced: If there are no such agreements, arrangements or understandings, state none NONE (c) Attachments Is a Supplemental Form 8 (Open Positions) attached? NO Date of disclosure: 5th May 2021 Contact name: Milos Naumovic Telephone number: +44 203 650 8203 Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service and must also be emailed to the Takeover Panel at [email protected]. The Panels Market Surveillance Unit is available for consultation in relation to the Codes disclosure requirements on +44 (0)20 7638 0129. The Code can be viewed on the Panels website at www.thetakeoverpanel.org.uk.
Answer: | Form 8.3 - Signature Aviation plc | LONDON--(BUSINESS WIRE)-- FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the Code) 1. KEY INFORMATION (a) Full name of discloser: Millennium International Management LP (b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named. (c) Name of offeror/offeree in relation to whose relevant securities this form relates: Use a separate form for each offeror/offeree Signature Aviation plc (d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree: (e) Date position held/dealing undertaken: For an opening position disclosure, state the latest practicable date prior to the disclosure 4th May 2021 (f) In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer? If it is a cash offer or possible cash offer, state N/A No 2. POSITIONS OF THE PERSON MAKING THE DISCLOSURE If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security. (a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any) Class of relevant security: 37p ordinary (GB00BKDM7X41) Interests Short positions Number % Number % (1) Relevant securities owned and/or controlled: - - - - (2) Cash-settled derivatives: 21,068,292 2.542% 29,165 0.004% (3) Stock-settled derivatives (including options) and agreements to purchase/sell: - - - - TOTAL: 21,068,292 2.542% 29,165 0.004% All interests and all short positions should be disclosed. Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions). (b) Rights to subscribe for new securities (including directors and other employee options) Class of relevant security in relation to which subscription right exists: Details, including nature of the rights concerned and relevant percentages: 3. DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in. The currency of all prices and other monetary amounts should be stated. (a) Purchases and sales Class of relevant security Purchase/sale Number of securities Price per unit (b) Cash-settled derivative transactions Class of relevant security Product description e.g. CFD Nature of dealing e.g. opening/closing a long/short position, increasing/reducing a long/short position Number of reference securities Price per unit GB00BKDM7X41 Equity Swap Reducing a long position 31 4.04 GBP GB00BKDM7X41 Equity Swap Increasing a long position 6,709 4.03 GBP GB00BKDM7X41 Equity Swap Reducing a long position 124 4.03 GBP GB00BKDM7X41 Equity Swap Increasing a long position 448 5.59 USD (c) Stock-settled derivative transactions (including options) (i) Writing, selling, purchasing or varying Class of relevant security Product description e.g. call option Writing, purchasing, selling, varying etc. Number of securities to which option relates Exercise price per unit Type e.g. American, European etc. Expiry date Option money paid/ received per unit (ii) Exercise Class of relevant security Product description e.g. call option Exercising/ exercised against Number of securities Exercise price per unit (d) Other dealings (including subscribing for new securities) Class of relevant security Nature of dealing e.g. subscription, conversion Details Price per unit (if applicable) 4. OTHER INFORMATION (a) Indemnity and other dealing arrangements Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer: Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state none NONE (b) Agreements, arrangements or understandings relating to options or derivatives Details of any agreement, arrangement or understanding, formal or informal, between the person making the disclosure and any other person relating to: (i) the voting rights of any relevant securities under any option; or (ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced: If there are no such agreements, arrangements or understandings, state none NONE (c) Attachments Is a Supplemental Form 8 (Open Positions) attached? NO Date of disclosure: 5th May 2021 Contact name: Milos Naumovic Telephone number: +44 203 650 8203 Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service and must also be emailed to the Takeover Panel at [email protected]. The Panels Market Surveillance Unit is available for consultation in relation to the Codes disclosure requirements on +44 (0)20 7638 0129. The Code can be viewed on the Panels website at www.thetakeoverpanel.org.uk. |
edtsum1938 | You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text.
Text: BEVERLY HILLS, Calif., March 17, 2021 /PRNewswire/ -- Beverly Hills Conference & Visitors Bureau(BHCVB) announces As You Wish, a new campaign that showcases the bespoke service and world-class amenities found in Beverly Hills through the lens of five "pawesome" pet ambassadors. The playful campaign underscores the destination's array of unique experiences that cater to the diverse needs of today's global travelers and the furry friends that so often accompany them. According to the American Pet Products Association, 37% of people travel with pets, a figure that rose by 19% over the past 10 years. (PRNewsfoto/Beverly Hills Conference & Visitors Bureau) "Over the last year, we have all realized more than ever how important our pets are to us," says Julie Wagner, CEO of BHCVB. "As travelers begin to plan trips again, it's hard for them to imagine parting with their loyal companions. Beverly Hills is a destination that visitors can count on to welcome both pets and their owners with unparalleled amenities and service." As part of the new campaign, each of five distinct canine personalities presents an exciting way to discover Beverly Hills. Whether traveling with family like Fred, on business like Bentley, or on a friends getaway with Frankie, each pup provides a unique way to spend the weekend. No matter the journey, the city's bright and open hotels, exceptional al fresco restaurants, renowned art galleries and iconic outdoor shopping offer visitors an unforgettable way to experience Beverly Hills as they wish. ThroughoutBeverly Hills, Fido-friendly activities abound including miles of spacious parks and fragrant gardens in which to take morning walks and a number of pet-welcoming boutiques and restaurants. Beverly Gardens Park, Beverly Caon Gardens, Will Rodgers Memorial Park and Coldwater Canyon Park each offer scenic palm-lined settings for pets to frolick and play. Pups of all sizes can be spoiled with red carpet-ready accessories from Pawsdelux, pampering at Sparky's Pet Salon and sweet dog-friendly treats from the cupcake-dispensing ATM at Sprinkles.Many of the city's award-winning hotels greet four-legged friends with amenities like housemade treats, premier dog walking service and luxe dog beds: The Peninsula Beverly Hills offers specialized room service and spa treatments for dogs; The Beverly Hills Hotel serves bone-shaped dog cookies with customized inscriptions of each tail-wagging guest's name; The Maybourne Beverly Hills treats pups to fluffy dog beds, fancy food bowls and to-go water bottles; Beverly Wilshire, a Four Seasons Hotel offers in-room amenities such as luxurious pet beds and piddle pads; AKA Beverly Hills boasts spacious private outdoor areas and close proximity to the neighborhood's best dog-friendly parks; and Viceroy L'Ermitage Beverly Hills offers a Canine Club including plush toys, courtesy bags and dog bed with a portion of proceeds from the hotel's pet fee benefiting Wags and Walks local adoption center.Guests enjoying a stay in Beverly Hills can take advantage of hotel packages to experience everything the city has to offer with their furry companions in tow. Families traveling with pets can book The Maybourne Beverly Hills and receive perks like waived pet fees, daily hotel credit and complimentary champagne, while business travelers can work from The Beverly Hills Hotel in a private room complete with a large desk, stationary and Wi-Fi, on-call IT service, and a supply of soft drinks and coffee. The Peninsula Beverly Hills, Beverly Wilshire and The Beverly Hilton offer a selection of varied amenititiessuch as adaily hotel credit of up to $200, flexible check-in and check-out and complimentary valet parking, room upgrades and luxury car rental. At Viceroy L'Ermitage Beverly Hills, travelers can enjoy 20% discount on overnight stays in honor of the hotel's 20th anniversary all year long.A world-class destination, Beverly Hills draws millions of global travelers to its sun-drenched palm-lined boulevards each year. The city boasts a storied collection of AAA Diamond properties and the most Forbes Five Star hotels in California, as well as unparalleled shopping, Michelin-starred gastronomic experiences, and a variety of artistic and cultural sites.Media Contact[emailprotected]About Beverly HillsBeverly Hills, a premier travel destination, is centrally located in greater Los Angeles with beautiful weather year-round, five-star hotel accommodations, superb dining from some of the biggest culinary names in the world, and unrivalled shopping. The city is also known worldwide for its grand mansions, multitude of art and architecture, spas and salons, and exceptional walkability. Learn more atLoveBeverlyHills.comor on Facebook, Twitterand Instagram. SOURCE Beverly Hills Conference & Visitors Bureau
Answer: | Beverly Hills Welcomes Visitors and Canine Companions with Pet-Friendly 'As You Wish' Campaign | BEVERLY HILLS, Calif., March 17, 2021 /PRNewswire/ -- Beverly Hills Conference & Visitors Bureau(BHCVB) announces As You Wish, a new campaign that showcases the bespoke service and world-class amenities found in Beverly Hills through the lens of five "pawesome" pet ambassadors. The playful campaign underscores the destination's array of unique experiences that cater to the diverse needs of today's global travelers and the furry friends that so often accompany them. According to the American Pet Products Association, 37% of people travel with pets, a figure that rose by 19% over the past 10 years. (PRNewsfoto/Beverly Hills Conference & Visitors Bureau) "Over the last year, we have all realized more than ever how important our pets are to us," says Julie Wagner, CEO of BHCVB. "As travelers begin to plan trips again, it's hard for them to imagine parting with their loyal companions. Beverly Hills is a destination that visitors can count on to welcome both pets and their owners with unparalleled amenities and service." As part of the new campaign, each of five distinct canine personalities presents an exciting way to discover Beverly Hills. Whether traveling with family like Fred, on business like Bentley, or on a friends getaway with Frankie, each pup provides a unique way to spend the weekend. No matter the journey, the city's bright and open hotels, exceptional al fresco restaurants, renowned art galleries and iconic outdoor shopping offer visitors an unforgettable way to experience Beverly Hills as they wish. ThroughoutBeverly Hills, Fido-friendly activities abound including miles of spacious parks and fragrant gardens in which to take morning walks and a number of pet-welcoming boutiques and restaurants. Beverly Gardens Park, Beverly Caon Gardens, Will Rodgers Memorial Park and Coldwater Canyon Park each offer scenic palm-lined settings for pets to frolick and play. Pups of all sizes can be spoiled with red carpet-ready accessories from Pawsdelux, pampering at Sparky's Pet Salon and sweet dog-friendly treats from the cupcake-dispensing ATM at Sprinkles.Many of the city's award-winning hotels greet four-legged friends with amenities like housemade treats, premier dog walking service and luxe dog beds: The Peninsula Beverly Hills offers specialized room service and spa treatments for dogs; The Beverly Hills Hotel serves bone-shaped dog cookies with customized inscriptions of each tail-wagging guest's name; The Maybourne Beverly Hills treats pups to fluffy dog beds, fancy food bowls and to-go water bottles; Beverly Wilshire, a Four Seasons Hotel offers in-room amenities such as luxurious pet beds and piddle pads; AKA Beverly Hills boasts spacious private outdoor areas and close proximity to the neighborhood's best dog-friendly parks; and Viceroy L'Ermitage Beverly Hills offers a Canine Club including plush toys, courtesy bags and dog bed with a portion of proceeds from the hotel's pet fee benefiting Wags and Walks local adoption center.Guests enjoying a stay in Beverly Hills can take advantage of hotel packages to experience everything the city has to offer with their furry companions in tow. Families traveling with pets can book The Maybourne Beverly Hills and receive perks like waived pet fees, daily hotel credit and complimentary champagne, while business travelers can work from The Beverly Hills Hotel in a private room complete with a large desk, stationary and Wi-Fi, on-call IT service, and a supply of soft drinks and coffee. The Peninsula Beverly Hills, Beverly Wilshire and The Beverly Hilton offer a selection of varied amenititiessuch as adaily hotel credit of up to $200, flexible check-in and check-out and complimentary valet parking, room upgrades and luxury car rental. At Viceroy L'Ermitage Beverly Hills, travelers can enjoy 20% discount on overnight stays in honor of the hotel's 20th anniversary all year long.A world-class destination, Beverly Hills draws millions of global travelers to its sun-drenched palm-lined boulevards each year. The city boasts a storied collection of AAA Diamond properties and the most Forbes Five Star hotels in California, as well as unparalleled shopping, Michelin-starred gastronomic experiences, and a variety of artistic and cultural sites.Media Contact[emailprotected]About Beverly HillsBeverly Hills, a premier travel destination, is centrally located in greater Los Angeles with beautiful weather year-round, five-star hotel accommodations, superb dining from some of the biggest culinary names in the world, and unrivalled shopping. The city is also known worldwide for its grand mansions, multitude of art and architecture, spas and salons, and exceptional walkability. Learn more atLoveBeverlyHills.comor on Facebook, Twitterand Instagram. SOURCE Beverly Hills Conference & Visitors Bureau |
edtsum1942 | You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text.
Text: NEW YORK--(BUSINESS WIRE)--Kroll Bond Rating Agency (KBRA) releases its assessment of the pandemics impact on the regional aircraft market, examining challenges the sector faces as well as demand and supply-side dynamics that will shape the future of this essential market. KBRA believes that the global regional market is poised to be a leader in the overall aviation market recovery as international travel remains restricted and passengers may be more comfortable with shorter-duration regional flights before long-haul flights, especially in light of vaccine rollouts which should support domestic and regional safety concerns more immediately. This dynamic would support demand for regional aircraft in the near term, while a potential supply glut is expected to be mitigated as operators rightsize their fleets through both retirement of older and larger gauge aircraft and lower levels of new aircraft orders. Longer term, the demand for new and used regional aircraft is expected to be supported by a growing global middle-class, a wave of aircraft retirements requiring replacements, and operators increased focus on efficiency and sustainability. The report also highlights: Click here to view the report. Related Reports About KBRA KBRA is a full-service credit rating agency registered in the U.S., the EU and the UK, and is designated to provide structured finance ratings in Canada. KBRAs ratings can be used by investors for regulatory capital purposes in multiple jurisdictions.
Answer: | KBRA Releases Research Regional Aircraft: Resilience and Challenges of an Essential Market During the Pandemic | NEW YORK--(BUSINESS WIRE)--Kroll Bond Rating Agency (KBRA) releases its assessment of the pandemics impact on the regional aircraft market, examining challenges the sector faces as well as demand and supply-side dynamics that will shape the future of this essential market. KBRA believes that the global regional market is poised to be a leader in the overall aviation market recovery as international travel remains restricted and passengers may be more comfortable with shorter-duration regional flights before long-haul flights, especially in light of vaccine rollouts which should support domestic and regional safety concerns more immediately. This dynamic would support demand for regional aircraft in the near term, while a potential supply glut is expected to be mitigated as operators rightsize their fleets through both retirement of older and larger gauge aircraft and lower levels of new aircraft orders. Longer term, the demand for new and used regional aircraft is expected to be supported by a growing global middle-class, a wave of aircraft retirements requiring replacements, and operators increased focus on efficiency and sustainability. The report also highlights: Click here to view the report. Related Reports About KBRA KBRA is a full-service credit rating agency registered in the U.S., the EU and the UK, and is designated to provide structured finance ratings in Canada. KBRAs ratings can be used by investors for regulatory capital purposes in multiple jurisdictions. |
edtsum1947 | You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text.
Text: TORONTO--(BUSINESS WIRE)--Li-Cycle Corp., North Americas largest lithium-ion battery resource recycling company, is honoring National Battery Day by encouraging consumers and organizations to locate their used batteries and take action to recycle them responsibly. Lithium-ion rechargeable batteries are increasingly powering the world in industrial energy storage, automotive, and consumer electronic applications. The number of mobile devices operating worldwide is expected to reach 17.72 billion by 2024, an increase of 3.7 billion devices compared to 2020 levels, according to Statista. Similarly, the rapid adoption of electric vehicles underway is even more impactful to related critical end markets. All of these applications use lithium-ion batteries, creating significant global demand for the materials used to manufacture them. To meet this growing demand, Li-Cycle provides an affordable, safe and environmentally friendly processes to recycle all types of lithium-ion batteries. Today serves as a reminder that we are celebrating Li-Cycles success while embracing our collective efforts to ensure a sustainable future through responsible battery recycling, said Li-Cycle Co-Founder and CEO Ajay Kochhar. We are strong advocates for the critical importance of battery recycling and are proud to amplify the message of National Battery Day to encourage citizens of the world to take action. We look forward to further growing our business across North America, as well as globally, while maintaining a firm commitment to environmental sustainability and rigorous health and safety standards. Li-Cycle has achieved the following recent company milestones to drive forward its mission to leverage its innovative Spoke & Hub Technologies to provide a customer-centric, end-of-life solution for lithium-ion batteries, while creating a secondary supply of critical battery materials About Li-Cycle Corp. Li-Cycle Corp. (Li-Cycle) is on a mission to leverage its innovative Spoke & Hub Technologies to provide a customer-centric, end-of-life solution for lithium-ion batteries, while creating a secondary supply of critical battery materials. Lithium-ion rechargeable batteries are increasingly powering our world in automotive, energy storage, consumer electronics, and other industrial and household applications. The world needs improved technology and supply chain innovations to better manage battery manufacturing waste and end-of-life batteries and to meet the rapidly growing demand for critical and scarce battery-grade raw materials through a closed-loop solution. For more information, visit https://li-cycle.com/. Additional Information and Where to Find It In connection with the proposed transaction involving Li-Cycle and Peridot, Li-Cycle Holdings Corp. (Newco) will prepare and file with the SEC a registration statement on Form F-4 that will include a document that will serve as both a prospectus of Newco and a proxy statement of Peridot (the Proxy Statement/Prospectus). Li-Cycle, Peridot and Newco will prepare and file the Proxy Statement/Prospectus with the SEC and Peridot will mail the Proxy Statement/Prospectus to its shareholders and file other documents regarding the proposed transaction with the SEC. This communication is not a substitute for any proxy statement, registration statement, proxy statement/prospectus or other documents Peridot or Newco may file with the SEC in connection with the proposed transaction. INVESTORS AND SECURITY HOLDERS ARE URGED TO READ CAREFULLY AND IN THEIR ENTIRETY THE PROXY STATEMENT/PROSPECTUS WHEN IT BECOMES AVAILABLE, ANY AMENDMENTS OR SUPPLEMENTS TO THE PROXY STATEMENT/PROSPECTUS, AND OTHER DOCUMENTS FILED BY PERIDOT OR NEWCO WITH THE SEC IN CONNECTION WITH THE PROPOSED TRANSACTION BECAUSE THESE DOCUMENTS WILL CONTAIN IMPORTANT INFORMATION. Investors and security holders will be able to obtain free copies of the Proxy Statement/Prospectus and other documents filed with the SEC by Peridot or Newco through the website maintained by the SEC at www.sec.gov. Investors and securityholders will also be able to obtain free copies of the documents filed by Peridot and/or Newco with the SEC on Peridots website at www.peridotspac.com or by emailing [email protected]. No Offer or Solicitation This communication does not constitute an offer to sell or the solicitation of an offer to buy any securities of Peridot or Newco or a solicitation of any vote or approval. No offer of securities shall be made except by means of a prospectus meeting the requirements of Section 10 of the Securities Act of 1933, as amended. Participants in the Solicitation Li-Cycle, Peridot, Newco, and certain of their respective directors, executive officers and employees may be deemed to be participants in the solicitation of proxies in connection with the proposed transaction. Information regarding the persons who may, under the rules of the SEC, be deemed participants in the solicitation of proxies in connection with the proposed transaction, including a description of their direct or indirect interests, by security holdings or otherwise, will be set forth in the Proxy Statement/Prospectus and other relevant materials when it is filed with the SEC. Information regarding the directors and executive officers of Peridot is contained in Peridots final prospectus for its initial public offering, filed with the SEC on September 24, 2020 and certain of its Current Reports filed on Form 8-K. These documents can be obtained free of charge from the sources indicated above. Caution Concerning Forward-Looking Statements Certain statements contained in this communication may be considered forward-looking statements within the meaning of the U.S. Private Securities Litigation Reform Act of 1995, Section 27A of the Securities Act of 1933, as amended, and Section 21 of the Securities Exchange Act of 1934, as amended, including statements regarding the proposed transaction involving Li-Cycle and Peridot and the ability to consummate the proposed transaction. Forward-looking statements generally include statements that are predictive in nature and depend upon or refer to future events or conditions, and include words such as may, will, should, would, expect, anticipate, plan, likely, believe, estimate, project, intend, and other similar expressions among others. Statements that are not historical facts are forward-looking statements. Forward-looking statements are based on current beliefs and assumptions that are subject to risks and uncertainties and are not guarantees of future performance. Actual results could differ materially from those contained in any forward-looking statement as a result of various factors, including, without limitation: (i) the risk that the conditions to the closing of the proposed transaction are not satisfied, including the failure to timely or at all obtain shareholder approval for the proposed transaction or the failure to timely or at all obtain any required regulatory clearances, including under the Hart-Scott Rodino Antitrust Improvements Act; (ii) uncertainties as to the timing of the consummation of the proposed transaction and the ability of each of Li-Cycle and Peridot to consummate the proposed transaction; (iii) the possibility that other anticipated benefits of the proposed transaction will not be realized, and the anticipated tax treatment of the combination; (iv) the occurrence of any event that could give rise to termination of the proposed transaction; (v) the risk that stockholder litigation in connection with the proposed transaction or other settlements or investigations may affect the timing or occurrence of the proposed transaction or result in significant costs of defense, indemnification and liability; (vi) changes in general economic and/or industry specific conditions; (vii) possible disruptions from the proposed transaction that could harm Li-Cycles business; (viii) the ability of Li-Cycle to retain, attract and hire key personnel; (ix) potential adverse reactions or changes to relationships with customers, employees, suppliers or other parties resulting from the announcement or completion of the proposed transaction; (x) potential business uncertainty, including changes to existing business relationships, during the pendency of the proposed transaction that could affect Li-Cycles financial performance; (xi) legislative, regulatory and economic developments; (xii) unpredictability and severity of catastrophic events, including, but not limited to, acts of terrorism, outbreak of war or hostilities and any epidemic, pandemic or disease outbreak (including COVID-19), as well as managements response to any of the aforementioned factors; and (xiii) other risk factors as detailed from time to time in Peridots reports filed with the SEC, including Peridots annual report on Form 10-K, periodic quarterly reports on Form 10-Q, periodic current reports on Form 8-K and other documents filed with the SEC. The foregoing list of important factors is not exclusive. Neither Li-Cycle nor Peridot can give any assurance that the conditions to the proposed transaction will be satisfied. Except as required by applicable law, neither Li-Cycle nor Peridot undertakes any obligation to revise or update any forward-looking statement, or to make any other forward-looking statements, whether as a result of new information, future events or otherwise.
Answer: | Li-Cycle Celebrates National Battery Day to Promote Responsible Recycling Achieves Key Growth Milestones to Advance Sustainable Battery Recycling Globally | TORONTO--(BUSINESS WIRE)--Li-Cycle Corp., North Americas largest lithium-ion battery resource recycling company, is honoring National Battery Day by encouraging consumers and organizations to locate their used batteries and take action to recycle them responsibly. Lithium-ion rechargeable batteries are increasingly powering the world in industrial energy storage, automotive, and consumer electronic applications. The number of mobile devices operating worldwide is expected to reach 17.72 billion by 2024, an increase of 3.7 billion devices compared to 2020 levels, according to Statista. Similarly, the rapid adoption of electric vehicles underway is even more impactful to related critical end markets. All of these applications use lithium-ion batteries, creating significant global demand for the materials used to manufacture them. To meet this growing demand, Li-Cycle provides an affordable, safe and environmentally friendly processes to recycle all types of lithium-ion batteries. Today serves as a reminder that we are celebrating Li-Cycles success while embracing our collective efforts to ensure a sustainable future through responsible battery recycling, said Li-Cycle Co-Founder and CEO Ajay Kochhar. We are strong advocates for the critical importance of battery recycling and are proud to amplify the message of National Battery Day to encourage citizens of the world to take action. We look forward to further growing our business across North America, as well as globally, while maintaining a firm commitment to environmental sustainability and rigorous health and safety standards. Li-Cycle has achieved the following recent company milestones to drive forward its mission to leverage its innovative Spoke & Hub Technologies to provide a customer-centric, end-of-life solution for lithium-ion batteries, while creating a secondary supply of critical battery materials About Li-Cycle Corp. Li-Cycle Corp. (Li-Cycle) is on a mission to leverage its innovative Spoke & Hub Technologies to provide a customer-centric, end-of-life solution for lithium-ion batteries, while creating a secondary supply of critical battery materials. Lithium-ion rechargeable batteries are increasingly powering our world in automotive, energy storage, consumer electronics, and other industrial and household applications. The world needs improved technology and supply chain innovations to better manage battery manufacturing waste and end-of-life batteries and to meet the rapidly growing demand for critical and scarce battery-grade raw materials through a closed-loop solution. For more information, visit https://li-cycle.com/. Additional Information and Where to Find It In connection with the proposed transaction involving Li-Cycle and Peridot, Li-Cycle Holdings Corp. (Newco) will prepare and file with the SEC a registration statement on Form F-4 that will include a document that will serve as both a prospectus of Newco and a proxy statement of Peridot (the Proxy Statement/Prospectus). Li-Cycle, Peridot and Newco will prepare and file the Proxy Statement/Prospectus with the SEC and Peridot will mail the Proxy Statement/Prospectus to its shareholders and file other documents regarding the proposed transaction with the SEC. This communication is not a substitute for any proxy statement, registration statement, proxy statement/prospectus or other documents Peridot or Newco may file with the SEC in connection with the proposed transaction. INVESTORS AND SECURITY HOLDERS ARE URGED TO READ CAREFULLY AND IN THEIR ENTIRETY THE PROXY STATEMENT/PROSPECTUS WHEN IT BECOMES AVAILABLE, ANY AMENDMENTS OR SUPPLEMENTS TO THE PROXY STATEMENT/PROSPECTUS, AND OTHER DOCUMENTS FILED BY PERIDOT OR NEWCO WITH THE SEC IN CONNECTION WITH THE PROPOSED TRANSACTION BECAUSE THESE DOCUMENTS WILL CONTAIN IMPORTANT INFORMATION. Investors and security holders will be able to obtain free copies of the Proxy Statement/Prospectus and other documents filed with the SEC by Peridot or Newco through the website maintained by the SEC at www.sec.gov. Investors and securityholders will also be able to obtain free copies of the documents filed by Peridot and/or Newco with the SEC on Peridots website at www.peridotspac.com or by emailing [email protected]. No Offer or Solicitation This communication does not constitute an offer to sell or the solicitation of an offer to buy any securities of Peridot or Newco or a solicitation of any vote or approval. No offer of securities shall be made except by means of a prospectus meeting the requirements of Section 10 of the Securities Act of 1933, as amended. Participants in the Solicitation Li-Cycle, Peridot, Newco, and certain of their respective directors, executive officers and employees may be deemed to be participants in the solicitation of proxies in connection with the proposed transaction. Information regarding the persons who may, under the rules of the SEC, be deemed participants in the solicitation of proxies in connection with the proposed transaction, including a description of their direct or indirect interests, by security holdings or otherwise, will be set forth in the Proxy Statement/Prospectus and other relevant materials when it is filed with the SEC. Information regarding the directors and executive officers of Peridot is contained in Peridots final prospectus for its initial public offering, filed with the SEC on September 24, 2020 and certain of its Current Reports filed on Form 8-K. These documents can be obtained free of charge from the sources indicated above. Caution Concerning Forward-Looking Statements Certain statements contained in this communication may be considered forward-looking statements within the meaning of the U.S. Private Securities Litigation Reform Act of 1995, Section 27A of the Securities Act of 1933, as amended, and Section 21 of the Securities Exchange Act of 1934, as amended, including statements regarding the proposed transaction involving Li-Cycle and Peridot and the ability to consummate the proposed transaction. Forward-looking statements generally include statements that are predictive in nature and depend upon or refer to future events or conditions, and include words such as may, will, should, would, expect, anticipate, plan, likely, believe, estimate, project, intend, and other similar expressions among others. Statements that are not historical facts are forward-looking statements. Forward-looking statements are based on current beliefs and assumptions that are subject to risks and uncertainties and are not guarantees of future performance. Actual results could differ materially from those contained in any forward-looking statement as a result of various factors, including, without limitation: (i) the risk that the conditions to the closing of the proposed transaction are not satisfied, including the failure to timely or at all obtain shareholder approval for the proposed transaction or the failure to timely or at all obtain any required regulatory clearances, including under the Hart-Scott Rodino Antitrust Improvements Act; (ii) uncertainties as to the timing of the consummation of the proposed transaction and the ability of each of Li-Cycle and Peridot to consummate the proposed transaction; (iii) the possibility that other anticipated benefits of the proposed transaction will not be realized, and the anticipated tax treatment of the combination; (iv) the occurrence of any event that could give rise to termination of the proposed transaction; (v) the risk that stockholder litigation in connection with the proposed transaction or other settlements or investigations may affect the timing or occurrence of the proposed transaction or result in significant costs of defense, indemnification and liability; (vi) changes in general economic and/or industry specific conditions; (vii) possible disruptions from the proposed transaction that could harm Li-Cycles business; (viii) the ability of Li-Cycle to retain, attract and hire key personnel; (ix) potential adverse reactions or changes to relationships with customers, employees, suppliers or other parties resulting from the announcement or completion of the proposed transaction; (x) potential business uncertainty, including changes to existing business relationships, during the pendency of the proposed transaction that could affect Li-Cycles financial performance; (xi) legislative, regulatory and economic developments; (xii) unpredictability and severity of catastrophic events, including, but not limited to, acts of terrorism, outbreak of war or hostilities and any epidemic, pandemic or disease outbreak (including COVID-19), as well as managements response to any of the aforementioned factors; and (xiii) other risk factors as detailed from time to time in Peridots reports filed with the SEC, including Peridots annual report on Form 10-K, periodic quarterly reports on Form 10-Q, periodic current reports on Form 8-K and other documents filed with the SEC. The foregoing list of important factors is not exclusive. Neither Li-Cycle nor Peridot can give any assurance that the conditions to the proposed transaction will be satisfied. Except as required by applicable law, neither Li-Cycle nor Peridot undertakes any obligation to revise or update any forward-looking statement, or to make any other forward-looking statements, whether as a result of new information, future events or otherwise. |
edtsum1952 | You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text.
Text: SALT LAKE CITY--(BUSINESS WIRE)--Spiff, the leading sales compensation software for forward-thinking revenue and sales organizations, announced today that it is a leader in four sales compensation Winter 2021 G2 Reports. The company also earned leader positions in sales performance management reports, highlighting the company for its implementation practice, momentum in the market, and user satisfaction and firmly entrenching Spiff as a market leader in this emerging business category. Sales compensation and performance management has been in need of a reboot for a long time, Jeron Paul, CEO and co-founder, Spiff, said. Selling itself has evolved, transitioning from handshakes and deals made after countless meetings and meals to a digitally-driven experience with savvy prospects who use internet tools and review sites - like G2 - to research solutions before talking to a salesperson. More than ever, salespeople need to become trusted partners and consultants. Spiff motivates the smartest and best sales decisions in real time. Performers get immediate feedback when they knock the ball out of the park or if they need to improve. We applaud G2 for the depth in which its evaluating this space and are thrilled to be recognized by the firm in the winter reports. Among the reports in which Spiff was a leader include: highest-ranked G2 Score Leader for the Sales Compensation Grid; the Momentum Leader for both the Sales Compensation and Sales Performance Management Grids, which measures employee growth, review growth, social growth, and web growth; the mid-market grid for both categories. Spiff also finished in the top three in the Relationship Index, which captures real-user satisfaction ratings for a number of relationship-related review questions, for both Sales Compensation and Sales Performance Management. I love that we have adopted Spiff. I know real-time where my commissions are, said Daniel, a mid-market business development representative. I have visibility of my entire comp plan and I can take action to correct any oversights. It's a great product. Everything is laid out in a super easy manner to read and digest. Said Gordon, a mid-market sales director, Spiff allows me to quickly understand trends and drill into specific goal attainment across teams. The platform allows all users to understand (proactively) how their commissions will play out by month and by quarter. The keyword here is 'simple.' Spiff, which has grown in excess of 200% over the last 6 months, closes out a strong year in which it closed a $10M Series A led by Norwest Venture Partners, released an entirely new version of its core commission engine, rolled out the most simple and effective ASC 606 compliance tool for commissions, and unveiled a new reporting product, Spiff Insights. Rankings on G2 reports are based on data provided to us by real users, said Michael Fauscette, chief research officer, G2. We are excited to share the achievements of the products ranked on our site because they represent the voice of the user and offer terrific insights to potential buyers around the world. To download the reports, please visit: www.spiff.com. About G2 G2, the worlds leading business solution review platform, leverages more than 1,000,000+ user reviews to drive better purchasing decisions. Business professionals, buyers, investors, and analysts use the site to compare and select the best software and services based on peer reviews and synthesized social data. Every month, more than three million people visit G2s site to gain unique insights. https://www.g2.com About Spiff Spiff is a leading sales compensation platform that automates commission calculations and motivates teams to drive top-line growth. Combining an intuitive UI, real-time visibility, and seamless integrations into your current systems. Spiff is the first choice among high-growth businesses. https://www.spiff.com
Answer: | Spiff Soars Into Leadership Position in Four G2 Sales Compensation Winter Reports Company achieves overall highest G2 score for sales compensation category, also emerges as leader in sales performance management categories | SALT LAKE CITY--(BUSINESS WIRE)--Spiff, the leading sales compensation software for forward-thinking revenue and sales organizations, announced today that it is a leader in four sales compensation Winter 2021 G2 Reports. The company also earned leader positions in sales performance management reports, highlighting the company for its implementation practice, momentum in the market, and user satisfaction and firmly entrenching Spiff as a market leader in this emerging business category. Sales compensation and performance management has been in need of a reboot for a long time, Jeron Paul, CEO and co-founder, Spiff, said. Selling itself has evolved, transitioning from handshakes and deals made after countless meetings and meals to a digitally-driven experience with savvy prospects who use internet tools and review sites - like G2 - to research solutions before talking to a salesperson. More than ever, salespeople need to become trusted partners and consultants. Spiff motivates the smartest and best sales decisions in real time. Performers get immediate feedback when they knock the ball out of the park or if they need to improve. We applaud G2 for the depth in which its evaluating this space and are thrilled to be recognized by the firm in the winter reports. Among the reports in which Spiff was a leader include: highest-ranked G2 Score Leader for the Sales Compensation Grid; the Momentum Leader for both the Sales Compensation and Sales Performance Management Grids, which measures employee growth, review growth, social growth, and web growth; the mid-market grid for both categories. Spiff also finished in the top three in the Relationship Index, which captures real-user satisfaction ratings for a number of relationship-related review questions, for both Sales Compensation and Sales Performance Management. I love that we have adopted Spiff. I know real-time where my commissions are, said Daniel, a mid-market business development representative. I have visibility of my entire comp plan and I can take action to correct any oversights. It's a great product. Everything is laid out in a super easy manner to read and digest. Said Gordon, a mid-market sales director, Spiff allows me to quickly understand trends and drill into specific goal attainment across teams. The platform allows all users to understand (proactively) how their commissions will play out by month and by quarter. The keyword here is 'simple.' Spiff, which has grown in excess of 200% over the last 6 months, closes out a strong year in which it closed a $10M Series A led by Norwest Venture Partners, released an entirely new version of its core commission engine, rolled out the most simple and effective ASC 606 compliance tool for commissions, and unveiled a new reporting product, Spiff Insights. Rankings on G2 reports are based on data provided to us by real users, said Michael Fauscette, chief research officer, G2. We are excited to share the achievements of the products ranked on our site because they represent the voice of the user and offer terrific insights to potential buyers around the world. To download the reports, please visit: www.spiff.com. About G2 G2, the worlds leading business solution review platform, leverages more than 1,000,000+ user reviews to drive better purchasing decisions. Business professionals, buyers, investors, and analysts use the site to compare and select the best software and services based on peer reviews and synthesized social data. Every month, more than three million people visit G2s site to gain unique insights. https://www.g2.com About Spiff Spiff is a leading sales compensation platform that automates commission calculations and motivates teams to drive top-line growth. Combining an intuitive UI, real-time visibility, and seamless integrations into your current systems. Spiff is the first choice among high-growth businesses. https://www.spiff.com |
edtsum1979 | You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text.
Text: SANTA ANA, Calif., Jan. 14, 2021 /PRNewswire/ --Avvo has awarded Douglas Borthwick its prestigious Clients' Choice Award for Top Client Satisfaction in Criminal Defense. This award is given to attorneys whose outstanding legal services have resulted in highly satisfied clients. There's nothing that an attorney can do to ask for a Clients' Choice Award. Instead, Avvo makes the award based only on an attorney receiving quality reviews from satisfied clients throughout the year. Continue Reading Award Photo Avvo's comprehensive rating system carefully reviews a lawyer's background and overall profile, which includes years in practice, professional achievements and industry recognition. Avvo performs rankings in 19 different legal categories and periodically collects background data from multiple sources. As Avvo uses a mathematical model, it can ensure that the ratings are unbiased and not determined based on favoritism. Douglas Borthwick is also AV PREEMINENT RATED by Martindale-Hubbell. This is the highest possible attorney peer review rating in both legal ability and ethical standards. Martindale-Hubbell is the Gold Standard among attorney peer review ratings. Attorney Douglas Borthwick has further achieved a "SUPERB" Rating from Avvo , the highest evaluation given by the nationally acclaimed attorney rating agency. Douglas Borthwick has earned the trust and respect of his clients and colleagues for his integrity, preparation, determination, and attention to detail.Douglas Borthwick's experience includes, but is not exclusive of, the following areas: personal injury law, family law, criminal law, and general civil litigation practice.Mr. Borthwick's profile was featured in the California Business Journal in 2018: https://calbizjournal.com/attorney-douglas-borthwick/Also visit: Also visit: https://www.acq-intl.com/issues/2018-Leading-Adviser-Supplement/32/Law Offices of Douglas Borthwick can be found at: www.borthwicklawyer.com "Life is the most precious thing we have and it's probably the thing most people take for granted. We're busy. We don't even take time to consciously think of our lives because we are too busy living them. Appreciate your life. We all only get one. Invest in what makes you happy. There is so much to be thankful for. We all have rotten things happen to us and we all have unfortunate things. But there is good in everything that happens if you look for it. Give thanks every day. Live consciously with awareness and gratitude, appreciate the moments as they occur before they forever pass so quickly."- Attorney Douglas Borthwick, Esq.Media Contact: John Walter714-564-9400[emailprotected]SOURCE Law Offices of Douglas Borthwick Related Links http://www.borthwicklawyer.com
Answer: | Attorney Douglas Borthwick Receives Avvo Clients' Choice Award for Top Client Satisfaction in Criminal Defense, Complimenting His Avvo "Superb" Highest Rating | SANTA ANA, Calif., Jan. 14, 2021 /PRNewswire/ --Avvo has awarded Douglas Borthwick its prestigious Clients' Choice Award for Top Client Satisfaction in Criminal Defense. This award is given to attorneys whose outstanding legal services have resulted in highly satisfied clients. There's nothing that an attorney can do to ask for a Clients' Choice Award. Instead, Avvo makes the award based only on an attorney receiving quality reviews from satisfied clients throughout the year. Continue Reading Award Photo Avvo's comprehensive rating system carefully reviews a lawyer's background and overall profile, which includes years in practice, professional achievements and industry recognition. Avvo performs rankings in 19 different legal categories and periodically collects background data from multiple sources. As Avvo uses a mathematical model, it can ensure that the ratings are unbiased and not determined based on favoritism. Douglas Borthwick is also AV PREEMINENT RATED by Martindale-Hubbell. This is the highest possible attorney peer review rating in both legal ability and ethical standards. Martindale-Hubbell is the Gold Standard among attorney peer review ratings. Attorney Douglas Borthwick has further achieved a "SUPERB" Rating from Avvo , the highest evaluation given by the nationally acclaimed attorney rating agency. Douglas Borthwick has earned the trust and respect of his clients and colleagues for his integrity, preparation, determination, and attention to detail.Douglas Borthwick's experience includes, but is not exclusive of, the following areas: personal injury law, family law, criminal law, and general civil litigation practice.Mr. Borthwick's profile was featured in the California Business Journal in 2018: https://calbizjournal.com/attorney-douglas-borthwick/Also visit: Also visit: https://www.acq-intl.com/issues/2018-Leading-Adviser-Supplement/32/Law Offices of Douglas Borthwick can be found at: www.borthwicklawyer.com "Life is the most precious thing we have and it's probably the thing most people take for granted. We're busy. We don't even take time to consciously think of our lives because we are too busy living them. Appreciate your life. We all only get one. Invest in what makes you happy. There is so much to be thankful for. We all have rotten things happen to us and we all have unfortunate things. But there is good in everything that happens if you look for it. Give thanks every day. Live consciously with awareness and gratitude, appreciate the moments as they occur before they forever pass so quickly."- Attorney Douglas Borthwick, Esq.Media Contact: John Walter714-564-9400[emailprotected]SOURCE Law Offices of Douglas Borthwick Related Links http://www.borthwicklawyer.com |
edtsum1983 | You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text.
Text: MIAMI--(BUSINESS WIRE)--Lantern, the newly launched dating app, puts the fun back into online dating by immersing its users in virtual, movie-like scenarios that change with each answer, matching them with others on the same path. As the first dating app to leverage gamification technology, Lantern combines relationship psychology, a weighted algorithm, alluring design, and a dash of destiny to offer a deeper and more meaningful online dating experience. Lantern differentiates itself by taking you on a journey that changes with each selection. After an answer is chosen, You just won 50 million dollars, the jet is fueled up. Where do you go? the very next screen shows other people who made the same choice. Not only does Lantern provide an honest way to meet someone, but its also a great way to break the ice, 'Hey, we both said St. Tropez'. Have you been before? The Lantern inbox is filled with potential dates who want to talk about someones favorite topics. Online dating began to feel like a second job. We lost that sense of adventure and excitement that comes with meeting new people, says Lantern creator, Yehuda J Neuman. So we created an experience that makes the process of dating fun, introspective and connective... we all deserve to find someone who appreciates how unique we are. While it starts off fun the app packs some real psychology behind it. The structure was created by founders Caroline Gyllensporre and Yehuda Neuman based on his fathers work, M Gary Neuman, a licensed psychotherapist and award-winning New York Times best-selling author. Neuman has been the subject of 12 shows with Oprah Winfrey, more than 50 on Today Show segments, Anderson Cooper, Katie Couric, Steve Harvey and more. Oprah even dubbed him one of "the best psychotherapists in the world". The extensive knowledge and resources of the Lantern team continue to ensure the app delivers entertainment and psychological value to its users. Lantern eliminates the mundane action of swiping through endless amounts of people solely based on physical appearance by allowing users to uncover their own storyline through engaging questions. The new ad-free dating app is free to use with the option to pay for its premium service. Lantern is now available for free and can be downloaded in the app store here. About Lantern: Launched in 2021 by Yehuda J Neuman and Caroline Gyllensporre, Lantern makes online dating fun by immersing users in playful scenarios with outcomes they can choose, using compelling questions and thought-provoking storylines. The experience was created with a unique focus on entertaining users and incorporating psychology backed by Oprah featured psychologist and New York Times best-selling author, M Gary Neuman. Lantern ambitiously aims to entertain, and connect, all at the same time. More information about Lantern can be found at www.lanterndating.com and the app can be downloaded here.
Answer: | New Dating App, Lantern, Provides an Entertainment Driven Approach to Online Dating Lantern looks to Change the Dating Game, One Thought-Provoking Narrative at a Time | MIAMI--(BUSINESS WIRE)--Lantern, the newly launched dating app, puts the fun back into online dating by immersing its users in virtual, movie-like scenarios that change with each answer, matching them with others on the same path. As the first dating app to leverage gamification technology, Lantern combines relationship psychology, a weighted algorithm, alluring design, and a dash of destiny to offer a deeper and more meaningful online dating experience. Lantern differentiates itself by taking you on a journey that changes with each selection. After an answer is chosen, You just won 50 million dollars, the jet is fueled up. Where do you go? the very next screen shows other people who made the same choice. Not only does Lantern provide an honest way to meet someone, but its also a great way to break the ice, 'Hey, we both said St. Tropez'. Have you been before? The Lantern inbox is filled with potential dates who want to talk about someones favorite topics. Online dating began to feel like a second job. We lost that sense of adventure and excitement that comes with meeting new people, says Lantern creator, Yehuda J Neuman. So we created an experience that makes the process of dating fun, introspective and connective... we all deserve to find someone who appreciates how unique we are. While it starts off fun the app packs some real psychology behind it. The structure was created by founders Caroline Gyllensporre and Yehuda Neuman based on his fathers work, M Gary Neuman, a licensed psychotherapist and award-winning New York Times best-selling author. Neuman has been the subject of 12 shows with Oprah Winfrey, more than 50 on Today Show segments, Anderson Cooper, Katie Couric, Steve Harvey and more. Oprah even dubbed him one of "the best psychotherapists in the world". The extensive knowledge and resources of the Lantern team continue to ensure the app delivers entertainment and psychological value to its users. Lantern eliminates the mundane action of swiping through endless amounts of people solely based on physical appearance by allowing users to uncover their own storyline through engaging questions. The new ad-free dating app is free to use with the option to pay for its premium service. Lantern is now available for free and can be downloaded in the app store here. About Lantern: Launched in 2021 by Yehuda J Neuman and Caroline Gyllensporre, Lantern makes online dating fun by immersing users in playful scenarios with outcomes they can choose, using compelling questions and thought-provoking storylines. The experience was created with a unique focus on entertaining users and incorporating psychology backed by Oprah featured psychologist and New York Times best-selling author, M Gary Neuman. Lantern ambitiously aims to entertain, and connect, all at the same time. More information about Lantern can be found at www.lanterndating.com and the app can be downloaded here. |
edtsum1991 | You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text.
Text: VANCOUVER, British Columbia--(BUSINESS WIRE)--Great Pacific Media, the factual division of Thunderbird Entertainment Group Inc. (TSXV:TBRD) (OTCQX:THBRF) (Thunderbird or the Company) is proud to announce the development of a premium scripted drama series based on the father of the American Space Program and former Nazi scientist Wernher Von Braun, entitled Von Braun: Dreamer of Space, Engineer of War. The series is based on Canadian author Michael J. Neufelds definitive biography about Von Braun, a man who became an American hero, who was also one of the most controversial people ever to join NASA. Like Von Braun, the United States shared a vision for space travel, which led to the decision to bring the controversial German V-2 Rocket builder to work at NASA after World War II. The result was a complex, often uncomfortable alliance that culminated in Neil Armstrong successfully landing on the moon in 1969. Leading the creative is Simon Barry (Warrior Nun, Continuum, Bad Blood), who is also attached as an Executive Producer, writer and director through his production company Reality Distortion Field (RDF). Thunderbirds President Mark Miller will also Executive Produce on behalf of Great Pacific Media. Thunderbird and Miller acquired the books intellectual property (IP) from the Smithsonian Institution in 2019. Without Von Braun and his team of engineers, America would have lost the space race to the Russians, says Mark Miller, President of Thunderbird. This fascinating story is about whitewashing the history of men who played a major role in engineering the Nazi regime. At the centre, Von Braun and an American government were desperate to win the space race at all costs. Thunderbird has selected the story of Von Braun to launch its new initiative to develop dramatic scripted content that is based on real events through Great Pacific Media. The Space Race is a globally uplifting story, while the work of Nazi engineers is a murderous stain on history. This series will explore Von Brauns childhood dreams of interplanetary travel and dramatize the choices he made to fund his rockets, his vision for World War II Germany, and later, the United States. After being Hitlers greatest hope to destroy London, Von Braun became an American space pioneer who would win Americas National Medal of Science, while avoiding the war crime courts of Nuremberg. The story of Von Braun is set to be a breakthrough television event with global reach, continued Miller. He was a man caught between morality and progress glorified as a visionary and vilified as a war criminal. About Thunderbird Entertainment Group Thunderbird Entertainment Group is a global award-winning, full-service, multiplatform production, distribution, and rights management company, headquartered in Vancouver, with additional offices in Los Angeles, Toronto, and Ottawa. Thunderbird creates award-winning scripted, unscripted, and animated programming for the worlds leading digital platforms, as well as Canadian and international broadcasters. Thunderbirds vision is to produce high quality, socially responsible content that makes the world a better place. The Company develops, produces, and distributes animated, factual, and scripted content through its various divisions, including Thunderbird kids and family (Atomic Cartoons), Thunderbird factual (Great Pacific Media) and Thunderbird productions. Thunderbird is on Facebook, Twitter, and Instagram at @tbirdent. For more information, visit: www.thunderbird.tv. Neither the TSX-V nor its Regulation Services Provider (as that term is defined in the policies of the TSX-V) accepts responsibility of the adequacy or accuracy of this release, which has been prepared by management.
Answer: | Thunderbird Entertainment Announces Development of a Premium Limited Drama Series Based on the Life of Wernher Von Braun Von Braun: Dreamer of Space, Engineer of War - the controversial story of the father of Americas space program is being adapted for television | VANCOUVER, British Columbia--(BUSINESS WIRE)--Great Pacific Media, the factual division of Thunderbird Entertainment Group Inc. (TSXV:TBRD) (OTCQX:THBRF) (Thunderbird or the Company) is proud to announce the development of a premium scripted drama series based on the father of the American Space Program and former Nazi scientist Wernher Von Braun, entitled Von Braun: Dreamer of Space, Engineer of War. The series is based on Canadian author Michael J. Neufelds definitive biography about Von Braun, a man who became an American hero, who was also one of the most controversial people ever to join NASA. Like Von Braun, the United States shared a vision for space travel, which led to the decision to bring the controversial German V-2 Rocket builder to work at NASA after World War II. The result was a complex, often uncomfortable alliance that culminated in Neil Armstrong successfully landing on the moon in 1969. Leading the creative is Simon Barry (Warrior Nun, Continuum, Bad Blood), who is also attached as an Executive Producer, writer and director through his production company Reality Distortion Field (RDF). Thunderbirds President Mark Miller will also Executive Produce on behalf of Great Pacific Media. Thunderbird and Miller acquired the books intellectual property (IP) from the Smithsonian Institution in 2019. Without Von Braun and his team of engineers, America would have lost the space race to the Russians, says Mark Miller, President of Thunderbird. This fascinating story is about whitewashing the history of men who played a major role in engineering the Nazi regime. At the centre, Von Braun and an American government were desperate to win the space race at all costs. Thunderbird has selected the story of Von Braun to launch its new initiative to develop dramatic scripted content that is based on real events through Great Pacific Media. The Space Race is a globally uplifting story, while the work of Nazi engineers is a murderous stain on history. This series will explore Von Brauns childhood dreams of interplanetary travel and dramatize the choices he made to fund his rockets, his vision for World War II Germany, and later, the United States. After being Hitlers greatest hope to destroy London, Von Braun became an American space pioneer who would win Americas National Medal of Science, while avoiding the war crime courts of Nuremberg. The story of Von Braun is set to be a breakthrough television event with global reach, continued Miller. He was a man caught between morality and progress glorified as a visionary and vilified as a war criminal. About Thunderbird Entertainment Group Thunderbird Entertainment Group is a global award-winning, full-service, multiplatform production, distribution, and rights management company, headquartered in Vancouver, with additional offices in Los Angeles, Toronto, and Ottawa. Thunderbird creates award-winning scripted, unscripted, and animated programming for the worlds leading digital platforms, as well as Canadian and international broadcasters. Thunderbirds vision is to produce high quality, socially responsible content that makes the world a better place. The Company develops, produces, and distributes animated, factual, and scripted content through its various divisions, including Thunderbird kids and family (Atomic Cartoons), Thunderbird factual (Great Pacific Media) and Thunderbird productions. Thunderbird is on Facebook, Twitter, and Instagram at @tbirdent. For more information, visit: www.thunderbird.tv. Neither the TSX-V nor its Regulation Services Provider (as that term is defined in the policies of the TSX-V) accepts responsibility of the adequacy or accuracy of this release, which has been prepared by management. |
edtsum2012 | You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text.
Text: CAMBRIDGE, Mass. and LEBANON, N.H. and NEW YORK, Jan. 19, 2021 /PRNewswire/ --Celdara Medical, LLC ("Celdara") today announced that the National Institute of Allergy and Infectious Disease (NIAID) of the National Institutes of Health (NIH) has awarded it a two-year Small Business Technology Transfer Research (STTR) grant to fund the development of a novel, broad-spectrum therapeutic/prophylactic against RNA viruses, including SARS-CoV-2, SARS, Ebola, influenza, and pathogenic arenaviruses. This project builds on the discoveries of Principal Investigator Jason Botten, a professor at the University of Vermont's Larner College of Medicine in Burlington, Vt. Dr. Botten is also scientific founder of Celdara, and a founding member of Celdara's Pandemic Security Initiative Scientific Advisory Board. Pandemic Security Initiative Logo "We are excited for the support of this potentially game-changing therapy," Dr. Irena Ivanovska, Celdara's program lead and director, said. "RNA viruses such as SARS-CoV-2 (responsible for COVID-19), SARS, Ebola, and influenza continue to wreak havoc on a world ill-equipped to control them. Successful development of this broad-spectrum antiviral agent would provide a novel first-line therapy and importantly, enable rapid deployment during new or re-emerging viral outbreaks such as the current COVID-19 pandemic. We are grateful to the scientists and policymakers at NIAID and across NIH for their support of this program, and we look forward to executing the work and bringing this medicine to patients." Dr. Botten's research has demonstrated that the drug's target is required for the propagation of arenaviruses, coronaviruses, and filoviruses, and that it associates with these viruses as well as orthomyxoviruses and hantaviruses. In the target's absence, viral particles cannot attach to host cells, effectively stopping viral spread. "We've made great strides to understand how this protein regulates the infectivity of viral particles," said Dr. Botten. "This new funding from NIAID provides us with an exciting opportunity to move beyond the basic science and to translate our discoveries into medicines. "Because the host molecule targeted is required for multiple families of pathogenic viruses, we expect that a single antiviral could broadly protect against many of the most dangerous pathogenic threats, thereby preventing or at least mitigating future outbreaks and pandemics. We are thrilled by this opportunity to develop such a countermeasure." Celdara is an experienced biopharma developer focused on launching promising products to the patients who need them the most. Celdara has a robust anti-infectives pipeline which forms the foundation from which the Pandemic Security Initiative (PanSec) was launched. PanSec is a public-private partnership which has a singular goal to ensure that we are better prepared for the next pandemic.Dr. Jake Reder, Celdara's cofounder and CEO, commented, "We are proud to continue our highly productive partnership with Professor Botten and the University of Vermont, and we are especially excited about the potential of this work in particular. An innovative, safe, and effective broad-spectrum antiviral that could be used both prophylactically and therapeutically is the holy grail of pandemic preparedness. With the support of NIH, we will determine just how close we can come to this ideal. Should we be successful, the resulting medicine would redefine how humanity prepares itself against viral threats."Dr. Botten and Celdara began their collaboration in 2016 to develop medicines for treatment of emerging and re-emerging hemorrhagic fever viruses. Since that time, they have secured support from NIH and other funding sources to develop drugs to treat a range of highly pathogenic RNA viruses, including hantaviruses, arenaviruses, coronaviruses, and filoviruses.The research reported in this press release is supported by the National Institute of Allergy and Infectious Diseases of the National Institutes of Health Grant Award RAI157527. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.About the University of VermontSince 1791, the University of Vermont has worked to move humankind forward. UVM's strengths align with the most pressing needs of our time: the healthof our societies and the health of our environment. Our sizelarge enough to offer a breadth of ideas, resources, and opportunities, yet intimate enough to enable close faculty-student mentorship across all levels of studyallows us to pursue these interconnectedissues through cross-disciplinary research and collaboration. Providing an unparalleled educational experience for our students, and ensuring their success, are at the core of what we do. As one of the nation's first land grant universities, UVM advances Vermontandthe broader societythrough the discovery and application of new knowledge.About The Pandemic Security InitiativeThe Pandemic Security Initiativeseeks to protect the nation from future pandemicsby developing medical countermeasures that integrate the best of ground-breaking science, entrepreneurial innovation, public-sector investment, and private-sector efficiency. With support from the public and private sectors, including the Department of Health and Human Services, its mission is to identify and develop innovative diagnostics, prophylactics, and therapeutics against pandemic scale threats. Celdara Medical initiated this work in 2014 and formalized it under the Pandemic Security Initiative umbrella in early 2020 to capture learnings from and aid in the response to COVID-19. Celdara Medical's Academic Partner Network includes collaborations with over 60 leading universities, and thousands of pipeline innovations from hundreds of universities and research labs spanning all 50 states and dozens of countries. The Pandemic Security Initiative is an entrepreneurial, operating, health-security product developer. For more information on the Pandemic Security Initiative visitwww.pansec.org.About Celdara MedicalCeldara Medical was founded by Drs. Jake Reder and Michael Fanger in 2008 and is headquartered at the Dartmouth Regional Technology Center (DRTC) in Lebanon, N.H. Celdara Medical builds academic and early-stage innovations into high-potential medical companies, identifying discoveries of exceptional value at the earliest stages and moving them toward the market. Celdara Medical partners with inventors and their institutions, providing the developmental, financial, and business acumen required to bridge discovery and profitability. With robust funding options, a diverse and high impact Programmatic pipeline, and partnerships with world-class academic institutions and industry leaders, Celdara Medical navigates all aspects of a complex industry, accelerating science to improve human health. Further information about Celdara Medical is available atceldaramedical.com.SOURCE Celdara Medical Related Links https://www.celdaramedical.com/
Answer: | Celdara Medical and the University of Vermont Secure NIH Funding to Improve Pandemic Preparedness and Response | CAMBRIDGE, Mass. and LEBANON, N.H. and NEW YORK, Jan. 19, 2021 /PRNewswire/ --Celdara Medical, LLC ("Celdara") today announced that the National Institute of Allergy and Infectious Disease (NIAID) of the National Institutes of Health (NIH) has awarded it a two-year Small Business Technology Transfer Research (STTR) grant to fund the development of a novel, broad-spectrum therapeutic/prophylactic against RNA viruses, including SARS-CoV-2, SARS, Ebola, influenza, and pathogenic arenaviruses. This project builds on the discoveries of Principal Investigator Jason Botten, a professor at the University of Vermont's Larner College of Medicine in Burlington, Vt. Dr. Botten is also scientific founder of Celdara, and a founding member of Celdara's Pandemic Security Initiative Scientific Advisory Board. Pandemic Security Initiative Logo "We are excited for the support of this potentially game-changing therapy," Dr. Irena Ivanovska, Celdara's program lead and director, said. "RNA viruses such as SARS-CoV-2 (responsible for COVID-19), SARS, Ebola, and influenza continue to wreak havoc on a world ill-equipped to control them. Successful development of this broad-spectrum antiviral agent would provide a novel first-line therapy and importantly, enable rapid deployment during new or re-emerging viral outbreaks such as the current COVID-19 pandemic. We are grateful to the scientists and policymakers at NIAID and across NIH for their support of this program, and we look forward to executing the work and bringing this medicine to patients." Dr. Botten's research has demonstrated that the drug's target is required for the propagation of arenaviruses, coronaviruses, and filoviruses, and that it associates with these viruses as well as orthomyxoviruses and hantaviruses. In the target's absence, viral particles cannot attach to host cells, effectively stopping viral spread. "We've made great strides to understand how this protein regulates the infectivity of viral particles," said Dr. Botten. "This new funding from NIAID provides us with an exciting opportunity to move beyond the basic science and to translate our discoveries into medicines. "Because the host molecule targeted is required for multiple families of pathogenic viruses, we expect that a single antiviral could broadly protect against many of the most dangerous pathogenic threats, thereby preventing or at least mitigating future outbreaks and pandemics. We are thrilled by this opportunity to develop such a countermeasure." Celdara is an experienced biopharma developer focused on launching promising products to the patients who need them the most. Celdara has a robust anti-infectives pipeline which forms the foundation from which the Pandemic Security Initiative (PanSec) was launched. PanSec is a public-private partnership which has a singular goal to ensure that we are better prepared for the next pandemic.Dr. Jake Reder, Celdara's cofounder and CEO, commented, "We are proud to continue our highly productive partnership with Professor Botten and the University of Vermont, and we are especially excited about the potential of this work in particular. An innovative, safe, and effective broad-spectrum antiviral that could be used both prophylactically and therapeutically is the holy grail of pandemic preparedness. With the support of NIH, we will determine just how close we can come to this ideal. Should we be successful, the resulting medicine would redefine how humanity prepares itself against viral threats."Dr. Botten and Celdara began their collaboration in 2016 to develop medicines for treatment of emerging and re-emerging hemorrhagic fever viruses. Since that time, they have secured support from NIH and other funding sources to develop drugs to treat a range of highly pathogenic RNA viruses, including hantaviruses, arenaviruses, coronaviruses, and filoviruses.The research reported in this press release is supported by the National Institute of Allergy and Infectious Diseases of the National Institutes of Health Grant Award RAI157527. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.About the University of VermontSince 1791, the University of Vermont has worked to move humankind forward. UVM's strengths align with the most pressing needs of our time: the healthof our societies and the health of our environment. Our sizelarge enough to offer a breadth of ideas, resources, and opportunities, yet intimate enough to enable close faculty-student mentorship across all levels of studyallows us to pursue these interconnectedissues through cross-disciplinary research and collaboration. Providing an unparalleled educational experience for our students, and ensuring their success, are at the core of what we do. As one of the nation's first land grant universities, UVM advances Vermontandthe broader societythrough the discovery and application of new knowledge.About The Pandemic Security InitiativeThe Pandemic Security Initiativeseeks to protect the nation from future pandemicsby developing medical countermeasures that integrate the best of ground-breaking science, entrepreneurial innovation, public-sector investment, and private-sector efficiency. With support from the public and private sectors, including the Department of Health and Human Services, its mission is to identify and develop innovative diagnostics, prophylactics, and therapeutics against pandemic scale threats. Celdara Medical initiated this work in 2014 and formalized it under the Pandemic Security Initiative umbrella in early 2020 to capture learnings from and aid in the response to COVID-19. Celdara Medical's Academic Partner Network includes collaborations with over 60 leading universities, and thousands of pipeline innovations from hundreds of universities and research labs spanning all 50 states and dozens of countries. The Pandemic Security Initiative is an entrepreneurial, operating, health-security product developer. For more information on the Pandemic Security Initiative visitwww.pansec.org.About Celdara MedicalCeldara Medical was founded by Drs. Jake Reder and Michael Fanger in 2008 and is headquartered at the Dartmouth Regional Technology Center (DRTC) in Lebanon, N.H. Celdara Medical builds academic and early-stage innovations into high-potential medical companies, identifying discoveries of exceptional value at the earliest stages and moving them toward the market. Celdara Medical partners with inventors and their institutions, providing the developmental, financial, and business acumen required to bridge discovery and profitability. With robust funding options, a diverse and high impact Programmatic pipeline, and partnerships with world-class academic institutions and industry leaders, Celdara Medical navigates all aspects of a complex industry, accelerating science to improve human health. Further information about Celdara Medical is available atceldaramedical.com.SOURCE Celdara Medical Related Links https://www.celdaramedical.com/ |
edtsum2014 | You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text.
Text: WOBURN, Mass.--(BUSINESS WIRE)--Monotype today announced nominations are open now through Oct 16th, 2020 for the 2020 Type Champions Award program. In its second year, the Type Champions Award recognizes brands that are committed to excellence in design and typography. Leading brands recognized last year were & Other Stories, Alibaba Group, Audi, Dropbox, Juventus, Mailchimp, Ogilvy, Southwest Airlines, Squarespace, The Guardian, The New School and The New York Times. Typography has always played a critical role in a brands identity, but the pandemic has further highlighted its ability to convey a brands personality and mission across an ever-increasing list of digital interfaces, said James Fooks-Bale, creative director of Monotype. The 2020 Type Champions Award will celebrate the companies and designers that have found creative ways to use type to create authentic relationships with consumers. Nominated brands should demonstrate a focus on type in building brand messages, marketing and advertising campaigns, and creating unified overall customer experiences. Winners will be selected by a panel of global branding experts including: Good typography captures a brand's ethos and translates it immediatelyin a single letter, said Perrin Drumm, who was part of last years panel. That's not easy, and I'm excited to recognize the designers who are doing it best. Winners will be announced later this year. To learn more about the judging process and complete a nomination, click here. To follow the conversation around this years nominees, search #TypeChampions2020 on Twitter, Facebook, Instagram and LinkedIn. About Monotype Monotype empowers creative minds to build and express authentic brands through design, technology and expertise. Further information is available at www.monotype.com. Follow Monotype on Twitter, Instagram and LinkedIn. Monotype is a trademark of Monotype Imaging Inc. registered in the U.S. Patent and Trademark Office and may be registered in certain other jurisdictions. All other trademarks are the property of their respective owners. 2020 Monotype Imaging Holdings Inc. All rights reserved. Evaluated by a panel of branding experts from around the world, this years competition will recognize brands and designers that have used typefaces that make an impact.
Answer: | Monotype Opens Nomination Period for 2020 Type Champions Award | WOBURN, Mass.--(BUSINESS WIRE)--Monotype today announced nominations are open now through Oct 16th, 2020 for the 2020 Type Champions Award program. In its second year, the Type Champions Award recognizes brands that are committed to excellence in design and typography. Leading brands recognized last year were & Other Stories, Alibaba Group, Audi, Dropbox, Juventus, Mailchimp, Ogilvy, Southwest Airlines, Squarespace, The Guardian, The New School and The New York Times. Typography has always played a critical role in a brands identity, but the pandemic has further highlighted its ability to convey a brands personality and mission across an ever-increasing list of digital interfaces, said James Fooks-Bale, creative director of Monotype. The 2020 Type Champions Award will celebrate the companies and designers that have found creative ways to use type to create authentic relationships with consumers. Nominated brands should demonstrate a focus on type in building brand messages, marketing and advertising campaigns, and creating unified overall customer experiences. Winners will be selected by a panel of global branding experts including: Good typography captures a brand's ethos and translates it immediatelyin a single letter, said Perrin Drumm, who was part of last years panel. That's not easy, and I'm excited to recognize the designers who are doing it best. Winners will be announced later this year. To learn more about the judging process and complete a nomination, click here. To follow the conversation around this years nominees, search #TypeChampions2020 on Twitter, Facebook, Instagram and LinkedIn. About Monotype Monotype empowers creative minds to build and express authentic brands through design, technology and expertise. Further information is available at www.monotype.com. Follow Monotype on Twitter, Instagram and LinkedIn. Monotype is a trademark of Monotype Imaging Inc. registered in the U.S. Patent and Trademark Office and may be registered in certain other jurisdictions. All other trademarks are the property of their respective owners. 2020 Monotype Imaging Holdings Inc. All rights reserved. Evaluated by a panel of branding experts from around the world, this years competition will recognize brands and designers that have used typefaces that make an impact. |
edtsum2021 | You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text.
Text: TRUMBULL, Conn., Aug. 5, 2020 /PRNewswire/ --Sustained acoustic medicine (sam) from ZetrOZ heals a wide range of injuries and relieves the pain caused by them - and the wearable device is covered by personal injury and workers' compensation insurance. The safe and effective treatment eliminates the need for expensive and time-consuming surgery, painful injections and costly prescription pain medication that can cause dependence. Many Americans suffer from a degree of neck or back pain, especially those who have had a traumatic experience such as a car accident. This pain can prove debilitating and can significantly affect their quality of life. Then there are employees who are injured on the job and must recover quickly. All of these people need a cost-effective, low-maintenance, user-friendly solution. Fortunately, sam meets all of these criteria. Medical issues the ultrasound device treats include the following: Knee pain Lower back injuries Neck pain Whiplash Tendinitis and overuse injuries When surgery is necessary, sam aids in the post-operative recovery process, accelerating it and providing pain relief. The device can also delay the need for surgical procedures until a more convenient time. While an ultrasound treatment with this degree of efficacy may sound like it would be expensive, fortunately, most health insurance plans and automotive insurance carriers in the United States cover sam. Patient navigators at ZetrOZ, the company that produces sam, are happy to walk patients through the process of obtaining the device and getting it covered by their insurance carrier. Those who use sam experience results that are notable and fast, as illustrated by Corinne Poling, who broke her leg in multiple locations and suffered from a significant amount of pain and almost complete lack of mobility. Poling, who was not able to bend the affected leg or place enough weight on it to complete simple activities, had tried a walker, a wheelchair and several forms of therapy without success before her doctor suggested sam Sport. The wearable device produced results for her that none of the other treatments could. "The device has taken me from a 10-plus level of pain to a livable three to five level on a daily basis. The swelling has ceased and the leg barely ever bothers me now. If I were to rate the improvement in mobility, it would be 75 percent in just this short period of not quite 30 days, using it four hours once daily with two contacts. Application of sam was easy to learn and I quickly got used to wearing it," Poling said. While sam is technologically sophisticated, it is also easy to use and apply, making it the perfect choice for home application by patients. Users can engage in most activities while wearing the device and it only requires four hours per day of use to deliver results. Additionally, sam ships directly to patients' homes, preventing the need to pick it up at a doctor's office or hospital. "People suffering from neck or back injuries due to a traumatic event, or injuries they sustained at the workplace, should not have to endure expensive, risky and time-consuming surgery, injections or pain medications. With sam, patients have a budget-friendly, safe and non-invasive way to relieve their pain and heal their injuries. This is one of the reasons I created sam and I am very pleased the ultrasound treatment can help them," said Dr. George Lewis, chief executive officer of ZetrOZ Systems. About ZetrOZ Systems ZetrOZ Systems is an FDA cGMP and ISO 13585 medical technology company headquartered in the southern coastal region of Connecticut. The organization also has manufacturing facilities across the United States. ZetrOZ Systems produced UltrOZ, samSport and samPro 2.0 to provide safe and effective treatment options for prevalent conditions such as arthritis. Learn more at zetroz.comand samrecover.com. SOURCE ZetrOZ Systems Related Links http://zetroz.com
Answer: | The Highly Effective Sustained Acoustic Medicine (sam) Device for Injury Treatment Is Covered by Personal Injury and Workers' Compensation Insurance Those suffering from injuries experience pain relief and healing without the need for expensive surgery, injections or prescription drugs. | TRUMBULL, Conn., Aug. 5, 2020 /PRNewswire/ --Sustained acoustic medicine (sam) from ZetrOZ heals a wide range of injuries and relieves the pain caused by them - and the wearable device is covered by personal injury and workers' compensation insurance. The safe and effective treatment eliminates the need for expensive and time-consuming surgery, painful injections and costly prescription pain medication that can cause dependence. Many Americans suffer from a degree of neck or back pain, especially those who have had a traumatic experience such as a car accident. This pain can prove debilitating and can significantly affect their quality of life. Then there are employees who are injured on the job and must recover quickly. All of these people need a cost-effective, low-maintenance, user-friendly solution. Fortunately, sam meets all of these criteria. Medical issues the ultrasound device treats include the following: Knee pain Lower back injuries Neck pain Whiplash Tendinitis and overuse injuries When surgery is necessary, sam aids in the post-operative recovery process, accelerating it and providing pain relief. The device can also delay the need for surgical procedures until a more convenient time. While an ultrasound treatment with this degree of efficacy may sound like it would be expensive, fortunately, most health insurance plans and automotive insurance carriers in the United States cover sam. Patient navigators at ZetrOZ, the company that produces sam, are happy to walk patients through the process of obtaining the device and getting it covered by their insurance carrier. Those who use sam experience results that are notable and fast, as illustrated by Corinne Poling, who broke her leg in multiple locations and suffered from a significant amount of pain and almost complete lack of mobility. Poling, who was not able to bend the affected leg or place enough weight on it to complete simple activities, had tried a walker, a wheelchair and several forms of therapy without success before her doctor suggested sam Sport. The wearable device produced results for her that none of the other treatments could. "The device has taken me from a 10-plus level of pain to a livable three to five level on a daily basis. The swelling has ceased and the leg barely ever bothers me now. If I were to rate the improvement in mobility, it would be 75 percent in just this short period of not quite 30 days, using it four hours once daily with two contacts. Application of sam was easy to learn and I quickly got used to wearing it," Poling said. While sam is technologically sophisticated, it is also easy to use and apply, making it the perfect choice for home application by patients. Users can engage in most activities while wearing the device and it only requires four hours per day of use to deliver results. Additionally, sam ships directly to patients' homes, preventing the need to pick it up at a doctor's office or hospital. "People suffering from neck or back injuries due to a traumatic event, or injuries they sustained at the workplace, should not have to endure expensive, risky and time-consuming surgery, injections or pain medications. With sam, patients have a budget-friendly, safe and non-invasive way to relieve their pain and heal their injuries. This is one of the reasons I created sam and I am very pleased the ultrasound treatment can help them," said Dr. George Lewis, chief executive officer of ZetrOZ Systems. About ZetrOZ Systems ZetrOZ Systems is an FDA cGMP and ISO 13585 medical technology company headquartered in the southern coastal region of Connecticut. The organization also has manufacturing facilities across the United States. ZetrOZ Systems produced UltrOZ, samSport and samPro 2.0 to provide safe and effective treatment options for prevalent conditions such as arthritis. Learn more at zetroz.comand samrecover.com. SOURCE ZetrOZ Systems Related Links http://zetroz.com |
edtsum2022 | You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text.
Text: NAPA, Calif., Oct. 12, 2020 /PRNewswire/ -- Every wine tells its own story and contributes to the human experience, according to the team at Wine Ambassador. During October, the organization's wines are sending a message of hope and support to women who have survived and are living with breast cancer. All wine deliveries will, in fact, include a signature pink label and a portion of proceeds from those bottles will be donated to the Breast Cancer Awareness Foundation at the close of the month. Continue Reading Wine Ambassador Wine Ambassador is an exclusive fine wine club launched earlier this year by a group of Napa Valley wine industry experts. Its members choose to become a Customer or an Ambassador. Customers pay a monthly membership fee to have curated fine wines delivered to their door each month. Ambassadors can host wine tastings and make commissions on membership sales and earn other perks. The company is now also hosting virtual wine tastings for businesses to provide a means for employees to connect via sampling of Napa and Sonoma regional wines along with a presentation describing each selection. "A large portion of our customer base is women, and we want them to know we are in their corner when it comes to issues that affect them," explained Brett Hudson, President, Wine Ambassador. "Wine has a way of bringing people together, and we can think of no better cause to rally around."The statistics reinforce Hudson's assertions that his customer base is significantly affected. TheWineMarket Council estimates 60 percent of Americans who consumewineonce or more a weekare women, andwomenbuy 80 percent of thewinesold in the country. Meanwhile, 13 percent of women in the U.S., or one in eight women, are at risk of developing breast cancer in their lifetimes."The good news is that because so many organizations and individuals have joined forces over the years, more women are getting screenings and more money is going toward vital research, so the morbidity rate for breast cancer is declining. One in eight women may develop breast cancer, yet that also means that seven in eight will not. We want to be involved in continually improving those odds for the women who are part of our Wine Ambassador family," he added.Contact Media Relations: Joe Allocco (707) 294-1885 [emailprotected] Related Imagesimage1.png Related LinksJoin Wine Ambassador Wine Ambassador Overview Webinar SOURCE Wine Ambassador
Answer: | Wine Ambassador Joins National Effort to Raise Awareness for Breast Cancer With Intro of Pink Label for Wines Delivered in October | NAPA, Calif., Oct. 12, 2020 /PRNewswire/ -- Every wine tells its own story and contributes to the human experience, according to the team at Wine Ambassador. During October, the organization's wines are sending a message of hope and support to women who have survived and are living with breast cancer. All wine deliveries will, in fact, include a signature pink label and a portion of proceeds from those bottles will be donated to the Breast Cancer Awareness Foundation at the close of the month. Continue Reading Wine Ambassador Wine Ambassador is an exclusive fine wine club launched earlier this year by a group of Napa Valley wine industry experts. Its members choose to become a Customer or an Ambassador. Customers pay a monthly membership fee to have curated fine wines delivered to their door each month. Ambassadors can host wine tastings and make commissions on membership sales and earn other perks. The company is now also hosting virtual wine tastings for businesses to provide a means for employees to connect via sampling of Napa and Sonoma regional wines along with a presentation describing each selection. "A large portion of our customer base is women, and we want them to know we are in their corner when it comes to issues that affect them," explained Brett Hudson, President, Wine Ambassador. "Wine has a way of bringing people together, and we can think of no better cause to rally around."The statistics reinforce Hudson's assertions that his customer base is significantly affected. TheWineMarket Council estimates 60 percent of Americans who consumewineonce or more a weekare women, andwomenbuy 80 percent of thewinesold in the country. Meanwhile, 13 percent of women in the U.S., or one in eight women, are at risk of developing breast cancer in their lifetimes."The good news is that because so many organizations and individuals have joined forces over the years, more women are getting screenings and more money is going toward vital research, so the morbidity rate for breast cancer is declining. One in eight women may develop breast cancer, yet that also means that seven in eight will not. We want to be involved in continually improving those odds for the women who are part of our Wine Ambassador family," he added.Contact Media Relations: Joe Allocco (707) 294-1885 [emailprotected] Related Imagesimage1.png Related LinksJoin Wine Ambassador Wine Ambassador Overview Webinar SOURCE Wine Ambassador |
edtsum2026 | You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text.
Text: PURCHASE, N.Y., Feb. 4, 2021 /PRNewswire/ --Rockstar Energy Drink is shining a light on hustlers around the world in a new thirty-second advertisement airing during the Super Bowl LV pre-game show. Featuring Grammy-nominated rapper Lil Baby, the TV spot is the brand's first Super Bowl appearance. Rockstar Energy Drink Debuts Its Refresh with First-Ever Super Bowl "Spotlight" Ad Featuring Lil Baby The "Spotlight" television commercial marks a pivotal moment for Rockstar Energy, which was acquired by PepsiCo last year as it expands in the global, fast-growing energy category. The brand is introducing new creative, fresh packaging, and dialed-up digital components, including brand website and social channels, as well as flavor innovations and new stars joining the Rockstar Energy ambassador family. The portfolio-wide, global visual refresh was created in- house by PepsiCo's Global Design team and features a more modern and timeless star logo. After its Super Bowl premiere, the "Spotlight" campaign rolls out on multiple platforms during the first quarter of 2021, with additional activations planned throughout the year. "PepsiCo has always seen the potential of Rockstar Energy as a cultural leader," said Fabiola Torres, PepsiCo Chief Marketing Officer and Senior Vice President of the Energy Category. "2021 will be a pivotal moment for the brand as it deepens its cultural connections in the worlds of music and sports. Super Bowl is just the start of several milestone moments where we'll be reenergizing not only Rockstar Energy's core fans, but also a whole new group of energy drinkers, as we celebrate the journey of those who put in the work. Energy beverages have unlimited potential for us, and this is only the beginning." ROCKSTARENERGY:"Spotlight"The new Super Bowl ad available HERE showcases Lil Baby illuminated by a bright spotlight.As he shares his journey of how he had to grind to shine, the spotlight catches those around him who also are on their path to stardom, including Rockstar Energy pro skateboarder Chris Joslin, and gaming icon and 100 Thieves founder and CEO, Nadeshot. The spot also features emerging cultural influencers and local heroes - including a barber, tattoo artist, and first responder - showing the importance of hustle at all levels. The spot was created and directed by Goodby, Silverstein & Partners, and Grammy-winning director Dave Meyers."When Rockstar approached me about this Super Bowl ad, I knew right away that I wanted to bea part of it," said Lil Baby. "It's all about the hard work and hustle that it takes to succeed. Somepeople think I had instant success, but they don't understand how hard I worked. I know what it'slike to fall flat and how it feels when your energy is tapped. I still hustle every day to make mymusicand shareitwithmyfans. RockstarEnergyhelpsmedo that."AboutRockstarEnergyRockstarEnergy,foundedin2001,produces beverages thatcelebratetheyounghustlers whoarefocused on their journey. With over 20 Rockstar Energy products and five sublines available atconvenience and grocery outlets in over 30 countries globally, Rockstar gives you a bold,refreshing boost, full of benefits and loaded with flavors. For more information, visitwww.rockstarenergy.comAboutPepsiCoPepsiCo products are enjoyed by consumers more than one billion times a day in more than 200countries and territories around the world. PepsiCo generated more than $67 billion in netrevenuein2019,drivenbyacomplementary foodandbeverageportfoliothatincludesFrito-Lay,Gatorade, Pepsi-Cola, Quaker, and Tropicana. PepsiCo's product portfolio includes a wide rangeof enjoyable foods and beverages, including 23 brands that generate more than $1 billion each inestimated annualretailsales.Guiding PepsiCo is our vision to Be the Global Leader in Convenient Foods and Beverages byWinning with Purpose. "Winning with Purpose" reflects our ambition to win sustainably in themarketplaceandembedpurposeintoallaspects ofthebusiness.Formoreinformation, visitwww.pepsico.com. AboutLilBabyGrammy-nominatedLilBabyhasbeenoneofthemostdominant andcriticallyacclaimednamesin rap since his first release in 2017. This February, he released My Turn, which entered TheBillboard 200 at #1, hovered in the Top 5 for 15 weeks, and then returned to #1 three monthslater. The album was the #1 Streamed and #1 selling album of any genre for 2020. In 2021,Baby's catalog reached 21 billion global streams, had five consecutive #1 songs on urban radio,won the BET Award for Best New Artist, named Vevo's Top Performing Hip-Hop Artist of2020, named MVP on Rap Caviar. He won the top award of Global Artist of the Year at theApple Music Awards. The Bigger Picture" was nominated for two Grammy's for Best RapPerformance&BestRap Song.MediaContact: JoshLevitt:949.981.0757/[emailprotected]JaciePrietoLopez:310.804.5115/ [emailprotected]SOURCE PepsiCo Related Links https://rockstarenergy.com
Answer: | Rockstar Energy Drink Unveils New Look and Fresh Hustle in First-Ever Super Bowl Ad Rapper Lil Baby stars in the brand's "Spotlight" Super Bowl commercial, inspiring consumers to 'Hustle On' | PURCHASE, N.Y., Feb. 4, 2021 /PRNewswire/ --Rockstar Energy Drink is shining a light on hustlers around the world in a new thirty-second advertisement airing during the Super Bowl LV pre-game show. Featuring Grammy-nominated rapper Lil Baby, the TV spot is the brand's first Super Bowl appearance. Rockstar Energy Drink Debuts Its Refresh with First-Ever Super Bowl "Spotlight" Ad Featuring Lil Baby The "Spotlight" television commercial marks a pivotal moment for Rockstar Energy, which was acquired by PepsiCo last year as it expands in the global, fast-growing energy category. The brand is introducing new creative, fresh packaging, and dialed-up digital components, including brand website and social channels, as well as flavor innovations and new stars joining the Rockstar Energy ambassador family. The portfolio-wide, global visual refresh was created in- house by PepsiCo's Global Design team and features a more modern and timeless star logo. After its Super Bowl premiere, the "Spotlight" campaign rolls out on multiple platforms during the first quarter of 2021, with additional activations planned throughout the year. "PepsiCo has always seen the potential of Rockstar Energy as a cultural leader," said Fabiola Torres, PepsiCo Chief Marketing Officer and Senior Vice President of the Energy Category. "2021 will be a pivotal moment for the brand as it deepens its cultural connections in the worlds of music and sports. Super Bowl is just the start of several milestone moments where we'll be reenergizing not only Rockstar Energy's core fans, but also a whole new group of energy drinkers, as we celebrate the journey of those who put in the work. Energy beverages have unlimited potential for us, and this is only the beginning." ROCKSTARENERGY:"Spotlight"The new Super Bowl ad available HERE showcases Lil Baby illuminated by a bright spotlight.As he shares his journey of how he had to grind to shine, the spotlight catches those around him who also are on their path to stardom, including Rockstar Energy pro skateboarder Chris Joslin, and gaming icon and 100 Thieves founder and CEO, Nadeshot. The spot also features emerging cultural influencers and local heroes - including a barber, tattoo artist, and first responder - showing the importance of hustle at all levels. The spot was created and directed by Goodby, Silverstein & Partners, and Grammy-winning director Dave Meyers."When Rockstar approached me about this Super Bowl ad, I knew right away that I wanted to bea part of it," said Lil Baby. "It's all about the hard work and hustle that it takes to succeed. Somepeople think I had instant success, but they don't understand how hard I worked. I know what it'slike to fall flat and how it feels when your energy is tapped. I still hustle every day to make mymusicand shareitwithmyfans. RockstarEnergyhelpsmedo that."AboutRockstarEnergyRockstarEnergy,foundedin2001,produces beverages thatcelebratetheyounghustlers whoarefocused on their journey. With over 20 Rockstar Energy products and five sublines available atconvenience and grocery outlets in over 30 countries globally, Rockstar gives you a bold,refreshing boost, full of benefits and loaded with flavors. For more information, visitwww.rockstarenergy.comAboutPepsiCoPepsiCo products are enjoyed by consumers more than one billion times a day in more than 200countries and territories around the world. PepsiCo generated more than $67 billion in netrevenuein2019,drivenbyacomplementary foodandbeverageportfoliothatincludesFrito-Lay,Gatorade, Pepsi-Cola, Quaker, and Tropicana. PepsiCo's product portfolio includes a wide rangeof enjoyable foods and beverages, including 23 brands that generate more than $1 billion each inestimated annualretailsales.Guiding PepsiCo is our vision to Be the Global Leader in Convenient Foods and Beverages byWinning with Purpose. "Winning with Purpose" reflects our ambition to win sustainably in themarketplaceandembedpurposeintoallaspects ofthebusiness.Formoreinformation, visitwww.pepsico.com. AboutLilBabyGrammy-nominatedLilBabyhasbeenoneofthemostdominant andcriticallyacclaimednamesin rap since his first release in 2017. This February, he released My Turn, which entered TheBillboard 200 at #1, hovered in the Top 5 for 15 weeks, and then returned to #1 three monthslater. The album was the #1 Streamed and #1 selling album of any genre for 2020. In 2021,Baby's catalog reached 21 billion global streams, had five consecutive #1 songs on urban radio,won the BET Award for Best New Artist, named Vevo's Top Performing Hip-Hop Artist of2020, named MVP on Rap Caviar. He won the top award of Global Artist of the Year at theApple Music Awards. The Bigger Picture" was nominated for two Grammy's for Best RapPerformance&BestRap Song.MediaContact: JoshLevitt:949.981.0757/[emailprotected]JaciePrietoLopez:310.804.5115/ [emailprotected]SOURCE PepsiCo Related Links https://rockstarenergy.com |
edtsum2028 | You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text.
Text: BOSTON--(BUSINESS WIRE)--Compare all the latest early Kay Jewelers deals for Black Friday 2020, featuring engagement rings, diamond earrings, Fossil watches & more deals. Links to the top deals are listed below. Best Kay Jewelers Deals: Best Jewelry Deals: Searching for more deals? Click here to check out the entire range of active deals at Walmarts Black Friday sale and click here to check out Amazons current holiday deals. The Consumer Post earns commissions from purchases made using the links provided. Kay Jewelers is the destination for shoppers looking for the perfect piece of jewelry, whether it be a delicate gold chain necklace or a bold and brilliant diamond ring. Find something to celebrate a special occasion with a loved one or something to keep for yourself in their wide range of items. The retailers jewelry collection boasts of precious metals and sparkling stones put together in classic and modern designs. Kay Jewelers make buying the perfect gift convenient and affordable with its discounted prices on numerous selections. About The Consumer Post: The Consumer Post shares news for online shoppers. As an Amazon Associate and affiliate The Consumer Post earns from qualifying purchases.
Answer: | Kay Jewelers Black Friday Deals 2020: Early Heart Necklaces, Diamond Rings, Bridal Sets & Luxury Watch Savings Monitored by The Consumer Post Save on Kay Jewelers deals at the early Black Friday 2020 sale, including womens bands, religious jewelry & gemstone bracelets sales | BOSTON--(BUSINESS WIRE)--Compare all the latest early Kay Jewelers deals for Black Friday 2020, featuring engagement rings, diamond earrings, Fossil watches & more deals. Links to the top deals are listed below. Best Kay Jewelers Deals: Best Jewelry Deals: Searching for more deals? Click here to check out the entire range of active deals at Walmarts Black Friday sale and click here to check out Amazons current holiday deals. The Consumer Post earns commissions from purchases made using the links provided. Kay Jewelers is the destination for shoppers looking for the perfect piece of jewelry, whether it be a delicate gold chain necklace or a bold and brilliant diamond ring. Find something to celebrate a special occasion with a loved one or something to keep for yourself in their wide range of items. The retailers jewelry collection boasts of precious metals and sparkling stones put together in classic and modern designs. Kay Jewelers make buying the perfect gift convenient and affordable with its discounted prices on numerous selections. About The Consumer Post: The Consumer Post shares news for online shoppers. As an Amazon Associate and affiliate The Consumer Post earns from qualifying purchases. |
edtsum2039 | You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text.
Text: NEW YORK--(BUSINESS WIRE)--Pfizer Inc. (NYSE: PFE) announced today that it has acquired Amplyx Pharmaceuticals, Inc., a privately-held company dedicated to the development of therapies for debilitating and life-threatening diseases that affect people with compromised immune systems. Amplyxs lead compound, Fosmanogepix (APX001), is a novel investigational asset under development for the treatment of invasive fungal infections. More than 1.5 million cases of invasive fungal infections occur worldwide each year, with mortality rates as high as 30-80% across infection typesi. Fosmanogepix has a novel mechanism of action with the potential to target fungal strains resistant to standard of care therapy. As there are only three classes of antifungal medications currently available, antifungal resistance can severely limit treatment options; a potential new therapeutic class may therefore be of importance for both physicians and patientsii. There has been no novel therapeutic class of antifungal therapies approved by the U.S. Food and Drug Administration (FDA) in nearly 20 years. The COVID-19 pandemic has been a stark reminder of the devastating impact of infectious diseases, highlighting the continuous need for new anti-infective therapies to treat both emerging and difficult to treat bacterial, viral and fungal infections, said Angela Lukin, Global President, Pfizer Hospital. We are deeply committed to helping patients suffering from infectious diseases, continuously seeking opportunities to build our portfolio of anti-infective therapies. Weve already invested in assets that, if approved, could help address drug-resistant bacterial infections and critical viral infections; with this acquisition, we look forward to progressing the development of a novel anti-fungal as well. Fosmanogepix is currently in Phase 2 clinical trials evaluating the safety and efficacy of both intravenous (IV) and oral formulations for the treatment of patients with life-threatening invasive fungal infections caused by molds, yeasts and rare molds (e.g., Aspergillus spp, Candida spp including Candida auris, Fusarium spp. and Scedosporium spp). Fosmanogepix has demonstrated broad-spectrum activity in-vitro and has shown wide distribution to various tissues including the brain, lung, kidney and eye. With both IV and oral formulations in development, Fosmanogepix may allow for the transition from IV to oral, thus potentially enabling, for the benefit of patients, the continuation of treatment outside the hospital. In addition to Fosmanogepix, with this acquisition, Pfizer has secured ownership of Amplyx's early-stage pipeline that includes potential antiviral (MAU868) and antifungal (APX2039) therapies. Globally, infectious diseases are responsible for more than 8.4 million deaths annually*iii, accounting for two of the World Health Organizations top ten causes of death worldwideiv. Infections are caused by different types of pathogens, including bacteria, viruses, fungi and parasites, and can be acquired in the community or in a hospital or healthcare setting. The acquisition of Amplyx follows an initial equity investment by Pfizer in December 2019 as part of Amplyxs Series C financing. At that time, Pfizer joined a world class group of biotechnology investors that included 35 Partners, Adage Capital Management, Arix Bioscience, BioMed Ventures, Lundbeckfonden Ventures, New Enterprise Associates, Pappas Capital, RiverVest Venture Partners and Sofinnova Investments. Financial terms of this acquisition were not disclosed. DLA Piper LLP (US) served as Pfizer Inc.s legal advisor for the transaction, while Cooley LLP served as Amplyxs legal advisor and Evercore as its financial advisor. About Pfizer: Breakthroughs That Change Patients Lives At Pfizer, we apply science and our global resources to bring therapies to people that extend and significantly improve their lives. We strive to set the standard for quality, safety and value in the discovery, development and manufacture of health care products, including innovative medicines and vaccines. Every day, Pfizer colleagues work across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases of our time. Consistent with our responsibility as one of the world's premier innovative biopharmaceutical companies, we collaborate with health care providers, governments and local communities to support and expand access to reliable, affordable health care around the world. For more than 170 years, we have worked to make a difference for all who rely on us. We routinely post information that may be important to investors on our website at www.Pfizer.com. In addition, to learn more, please visit us on www.Pfizer.com and follow us on Twitter at @Pfizer and @Pfizer News, LinkedIn, YouTube and like us on Facebook at Facebook.com/Pfizer. PFIZER DISCLOSURE NOTICE The information contained in this release is as of April 28, 2021. Pfizer assumes no obligation to update forward-looking statements contained in this release as the result of new information or future events or developments. This release contains forward-looking information about Amplyx Pharmaceuticals, Amplyxs lead compound, Fosmanogepix (APX001), the acquisition of Amplyx by Pfizer and Pfizers anti-infectives portfolio that involves substantial risks and uncertainties that could cause actual results to differ materially from those expressed or implied by such statements. Risks and uncertainties include, among other things; risks related to the ability to realize the anticipated benefits of the acquisition, including the possibility that the expected benefits from the acquisition will not be realized or will not be realized within the expected time period; the risk that the businesses will not be integrated successfully; disruption from the transaction making it more difficult to maintain business and operational relationships; significant transaction costs; unknown liabilities; the risk of litigation and/or regulatory actions related to the acquisition; other business effects, including the effects of industry, market, economic, political or regulatory conditions; future exchange and interest rates; changes in tax and other laws, regulations, rates and policies; future business combinations or disposals; the uncertainties inherent in research and development, including the ability to meet anticipated clinical endpoints, commencement and/or completion dates for clinical trials, regulatory submission dates, regulatory approval dates and/or launch dates, as well as the possibility of unfavorable new clinical data and further analyses of existing clinical data; the risk that clinical trial data are subject to differing interpretations and assessments by regulatory authorities; whether regulatory authorities will be satisfied with the design of and results from our clinical studies; whether and when drug applications may be filed in any jurisdictions for Fosmanogepix or any other anti-infectives; whether and when any such applications may be approved by regulatory authorities, which will depend on myriad factors, including making a determination as to whether the product's benefits outweigh its known risks and determination of the product's efficacy and, if approved, whether Fosmanogepix or any such other anti-infectives will be commercially successful; decisions by regulatory authorities impacting labeling, manufacturing processes, safety and/or other matters that could affect the availability or commercial potential of Fosmanogepix or any such other anti-infectives; the impact of COVID-19 on Pfizers business, operations and financial results; and competitive developments. A further description of risks and uncertainties can be found in Pfizers Annual Report on Form 10-K for the fiscal year ended December 31, 2020 and in its subsequent reports on Form 10-Q, including in the sections thereof captioned Risk Factors and Forward-Looking Information and Factors That May Affect Future Results, as well as in its subsequent reports on Form 8-K, all of which are filed with the U.S. Securities and Exchange Commission and available at www.sec.gov and www.pfizer.com. * Excludes deaths attributed to COVID-19. i Bongomin F et al J. Fungi 2017, 3, 57. Global and Multi-National Prevalence of Fungal Diseases-Estimate Precision. Available at: https://pubmed.ncbi.nlm.nih.gov/29371573/. Accessed April 2021. ii Center for Disease Control and Prevention. Antifungal Resistance. Available at: https://www.cdc.gov/fungal/antifungal-resistance.html. Accessed April 2021. iii Global Burden of Disease Tool [Data set], University of Washington, Institute for Health Metrics and Evaluation, Global Health Data Exchange, 2020. Available at: http://ghdx.healthdata.org/gbd-results-tool. Accessed April 2021. iv World Health Organization. Top 10 Causes of Death. Available at: https://www.who.int/en/news-room/fact-sheets/detail/the-top-10-causes-of-death. Accessed April 2021.
Answer: | Pfizer Acquires Amplyx Pharmaceuticals Deal expands anti-infectives pipeline with addition of novel antifungal Phase 2 candidate, Fosmanogepix (APX001) Opportunity to advance Pfizers expertise and deep heritage in infectious disease | NEW YORK--(BUSINESS WIRE)--Pfizer Inc. (NYSE: PFE) announced today that it has acquired Amplyx Pharmaceuticals, Inc., a privately-held company dedicated to the development of therapies for debilitating and life-threatening diseases that affect people with compromised immune systems. Amplyxs lead compound, Fosmanogepix (APX001), is a novel investigational asset under development for the treatment of invasive fungal infections. More than 1.5 million cases of invasive fungal infections occur worldwide each year, with mortality rates as high as 30-80% across infection typesi. Fosmanogepix has a novel mechanism of action with the potential to target fungal strains resistant to standard of care therapy. As there are only three classes of antifungal medications currently available, antifungal resistance can severely limit treatment options; a potential new therapeutic class may therefore be of importance for both physicians and patientsii. There has been no novel therapeutic class of antifungal therapies approved by the U.S. Food and Drug Administration (FDA) in nearly 20 years. The COVID-19 pandemic has been a stark reminder of the devastating impact of infectious diseases, highlighting the continuous need for new anti-infective therapies to treat both emerging and difficult to treat bacterial, viral and fungal infections, said Angela Lukin, Global President, Pfizer Hospital. We are deeply committed to helping patients suffering from infectious diseases, continuously seeking opportunities to build our portfolio of anti-infective therapies. Weve already invested in assets that, if approved, could help address drug-resistant bacterial infections and critical viral infections; with this acquisition, we look forward to progressing the development of a novel anti-fungal as well. Fosmanogepix is currently in Phase 2 clinical trials evaluating the safety and efficacy of both intravenous (IV) and oral formulations for the treatment of patients with life-threatening invasive fungal infections caused by molds, yeasts and rare molds (e.g., Aspergillus spp, Candida spp including Candida auris, Fusarium spp. and Scedosporium spp). Fosmanogepix has demonstrated broad-spectrum activity in-vitro and has shown wide distribution to various tissues including the brain, lung, kidney and eye. With both IV and oral formulations in development, Fosmanogepix may allow for the transition from IV to oral, thus potentially enabling, for the benefit of patients, the continuation of treatment outside the hospital. In addition to Fosmanogepix, with this acquisition, Pfizer has secured ownership of Amplyx's early-stage pipeline that includes potential antiviral (MAU868) and antifungal (APX2039) therapies. Globally, infectious diseases are responsible for more than 8.4 million deaths annually*iii, accounting for two of the World Health Organizations top ten causes of death worldwideiv. Infections are caused by different types of pathogens, including bacteria, viruses, fungi and parasites, and can be acquired in the community or in a hospital or healthcare setting. The acquisition of Amplyx follows an initial equity investment by Pfizer in December 2019 as part of Amplyxs Series C financing. At that time, Pfizer joined a world class group of biotechnology investors that included 35 Partners, Adage Capital Management, Arix Bioscience, BioMed Ventures, Lundbeckfonden Ventures, New Enterprise Associates, Pappas Capital, RiverVest Venture Partners and Sofinnova Investments. Financial terms of this acquisition were not disclosed. DLA Piper LLP (US) served as Pfizer Inc.s legal advisor for the transaction, while Cooley LLP served as Amplyxs legal advisor and Evercore as its financial advisor. About Pfizer: Breakthroughs That Change Patients Lives At Pfizer, we apply science and our global resources to bring therapies to people that extend and significantly improve their lives. We strive to set the standard for quality, safety and value in the discovery, development and manufacture of health care products, including innovative medicines and vaccines. Every day, Pfizer colleagues work across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases of our time. Consistent with our responsibility as one of the world's premier innovative biopharmaceutical companies, we collaborate with health care providers, governments and local communities to support and expand access to reliable, affordable health care around the world. For more than 170 years, we have worked to make a difference for all who rely on us. We routinely post information that may be important to investors on our website at www.Pfizer.com. In addition, to learn more, please visit us on www.Pfizer.com and follow us on Twitter at @Pfizer and @Pfizer News, LinkedIn, YouTube and like us on Facebook at Facebook.com/Pfizer. PFIZER DISCLOSURE NOTICE The information contained in this release is as of April 28, 2021. Pfizer assumes no obligation to update forward-looking statements contained in this release as the result of new information or future events or developments. This release contains forward-looking information about Amplyx Pharmaceuticals, Amplyxs lead compound, Fosmanogepix (APX001), the acquisition of Amplyx by Pfizer and Pfizers anti-infectives portfolio that involves substantial risks and uncertainties that could cause actual results to differ materially from those expressed or implied by such statements. Risks and uncertainties include, among other things; risks related to the ability to realize the anticipated benefits of the acquisition, including the possibility that the expected benefits from the acquisition will not be realized or will not be realized within the expected time period; the risk that the businesses will not be integrated successfully; disruption from the transaction making it more difficult to maintain business and operational relationships; significant transaction costs; unknown liabilities; the risk of litigation and/or regulatory actions related to the acquisition; other business effects, including the effects of industry, market, economic, political or regulatory conditions; future exchange and interest rates; changes in tax and other laws, regulations, rates and policies; future business combinations or disposals; the uncertainties inherent in research and development, including the ability to meet anticipated clinical endpoints, commencement and/or completion dates for clinical trials, regulatory submission dates, regulatory approval dates and/or launch dates, as well as the possibility of unfavorable new clinical data and further analyses of existing clinical data; the risk that clinical trial data are subject to differing interpretations and assessments by regulatory authorities; whether regulatory authorities will be satisfied with the design of and results from our clinical studies; whether and when drug applications may be filed in any jurisdictions for Fosmanogepix or any other anti-infectives; whether and when any such applications may be approved by regulatory authorities, which will depend on myriad factors, including making a determination as to whether the product's benefits outweigh its known risks and determination of the product's efficacy and, if approved, whether Fosmanogepix or any such other anti-infectives will be commercially successful; decisions by regulatory authorities impacting labeling, manufacturing processes, safety and/or other matters that could affect the availability or commercial potential of Fosmanogepix or any such other anti-infectives; the impact of COVID-19 on Pfizers business, operations and financial results; and competitive developments. A further description of risks and uncertainties can be found in Pfizers Annual Report on Form 10-K for the fiscal year ended December 31, 2020 and in its subsequent reports on Form 10-Q, including in the sections thereof captioned Risk Factors and Forward-Looking Information and Factors That May Affect Future Results, as well as in its subsequent reports on Form 8-K, all of which are filed with the U.S. Securities and Exchange Commission and available at www.sec.gov and www.pfizer.com. * Excludes deaths attributed to COVID-19. i Bongomin F et al J. Fungi 2017, 3, 57. Global and Multi-National Prevalence of Fungal Diseases-Estimate Precision. Available at: https://pubmed.ncbi.nlm.nih.gov/29371573/. Accessed April 2021. ii Center for Disease Control and Prevention. Antifungal Resistance. Available at: https://www.cdc.gov/fungal/antifungal-resistance.html. Accessed April 2021. iii Global Burden of Disease Tool [Data set], University of Washington, Institute for Health Metrics and Evaluation, Global Health Data Exchange, 2020. Available at: http://ghdx.healthdata.org/gbd-results-tool. Accessed April 2021. iv World Health Organization. Top 10 Causes of Death. Available at: https://www.who.int/en/news-room/fact-sheets/detail/the-top-10-causes-of-death. Accessed April 2021. |
edtsum2040 | You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text.
Text: NEW YORK, May 4, 2020 /PRNewswire/ --O'Dwyer's, a leading public relations industry publication, has officially released its annual PR rankings naming 5W Public Relations' Financial PR practice the 17thlargest in the US. With net fees of $2.1 million, the division experienced a 31.3% increase from 2019 and continued to remain in the top 20 rankingsfor the fourth consecutive year. "The 5WPR financial services team and fintech group possess a deep technical knowledge of the industry, which has given them an edge. Clients recognize their ability to act quickly, and trust the team, which has led to incredible growth in this sector, both in client retention, and word-of-mouth referrals," said Ronn Torossian, CEO and Founder of 5WPR. Notable clients of 5WPR's Financial PR division include N26, one of the fastest growing banks in Europe that is eliminating physical branches, Payoneer, the digital payment platform empowering businesses around the world to grow globally, and AvidXchange, the largest B2B payment network in the US. 5WPR has a proven track record of ensuring financial clients' brands are as dynamic as the industry they operate. From activist investing and proxy fights, to capital markets, IPOs, consumer finance, insurance and banking, the team delivers top-tier results based on market intelligence, strategic messaging and timing. About 5W Public Relations 5W Public Relations is a full-service PR agency in NYC known for cutting-edge programs that engage with businesses, issues and ideas. With more than 175 professionals serving clients in B2C (Beauty & Fashion, Consumer Brands, Entertainment, Food & Beverage, Health & Wellness, Travel & Hospitality, Technology, Nonprofit), B2B (Corporate Communications and Reputation Management), Public Affairs, Crisis Communications and digital strategy, 5W brings leading businesses a resourceful, bold and results-driven approach to communication. Media Contact Ronn Torossian [emailprotected]/ 212-999-5585 SOURCE 5W Public Relations Related Links http://www.5wpr.com
Answer: | 5W Public Relations' Financial PR Division Named Among Top in U.S. | NEW YORK, May 4, 2020 /PRNewswire/ --O'Dwyer's, a leading public relations industry publication, has officially released its annual PR rankings naming 5W Public Relations' Financial PR practice the 17thlargest in the US. With net fees of $2.1 million, the division experienced a 31.3% increase from 2019 and continued to remain in the top 20 rankingsfor the fourth consecutive year. "The 5WPR financial services team and fintech group possess a deep technical knowledge of the industry, which has given them an edge. Clients recognize their ability to act quickly, and trust the team, which has led to incredible growth in this sector, both in client retention, and word-of-mouth referrals," said Ronn Torossian, CEO and Founder of 5WPR. Notable clients of 5WPR's Financial PR division include N26, one of the fastest growing banks in Europe that is eliminating physical branches, Payoneer, the digital payment platform empowering businesses around the world to grow globally, and AvidXchange, the largest B2B payment network in the US. 5WPR has a proven track record of ensuring financial clients' brands are as dynamic as the industry they operate. From activist investing and proxy fights, to capital markets, IPOs, consumer finance, insurance and banking, the team delivers top-tier results based on market intelligence, strategic messaging and timing. About 5W Public Relations 5W Public Relations is a full-service PR agency in NYC known for cutting-edge programs that engage with businesses, issues and ideas. With more than 175 professionals serving clients in B2C (Beauty & Fashion, Consumer Brands, Entertainment, Food & Beverage, Health & Wellness, Travel & Hospitality, Technology, Nonprofit), B2B (Corporate Communications and Reputation Management), Public Affairs, Crisis Communications and digital strategy, 5W brings leading businesses a resourceful, bold and results-driven approach to communication. Media Contact Ronn Torossian [emailprotected]/ 212-999-5585 SOURCE 5W Public Relations Related Links http://www.5wpr.com |
edtsum2042 | You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text.
Text: LONDON, Aug. 21, 2020 /PRNewswire/ -- Elsevier, a global research publishing and information analytics provider, and part of RELX, has acquired SciBite, a semantic AI company headquartered in Cambridge, UK, to help customers make faster, more effective R&D decisions through advanced text and data intelligence solutions. SciBite Logo (PRNewsfoto/Elsevier) SciBite's solutions identify and extract scientificinsights from structured and unstructured text and content, to identify key concepts such as drugs, proteins, companies, targets, and outcomes. This semantically-enriched, machine-readable data, helps SciBite's customers around the world make streamlined, more efficient decisions. SciBite was founded in 2011 by Dr. Lee Harland, who currently serves as Chief Scientific Officer at the company, with a mission to help customers better understand the complexities of life sciences data. SciBite's major products include: TERMite, an AI and ontology driven text analysis engine; DOCstore, which transforms search through semantic indexing; and CENtree, a next-generation collaborative ontology management platform; they are complemented by a suite of apps that support its core technology and allow customers to automate data-curation and manage terminology standards. Dr. Harland said: "I am incredibly proud of everyone at SciBite; we believe that our continued investment in innovative technology enables our customers to address the huge challenges they face in creating, connecting and analyzing disparate content and data. Our track record in driving new insights and efficiencies within drug discovery and the wider life sciences is something we will continue to build upon in this next phase of our journey."Rob Greenwood, CEO and President, SciBite, said: "This is an exciting next step for our business. The combined offering of Elsevier's high-quality content and data and the innovative technology from SciBite will deliver amazing value for any data led strategy across the scientific community. As part of the Elsevier organization, SciBite will have the ability to deliver enterprise technology, and new advances in scientific insight and discovery across its broad reaching global customer base."Elsevier helps researchers and healthcare professionals advance science and improve health outcomes for the benefit of society. To support this, Elsevier's Life Sciences Solutions division is transforming from a provider of reference solutions into a creator of data and information analytics capable of supporting multiple scientific domain-specific use cases, ranging from search and discovery through to machine learning and AI. SciBite's proven and award-winning solutions will enable Elsevier to develop its Life Sciences Solutions services, such as: Reaxys, which powers chemistry research and development; Embase, the world's most comprehensive international database of biomedical information; and Entellect, its FAIR data compliant platform that integrates, stores, and enriches client data with Elsevier and third-party content into a common analytical environment.Cameron Ross, Managing Director Life Sciences Solutions, Elsevier, said: "The life sciences and corporate R&D communities face complex challenges, with an ever-expanding sea of data and content to extract knowledge from. We aim to combine Elsevier's expertise and content from existing products, with SciBite's impressive capabilities and suite of ontology-led products, to support more customers around the world make data led decisions in the drug development process."Stuart Whayman, Chief Commercial Officer, Elsevier, said: "Elsevier and SciBite have an aligned vision to better understand the complexities of the life sciences to better serve our customers, a vision which we believe will create exciting opportunities in the future. I am very pleased to welcome the SciBite team to Elsevier and look forward to working with them in the future."About SciBiteSciBite provides an enterprise-ready semantic software infrastructure to standardise and transform scientific information silos into clean, interoperable data. Combining world-leading ontologies, cutting edge software and FAIR data principles, SciBite offers a differentiated set of capabilities to enrich the innovation processes of the world's leading life science R&D companies, SciBite is headquartered in the UK with additional sites in the US andJapan. Find out more atwww.scibite.comAbout RELXRELX is a global provider of information-based analytics and decision tools for professional and business customers. The group serves customers in more than 180 countries and has offices in about 40 countries. It employs over 30,000 people of whom almost half are in North America. The shares of RELX PLC, the parent company, are traded on the London, Amsterdam and New York Stock Exchanges using the following ticker symbols: London: REL; Amsterdam: REN; New York: RELX. The market capitalisation is approximately 33.5bn, 37.1bn, $44.2bn.www.relx.comAbout ElsevierElsevier is a global information analytics business that helps scientists and clinicians to find new answers, reshape human knowledge, and tackle the most urgent human crises. For 140 years, we have partnered with the research world to curate and verify scientific knowledge. Today, we're committed to bringing that rigor to a new generation of platforms. Elsevier provides digital solutions and tools in the areas of strategic research management, R&D performance, clinical decision support, and professional education; including ScienceDirect, Scopus, SciVal, ClinicalKey and Sherpath. Elsevier publishes over 2,500 digitized journals, including The Lancet and Cell, 39,000 e-book titles and many iconic reference works, including Gray's Anatomy. Elsevier is part of RELX, a global provider of information-based analytics and decision tools for professional and business customers. www.elsevier.comMedia contact David TuckerElsevier Communications, Europe+44 7920 536 160[emailprotected]SOURCE Elsevier Related Links http://www.elsevier.com/
Answer: | Elsevier acquires SciBite to accelerate solutions for life sciences and corporate R&D industries | LONDON, Aug. 21, 2020 /PRNewswire/ -- Elsevier, a global research publishing and information analytics provider, and part of RELX, has acquired SciBite, a semantic AI company headquartered in Cambridge, UK, to help customers make faster, more effective R&D decisions through advanced text and data intelligence solutions. SciBite Logo (PRNewsfoto/Elsevier) SciBite's solutions identify and extract scientificinsights from structured and unstructured text and content, to identify key concepts such as drugs, proteins, companies, targets, and outcomes. This semantically-enriched, machine-readable data, helps SciBite's customers around the world make streamlined, more efficient decisions. SciBite was founded in 2011 by Dr. Lee Harland, who currently serves as Chief Scientific Officer at the company, with a mission to help customers better understand the complexities of life sciences data. SciBite's major products include: TERMite, an AI and ontology driven text analysis engine; DOCstore, which transforms search through semantic indexing; and CENtree, a next-generation collaborative ontology management platform; they are complemented by a suite of apps that support its core technology and allow customers to automate data-curation and manage terminology standards. Dr. Harland said: "I am incredibly proud of everyone at SciBite; we believe that our continued investment in innovative technology enables our customers to address the huge challenges they face in creating, connecting and analyzing disparate content and data. Our track record in driving new insights and efficiencies within drug discovery and the wider life sciences is something we will continue to build upon in this next phase of our journey."Rob Greenwood, CEO and President, SciBite, said: "This is an exciting next step for our business. The combined offering of Elsevier's high-quality content and data and the innovative technology from SciBite will deliver amazing value for any data led strategy across the scientific community. As part of the Elsevier organization, SciBite will have the ability to deliver enterprise technology, and new advances in scientific insight and discovery across its broad reaching global customer base."Elsevier helps researchers and healthcare professionals advance science and improve health outcomes for the benefit of society. To support this, Elsevier's Life Sciences Solutions division is transforming from a provider of reference solutions into a creator of data and information analytics capable of supporting multiple scientific domain-specific use cases, ranging from search and discovery through to machine learning and AI. SciBite's proven and award-winning solutions will enable Elsevier to develop its Life Sciences Solutions services, such as: Reaxys, which powers chemistry research and development; Embase, the world's most comprehensive international database of biomedical information; and Entellect, its FAIR data compliant platform that integrates, stores, and enriches client data with Elsevier and third-party content into a common analytical environment.Cameron Ross, Managing Director Life Sciences Solutions, Elsevier, said: "The life sciences and corporate R&D communities face complex challenges, with an ever-expanding sea of data and content to extract knowledge from. We aim to combine Elsevier's expertise and content from existing products, with SciBite's impressive capabilities and suite of ontology-led products, to support more customers around the world make data led decisions in the drug development process."Stuart Whayman, Chief Commercial Officer, Elsevier, said: "Elsevier and SciBite have an aligned vision to better understand the complexities of the life sciences to better serve our customers, a vision which we believe will create exciting opportunities in the future. I am very pleased to welcome the SciBite team to Elsevier and look forward to working with them in the future."About SciBiteSciBite provides an enterprise-ready semantic software infrastructure to standardise and transform scientific information silos into clean, interoperable data. Combining world-leading ontologies, cutting edge software and FAIR data principles, SciBite offers a differentiated set of capabilities to enrich the innovation processes of the world's leading life science R&D companies, SciBite is headquartered in the UK with additional sites in the US andJapan. Find out more atwww.scibite.comAbout RELXRELX is a global provider of information-based analytics and decision tools for professional and business customers. The group serves customers in more than 180 countries and has offices in about 40 countries. It employs over 30,000 people of whom almost half are in North America. The shares of RELX PLC, the parent company, are traded on the London, Amsterdam and New York Stock Exchanges using the following ticker symbols: London: REL; Amsterdam: REN; New York: RELX. The market capitalisation is approximately 33.5bn, 37.1bn, $44.2bn.www.relx.comAbout ElsevierElsevier is a global information analytics business that helps scientists and clinicians to find new answers, reshape human knowledge, and tackle the most urgent human crises. For 140 years, we have partnered with the research world to curate and verify scientific knowledge. Today, we're committed to bringing that rigor to a new generation of platforms. Elsevier provides digital solutions and tools in the areas of strategic research management, R&D performance, clinical decision support, and professional education; including ScienceDirect, Scopus, SciVal, ClinicalKey and Sherpath. Elsevier publishes over 2,500 digitized journals, including The Lancet and Cell, 39,000 e-book titles and many iconic reference works, including Gray's Anatomy. Elsevier is part of RELX, a global provider of information-based analytics and decision tools for professional and business customers. www.elsevier.comMedia contact David TuckerElsevier Communications, Europe+44 7920 536 160[emailprotected]SOURCE Elsevier Related Links http://www.elsevier.com/ |
edtsum2047 | You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text.
Text: DUBLIN--(BUSINESS WIRE)--The "Global Cosmetic Preservatives Market 2021-2025" report has been added to ResearchAndMarkets.com's offering. The publisher has been monitoring the cosmetic preservatives market and it is poised to grow by $ 109.85 million during 2021-2025, progressing at a CAGR of over 5% during the forecast period. The report on the cosmetic preservatives market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors. The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment. The market is driven by the growing demand for multifunctional cosmetic products and the increasing number of product launches. The cosmetic preservatives market analysis includes the product and application segments and geographic landscape. This study identifies the increasing use of cosmeceuticals as one of the prime reasons driving the cosmetic preservatives market growth during the next few years. Companies Mentioned The report on cosmetic preservatives market covers the following areas: The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors. The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth. Key Topics Covered: 1. Executive Summary 2. Market Landscape 3. Market Sizing 4. Five Forces Analysis 5. Market Segmentation by Product 6. Market Segmentation by Application 7. Customer landscape 8. Geographic Landscape 9. Vendor Landscape 10. Vendor Analysis 11. Appendix For more information about this report visit https://www.researchandmarkets.com/r/bs74nn
Answer: | Global Cosmetic Preservatives Market (2021 to 2025) - Featuring Ashland Global Holdings, BASF and Dow Among Others - ResearchAndMarkets.com | DUBLIN--(BUSINESS WIRE)--The "Global Cosmetic Preservatives Market 2021-2025" report has been added to ResearchAndMarkets.com's offering. The publisher has been monitoring the cosmetic preservatives market and it is poised to grow by $ 109.85 million during 2021-2025, progressing at a CAGR of over 5% during the forecast period. The report on the cosmetic preservatives market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors. The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment. The market is driven by the growing demand for multifunctional cosmetic products and the increasing number of product launches. The cosmetic preservatives market analysis includes the product and application segments and geographic landscape. This study identifies the increasing use of cosmeceuticals as one of the prime reasons driving the cosmetic preservatives market growth during the next few years. Companies Mentioned The report on cosmetic preservatives market covers the following areas: The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors. The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth. Key Topics Covered: 1. Executive Summary 2. Market Landscape 3. Market Sizing 4. Five Forces Analysis 5. Market Segmentation by Product 6. Market Segmentation by Application 7. Customer landscape 8. Geographic Landscape 9. Vendor Landscape 10. Vendor Analysis 11. Appendix For more information about this report visit https://www.researchandmarkets.com/r/bs74nn |
edtsum2050 | You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text.
Text: MISSION VIEJO, Calif., Jan. 7, 2021 /PRNewswire/ --BENEV Company Inc., an FDA Registered cosmeceutical manufacturer of globally recognized medical professional line, along with their Medical Advisory Board comprised of five global medical leaders, is proud to announce that that the 12-week Prospective, Double-blind, Randomized, Split-face Investigative Report on Combination Treatment with Human Adipose Tissue Stem Cell-derived Exosomes and Fractional CO2Laser for Acne Scars by ExoCoBio Inc., an equity invested partner of BENEV, was published on Oct 19th, 2020, in Acta Dermato-Venereologica. (PRNewsfoto/BENEV) This report outlines the investigative study that was conducted by a team of world renowned scientists, doctors including Hyuck Hoon KWON, Steven Hoseong YANG, Joon LEE, Byung Chul PARK, Kui Young PARK, Jae Yoon JUNG, Youin BAE,and Gyeong-Hun at Oaro Dermatology Institute (Seoul, South Korea), Guam Dermatology Institute (Guam, USA), Department of Dermatology, Dankook University, College of Medicine (Cheonan, South Korea), Department of Dermatology, Chung-Ang University, College of Medicine (Seoul, South Korea), and Department of Dermatology, Dongtan Sacred Heart Hospital, Hallym University College of Medicine (Hwaseong, South Korea). Researchers involved in this study evaluated the clinical efficacy and safety of adipose tissue stem cell-derived exosomes as an adjuvant therapy after application of fractional CO2laser for acne scars. 25 patients consisting of 18 men and 7 women, between ages 19 and 54, 12 with Fitzpatrick Skin Type 3 and 13 with Fitzpatrick skin type 4 and atrophic acne scars, underwent the 12-week prospective, double-blind, randomized, split-face trial. Each received three consecutive treatment sessions of fractional CO2laser to the whole face, with a follow-up evaluation, and a post- laser split face regimen, where one side of each patient's face was treated with an adipose tissue stem cell-derived exosome gel. Exosomes in this study were acquired from human ASC-CM by ExoSCRT technology developed by ExoCoBio Inc., and the other side of the face was treated with control gel. Findings revealed that the adipose tissue stem cell-derived exosome-treated sides of the face had achieved a significantly greater improvement than the control sides at the final follow-up visit (percentage reduction in echelle d'evaluation clinique des cicatrices d'acne scores: 32.5 vs 19.9%, p<0.01). Treatment-related erythema was milder, and post-treatment downtime was shorter on the applications of human adipose tissue stem cell-derived exosome-treated side. The investigative study proved that a variety of applications of human adipose tissue stem cell-derived exosomes can serve as a novel cell-free therapeutic strategy in the regenerative and aesthetic medical fields and demonstrated the suitability of adipose tissue stem cell derived exosomes as an adjuvant treatment modality in combination with fractional carbon dioxide laser for the treatment of acne scars. This reportis an open access article under the CC BY-NC license Society for Publication of Acta Dermato-Venereologica. "The science is clearly demonstrating that exosomes are the wave of the future not just for aesthetics but for many other areas of medicine, and the richest source of this material, by far, is adipose tissue," says Dr. Randy Miller, M.D., F.A.C.S. Facial atrophic acne scarring is a psychologically damaging condition that can cause emotional, mental, and social disability. "With a huge percentage of the world population struggling with this condition, the need for widening of therapeutic options was astoundingly clear," says Dr. Diane Duncan, M.D., F.A.C.S. who added, "While ablative fractional carbon dioxide laser resurfacing has demonstrated clinical efficacy in acne scar treatments, patients have sustained side-effects during post-procedural wound healing and had demanded improvement. The adjuvant application of adipose-derived stem cell conditioned medium with synergistic effects in augmenting treatment responses and reducing adverse effects through its potential to accelerate tissue rejuvenation is a victory for those suffering."The sentiments have been echoed by so many other medical professionals, including, Dr. JD McCoy, NMP, whose patient roster includes professional athletes who do not have time for extended downtime and need to recover fast. "Since implementing the addition of Exosome Regenerative Complex powered by ExoSCRT into my protocol, I've observed a significant improvement in the speed of healing, skin quality and comfort during recovery," said Dr. Richard Jin, M.D., PhD. "Patients suffering from acne scarring range in all ages, and the pain that they feel is very real. Ensuring that my patients receive the best treatment results with the least amount of downtime and discomfort is non-negotiable, and that's why I choose to integrate Exosome Regenerative Complex powered by ExoSCRT, into all of my treatments."Exosomes are lipid bilayer-enclosed extracellular vesicles, 30200 nm in diameter, produced by almost all cells and present in all body fluids (810). They are regarded as an essential mediator of intercellular communication by transferring proteins and genetic material between cells. Several studies have shown that mesenchymal stem cell-derived exosomes carry the essential properties of mesenchymal stem cells suggesting that exosomes may be a compelling alternative in regenerative and aesthetic medicine, as they would avoid most of the problems associated with live mesenchymal stem cell-based therapy. Interestingly, recent studies have shown that human adipose tissue stem cell-derived exosomes possess the critical properties of stem cells and are as potent as mesenchymal stem cells in the repair of various organ injuries. BENEV's Exosome Regenerative Complex powered by ExoSCRT was developed and designed in tandem with the 4th largest exosome research company in the world, ExoCoBio. The intensive dual action complex is quickly absorbed into the skin, delivering the concentrated power of over 2.5 billion lyophilized exosomes, potent growth factors, peptides, co-enzymes, minerals, amino acids and vitamins. The paraben-free, steroid-free, and hypoallergenic patented technologies and ingredients are clinically proven to rejuvenate and regenerate the skin. "Lyophilizing exosomes maximize topical therapeutic potential. Making them ideal for treatments," says Dr. Richard Goldfarb, M.D., F.A.C.S.ExoCoBio's ExoSCRT, is an innovative patented purification method of separating and refining 0.1 pure exosomes from stem cell conditioned media. The concentration of materials is significantly greater than what can be achieved with a product such as PRP. Studies have shown that this product increases fibroblast production by 180% and collagen production by 300%. BENEV Company Inc. Medical Advisory Board Members:Richard Jin, MD, PhD, BENEV's Chief Medical Director, studied at the Boston University School of Medicine, Harvard Medical School and the University of California Irvine. He completed research in the areas of cardiovascular disease, pulmonary hypertension, antioxidant enzyme properties, cell signaling, cellular redox mechanisms, free radical-induced oxidant stress, platelet biology, growth factors, and wound healing. For more information visitwww.rjclinicalinstitute.comRichard M. Goldfarb, M.D, F.A.C.S., graduated from the University of Health Sciences /Finch University, The Chicago Medical School with top honors in Surgery. He completed his surgical training atNortheastern Ohio College of Medicine. He did additional training in cosmetic surgery at theUniversity of Pennsylvania, Department of Plastic Surgery andYale University. Dr. Goldfarb's 30 years of combined experience in General, Vascular, and Cosmetic Surgery provides his patients with the surgical expertise they are seeking. Dr. Goldfarb established the Center for SmartLipo & Plastic Surgery in 2007. For more information visitwww.centerforsmartlipo.com Diane I. Duncan, M.D., F.A.C.S., obtained her medical degree from the Tulane University School of Medicine. She is certified by the American Board of Plastic Surgery and is a member of several plastic surgery professional societies, including the American Society of Plastic Surgeons (ASPS), the American Society of Aesthetic Plastic Surgeons (ASAPS) and the International Society of Aesthetic Plastic Surgeons (ISAPS). In addition to these affiliations, Dr. Duncan is a fellow of the American College of Surgeons (ACS). Dr. Duncan joined our Medical Advisory Board with over 30 years of experience in private practice as a plastic surgeon. She is an internationally recognized speaker and educator in plastic surgery and has delivered presentations at industry conferences around the world. She has also authored medical journal articles on a variety of subjects in plastic surgery and currently serves as a member of the editorial review board for theAesthetic Surgery Journal. For more information visit www.drdianeduncan.com Randy B. Miller, M.D., is a board certified cosmetic and reconstructive plastic surgeon practicing in Miami, Florida. Dr. Miller earned his Bachelor of Arts in psychology and a Master's degree in clinical immunology and completed medical school at Jefferson Medical College where he graduated at the top of his class. He completed his training in general surgery and otolaryngology - head and neck surgery at Thomas Jefferson University Hospital in Philadelphia. Dr. Miller performed his plastic surgery training at Baylor College of Medicine located within the Texas Medical Center in Houston, which is the largest medical center in the world. Dr. Miller is a former president of the Miami Society of Plastic Surgeons, the Florida Society of Plastic Surgeons, and the Plastic Surgeons Patient Safety Foundation. Having served five consecutive terms on the Board of Directors of the Dade County Medical Association and as a delegate to the Florida Medical Association, Dr. Miller is a member of, and has received presidential appointments from, the American Society of Plastic Surgeons. In addition to his role as a clinical professor in the Division of Plastic Surgery at the University of Miami, Dr. Miller serves as a plastic surgery resident mentor. For many years he has served as the liaison between the University of Miami, Division of Plastic Surgery, and the Miami Society of Plastic Surgeons. Based on his research, publications and 25 years of clinical experience, Dr. Miller has become an internationally recognized expert in the fields of stem cell research and therapy, including human and veterinary tissue regeneration. Dr. Miller provides a uniquely comprehensive approach to aesthetics and age management. For more information visit www.millerplasticsurgery.com Dr. J.D. McCoy, NMP, received his doctorate in Naturopathic Medicine at the Canadian College of Naturopathic Medicine. He is one of the most accomplished naturopathic physicians practicing aesthetic medicine in the country. He completed an internship in internal medicine in Hawaii, and began specialized training, certification, and externship in cosmetic medicine and light-based therapies. Dr. McCoy has devoted his specialization, passion and his entire practice to the art of less-invasive cosmetic rejuvenation, weight-management, and natural bio-identical hormone therapy since 2003. Dr. McCoy's principles in the practice of aesthetic medicine include prevention, the use of natural substances (light/energy, nutrients and other natural substances), and the use of the least invasive treatments possible. Dr. McCoy finds innovative solutions that reduce or eliminate the need for more invasive surgery- beautiful results naturally. He is recognized as an innovator and physician trainer for multiple technologies and techniques in cosmetic medicine including but most certainly not limited to a Physician Member: American Academy of Cosmetic Surgery, American Academy of Aesthetic Medicine, American Society of Aesthetic Mesotherapy, International Federation for Adipose Therapeutics and Science. For more information visitwww.contourmedical.com BENEV Company Inc.1-949-457-2222 www.BENEV.com SOURCE BENEV Related Links http://benev.com/
Answer: | BENEV Announces Investigative Report on Combination Treatment with Human Adipose Tissue Stem Cell- derived Exosomes and Fractional CO2 Laser for Acne Scars: A 12-week Prospective, Double blind, Randomized, Split-face | MISSION VIEJO, Calif., Jan. 7, 2021 /PRNewswire/ --BENEV Company Inc., an FDA Registered cosmeceutical manufacturer of globally recognized medical professional line, along with their Medical Advisory Board comprised of five global medical leaders, is proud to announce that that the 12-week Prospective, Double-blind, Randomized, Split-face Investigative Report on Combination Treatment with Human Adipose Tissue Stem Cell-derived Exosomes and Fractional CO2Laser for Acne Scars by ExoCoBio Inc., an equity invested partner of BENEV, was published on Oct 19th, 2020, in Acta Dermato-Venereologica. (PRNewsfoto/BENEV) This report outlines the investigative study that was conducted by a team of world renowned scientists, doctors including Hyuck Hoon KWON, Steven Hoseong YANG, Joon LEE, Byung Chul PARK, Kui Young PARK, Jae Yoon JUNG, Youin BAE,and Gyeong-Hun at Oaro Dermatology Institute (Seoul, South Korea), Guam Dermatology Institute (Guam, USA), Department of Dermatology, Dankook University, College of Medicine (Cheonan, South Korea), Department of Dermatology, Chung-Ang University, College of Medicine (Seoul, South Korea), and Department of Dermatology, Dongtan Sacred Heart Hospital, Hallym University College of Medicine (Hwaseong, South Korea). Researchers involved in this study evaluated the clinical efficacy and safety of adipose tissue stem cell-derived exosomes as an adjuvant therapy after application of fractional CO2laser for acne scars. 25 patients consisting of 18 men and 7 women, between ages 19 and 54, 12 with Fitzpatrick Skin Type 3 and 13 with Fitzpatrick skin type 4 and atrophic acne scars, underwent the 12-week prospective, double-blind, randomized, split-face trial. Each received three consecutive treatment sessions of fractional CO2laser to the whole face, with a follow-up evaluation, and a post- laser split face regimen, where one side of each patient's face was treated with an adipose tissue stem cell-derived exosome gel. Exosomes in this study were acquired from human ASC-CM by ExoSCRT technology developed by ExoCoBio Inc., and the other side of the face was treated with control gel. Findings revealed that the adipose tissue stem cell-derived exosome-treated sides of the face had achieved a significantly greater improvement than the control sides at the final follow-up visit (percentage reduction in echelle d'evaluation clinique des cicatrices d'acne scores: 32.5 vs 19.9%, p<0.01). Treatment-related erythema was milder, and post-treatment downtime was shorter on the applications of human adipose tissue stem cell-derived exosome-treated side. The investigative study proved that a variety of applications of human adipose tissue stem cell-derived exosomes can serve as a novel cell-free therapeutic strategy in the regenerative and aesthetic medical fields and demonstrated the suitability of adipose tissue stem cell derived exosomes as an adjuvant treatment modality in combination with fractional carbon dioxide laser for the treatment of acne scars. This reportis an open access article under the CC BY-NC license Society for Publication of Acta Dermato-Venereologica. "The science is clearly demonstrating that exosomes are the wave of the future not just for aesthetics but for many other areas of medicine, and the richest source of this material, by far, is adipose tissue," says Dr. Randy Miller, M.D., F.A.C.S. Facial atrophic acne scarring is a psychologically damaging condition that can cause emotional, mental, and social disability. "With a huge percentage of the world population struggling with this condition, the need for widening of therapeutic options was astoundingly clear," says Dr. Diane Duncan, M.D., F.A.C.S. who added, "While ablative fractional carbon dioxide laser resurfacing has demonstrated clinical efficacy in acne scar treatments, patients have sustained side-effects during post-procedural wound healing and had demanded improvement. The adjuvant application of adipose-derived stem cell conditioned medium with synergistic effects in augmenting treatment responses and reducing adverse effects through its potential to accelerate tissue rejuvenation is a victory for those suffering."The sentiments have been echoed by so many other medical professionals, including, Dr. JD McCoy, NMP, whose patient roster includes professional athletes who do not have time for extended downtime and need to recover fast. "Since implementing the addition of Exosome Regenerative Complex powered by ExoSCRT into my protocol, I've observed a significant improvement in the speed of healing, skin quality and comfort during recovery," said Dr. Richard Jin, M.D., PhD. "Patients suffering from acne scarring range in all ages, and the pain that they feel is very real. Ensuring that my patients receive the best treatment results with the least amount of downtime and discomfort is non-negotiable, and that's why I choose to integrate Exosome Regenerative Complex powered by ExoSCRT, into all of my treatments."Exosomes are lipid bilayer-enclosed extracellular vesicles, 30200 nm in diameter, produced by almost all cells and present in all body fluids (810). They are regarded as an essential mediator of intercellular communication by transferring proteins and genetic material between cells. Several studies have shown that mesenchymal stem cell-derived exosomes carry the essential properties of mesenchymal stem cells suggesting that exosomes may be a compelling alternative in regenerative and aesthetic medicine, as they would avoid most of the problems associated with live mesenchymal stem cell-based therapy. Interestingly, recent studies have shown that human adipose tissue stem cell-derived exosomes possess the critical properties of stem cells and are as potent as mesenchymal stem cells in the repair of various organ injuries. BENEV's Exosome Regenerative Complex powered by ExoSCRT was developed and designed in tandem with the 4th largest exosome research company in the world, ExoCoBio. The intensive dual action complex is quickly absorbed into the skin, delivering the concentrated power of over 2.5 billion lyophilized exosomes, potent growth factors, peptides, co-enzymes, minerals, amino acids and vitamins. The paraben-free, steroid-free, and hypoallergenic patented technologies and ingredients are clinically proven to rejuvenate and regenerate the skin. "Lyophilizing exosomes maximize topical therapeutic potential. Making them ideal for treatments," says Dr. Richard Goldfarb, M.D., F.A.C.S.ExoCoBio's ExoSCRT, is an innovative patented purification method of separating and refining 0.1 pure exosomes from stem cell conditioned media. The concentration of materials is significantly greater than what can be achieved with a product such as PRP. Studies have shown that this product increases fibroblast production by 180% and collagen production by 300%. BENEV Company Inc. Medical Advisory Board Members:Richard Jin, MD, PhD, BENEV's Chief Medical Director, studied at the Boston University School of Medicine, Harvard Medical School and the University of California Irvine. He completed research in the areas of cardiovascular disease, pulmonary hypertension, antioxidant enzyme properties, cell signaling, cellular redox mechanisms, free radical-induced oxidant stress, platelet biology, growth factors, and wound healing. For more information visitwww.rjclinicalinstitute.comRichard M. Goldfarb, M.D, F.A.C.S., graduated from the University of Health Sciences /Finch University, The Chicago Medical School with top honors in Surgery. He completed his surgical training atNortheastern Ohio College of Medicine. He did additional training in cosmetic surgery at theUniversity of Pennsylvania, Department of Plastic Surgery andYale University. Dr. Goldfarb's 30 years of combined experience in General, Vascular, and Cosmetic Surgery provides his patients with the surgical expertise they are seeking. Dr. Goldfarb established the Center for SmartLipo & Plastic Surgery in 2007. For more information visitwww.centerforsmartlipo.com Diane I. Duncan, M.D., F.A.C.S., obtained her medical degree from the Tulane University School of Medicine. She is certified by the American Board of Plastic Surgery and is a member of several plastic surgery professional societies, including the American Society of Plastic Surgeons (ASPS), the American Society of Aesthetic Plastic Surgeons (ASAPS) and the International Society of Aesthetic Plastic Surgeons (ISAPS). In addition to these affiliations, Dr. Duncan is a fellow of the American College of Surgeons (ACS). Dr. Duncan joined our Medical Advisory Board with over 30 years of experience in private practice as a plastic surgeon. She is an internationally recognized speaker and educator in plastic surgery and has delivered presentations at industry conferences around the world. She has also authored medical journal articles on a variety of subjects in plastic surgery and currently serves as a member of the editorial review board for theAesthetic Surgery Journal. For more information visit www.drdianeduncan.com Randy B. Miller, M.D., is a board certified cosmetic and reconstructive plastic surgeon practicing in Miami, Florida. Dr. Miller earned his Bachelor of Arts in psychology and a Master's degree in clinical immunology and completed medical school at Jefferson Medical College where he graduated at the top of his class. He completed his training in general surgery and otolaryngology - head and neck surgery at Thomas Jefferson University Hospital in Philadelphia. Dr. Miller performed his plastic surgery training at Baylor College of Medicine located within the Texas Medical Center in Houston, which is the largest medical center in the world. Dr. Miller is a former president of the Miami Society of Plastic Surgeons, the Florida Society of Plastic Surgeons, and the Plastic Surgeons Patient Safety Foundation. Having served five consecutive terms on the Board of Directors of the Dade County Medical Association and as a delegate to the Florida Medical Association, Dr. Miller is a member of, and has received presidential appointments from, the American Society of Plastic Surgeons. In addition to his role as a clinical professor in the Division of Plastic Surgery at the University of Miami, Dr. Miller serves as a plastic surgery resident mentor. For many years he has served as the liaison between the University of Miami, Division of Plastic Surgery, and the Miami Society of Plastic Surgeons. Based on his research, publications and 25 years of clinical experience, Dr. Miller has become an internationally recognized expert in the fields of stem cell research and therapy, including human and veterinary tissue regeneration. Dr. Miller provides a uniquely comprehensive approach to aesthetics and age management. For more information visit www.millerplasticsurgery.com Dr. J.D. McCoy, NMP, received his doctorate in Naturopathic Medicine at the Canadian College of Naturopathic Medicine. He is one of the most accomplished naturopathic physicians practicing aesthetic medicine in the country. He completed an internship in internal medicine in Hawaii, and began specialized training, certification, and externship in cosmetic medicine and light-based therapies. Dr. McCoy has devoted his specialization, passion and his entire practice to the art of less-invasive cosmetic rejuvenation, weight-management, and natural bio-identical hormone therapy since 2003. Dr. McCoy's principles in the practice of aesthetic medicine include prevention, the use of natural substances (light/energy, nutrients and other natural substances), and the use of the least invasive treatments possible. Dr. McCoy finds innovative solutions that reduce or eliminate the need for more invasive surgery- beautiful results naturally. He is recognized as an innovator and physician trainer for multiple technologies and techniques in cosmetic medicine including but most certainly not limited to a Physician Member: American Academy of Cosmetic Surgery, American Academy of Aesthetic Medicine, American Society of Aesthetic Mesotherapy, International Federation for Adipose Therapeutics and Science. For more information visitwww.contourmedical.com BENEV Company Inc.1-949-457-2222 www.BENEV.com SOURCE BENEV Related Links http://benev.com/ |
edtsum2054 | You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text.
Text: SEATTLE, July 27, 2020 /PRNewswire/ --As schools across the country look for ways to safely re-open, Safeology today released a video demonstrating new technology that will allow students to safely get back into the classroom. The Safeology Tower is an effective tool for widescale disinfection of classrooms and other facilities working to re-open amid COVID-19. The UVC-disinfection product uses smart technology to eliminate up to 99.9% of pathogens, which is the key to keeping our nation's future leaders safe and healthy in a school environment. Continue Reading Safeology UVC Tower Disinfects Schools From SARS-CoV-2 to Help Get Kids Safely Back In School The Safeology UVC Tower safely, quickly and efficiently eliminates SARS-CoV-2, the virus that causes COVID-19, helping to get tomorrow's leaders back in the classroom today. The Safeology UVC Tower uses the scientifically-proven power of UVC light to disinfect virtually any space, eliminating up to 99.9% of surface and airborne pathogens "It's important for our children to learn, and for parents to have peace of mind that the classroom is safe and free from harmful pathogens," said Safeology CEO Jim Mischel. "You can see for yourself, our groundbreaking technology is ready for everyone to embrace back-to-school season with safety as a top priority." This videoallows you to see how the tower works in a classroom environment. Text of the video: Introducing the Safeology UVC Light Tower, the key to getting students safely back into the classroom. Using scientifically proven technology, it safely eliminates up to 99.9 percent of surface pathogens like the coronavirus that are exposed to the Tower's UVC light. Leverage the science of Safeology UVC technology and get tomorrow's future leaders back in the classroom today. Designed, engineered and manufactured in Everett, Washington where the first U.S. case of COVID-19 was diagnosed the Safeology Tower uses UVC and loT technology to allow widescale disinfection of classrooms, hotels, cruise lines, healthcare facilities, and other spaces with ease and unmatched efficiency. Far more than just a UVC lamp, the Safeology Tower was specifically created with smart technology, complete with wireless touch pad, remote-control functions, safety features, and data collection software useful for a wide range of hospitality and healthcare industry needs. Safeology has also brought together a team of national experts to navigate the UVC technology and its use. The team includes George Diaz, M.D., who treated the first U.S. case of COVID-19; chemical engineer Joseph Anderson, Ph.D.; microbiologist David Rockabrand, Ph.D.; and electrical engineer Rolf Bergman, Ph.D.The Safeology Tower: Smart Reduction of PathogensThe Safeology Tower eliminates up to 99.9% of surface pathogens through the effective use of UVC disinfection a well-studiedgermicidal technique gaining prominence in the fight against COVID-19 and other coronaviruses. Designed for both function and beauty, the sleek Safeology Tower offers a unique and complete total-disinfection solution loaded with literally dozens of features, including: Laser mapping technology to determine required UV dosage to deactivate the virus. Multiple safety features including PIR (passive infrared) motion sensors and AI (artificial intelligence) movement detection to ensure safe operation in unoccupied spaces. Interactive 6.3-inch tablet with integrated wireless charger; Wi-Fi Cloud-based control and monitoring; multiple languages, and cycle-completion notification. 74-inch height for floor to ceiling, 360o disinfection coverage; 6 high-output shatter resistant amalgam 253.7 nm UVC lamp emitters with 12,000-hour lamp life; handles and easy-roll wheels for fast deployment of unit, with self-locking casters for secure placement. Full range of other supportive resources, including PPE equipment; complete marketing support; customer service for help with provisioning, set up, and questions; and a continuously updated online archive of related UVC information. About SafeologyCreated by the same team that leads Electric Mirror, the world's largest manufacturer of lighted-mirror technology products, Safeology specializes in UVC-light disinfection. Crafting LEDs, lamps, and related IoT technology, Safeology employs researchers, engineering and R&D teams to provide wireless product solutions that reduce the spread of viruses and other pathogens. Guided by a preeminent Scientific Advisory Board with world-class experts in infectious disease, microbiology, bioengineering, and electrical engineering, Safeology is leading the 21st century vanguard in the battle against pathogenic illness. Learn more about the future of disinfection at www.Safeology.com.Media Contact: Teresa Wenta, Executive Director of Global MarketingCell: 425-350-7407Email: [emailprotected]SOURCE Safeology Related Links http://www.Safeology.com
Answer: | Video Shows Safeology Tower Making Back-to-School Season Safer Groundbreaking UVC technology gives peace of mind to parents, students, and educators | SEATTLE, July 27, 2020 /PRNewswire/ --As schools across the country look for ways to safely re-open, Safeology today released a video demonstrating new technology that will allow students to safely get back into the classroom. The Safeology Tower is an effective tool for widescale disinfection of classrooms and other facilities working to re-open amid COVID-19. The UVC-disinfection product uses smart technology to eliminate up to 99.9% of pathogens, which is the key to keeping our nation's future leaders safe and healthy in a school environment. Continue Reading Safeology UVC Tower Disinfects Schools From SARS-CoV-2 to Help Get Kids Safely Back In School The Safeology UVC Tower safely, quickly and efficiently eliminates SARS-CoV-2, the virus that causes COVID-19, helping to get tomorrow's leaders back in the classroom today. The Safeology UVC Tower uses the scientifically-proven power of UVC light to disinfect virtually any space, eliminating up to 99.9% of surface and airborne pathogens "It's important for our children to learn, and for parents to have peace of mind that the classroom is safe and free from harmful pathogens," said Safeology CEO Jim Mischel. "You can see for yourself, our groundbreaking technology is ready for everyone to embrace back-to-school season with safety as a top priority." This videoallows you to see how the tower works in a classroom environment. Text of the video: Introducing the Safeology UVC Light Tower, the key to getting students safely back into the classroom. Using scientifically proven technology, it safely eliminates up to 99.9 percent of surface pathogens like the coronavirus that are exposed to the Tower's UVC light. Leverage the science of Safeology UVC technology and get tomorrow's future leaders back in the classroom today. Designed, engineered and manufactured in Everett, Washington where the first U.S. case of COVID-19 was diagnosed the Safeology Tower uses UVC and loT technology to allow widescale disinfection of classrooms, hotels, cruise lines, healthcare facilities, and other spaces with ease and unmatched efficiency. Far more than just a UVC lamp, the Safeology Tower was specifically created with smart technology, complete with wireless touch pad, remote-control functions, safety features, and data collection software useful for a wide range of hospitality and healthcare industry needs. Safeology has also brought together a team of national experts to navigate the UVC technology and its use. The team includes George Diaz, M.D., who treated the first U.S. case of COVID-19; chemical engineer Joseph Anderson, Ph.D.; microbiologist David Rockabrand, Ph.D.; and electrical engineer Rolf Bergman, Ph.D.The Safeology Tower: Smart Reduction of PathogensThe Safeology Tower eliminates up to 99.9% of surface pathogens through the effective use of UVC disinfection a well-studiedgermicidal technique gaining prominence in the fight against COVID-19 and other coronaviruses. Designed for both function and beauty, the sleek Safeology Tower offers a unique and complete total-disinfection solution loaded with literally dozens of features, including: Laser mapping technology to determine required UV dosage to deactivate the virus. Multiple safety features including PIR (passive infrared) motion sensors and AI (artificial intelligence) movement detection to ensure safe operation in unoccupied spaces. Interactive 6.3-inch tablet with integrated wireless charger; Wi-Fi Cloud-based control and monitoring; multiple languages, and cycle-completion notification. 74-inch height for floor to ceiling, 360o disinfection coverage; 6 high-output shatter resistant amalgam 253.7 nm UVC lamp emitters with 12,000-hour lamp life; handles and easy-roll wheels for fast deployment of unit, with self-locking casters for secure placement. Full range of other supportive resources, including PPE equipment; complete marketing support; customer service for help with provisioning, set up, and questions; and a continuously updated online archive of related UVC information. About SafeologyCreated by the same team that leads Electric Mirror, the world's largest manufacturer of lighted-mirror technology products, Safeology specializes in UVC-light disinfection. Crafting LEDs, lamps, and related IoT technology, Safeology employs researchers, engineering and R&D teams to provide wireless product solutions that reduce the spread of viruses and other pathogens. Guided by a preeminent Scientific Advisory Board with world-class experts in infectious disease, microbiology, bioengineering, and electrical engineering, Safeology is leading the 21st century vanguard in the battle against pathogenic illness. Learn more about the future of disinfection at www.Safeology.com.Media Contact: Teresa Wenta, Executive Director of Global MarketingCell: 425-350-7407Email: [emailprotected]SOURCE Safeology Related Links http://www.Safeology.com |
edtsum2062 | You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text.
Text: NEW YORK, Aug. 11, 2020 /PRNewswire/ -- As Congress fails to renew supplemental unemployment benefits and a second wave of COVID-19 spreads across the country, Teamsters Local 813 and ALIGN NY are creating a new $30,000 relief fund to support New York City's commercial sanitation workers, an often overlooked group of essential workers. Commercial sanitation workers collect trash and recycling from businesses across the city. At the height of the pandemic, they stayed on the job so that essential businesses could continue operating, exposing themselves to the virus. But as more and more economic sectors shut down, many of these workers either lost their jobs or saw their hours severely curtailed. "A lot of us, especially non-union workers, were sent out on trucks without the sanitizer or PPE we needed to be safe," said Doug Washington, a sanitation worker and Teamsters member. "Our union is coming together with our allies at ALIGN to make sure all workers are protected, union and non-union." The relief fund grows out of years of advocacy and organizing by the organizations alongside sanitation workers. The job is the fifth most deadly in the country and many workers are forced to work off the books, without benefits and protections, or for substandard wages. "Commercial sanitation workers have been organizing for better labor, environmental, and safety standards for years, and we will not let this pandemic stop the struggle to build worker power," said Maritza Silva-Farrell, Executive Director of ALIGN NY. "This fund is about supporting workers and families in this unprecedented economic crisis, but it will also help them continue to make bold, transformative changes in some of the most exploitative workplaces in New York City." "Commercial sanitation workers were hurting before the pandemic, and this crisis has pushed many over the edge," said Sean Campbell, President of Teamsters Local 813. "We are helping these New York heroes provide for their families now, but we will also help them advocate for their coworkers and protect themselves when they return to work." City officials have an opportunity to transform these jobs for the better through the recently passed Commercial Waste Zones Law. Zoning waste collection will dramatically decrease the distances that workers must cover in a single shift, and give the city new authority to set safety standards and hold notoriously unscrupulous private carters accountable for other labor and environmental violations. The Department of Sanitation has stated that implementation of the policy will be underway by later this year. The Commercial Sanitation Worker Relief Fund will provide monetary, food, and other support for impacted workers. New York City commercial sanitation workers who have been affected by COVID-19's health or economic impacts and need assistance should contact Teamsters Local 813. While the fund is beginning with $30,000 provided by a generous donor, organizers are hoping to grow that amount. Members of the public can donate to the fund by visiting https://alignny.org/commercial-sanitation-worker-relief-fund/. Contact: Alex Moore, [emailprotected]Patrick Nevada, [emailprotected] SOURCE Teamsters Joint Council 16, New York, NY
Answer: | COVID Relief Fund Launches for NYC's Commercial Sanitation Workers | NEW YORK, Aug. 11, 2020 /PRNewswire/ -- As Congress fails to renew supplemental unemployment benefits and a second wave of COVID-19 spreads across the country, Teamsters Local 813 and ALIGN NY are creating a new $30,000 relief fund to support New York City's commercial sanitation workers, an often overlooked group of essential workers. Commercial sanitation workers collect trash and recycling from businesses across the city. At the height of the pandemic, they stayed on the job so that essential businesses could continue operating, exposing themselves to the virus. But as more and more economic sectors shut down, many of these workers either lost their jobs or saw their hours severely curtailed. "A lot of us, especially non-union workers, were sent out on trucks without the sanitizer or PPE we needed to be safe," said Doug Washington, a sanitation worker and Teamsters member. "Our union is coming together with our allies at ALIGN to make sure all workers are protected, union and non-union." The relief fund grows out of years of advocacy and organizing by the organizations alongside sanitation workers. The job is the fifth most deadly in the country and many workers are forced to work off the books, without benefits and protections, or for substandard wages. "Commercial sanitation workers have been organizing for better labor, environmental, and safety standards for years, and we will not let this pandemic stop the struggle to build worker power," said Maritza Silva-Farrell, Executive Director of ALIGN NY. "This fund is about supporting workers and families in this unprecedented economic crisis, but it will also help them continue to make bold, transformative changes in some of the most exploitative workplaces in New York City." "Commercial sanitation workers were hurting before the pandemic, and this crisis has pushed many over the edge," said Sean Campbell, President of Teamsters Local 813. "We are helping these New York heroes provide for their families now, but we will also help them advocate for their coworkers and protect themselves when they return to work." City officials have an opportunity to transform these jobs for the better through the recently passed Commercial Waste Zones Law. Zoning waste collection will dramatically decrease the distances that workers must cover in a single shift, and give the city new authority to set safety standards and hold notoriously unscrupulous private carters accountable for other labor and environmental violations. The Department of Sanitation has stated that implementation of the policy will be underway by later this year. The Commercial Sanitation Worker Relief Fund will provide monetary, food, and other support for impacted workers. New York City commercial sanitation workers who have been affected by COVID-19's health or economic impacts and need assistance should contact Teamsters Local 813. While the fund is beginning with $30,000 provided by a generous donor, organizers are hoping to grow that amount. Members of the public can donate to the fund by visiting https://alignny.org/commercial-sanitation-worker-relief-fund/. Contact: Alex Moore, [emailprotected]Patrick Nevada, [emailprotected] SOURCE Teamsters Joint Council 16, New York, NY |
edtsum2072 | You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text.
Text: DUBLIN, May 14, 2020 /PRNewswire/ -- The "Savory Ingredients Market by Type ((Monosodium Glutamate, Yeast Extracts, HVPs, HAPs, Nucleotides, and Other Types), Form (Powder, Liquid, and Others), Origin (Natural and Synthetic), Application (Food and Feed), and Region - Global Forecast to 2025" report has been added to ResearchAndMarkets.com's offering. This report segments the savory ingredients market, on the basis of type, origin, form, application, and region. In terms of insights, this research report focuses on various levels of analyses - competitive landscape, end-use analysis, and company profiles - which together comprise and discuss the basic views on the emerging & high-growth segments of the savory ingredients market, high-growth regions, countries, industry trends, drivers, restraints, opportunities, and challenges. The global savory ingredients market is estimated to be valued at US$ 7.2 billion in 2020 and projected to reach US$ 9.3 billion by 2025, recording a CAGR of 5.2% Factors such as the growing demand for savory-flavored ready-to-eat snacks and canned food across the globe drive the growth of the savory ingredients market during the forecast period.By origin, the synthetic segment accounted for a larger share in 2019The synthetic segment accounted for a major share of the global savory ingredients market, on the basis of origin, in 2019. Synthetic flavor enhancers are those produced through chemical processes; they are comparatively low-priced because they are easy to avail and produce. In the synthetic savory ingredients market, monosodium glutamate, commonly known as MSG, is the most widely synthesized ingredient. It finds applications in savory foods, soups, sauces, and other processed products.By form, the powder segment is estimated to account for the largest shareBased on form, the savory ingredients market is segmented into powder, liquid, and other forms. The powdered form is estimated to account for the largest share because of its high usage in the food industry. Powdered savory ingredients are widely used in sugary powders, dried cheese powders, sauce powders, savory spice mixes, and soy sauce powder, which are made from fermented beans and roasted ground wheat. Dry powder ingredients are mainly used in confectioneries, bakery products, dressings, and snacks.Asia-Pacific accounted for the largest share in the savory ingredients market due to the wider acceptability and usage of savory ingredients in Asian cuisinesThe Asia-Pacific region remains a focus area for savory ingredients as consumer awareness is limited, and regulations are not standardized. Growth in the demand can be seen for savory ingredients used in processed food due to the increasingly busy lifestyles of consumers and their preference for ready-to-eat products. China remains the dominating country in the Asia-Pacific region. Major food companies such as Givaudan (Switzerland), Kerry Group PLC (Ireland), and Symrise (Germany) are investing in expanding their presence in China and India. Key Topics Covered 1 Introduction 2 Research Methodology 3 Executive Summary 4 Premium Insights 4.1 Overview of The Savory Ingredients Market4.2 Market, By Origin, 20194.3 Asia Pacific: Market, By Application and Key Country4.4 Market, By Application and Region, 20194.5 Market, By Key Country/Region, 20195 Market Overview 5.1 Introduction5.2 Market Dynamics5.2.1 Drivers5.2.1.1 Increasing Popularity of Convenience Food Products5.2.1.2 Growing Government Intervention Toward the Reduction of Salt Intake in Developed Countries5.2.1.3 Increase in the Number of End-use Applications of Savory Ingredients5.2.1.4 Changing Consumer Food Preferences in Developing Regions5.2.2 Restraints5.2.2.1 Stringent Regulations on International Quality Standards5.2.2.2 High Cost of Processing and Raw Materials5.2.3 Opportunities5.2.3.1 Rising Demand for Natural and Healthy Flavor Ingredients5.2.3.2 Growing Need for the Replacement of MSG5.2.4 Challenges5.2.4.1 Consumer Awareness About the Ill-Effects of Flavor Enhancers5.2.4.2 Growing Demand for Clean Labels5.3 Regulations5.3.1 US & Canada5.3.2 India5.3.3 Australia5.3.4 Europe5.4 Yc-Ycc Shift6 Savory Ingredients Market, By Type 6.1 Introduction6.2 Yeast Extracts6.2.1 Growing Demand for Natural Ingredients Supports The Growth of Yeast Extracts6.3 Hydrolyzed Vegetable Proteins6.3.1 The Growing Demand for Convenience Food and Prepared Meals Drives The Market for Hydrolyzed Vegetable Proteins6.4 Hydrolyzed Animal Proteins6.4.1 Hydrolyzed Animal Proteins (Haps) Are Majorly Used in The Feed Sector6.5 Monosodium Glutamate (Msg)6.5.1 Msg Is The Most Consumed Savory Ingredient in Developing Countries6.6 Nucleotides6.6.1 Nucleotides Are Expected to Have a High Potential to Enhance The Profitability of Livestock6.7 Other Types7 Savory Ingredients Market, By Origin 7.1 Introduction7.2 Natural7.2.1 Rising Health Concerns Among Consumers Result in The Growth in Demand for Naturally Sourced Ingredients in Food Products7.3 Synthetic7.3.1 Low-Cost Manufacturing Process for Synthetic Savory Ingredients Drives The Market Growth8 Savory Ingredients Market, By Form 8.1 Introduction8.2 Powder8.2.1 Wide Usage of Powdered Savory Ingredients in Foodservice Outlets and Households Drives The Market Growth8.3 Liquid8.3.1 High Solubility of The Liquid Form Supports Its Usage in Beverages8.4 Other Forms9 Savory Ingredients Market, By Application 9.1 Introduction9.2 Food9.2.1 Growing Demand for Convenience and Ready-to-Eat Food With Umami Flavor Drives The Growth of Savory Ingredients in The Food Segment9.3 Feed9.3.1 Demand for Natural Savory Ingredients, Such As Yeast Extracts and HVP, in Feed Supports The Growth of The Market10 Savory Ingredients Market, By Region 10.1 Introduction10.2 North America10.2.1 US10.2.1.1 Increasing Demand for Savory Flavors in Packaged and Ready-to-Eat Food Products to Drive The US Market10.2.2 Canada10.2.2.1 Varied Regulations By The Government for Synthetic Ingredients Create Opportunities for Market Players to Produce Natural Savory Food Ingredients10.2.3 Mexico10.2.3.1 Challenge for Manufacturers to Produce Plant-Based Food Products With a Blend of Savory Flavors10.3 Europe10.3.1 UK10.3.1.1 Growing Trend of Free-From Products Drives The Natural Savory Ingredients Market Growth10.3.2 Germany10.3.2.1 Inclination Toward Healthy Snacking Supports The Demand for Savory Ingredients in Snacks10.3.3 Spain10.3.3.1 Growth in Applications Such As Cheese, Cured Meat, and Bakery & Confectionery Products Drives The Market for Savory Ingredients10.3.4 Italy10.3.4.1 Adoption of Umami Taste in Traditional Italian Food Drives The Market Growth10.3.5 France10.3.5.1 Demand for Convenience Food With Savory Flavors in The Country Drives The Market Growth10.3.6 Rest of Europe10.4 Asia Pacific10.4.1 China10.4.1.1 Growth Potential of Yeast Extracts in Bakery and Brewing Industries10.4.2 Japan10.4.2.1 Change in Lifestyles and Rising Disposable Incomes of Consumers Influence The Growth of Savory Ingredients10.4.3 India10.4.3.1 Favorable Government Policies for Savory-Flavored Processed Food Support The Growth of Savory Ingredients10.4.4 Indonesia10.4.4.1 Use of Monosodium Glutamate (Msg) As a Flavor Enhancer in Food Products Supports The Market Growth for Savory Ingredients10.4.5 Thailand10.4.5.1 Extensive Use of Umami-Flavored Seasonings in Food Products Drive The Market Growth10.4.6 Vietnam10.4.6.1 Well-Established Presence of Savory Manufacturers and Suppliers Drives The Market Significantly in The Country10.4.7 Rest of Asia Pacific10.5 South America10.5.1 Brazil10.5.1.1 High Growth in The Demand for Packed Food With Blends of Savory Flavors Drives The Market for Savory Ingredients10.5.2 Argentina10.5.2.1 Rise in The Domestic Consumption for Processed Food and Snacks Made With Natural Ingredients Supports The Growth of The Savory Ingredients Market10.5.3 Rest of South America10.6 Rest of The World (RoW)10.6.1 Middle East10.6.1.1 Increasing Consumer Trend of Opting for Snacks and Ready-to-Eat Food Products Presents Growth Potential for Savory Products10.6.2 Africa10.6.2.1 Rapid Urbanization and Changes in Consumer Trends for Natural Flavored Food & Beverages to Drive The Market for Savory Ingredients11 Competitive Landscape 11.1 Overview11.2 Competitive Leadership Mapping11.2.1 Dynamic Differentiators11.2.2 Innovators11.2.3 Visionary Leaders11.2.4 Emerging Companies11.3 Product Portfolio Analysis (Global)11.4 Business Strategy Excellence (Global)11.5 Competitive Scenario11.5.1 Expansions & Investments11.5.2 New Product Launches11.5.3 Agreements, Joint Ventures, and Partnerships11.6 Competitive Leadership Mapping (Start-Up/SME)11.6.1 Progressive Companies11.6.2 Starting Blocks11.6.3 Responsive Companies11.6.4 Dynamic Companies11.7 Strength of Product Portfolio (Start-Up/SME)11.8 Business Strategy Excellence (Start-Up/SME)12 Company Profiles 12.1 Ajinomoto Co. Inc.12.2 Koninklijke DSM N.V.12.3 Kerry Group PLC12.4 Tate & Lyle PLC12.5 Givaudan12.6 Symrise12.7 Lesaffre Group12.8 Sensient Technologies Corporation12.9 Angelyeast Co. Ltd.12.10 Vedan International (Holdings) Limited12.11 Synergy Flavors12.12 Vinayak Ingredients India Pvt. Ltd.12.13 Halcyon Proteins Pvy. Ltd.12.14 Novozymes12.15 ADM12.16 Cargill12.17 Food Chem International Corporation12.18 ABF Ingredients12.19 The Fufeng Group12.20 Meihua Holdings Group Co. Ltd. For more information about this report visit https://www.researchandmarkets.com/r/b5qh66 Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research. Media Contact: Research and Markets Laura Wood, Senior Manager [emailprotected] For E.S.T Office Hours Call +1-917-300-0470 For U.S./CAN Toll Free Call +1-800-526-8630 For GMT Office Hours Call +353-1-416-8900 U.S. Fax: 646-607-1907 Fax (outside U.S.): +353-1-481-1716 SOURCE Research and Markets Related Links http://www.researchandmarkets.com
Answer: | Savory Ingredients Market Assessment Report 2020-2025 - Growing Need for the Replacement of MSG Presents Opportunities | DUBLIN, May 14, 2020 /PRNewswire/ -- The "Savory Ingredients Market by Type ((Monosodium Glutamate, Yeast Extracts, HVPs, HAPs, Nucleotides, and Other Types), Form (Powder, Liquid, and Others), Origin (Natural and Synthetic), Application (Food and Feed), and Region - Global Forecast to 2025" report has been added to ResearchAndMarkets.com's offering. This report segments the savory ingredients market, on the basis of type, origin, form, application, and region. In terms of insights, this research report focuses on various levels of analyses - competitive landscape, end-use analysis, and company profiles - which together comprise and discuss the basic views on the emerging & high-growth segments of the savory ingredients market, high-growth regions, countries, industry trends, drivers, restraints, opportunities, and challenges. The global savory ingredients market is estimated to be valued at US$ 7.2 billion in 2020 and projected to reach US$ 9.3 billion by 2025, recording a CAGR of 5.2% Factors such as the growing demand for savory-flavored ready-to-eat snacks and canned food across the globe drive the growth of the savory ingredients market during the forecast period.By origin, the synthetic segment accounted for a larger share in 2019The synthetic segment accounted for a major share of the global savory ingredients market, on the basis of origin, in 2019. Synthetic flavor enhancers are those produced through chemical processes; they are comparatively low-priced because they are easy to avail and produce. In the synthetic savory ingredients market, monosodium glutamate, commonly known as MSG, is the most widely synthesized ingredient. It finds applications in savory foods, soups, sauces, and other processed products.By form, the powder segment is estimated to account for the largest shareBased on form, the savory ingredients market is segmented into powder, liquid, and other forms. The powdered form is estimated to account for the largest share because of its high usage in the food industry. Powdered savory ingredients are widely used in sugary powders, dried cheese powders, sauce powders, savory spice mixes, and soy sauce powder, which are made from fermented beans and roasted ground wheat. Dry powder ingredients are mainly used in confectioneries, bakery products, dressings, and snacks.Asia-Pacific accounted for the largest share in the savory ingredients market due to the wider acceptability and usage of savory ingredients in Asian cuisinesThe Asia-Pacific region remains a focus area for savory ingredients as consumer awareness is limited, and regulations are not standardized. Growth in the demand can be seen for savory ingredients used in processed food due to the increasingly busy lifestyles of consumers and their preference for ready-to-eat products. China remains the dominating country in the Asia-Pacific region. Major food companies such as Givaudan (Switzerland), Kerry Group PLC (Ireland), and Symrise (Germany) are investing in expanding their presence in China and India. Key Topics Covered 1 Introduction 2 Research Methodology 3 Executive Summary 4 Premium Insights 4.1 Overview of The Savory Ingredients Market4.2 Market, By Origin, 20194.3 Asia Pacific: Market, By Application and Key Country4.4 Market, By Application and Region, 20194.5 Market, By Key Country/Region, 20195 Market Overview 5.1 Introduction5.2 Market Dynamics5.2.1 Drivers5.2.1.1 Increasing Popularity of Convenience Food Products5.2.1.2 Growing Government Intervention Toward the Reduction of Salt Intake in Developed Countries5.2.1.3 Increase in the Number of End-use Applications of Savory Ingredients5.2.1.4 Changing Consumer Food Preferences in Developing Regions5.2.2 Restraints5.2.2.1 Stringent Regulations on International Quality Standards5.2.2.2 High Cost of Processing and Raw Materials5.2.3 Opportunities5.2.3.1 Rising Demand for Natural and Healthy Flavor Ingredients5.2.3.2 Growing Need for the Replacement of MSG5.2.4 Challenges5.2.4.1 Consumer Awareness About the Ill-Effects of Flavor Enhancers5.2.4.2 Growing Demand for Clean Labels5.3 Regulations5.3.1 US & Canada5.3.2 India5.3.3 Australia5.3.4 Europe5.4 Yc-Ycc Shift6 Savory Ingredients Market, By Type 6.1 Introduction6.2 Yeast Extracts6.2.1 Growing Demand for Natural Ingredients Supports The Growth of Yeast Extracts6.3 Hydrolyzed Vegetable Proteins6.3.1 The Growing Demand for Convenience Food and Prepared Meals Drives The Market for Hydrolyzed Vegetable Proteins6.4 Hydrolyzed Animal Proteins6.4.1 Hydrolyzed Animal Proteins (Haps) Are Majorly Used in The Feed Sector6.5 Monosodium Glutamate (Msg)6.5.1 Msg Is The Most Consumed Savory Ingredient in Developing Countries6.6 Nucleotides6.6.1 Nucleotides Are Expected to Have a High Potential to Enhance The Profitability of Livestock6.7 Other Types7 Savory Ingredients Market, By Origin 7.1 Introduction7.2 Natural7.2.1 Rising Health Concerns Among Consumers Result in The Growth in Demand for Naturally Sourced Ingredients in Food Products7.3 Synthetic7.3.1 Low-Cost Manufacturing Process for Synthetic Savory Ingredients Drives The Market Growth8 Savory Ingredients Market, By Form 8.1 Introduction8.2 Powder8.2.1 Wide Usage of Powdered Savory Ingredients in Foodservice Outlets and Households Drives The Market Growth8.3 Liquid8.3.1 High Solubility of The Liquid Form Supports Its Usage in Beverages8.4 Other Forms9 Savory Ingredients Market, By Application 9.1 Introduction9.2 Food9.2.1 Growing Demand for Convenience and Ready-to-Eat Food With Umami Flavor Drives The Growth of Savory Ingredients in The Food Segment9.3 Feed9.3.1 Demand for Natural Savory Ingredients, Such As Yeast Extracts and HVP, in Feed Supports The Growth of The Market10 Savory Ingredients Market, By Region 10.1 Introduction10.2 North America10.2.1 US10.2.1.1 Increasing Demand for Savory Flavors in Packaged and Ready-to-Eat Food Products to Drive The US Market10.2.2 Canada10.2.2.1 Varied Regulations By The Government for Synthetic Ingredients Create Opportunities for Market Players to Produce Natural Savory Food Ingredients10.2.3 Mexico10.2.3.1 Challenge for Manufacturers to Produce Plant-Based Food Products With a Blend of Savory Flavors10.3 Europe10.3.1 UK10.3.1.1 Growing Trend of Free-From Products Drives The Natural Savory Ingredients Market Growth10.3.2 Germany10.3.2.1 Inclination Toward Healthy Snacking Supports The Demand for Savory Ingredients in Snacks10.3.3 Spain10.3.3.1 Growth in Applications Such As Cheese, Cured Meat, and Bakery & Confectionery Products Drives The Market for Savory Ingredients10.3.4 Italy10.3.4.1 Adoption of Umami Taste in Traditional Italian Food Drives The Market Growth10.3.5 France10.3.5.1 Demand for Convenience Food With Savory Flavors in The Country Drives The Market Growth10.3.6 Rest of Europe10.4 Asia Pacific10.4.1 China10.4.1.1 Growth Potential of Yeast Extracts in Bakery and Brewing Industries10.4.2 Japan10.4.2.1 Change in Lifestyles and Rising Disposable Incomes of Consumers Influence The Growth of Savory Ingredients10.4.3 India10.4.3.1 Favorable Government Policies for Savory-Flavored Processed Food Support The Growth of Savory Ingredients10.4.4 Indonesia10.4.4.1 Use of Monosodium Glutamate (Msg) As a Flavor Enhancer in Food Products Supports The Market Growth for Savory Ingredients10.4.5 Thailand10.4.5.1 Extensive Use of Umami-Flavored Seasonings in Food Products Drive The Market Growth10.4.6 Vietnam10.4.6.1 Well-Established Presence of Savory Manufacturers and Suppliers Drives The Market Significantly in The Country10.4.7 Rest of Asia Pacific10.5 South America10.5.1 Brazil10.5.1.1 High Growth in The Demand for Packed Food With Blends of Savory Flavors Drives The Market for Savory Ingredients10.5.2 Argentina10.5.2.1 Rise in The Domestic Consumption for Processed Food and Snacks Made With Natural Ingredients Supports The Growth of The Savory Ingredients Market10.5.3 Rest of South America10.6 Rest of The World (RoW)10.6.1 Middle East10.6.1.1 Increasing Consumer Trend of Opting for Snacks and Ready-to-Eat Food Products Presents Growth Potential for Savory Products10.6.2 Africa10.6.2.1 Rapid Urbanization and Changes in Consumer Trends for Natural Flavored Food & Beverages to Drive The Market for Savory Ingredients11 Competitive Landscape 11.1 Overview11.2 Competitive Leadership Mapping11.2.1 Dynamic Differentiators11.2.2 Innovators11.2.3 Visionary Leaders11.2.4 Emerging Companies11.3 Product Portfolio Analysis (Global)11.4 Business Strategy Excellence (Global)11.5 Competitive Scenario11.5.1 Expansions & Investments11.5.2 New Product Launches11.5.3 Agreements, Joint Ventures, and Partnerships11.6 Competitive Leadership Mapping (Start-Up/SME)11.6.1 Progressive Companies11.6.2 Starting Blocks11.6.3 Responsive Companies11.6.4 Dynamic Companies11.7 Strength of Product Portfolio (Start-Up/SME)11.8 Business Strategy Excellence (Start-Up/SME)12 Company Profiles 12.1 Ajinomoto Co. Inc.12.2 Koninklijke DSM N.V.12.3 Kerry Group PLC12.4 Tate & Lyle PLC12.5 Givaudan12.6 Symrise12.7 Lesaffre Group12.8 Sensient Technologies Corporation12.9 Angelyeast Co. Ltd.12.10 Vedan International (Holdings) Limited12.11 Synergy Flavors12.12 Vinayak Ingredients India Pvt. Ltd.12.13 Halcyon Proteins Pvy. Ltd.12.14 Novozymes12.15 ADM12.16 Cargill12.17 Food Chem International Corporation12.18 ABF Ingredients12.19 The Fufeng Group12.20 Meihua Holdings Group Co. Ltd. For more information about this report visit https://www.researchandmarkets.com/r/b5qh66 Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research. Media Contact: Research and Markets Laura Wood, Senior Manager [emailprotected] For E.S.T Office Hours Call +1-917-300-0470 For U.S./CAN Toll Free Call +1-800-526-8630 For GMT Office Hours Call +353-1-416-8900 U.S. Fax: 646-607-1907 Fax (outside U.S.): +353-1-481-1716 SOURCE Research and Markets Related Links http://www.researchandmarkets.com |
edtsum2079 | You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text.
Text: TOKYO--(BUSINESS WIRE)-- This announcement is for our U.S.$5,000,000,000 Euro Medium Term Note Programme. Mitsui & Co., Ltd. announced its consolidated financial results for the year ended March 31, 2021, based on International Financial Reporting Standards (IFRS). Mitsui & Co., Ltd. and subsidiaries (Web Site : https://www.mitsui.com/jp/en/) President and Chief Executive Officer : Kenichi Hori Investor Relations Contacts : Masaya Inamuro, Investor Relations Division TEL 81-3-3285-1111 1. Consolidated financial results (1) Consolidated operating results information for the year ended March 31, 2021 (from April 1, 2020 to March 31, 2021) Years ended March 31, 2021 2020 % % Revenue Millions of yen 8,010,235 (5.6) 8,484,130 (5.3) Profit before income taxes Millions of yen 450,202 (15.7) 534,320 (8.6) Profit for the year Millions of yen 350,381 (14.8) 411,312 (4.7) Profit for the year attributable to owners of the parent Millions of yen 335,458 (14.3) 391,513 (5.5) Comprehensive income for the year Millions of yen 996,046 (261,856) Earnings per share attributable to owners of the parent, basic Yen 199.28 226.13 Earnings per share attributable to owners of the parent, diluted Yen 199.18 225.98 Profit ratio to equity attributable to owners of the parent % 8.0 9.7 Profit before income taxes to total assets % 3.7 4.5 Note: 1. Percentage figures for Revenue, Profit before income taxes, Profit for the year, Profit for the year attributable to owners of the parent, and Comprehensive income for the year represent changes from the previous year. 2. Share of profit (loss) of investments accounted for using the equity method for the years ended March 31, 2021 and 2020 were 227,910 million and 269,232 million, respectively. 3. As described in the Note in Consolidated Statements of Income, the Company has reconsidered the presentation of revenue from certain transactions, and has restated revenues for the previous fiscal year. (2) Consolidated financial position information March 31, 2021 March 31, 2020 Total assets Millions of yen 12,515,845 11,806,292 Total equity Millions of yen 4,822,887 4,060,932 Total equity attributable to owners of the parent Millions of yen 4,570,420 3,817,677 Equity attributable to owners of the parent ratio % 36.5 32.3 Equity per share attributable to owners of the parent Yen 2,739.28 2,235.83 (3) Consolidated cash flow information Years ended March 31, 2021 2020 Operating activities Millions of yen 772,696 526,376 Investing activities Millions of yen (322,474) (185,230) Financing activities Millions of yen (486,963) (204,561) Cash and cash equivalents at the end of the year Millions of yen 1,063,150 1,058,733 2. Dividend information Years ended March 31, Year ending March 31, 2022 (Forecast) 2021 2020 Interim dividend per share Yen 40 40 45 Year-end dividend per share Yen 45 40 45 Annual dividend per share Yen 85 80 90 Annual dividend (total) Millions of yen 142,589 137,848 Consolidated dividend payout ratio % 42.7 35.4 32.4 Consolidated dividend on equity attributable to owners of the parent % 3.4 3.4 Note: The amount of Annual dividend includes 331 million of dividend for the shares related to the share-based compensation plan for employees. 3. Forecast of consolidated operating results for the year ending March 31, 2022 (from April 1, 2021 to March 31, 2022) Year ending March 31, 2022 Profit attributable to owners of the parent Millions of yen 460,000 Earnings per share attributable to owners of the parent, basic Yen 277.49 4. Others (1) Increase/decrease of important subsidiaries during the period : None (2) Changes in accounting policies and accounting estimate : () Changes in accounting policies required by IFRS Yes () Other changes None () Changes in accounting estimates Yes Note: For further details please refer to p.28 5. Consolidated Financial Statements (7) Changes in Accounting Policies and Changes in Accounting Estimates. (3) Number of shares: March 31, 2021 March 31, 2020 Number of shares of common stock issued, including treasury stock 1,717,104,808 1,742,684,906 Number of shares of treasury stock 48,628,466 35,184,567 Year ended March 31, 2021 Year ended March 31, 2020 Average number of shares of common stock outstanding 1,683,338,251 1,731,383,943 This earnings report is not subject to audit. A Cautionary Note on Forward-Looking Statements: This report contains forward-looking statements including those concerning future performance of Mitsui & Co., Ltd. (Mitsui), and those statements are based on Mitsuis current assumptions, expectations and beliefs in light of the information currently possessed by it. Various factors may cause Mitsuis actual results to be materially different from any future performance expressed or implied by these forward-looking statements. Therefore, these statements do not constitute a guarantee by Mitsui that such future performance will be realized. For key assumptions on which the statements concerning future performance are based, please refer to (2)Forecasts for the Year Ending March 31, 2022 on p.16. For cautionary notes with respect to forward-looking statements, please refer to the Notice section on p.20. Supplementary materials and IR meetings on financial results: Supplementary materials on financial results can be found on our web site. We will hold an IR meeting on financial results for analysts and institutional investors on May 7, 2021. Contents of the meeting (English and Japanese) will be posted on our web site immediately after the meeting. Table of Contents 1. Qualitative Information (1) Operating Environment 2 (2) Results of Operations 3 (3) Financial Condition and Cash Flows 11 2. Management Policies (1) Progress with the Medium-term Management Plan 16 (2) Forecasts for the Year Ending March 31, 2022 16 (3) Profit Distribution Policy 19 3. Basic Approach on Adoption of Accounting Standards 19 4. Other Information 20 5. Consolidated Financial Statements (1) Consolidated Statements of Financial Position 21 (2) Consolidated Statements of Income and Comprehensive Income 23 (3) Consolidated Statements of Changes in Equity 25 (4) Consolidated Statements of Cash Flows 26 (5) Assumption for Going Concern 27 (6) Basis of Consolidated Financial Statements 27 (7) Changes in Accounting Policies and Changes in Accounting Estimates 28 (8) Changes in Presentation 30 (9) Notes to Consolidated Financial Statements 31 1. Qualitative Information As of the date of disclosure of this earnings report, the audit procedures for consolidated financial statements have not been completed. As used in this report, "Mitsui" and the "Company" refer to Mitsui & Co., Ltd. (Mitsui Bussan Kabushiki Kaisha), and "we", "us", "our" and the "companies" are used to indicate Mitsui & Co., Ltd. and its subsidiaries, unless otherwise indicated. (1) Operating Environment In the year ended March 31, 2021, the global economy declined rapidly and significantly at the beginning of the fiscal year due to widespread restraints on economic activities, which included curfew in many countries due to the global spread of COVID-19. However, the overall economy subsequently rebounded as economic activities resumed intermittently depending on the spread of infection, and major economies such as the U.S. provided large-scale support for households and businesses and implemented financial measures. In the U.S., the economic recovery trend is expected to strengthen due to large-scale economic measures by the new Biden administration and increasing vaccinations. In Europe, there are concerns that the economic recovery may be delayed as restraints on activities continue due to the resurgence in infections and the slowing pace of vaccinations in major countries other than the UK. In Japan, despite the recovery in exports, there are concerns about the resurgence of COVID-19 cases and the impact of reduced automobile production due to a global shortage of semiconductors. As a result, a full-fledged recovery is not expected until after the summer when more vaccinations are available. In China, in addition to an increase in exports, investment and consumer spending are recovering and the economic growth rate is expected to exceed the rate prior to the COVID-19 outbreak. In Russia and Brazil, although exports and consumer spending continue to recover, Brazil remains unable to stop the spread of infection and there are concerns that this will hinder the economic recovery. The global economic recovery is expected to be boosted by additional economic measures in major countries as well as by widespread availability of vaccinations. China, which controlled the spread of infection during the early stage, is already on a recovery path, and the U.S., which is expanding large-scale financial measures, is expected to return to the level before the COVID-19 outbreak in the first half of the year. Then, Japan is expected to return to the pre-COVID-19 level by the end of the year and Europe by next year. (2) Results of Operations 1) Analysis of Consolidated Income Statements (Billions of Yen) Current Year Previous Year (As restated) Change Revenue 8,010.2 8,484.1 (473.9) Gross Profit 811.5 839.4 (27.9) Selling, general and administrative expenses (606.4) (584.9) (21.5) Other Income (Expenses) Gain (Loss) on Securities and Other InvestmentsNet 7.9 25.1 (17.2) Impairment Reversal (Loss) of Fixed AssetsNet (52.9) (110.8) +57.9 Gain (Loss) on Disposal or Sales of Fixed AssetsNet 4.6 9.5 (4.9) Other Income (Expense)Net (13.9) 38.5 (52.4) Finance Income (Costs) Interest Income 19.9 41.4 (21.5) Dividend Income 103.7 96.5 +7.2 Interest Expense (51.9) (89.6) +37.7 Share of Profit (Loss) of Investments Accounted for Using the Equity Method 227.9 269.2 (41.3) Income Taxes (99.8) (123.0) +23.2 Profit for the Year 350.4 411.3 (60.9) Profit for the Year Attributable to Owners of the Parent 335.5 391.5 (56.0) * May not match with the total of items due to rounding off. The same shall apply hereafter. Revenue Revenue for the year ended March 31, 2021 (current year) was 8,010.2 billion, a decrease of 473.9 billion from the year ended March 31, 2020 (previous year). * We have presented the "revenue" and corresponding "cost" of certain transactions in gross amounts beginning with the current fiscal year. Those amounts for the previous fiscal year have also been restated to conform to the presentation in the current fiscal year. This restatement has no impact on gross profit, profit for the year attributable to owners of the parent, or total equity attributable to owners of the parent. For further details please refer to 5. Consolidated Financial Statements (2) Consolidated Statements of Income and Comprehensive Income. Gross Profit Mainly the Energy Segment, the Machinery & Infrastructure Segment, the Lifestyle Segment recorded a decrease, while the Innovation & Corporate Development Segment, Mineral & Metal Resources Segment and the Chemicals Segment recorded an increase. Selling, general and administrative expenses Mainly the Lifestyle Segment and the Machinery & Infrastructure Segment recorded a decline, while a cost increasing factor was recorded in the Machinery & Infrastructure Segments. On the other hand, the Mineral & Metal Resources Segment recorded increasing factors. The table provides a breakdown of selling, general and administrative expenses. Billions of Yen Current Year Previous Year Change Personnel (296.9) (298.8) +1.9 Welfare (9.2) (10.4) +1.2 Travel (7.0) (27.5) +20.5 Entertainment (1.7) (6.1) +4.4 Communication (46.4) (44.1) (2.3) Rent (8.7) (9.3) +0.6 Depreciation (36.7) (41.9) +5.2 Fees and Taxes (12.4) (13.3) +0.9 Loss Allowance (80.6) (31.3) (49.3) Others (106.8) (102.2) (4.6) Total (606.4) (584.9) (21.5) Other Income (Expenses) Gain (Loss) on Securities and Other InvestmentsNet For the current year, a gain on securities was recorded in the Machinery & Infrastructure Segment, while an impairment loss was recorded in the Mineral & Metal Resources Segment and the Machinery & Infrastructure Segment. For the previous year, a gain on securities was recorded in the Machinery & Infrastructure Segment, the Lifestyle Segment and the Innovation & Corporate Development Segment. Impairment Reversal (Loss) of Fixed AssetsNet For the current year, mainly the Energy Segment and the Machinery & Infrastructure Segment recorded an impairment loss on fixed assets, while the Innovation & Corporate Development Segment recorded an impairment reversal. For the previous year, impairment losses on fixed assets were recorded in the Energy Segment, the Lifestyle Segment and the Machinery & Infrastructure Segment. Other Income (Expense)Net For the current year, the impairment loss on loans in the Mineral & Metal Resources Segment and Machinery & Infrastructure Segment, the foreign exchange related loss in the Mineral & Metal Resources Segment, and the cost related to asset retirement obligation in the Energy Segment were recorded while insurance proceeds were recorded in the business in North America in the Chemicals Segment. For the previous year, the Chemicals Segment recorded insurance proceeds in the business in North America, the Innovation & Corporate Development Segment recorded a valuation profit on a derivative in relation to a put option of an investment, and the Machinery & Infrastructure Segment recorded insurance proceeds. Furthermore, a gain on the sales of property management business was recorded in the Lifestyle Segment. Finance Income (Costs) Dividend Income Mainly the Mineral & Metal Resources Segment recorded an increase, while the Energy Segment recorded a decrease. Share of Profit (Loss) of Investments Accounted for Using the Equity Method Mainly the Energy Segment, the Lifestyle Segment and the Iron & Steel Products Segment recorded a decrease, while the Mineral & Metal Resources Segment and the Machinery & Infrastructure Segment recorded an increase. Income Taxes Income taxes for the current year were 99.8 billion, a reduction of 23.2 billion from 123.0 billion for the previous year. For the current year, 39.0 billion profit was recorded through the deferred tax assets recognitions due to the reorganization of the U.S. subsidiaries in the Energy Segment. The effective tax rate for the current year was 22.2%, a decrease of 0.8 points from 23.0% for the previous year. Although there was an increase in tax effective rate due to an impairment loss not recognizable for deferred tax in the Mineral & Metal Resources Segment, there was a decrease in tax effective rate due to a deferred tax assets recognition in the Energy Segment and reversal of deferred tax liabilities on equity accounted investments due to dividends from those investees. Considering these items, the tax effective rate was lower than the previous year. Profit for the Year Attributable to Owners of the Parent Profit for the year attributable to owners of the parent was 335.5 billion, a decrease of 56.0 billion from the previous year. For the impact of COVID-19 pandemic, please refer "3) Impact of COVID-19 pandemic". 2) Operating Results by Operating Segment A part of next-generation electric power business was transferred from the Machinery & Infrastructure Segment to Energy Segment effective April 1, 2020. In accordance with the aforementioned changes, the operating segment information for the previous year has been restated to conform to the current year's presentation. Iron & Steel Products Segment (Billions of Yen) Current Year Previous Year Change Profit for the year attributable to owners of the parent 2.1 4.7 (2.6) Gross profit 21.2 24.6 (3.4) Profit (loss) of equity method investments 4.3 13.1 (8.8) Dividend income 1.4 1.9 (0.5) Selling, general and administrative expenses (22.0) (27.2) +5.2 Others (2.8) (7.7) +4.9 Profit (loss) of equity method investments decreased mainly due to the following factor: - For the current year, Gestamp companies reported a decrease of 9.1 billion mainly due to the lower operating time caused by lower automotive production, the impact of foreign exchange fluctuations, and one-time cost related to the structural transformation. Mineral & Metal Resources Segment (Billions of Yen) Current Year Previous Year Change Profit for the year attributable to owners of the parent 179.9 183.3 (3.4) Gross profit 251.2 226.0 +25.2 Profit (loss) of equity method investments 70.4 59.2 +11.2 Dividend income 59.8 25.2 +34.6 Selling, general and administrative expenses (72.3) (41.6) (30.7) Others (129.2) (85.5) (43.7) Gross profit increased mainly due to the following factors: - Iron ore mining operations in Australia recorded an increase of 54.3 billion mainly due to higher sales prices. - Coal mining operations in Australia recorded a decrease of 30.2 billion mainly due to lower sales prices. Profit (loss) of equity method investments increased mainly due to the following factors: - Iron ore mining operations in Australia recorded an increase of 10.8 billion mainly due to higher sales prices. - Compaa Minera Doa Ins de Collahuasi SCM, a copper mining company in Chile, recorded an increase of 6.1 billion mainly due to higher sales prices and sales volume. - Coal mining operations in Australia recorded a decrease of profit mainly due to lower sales prices. - Following the revisions to our various assumptions, impairment losses of 3.8 billion for the current year, and 5.1 billion for the previous year were recorded for the Nacala Corridor rail & port infrastructure business in Mozambique. Dividend income increased mainly due to higher dividends from Vale S.A. and iron ore mining operations in Australia. Selling, general and administrative expenses increased mainly due to the following factors: - Following the revisions to our various assumptions, impairment losses of 35.9 billion for the current year and 9.8 billion for the previous year for doubtful debts were recorded regarding the Moatize mine business and Nacala Corridor rail & port infrastructure business in Mozambique. - For the current year, an impairment loss of 8.3 billion for doubtful debt was recorded, based on the conclusion of share transfer agreement for the SCM Minera Lumina Copper Chile, the project company for the Caserones Copper Mine. In addition to the above, the following factors also affected results: - Following the revisions to our various assumptions, impairment losses of 19.2 billion for the current year and 2.8 billion for the previous year were recorded regarding the Moatize mine business and Nacala Corridor rail & port infrastructure business in Mozambique. - Coal mining operations in Australia recorded a decrease of 6.7 billion due to foreign exchange related losses. - Iron ore mining operations in Australia recorded a decrease of 6.0 billion due to foreign exchange related losses. Energy Segment (Billions of Yen) Current Year Previous Year Change Profit for the year attributable to owners of the parent 27.2 57.8 (30.6) Gross profit 62.9 141.1 (78.2) Profit (loss) of equity method investments 18.8 45.2 (26.4) Dividend income 25.1 52.7 (27.6) Selling, general and administrative expenses (47.2) (44.5) (2.7) Others (32.4) (136.7) +104.3 Gross profit decreased mainly due to the following factors: - Mitsui Oil Exploration Co., Ltd. recorded a decrease of 54.6 billion mainly due to decline in production, and lower oil and gas prices. - Business division at the Headquarters recorded a decrease mainly due to impact of hurricane in LNG trading business. - Mitsui E&P Italia A S.r.l recorded a decrease of 8.4 billion mainly due to an increase in cost. - MEP Texas Holdings LLC recorded a decrease of 4.9 billion mainly due to lower oil and gas prices. - Mitsui E&P USA LLC recorded a decrease of 4.3 billion mainly due to lower oil and gas prices. - AWE recorded an increase of 4.8 billion due to decrease of depreciation cost. Profit (loss) of equity method investment decreased mainly due to the following factors: - Japan Australia LNG(MIMI) Pty. Ltd recorded a decrease mainly due to lower oil and gas prices. - Mitsui E&P Mozambique Area 1 Limited recorded a decrease of 11.8 billion mainly due to the recognition of deferred tax assets in accordance with the Final Investment Decision for the project in the previous year. - Japan Arctic LNG recorded a decrease of 10.1 billion mainly due to valuation loss on changes in oil price, foreign exchange and others. - Mitsui & Co. LNG Investment USA, Inc. recorded an increase of 9.2 billion due to the commencement of commercial production in all three trains at the Cameron LNG Project. Dividends from six LNG projects (Sakhalin II, Qatargas 1, Abu Dhabi, Oman, Qatargas 3 and Equatorial Guinea) were 24.3 billion in total, a decrease of 25.9 billion from the previous year. In addition to the above, the following factors also affected results: - For the current year, profit of 39.0 billion was recorded due to recognition of deferred tax assets in accordance with transferring and reorganizing the U.S. energy subsidiaries to MBK Energy Holdings USA Inc. - For the current year, mainly due to lower oil price, Mitsui E&P Italia A S.r.l recorded an impairment loss of 23.4 billion for its Tempa Rossa project while impairment loss of 13.9 billion was recorded for the same project in the previous year. - For the current year, Mitsui E&P Australia recorded an impairment loss of 17.3 billion mainly for its Meridian project mainly due to the update of production profile, Toro/Ragnar and Libra exploration projects due to changes in the future development plan, while impairment loss of 31.2 billion was recorded for Greater Enfield project in the previous year. - For the current year, Mitsui E&P Australia recorded a cost of 7.7 billion due to a revision of asset retirement obligation. - For the previous year, MEP Texas Holdings recorded an impairment loss of 23.4 billion for its Eagle Ford shale oil and gas business. - For the previous year, a subsidiary of Mitsui Oil Exploration Co., Ltd. recorded an impairment loss of 4.3 billion for its offshore project in the Gulf of Mexico. Machinery & Infrastructure Segment (Billions of Yen) Current Year Previous Year Change Profit for the year attributable to owners of the parent 45.9 89.4 (43.5) Gross profit 107.7 134.6 (26.9) Profit (loss) of equity method investments 95.3 88.4 +6.9 Dividend income 3.9 5.1 (1.2) Selling, general and administrative expenses (132.9) (133.4) +0.5 Others (28.1) (5.3) (22.8) Gross profit decreased mainly due to the following factor: - For the current year, the subsidiaries in relation to the railways, construction & industrial machinery, and automobile business recorded a decrease due to the effect of the COVID-19 pandemic. Profit (loss) of equity method investments increased mainly due to the following factors: - A gain was recorded at an automobile company in Canada due to good sales results. - A gain was recorded at a construction & mining machinery company in Australia due to good sales results. - Mitsui & Co. LNG Investment USA, Inc. recorded an increase of 4.0 billion due to the commencement of commercial production in all three trains at the Cameron LNG Project. - FPSO/FSO leasing companies recorded an increase of 3.8 billion due to the absence of refinancing and other costs in the previous year. - Offshore supporting vessels business was improved due to the absence of impairment of assets in the previous year. - For the current year, a portion of impairment loss of 4.7 billion for equity investments was recorded following current estimates, based on status to date, and the final valuation of termination payments for early termination of the franchise agreements in relation to passenger rail business with the Department of Transport, UK (The current estimate in the passenger rail franchise business in the UK). - Investments in gas distribution companies in Brazil recorded a decrease of 4.6 billion because of the depreciation of the Brazilian Real and tariff reduction as prior year adjustment for the current year, while the refund of service tax payments through arbitrations led to a transient increase in the previous year. - Following the revisions to our various assumptions, impairment losses of 0.9 billion for the current year, and 1.3 billion for the previous year were recorded for the Nacala Corridor rail & port infrastructure business in Mozambique. Selling, general and administrative expenses decreased, while there was the following increase factors: - Following the revisions to our various assumptions, impairment losses of 9.0 billion for the current year and 2.4 billion for the previous year for doubtful debts were recorded regarding the Moatize mine business and Nacala Corridor rail & port infrastructure business in Mozambique. - For the current year, a loss allowance for doubtful debt of 4.9 billion was recorded based on the current estimate in the passenger rail franchise business in the UK. In addition to the above, the following factors also affected results: - For the current year, 9.3 billion impairment loss was recorded in the rolling stock leasing business. - Following the revisions to our various assumptions, impairment losses of 4.8 billion for the current year and 0.7 billion for the previous year were recorded regarding the Moatize mine business and Nacala Corridor rail & port infrastructure business in Mozambique. - For the previous year, Mitsui Bussan Aerospace Co., Ltd. reported an other income and expense of 4.0 billion mainly due to insurance proceeds. - For the current year, a provision for loss on guarantee of 1.5 billion was recorded based on the current estimate in the passenger rail franchise business in the UK. - Gains on sale of the IPP business in North America were recorded both in the current and previous year. - For the previous year, the overseas railway business recorded an impairment loss of fixed asset. Chemicals Segment (Billions of Yen) Current Year Previous Year Change Profit for the year attributable to owners of the parent 43.5 22.3 +21.2 Gross profit 124.9 116.8 +8.1 Profit (loss) of equity method investments 11.3 11.5 (0.2) Dividend income 3.0 2.7 +0.3 Selling, general and administrative expenses (95.5) (101.9) +6.4 Others (0.2) (6.8) +6.6 Gross profit increased mainly due to the following factor: - An increase of 3.1 billion was recorded due to price increase and cost reduction of main products in Novus International, Inc. In addition to the above, the following factor also affected results: - Insurance proceeds were recorded in the business in North America both for the current and previous year. Lifestyle Segment (Billions of Yen) Current Year Previous Year Change Profit for the year attributable to owners of the parent 12.7 32.0 (19.3) Gross profit 133.8 134.9 (1.1) Profit (loss) of equity method investments 13.4 35.0 (21.6) Dividend income 5.6 4.2 +1.4 Selling, general and administrative expenses (129.4) (139.3) +9.9 Others (10.7) (2.8) (7.9) Gross profit decreased mainly due to the following factors: - For the current year, subsidiaries, whose businesses are fashion, food and distribution, recorded a decrease of profit due to the closure of stores and lower demand for commercial ingredients for the food service industry caused by the state of emergency and curfew. - For the current year, reclassification from a consolidated subsidiary for the fashion & textile businesses in Asia to an equity method investee caused a 4.8 billion decrease. - Drug development in the life science and healthcare fund invested through MBK Pharma Partnering Inc recorded a 3.8 billion gain mainly from the valuation of fair value for the current year due to the progress on drug development, and a 2.4 billion loss mainly due to the suspension of drug development for the previous year. - For the current year, United Grain Corporation of Oregon which runs an origination and merchandising of grain business in the U.S. West Coast recorded an increase of 5.0 billion mainly due to strong wheat and soybean sales. - For the current year, PRIFOODS CO., LTD. which runs a production, processing and sales of broilers recorded an increase of 3.2 billion mainly due to an increase in sales volume with stay-at-homes orders. Profit (loss) of equity method investment decreased mainly due to the following factors: - For the current year, equity method investees, whose businesses are food, fashion, and services, recorded a decrease of profit due to curfew and self-restraint. - For the current year, IHH Healthcare Berhad recorded a decrease of 3.4 billion mainly because of decline in operation rate due to lower demand for medical tourism and from patients with minor illnesses caused by the effect of the COVID-19 pandemic, and impairment of goodwill over subsidiary in India. - For the previous year, International Columbia U.S. LLC divested Columbia Asia Healthcare Pte. Ltd and a capital gain of 13.0 billion from this transaction was recorded. Selling, general and administrative expenses decreased mainly due to the following factor: - For the current year, reclassification from a consolidated subsidiary for the fashion & textile businesses in Asia to an equity method investee caused a 4.3 billion decrease. In addition to the above, the following factors also affected results: - For the previous year, there was a 12.5 billion decline in tax burden in relation to income taxes recognized as other comprehensive income corresponding to sales of financial assets measured at FVTOCI, including the share of Recruit Holdings Co., Ltd. - For the previous year, a capital gain from the sales of Sogo Medical Holdings Co., Ltd. and the reversal of deferred tax liability for the retained earnings, totaling 8.7 billion, were recorded. - For the previous year, Mitsui & Co. Foresight recorded a gain on the sales of the property management business. - For the previous year, a capital gain from the partial sale of RareJob, Inc. was recorded. - For the previous year, an impairment loss on fixed assets of 14.0 billion was recorded due to a decline of the fair value of its farmland and others mainly caused by a depreciation of the Brazilian real against the U.S. dollar in XINGU AGRI AG conducting a production business of agricultural products in Brazil. - For the previous year, an impairment loss of fixed assets of 6.8 billion was recorded mainly due to a partially poor business performance in Accountable Healthcare Holdings Corporation, which conducts healthcare staffing in the U.S. Innovation & Corporate Development Segment (Billions of Yen) Current Year Previous Year Change Profit for the year attributable to owners of the parent 50.2 14.6 +35.6 Gross profit 107.0 60.1 +46.9 Profit (loss) of equity method investments 13.9 17.0 (3.1) Dividend income 3.8 3.3 +0.5 Selling, general and administrative expenses (63.7) (64.5) +0.8 Others (10.8) (1.3) (9.5) Gross profit increased mainly due to the following factors: - For the current year, a 13.1 billion gain on the sales was recorded at a holding company as a result of sales of its entire shareholding in OSIsoft LLC. - For the previous year, 6.5 billion loss was recorded due to the valuation of fair value on shares in Hutchison China MediTech Ltd., while for the current year, 5.6 billion gain was recorded due to the valuation and sales of the shares. - For the current year, an increase of 5.1 billion was recorded mainly due to good results of energy trading in Mitsui Bussan Commodities Ltd. - For the current year, an increase of 5.0 billion was recorded mainly due to good results of precious metal trading at a business division at the Headquarters. - For the previous year, MGI Global Fund L.P. recorded 1.0 billion loss for the valuation of shares, while for the current year, it recorded 2.8 billion gain for the valuation and sales of shares mainly associated with the IPO of QD Laser, Inc. - For the current year, a gain of 3.3 billion in the valuation of fair value was recorded associated with the IPO of shares held through G2VP, LLC. - An increase of 2.7 billion was caused from the combined effect of the loss on the valuation and sales of the shares in Mercari, Inc. recognized for the previous year, and the profit on the sales of it's entire shareholding for the current year. In addition to the above, the following factors also affected results: - For the current year, 4.3 billion of reversal of impairment loss on land was recorded. - For the previous year, a gain on the sales of equity stake in real estate business in Singapore was recorded. - For the previous year, a valuation profit on the derivative of 4.4 billion was recorded in relation to a put option on an investment. 3) Impact of COVID-19 pandemic For the current year, the Machinery & Infrastructure Segment, which suffered from lower demand in the passenger rail franchise business and locomotive leasing business, and the Iron & Steel Products Segment, which suffered from lower plant utilization rates, recorded a decrease of profit due to the COVID-19 pandemic and lockdown or travel bans in various regions and countries. Also, the Lifestyle Segment recorded a decrease of profit due to lower demand for commercial ingredients for the food service industry and fashion-related products amid a continuing trend in many countries to refrain from unnecessary going out, as well as a decline in occupancy rates in the hospital business due to a decrease in medical tourism and patients with minor illnesses. Additionally, the Energy Segment recorded a decrease of profit due to lower oil and gas prices caused by lower demand mainly for transportation fuels. On the other hand, the Innovation & Corporate Development Segment recorded an increase of profits due to FVTPL gain in relation to the stock market recovered mainly by economic support measures in each country, in addition to the steady capture of demands related to stay-at-home orders and IT infrastructure in the digital security business and in the TV shopping business. Also, the automobile-related business in the Machinery & Infrastructure Segment, recorded an increase of profit as a result of the recovery of demand in the second half of the current year, mainly in North America, amid a shift in the means of transportation from public transportation to private cars. As mentioned above, there were some factors that contributed to the improvement in our results, but the impact of the decrease in profit due to factors that worsened our results was significant, thus our results were lower than the previous year due to the COVID-19 pandemic. (3) Financial Condition and Cash Flows 1) Financial Condition (Billions of yen) March 31, 2021 March 31, 2020 Change Total Assets 12,515.8 11,806.3 +709.5 Current Assets 4,207.5 4,124.4 +83.1 Non-current Assets 8,308.4 7,681.9 +626.5 Current Liabilities 2,701.7 2,701.1 +0.6 Non-current Liabilities 4,991.2 5,044.3 (53.1) Net Interest-bearing Debt 3,299.8 3,486.7 (186.9) Total Equity Attributable to Owners of the Parent 4,570.4 3,817.7 +752.7 Net Debt-to-Equity Ratio (times) 0.72 0.91 (0.19) Assets Current Assets: Cash and cash equivalents increased by 4.5 billion. Trade and other receivables increased by 189.5 billion, mainly due to following factors: - An increase in trade receivable by 147.3 billion due to favorable market conditions for the Mineral & Metal Resources Segment, and an increase in trading volume in the Energy Segment, and due to both favorable market conditions and the increase in trading volume in the Chemicals Segment; and - An increase of 49.8 billion in current portion of long-term receivables of Mineral & Metal Resources Segment, mainly due to reclassification to current maturities. Other financial assets declined by 132.9 billion, mainly due to market volatility and decreases in trading volume of derivative trading in the Energy Segment and the Innovation & Corporate Development Segment. Inventories increased by 61.3 billion, mainly due to favorable market condition and increases in trading volume in the Mineral & Metal Resources Segment, the Energy Segment and the Lifestyle Segment. Non-current Assets: Investments accounted for using the equity method increased by 163.0 billion, mainly due to the following factors: - An increase of 108.7 billion resulting from foreign currency exchange fluctuations; - An increase of 36.3 billion due to an investment in Mitsui E&P Mozambique Area 1 Limited, which participates in the Mozambique LNG Project; - An increase of 227.9 billion corresponding to the profit of equity method investments for the current year, despite a decline of 194.8 billion due to dividends from equity accounted investees; - An increase due to an investment in Japan Arctic LNG B.V., which participates in the Arctic LNG 2 Project in Russia; - An increase of 10.5 billion due to an investment in Caitan S.p.A, which participate in desalination and conveyance projects for BHP Spence copper mine in Chile; and - A decline in equity method investment in Mitsui & Co. Cameron LNG Investment LLC as result of conversion of equity method investment into shareholder loans by 25.9 billion. Other investments increased by 471.2 billion, mainly due to the following factor: - As a result of higher share prices, fair value on financial assets measured at FVTOCI increased by 472.8 billion. Trade and other receivables declined by 116.4 billion, mainly due to the following factors: - An impairment of 66.9 billion for doubtful debt regarding the Moatize mine business and Nacala Corridor rail & port infrastructure businesses in Mozambique; - A decline of 49.8 billion in current portion of long-term receivables of Mineral & Metal Resources Segment, mainly due to reclassification to current maturities; and - An increase in receivable balance from Mitsui & Co. Cameron LNG Investment LLC as result of conversion of equity method investment into shareholder loans by 25.9 billion. Property, plant and equipment increased by 53.7 billion, mainly due to the following factors: - An increase of 94.3 billion (including foreign exchange translation profit of 77.4 billion) at iron ore mining operations in Australia; - An increase of 31.5 billion (including foreign exchange translation profit of 16.8 billion) at coal mining operations in Australia; and - A decline of 74.3 billion (including foreign exchange translation profit of 19.0 billion) at the oil and gas projects (*), mainly due to impairment losses at Mitsui E&P Italia A S.r.l and Mitsui E&P Australia. (*) including the U.S. shale gas and oil projects from the current year. Investment property increased by 23.0 billion, mainly due to an increase in the Innovation & Corporate Development Segment. Deferred tax assets increased by 53.2 billion, mainly due to following factors: - Recognition of deferred tax assets by 39.0 billion in accordance with transferring and reorganizing the U.S. energy subsidiaries to MBK Energy Holdings USA Inc.; and - Recognition of deferred tax assets related to losses from valuation of fixed assets and impact of exchange rate at Mitsui E&P Australia were main reasons for increase by 19.2 billion. Liabilities Current Liabilities: Short-term debt increased by 3.0 billion. Furthermore, the current portion of long-term debt increased by 51.0 billion, mainly due to a reclassification to current maturities. Trade and other payables increased by 176.8 billion, corresponding to the increase in trade and other receivables. Other financial liabilities declined by 255.7 billion, mainly due to corresponding decline in other financial assets and payments on account payable at the integrated development project in the 2, Otemachi 1-Chome District. Non-current Liabilities: Long-term debt, less the current portion, declined by 233.9 billion. Provisions increased by 33.2 billion mainly due to increase in asset retirement obligations in Mitsui E&P Australia and Mitsui Coal Holdings. Total Equity Attributable to Owners of the Parent Retained earnings increased by 185.5 billion. Other components of equity increased by 597.7 billion, mainly due to the following factors: - Financial assets measured at FVTOCI increased by 359.7 billion; and - Foreign currency translation adjustments increased by 258.9 billion, mainly reflecting the appreciation of the Australian dollar, and the U.S. dollar against the Japanese Yen, even though the Brazilian real has depreciated. Treasury stock which is a subtraction item in shareholders' equity increased by 24.4 billion, mainly due to the shares buy-back for 71.3 billion(including a buy-back for share-based compensation plan for employees of 6.9 billion), despite cancellation of the stock for 46.7 billion. 2) Cash Flows (Billions of yen) Current Year Previous Year Change Cash flows from operating activities 772.7 526.4 +246.3 Cash flows from investing activities (322.5) (185.2) (137.3) Free cash flow 450.2 341.2 +109.0 Cash flows from financing activities (487.0) (204.6) (282.4) Effect of exchange rate changes on cash and cash equivalents etc. 41.2 (34.0) +75.2 Change in cash and cash equivalents 4.4 102.6 (98.2) Cash Flows from Operating Activities (Billions of Yen) Current Year Previous Year Change Cash flows from operating activities a 772.7 526.4 +246.3 Cash flows from change in working capital b 56.2 (95.5) +151.7 Repayments of lease liabilities c (58.4) (60.9) +2.5 Core operating cash flow a-b+c 658.1 561.0 +97.1 Net cash from an increase or a decrease in working capital, or changes in operating assets and liabilities for the current year was 56.2 billion of net cash inflow. Repayments of lease liabilities for the current year was 58.4 billion of cash outflow. Core operating cash flow, which equaled cash flows from operating activities without both cash flows from changes in working capital and repayments of lease liabilities, for the current year amounted to 658.1 billion. From the current year, in order to reflect a regular cash generation output from operating activities more appropriately, repayments of lease liabilities have been deducted. In conformity with this change, core operating cash flow for the previous year has been restated. - Net cash inflow from dividend income, including dividends received from equity accounted investees, for the current year totaled 307.8 billion, an increase of 8.6 billion from 299.2 billion for the previous year; and - Depreciation and amortization for the current year was 273.6 billion, an increase of 17.5 billion from 256.1 billion for the previous year. The following table shows core operating cash flow by operating segment. (Billions of Yen) Current Year Previous Year Change Iron & Steel Products 2.0 2.2 (0.2) Mineral & Metal Resources 308.1 243.7 +64.4 Energy 123.2 206.5 (83.3) Machinery & Infrastructure 78.7 86.8 (8.1) Chemicals 62.5 35.8 +26.7 Lifestyle 19.8 20.5 (0.7) Innovation & Corporate Development 55.1 3.9 +51.2 All Other and Adjustments and Eliminations 8.7 (38.4) +47.1 Consolidated Total 658.1 561.0 +97.1 Cash Flows from Investing Activities Net cash outflows that corresponded to investments in equity accounted investees (net of sales of investments in equity accounted investees) were 56.5 billion, mainly due to the following factors: - An investment in Mitsui E&P Mozambique Area 1 Limited, which participates in the Mozambique LNG Project, for 36.3 billion; - An investment in Japan Arctic LNG B.V, which participates in the Arctic LNG 2 Project in Russia; - An investment in Caitan S.p.A, which participates in desalination and conveyance projects for BHP Spence copper mine in Chile, for 10.5 billion; and - A sale of the IPP business in North America. Net cash inflows that corresponded to other investments (net of sales and maturities of other investments) were 9.5 billion, mainly due to the following factors: - A sale of investment in San-ei Sucrochemical Co., Ltd., for 13.5 billion; and - Investments in power generating businesses for 10.9 billion. Net cash inflows that corresponded to increase in loan receivable (net of collections of loan receivable) were 14.2 billion, despite of execution of loan to Japan Arctic LNG B.V. Net cash outflows that corresponded to purchases of property, plant, and equipment (net of sales of those assets) were 206.4 billion, mainly due to the following factors: - An expenditure for iron ore mining operations in Australia for 39.3 billion; - An expenditure for the oil and gas projects for 37.0 billion; - An expenditure for the integrated development project in the 2, Otemachi 1-Chome District for 36.9 billion; - An expenditure for coal mining operations in Australia for 19.6 billion; and - An expenditure for power generating businesses for 18.2 billion. Net cash outflows that corresponded to purchases of investment property (net of sales of those assets) were 53.1 billion, mainly due to an expenditure for the integrated development project in the 2, Otemachi 1-Chome District for 37.8 billion. Cash Flows from Financing Activities Net cash outflows from net change in short-term debt were 26.5 billion, net cash outflows from net change in long-term debt were 177.0 billion, and cash outflow from repayments of lease liabilities were 58.4 billion. The cash outflow from the purchases of treasury stock was 71.3 billion (including a buy-back for share-based compensation plan for employees of 6.9 billion). The cash outflow from payments of cash dividends was 135.5 billion. The cash outflow from transactions with non-controlling interest shareholders was 18.2 billion, mainly due to an additional acquisition of a stake in Collahuasi copper mine in Chile. 2. Management Policies (1) Progress with the Medium-term Management Plan Reference is made to our Presentation Material of Financial Results for the year ended March 31, 2021 "Review of Medium-term Management Plan 2023 and plan for FY Ending March 2022" on our web site. Reference is also made to "Medium-term Management Plan 2023 Transform and Grow" released on May 1, 2020. (2) Forecasts for the Year Ending March 31, 2022 1) Forecasts for the year ending March 31, 2022 [Assumption] Forecast Result Exchange rate (JPY/USD) 105.00 105.94 Crude oil (JCC) $61/bbl $43/bbl Consolidated oil price $59/bbl $46/bbl (Billions of yen) March 31, 2022 Forecast March 31, 2021 Result Change Description Gross profit 820.0 811.5 +8.5 Selling, general and administrative expenses (590.0) (606.4) +16.4 Reversal effects of impairment losses Gain (loss) on investments, fixed assets and other 0 (54.4) +54.4 Reversal effects of impairment losses Interest expenses (30.0) (32.1) +2.1 Dividend income 120.0 103.7 +16.3 Mineral & Metal Resources Segment Energy Segment Profit (loss) of equity method investments 280.0 227.9 +52.1 Machinery & Infrastructure Segment Lifestyle Segment Iron & Steel Products Segment Profit before income taxes 600.0 450.2 +149.8 Income taxes (130.0) (99.8) (30.2) Non-controlling interests (10.0) (14.9) +4.9 Profit for the year attributable to owners of the parent 460.0 335.5 +124.5 Depreciation and amortization 300.0 273.6 +26.4 Core operating cash flow 680.0 658.1 +21.9 The forecast for the fiscal year ending March 31, 2022 is based on the assumption that the global economy will head for recovery, although there are disparities among countries and regions. Business performance is expected to rebound due to absence of the impairment losses recorded in the year ended March 31, 2021 in the Mineral & Metal Resources Segment, the Machinery & Infrastructure Segment and the Energy Segment. In addition, it is also expected that there will be a recovery in the Iron & Steel Products Segment and the Lifestyle Segment, which experienced a decline in demand and capacity utilization due to the COVID-19 pandemic. We assume foreign exchange rates for the year ending March 31, 2022 will be 105/US$, 80/AU$ and 19/BRL, while average foreign exchange rates for the year ended March 31, 2021 were 105.94/US$, 76.71/AU$ and 19.46/BRL. Also, we assume the annual average consolidated oil price applicable to our financial results for the year ending March 31, 2022 will be US$59/barrel, up US$13/barrel from the previous year, based on the assumption that the crude oil price (JCC) will average US$61/barrel throughout the year ending March 31, 2022. The forecast for profit for the year attributable to owners of the parent by operating segment compared to the previous year is as follows: (Billions of yen) Year ending March 31, 2022 Year ended March 31, 2021 Change Description Iron & Steel Products 10.0 2.1 +7.9 Reversal effects of COVID-19 impact Mineral & Metal Resources 260.0 179.9 +80.1 Reversal effects of impairment losses Energy 50.0 27.2 +22.8 Higher oil and gas price Reversal effects of impairment losses Machinery & Infrastructure 80.0 45.9 +34.1 Reversal effects of COVID-19 impact Chemicals 40.0 43.5 (3.5) Lifestyle 20.0 12.7 +7.3 Reversal effects of COVID-19 impact Innovation & Corporate Development 30.0 50.2 (20.2) Reversal effects of FVTPL profit Others / Adjustments and Eliminations (30.0) (26.0) (4.0) Consolidated Total 460.0 335.5 +124.5 The forecast for core operating cash flow by operating segment compared to the previous year is as follows: (Billions of yen) Year ending March 31, 2022 Year ended March 31, 2021 Change Description Iron & Steel Products 5.0 2.0 +3.0 Mineral & Metal Resources 290.0 308.1 (18.1) AUD appreciation, tax payment Energy 170.0 123.2 +46.8 Higher oil and gas price Machinery & Infrastructure 100.0 78.7 +21.3 Reversal effects of COVID-19 impact Chemicals 55.0 62.5 (7.5) Lifestyle 30.0 19.8 +10.2 Reversal effects of COVID-19 impact Innovation & Corporate Development 30.0 55.1 (25.1) Reversal effects of FVTPL profit Others / Adjustments and Eliminations 0.0 8.7 (8.7) Consolidated Total 680.0 658.1 +21.9 2) Key commodity prices and other parameters for the year ending March 31, 2022 The table below shows assumptions for key commodity prices and foreign exchange rates for the forecast for the year ending March 31, 2022. The effects of movements on each commodity price and foreign exchange rates on profit for the year attributable to owners of the parent are included in the table. Impact on profit for the year attributable to owners of the parent for the year ending March 31, 2022 March 2022 Assumption March 2021 Result Commodity Crude Oil/JCC - 61 43 Consolidated Oil Price (*1) 2.5 bn (US$1/bbl) 59 46 U.S. Natural Gas (*2) 1.1 bn (US$0.1/mmBtu) 2.74 2.13 (*3) Iron Ore (*4) 2.2 bn (US$1/ton) (*5) 128 (*6) Coal Coking 0.4 bn (US$1/ton) (*5) 119 (*7) Thermal 0.1 bn (US$1/ton) (*5) 69 (*7) Copper (*8) 0.7 bn (US$100/ton) 7,650 6,169 (*9) Forex (*10) USD 2.6 bn (1/USD) 105.00 105.94 AUD 2.4 bn (1/AUD) 80.00 76.71 BRL 0.2 bn (1/BRL) 19.00 19.46 (*1) As the crude oil price affects our consolidated results with a 0-6 month time lag, the effect of crude oil prices on consolidated results is estimated as the Consolidated Oil Price, which reflects this lag. For the year ending March 2022, we have assumed that there is a 4-6 month lag for approx. 35%, a 1-3 month lag for approx. 60%, and no lag for approx. 5%. The above sensitivities show annual impact of changes in consolidated oil price. (*2) As Mitsui has very limited exposure to U.S. natural gas sold at Henry Hub (HH), the above sensitivities show annual impact of changes in the weighted average sale price. (*3) U.S. gas figures for the year ended March 2021 are the Henry Hub Natural Gas Futures average daily prompt month closing prices traded on NYMEX during January to December 2020. (*4) The effect of dividend income from Vale S.A. has not been included. (*5) Iron ore and coal price assumptions are not disclosed. (*6) Iron ore results figures for the year ended March 2021 are the daily average (reference price) spot indicated price (Fe 62% CFR North China) recorded in several industry trade magazines from April 2020 to March 2021. (*7) Coal results figures for the year ended March 2021 are the quarterly average prices of representative coal brands in Japan (US$/MT). (*8) As the copper price affects our consolidated results with a 3-month time lag, the above sensitivities show the annual impact of US$100/ton change in averages of the LME monthly average cash settlement prices for the period March to December 2021. (*9) Copper results figures for the year ended March 2021 are the averages of the LME monthly average cash settlement prices for the period January to December 2020. (*10) Impact of currency fluctuations on reported profit for the year of overseas subsidiaries and equity accounted investees denominated in their respective functional currencies and the impact of dividend received from major foreign investees. Depreciation of the yen has the effect of increasing profit for the year through the conversion of profit (denominated in functional currencies) into yen. In the overseas subsidiaries and equity accounted investees where the sales contract is in USD, the impact of currency fluctuations between the USD and the functional currencies (AUD and BRL) and the impact of currency hedging are not included. (3) Profit Distribution Policy Our profit distribution policy is as follows: In order to increase corporate value and maximize shareholder value, we seek to maintain an optimal balance between (a) meeting investment demand in our core and growth areas through re-investments of our retained earnings, and (b) directly providing returns to shareholders by paying out cash dividends. In addition to the above, share buy-backs aimed at improving capital efficiency should be decided in a prompt and flexible manner as needed concerning buy-back timing and amount by taking into consideration the business environment such as, future investment activity trends, free cash flow and interest-bearing debt levels, and return on equity. For the current year, we conducted a buy-back program of 71.3 billion yen (including for share-based compensation plan for employees of 6.9 billion). On April 27, 2021, we announced that we completed the buy-back program announced on February 24, 2021, and we had purchased 24.6 billion yen from April 1 to April 26, 2021. Furthermore, on April 30, 2021, we announced a new buy-back program up to 50.0 billion of our own shares from May 6, 2021 to June 23, 2021. For details, please refer to the "Notification of Stock Repurchase" on our website. The annual dividend for the year ended March 31, 2021 will be 85 per share (including an interim dividend of 40 per share, an increase of 5 from the previous year), an upward revision of 5 from the previous forecast, taking into consideration the core operating cash flow and net income (attributable to owners of the parent) in the consolidated financial results, as well as the stability and continuity of dividend payments. Under the Medium-term management plan announced on May 1, 2020, the minimum annual dividend per share was set at 80 based on the level of core operating cash flow, which was judged to be stable and sustainable. Considering the improvement of cash flow generation ability, we decided to upwardly revise the minimum annual by dividend 10 per share, setting the minimum at 90 per share. . In addition, we will continue to flexibly and strategically allocate funds for investment in growth and additional shareholder returns (additional dividends and share buybacks) according to the business performance during the Medium-term business plan period. For the fiscal year ending March 31, 2022, we plan to pay an annual dividend of 90 per share (an increase of 5 from the previous fiscal year) . 3. Basic Approach on Adoption of Accounting Standards International Financial Reporting Standards was adopted on our annual securities report under the Financial Instruments and Exchange Act for the year ended March 31, 2014 for the purpose of improving international comparability of financial information as well as enhancement and efficiency of our financial reporting. 4. Other Information Notice: This flash report contains forward-looking statements about Mitsui and its consolidated subsidiaries. These forward-looking statements are based on Mitsuis current assumptions, expectations and beliefs in light of the information currently possessed by it and involve known and unknown risks, uncertainties and other factors. Such risks, uncertainties and other factors may cause Mitsuis actual consolidated financial position, consolidated operating results or consolidated cash flows to be materially different from any future consolidated financial position, consolidated operating results or consolidated cash flows expressed or implied by these forward-looking statements. These important risks, uncertainties and other factors include, among others, (1) risk of COVID-19, (2) business investment risks, (3) country risks, (4) risks regarding climate changes, (5) commodity market risks, (6) foreign currency risks, (7) stock price risks of listed stock Mitsui and its subsidiaries hold, (8) credit risks, (9) risks regarding fund procurement, (10) operational risks, (11) risks regarding employees compliance with laws, regulations, and internal policies, (12) risks regarding information systems and information securities, (13) risks relating to natural disasters, terrorists and violent groups. For further information on the above, please refer to Mitsuis Annual Securities Report. Forward-looking statements may be included in Mitsuis Annual Securities Report and Quarterly Securities Reports or in its other disclosure documents, press releases or website disclosures. Mitsui undertakes no obligation to publicly update or revise any forward-looking statements. 5. Consolidated Financial Statements (1) Consolidated Statements of Financial Position (Millions of Yen) Assets March 31, 2021 March 31, 2020 Current Assets: Cash and cash equivalents 1,063,150 1,058,733 Trade and other receivables 1,811,990 1,622,501 Other financial assets 429,986 562,899 Inventories 615,155 553,861 Advance payments to suppliers 143,714 167,250 Other current assets 143,477 159,175 Total current assets 4,207,472 4,124,419 Non-current Assets: Investments accounted for using the equity method 3,044,001 2,880,958 Other investments 1,955,607 1,484,422 Trade and other receivables 305,952 422,423 Other financial assets 141,848 186,010 Property, plant and equipment 2,175,072 2,121,371 Investment property 274,847 251,838 Intangible assets 188,555 195,289 Deferred tax assets 112,055 58,908 Other non-current assets 110,436 80,654 Total non-current assets 8,308,373 7,681,873 Total 12,515,845 11,806,292 (Millions of Yen) Liabilities and Equity March 31, 2021 March 31, 2020 Current Liabilities: Short-term debt 300,485 297,458 Current portion of long-term debt 450,941 399,904 Trade and other payables 1,313,341 1,136,504 Other financial liabilities 371,298 626,963 Income tax payables 58,915 46,206 Advances from customers 123,806 133,247 Provisions 36,909 25,844 Other current liabilities 46,027 34,984 Total current liabilities 2,701,722 2,701,110 Non-current Liabilities: Long-term debt, less current portion 3,995,311 4,229,218 Other financial liabilities 116,531 105,279 Retirement benefit liabilities 40,253 39,956 Provisions 261,365 228,173 Deferred tax liabilities 550,776 412,971 Other non-current liabilities 27,000 28,653 Total non-current liabilities 4,991,236 5,044,250 Total liabilities 7,692,958 7,745,360 Equity: Common stock 342,080 341,776 Capital surplus 396,238 402,652 Retained earnings 3,547,789 3,362,297 Other components of equity 373,786 (223,910) Treasury stock (89,473) (65,138) Total equity attributable to owners of the parent 4,570,420 3,817,677 Non-controlling interests 252,467 243,255 Total equity 4,822,887 4,060,932 Total 12,515,845 11,806,292 (2) Consolidated Statements of Income and Comprehensive Income Consolidated Statements of Income (Millions of Yen) Year ended March 31, 2021 Year ended March 31, 2020 (As restated) Revenue: 8,010,235 8,484,130 Cost: (7,198,770) (7,644,707) Gross Profit 811,465 839,423 Other Income (Expenses): Selling, general and administrative expenses (606,423) (584,885) Gain (loss) on securities and other investments-net 7,888 25,060 Impairment reversal (loss) of fixed assets-net (52,923) (110,809) Gain (loss) on disposal or sales of fixed assets-net 4,646 9,510 Other income (expense)-net (13,945) 38,528 Total other income (expenses) (660,757) (622,596) Finance Income (Costs): Interest income 19,877 41,373 Dividend income 103,655 96,526 Interest expense (51,948) (89,638) Total finance income (costs) 71,584 48,261 Share of Profit (Loss) of Investments Accounted for Using the Equity Method 227,910 269,232 Profit before Income Taxes 450,202 534,320 Income Taxes (99,821) (123,008) Profit for the Year 350,381 411,312 Profit for the Year Attributable to: Owners of the parent 335,458 391,513 Non-controlling interests 14,923 19,799 (Note) Considering the presentation of revenue in the consolidated statement of income in more detail in accordance with IFRS 15 "Revenue from Contracts with Customers", the Company has presented the "revenue" and corresponding "cost" of certain transactions in gross amounts beginning with the current fiscal year. Those amounts for the previous fiscal year have also been restated to conform to the presentation in the current fiscal year. This restatement has no impact on gross profit, profit for the year attributable to owners of the parent, or total equity attributable to owners of the parent. Consolidated Statements of Comprehensive Income (Millions of Yen) Year ended March 31, 2021 Year ended March 31, 2020 Profit for the Year 350,381 411,312 Other Comprehensive Income: Items that will not be reclassified to profit or loss: Financial assets measured at FVTOCI 477,184 (376,024) Remeasurements of defined benefit pension plans 32,514 (7,007) Share of other comprehensive income of investments accounted for using the equity method 1,671 (11,239) Income tax relating to items not reclassified (119,092) 79,856 Items that may be reclassified subsequently to profit or loss: Foreign currency translation adjustments 174,725 (152,404) Cash flow hedges (831) (10,070) Share of other comprehensive income of investments accounted for using the equity method 86,445 (205,343) Income tax relating to items that may be reclassified (6,951) 9,063 Total other comprehensive income 645,665 (673,168) Comprehensive Income for the Year 996,046 (261,856) Comprehensive Income for the Year Attributable to: Owners of the parent 964,652 (259,448) Non-controlling interests 31,394 (2,408) (3) Consolidated Statements of Changes in Equity (Millions of Yen) Attributable to owners of the parent Non- controlling Interests Total Equity Common Stock Capital Surplus Retained Earnings Other Components of Equity Treasury Stock Total Balance as at April 1, 2019 341,482 387,335 3,078,655 463,270 (7,576) 4,263,166 267,142 4,530,308 Cumulative effect of changes in accounting policies (5,306) (5,306) (5,306) Balance as at April 1, 2019 after changes in accounting policies 341,482 387,335 3,073,349 463,270 (7,576) 4,257,860 267,142 4,525,002 Profit for the year 391,513 391,513 19,799 411,312 Other comprehensive income for the year (650,961) (650,961) (22,207) (673,168) Comprehensive income for the year 391,513 (650,961) (259,448) (2,408) (261,856) Transaction with owners: Dividends paid to the owners of the parent (139,071) (139,071) (139,071) Dividends paid to non-controlling interest shareholders (14,130) (14,130) Acquisition of treasury stock (58,092) (58,092) (58,092) Sales of treasury stock (167) (363) 530 0 0 Compensation costs related to share-based payment 294 317 611 611 Equity transactions with non-controlling interest shareholders 15,167 650 15,817 (7,349) 8,468 Transfer to retained earnings 36,869 (36,869) - - Balance as at March 31, 2020 341,776 402,652 3,362,297 (223,910) (65,138) 3,817,677 243,255 4,060,932 Profit for the year 335,458 335,458 14,923 350,381 Other comprehensive income for the year 629,194 629,194 16,471 645,665 Comprehensive income for the year 335,458 629,194 964,652 31,394 996,046 Transaction with owners: Dividends paid to the owners of the parent (135,476) (135,476) (135,476) Dividends paid to non-controlling interest shareholders (13,982) (13,982) Acquisition of treasury stock (71,337) (71,337) (71,337) Sales of treasury stock (125) (154) 280 1 1 Cancellation of treasury stock (46,722) 46,722 - - Compensation costs related to share-based payment 304 1,771 2,075 2,075 Equity transactions with non-controlling interest shareholders (8,060) 888 (7,172) (8,200) (15,372) Transfer to retained earnings 32,386 (32,386) - - Balance as at March 31, 2021 342,080 396,238 3,547,789 373,786 (89,473) 4,570,420 252,467 4,822,887 (4) Consolidated Statements of Cash Flows (Millions of Yen) Year ended March 31, 2021 Year ended March 31, 2020 Operating Activities: Profit for the year 350,381 411,312 Adjustments to reconcile profit for the year to cash flows from operating activities: Depreciation and amortization 273,639 256,125 Change in retirement benefit liabilities 1,884 (46,793) Loss allowance 80,640 31,170 (Gain) loss on securities and other investmentsnet (7,888) (25,060) (Gain) Loss on loans measured at FVTPL 21,657 - Impairment (reversal) loss of fixed assetsnet 52,923 110,809 (Gain) loss on disposal or sales of fixed assetsnet (4,646) (9,510) Interest income, dividend income and interest expense (98,442) (77,624) Income taxes 99,821 123,008 Share of (profit) loss of investments accounted for using the equity method (227,910) (269,232) Valuation (gain) loss related to contingent considerations and others (6,694) (6,447) Changes in operating assets and liabilities: Change in trade and other receivables (40,799) 105,425 Change in inventories (34,116) 38,159 Change in trade and other payables 139,474 (178,921) Othernet (8,381) (60,179) Interest received 52,702 72,699 Interest paid (59,904) (96,624) Dividends received 307,838 299,244 Income taxes paid (119,483) (151,185) Cash flows from operating activities 772,696 526,376 Investing Activities: Net change in time deposits (30,080) 3,823 Net change in investments in equity accounted investees (56,518) 9,101 Net change in other investments 9,462 70,749 Net change in loan receivables 14,184 746 Net change in property, plant and equipment (206,404) (253,127) Net change in investment property (53,118) (16,522) Cash flows from investing activities (322,474) (185,230) Financing Activities: Net change in short-term debt (26,527) (27,158) Net change in long-term debt (177,035) 88,397 Repayments of lease liabilities (58,380) (60,861) Purchases and sales of treasury stock (71,337) (58,092) Dividends paid (135,476) (139,071) Transactions with non-controlling interest shareholders (18,208) (7,776) Cash flows from financing activities (486,963) (204,561) Effect of Exchange Rate Changes on Cash and Cash Equivalents 41,158 (33,959) Change in Cash and Cash Equivalents 4,417 102,626 Cash and Cash Equivalents at Beginning of Year 1,058,733 956,107 Cash and Cash Equivalents at End of Year 1,063,150 1,058,733 Interest income, dividend income and interest expense, Interest received, Interest paid and Dividends received of Consolidated Statements of Cash Flows include not only interest income, dividend income and interest expense that are included in Finance Income (Costs) of Consolidated Statements of Income, but also interest income, dividend income, interest expense that are included in Revenue and Cost respectively and cash flows related with them. (5) Assumption for Going Concern: None (6) Basis of Consolidated Financial Statements Scope of subsidiaries and equity accounted investees Subsidiaries 1) Overseas 203 2) Japan 77 Equity accounted investees (associated companies and joint ventures) 1) Overseas 186 2) Japan 48 A total of 486 subsidiaries and equity accounted investees are excluded from the above. These include companies which are sub-consolidated or accounted for under the equity method by subsidiaries other than trading subsidiaries. (7) Changes in Accounting Policies and Changes in Accounting Estimates 1) Changes in Accounting Policies Significant accounting policies applied in the Consolidated Financial Statements for the year ended March 31, 2021 are the same as those applied in the Consolidated Financial Statements of the previous fiscal year except for the following. The companies applied the following new standards to the Consolidated Financial Statements from April 1, 2020. IFRS Title Summaries IFRS 3 Business Combinations (amended in October 2018) Amendment of definition of a business Impacts from the application of IFRS 3 "Business Combinations" amended in October 2018 on the Consolidated Financial Statements are immaterial. 2) Changes in Accounting Estimates The significant changes in accounting estimates in the Consolidated Financial Statements for the year ended March 31, 2021 are as follows. (Impairment losses for the Moatize mine business and Nacala Corridor rail & port infrastructure business in Mozambique) Mitsui & Co. Mozambique Coal Finance Limited, Mitsui & Co. Nacala Infrastructure Finance Limited and Mitsui & Co. Nacala Infrastructure Investment B.V., which lends to Mozambique coal business, or lend to and invest in Mozambique rail & port infrastructure business, recognized full impairment to the carrying amount for both investment and loans of 73,599 million as a loss allowance for doubtful debt, a loss on loans measured at FVTPL, an impairment loss included in share of profit (loss) of investments accounted for using the equity method and an impairment loss for investments accounted for using the equity method, due to the decrease of our production assumptions based on the revision of the production plan and the decline in the coal prices which are based on several third parties mid-long term forecasts. In the Consolidated Statements of Income, a loss allowance is recorded by 44,823 million (Mineral & Metal Resources 35,858 million, Machinery & Infrastructure 8,965 million) in Selling, general and administrative expenses, a loss on loans measured at FVTPL is recorded by 21,657 million (Mineral & Metal Resources 17,326 million, Machinery & Infrastructure 4,331 million) in Other income (expense) -net, an impairment loss included in share of profit (loss) of investments accounted for using the equity method is recorded by 4,727 million (Mineral & Metal Resources 3,782 million, Machinery & Infrastructure 945 million) in Share of Profit (Loss) of Investments Accounted for Using the Equity Methodand an impairment loss for investments accounted for using the equity method is recorded by 2,392 million (Mineral & Metal Resources 1,914 million, Machinery & Infrastructure 478 million) in Gain (loss) on securities and other investments-net, respectively. (Loss related to selling the entire interest in Caserones copper mine business) Mitsui & Co., Ltd. and its subsidiary, Mitsui Bussan Copper Investment & Co., Ltd., in Mineral & Metal Resources segment which invests and lends to Caserones copper mine business, recognized a loss of 7,215 million, with the conclusion and the completion of the basic agreement to sell the entire interest as a part of reorganization and reconstructing of asset portfolio. In the Consolidated Statements of Income, a loss allowance for the related lending and others is recorded by 8,308 million in Selling, general and administrative expenses and a loss for the related investments accounted for using the equity method is recorded by 888 million in Gain (loss) on securities and other investments - net, and the profit of the realized foreign currency translation adjustment on disposal of foreign operations and others is recorded by 1,981 million in Gain (loss) on securities and other investments - net, respectively. (Impairment loss for the oil development business) Mitsui E&P Italia A S.r.l., a subsidiary in the Energy Segment engaged in the onshore oil development in the Basilicata region in Italy, recognized an impairment loss of 23,351 million in Impairment reversal (loss) of fixed assets - net in the Consolidated Statements of Income, of which impairment loss of property, plant and equipment is 16,169 million and impairment loss of goodwill is 7,182 million, by reducing the carrying amount of the goodwill and production equipment and others to the recoverable amount of 158,206 million. The impairment loss was mainly related to a decline in the crude oil price. The recoverable amount above represented the value in use. The discount rate used to calculate the value in use is deemed to reflect the market average profit margin and the risks inherent to the cash-generating unit. (Impairment loss for the locomotive leasing business in Europe) Mitsui Rail Capital Europe B.V., a subsidiary in the Machinery & Infrastructure Segment engaged in the locomotive leasing business in Europe, recognized an impairment loss of 9,300 million in Impairment reversal (loss) of fixed assets - net in the Consolidated Statements of Income by reducing the carrying amount of the locomotives, goodwill and others to the recoverable amount of 79,651 million. Out of the impairment loss, the amount of property, plant and equipment is 5,138 million, and the amount of goodwill and others is 4,162 million. The impairment loss was mainly related to a lower operating ratio of the locomotives. The recoverable amount of property, plant and equipment represented the value in use and the fair value less costs of disposal, and the recoverable amount of goodwill and others represented the value in use. The discount rate used to calculate the value in use is deemed to reflect the market average profit margin and the risks inherent to the cash-generating unit. The fair value less costs of disposal is based on the reasonable price considering the recent sale cases of the asset being valued, and the fair value is classified as level 3. (Loss related to the passenger rail franchise business in the United Kingdom(UK)) The passenger rail franchise business in the UK in the Machinery & Infrastructure Segment, which is invested and financed by the Company and its equity method investee, has been in continuous discussions regarding early termination of the franchise agreements under effect of the COVID-19 pandemic, and finally has received the final valuation of termination payments by the UK Department for Transport(DfT). The Company recognized a loss to the carrying amount for investments, loans, future loan contribution obligations of 11,013 million as a loss allowance for doubtful debt, a provision for loss on guarantees, an impairment loss included in share of profit (loss) of investments accounted for using the equity method and additional losses included in share of profit (loss) of investments accounted for using the equity method for future loan contribution obligations, based on the final valuation of termination payments presented by the DfT and the status of discussions to date. In the Consolidated Statements of Income, a loss allowance for doubtful debt is recorded by 4,902 million in Selling, general and administrative expenses, a provision for loss on guarantees is recorded by 1,457 million in Other income(expenses)-net, an impairment loss and additional losses included in share of profit (loss) of investments accounted for using the equity method is recorded by 4,654 million in Share of Profit(Loss) of Investments Accounted for Using the Equity Method, respectively. (Recognition of deferred tax assets in the U.S. energy subsidiaries) The Company transferred and reorganized investment subsidiaries in U.S. oil and gas project business to MBK Energy Holdings USA Inc. (MEH) on November 30, 2020 for the centralization of management of the oil and gas projects in the U.S. Due to this reorganization, the Company recognized deferred tax assets mainly relating to tax losses in MEHs subsidiaries to be realized against future taxable income generated primarily from long-term service agreements of U.S. LNG project, and gain of 39,030 million has been recognized in Income Taxes on the Consolidated Statement of Income for the year ended March 31, 2021. (Change in estimate for asset retirement obligations) Mitsui E&P Australia Pty Ltd, a subsidiary in the Energy Segment, has changed its estimate of the asset retirement obligations as the decommissioning costs associated with Enfield project based on new information on the decommissioning costs from the operator. The increase of 7,654 million in asset retirement obligations due to this change in estimate has been recorded in "Other income(expense)-net" in the Consolidated Statements of Income because the depreciation of fixed assets has been completed. (8) Changes in Presentation Consolidated Statements of Cash Flows Repayments of lease liabilities, which was included in Net change in long-term debt for the year ended March 31, 2020 is separately presented from the year ended March 31, 2021 in order to indicate the calculation of Core Operating Cash Flow whose formula has been altered from the year ended March 31, 2021. Consolidated Statements of Cash Flows for the year ended March 31, 2020 is reclassified to conform to this change in presentation. As a result, the amount of 27,536 million for the year ended March 31, 2020, which was presented in Net change in long-term debt within Cash Flows from Financing Activities in the Consolidated Statements of Cash Flows for the year ended March 31, 2020 has been reclassified and presented as 88,397 million for Net change in long-term debt and as (60,861) million for Repayments of lease liabilities. Consolidated Statements of Changes in Equity Compensation costs related to stock options and share performance-linked restricted stock are integrated in Compensation costs related to share-based payment from the year ended March 31, 2021. Compensation costs related to the share-based compensation plan for employees introduced in the year ended March 31, 2021 is also included in this account. As a result, in Consolidated Statements of Changes in Equity for the year ended March 31, 2020, the capital surplus of 23 million for Compensation costs related to stock options, the common stock of 294 million and the capital surplus of 294 million for Compensation costs related to share performance-linked restricted stock have been reclassified and presented as the common stock of 294 million and the capital surplus of 317 million for Compensation costs related to share-based payment. (9) Notes to Consolidated Financial Statements Segment Information Year ended March 31, 2021 (from April 1, 2020 to March 31, 2021) (Millions of Yen) Iron & Steel Products Mineral & Metal Resources Energy Machinery & Infrastructure Chemicals Lifestyle Innovation & Corporate Development Total Others/ Adjustments and Eliminations Consolidated Total Revenue 436,579 1,396,902 838,598 792,200 1,933,795 2,373,082 236,120 8,007,276 2,959 8,010,235 Gross Profit 21,184 251,150 62,887 107,729 124,904 133,782 107,001 808,637 2,828 811,465 Share of Profit (Loss) of Investments Accounted for Using the Equity Method 4,309 70,390 18,820 95,268 11,304 13,445 13,883 227,419 491 227,910 Profit for the Year Attributable to Owners of the Parent 2,119 179,917 27,161 45,935 43,520 12,724 50,161 361,537 (26,079) 335,458 Core Operating Cash Flow 2,030 308,146 123,156 78,700 62,513 19,776 55,147 649,468 8,670 658,138 Total Assets at March 31, 2021 566,020 2,566,491 2,566,305 2,291,278 1,345,469 2,009,315 1,191,842 12,536,720 (20,875) 12,515,845 Year ended March 31, 2020 (from April 1, 2019 to March 31, 2020) (As restated) (Millions of Yen) Iron & Steel Products Mineral & Metal Resources Energy Machinery & Infrastructure Chemicals Lifestyle Innovation & Corporate Development Total Others/ Adjustments and Eliminations Consolidated Total Revenue 492,291 1,173,163 893,647 1,065,065 2,171,610 2,495,813 185,921 8,477,510 6,620 8,484,130 Gross Profit 24,554 225,966 141,123 134,596 116,757 134,924 60,099 838,019 1,404 839,423 Share of Profit (Loss) of Investments Accounted for Using the Equity Method 13,121 59,152 45,211 88,372 11,540 34,996 16,984 269,376 (144) 269,232 Profit for the Year Attributable to Owners of the Parent 4,749 183,273 57,835 89,356 22,332 32,034 14,568 404,147 (12,634) 391,513 Core Operating Cash Flow 2,153 243,716 206,459 86,841 35,841 20,494 3,916 599,420 (38,389) 561,031 Total Assets at March 31, 2020 539,599 1,921,883 2,566,282 2,360,321 1,217,737 1,907,621 1,198,286 11,711,729 94,563 11,806,292 Notes:1. Others / Adjustments and Eliminations includes of the Corporate Staff Unit which provides financing services and operations services to the companies and affiliated companies. Total assets of Others / Adjustments and Eliminations at March 31, 2020 and March 31, 2021 includes cash, cash equivalents and time deposits related to financing activities, and assets of the Corporate Staff Unit and certain subsidiaries related to the above services amounting to 7,142,647 million and 7,202,925 million, respectively. 2. Transfers between reportable segments are made at cost plus a markup. 3. Profit for the Period Attributable to Owners of the parent of Others /Adjustments and Eliminations includes income and expense items that are not allocated to specific reportable segments, and eliminations of intersegment transactions. 4. Total assets of Others / Adjustments and Eliminations at March 31, 2020 and March 31, 2021 includes elimination of receivables and payables between segments amounting to 7,048,084 million and 7,223,800 million, respectively. 5. Formerly, Core Operating Cash Flow was calculated by eliminating the sum of the Changes in Operating Assets and Liabilities from Cash Flows from Operating Activities as presented in the Consolidated Statements of Cash Flows. During the year ended March 31 2021, it is calculated by additionally deducting the Repayments of lease liabilities as presented in the Cash Flows from Financing Activities. In accordance with this change, Core Operating Cash Flow for the year ended March 31, 2020 has been restated. 6. In order to accelerate our multifaceted, flexible initiatives that combine various kinds of knowledge from different business domains, a part of business of next-generation electric power was transferred from the Machinery & Infrastructure segment to the Energy segment, in conjunction with the creation of the Energy Solutions Business Unit in Energy segment, during the year ended March 31 2021. In accordance with this change, the segment information for the year ended March 31, 2020 has been restated to conform to the current and previous fiscal year. 7.As described in the Note in Consolidated Statements of Income, the Company has reconsidered the presentation of revenue from certain transactions, and has presented revenues based on the results of the reconsideration for the current and previous fiscal year. Earnings per share The following is a reconciliation of basic earnings per share attributable to owners of the parent to diluted earnings per share attributable to owners of the parent for the years ended March 31, 2021 and 2020: Year ended March 31, 2021(from April 1, 2020 to March 31, 2021) Profit (numerator) Shares (denominator) Per share amount Millions of Yen In Thousands Yen Basic Earnings per Share Attributable to Owners of the Parent: Profit for the Year Attributable to Owners of the Parent 335,458 1,683,338 199.28 Effect of Dilutive Securities: Adjustments of effect of: Dilutive securities of associated companies (1) Stock options 836 Diluted Earnings per Share Attributable to Owners of the Parent: Profit for the Year Attributable to Owners of the Parent after effect of dilutive securities 335,457 1,684,174 199.18 Year ended March 31, 2020(from April 1, 2019 to March 31, 2020) Profit (numerator) Shares (denominator) Per share amount Millions of Yen In Thousands Yen Basic Earnings per Share Attributable to Owners of the Parent: Profit for the Year Attributable to Owners of the Parent 391,513 1,731,384 226.13 Effect of Dilutive Securities: Adjustments of effect of: Dilutive securities of associated companies (22) Stock options 1,046 Diluted Earnings per Share Attributable to Owners of the Parent: Profit for the Year Attributable to Owners of the Parent after effect of dilutive securities 391,491 1,732,430 225.98 Subsequent Events Stock Repurchase At the meeting of the Board of Directors held on April 30, 2021, the Company resolved to repurchase its stock in accordance with Article 156 of the Companies Act of Japan, as applied pursuant to paragraph 3 of Article 165 of the Companies Act of Japan. Details of the repurchase are as follows. 1. Purpose of stock repurchase To enhance shareholder return and to improve capital efficiency 2. Details of repurchase (1) Class of share Common stock of the Company (2) Total number of shares of common stock to be repurchased Up to 30 million shares1.8% of the total number of shares outstanding excluding treasury stock (3) Total amount Up to 50,000 million (4) Period From May 6, 2021 to June 23, 2021 (5) Repurchase method Auction market on Tokyo Stock Exchange The Fire Incident of Intercontinental Terminals Company LLC On March 17, 2019 (US time) a fire began at the Deer Park tank terminal of Intercontinental Terminals Company LLC (ITC), a wholly owned U.S. subsidiary of Mitsui & Co., Ltd. The Deer Park tank terminal is located in the outskirts of Houston, Texas. The fire partially damaged tanks owned by ITC. ITC has resumed its operation after discussions with related authorities. Harris County Fire Marshal's Office released its final report with respect to the fire incident on December 6, 2019 (US time) and the report classified the fire as accidental, while not specifying the cause of the fire. The cause of the fire is still under investigation by other relevant authorities. The profit and loss related to this incident recognized in the year ended March 31, 2020 and 2021, and the outstanding balance of related provision as of March 31, 2021 are immaterial. There are multiple lawsuits that have been brought against ITC in relation to this incident. These lawsuits are at the early stages and the ultimate outcome of these lawsuits is not expected to have significant impact on our consolidated financial position, operating results and cash flow. Taxation on capital gain in India Earlyguard Limited (EG), a UK subsidiary of Mitsui & Co., Ltd., received a tax payment notice dated January 21, 2020 which requested payment of 24.0 billion Indian Rupees (36.0 billion) from Indian tax authority. The taxable income of this notice is the capital gain on sales of Finsider International Company Limited (a UK company that owned 51% of Sesa Goa, an Indian iron ore company) shares held by EG in April 2007. Although EG treated the capital gain properly according to the tax laws at that time, the tax payment notice has been issued. On February 17, 2021, EG commenced arbitration under the UK-India bilateral investment treaty in order to dispute this tax payment notice. The company does not expect a significant impact on our consolidated financial position, operating results and cash flow at this stage.
Answer: | Consolidated Financial Results for the Year Ended March 31, 2021 [IFRS] | TOKYO--(BUSINESS WIRE)-- This announcement is for our U.S.$5,000,000,000 Euro Medium Term Note Programme. Mitsui & Co., Ltd. announced its consolidated financial results for the year ended March 31, 2021, based on International Financial Reporting Standards (IFRS). Mitsui & Co., Ltd. and subsidiaries (Web Site : https://www.mitsui.com/jp/en/) President and Chief Executive Officer : Kenichi Hori Investor Relations Contacts : Masaya Inamuro, Investor Relations Division TEL 81-3-3285-1111 1. Consolidated financial results (1) Consolidated operating results information for the year ended March 31, 2021 (from April 1, 2020 to March 31, 2021) Years ended March 31, 2021 2020 % % Revenue Millions of yen 8,010,235 (5.6) 8,484,130 (5.3) Profit before income taxes Millions of yen 450,202 (15.7) 534,320 (8.6) Profit for the year Millions of yen 350,381 (14.8) 411,312 (4.7) Profit for the year attributable to owners of the parent Millions of yen 335,458 (14.3) 391,513 (5.5) Comprehensive income for the year Millions of yen 996,046 (261,856) Earnings per share attributable to owners of the parent, basic Yen 199.28 226.13 Earnings per share attributable to owners of the parent, diluted Yen 199.18 225.98 Profit ratio to equity attributable to owners of the parent % 8.0 9.7 Profit before income taxes to total assets % 3.7 4.5 Note: 1. Percentage figures for Revenue, Profit before income taxes, Profit for the year, Profit for the year attributable to owners of the parent, and Comprehensive income for the year represent changes from the previous year. 2. Share of profit (loss) of investments accounted for using the equity method for the years ended March 31, 2021 and 2020 were 227,910 million and 269,232 million, respectively. 3. As described in the Note in Consolidated Statements of Income, the Company has reconsidered the presentation of revenue from certain transactions, and has restated revenues for the previous fiscal year. (2) Consolidated financial position information March 31, 2021 March 31, 2020 Total assets Millions of yen 12,515,845 11,806,292 Total equity Millions of yen 4,822,887 4,060,932 Total equity attributable to owners of the parent Millions of yen 4,570,420 3,817,677 Equity attributable to owners of the parent ratio % 36.5 32.3 Equity per share attributable to owners of the parent Yen 2,739.28 2,235.83 (3) Consolidated cash flow information Years ended March 31, 2021 2020 Operating activities Millions of yen 772,696 526,376 Investing activities Millions of yen (322,474) (185,230) Financing activities Millions of yen (486,963) (204,561) Cash and cash equivalents at the end of the year Millions of yen 1,063,150 1,058,733 2. Dividend information Years ended March 31, Year ending March 31, 2022 (Forecast) 2021 2020 Interim dividend per share Yen 40 40 45 Year-end dividend per share Yen 45 40 45 Annual dividend per share Yen 85 80 90 Annual dividend (total) Millions of yen 142,589 137,848 Consolidated dividend payout ratio % 42.7 35.4 32.4 Consolidated dividend on equity attributable to owners of the parent % 3.4 3.4 Note: The amount of Annual dividend includes 331 million of dividend for the shares related to the share-based compensation plan for employees. 3. Forecast of consolidated operating results for the year ending March 31, 2022 (from April 1, 2021 to March 31, 2022) Year ending March 31, 2022 Profit attributable to owners of the parent Millions of yen 460,000 Earnings per share attributable to owners of the parent, basic Yen 277.49 4. Others (1) Increase/decrease of important subsidiaries during the period : None (2) Changes in accounting policies and accounting estimate : () Changes in accounting policies required by IFRS Yes () Other changes None () Changes in accounting estimates Yes Note: For further details please refer to p.28 5. Consolidated Financial Statements (7) Changes in Accounting Policies and Changes in Accounting Estimates. (3) Number of shares: March 31, 2021 March 31, 2020 Number of shares of common stock issued, including treasury stock 1,717,104,808 1,742,684,906 Number of shares of treasury stock 48,628,466 35,184,567 Year ended March 31, 2021 Year ended March 31, 2020 Average number of shares of common stock outstanding 1,683,338,251 1,731,383,943 This earnings report is not subject to audit. A Cautionary Note on Forward-Looking Statements: This report contains forward-looking statements including those concerning future performance of Mitsui & Co., Ltd. (Mitsui), and those statements are based on Mitsuis current assumptions, expectations and beliefs in light of the information currently possessed by it. Various factors may cause Mitsuis actual results to be materially different from any future performance expressed or implied by these forward-looking statements. Therefore, these statements do not constitute a guarantee by Mitsui that such future performance will be realized. For key assumptions on which the statements concerning future performance are based, please refer to (2)Forecasts for the Year Ending March 31, 2022 on p.16. For cautionary notes with respect to forward-looking statements, please refer to the Notice section on p.20. Supplementary materials and IR meetings on financial results: Supplementary materials on financial results can be found on our web site. We will hold an IR meeting on financial results for analysts and institutional investors on May 7, 2021. Contents of the meeting (English and Japanese) will be posted on our web site immediately after the meeting. Table of Contents 1. Qualitative Information (1) Operating Environment 2 (2) Results of Operations 3 (3) Financial Condition and Cash Flows 11 2. Management Policies (1) Progress with the Medium-term Management Plan 16 (2) Forecasts for the Year Ending March 31, 2022 16 (3) Profit Distribution Policy 19 3. Basic Approach on Adoption of Accounting Standards 19 4. Other Information 20 5. Consolidated Financial Statements (1) Consolidated Statements of Financial Position 21 (2) Consolidated Statements of Income and Comprehensive Income 23 (3) Consolidated Statements of Changes in Equity 25 (4) Consolidated Statements of Cash Flows 26 (5) Assumption for Going Concern 27 (6) Basis of Consolidated Financial Statements 27 (7) Changes in Accounting Policies and Changes in Accounting Estimates 28 (8) Changes in Presentation 30 (9) Notes to Consolidated Financial Statements 31 1. Qualitative Information As of the date of disclosure of this earnings report, the audit procedures for consolidated financial statements have not been completed. As used in this report, "Mitsui" and the "Company" refer to Mitsui & Co., Ltd. (Mitsui Bussan Kabushiki Kaisha), and "we", "us", "our" and the "companies" are used to indicate Mitsui & Co., Ltd. and its subsidiaries, unless otherwise indicated. (1) Operating Environment In the year ended March 31, 2021, the global economy declined rapidly and significantly at the beginning of the fiscal year due to widespread restraints on economic activities, which included curfew in many countries due to the global spread of COVID-19. However, the overall economy subsequently rebounded as economic activities resumed intermittently depending on the spread of infection, and major economies such as the U.S. provided large-scale support for households and businesses and implemented financial measures. In the U.S., the economic recovery trend is expected to strengthen due to large-scale economic measures by the new Biden administration and increasing vaccinations. In Europe, there are concerns that the economic recovery may be delayed as restraints on activities continue due to the resurgence in infections and the slowing pace of vaccinations in major countries other than the UK. In Japan, despite the recovery in exports, there are concerns about the resurgence of COVID-19 cases and the impact of reduced automobile production due to a global shortage of semiconductors. As a result, a full-fledged recovery is not expected until after the summer when more vaccinations are available. In China, in addition to an increase in exports, investment and consumer spending are recovering and the economic growth rate is expected to exceed the rate prior to the COVID-19 outbreak. In Russia and Brazil, although exports and consumer spending continue to recover, Brazil remains unable to stop the spread of infection and there are concerns that this will hinder the economic recovery. The global economic recovery is expected to be boosted by additional economic measures in major countries as well as by widespread availability of vaccinations. China, which controlled the spread of infection during the early stage, is already on a recovery path, and the U.S., which is expanding large-scale financial measures, is expected to return to the level before the COVID-19 outbreak in the first half of the year. Then, Japan is expected to return to the pre-COVID-19 level by the end of the year and Europe by next year. (2) Results of Operations 1) Analysis of Consolidated Income Statements (Billions of Yen) Current Year Previous Year (As restated) Change Revenue 8,010.2 8,484.1 (473.9) Gross Profit 811.5 839.4 (27.9) Selling, general and administrative expenses (606.4) (584.9) (21.5) Other Income (Expenses) Gain (Loss) on Securities and Other InvestmentsNet 7.9 25.1 (17.2) Impairment Reversal (Loss) of Fixed AssetsNet (52.9) (110.8) +57.9 Gain (Loss) on Disposal or Sales of Fixed AssetsNet 4.6 9.5 (4.9) Other Income (Expense)Net (13.9) 38.5 (52.4) Finance Income (Costs) Interest Income 19.9 41.4 (21.5) Dividend Income 103.7 96.5 +7.2 Interest Expense (51.9) (89.6) +37.7 Share of Profit (Loss) of Investments Accounted for Using the Equity Method 227.9 269.2 (41.3) Income Taxes (99.8) (123.0) +23.2 Profit for the Year 350.4 411.3 (60.9) Profit for the Year Attributable to Owners of the Parent 335.5 391.5 (56.0) * May not match with the total of items due to rounding off. The same shall apply hereafter. Revenue Revenue for the year ended March 31, 2021 (current year) was 8,010.2 billion, a decrease of 473.9 billion from the year ended March 31, 2020 (previous year). * We have presented the "revenue" and corresponding "cost" of certain transactions in gross amounts beginning with the current fiscal year. Those amounts for the previous fiscal year have also been restated to conform to the presentation in the current fiscal year. This restatement has no impact on gross profit, profit for the year attributable to owners of the parent, or total equity attributable to owners of the parent. For further details please refer to 5. Consolidated Financial Statements (2) Consolidated Statements of Income and Comprehensive Income. Gross Profit Mainly the Energy Segment, the Machinery & Infrastructure Segment, the Lifestyle Segment recorded a decrease, while the Innovation & Corporate Development Segment, Mineral & Metal Resources Segment and the Chemicals Segment recorded an increase. Selling, general and administrative expenses Mainly the Lifestyle Segment and the Machinery & Infrastructure Segment recorded a decline, while a cost increasing factor was recorded in the Machinery & Infrastructure Segments. On the other hand, the Mineral & Metal Resources Segment recorded increasing factors. The table provides a breakdown of selling, general and administrative expenses. Billions of Yen Current Year Previous Year Change Personnel (296.9) (298.8) +1.9 Welfare (9.2) (10.4) +1.2 Travel (7.0) (27.5) +20.5 Entertainment (1.7) (6.1) +4.4 Communication (46.4) (44.1) (2.3) Rent (8.7) (9.3) +0.6 Depreciation (36.7) (41.9) +5.2 Fees and Taxes (12.4) (13.3) +0.9 Loss Allowance (80.6) (31.3) (49.3) Others (106.8) (102.2) (4.6) Total (606.4) (584.9) (21.5) Other Income (Expenses) Gain (Loss) on Securities and Other InvestmentsNet For the current year, a gain on securities was recorded in the Machinery & Infrastructure Segment, while an impairment loss was recorded in the Mineral & Metal Resources Segment and the Machinery & Infrastructure Segment. For the previous year, a gain on securities was recorded in the Machinery & Infrastructure Segment, the Lifestyle Segment and the Innovation & Corporate Development Segment. Impairment Reversal (Loss) of Fixed AssetsNet For the current year, mainly the Energy Segment and the Machinery & Infrastructure Segment recorded an impairment loss on fixed assets, while the Innovation & Corporate Development Segment recorded an impairment reversal. For the previous year, impairment losses on fixed assets were recorded in the Energy Segment, the Lifestyle Segment and the Machinery & Infrastructure Segment. Other Income (Expense)Net For the current year, the impairment loss on loans in the Mineral & Metal Resources Segment and Machinery & Infrastructure Segment, the foreign exchange related loss in the Mineral & Metal Resources Segment, and the cost related to asset retirement obligation in the Energy Segment were recorded while insurance proceeds were recorded in the business in North America in the Chemicals Segment. For the previous year, the Chemicals Segment recorded insurance proceeds in the business in North America, the Innovation & Corporate Development Segment recorded a valuation profit on a derivative in relation to a put option of an investment, and the Machinery & Infrastructure Segment recorded insurance proceeds. Furthermore, a gain on the sales of property management business was recorded in the Lifestyle Segment. Finance Income (Costs) Dividend Income Mainly the Mineral & Metal Resources Segment recorded an increase, while the Energy Segment recorded a decrease. Share of Profit (Loss) of Investments Accounted for Using the Equity Method Mainly the Energy Segment, the Lifestyle Segment and the Iron & Steel Products Segment recorded a decrease, while the Mineral & Metal Resources Segment and the Machinery & Infrastructure Segment recorded an increase. Income Taxes Income taxes for the current year were 99.8 billion, a reduction of 23.2 billion from 123.0 billion for the previous year. For the current year, 39.0 billion profit was recorded through the deferred tax assets recognitions due to the reorganization of the U.S. subsidiaries in the Energy Segment. The effective tax rate for the current year was 22.2%, a decrease of 0.8 points from 23.0% for the previous year. Although there was an increase in tax effective rate due to an impairment loss not recognizable for deferred tax in the Mineral & Metal Resources Segment, there was a decrease in tax effective rate due to a deferred tax assets recognition in the Energy Segment and reversal of deferred tax liabilities on equity accounted investments due to dividends from those investees. Considering these items, the tax effective rate was lower than the previous year. Profit for the Year Attributable to Owners of the Parent Profit for the year attributable to owners of the parent was 335.5 billion, a decrease of 56.0 billion from the previous year. For the impact of COVID-19 pandemic, please refer "3) Impact of COVID-19 pandemic". 2) Operating Results by Operating Segment A part of next-generation electric power business was transferred from the Machinery & Infrastructure Segment to Energy Segment effective April 1, 2020. In accordance with the aforementioned changes, the operating segment information for the previous year has been restated to conform to the current year's presentation. Iron & Steel Products Segment (Billions of Yen) Current Year Previous Year Change Profit for the year attributable to owners of the parent 2.1 4.7 (2.6) Gross profit 21.2 24.6 (3.4) Profit (loss) of equity method investments 4.3 13.1 (8.8) Dividend income 1.4 1.9 (0.5) Selling, general and administrative expenses (22.0) (27.2) +5.2 Others (2.8) (7.7) +4.9 Profit (loss) of equity method investments decreased mainly due to the following factor: - For the current year, Gestamp companies reported a decrease of 9.1 billion mainly due to the lower operating time caused by lower automotive production, the impact of foreign exchange fluctuations, and one-time cost related to the structural transformation. Mineral & Metal Resources Segment (Billions of Yen) Current Year Previous Year Change Profit for the year attributable to owners of the parent 179.9 183.3 (3.4) Gross profit 251.2 226.0 +25.2 Profit (loss) of equity method investments 70.4 59.2 +11.2 Dividend income 59.8 25.2 +34.6 Selling, general and administrative expenses (72.3) (41.6) (30.7) Others (129.2) (85.5) (43.7) Gross profit increased mainly due to the following factors: - Iron ore mining operations in Australia recorded an increase of 54.3 billion mainly due to higher sales prices. - Coal mining operations in Australia recorded a decrease of 30.2 billion mainly due to lower sales prices. Profit (loss) of equity method investments increased mainly due to the following factors: - Iron ore mining operations in Australia recorded an increase of 10.8 billion mainly due to higher sales prices. - Compaa Minera Doa Ins de Collahuasi SCM, a copper mining company in Chile, recorded an increase of 6.1 billion mainly due to higher sales prices and sales volume. - Coal mining operations in Australia recorded a decrease of profit mainly due to lower sales prices. - Following the revisions to our various assumptions, impairment losses of 3.8 billion for the current year, and 5.1 billion for the previous year were recorded for the Nacala Corridor rail & port infrastructure business in Mozambique. Dividend income increased mainly due to higher dividends from Vale S.A. and iron ore mining operations in Australia. Selling, general and administrative expenses increased mainly due to the following factors: - Following the revisions to our various assumptions, impairment losses of 35.9 billion for the current year and 9.8 billion for the previous year for doubtful debts were recorded regarding the Moatize mine business and Nacala Corridor rail & port infrastructure business in Mozambique. - For the current year, an impairment loss of 8.3 billion for doubtful debt was recorded, based on the conclusion of share transfer agreement for the SCM Minera Lumina Copper Chile, the project company for the Caserones Copper Mine. In addition to the above, the following factors also affected results: - Following the revisions to our various assumptions, impairment losses of 19.2 billion for the current year and 2.8 billion for the previous year were recorded regarding the Moatize mine business and Nacala Corridor rail & port infrastructure business in Mozambique. - Coal mining operations in Australia recorded a decrease of 6.7 billion due to foreign exchange related losses. - Iron ore mining operations in Australia recorded a decrease of 6.0 billion due to foreign exchange related losses. Energy Segment (Billions of Yen) Current Year Previous Year Change Profit for the year attributable to owners of the parent 27.2 57.8 (30.6) Gross profit 62.9 141.1 (78.2) Profit (loss) of equity method investments 18.8 45.2 (26.4) Dividend income 25.1 52.7 (27.6) Selling, general and administrative expenses (47.2) (44.5) (2.7) Others (32.4) (136.7) +104.3 Gross profit decreased mainly due to the following factors: - Mitsui Oil Exploration Co., Ltd. recorded a decrease of 54.6 billion mainly due to decline in production, and lower oil and gas prices. - Business division at the Headquarters recorded a decrease mainly due to impact of hurricane in LNG trading business. - Mitsui E&P Italia A S.r.l recorded a decrease of 8.4 billion mainly due to an increase in cost. - MEP Texas Holdings LLC recorded a decrease of 4.9 billion mainly due to lower oil and gas prices. - Mitsui E&P USA LLC recorded a decrease of 4.3 billion mainly due to lower oil and gas prices. - AWE recorded an increase of 4.8 billion due to decrease of depreciation cost. Profit (loss) of equity method investment decreased mainly due to the following factors: - Japan Australia LNG(MIMI) Pty. Ltd recorded a decrease mainly due to lower oil and gas prices. - Mitsui E&P Mozambique Area 1 Limited recorded a decrease of 11.8 billion mainly due to the recognition of deferred tax assets in accordance with the Final Investment Decision for the project in the previous year. - Japan Arctic LNG recorded a decrease of 10.1 billion mainly due to valuation loss on changes in oil price, foreign exchange and others. - Mitsui & Co. LNG Investment USA, Inc. recorded an increase of 9.2 billion due to the commencement of commercial production in all three trains at the Cameron LNG Project. Dividends from six LNG projects (Sakhalin II, Qatargas 1, Abu Dhabi, Oman, Qatargas 3 and Equatorial Guinea) were 24.3 billion in total, a decrease of 25.9 billion from the previous year. In addition to the above, the following factors also affected results: - For the current year, profit of 39.0 billion was recorded due to recognition of deferred tax assets in accordance with transferring and reorganizing the U.S. energy subsidiaries to MBK Energy Holdings USA Inc. - For the current year, mainly due to lower oil price, Mitsui E&P Italia A S.r.l recorded an impairment loss of 23.4 billion for its Tempa Rossa project while impairment loss of 13.9 billion was recorded for the same project in the previous year. - For the current year, Mitsui E&P Australia recorded an impairment loss of 17.3 billion mainly for its Meridian project mainly due to the update of production profile, Toro/Ragnar and Libra exploration projects due to changes in the future development plan, while impairment loss of 31.2 billion was recorded for Greater Enfield project in the previous year. - For the current year, Mitsui E&P Australia recorded a cost of 7.7 billion due to a revision of asset retirement obligation. - For the previous year, MEP Texas Holdings recorded an impairment loss of 23.4 billion for its Eagle Ford shale oil and gas business. - For the previous year, a subsidiary of Mitsui Oil Exploration Co., Ltd. recorded an impairment loss of 4.3 billion for its offshore project in the Gulf of Mexico. Machinery & Infrastructure Segment (Billions of Yen) Current Year Previous Year Change Profit for the year attributable to owners of the parent 45.9 89.4 (43.5) Gross profit 107.7 134.6 (26.9) Profit (loss) of equity method investments 95.3 88.4 +6.9 Dividend income 3.9 5.1 (1.2) Selling, general and administrative expenses (132.9) (133.4) +0.5 Others (28.1) (5.3) (22.8) Gross profit decreased mainly due to the following factor: - For the current year, the subsidiaries in relation to the railways, construction & industrial machinery, and automobile business recorded a decrease due to the effect of the COVID-19 pandemic. Profit (loss) of equity method investments increased mainly due to the following factors: - A gain was recorded at an automobile company in Canada due to good sales results. - A gain was recorded at a construction & mining machinery company in Australia due to good sales results. - Mitsui & Co. LNG Investment USA, Inc. recorded an increase of 4.0 billion due to the commencement of commercial production in all three trains at the Cameron LNG Project. - FPSO/FSO leasing companies recorded an increase of 3.8 billion due to the absence of refinancing and other costs in the previous year. - Offshore supporting vessels business was improved due to the absence of impairment of assets in the previous year. - For the current year, a portion of impairment loss of 4.7 billion for equity investments was recorded following current estimates, based on status to date, and the final valuation of termination payments for early termination of the franchise agreements in relation to passenger rail business with the Department of Transport, UK (The current estimate in the passenger rail franchise business in the UK). - Investments in gas distribution companies in Brazil recorded a decrease of 4.6 billion because of the depreciation of the Brazilian Real and tariff reduction as prior year adjustment for the current year, while the refund of service tax payments through arbitrations led to a transient increase in the previous year. - Following the revisions to our various assumptions, impairment losses of 0.9 billion for the current year, and 1.3 billion for the previous year were recorded for the Nacala Corridor rail & port infrastructure business in Mozambique. Selling, general and administrative expenses decreased, while there was the following increase factors: - Following the revisions to our various assumptions, impairment losses of 9.0 billion for the current year and 2.4 billion for the previous year for doubtful debts were recorded regarding the Moatize mine business and Nacala Corridor rail & port infrastructure business in Mozambique. - For the current year, a loss allowance for doubtful debt of 4.9 billion was recorded based on the current estimate in the passenger rail franchise business in the UK. In addition to the above, the following factors also affected results: - For the current year, 9.3 billion impairment loss was recorded in the rolling stock leasing business. - Following the revisions to our various assumptions, impairment losses of 4.8 billion for the current year and 0.7 billion for the previous year were recorded regarding the Moatize mine business and Nacala Corridor rail & port infrastructure business in Mozambique. - For the previous year, Mitsui Bussan Aerospace Co., Ltd. reported an other income and expense of 4.0 billion mainly due to insurance proceeds. - For the current year, a provision for loss on guarantee of 1.5 billion was recorded based on the current estimate in the passenger rail franchise business in the UK. - Gains on sale of the IPP business in North America were recorded both in the current and previous year. - For the previous year, the overseas railway business recorded an impairment loss of fixed asset. Chemicals Segment (Billions of Yen) Current Year Previous Year Change Profit for the year attributable to owners of the parent 43.5 22.3 +21.2 Gross profit 124.9 116.8 +8.1 Profit (loss) of equity method investments 11.3 11.5 (0.2) Dividend income 3.0 2.7 +0.3 Selling, general and administrative expenses (95.5) (101.9) +6.4 Others (0.2) (6.8) +6.6 Gross profit increased mainly due to the following factor: - An increase of 3.1 billion was recorded due to price increase and cost reduction of main products in Novus International, Inc. In addition to the above, the following factor also affected results: - Insurance proceeds were recorded in the business in North America both for the current and previous year. Lifestyle Segment (Billions of Yen) Current Year Previous Year Change Profit for the year attributable to owners of the parent 12.7 32.0 (19.3) Gross profit 133.8 134.9 (1.1) Profit (loss) of equity method investments 13.4 35.0 (21.6) Dividend income 5.6 4.2 +1.4 Selling, general and administrative expenses (129.4) (139.3) +9.9 Others (10.7) (2.8) (7.9) Gross profit decreased mainly due to the following factors: - For the current year, subsidiaries, whose businesses are fashion, food and distribution, recorded a decrease of profit due to the closure of stores and lower demand for commercial ingredients for the food service industry caused by the state of emergency and curfew. - For the current year, reclassification from a consolidated subsidiary for the fashion & textile businesses in Asia to an equity method investee caused a 4.8 billion decrease. - Drug development in the life science and healthcare fund invested through MBK Pharma Partnering Inc recorded a 3.8 billion gain mainly from the valuation of fair value for the current year due to the progress on drug development, and a 2.4 billion loss mainly due to the suspension of drug development for the previous year. - For the current year, United Grain Corporation of Oregon which runs an origination and merchandising of grain business in the U.S. West Coast recorded an increase of 5.0 billion mainly due to strong wheat and soybean sales. - For the current year, PRIFOODS CO., LTD. which runs a production, processing and sales of broilers recorded an increase of 3.2 billion mainly due to an increase in sales volume with stay-at-homes orders. Profit (loss) of equity method investment decreased mainly due to the following factors: - For the current year, equity method investees, whose businesses are food, fashion, and services, recorded a decrease of profit due to curfew and self-restraint. - For the current year, IHH Healthcare Berhad recorded a decrease of 3.4 billion mainly because of decline in operation rate due to lower demand for medical tourism and from patients with minor illnesses caused by the effect of the COVID-19 pandemic, and impairment of goodwill over subsidiary in India. - For the previous year, International Columbia U.S. LLC divested Columbia Asia Healthcare Pte. Ltd and a capital gain of 13.0 billion from this transaction was recorded. Selling, general and administrative expenses decreased mainly due to the following factor: - For the current year, reclassification from a consolidated subsidiary for the fashion & textile businesses in Asia to an equity method investee caused a 4.3 billion decrease. In addition to the above, the following factors also affected results: - For the previous year, there was a 12.5 billion decline in tax burden in relation to income taxes recognized as other comprehensive income corresponding to sales of financial assets measured at FVTOCI, including the share of Recruit Holdings Co., Ltd. - For the previous year, a capital gain from the sales of Sogo Medical Holdings Co., Ltd. and the reversal of deferred tax liability for the retained earnings, totaling 8.7 billion, were recorded. - For the previous year, Mitsui & Co. Foresight recorded a gain on the sales of the property management business. - For the previous year, a capital gain from the partial sale of RareJob, Inc. was recorded. - For the previous year, an impairment loss on fixed assets of 14.0 billion was recorded due to a decline of the fair value of its farmland and others mainly caused by a depreciation of the Brazilian real against the U.S. dollar in XINGU AGRI AG conducting a production business of agricultural products in Brazil. - For the previous year, an impairment loss of fixed assets of 6.8 billion was recorded mainly due to a partially poor business performance in Accountable Healthcare Holdings Corporation, which conducts healthcare staffing in the U.S. Innovation & Corporate Development Segment (Billions of Yen) Current Year Previous Year Change Profit for the year attributable to owners of the parent 50.2 14.6 +35.6 Gross profit 107.0 60.1 +46.9 Profit (loss) of equity method investments 13.9 17.0 (3.1) Dividend income 3.8 3.3 +0.5 Selling, general and administrative expenses (63.7) (64.5) +0.8 Others (10.8) (1.3) (9.5) Gross profit increased mainly due to the following factors: - For the current year, a 13.1 billion gain on the sales was recorded at a holding company as a result of sales of its entire shareholding in OSIsoft LLC. - For the previous year, 6.5 billion loss was recorded due to the valuation of fair value on shares in Hutchison China MediTech Ltd., while for the current year, 5.6 billion gain was recorded due to the valuation and sales of the shares. - For the current year, an increase of 5.1 billion was recorded mainly due to good results of energy trading in Mitsui Bussan Commodities Ltd. - For the current year, an increase of 5.0 billion was recorded mainly due to good results of precious metal trading at a business division at the Headquarters. - For the previous year, MGI Global Fund L.P. recorded 1.0 billion loss for the valuation of shares, while for the current year, it recorded 2.8 billion gain for the valuation and sales of shares mainly associated with the IPO of QD Laser, Inc. - For the current year, a gain of 3.3 billion in the valuation of fair value was recorded associated with the IPO of shares held through G2VP, LLC. - An increase of 2.7 billion was caused from the combined effect of the loss on the valuation and sales of the shares in Mercari, Inc. recognized for the previous year, and the profit on the sales of it's entire shareholding for the current year. In addition to the above, the following factors also affected results: - For the current year, 4.3 billion of reversal of impairment loss on land was recorded. - For the previous year, a gain on the sales of equity stake in real estate business in Singapore was recorded. - For the previous year, a valuation profit on the derivative of 4.4 billion was recorded in relation to a put option on an investment. 3) Impact of COVID-19 pandemic For the current year, the Machinery & Infrastructure Segment, which suffered from lower demand in the passenger rail franchise business and locomotive leasing business, and the Iron & Steel Products Segment, which suffered from lower plant utilization rates, recorded a decrease of profit due to the COVID-19 pandemic and lockdown or travel bans in various regions and countries. Also, the Lifestyle Segment recorded a decrease of profit due to lower demand for commercial ingredients for the food service industry and fashion-related products amid a continuing trend in many countries to refrain from unnecessary going out, as well as a decline in occupancy rates in the hospital business due to a decrease in medical tourism and patients with minor illnesses. Additionally, the Energy Segment recorded a decrease of profit due to lower oil and gas prices caused by lower demand mainly for transportation fuels. On the other hand, the Innovation & Corporate Development Segment recorded an increase of profits due to FVTPL gain in relation to the stock market recovered mainly by economic support measures in each country, in addition to the steady capture of demands related to stay-at-home orders and IT infrastructure in the digital security business and in the TV shopping business. Also, the automobile-related business in the Machinery & Infrastructure Segment, recorded an increase of profit as a result of the recovery of demand in the second half of the current year, mainly in North America, amid a shift in the means of transportation from public transportation to private cars. As mentioned above, there were some factors that contributed to the improvement in our results, but the impact of the decrease in profit due to factors that worsened our results was significant, thus our results were lower than the previous year due to the COVID-19 pandemic. (3) Financial Condition and Cash Flows 1) Financial Condition (Billions of yen) March 31, 2021 March 31, 2020 Change Total Assets 12,515.8 11,806.3 +709.5 Current Assets 4,207.5 4,124.4 +83.1 Non-current Assets 8,308.4 7,681.9 +626.5 Current Liabilities 2,701.7 2,701.1 +0.6 Non-current Liabilities 4,991.2 5,044.3 (53.1) Net Interest-bearing Debt 3,299.8 3,486.7 (186.9) Total Equity Attributable to Owners of the Parent 4,570.4 3,817.7 +752.7 Net Debt-to-Equity Ratio (times) 0.72 0.91 (0.19) Assets Current Assets: Cash and cash equivalents increased by 4.5 billion. Trade and other receivables increased by 189.5 billion, mainly due to following factors: - An increase in trade receivable by 147.3 billion due to favorable market conditions for the Mineral & Metal Resources Segment, and an increase in trading volume in the Energy Segment, and due to both favorable market conditions and the increase in trading volume in the Chemicals Segment; and - An increase of 49.8 billion in current portion of long-term receivables of Mineral & Metal Resources Segment, mainly due to reclassification to current maturities. Other financial assets declined by 132.9 billion, mainly due to market volatility and decreases in trading volume of derivative trading in the Energy Segment and the Innovation & Corporate Development Segment. Inventories increased by 61.3 billion, mainly due to favorable market condition and increases in trading volume in the Mineral & Metal Resources Segment, the Energy Segment and the Lifestyle Segment. Non-current Assets: Investments accounted for using the equity method increased by 163.0 billion, mainly due to the following factors: - An increase of 108.7 billion resulting from foreign currency exchange fluctuations; - An increase of 36.3 billion due to an investment in Mitsui E&P Mozambique Area 1 Limited, which participates in the Mozambique LNG Project; - An increase of 227.9 billion corresponding to the profit of equity method investments for the current year, despite a decline of 194.8 billion due to dividends from equity accounted investees; - An increase due to an investment in Japan Arctic LNG B.V., which participates in the Arctic LNG 2 Project in Russia; - An increase of 10.5 billion due to an investment in Caitan S.p.A, which participate in desalination and conveyance projects for BHP Spence copper mine in Chile; and - A decline in equity method investment in Mitsui & Co. Cameron LNG Investment LLC as result of conversion of equity method investment into shareholder loans by 25.9 billion. Other investments increased by 471.2 billion, mainly due to the following factor: - As a result of higher share prices, fair value on financial assets measured at FVTOCI increased by 472.8 billion. Trade and other receivables declined by 116.4 billion, mainly due to the following factors: - An impairment of 66.9 billion for doubtful debt regarding the Moatize mine business and Nacala Corridor rail & port infrastructure businesses in Mozambique; - A decline of 49.8 billion in current portion of long-term receivables of Mineral & Metal Resources Segment, mainly due to reclassification to current maturities; and - An increase in receivable balance from Mitsui & Co. Cameron LNG Investment LLC as result of conversion of equity method investment into shareholder loans by 25.9 billion. Property, plant and equipment increased by 53.7 billion, mainly due to the following factors: - An increase of 94.3 billion (including foreign exchange translation profit of 77.4 billion) at iron ore mining operations in Australia; - An increase of 31.5 billion (including foreign exchange translation profit of 16.8 billion) at coal mining operations in Australia; and - A decline of 74.3 billion (including foreign exchange translation profit of 19.0 billion) at the oil and gas projects (*), mainly due to impairment losses at Mitsui E&P Italia A S.r.l and Mitsui E&P Australia. (*) including the U.S. shale gas and oil projects from the current year. Investment property increased by 23.0 billion, mainly due to an increase in the Innovation & Corporate Development Segment. Deferred tax assets increased by 53.2 billion, mainly due to following factors: - Recognition of deferred tax assets by 39.0 billion in accordance with transferring and reorganizing the U.S. energy subsidiaries to MBK Energy Holdings USA Inc.; and - Recognition of deferred tax assets related to losses from valuation of fixed assets and impact of exchange rate at Mitsui E&P Australia were main reasons for increase by 19.2 billion. Liabilities Current Liabilities: Short-term debt increased by 3.0 billion. Furthermore, the current portion of long-term debt increased by 51.0 billion, mainly due to a reclassification to current maturities. Trade and other payables increased by 176.8 billion, corresponding to the increase in trade and other receivables. Other financial liabilities declined by 255.7 billion, mainly due to corresponding decline in other financial assets and payments on account payable at the integrated development project in the 2, Otemachi 1-Chome District. Non-current Liabilities: Long-term debt, less the current portion, declined by 233.9 billion. Provisions increased by 33.2 billion mainly due to increase in asset retirement obligations in Mitsui E&P Australia and Mitsui Coal Holdings. Total Equity Attributable to Owners of the Parent Retained earnings increased by 185.5 billion. Other components of equity increased by 597.7 billion, mainly due to the following factors: - Financial assets measured at FVTOCI increased by 359.7 billion; and - Foreign currency translation adjustments increased by 258.9 billion, mainly reflecting the appreciation of the Australian dollar, and the U.S. dollar against the Japanese Yen, even though the Brazilian real has depreciated. Treasury stock which is a subtraction item in shareholders' equity increased by 24.4 billion, mainly due to the shares buy-back for 71.3 billion(including a buy-back for share-based compensation plan for employees of 6.9 billion), despite cancellation of the stock for 46.7 billion. 2) Cash Flows (Billions of yen) Current Year Previous Year Change Cash flows from operating activities 772.7 526.4 +246.3 Cash flows from investing activities (322.5) (185.2) (137.3) Free cash flow 450.2 341.2 +109.0 Cash flows from financing activities (487.0) (204.6) (282.4) Effect of exchange rate changes on cash and cash equivalents etc. 41.2 (34.0) +75.2 Change in cash and cash equivalents 4.4 102.6 (98.2) Cash Flows from Operating Activities (Billions of Yen) Current Year Previous Year Change Cash flows from operating activities a 772.7 526.4 +246.3 Cash flows from change in working capital b 56.2 (95.5) +151.7 Repayments of lease liabilities c (58.4) (60.9) +2.5 Core operating cash flow a-b+c 658.1 561.0 +97.1 Net cash from an increase or a decrease in working capital, or changes in operating assets and liabilities for the current year was 56.2 billion of net cash inflow. Repayments of lease liabilities for the current year was 58.4 billion of cash outflow. Core operating cash flow, which equaled cash flows from operating activities without both cash flows from changes in working capital and repayments of lease liabilities, for the current year amounted to 658.1 billion. From the current year, in order to reflect a regular cash generation output from operating activities more appropriately, repayments of lease liabilities have been deducted. In conformity with this change, core operating cash flow for the previous year has been restated. - Net cash inflow from dividend income, including dividends received from equity accounted investees, for the current year totaled 307.8 billion, an increase of 8.6 billion from 299.2 billion for the previous year; and - Depreciation and amortization for the current year was 273.6 billion, an increase of 17.5 billion from 256.1 billion for the previous year. The following table shows core operating cash flow by operating segment. (Billions of Yen) Current Year Previous Year Change Iron & Steel Products 2.0 2.2 (0.2) Mineral & Metal Resources 308.1 243.7 +64.4 Energy 123.2 206.5 (83.3) Machinery & Infrastructure 78.7 86.8 (8.1) Chemicals 62.5 35.8 +26.7 Lifestyle 19.8 20.5 (0.7) Innovation & Corporate Development 55.1 3.9 +51.2 All Other and Adjustments and Eliminations 8.7 (38.4) +47.1 Consolidated Total 658.1 561.0 +97.1 Cash Flows from Investing Activities Net cash outflows that corresponded to investments in equity accounted investees (net of sales of investments in equity accounted investees) were 56.5 billion, mainly due to the following factors: - An investment in Mitsui E&P Mozambique Area 1 Limited, which participates in the Mozambique LNG Project, for 36.3 billion; - An investment in Japan Arctic LNG B.V, which participates in the Arctic LNG 2 Project in Russia; - An investment in Caitan S.p.A, which participates in desalination and conveyance projects for BHP Spence copper mine in Chile, for 10.5 billion; and - A sale of the IPP business in North America. Net cash inflows that corresponded to other investments (net of sales and maturities of other investments) were 9.5 billion, mainly due to the following factors: - A sale of investment in San-ei Sucrochemical Co., Ltd., for 13.5 billion; and - Investments in power generating businesses for 10.9 billion. Net cash inflows that corresponded to increase in loan receivable (net of collections of loan receivable) were 14.2 billion, despite of execution of loan to Japan Arctic LNG B.V. Net cash outflows that corresponded to purchases of property, plant, and equipment (net of sales of those assets) were 206.4 billion, mainly due to the following factors: - An expenditure for iron ore mining operations in Australia for 39.3 billion; - An expenditure for the oil and gas projects for 37.0 billion; - An expenditure for the integrated development project in the 2, Otemachi 1-Chome District for 36.9 billion; - An expenditure for coal mining operations in Australia for 19.6 billion; and - An expenditure for power generating businesses for 18.2 billion. Net cash outflows that corresponded to purchases of investment property (net of sales of those assets) were 53.1 billion, mainly due to an expenditure for the integrated development project in the 2, Otemachi 1-Chome District for 37.8 billion. Cash Flows from Financing Activities Net cash outflows from net change in short-term debt were 26.5 billion, net cash outflows from net change in long-term debt were 177.0 billion, and cash outflow from repayments of lease liabilities were 58.4 billion. The cash outflow from the purchases of treasury stock was 71.3 billion (including a buy-back for share-based compensation plan for employees of 6.9 billion). The cash outflow from payments of cash dividends was 135.5 billion. The cash outflow from transactions with non-controlling interest shareholders was 18.2 billion, mainly due to an additional acquisition of a stake in Collahuasi copper mine in Chile. 2. Management Policies (1) Progress with the Medium-term Management Plan Reference is made to our Presentation Material of Financial Results for the year ended March 31, 2021 "Review of Medium-term Management Plan 2023 and plan for FY Ending March 2022" on our web site. Reference is also made to "Medium-term Management Plan 2023 Transform and Grow" released on May 1, 2020. (2) Forecasts for the Year Ending March 31, 2022 1) Forecasts for the year ending March 31, 2022 [Assumption] Forecast Result Exchange rate (JPY/USD) 105.00 105.94 Crude oil (JCC) $61/bbl $43/bbl Consolidated oil price $59/bbl $46/bbl (Billions of yen) March 31, 2022 Forecast March 31, 2021 Result Change Description Gross profit 820.0 811.5 +8.5 Selling, general and administrative expenses (590.0) (606.4) +16.4 Reversal effects of impairment losses Gain (loss) on investments, fixed assets and other 0 (54.4) +54.4 Reversal effects of impairment losses Interest expenses (30.0) (32.1) +2.1 Dividend income 120.0 103.7 +16.3 Mineral & Metal Resources Segment Energy Segment Profit (loss) of equity method investments 280.0 227.9 +52.1 Machinery & Infrastructure Segment Lifestyle Segment Iron & Steel Products Segment Profit before income taxes 600.0 450.2 +149.8 Income taxes (130.0) (99.8) (30.2) Non-controlling interests (10.0) (14.9) +4.9 Profit for the year attributable to owners of the parent 460.0 335.5 +124.5 Depreciation and amortization 300.0 273.6 +26.4 Core operating cash flow 680.0 658.1 +21.9 The forecast for the fiscal year ending March 31, 2022 is based on the assumption that the global economy will head for recovery, although there are disparities among countries and regions. Business performance is expected to rebound due to absence of the impairment losses recorded in the year ended March 31, 2021 in the Mineral & Metal Resources Segment, the Machinery & Infrastructure Segment and the Energy Segment. In addition, it is also expected that there will be a recovery in the Iron & Steel Products Segment and the Lifestyle Segment, which experienced a decline in demand and capacity utilization due to the COVID-19 pandemic. We assume foreign exchange rates for the year ending March 31, 2022 will be 105/US$, 80/AU$ and 19/BRL, while average foreign exchange rates for the year ended March 31, 2021 were 105.94/US$, 76.71/AU$ and 19.46/BRL. Also, we assume the annual average consolidated oil price applicable to our financial results for the year ending March 31, 2022 will be US$59/barrel, up US$13/barrel from the previous year, based on the assumption that the crude oil price (JCC) will average US$61/barrel throughout the year ending March 31, 2022. The forecast for profit for the year attributable to owners of the parent by operating segment compared to the previous year is as follows: (Billions of yen) Year ending March 31, 2022 Year ended March 31, 2021 Change Description Iron & Steel Products 10.0 2.1 +7.9 Reversal effects of COVID-19 impact Mineral & Metal Resources 260.0 179.9 +80.1 Reversal effects of impairment losses Energy 50.0 27.2 +22.8 Higher oil and gas price Reversal effects of impairment losses Machinery & Infrastructure 80.0 45.9 +34.1 Reversal effects of COVID-19 impact Chemicals 40.0 43.5 (3.5) Lifestyle 20.0 12.7 +7.3 Reversal effects of COVID-19 impact Innovation & Corporate Development 30.0 50.2 (20.2) Reversal effects of FVTPL profit Others / Adjustments and Eliminations (30.0) (26.0) (4.0) Consolidated Total 460.0 335.5 +124.5 The forecast for core operating cash flow by operating segment compared to the previous year is as follows: (Billions of yen) Year ending March 31, 2022 Year ended March 31, 2021 Change Description Iron & Steel Products 5.0 2.0 +3.0 Mineral & Metal Resources 290.0 308.1 (18.1) AUD appreciation, tax payment Energy 170.0 123.2 +46.8 Higher oil and gas price Machinery & Infrastructure 100.0 78.7 +21.3 Reversal effects of COVID-19 impact Chemicals 55.0 62.5 (7.5) Lifestyle 30.0 19.8 +10.2 Reversal effects of COVID-19 impact Innovation & Corporate Development 30.0 55.1 (25.1) Reversal effects of FVTPL profit Others / Adjustments and Eliminations 0.0 8.7 (8.7) Consolidated Total 680.0 658.1 +21.9 2) Key commodity prices and other parameters for the year ending March 31, 2022 The table below shows assumptions for key commodity prices and foreign exchange rates for the forecast for the year ending March 31, 2022. The effects of movements on each commodity price and foreign exchange rates on profit for the year attributable to owners of the parent are included in the table. Impact on profit for the year attributable to owners of the parent for the year ending March 31, 2022 March 2022 Assumption March 2021 Result Commodity Crude Oil/JCC - 61 43 Consolidated Oil Price (*1) 2.5 bn (US$1/bbl) 59 46 U.S. Natural Gas (*2) 1.1 bn (US$0.1/mmBtu) 2.74 2.13 (*3) Iron Ore (*4) 2.2 bn (US$1/ton) (*5) 128 (*6) Coal Coking 0.4 bn (US$1/ton) (*5) 119 (*7) Thermal 0.1 bn (US$1/ton) (*5) 69 (*7) Copper (*8) 0.7 bn (US$100/ton) 7,650 6,169 (*9) Forex (*10) USD 2.6 bn (1/USD) 105.00 105.94 AUD 2.4 bn (1/AUD) 80.00 76.71 BRL 0.2 bn (1/BRL) 19.00 19.46 (*1) As the crude oil price affects our consolidated results with a 0-6 month time lag, the effect of crude oil prices on consolidated results is estimated as the Consolidated Oil Price, which reflects this lag. For the year ending March 2022, we have assumed that there is a 4-6 month lag for approx. 35%, a 1-3 month lag for approx. 60%, and no lag for approx. 5%. The above sensitivities show annual impact of changes in consolidated oil price. (*2) As Mitsui has very limited exposure to U.S. natural gas sold at Henry Hub (HH), the above sensitivities show annual impact of changes in the weighted average sale price. (*3) U.S. gas figures for the year ended March 2021 are the Henry Hub Natural Gas Futures average daily prompt month closing prices traded on NYMEX during January to December 2020. (*4) The effect of dividend income from Vale S.A. has not been included. (*5) Iron ore and coal price assumptions are not disclosed. (*6) Iron ore results figures for the year ended March 2021 are the daily average (reference price) spot indicated price (Fe 62% CFR North China) recorded in several industry trade magazines from April 2020 to March 2021. (*7) Coal results figures for the year ended March 2021 are the quarterly average prices of representative coal brands in Japan (US$/MT). (*8) As the copper price affects our consolidated results with a 3-month time lag, the above sensitivities show the annual impact of US$100/ton change in averages of the LME monthly average cash settlement prices for the period March to December 2021. (*9) Copper results figures for the year ended March 2021 are the averages of the LME monthly average cash settlement prices for the period January to December 2020. (*10) Impact of currency fluctuations on reported profit for the year of overseas subsidiaries and equity accounted investees denominated in their respective functional currencies and the impact of dividend received from major foreign investees. Depreciation of the yen has the effect of increasing profit for the year through the conversion of profit (denominated in functional currencies) into yen. In the overseas subsidiaries and equity accounted investees where the sales contract is in USD, the impact of currency fluctuations between the USD and the functional currencies (AUD and BRL) and the impact of currency hedging are not included. (3) Profit Distribution Policy Our profit distribution policy is as follows: In order to increase corporate value and maximize shareholder value, we seek to maintain an optimal balance between (a) meeting investment demand in our core and growth areas through re-investments of our retained earnings, and (b) directly providing returns to shareholders by paying out cash dividends. In addition to the above, share buy-backs aimed at improving capital efficiency should be decided in a prompt and flexible manner as needed concerning buy-back timing and amount by taking into consideration the business environment such as, future investment activity trends, free cash flow and interest-bearing debt levels, and return on equity. For the current year, we conducted a buy-back program of 71.3 billion yen (including for share-based compensation plan for employees of 6.9 billion). On April 27, 2021, we announced that we completed the buy-back program announced on February 24, 2021, and we had purchased 24.6 billion yen from April 1 to April 26, 2021. Furthermore, on April 30, 2021, we announced a new buy-back program up to 50.0 billion of our own shares from May 6, 2021 to June 23, 2021. For details, please refer to the "Notification of Stock Repurchase" on our website. The annual dividend for the year ended March 31, 2021 will be 85 per share (including an interim dividend of 40 per share, an increase of 5 from the previous year), an upward revision of 5 from the previous forecast, taking into consideration the core operating cash flow and net income (attributable to owners of the parent) in the consolidated financial results, as well as the stability and continuity of dividend payments. Under the Medium-term management plan announced on May 1, 2020, the minimum annual dividend per share was set at 80 based on the level of core operating cash flow, which was judged to be stable and sustainable. Considering the improvement of cash flow generation ability, we decided to upwardly revise the minimum annual by dividend 10 per share, setting the minimum at 90 per share. . In addition, we will continue to flexibly and strategically allocate funds for investment in growth and additional shareholder returns (additional dividends and share buybacks) according to the business performance during the Medium-term business plan period. For the fiscal year ending March 31, 2022, we plan to pay an annual dividend of 90 per share (an increase of 5 from the previous fiscal year) . 3. Basic Approach on Adoption of Accounting Standards International Financial Reporting Standards was adopted on our annual securities report under the Financial Instruments and Exchange Act for the year ended March 31, 2014 for the purpose of improving international comparability of financial information as well as enhancement and efficiency of our financial reporting. 4. Other Information Notice: This flash report contains forward-looking statements about Mitsui and its consolidated subsidiaries. These forward-looking statements are based on Mitsuis current assumptions, expectations and beliefs in light of the information currently possessed by it and involve known and unknown risks, uncertainties and other factors. Such risks, uncertainties and other factors may cause Mitsuis actual consolidated financial position, consolidated operating results or consolidated cash flows to be materially different from any future consolidated financial position, consolidated operating results or consolidated cash flows expressed or implied by these forward-looking statements. These important risks, uncertainties and other factors include, among others, (1) risk of COVID-19, (2) business investment risks, (3) country risks, (4) risks regarding climate changes, (5) commodity market risks, (6) foreign currency risks, (7) stock price risks of listed stock Mitsui and its subsidiaries hold, (8) credit risks, (9) risks regarding fund procurement, (10) operational risks, (11) risks regarding employees compliance with laws, regulations, and internal policies, (12) risks regarding information systems and information securities, (13) risks relating to natural disasters, terrorists and violent groups. For further information on the above, please refer to Mitsuis Annual Securities Report. Forward-looking statements may be included in Mitsuis Annual Securities Report and Quarterly Securities Reports or in its other disclosure documents, press releases or website disclosures. Mitsui undertakes no obligation to publicly update or revise any forward-looking statements. 5. Consolidated Financial Statements (1) Consolidated Statements of Financial Position (Millions of Yen) Assets March 31, 2021 March 31, 2020 Current Assets: Cash and cash equivalents 1,063,150 1,058,733 Trade and other receivables 1,811,990 1,622,501 Other financial assets 429,986 562,899 Inventories 615,155 553,861 Advance payments to suppliers 143,714 167,250 Other current assets 143,477 159,175 Total current assets 4,207,472 4,124,419 Non-current Assets: Investments accounted for using the equity method 3,044,001 2,880,958 Other investments 1,955,607 1,484,422 Trade and other receivables 305,952 422,423 Other financial assets 141,848 186,010 Property, plant and equipment 2,175,072 2,121,371 Investment property 274,847 251,838 Intangible assets 188,555 195,289 Deferred tax assets 112,055 58,908 Other non-current assets 110,436 80,654 Total non-current assets 8,308,373 7,681,873 Total 12,515,845 11,806,292 (Millions of Yen) Liabilities and Equity March 31, 2021 March 31, 2020 Current Liabilities: Short-term debt 300,485 297,458 Current portion of long-term debt 450,941 399,904 Trade and other payables 1,313,341 1,136,504 Other financial liabilities 371,298 626,963 Income tax payables 58,915 46,206 Advances from customers 123,806 133,247 Provisions 36,909 25,844 Other current liabilities 46,027 34,984 Total current liabilities 2,701,722 2,701,110 Non-current Liabilities: Long-term debt, less current portion 3,995,311 4,229,218 Other financial liabilities 116,531 105,279 Retirement benefit liabilities 40,253 39,956 Provisions 261,365 228,173 Deferred tax liabilities 550,776 412,971 Other non-current liabilities 27,000 28,653 Total non-current liabilities 4,991,236 5,044,250 Total liabilities 7,692,958 7,745,360 Equity: Common stock 342,080 341,776 Capital surplus 396,238 402,652 Retained earnings 3,547,789 3,362,297 Other components of equity 373,786 (223,910) Treasury stock (89,473) (65,138) Total equity attributable to owners of the parent 4,570,420 3,817,677 Non-controlling interests 252,467 243,255 Total equity 4,822,887 4,060,932 Total 12,515,845 11,806,292 (2) Consolidated Statements of Income and Comprehensive Income Consolidated Statements of Income (Millions of Yen) Year ended March 31, 2021 Year ended March 31, 2020 (As restated) Revenue: 8,010,235 8,484,130 Cost: (7,198,770) (7,644,707) Gross Profit 811,465 839,423 Other Income (Expenses): Selling, general and administrative expenses (606,423) (584,885) Gain (loss) on securities and other investments-net 7,888 25,060 Impairment reversal (loss) of fixed assets-net (52,923) (110,809) Gain (loss) on disposal or sales of fixed assets-net 4,646 9,510 Other income (expense)-net (13,945) 38,528 Total other income (expenses) (660,757) (622,596) Finance Income (Costs): Interest income 19,877 41,373 Dividend income 103,655 96,526 Interest expense (51,948) (89,638) Total finance income (costs) 71,584 48,261 Share of Profit (Loss) of Investments Accounted for Using the Equity Method 227,910 269,232 Profit before Income Taxes 450,202 534,320 Income Taxes (99,821) (123,008) Profit for the Year 350,381 411,312 Profit for the Year Attributable to: Owners of the parent 335,458 391,513 Non-controlling interests 14,923 19,799 (Note) Considering the presentation of revenue in the consolidated statement of income in more detail in accordance with IFRS 15 "Revenue from Contracts with Customers", the Company has presented the "revenue" and corresponding "cost" of certain transactions in gross amounts beginning with the current fiscal year. Those amounts for the previous fiscal year have also been restated to conform to the presentation in the current fiscal year. This restatement has no impact on gross profit, profit for the year attributable to owners of the parent, or total equity attributable to owners of the parent. Consolidated Statements of Comprehensive Income (Millions of Yen) Year ended March 31, 2021 Year ended March 31, 2020 Profit for the Year 350,381 411,312 Other Comprehensive Income: Items that will not be reclassified to profit or loss: Financial assets measured at FVTOCI 477,184 (376,024) Remeasurements of defined benefit pension plans 32,514 (7,007) Share of other comprehensive income of investments accounted for using the equity method 1,671 (11,239) Income tax relating to items not reclassified (119,092) 79,856 Items that may be reclassified subsequently to profit or loss: Foreign currency translation adjustments 174,725 (152,404) Cash flow hedges (831) (10,070) Share of other comprehensive income of investments accounted for using the equity method 86,445 (205,343) Income tax relating to items that may be reclassified (6,951) 9,063 Total other comprehensive income 645,665 (673,168) Comprehensive Income for the Year 996,046 (261,856) Comprehensive Income for the Year Attributable to: Owners of the parent 964,652 (259,448) Non-controlling interests 31,394 (2,408) (3) Consolidated Statements of Changes in Equity (Millions of Yen) Attributable to owners of the parent Non- controlling Interests Total Equity Common Stock Capital Surplus Retained Earnings Other Components of Equity Treasury Stock Total Balance as at April 1, 2019 341,482 387,335 3,078,655 463,270 (7,576) 4,263,166 267,142 4,530,308 Cumulative effect of changes in accounting policies (5,306) (5,306) (5,306) Balance as at April 1, 2019 after changes in accounting policies 341,482 387,335 3,073,349 463,270 (7,576) 4,257,860 267,142 4,525,002 Profit for the year 391,513 391,513 19,799 411,312 Other comprehensive income for the year (650,961) (650,961) (22,207) (673,168) Comprehensive income for the year 391,513 (650,961) (259,448) (2,408) (261,856) Transaction with owners: Dividends paid to the owners of the parent (139,071) (139,071) (139,071) Dividends paid to non-controlling interest shareholders (14,130) (14,130) Acquisition of treasury stock (58,092) (58,092) (58,092) Sales of treasury stock (167) (363) 530 0 0 Compensation costs related to share-based payment 294 317 611 611 Equity transactions with non-controlling interest shareholders 15,167 650 15,817 (7,349) 8,468 Transfer to retained earnings 36,869 (36,869) - - Balance as at March 31, 2020 341,776 402,652 3,362,297 (223,910) (65,138) 3,817,677 243,255 4,060,932 Profit for the year 335,458 335,458 14,923 350,381 Other comprehensive income for the year 629,194 629,194 16,471 645,665 Comprehensive income for the year 335,458 629,194 964,652 31,394 996,046 Transaction with owners: Dividends paid to the owners of the parent (135,476) (135,476) (135,476) Dividends paid to non-controlling interest shareholders (13,982) (13,982) Acquisition of treasury stock (71,337) (71,337) (71,337) Sales of treasury stock (125) (154) 280 1 1 Cancellation of treasury stock (46,722) 46,722 - - Compensation costs related to share-based payment 304 1,771 2,075 2,075 Equity transactions with non-controlling interest shareholders (8,060) 888 (7,172) (8,200) (15,372) Transfer to retained earnings 32,386 (32,386) - - Balance as at March 31, 2021 342,080 396,238 3,547,789 373,786 (89,473) 4,570,420 252,467 4,822,887 (4) Consolidated Statements of Cash Flows (Millions of Yen) Year ended March 31, 2021 Year ended March 31, 2020 Operating Activities: Profit for the year 350,381 411,312 Adjustments to reconcile profit for the year to cash flows from operating activities: Depreciation and amortization 273,639 256,125 Change in retirement benefit liabilities 1,884 (46,793) Loss allowance 80,640 31,170 (Gain) loss on securities and other investmentsnet (7,888) (25,060) (Gain) Loss on loans measured at FVTPL 21,657 - Impairment (reversal) loss of fixed assetsnet 52,923 110,809 (Gain) loss on disposal or sales of fixed assetsnet (4,646) (9,510) Interest income, dividend income and interest expense (98,442) (77,624) Income taxes 99,821 123,008 Share of (profit) loss of investments accounted for using the equity method (227,910) (269,232) Valuation (gain) loss related to contingent considerations and others (6,694) (6,447) Changes in operating assets and liabilities: Change in trade and other receivables (40,799) 105,425 Change in inventories (34,116) 38,159 Change in trade and other payables 139,474 (178,921) Othernet (8,381) (60,179) Interest received 52,702 72,699 Interest paid (59,904) (96,624) Dividends received 307,838 299,244 Income taxes paid (119,483) (151,185) Cash flows from operating activities 772,696 526,376 Investing Activities: Net change in time deposits (30,080) 3,823 Net change in investments in equity accounted investees (56,518) 9,101 Net change in other investments 9,462 70,749 Net change in loan receivables 14,184 746 Net change in property, plant and equipment (206,404) (253,127) Net change in investment property (53,118) (16,522) Cash flows from investing activities (322,474) (185,230) Financing Activities: Net change in short-term debt (26,527) (27,158) Net change in long-term debt (177,035) 88,397 Repayments of lease liabilities (58,380) (60,861) Purchases and sales of treasury stock (71,337) (58,092) Dividends paid (135,476) (139,071) Transactions with non-controlling interest shareholders (18,208) (7,776) Cash flows from financing activities (486,963) (204,561) Effect of Exchange Rate Changes on Cash and Cash Equivalents 41,158 (33,959) Change in Cash and Cash Equivalents 4,417 102,626 Cash and Cash Equivalents at Beginning of Year 1,058,733 956,107 Cash and Cash Equivalents at End of Year 1,063,150 1,058,733 Interest income, dividend income and interest expense, Interest received, Interest paid and Dividends received of Consolidated Statements of Cash Flows include not only interest income, dividend income and interest expense that are included in Finance Income (Costs) of Consolidated Statements of Income, but also interest income, dividend income, interest expense that are included in Revenue and Cost respectively and cash flows related with them. (5) Assumption for Going Concern: None (6) Basis of Consolidated Financial Statements Scope of subsidiaries and equity accounted investees Subsidiaries 1) Overseas 203 2) Japan 77 Equity accounted investees (associated companies and joint ventures) 1) Overseas 186 2) Japan 48 A total of 486 subsidiaries and equity accounted investees are excluded from the above. These include companies which are sub-consolidated or accounted for under the equity method by subsidiaries other than trading subsidiaries. (7) Changes in Accounting Policies and Changes in Accounting Estimates 1) Changes in Accounting Policies Significant accounting policies applied in the Consolidated Financial Statements for the year ended March 31, 2021 are the same as those applied in the Consolidated Financial Statements of the previous fiscal year except for the following. The companies applied the following new standards to the Consolidated Financial Statements from April 1, 2020. IFRS Title Summaries IFRS 3 Business Combinations (amended in October 2018) Amendment of definition of a business Impacts from the application of IFRS 3 "Business Combinations" amended in October 2018 on the Consolidated Financial Statements are immaterial. 2) Changes in Accounting Estimates The significant changes in accounting estimates in the Consolidated Financial Statements for the year ended March 31, 2021 are as follows. (Impairment losses for the Moatize mine business and Nacala Corridor rail & port infrastructure business in Mozambique) Mitsui & Co. Mozambique Coal Finance Limited, Mitsui & Co. Nacala Infrastructure Finance Limited and Mitsui & Co. Nacala Infrastructure Investment B.V., which lends to Mozambique coal business, or lend to and invest in Mozambique rail & port infrastructure business, recognized full impairment to the carrying amount for both investment and loans of 73,599 million as a loss allowance for doubtful debt, a loss on loans measured at FVTPL, an impairment loss included in share of profit (loss) of investments accounted for using the equity method and an impairment loss for investments accounted for using the equity method, due to the decrease of our production assumptions based on the revision of the production plan and the decline in the coal prices which are based on several third parties mid-long term forecasts. In the Consolidated Statements of Income, a loss allowance is recorded by 44,823 million (Mineral & Metal Resources 35,858 million, Machinery & Infrastructure 8,965 million) in Selling, general and administrative expenses, a loss on loans measured at FVTPL is recorded by 21,657 million (Mineral & Metal Resources 17,326 million, Machinery & Infrastructure 4,331 million) in Other income (expense) -net, an impairment loss included in share of profit (loss) of investments accounted for using the equity method is recorded by 4,727 million (Mineral & Metal Resources 3,782 million, Machinery & Infrastructure 945 million) in Share of Profit (Loss) of Investments Accounted for Using the Equity Methodand an impairment loss for investments accounted for using the equity method is recorded by 2,392 million (Mineral & Metal Resources 1,914 million, Machinery & Infrastructure 478 million) in Gain (loss) on securities and other investments-net, respectively. (Loss related to selling the entire interest in Caserones copper mine business) Mitsui & Co., Ltd. and its subsidiary, Mitsui Bussan Copper Investment & Co., Ltd., in Mineral & Metal Resources segment which invests and lends to Caserones copper mine business, recognized a loss of 7,215 million, with the conclusion and the completion of the basic agreement to sell the entire interest as a part of reorganization and reconstructing of asset portfolio. In the Consolidated Statements of Income, a loss allowance for the related lending and others is recorded by 8,308 million in Selling, general and administrative expenses and a loss for the related investments accounted for using the equity method is recorded by 888 million in Gain (loss) on securities and other investments - net, and the profit of the realized foreign currency translation adjustment on disposal of foreign operations and others is recorded by 1,981 million in Gain (loss) on securities and other investments - net, respectively. (Impairment loss for the oil development business) Mitsui E&P Italia A S.r.l., a subsidiary in the Energy Segment engaged in the onshore oil development in the Basilicata region in Italy, recognized an impairment loss of 23,351 million in Impairment reversal (loss) of fixed assets - net in the Consolidated Statements of Income, of which impairment loss of property, plant and equipment is 16,169 million and impairment loss of goodwill is 7,182 million, by reducing the carrying amount of the goodwill and production equipment and others to the recoverable amount of 158,206 million. The impairment loss was mainly related to a decline in the crude oil price. The recoverable amount above represented the value in use. The discount rate used to calculate the value in use is deemed to reflect the market average profit margin and the risks inherent to the cash-generating unit. (Impairment loss for the locomotive leasing business in Europe) Mitsui Rail Capital Europe B.V., a subsidiary in the Machinery & Infrastructure Segment engaged in the locomotive leasing business in Europe, recognized an impairment loss of 9,300 million in Impairment reversal (loss) of fixed assets - net in the Consolidated Statements of Income by reducing the carrying amount of the locomotives, goodwill and others to the recoverable amount of 79,651 million. Out of the impairment loss, the amount of property, plant and equipment is 5,138 million, and the amount of goodwill and others is 4,162 million. The impairment loss was mainly related to a lower operating ratio of the locomotives. The recoverable amount of property, plant and equipment represented the value in use and the fair value less costs of disposal, and the recoverable amount of goodwill and others represented the value in use. The discount rate used to calculate the value in use is deemed to reflect the market average profit margin and the risks inherent to the cash-generating unit. The fair value less costs of disposal is based on the reasonable price considering the recent sale cases of the asset being valued, and the fair value is classified as level 3. (Loss related to the passenger rail franchise business in the United Kingdom(UK)) The passenger rail franchise business in the UK in the Machinery & Infrastructure Segment, which is invested and financed by the Company and its equity method investee, has been in continuous discussions regarding early termination of the franchise agreements under effect of the COVID-19 pandemic, and finally has received the final valuation of termination payments by the UK Department for Transport(DfT). The Company recognized a loss to the carrying amount for investments, loans, future loan contribution obligations of 11,013 million as a loss allowance for doubtful debt, a provision for loss on guarantees, an impairment loss included in share of profit (loss) of investments accounted for using the equity method and additional losses included in share of profit (loss) of investments accounted for using the equity method for future loan contribution obligations, based on the final valuation of termination payments presented by the DfT and the status of discussions to date. In the Consolidated Statements of Income, a loss allowance for doubtful debt is recorded by 4,902 million in Selling, general and administrative expenses, a provision for loss on guarantees is recorded by 1,457 million in Other income(expenses)-net, an impairment loss and additional losses included in share of profit (loss) of investments accounted for using the equity method is recorded by 4,654 million in Share of Profit(Loss) of Investments Accounted for Using the Equity Method, respectively. (Recognition of deferred tax assets in the U.S. energy subsidiaries) The Company transferred and reorganized investment subsidiaries in U.S. oil and gas project business to MBK Energy Holdings USA Inc. (MEH) on November 30, 2020 for the centralization of management of the oil and gas projects in the U.S. Due to this reorganization, the Company recognized deferred tax assets mainly relating to tax losses in MEHs subsidiaries to be realized against future taxable income generated primarily from long-term service agreements of U.S. LNG project, and gain of 39,030 million has been recognized in Income Taxes on the Consolidated Statement of Income for the year ended March 31, 2021. (Change in estimate for asset retirement obligations) Mitsui E&P Australia Pty Ltd, a subsidiary in the Energy Segment, has changed its estimate of the asset retirement obligations as the decommissioning costs associated with Enfield project based on new information on the decommissioning costs from the operator. The increase of 7,654 million in asset retirement obligations due to this change in estimate has been recorded in "Other income(expense)-net" in the Consolidated Statements of Income because the depreciation of fixed assets has been completed. (8) Changes in Presentation Consolidated Statements of Cash Flows Repayments of lease liabilities, which was included in Net change in long-term debt for the year ended March 31, 2020 is separately presented from the year ended March 31, 2021 in order to indicate the calculation of Core Operating Cash Flow whose formula has been altered from the year ended March 31, 2021. Consolidated Statements of Cash Flows for the year ended March 31, 2020 is reclassified to conform to this change in presentation. As a result, the amount of 27,536 million for the year ended March 31, 2020, which was presented in Net change in long-term debt within Cash Flows from Financing Activities in the Consolidated Statements of Cash Flows for the year ended March 31, 2020 has been reclassified and presented as 88,397 million for Net change in long-term debt and as (60,861) million for Repayments of lease liabilities. Consolidated Statements of Changes in Equity Compensation costs related to stock options and share performance-linked restricted stock are integrated in Compensation costs related to share-based payment from the year ended March 31, 2021. Compensation costs related to the share-based compensation plan for employees introduced in the year ended March 31, 2021 is also included in this account. As a result, in Consolidated Statements of Changes in Equity for the year ended March 31, 2020, the capital surplus of 23 million for Compensation costs related to stock options, the common stock of 294 million and the capital surplus of 294 million for Compensation costs related to share performance-linked restricted stock have been reclassified and presented as the common stock of 294 million and the capital surplus of 317 million for Compensation costs related to share-based payment. (9) Notes to Consolidated Financial Statements Segment Information Year ended March 31, 2021 (from April 1, 2020 to March 31, 2021) (Millions of Yen) Iron & Steel Products Mineral & Metal Resources Energy Machinery & Infrastructure Chemicals Lifestyle Innovation & Corporate Development Total Others/ Adjustments and Eliminations Consolidated Total Revenue 436,579 1,396,902 838,598 792,200 1,933,795 2,373,082 236,120 8,007,276 2,959 8,010,235 Gross Profit 21,184 251,150 62,887 107,729 124,904 133,782 107,001 808,637 2,828 811,465 Share of Profit (Loss) of Investments Accounted for Using the Equity Method 4,309 70,390 18,820 95,268 11,304 13,445 13,883 227,419 491 227,910 Profit for the Year Attributable to Owners of the Parent 2,119 179,917 27,161 45,935 43,520 12,724 50,161 361,537 (26,079) 335,458 Core Operating Cash Flow 2,030 308,146 123,156 78,700 62,513 19,776 55,147 649,468 8,670 658,138 Total Assets at March 31, 2021 566,020 2,566,491 2,566,305 2,291,278 1,345,469 2,009,315 1,191,842 12,536,720 (20,875) 12,515,845 Year ended March 31, 2020 (from April 1, 2019 to March 31, 2020) (As restated) (Millions of Yen) Iron & Steel Products Mineral & Metal Resources Energy Machinery & Infrastructure Chemicals Lifestyle Innovation & Corporate Development Total Others/ Adjustments and Eliminations Consolidated Total Revenue 492,291 1,173,163 893,647 1,065,065 2,171,610 2,495,813 185,921 8,477,510 6,620 8,484,130 Gross Profit 24,554 225,966 141,123 134,596 116,757 134,924 60,099 838,019 1,404 839,423 Share of Profit (Loss) of Investments Accounted for Using the Equity Method 13,121 59,152 45,211 88,372 11,540 34,996 16,984 269,376 (144) 269,232 Profit for the Year Attributable to Owners of the Parent 4,749 183,273 57,835 89,356 22,332 32,034 14,568 404,147 (12,634) 391,513 Core Operating Cash Flow 2,153 243,716 206,459 86,841 35,841 20,494 3,916 599,420 (38,389) 561,031 Total Assets at March 31, 2020 539,599 1,921,883 2,566,282 2,360,321 1,217,737 1,907,621 1,198,286 11,711,729 94,563 11,806,292 Notes:1. Others / Adjustments and Eliminations includes of the Corporate Staff Unit which provides financing services and operations services to the companies and affiliated companies. Total assets of Others / Adjustments and Eliminations at March 31, 2020 and March 31, 2021 includes cash, cash equivalents and time deposits related to financing activities, and assets of the Corporate Staff Unit and certain subsidiaries related to the above services amounting to 7,142,647 million and 7,202,925 million, respectively. 2. Transfers between reportable segments are made at cost plus a markup. 3. Profit for the Period Attributable to Owners of the parent of Others /Adjustments and Eliminations includes income and expense items that are not allocated to specific reportable segments, and eliminations of intersegment transactions. 4. Total assets of Others / Adjustments and Eliminations at March 31, 2020 and March 31, 2021 includes elimination of receivables and payables between segments amounting to 7,048,084 million and 7,223,800 million, respectively. 5. Formerly, Core Operating Cash Flow was calculated by eliminating the sum of the Changes in Operating Assets and Liabilities from Cash Flows from Operating Activities as presented in the Consolidated Statements of Cash Flows. During the year ended March 31 2021, it is calculated by additionally deducting the Repayments of lease liabilities as presented in the Cash Flows from Financing Activities. In accordance with this change, Core Operating Cash Flow for the year ended March 31, 2020 has been restated. 6. In order to accelerate our multifaceted, flexible initiatives that combine various kinds of knowledge from different business domains, a part of business of next-generation electric power was transferred from the Machinery & Infrastructure segment to the Energy segment, in conjunction with the creation of the Energy Solutions Business Unit in Energy segment, during the year ended March 31 2021. In accordance with this change, the segment information for the year ended March 31, 2020 has been restated to conform to the current and previous fiscal year. 7.As described in the Note in Consolidated Statements of Income, the Company has reconsidered the presentation of revenue from certain transactions, and has presented revenues based on the results of the reconsideration for the current and previous fiscal year. Earnings per share The following is a reconciliation of basic earnings per share attributable to owners of the parent to diluted earnings per share attributable to owners of the parent for the years ended March 31, 2021 and 2020: Year ended March 31, 2021(from April 1, 2020 to March 31, 2021) Profit (numerator) Shares (denominator) Per share amount Millions of Yen In Thousands Yen Basic Earnings per Share Attributable to Owners of the Parent: Profit for the Year Attributable to Owners of the Parent 335,458 1,683,338 199.28 Effect of Dilutive Securities: Adjustments of effect of: Dilutive securities of associated companies (1) Stock options 836 Diluted Earnings per Share Attributable to Owners of the Parent: Profit for the Year Attributable to Owners of the Parent after effect of dilutive securities 335,457 1,684,174 199.18 Year ended March 31, 2020(from April 1, 2019 to March 31, 2020) Profit (numerator) Shares (denominator) Per share amount Millions of Yen In Thousands Yen Basic Earnings per Share Attributable to Owners of the Parent: Profit for the Year Attributable to Owners of the Parent 391,513 1,731,384 226.13 Effect of Dilutive Securities: Adjustments of effect of: Dilutive securities of associated companies (22) Stock options 1,046 Diluted Earnings per Share Attributable to Owners of the Parent: Profit for the Year Attributable to Owners of the Parent after effect of dilutive securities 391,491 1,732,430 225.98 Subsequent Events Stock Repurchase At the meeting of the Board of Directors held on April 30, 2021, the Company resolved to repurchase its stock in accordance with Article 156 of the Companies Act of Japan, as applied pursuant to paragraph 3 of Article 165 of the Companies Act of Japan. Details of the repurchase are as follows. 1. Purpose of stock repurchase To enhance shareholder return and to improve capital efficiency 2. Details of repurchase (1) Class of share Common stock of the Company (2) Total number of shares of common stock to be repurchased Up to 30 million shares1.8% of the total number of shares outstanding excluding treasury stock (3) Total amount Up to 50,000 million (4) Period From May 6, 2021 to June 23, 2021 (5) Repurchase method Auction market on Tokyo Stock Exchange The Fire Incident of Intercontinental Terminals Company LLC On March 17, 2019 (US time) a fire began at the Deer Park tank terminal of Intercontinental Terminals Company LLC (ITC), a wholly owned U.S. subsidiary of Mitsui & Co., Ltd. The Deer Park tank terminal is located in the outskirts of Houston, Texas. The fire partially damaged tanks owned by ITC. ITC has resumed its operation after discussions with related authorities. Harris County Fire Marshal's Office released its final report with respect to the fire incident on December 6, 2019 (US time) and the report classified the fire as accidental, while not specifying the cause of the fire. The cause of the fire is still under investigation by other relevant authorities. The profit and loss related to this incident recognized in the year ended March 31, 2020 and 2021, and the outstanding balance of related provision as of March 31, 2021 are immaterial. There are multiple lawsuits that have been brought against ITC in relation to this incident. These lawsuits are at the early stages and the ultimate outcome of these lawsuits is not expected to have significant impact on our consolidated financial position, operating results and cash flow. Taxation on capital gain in India Earlyguard Limited (EG), a UK subsidiary of Mitsui & Co., Ltd., received a tax payment notice dated January 21, 2020 which requested payment of 24.0 billion Indian Rupees (36.0 billion) from Indian tax authority. The taxable income of this notice is the capital gain on sales of Finsider International Company Limited (a UK company that owned 51% of Sesa Goa, an Indian iron ore company) shares held by EG in April 2007. Although EG treated the capital gain properly according to the tax laws at that time, the tax payment notice has been issued. On February 17, 2021, EG commenced arbitration under the UK-India bilateral investment treaty in order to dispute this tax payment notice. The company does not expect a significant impact on our consolidated financial position, operating results and cash flow at this stage. |
edtsum2081 | You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text.
Text: FORT COLLINS, Colo., Feb. 18, 2021 /PRNewswire/ --In response to gaps in the short-range air defense radar market, Numerica, a leader in designing and deploying best-in-class defense technology, announces the development of a new U.S.-made, 3D radar solution for Counter Unmanned Aircraft Systems (C-UAS) and other short-range defense missions introducing Spyglass Short Range Surveillance Radar. Designed to fill the need for exceptional C-UAS detection and tracking performance, Spyglass from Numerica will be available soon for a broad set of applications including facility security, border surveillance, convoy and vehicle protection, air space monitoring and more. "Spyglass was born out of our first-hand experience with gaps in the short-range radar market," Nate Knight, vice president of air and missile defense at Numerica, said. "The rapidly-growing autonomous drone threat presented an opportunity to turn our attention to building a new radar from the ground up that would leverage our decades of experience solving critical air and missile defense problems and applying our proven radar processing and tracking technologies in new ways." Spyglass will offer advantages including: Superior precision:Spyglass utilizes Ku-Band Phased Array technology to provide high-precision measurements, improving targeting and classification performance at longer ranges and providing critical time for decision making and threat mitigation. See farther + react faster: Advanced signal processing algorithms and autonomy extend the detection range of the 3D radar allowing users to see farther and faster. Close the gap: Traditional pulse-doppler radar designs leave users blind up close, Spyglass' simultaneous transmit-and-receive design ensures threats are not missed at close ranges. Deploy anywhere: With a rugged, solid-state design, low power consumption and low transmit power, Spyglass is built to be deployed anywhere needed. Any missioncovered: With embedded C2 and AI software, Spyglass is designed to enable broad-area autonomous sensor networks. Software-defined operating modes enable rapid customization to specific mission requirements. Trusted U.S. partner:Designed and manufactured in the U.S. by trusted defense partners. Spyglass is designed to detect and track small, autonomous, UAS beyond three and a half kilometers with precise measurements to support a range of mitigation techniques. With a high degree of configurability and out-of-the-box support for distributed operations, Spyglass' software-driven control capabilities will enable seamless integration into layered defense systems. "We carefully selected partners for this effort who could support the delivery and integration of Spyglass to key military customers and also leverage the best in U.S. manufacturing talent," Jeff Poore,president of Numerica, said. "We have collaborated with respected partners including Liteye Systems and NEOTech to bring to life this 3D radar solution urgently needed by the U.S. Armed Forces." Liteye Systems, a world leader and technology solutions provider and integrator of military and commercial solutions based in Centennial, Colo., will be the exclusive distributor of Spyglass for Numerica. As an industry expert, Liteye will provide seamless sales support, qualified field service and expert maintenance to ensure the best performance and experience for Spyglass end-users. In collaboration to bring Spyglass to market, both Numerica and Liteye have built a solid foundation for delivering the next generation of C-UAS solutions. "Numerica has developed an extremely advanced radar solution that comes from deep-rooted experience working withtheU.S.military since1996,"stated Kenneth Geyer, CEOofLiteye Systems. "This 3D radar is uniquely designed from the warfighter's standpoint and Liteye isexcited tobepart of thisprogram." For more information about Spyglass Short Range Surveillance Radar from Numerica, visit numerica.us/spyglass. About NumericaFounded in 1996, Numerica brings innovation to national security challenges in the areas of air and missile defense and space domain awareness. Headquartered in Fort Collins, and with a satellite office in Colorado Springs, Colo. Numerica's team of talented research scientists and engineers tackle customer's most challenging problems requiring advanced algorithm and software solutions. Numerica's state-of-the-art technologies have been deployed around the world to bring clarity and precision to real-time decision-making in the face of rapidly evolving threats. Numerica's team is currently growing, to learn more about the exciting opportunities with a career at Numerica, visit www.numerica.us. CONTACT: Kelly Wakefield [emailprotected] SOURCE Numerica Related Links https://www.numerica.us/
Answer: | Numerica announces Spyglass, a new 3D radar for C-UAS & short-range defense missions | FORT COLLINS, Colo., Feb. 18, 2021 /PRNewswire/ --In response to gaps in the short-range air defense radar market, Numerica, a leader in designing and deploying best-in-class defense technology, announces the development of a new U.S.-made, 3D radar solution for Counter Unmanned Aircraft Systems (C-UAS) and other short-range defense missions introducing Spyglass Short Range Surveillance Radar. Designed to fill the need for exceptional C-UAS detection and tracking performance, Spyglass from Numerica will be available soon for a broad set of applications including facility security, border surveillance, convoy and vehicle protection, air space monitoring and more. "Spyglass was born out of our first-hand experience with gaps in the short-range radar market," Nate Knight, vice president of air and missile defense at Numerica, said. "The rapidly-growing autonomous drone threat presented an opportunity to turn our attention to building a new radar from the ground up that would leverage our decades of experience solving critical air and missile defense problems and applying our proven radar processing and tracking technologies in new ways." Spyglass will offer advantages including: Superior precision:Spyglass utilizes Ku-Band Phased Array technology to provide high-precision measurements, improving targeting and classification performance at longer ranges and providing critical time for decision making and threat mitigation. See farther + react faster: Advanced signal processing algorithms and autonomy extend the detection range of the 3D radar allowing users to see farther and faster. Close the gap: Traditional pulse-doppler radar designs leave users blind up close, Spyglass' simultaneous transmit-and-receive design ensures threats are not missed at close ranges. Deploy anywhere: With a rugged, solid-state design, low power consumption and low transmit power, Spyglass is built to be deployed anywhere needed. Any missioncovered: With embedded C2 and AI software, Spyglass is designed to enable broad-area autonomous sensor networks. Software-defined operating modes enable rapid customization to specific mission requirements. Trusted U.S. partner:Designed and manufactured in the U.S. by trusted defense partners. Spyglass is designed to detect and track small, autonomous, UAS beyond three and a half kilometers with precise measurements to support a range of mitigation techniques. With a high degree of configurability and out-of-the-box support for distributed operations, Spyglass' software-driven control capabilities will enable seamless integration into layered defense systems. "We carefully selected partners for this effort who could support the delivery and integration of Spyglass to key military customers and also leverage the best in U.S. manufacturing talent," Jeff Poore,president of Numerica, said. "We have collaborated with respected partners including Liteye Systems and NEOTech to bring to life this 3D radar solution urgently needed by the U.S. Armed Forces." Liteye Systems, a world leader and technology solutions provider and integrator of military and commercial solutions based in Centennial, Colo., will be the exclusive distributor of Spyglass for Numerica. As an industry expert, Liteye will provide seamless sales support, qualified field service and expert maintenance to ensure the best performance and experience for Spyglass end-users. In collaboration to bring Spyglass to market, both Numerica and Liteye have built a solid foundation for delivering the next generation of C-UAS solutions. "Numerica has developed an extremely advanced radar solution that comes from deep-rooted experience working withtheU.S.military since1996,"stated Kenneth Geyer, CEOofLiteye Systems. "This 3D radar is uniquely designed from the warfighter's standpoint and Liteye isexcited tobepart of thisprogram." For more information about Spyglass Short Range Surveillance Radar from Numerica, visit numerica.us/spyglass. About NumericaFounded in 1996, Numerica brings innovation to national security challenges in the areas of air and missile defense and space domain awareness. Headquartered in Fort Collins, and with a satellite office in Colorado Springs, Colo. Numerica's team of talented research scientists and engineers tackle customer's most challenging problems requiring advanced algorithm and software solutions. Numerica's state-of-the-art technologies have been deployed around the world to bring clarity and precision to real-time decision-making in the face of rapidly evolving threats. Numerica's team is currently growing, to learn more about the exciting opportunities with a career at Numerica, visit www.numerica.us. CONTACT: Kelly Wakefield [emailprotected] SOURCE Numerica Related Links https://www.numerica.us/ |
edtsum2094 | You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text.
Text: BATON ROUGE, La., Dec. 16, 2020 /PRNewswire/ --Prescience Point Capital Management, a research-focused, catalyst-driven investment firm, today announced it has issued new research on MiMedx Group Inc. (Nasdaq: MDXG), raising the price target on the leading advanced wound care and therapeutic biologics company to $31 per share. Prescience Point is one of the company's largest shareholders, owning 9 million or approximately 6.5% of the fully-diluted common stock of MiMedx. Over the past six months, Prescience Point has conducted an in-depth analysis of MiMedx's Amniofix injectable product, which is currently in Phase 2b trials for knee osteoarthritis ("knee OA"), as well as Phase 3 trials for plantar fasciitis and Achillles tendonitis. Following the extensive analysis, which included a comprehensive review of the knee OA and osteoarthritis market, an analysis of clinical data, an analysis of competing treatment options, and conversations with dozens of physicians and patients who have used and been treated with the product, Prescience Point has concluded that Amniofix will be a game-changing treatment for knee OA and other musculoskeletal ailments, which will generate billions of dollars in annual sales for MiMedx. Prescience Point's research indicates that Amniofix is a far superior treatment for knee OA than the few FDA approved treatments now available for the 20 million people in the U.S. who suffer from this chronic and debilitating condition. Prescience Point's research also indicates that Amniofix is a highly effective treatment for a variety of other musculoskeletal ailments including plantar fasciitis, shoulder osteoarthritis, and ankle osteoarthritis. Based on the findings of its research, Prescience Point believes that the FDA will approve Amniofix for knee OA and multiple other indications beyond knee OA. Prescience Point also believes that the RMAT designation that the FDA granted to Amniofix could open the door for MiMedx to receive early approval after its Phase 2b knee OA trial, as the FDA can and often does approve fast track treatments following a successful Phase 2 trial. "Although MiMedx's share price has increased by more than 200% since we published our initial report in January 2019, its shares are still trading at just a fraction of their fair value." said Eiad Asbahi, Founder and Managing Partner of Prescience Point. "We believe that MiMedx's wound care business by itself is worth at least $8 per share. This means that investors who purchase MiMedx shares today are buying the wound care business at a substantial discount and, on top of this, are receiving Amniofix, an asset that we believe is worth multi-billions of dollars, essentially for free." To view the full research report, please click here: MiMedx Group, Inc. Raising our price target to $31 on increased optimism over MDXG's Amniofix injectable product. About Prescience Point Prescience Point Capital Management is a research-focused, catalyst-driven investment firm that seeks to earn superior risk-adjusted returns uncorrelated to the broader market. Unlike traditional investment strategies, we are unconstrained and can opportunistically invest globally, across asset classes, industry verticals and capital structures. Whether investing in misunderstood distressed assets, creating value through shareholder activism, or uncovering fraud, we seek to capitalize on opportunities that others miss or fall outside the rigid mandates of most investment firms. Our uniqueness resides in our unconventional thinking, deep research, intellectual curiosity and willingness to go against the prevailing wisdom. The firm was founded by investor Eiad Asbahi in 2009 and is headquartered in Baton Rouge, LA. Prescience Point Capital Management is a registered investment advisor with the State of Louisiana. For updates follow Prescience Point on Twitter @PresciencePoint DisclaimerTHIS RELEASE EXPRESSES SOLELY PRESCIENCE POINT CAPITAL MANAGEMENT'S OPINIONS. Use Prescience Point's research opinions at your own risk. This is not investment advice nor should it be construed as such. You should do your own research and due diligence before making any investment decisions with respect to the securities covered herein. Forward-looking statement and projections are inherently susceptible to uncertainty and involve many risks (known and unknown) that could cause actual results to differ materially from expected results. Please refer to our full disclaimer located on the last page of our research report (linked herein). Prescience Investment Group, LLC is a member of the Financial Industry Regulatory Authority, CRD number 152721. SOURCE Prescience Point Capital Management Related Links http://www.presciencepoint.com
Answer: | Prescience Point Capital Management Raises Price Target on MiMedx Group to $31 Per Share | BATON ROUGE, La., Dec. 16, 2020 /PRNewswire/ --Prescience Point Capital Management, a research-focused, catalyst-driven investment firm, today announced it has issued new research on MiMedx Group Inc. (Nasdaq: MDXG), raising the price target on the leading advanced wound care and therapeutic biologics company to $31 per share. Prescience Point is one of the company's largest shareholders, owning 9 million or approximately 6.5% of the fully-diluted common stock of MiMedx. Over the past six months, Prescience Point has conducted an in-depth analysis of MiMedx's Amniofix injectable product, which is currently in Phase 2b trials for knee osteoarthritis ("knee OA"), as well as Phase 3 trials for plantar fasciitis and Achillles tendonitis. Following the extensive analysis, which included a comprehensive review of the knee OA and osteoarthritis market, an analysis of clinical data, an analysis of competing treatment options, and conversations with dozens of physicians and patients who have used and been treated with the product, Prescience Point has concluded that Amniofix will be a game-changing treatment for knee OA and other musculoskeletal ailments, which will generate billions of dollars in annual sales for MiMedx. Prescience Point's research indicates that Amniofix is a far superior treatment for knee OA than the few FDA approved treatments now available for the 20 million people in the U.S. who suffer from this chronic and debilitating condition. Prescience Point's research also indicates that Amniofix is a highly effective treatment for a variety of other musculoskeletal ailments including plantar fasciitis, shoulder osteoarthritis, and ankle osteoarthritis. Based on the findings of its research, Prescience Point believes that the FDA will approve Amniofix for knee OA and multiple other indications beyond knee OA. Prescience Point also believes that the RMAT designation that the FDA granted to Amniofix could open the door for MiMedx to receive early approval after its Phase 2b knee OA trial, as the FDA can and often does approve fast track treatments following a successful Phase 2 trial. "Although MiMedx's share price has increased by more than 200% since we published our initial report in January 2019, its shares are still trading at just a fraction of their fair value." said Eiad Asbahi, Founder and Managing Partner of Prescience Point. "We believe that MiMedx's wound care business by itself is worth at least $8 per share. This means that investors who purchase MiMedx shares today are buying the wound care business at a substantial discount and, on top of this, are receiving Amniofix, an asset that we believe is worth multi-billions of dollars, essentially for free." To view the full research report, please click here: MiMedx Group, Inc. Raising our price target to $31 on increased optimism over MDXG's Amniofix injectable product. About Prescience Point Prescience Point Capital Management is a research-focused, catalyst-driven investment firm that seeks to earn superior risk-adjusted returns uncorrelated to the broader market. Unlike traditional investment strategies, we are unconstrained and can opportunistically invest globally, across asset classes, industry verticals and capital structures. Whether investing in misunderstood distressed assets, creating value through shareholder activism, or uncovering fraud, we seek to capitalize on opportunities that others miss or fall outside the rigid mandates of most investment firms. Our uniqueness resides in our unconventional thinking, deep research, intellectual curiosity and willingness to go against the prevailing wisdom. The firm was founded by investor Eiad Asbahi in 2009 and is headquartered in Baton Rouge, LA. Prescience Point Capital Management is a registered investment advisor with the State of Louisiana. For updates follow Prescience Point on Twitter @PresciencePoint DisclaimerTHIS RELEASE EXPRESSES SOLELY PRESCIENCE POINT CAPITAL MANAGEMENT'S OPINIONS. Use Prescience Point's research opinions at your own risk. This is not investment advice nor should it be construed as such. You should do your own research and due diligence before making any investment decisions with respect to the securities covered herein. Forward-looking statement and projections are inherently susceptible to uncertainty and involve many risks (known and unknown) that could cause actual results to differ materially from expected results. Please refer to our full disclaimer located on the last page of our research report (linked herein). Prescience Investment Group, LLC is a member of the Financial Industry Regulatory Authority, CRD number 152721. SOURCE Prescience Point Capital Management Related Links http://www.presciencepoint.com |
edtsum2097 | You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text.
Text: SAN FRANCISCO--(BUSINESS WIRE)--Atlas Health (Atlas), the leader in philanthropic reimbursement that empowers health systems with an end-to-end solution for enrolling patients in medical financial aid programs, adds COVID-19 financial aid programs and matching as a free service for existing and new healthcare partners seeking to solve financial challenges related to new COVID-19 coverage legislation. As health systems and underinsured or uninsured patients face reimbursement challenges related to high, unexpected medical bills and out-of-pocket expenses associated with COVID-19 treatment, this addition enables health systems to leverage Atlas Navigators proprietary technology to save time in identifying HRSA-eligible reimbursement claims and reduce submission errors. The federal program is meant to cover testing and treatment for uninsured people with COVID-19, using funds from the federal coronavirus relief package. Large numbers of patients with other serious medical conditions, however, have been disqualified because COVID-19 must be the primary diagnosis. At one hospital in Miami, for example, only 60 percent of uninsured COVID-19 patients were covered under the new legislation. During this pandemic and beyond, Atlas Navigator offers an opportunity for health systems to reinforce their mission and support their communities, says Ethan Davidoff, CEO and founder, Atlas. At the same time, our solution helps hospitals to recover lost cash and inventory associated with uncompensated care, increase patient satisfaction and referrals, improve operating margins and achieve higher levels of compliance. We are helping our health system partners to remain solvent and resilient during this unprecedented public health crisis. Atlas has added COVID-19-related programs to its database of more than 10,000 medical financial aid programs, which fund $75 billion of patient care. This solution is particularly timely given a report from the American Hospital Association (AHA), which estimates that, due to the pandemic, Americas hospitals and health systems suffered a total four-month financial impact of $202.6 billion in losses or an average of $50.7 billion per month. Davidoff adds, The inclusion of COVID-19 programs is critical to the current and future financial performance of hospital systems across the country. These capabilities transform a complex process of medical financial aid identification, enrollment, and reimbursement into a simple, easy-to-use workflow. About Atlas Health Atlas Health, the leader in philanthropic reimbursement, is improving and saving lives by empowering providers with an end-to-end solution for matching and enrolling patients in medical financial aid programs through its proprietary technology and AI-powered platform, Atlas Navigator. Patients receive the care they need and providers secure reimbursement for care delivered. Find out how no patient is left behind at https://atlas.health/.
Answer: | Free, Automated Identification of Financial Aid for COVID-19 Treatment: Atlas Health Helps Hospitals, Uninsured & Underinsured Patients Mitigate Surprise Bills | SAN FRANCISCO--(BUSINESS WIRE)--Atlas Health (Atlas), the leader in philanthropic reimbursement that empowers health systems with an end-to-end solution for enrolling patients in medical financial aid programs, adds COVID-19 financial aid programs and matching as a free service for existing and new healthcare partners seeking to solve financial challenges related to new COVID-19 coverage legislation. As health systems and underinsured or uninsured patients face reimbursement challenges related to high, unexpected medical bills and out-of-pocket expenses associated with COVID-19 treatment, this addition enables health systems to leverage Atlas Navigators proprietary technology to save time in identifying HRSA-eligible reimbursement claims and reduce submission errors. The federal program is meant to cover testing and treatment for uninsured people with COVID-19, using funds from the federal coronavirus relief package. Large numbers of patients with other serious medical conditions, however, have been disqualified because COVID-19 must be the primary diagnosis. At one hospital in Miami, for example, only 60 percent of uninsured COVID-19 patients were covered under the new legislation. During this pandemic and beyond, Atlas Navigator offers an opportunity for health systems to reinforce their mission and support their communities, says Ethan Davidoff, CEO and founder, Atlas. At the same time, our solution helps hospitals to recover lost cash and inventory associated with uncompensated care, increase patient satisfaction and referrals, improve operating margins and achieve higher levels of compliance. We are helping our health system partners to remain solvent and resilient during this unprecedented public health crisis. Atlas has added COVID-19-related programs to its database of more than 10,000 medical financial aid programs, which fund $75 billion of patient care. This solution is particularly timely given a report from the American Hospital Association (AHA), which estimates that, due to the pandemic, Americas hospitals and health systems suffered a total four-month financial impact of $202.6 billion in losses or an average of $50.7 billion per month. Davidoff adds, The inclusion of COVID-19 programs is critical to the current and future financial performance of hospital systems across the country. These capabilities transform a complex process of medical financial aid identification, enrollment, and reimbursement into a simple, easy-to-use workflow. About Atlas Health Atlas Health, the leader in philanthropic reimbursement, is improving and saving lives by empowering providers with an end-to-end solution for matching and enrolling patients in medical financial aid programs through its proprietary technology and AI-powered platform, Atlas Navigator. Patients receive the care they need and providers secure reimbursement for care delivered. Find out how no patient is left behind at https://atlas.health/. |
edtsum2101 | You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text.
Text: DUBLIN--(BUSINESS WIRE)--The "Ventricular Assist Device Market - Growth, Trends, and Forecasts (2020 - 2025)" report has been added to ResearchAndMarkets.com's offering. The ventricular assist device (VAD) market is anticipated to record a CAGR of about 7.23% during the forecast period. The major factors attributing to the growth of the ventricular assist device market are technological advancement of devices for cardiac diseases management, growing initiatives and awareness regarding cardiovascular diseases, and the increasing burden of cardiac diseases and heart failure. According to the World Health Organization, an estimated 17.9 million people die due to cardiovascular diseases worldwide, each year. This represents 35% of global deaths. Additionally, 85% of these cardiovascular disease deaths are due to heart attack and stroke. Companies Mentioned Key Market Trends Left Ventricular Assist Device (LVAD) is Expected to Hold the Major Share in the Type of Ventricular Device Segment LVAD is implanted during an open heart surgery, where it receives blood from the left ventricle and delivers it to the aorta. It works along with the patient's own heart. It is mostly given as a treatment option for patients with end-stage heart failure. There are a number of international hospitals and research centres that widely use VAD programs since the past two decades, particularly in the developed markets, as well as for help in new investigational devices. Abbott (Thoratec), Berlin Heart, and Medtronic are among the top players in this segment that are well established in the developed market. Moreover, new product launches and continuous government support projected to boost the segment growth. For instance, in February 2020, Abbott has received Breakthrough Device designation from the U.S. Food and Drug Administration (FDA) for its in-development Fully Implantable Left Ventricular Assist System (FILVAS). The FDA launched the Breakthrough Devices Programme in 2018 to help expedite the development and review of submissions for technology that offers significant advantages over existing approved products. Furthermore, with the increased utilization of durable mechanical support devices, it is important for all emergency departments of hospitals to have a well-written protocol to provide optimal care for patients with VADs. North America Dominates the Market and Expected to do Same in the Forecast Period North America is expected to dominate the overall market, throughout the forecast period. The presence of high per capita healthcare expenditure, coupled with the rising prevalence of cardiac diseases, is expected to propel the high growth of the ventricular assist device in the North American region. In the North American region, the United States holds the largest share. This is due to the presence of a large population with heart disease. In the United States, cardiovascular diseases and hypertension cases account for a major share of the people that require surgery. A large number of cardiac considerations and systemic considerations are taken into account, as there are several factors associated with preoperative, perioperative, and postoperative complications. The high burden of patients with heart failure-related indications is mostly above the age of 40, which majorly boosts the demand for VAD in hospitals and clinics. According to the American Heart Association Research Report 2017, about 92.1 million American adults are living with some form of cardiovascular disease or the after-effects of stroke. The global high burden of cardiac diseases and heart failures has been one of the major factors for the growing demand and growth of the segment over the period. Key Topics Covered: 1 INTRODUCTION 2 RESEARCH METHODOLOGY 3 EXECUTIVE SUMMARY 4 MARKET DYNAMICS 4.1 Market Overview 4.2 Market Drivers 4.2.1 Growing Burden of Cardiac Diseases and Heart Failure 4.2.2 Technological Advancement of Devices for Cardiac Diseases Management 4.2.3 Growing Initiatives and Awareness Regarding Cardiovascular Diseases 4.3 Market Restraints 4.3.1 High Cost of Devices and Procedures 4.3.2 Several Risks Associated to VAD Implant 4.4 Porter's Five Forces Analysis 5 MARKET SEGMENTATION 5.1 By Type of Ventricular Device 5.1.1 Left Ventricular Assist Device (LVAD) 5.1.2 Right Ventricular Assist Device (RVAD) 5.1.3 Biventricular Assist Device (BIVAD) 5.2 By Application 5.2.1 Bridge-to-transplant (BTT) Therapy 5.2.2 Destination Therapy 5.2.3 Other Therapies 5.3 Geography 5.3.1 North America 5.3.1.1 United States 5.3.1.2 Canada 5.3.1.3 Mexico 5.3.2 Europe 5.3.2.1 Germany 5.3.2.2 United Kingdom 5.3.2.3 France 5.3.2.4 Italy 5.3.2.5 Spain 5.3.2.6 Rest of Europe 5.3.3 Asia-Pacific 5.3.3.1 China 5.3.3.2 Japan 5.3.3.3 India 5.3.3.4 Australia 5.3.3.5 South Korea 5.3.3.6 Rest of Asia-Pacific 5.3.4 Middle East & Africa 5.3.4.1 GCC 5.3.4.2 South Africa 5.3.4.3 Rest of Middle East & Africa 5.3.5 South America 5.3.5.1 Brazil 5.3.5.2 Argentina 5.3.5.3 Rest of South America 6 COMPETITIVE LANDSCAPE 6.1 Company Profiles 7 MARKET OPPORTUNITIES AND FUTURE TRENDS For more information about this report visit https://www.researchandmarkets.com/r/i6goq4
Answer: | Global Ventricular Assist Device Market (2020 to 2025) - Growth, Trends, and Forecasts - ResearchAndMarkets.com | DUBLIN--(BUSINESS WIRE)--The "Ventricular Assist Device Market - Growth, Trends, and Forecasts (2020 - 2025)" report has been added to ResearchAndMarkets.com's offering. The ventricular assist device (VAD) market is anticipated to record a CAGR of about 7.23% during the forecast period. The major factors attributing to the growth of the ventricular assist device market are technological advancement of devices for cardiac diseases management, growing initiatives and awareness regarding cardiovascular diseases, and the increasing burden of cardiac diseases and heart failure. According to the World Health Organization, an estimated 17.9 million people die due to cardiovascular diseases worldwide, each year. This represents 35% of global deaths. Additionally, 85% of these cardiovascular disease deaths are due to heart attack and stroke. Companies Mentioned Key Market Trends Left Ventricular Assist Device (LVAD) is Expected to Hold the Major Share in the Type of Ventricular Device Segment LVAD is implanted during an open heart surgery, where it receives blood from the left ventricle and delivers it to the aorta. It works along with the patient's own heart. It is mostly given as a treatment option for patients with end-stage heart failure. There are a number of international hospitals and research centres that widely use VAD programs since the past two decades, particularly in the developed markets, as well as for help in new investigational devices. Abbott (Thoratec), Berlin Heart, and Medtronic are among the top players in this segment that are well established in the developed market. Moreover, new product launches and continuous government support projected to boost the segment growth. For instance, in February 2020, Abbott has received Breakthrough Device designation from the U.S. Food and Drug Administration (FDA) for its in-development Fully Implantable Left Ventricular Assist System (FILVAS). The FDA launched the Breakthrough Devices Programme in 2018 to help expedite the development and review of submissions for technology that offers significant advantages over existing approved products. Furthermore, with the increased utilization of durable mechanical support devices, it is important for all emergency departments of hospitals to have a well-written protocol to provide optimal care for patients with VADs. North America Dominates the Market and Expected to do Same in the Forecast Period North America is expected to dominate the overall market, throughout the forecast period. The presence of high per capita healthcare expenditure, coupled with the rising prevalence of cardiac diseases, is expected to propel the high growth of the ventricular assist device in the North American region. In the North American region, the United States holds the largest share. This is due to the presence of a large population with heart disease. In the United States, cardiovascular diseases and hypertension cases account for a major share of the people that require surgery. A large number of cardiac considerations and systemic considerations are taken into account, as there are several factors associated with preoperative, perioperative, and postoperative complications. The high burden of patients with heart failure-related indications is mostly above the age of 40, which majorly boosts the demand for VAD in hospitals and clinics. According to the American Heart Association Research Report 2017, about 92.1 million American adults are living with some form of cardiovascular disease or the after-effects of stroke. The global high burden of cardiac diseases and heart failures has been one of the major factors for the growing demand and growth of the segment over the period. Key Topics Covered: 1 INTRODUCTION 2 RESEARCH METHODOLOGY 3 EXECUTIVE SUMMARY 4 MARKET DYNAMICS 4.1 Market Overview 4.2 Market Drivers 4.2.1 Growing Burden of Cardiac Diseases and Heart Failure 4.2.2 Technological Advancement of Devices for Cardiac Diseases Management 4.2.3 Growing Initiatives and Awareness Regarding Cardiovascular Diseases 4.3 Market Restraints 4.3.1 High Cost of Devices and Procedures 4.3.2 Several Risks Associated to VAD Implant 4.4 Porter's Five Forces Analysis 5 MARKET SEGMENTATION 5.1 By Type of Ventricular Device 5.1.1 Left Ventricular Assist Device (LVAD) 5.1.2 Right Ventricular Assist Device (RVAD) 5.1.3 Biventricular Assist Device (BIVAD) 5.2 By Application 5.2.1 Bridge-to-transplant (BTT) Therapy 5.2.2 Destination Therapy 5.2.3 Other Therapies 5.3 Geography 5.3.1 North America 5.3.1.1 United States 5.3.1.2 Canada 5.3.1.3 Mexico 5.3.2 Europe 5.3.2.1 Germany 5.3.2.2 United Kingdom 5.3.2.3 France 5.3.2.4 Italy 5.3.2.5 Spain 5.3.2.6 Rest of Europe 5.3.3 Asia-Pacific 5.3.3.1 China 5.3.3.2 Japan 5.3.3.3 India 5.3.3.4 Australia 5.3.3.5 South Korea 5.3.3.6 Rest of Asia-Pacific 5.3.4 Middle East & Africa 5.3.4.1 GCC 5.3.4.2 South Africa 5.3.4.3 Rest of Middle East & Africa 5.3.5 South America 5.3.5.1 Brazil 5.3.5.2 Argentina 5.3.5.3 Rest of South America 6 COMPETITIVE LANDSCAPE 6.1 Company Profiles 7 MARKET OPPORTUNITIES AND FUTURE TRENDS For more information about this report visit https://www.researchandmarkets.com/r/i6goq4 |
edtsum2109 | You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text.
Text: LOS ANGELES, May 28, 2020 /PRNewswire/ -- 40 YEARS OF ROCKY: THE BIRTH OF A CLASSIC documentary will be released digitally in North America via Virgil Films on June 9. The film chronicles the behind-the-scenes journey of a 1976 low budget movie that was written by an unknown actor, Sylvester Stallone, and when released, inspired audiences all around the world to go the distance. The international release of the film will be titled BECOMING ROCKY: THE BIRTH OF A CLASSIC, and will be available on June 9 via Branded Studios. The North American versionwill stream via on iTunes/AppleTV (PRE-ORDER HERE), Amazon (PRE-ORDER HERE), Vimeo On Demand and Google Play. The international release will be available on iTunes/AppleTV and Amazon. Continue Reading (PRNewsfoto/Cinema 83 Entertainment) The documentary was written and directed by Derek Wayne Johnson, who served as producer alongside Chris May, both of Cinema 83 Entertainment and Cinema 83 Documentary Films. The film follows the iconic "Rocky" story which became the ultimate underdog movie, and more than 40 years later, Sylvester Stallone recounts the making of the beloved classic through rare home movies filmed by "Rocky" director John G. Avildsen. "The documentary is a golden nugget for 'Rocky' fans and casual audiences alike," says Johnson. "It's a charming piece of film history narrated by Rocky himself, Sylvester Stallone, and will give audiences an intimate, and at times, emotional experience. We're proud of the film, and audiences can expect new stories and new footage that they've never seen before in a blend of director John Avildsen's home movies, rehearsal footage and behind-the-scenes footage from the making of the ultimate underdog film."Adds May, "It has been an incredible journey working on this film and we are very excited for everybody to get to see it now. The cultural impact and value of 'Rocky' can't be understated, and we are proud to have been able to add '40 Years of Rocky: The Birth of a Classic' into that world."Leonard Martin raves, "I enjoyed stepping back in time with this peek behind the scenes of 'Rocky'and so will any fan of the movie."Executive Producer David Polemeni funded the picture through Visionary Private Equity Group. Cinema 83's next project will be a new documentary via Related Pictures Group about comedic legends Don Rickles and Bob Newhart's long term friendship, and their impact on comedy.About Cinema 83Cinema 83 Entertainment (and its twin company Cinema 83 Documentary Films) is a newly formed production company based in Hollywood, California, created by longtime filmmaking partners Derek Wayne Johnson and Chris May. Cinema 83 produces feature length motion pictures and documentaries designed to inspire, educate and entertain the world. Starting with "40 Years of Rocky: The Birth of a Classic" narrated by Sylvester Stallone, Cinema 83 is committed to telling captivating stories.For more information visit: Cinema 83 EntertainmentCONTACT:Lira MendozaCinema 83 Entertainment[emailprotected]SOURCE Cinema 83 Entertainment Related Links https://cinema83entertainment.com
Answer: | "40 YEARS OF ROCKY: THE BIRTH OF A CLASSIC" Documentary To Be Released Digitally On June 9 In North America Via Virgil Films | LOS ANGELES, May 28, 2020 /PRNewswire/ -- 40 YEARS OF ROCKY: THE BIRTH OF A CLASSIC documentary will be released digitally in North America via Virgil Films on June 9. The film chronicles the behind-the-scenes journey of a 1976 low budget movie that was written by an unknown actor, Sylvester Stallone, and when released, inspired audiences all around the world to go the distance. The international release of the film will be titled BECOMING ROCKY: THE BIRTH OF A CLASSIC, and will be available on June 9 via Branded Studios. The North American versionwill stream via on iTunes/AppleTV (PRE-ORDER HERE), Amazon (PRE-ORDER HERE), Vimeo On Demand and Google Play. The international release will be available on iTunes/AppleTV and Amazon. Continue Reading (PRNewsfoto/Cinema 83 Entertainment) The documentary was written and directed by Derek Wayne Johnson, who served as producer alongside Chris May, both of Cinema 83 Entertainment and Cinema 83 Documentary Films. The film follows the iconic "Rocky" story which became the ultimate underdog movie, and more than 40 years later, Sylvester Stallone recounts the making of the beloved classic through rare home movies filmed by "Rocky" director John G. Avildsen. "The documentary is a golden nugget for 'Rocky' fans and casual audiences alike," says Johnson. "It's a charming piece of film history narrated by Rocky himself, Sylvester Stallone, and will give audiences an intimate, and at times, emotional experience. We're proud of the film, and audiences can expect new stories and new footage that they've never seen before in a blend of director John Avildsen's home movies, rehearsal footage and behind-the-scenes footage from the making of the ultimate underdog film."Adds May, "It has been an incredible journey working on this film and we are very excited for everybody to get to see it now. The cultural impact and value of 'Rocky' can't be understated, and we are proud to have been able to add '40 Years of Rocky: The Birth of a Classic' into that world."Leonard Martin raves, "I enjoyed stepping back in time with this peek behind the scenes of 'Rocky'and so will any fan of the movie."Executive Producer David Polemeni funded the picture through Visionary Private Equity Group. Cinema 83's next project will be a new documentary via Related Pictures Group about comedic legends Don Rickles and Bob Newhart's long term friendship, and their impact on comedy.About Cinema 83Cinema 83 Entertainment (and its twin company Cinema 83 Documentary Films) is a newly formed production company based in Hollywood, California, created by longtime filmmaking partners Derek Wayne Johnson and Chris May. Cinema 83 produces feature length motion pictures and documentaries designed to inspire, educate and entertain the world. Starting with "40 Years of Rocky: The Birth of a Classic" narrated by Sylvester Stallone, Cinema 83 is committed to telling captivating stories.For more information visit: Cinema 83 EntertainmentCONTACT:Lira MendozaCinema 83 Entertainment[emailprotected]SOURCE Cinema 83 Entertainment Related Links https://cinema83entertainment.com |
edtsum2111 | You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text.
Text: MENLO PARK, Calif., Aug. 6, 2020 /PRNewswire/ --WelbeHealth today announced the appointment of Robert Margolis, MD to its Board of Directors. "Bob's decades of visionary leadership in managed care will be extremely valuable in helping us accomplish our mission of bringing high quality, compassionate, aligned care to underserved communities," said Si France, MD, Founder and CEO of WelbeHealth. "We're honored to have him on our team and look forward to benefiting from his experience and counsel." Dr. Margolis was a founder and managing partner of California Primary Physicians Medical Group, the predecessor to HealthCare Partners. Under his leadership as managing partner and CEO, HealthCare Partners became a highly respected and innovative physician-owned and operated medical group, independent physician association, and management services organization. Dr. Margolis also served as co-chair of the DaVita HealthCare Partners board of directors. Dr. Margolis has been a pioneer of managed care for over 30 years. He has served as a member of the healthcare policy advisory council for Harvard Medical School and the advisory board of the Schaeffer Center for Health Policy and Economics at USC. He has served as a board member of the MLK Community Health Foundation, the National Committee for Quality Assurance (NCQA), the California Association of Physician Groups (CAPG), California Hospital Medical Center - Los Angeles, and the Council of Accountable Physician Practices (CAPP). Dr. Margolis joins WelbeHealth's board alongside biotech entrepreneur Errik Anderson; Chip Adams, Chairman of the Center for Conscientious Leadership; healthcare economist Michael Zubkoff, PhD; Gregory Grunberg, MD, Managing Director at Longitude Capital; Jon Lim, Partner at F-Prime Capital Partners; Liam Donohue, Founding Partner at .406 Ventures; and WelbeHealth CEO Si France, MD. About WelbeHealth At WelbeHealth, our mission is to unlock the full potential of our most vulnerable seniors with empathy and love. We do it through PACE (Program of All-Inclusive Care for the Elderly), a comprehensive medical and social care model with a decades-long track record of improved quality of life, life expectancy, and personal empowerment for frail seniors. As part of our programs, most participants are able to live safely and independently in their own homes and communities rather than receive care in a nursing home. For more information, please visit welbehealth.com. Contact: Maricela Cueva, [emailprotected] SOURCE WelbeHealth Related Links http://welbehealth.com
Answer: | Robert Margolis, MD Joins WelbeHealth Board of Directors English USA - espaol | MENLO PARK, Calif., Aug. 6, 2020 /PRNewswire/ --WelbeHealth today announced the appointment of Robert Margolis, MD to its Board of Directors. "Bob's decades of visionary leadership in managed care will be extremely valuable in helping us accomplish our mission of bringing high quality, compassionate, aligned care to underserved communities," said Si France, MD, Founder and CEO of WelbeHealth. "We're honored to have him on our team and look forward to benefiting from his experience and counsel." Dr. Margolis was a founder and managing partner of California Primary Physicians Medical Group, the predecessor to HealthCare Partners. Under his leadership as managing partner and CEO, HealthCare Partners became a highly respected and innovative physician-owned and operated medical group, independent physician association, and management services organization. Dr. Margolis also served as co-chair of the DaVita HealthCare Partners board of directors. Dr. Margolis has been a pioneer of managed care for over 30 years. He has served as a member of the healthcare policy advisory council for Harvard Medical School and the advisory board of the Schaeffer Center for Health Policy and Economics at USC. He has served as a board member of the MLK Community Health Foundation, the National Committee for Quality Assurance (NCQA), the California Association of Physician Groups (CAPG), California Hospital Medical Center - Los Angeles, and the Council of Accountable Physician Practices (CAPP). Dr. Margolis joins WelbeHealth's board alongside biotech entrepreneur Errik Anderson; Chip Adams, Chairman of the Center for Conscientious Leadership; healthcare economist Michael Zubkoff, PhD; Gregory Grunberg, MD, Managing Director at Longitude Capital; Jon Lim, Partner at F-Prime Capital Partners; Liam Donohue, Founding Partner at .406 Ventures; and WelbeHealth CEO Si France, MD. About WelbeHealth At WelbeHealth, our mission is to unlock the full potential of our most vulnerable seniors with empathy and love. We do it through PACE (Program of All-Inclusive Care for the Elderly), a comprehensive medical and social care model with a decades-long track record of improved quality of life, life expectancy, and personal empowerment for frail seniors. As part of our programs, most participants are able to live safely and independently in their own homes and communities rather than receive care in a nursing home. For more information, please visit welbehealth.com. Contact: Maricela Cueva, [emailprotected] SOURCE WelbeHealth Related Links http://welbehealth.com |
edtsum2113 | You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text.
Text: NEWPORT, R.I., Aug. 12, 2020 /PRNewswire/ -- Pangaea Logistics Solutions Ltd. ("Pangaea" or the "Company") (NASDAQ: PANL), a global provider of comprehensive maritime logistics solutions, announced today its results for the three months ended June30, 2020. 2nd Quarter Highlights Net income attributable to Pangaea Logistics Solutions Ltd. was $3.0 million for three months ended June 30, 2020 as compared to $4.0 million of net income for the same period of 2019. Non-GAAP adjusted net income attributable to Pangaea Logistics Solutions Ltd. of $3.7 million as compared to $3.8 million for the three months ended June 30, 2019. Net income per share was $0.07 for three months ended June 30, 2020 as compared to earnings per share of $0.09 for the same period of 2019. Pangaea's TCE rates were $10,733 for the three months ended June 30, 2020 and $12,933 for the three months ended June 30, 2019. The market average for the second quarter of 2020 was approximately $5,548, giving the Company an overall average premium over market rates of approximately $5,185 or 93%. Adjusted EBITDA of $10.7 million for the three months ended June 30, 2020. Total revenue decreased to $70.4 million for the three months ended June 30, 2020, from $83.3 million for the three months ended June 30, 2019 due to a decrease in market hire and freight rates. At the end of the quarter, Pangaea had $49.5 million in cash, restricted cash and cash equivalents. Ed Coll, Chief Executive Officer of Pangaea Logistics Solutions, commented: "Our strong second quarter results outperformed in a challenging dry bulk market that tested historic lows in April and May. Adhering to our strategy in turbulent markets, we limited our exposure by adjusting our fleet composition, redelivering chartered vessels back to their owners over the last several months and replacing them when needed at lower cost. Second quarter 2020 operating income of $6.1 million, before non-cash impairment charges, is a remarkable turnaround from our first quarter of 2020 operating loss of $2.3 million. Our achieved TCE rate of $10,733 per day represented an outperformance of $5,548, or 93% premium over the average market rates. Mr. Coll added, "Looking forward we move into our seasonally strong summer ice season in a strong position. Although the market has recovered somewhat since June, we are watching global economic output and the disruptions caused by COVID-19, from changes to our working environment to rotating crews aboard our vessels. We sincerely empathize with the hardships our people and their familiars are facing, ashore and aboard our vessels. Our results are encouraging, but we expect, and will prepare for, continued uncertainty and turbulence in our markets over the next few quarters." Results for the three months ended June30, 2020 and 2019 Total revenue was $70.4 million for the three months ended June 30, 2020, compared with $83.3 million for the three months ended June 30, 2019. The 15% decrease in revenues was mainly attributed to the decrease in the average time charter rates achieved by our vessels during the second quarter of 2020 compared to the same period in 2019. Time Charter Equivalent rate (TCE) was $10,733 per day for the three months ended June 30, 2020, compared to an average of $12,933 per day for the same period in 2019. However, the achieved premium over the average market increased by $5,185 per day or 93% for the three months ended June 30, 2020. The total number of shipping days remained relatively consistent with a 1% increase to 3,600 days in the three months ended June 30, 2020, compared to 3,562 for the same period in 2019, predominantly due to the increase in voyage days. Liquidity and Cash Flows Cash, restricted cash and cash equivalents were $49.5 million as of June30, 2020, compared with $53.1 million on December31, 2019. At June30, 2020 and December31, 2019, the Company had working capital of $37.3 million and $37.1 million, respectively. Operating cash flows during thesixmonths endedJune30, 2020 was a net inflow of$6.9 million as compared toa net inflow of $19.6 millionduring the same period of 2019. Investing cash flows during the six months ended June30, 2020 was a net inflow of $5.8 million as compared to a net outflow of $33.5 million during the same period of2019. Financing cash flows during the six months ended June30, 2020 was a net outflow of $16.2 million as compared to net inflow of $1.5 million during the same period of 2019. The Company sold two vessels and paid off a lease obligation during the six months ended June 30, 2020. Subsequent Event On June 29, 2020, the Company entered into a memorandum of agreement to sell the Bulk Beothuk, a 2002-built Supramax vessel, to a third party for $4.6million less a broker commission payable to a third party. The vessel was delivered to its new owner on August 4, 2020. Conference Call Details The Company's management team will host a conference call to discuss the Company's financial results on August 13, 2020 at 8:00 a.m., Eastern Time (ET). To access the conference call, please dial (888) 895-3561 (domestic) or (904) 685-6494 (international) approximately ten minutes before the scheduled start time and reference ID#8947025. A supplemental slide presentation will accompany this quarter's conference call and can be found attached to the Current Report on Form 8-K that the Company filed concurrently with this press release. This document will be available at http://www.pangaeals.com/company-filings or at sec.gov. A recording of the call will also be available for two weeks and can be accessed by calling (855) 859-2056 (domestic) or (404) 537-3406 (international) and referencing ID#8947025. Pangaea Logistics Solutions Ltd. Consolidated Statements of Operations (unaudited) Three Months Ended June 30, Six Months Ended June 30, 2020 2019 2020 2019 Revenues: Voyage revenue $ 66,857,166 $ 77,430,067 $ 153,381,057 $ 143,281,414 Charter revenue 3,539,004 5,860,548 12,895,050 19,553,386 70,396,170 83,290,615 166,276,107 162,834,800 Expenses: Voyage expense 31,757,910 37,224,412 79,553,822 69,398,519 Charter hire expense 15,203,731 18,317,345 47,529,178 43,264,714 Vessel operating expense 9,325,060 11,074,547 19,258,922 20,828,922 General and administrative 3,872,388 5,358,991 7,865,631 9,392,671 Depreciation and amortization 4,345,707 4,491,327 8,587,958 8,868,515 Loss on impairment of vessels 1,801,039 1,801,039 Loss on sale of vessels 297,475 219,485 Total expenses 66,603,310 76,466,622 164,816,035 151,753,341 Income from operations 3,792,860 6,823,993 1,460,072 11,081,459 Other (expense) income: Interest expense, net (2,000,550) (2,101,052) (4,116,870) (4,308,220) Interest expense on related party debt (11,138) (38,036) Unrealized gain (loss) on derivative instruments, net 1,404,317 215,171 (1,512,777) 2,504,957 Other income 98,635 232,092 695,191 399,912 Total other (expense), net (497,598) (1,664,927) (4,934,456) (1,441,387) Net income (loss) 3,295,262 5,159,066 (3,474,384) 9,640,072 Income attributable to non-controlling interests (290,086) (1,126,565) (315,815) (1,905,017) Net income (loss) attributable to Pangaea Logistics Solutions Ltd. $ 3,005,176 $ 4,032,501 $ (3,790,199) $ 7,735,055 Earnings per common share: Basic $ 0.07 $ 0.09 $ (0.09) $ 0.18 Diluted $ 0.07 $ 0.09 $ (0.09) $ 0.18 Weighted average shares used to compute earnings per common share: Basic 43,445,789 42,767,785 43,442,773 42,684,966 Diluted 43,445,789 43,293,022 43,442,773 43,202,187 Pangaea Logistics Solutions Ltd. Consolidated Balance Sheets June 30, 2020 December 31, 2019 (unaudited) Assets Current assets Cash and cash equivalents $ 46,993,067 $ 50,555,091 Restricted cash 1,000,000 1,000,000 Accounts receivable (net of allowance of $1,723,510 and $1,908,841 at June 30, 2020 and December 31, 2019, respectively) 18,197,943 28,309,402 Bunker inventory 11,648,319 21,001,010 Advance hire, prepaid expenses and other current assets 15,575,442 18,770,825 Vessel held for sale 4,563,000 8,319,152 Total current assets 97,977,771 127,955,480 Restricted cash 1,500,000 1,500,000 Fixed assets, net 278,383,059 281,474,857 Investment in newbuildings in-process 15,390,634 15,357,189 Finance lease right of use assets, net 46,259,982 53,615,305 Total assets $ 439,511,446 $ 479,902,831 Liabilities and stockholders' equity Current liabilities Accounts payable, accrued expenses and other current liabilities $ 26,528,278 $ 39,973,635 Related party debt 242,852 332,987 Deferred revenue 5,343,392 14,376,394 Current portion of secured long-term debt 21,490,674 22,990,674 Current portion of finance lease liabilities 6,927,362 12,549,208 Dividend payable 95,500 631,961 Total current liabilities 60,628,058 90,854,859 Secured long-term debt, net 78,779,452 83,649,717 Finance lease liabilities, net 54,028,493 57,498,217 Long-term liabilities - other 5,108,793 4,828,364 Commitments and contingencies Stockholders' equity: Preferred stock, $0.0001 par value, 1,000,000 shares authorized and no shares issued or outstanding Common stock, $0.0001 par value, 100,000,000 shares authorized; 45,065,662 shares issued and outstanding at June 30, 2020; 44,886,122 shares issued and outstanding at December 31, 2019 4,507 4,489 Additional paid-in capital 158,874,237 157,504,895 Retained earnings 8,946,381 12,736,580 Total Pangaea Logistics Solutions Ltd. equity 167,825,125 170,245,964 Non-controlling interests 73,141,525 72,825,710 Total stockholders' equity 240,966,650 243,071,674 Total liabilities and stockholders' equity $ 439,511,446 $ 479,902,831 Pangaea Logistics Solutions Ltd. Consolidated Statements of Cash Flows (unaudited) Six Months Ended June 30, 2020 2019 Operating activities Net (loss) income $ (3,474,384) $ 9,640,072 Adjustments to reconcile net income to net cash (used in) provided by operations: Depreciation and amortization expense 8,587,958 8,868,515 Amortization of deferred financing costs 346,985 365,564 Amortization of prepaid rent 61,136 59,299 Unrealized loss (gain) on derivative instruments 1,512,777 (2,504,957) Gain from equity method investee (795,988) (247,312) Earnings attributable to non-controlling interest recorded as interest expense 28,166 (Recovery) provision for doubtful accounts (185,331) 320,491 Loss on impairment of vessels 1,801,039 Loss on sale of vessel 219,485 Drydocking costs (2,882,109) (1,545,094) Share-based compensation 1,523,486 1,045,507 Change in operating assets and liabilities: Accounts receivable 10,296,790 7,984,657 Bunker inventory 9,352,691 1,775,598 Advance hire, prepaid expenses and other current assets 3,991,371 (1,821,751) Accounts payable, accrued expenses and other current liabilities (14,444,003) 1,546,305 Deferred revenue (9,033,002) (5,902,610) Net cash provided by operating activities 6,907,067 19,584,284 Investing activities Purchase of vessels and vessel improvements (1,652,366) (25,557,060) Investment in newbuildings in-process (33,445) (7,657,000) Purchase of fixed assets and equipment (7,801) (281,011) Proceeds from sale of vessels 8,099,667 Purchase of derivative instrument (628,000) Net cash provided by (used in) investing activities 5,778,055 (33,495,071) Financing activities Proceeds from long-term debt 14,000,000 Payments of related party debt (1,691,964) Payments of financing fees and issuance costs (149,118) (277,577) Payments of long-term debt (6,568,134) (12,242,949) Proceeds from finance leases 13,000,000 Dividends paid to non-controlling interests (4,666,665) Payments of finance lease obligations (9,091,570) (2,908,693) Accrued common stock dividends paid (536,461) (3,754,985) Cash paid for incentive compensation shares relinquished (154,126) Contributions from non-controlling interest recorded as long-term liability 322,750 Payments to non-controlling interest recorded as long-term liability (70,487) Net cash (used in) provided by financing activities (16,247,146) 1,457,167 Net decrease in cash, cash equivalents and restricted cash (3,562,024) (12,453,620) Cash, cash equivalents and restricted cash at beginning of period 53,055,091 56,114,735 Cash, cash equivalents and restricted cash at end of period $ 49,493,067 $ 43,661,115 Supplemental cash flow information Cash and cash equivalents $ 46,993,067 $ 41,161,115 Restricted cash 2,500,000 2,500,000 $ 49,493,067 $ 43,661,115 Pangaea Logistics Solutions Ltd. Reconciliation of Non-GAAP Measures (unaudited) Three Months Ended June 30, Six Months Ended June 30, 2020 2019 2020 2019 Net Transportation and Service Revenue Gross Profit 9,781,061 12,218,543 11,409,632 20,545,840 Add: Vessel Depreciation and Amortization 4,328,408 4,455,768 8,524,553 8,796,805 Net transportation and service revenue $ 14,109,469 $ 16,674,311 $ 19,934,185 $ 29,342,645 Adjusted EBITDA Income from operations $ 3,792,860 $ 6,823,993 $ 1,460,072 $ 11,081,459 Depreciation and amortization 4,345,707 4,491,327 8,587,958 8,868,515 Loss on impairment of vessels 1,801,039 1,801,039 Loss on sale of vessel 297,475 219,485 Share-based compensation 420,717 370,908 1,523,486 1,045,507 Adjusted EBITDA $ 10,657,798 $ 11,686,228 $ 13,592,040 $ 20,995,481 Earnings Per Common Share Net income (loss) attributable to Pangaea Logistics Solutions Ltd. $ 3,005,176 $ 4,032,501 $ (3,790,199) $ 7,735,055 Weighted average number of common shares outstanding - basic 43,445,789 42,767,785 43,442,773 42,684,966 Weighted average number of common shares outstanding - diluted 43,445,789 43,293,022 43,442,773 43,202,187 Earnings per common share - basic $ 0.07 $ 0.09 $ (0.09) $ 0.18 Earnings per common share - diluted $ 0.07 $ 0.09 $ (0.09) $ 0.18 Adjusted EPS Net Income attributable to Pangaea Logistics Solutions Ltd. $ 3,005,176 $ 4,032,501 $ (3,790,199) $ 7,735,055 Non-GAAP Add: loss on sale of vessels 297,475 219,485 Loss on impairment of vessels 1,801,039 1,801,039 Unrealized (gain) loss on derivative instruments (1,404,317) (215,171) 1,512,777 (2,504,957) Non-GAAP adjusted net income (loss) attributable to Pangaea Logistics Solutions Ltd. $ 3,699,373 $ 3,817,330 $ (256,898) $ 5,230,098 Weighted average number of common shares - basic 43,445,789 42,767,785 43,442,773 42,684,966 Weighted average number of common shares - diluted 43,445,789 43,293,022 43,442,773 43,202,187 Adjusted EPS - basic $ 0.09 $ 0.09 $ (0.01) $ 0.12 Adjusted EPS - diluted $ 0.09 $ 0.09 $ (0.01) $ 0.12 INFORMATION ABOUT NON-GAAP FINANCIAL MEASURES. As used herein, "GAAP" refers to accounting principles generally accepted in the United States of America. To supplement our consolidated financial statements prepared and presented in accordance with GAAP, this earnings release discusses non-GAAP financial measures, including non-GAAP net revenue and non-GAAP adjusted EBITDA. This is considered a non-GAAP financial measure as defined in Rule 101 of Regulation G promulgated by the Securities and Exchange Commission. Generally, a non-GAAP financial measure is a numerical measure of a company's historical or future performance, financial position, or cash flows that either excludes or includes amounts that are not normally excluded or included in the most directly comparable measure calculated and presented in accordance with GAAP. The presentation of this non-GAAP financial information is not intended to be considered in isolation or as a substitute for, or superior to, the financial information prepared and presented in accordance with GAAP. We use non-GAAP financial measures for internal financial and operational decision making purposes and as a means to evaluate period-to-period comparisons of the performance and results of operations of our core business. Our management believes that non-GAAP financial measures provide meaningful supplemental information regarding the performance of our core business by excluding charges that are not incurred in the normal course of business. Non-GAAP financial measures also facilitate management's internal planning and comparisons to our historical performance and liquidity. We believe certain non-GAAP financial measures are useful to investors as they allow for greater transparency with respect to key metrics used by management in its financial and operational decision making and are used by our institutional investors and the analyst community to help them analyze the performance and operational results of our core business. Net transportation and service revenue.Net transportation and service revenue represents total revenue less the total direct costs of transportation and services, which includes charter hire, voyage and vessel operating expenses. Net transportation and service revenue is included because it is used by management and certain investors to measure performance by comparison to other logistic service providers. Net transportation and service revenue is not an item recognized by the generally accepted accounting principles in the United States of America, or U.S. GAAP, and should not be considered as an alternative to net income, operating income, or any other indicator of a company's operating performance required by U.S. GAAP. Pangaea's definition of net transportation and service revenue used here may not be comparable to an operating measure used by other companies. Adjusted EBITDA and adjusted EPS. Adjusted EBITDA represents income or loss from operations before depreciation, amortization and, when applicable, loss on sale and leaseback of vessel, loss on impairment of vessels, stock-based compensation and certain non-recurring charges. Earnings per share represents net income divided by the weighted average number of common shares outstanding. Adjusted earnings per share represents net income attributable to Pangaea Logistics Solutions Ltd. plus, when applicable, loss on sale of vessel, loss on sale and leaseback of vessel, loss on impairment of vessel, unrealized gains and losses on derivative instruments, and certain non-recurring charges, divided by the weighted average number of shares of common stock. There are limitations related to the use of net revenue versus income from operations, adjusted EBITDA versus income from operations, and adjusted EPS versus EPS calculated in accordance with GAAP. In particular, Pangaea's definition of adjusted EBITDA used here are not comparable to EBITDA. The table set forth above provides a reconciliation of the non-GAAP financial measures presented during the period to the most directly comparable financial measures prepared in accordance with GAAP. About Pangaea Logistics Solutions Ltd. Pangaea Logistics Solutions Ltd. (NASDAQ: PANL) provides logistics services to a broad base of industrial customers who require the transportation of a wide variety of dry bulk cargoes, including grains, pig iron, hot briquetted iron, bauxite, alumina, cement clinker, dolomite, and limestone. The Company addresses the transportation needs of its customers with a comprehensive set of services and activities, including cargo loading, cargo discharge, vessel chartering, and voyage planning. Learn more at www.pangaeals.com. Investor Relations Contacts Gianni Del Signore Tiya Gulanikar Chief Financial Officer Prosek Partners 401-846-7790 646-818-9288 [emailprotected] [emailprotected] Forward-Looking Statements Certain statements in this press release are "forward-looking statements" within the meaning of the Private Securities Litigation Act of 1995. These forward-looking statements are based on our current expectations and beliefs and are subject to a number of risk factors and uncertainties that could cause actual results to differ materially from those described in the forward-looking statements. The Company disclaims any obligation to publicly update or revise these statements whether as a result of new information, future events or otherwise, except as required by law. Such risks and uncertainties include, without limitation, the strength of world economies and currencies, general market conditions, including fluctuations in charter rates and vessel values, changes in demand for dry bulk shipping capacity, changes in our operating expenses, including bunker prices, dry-docking and insurance costs, the market for our vessels, availability of financing and refinancing, charter counterparty performance, ability to obtain financing and comply with covenants in such financing arrangements, changes in governmental rules and regulations or actions taken by regulatory authorities, potential liability from pending or future litigation, general domestic and international political conditions, potential disruption of shipping routes due to accidents or political events, vessels breakdowns and instances of off-hires and other factors, as well as other risks that have been included in filings with the Securities and Exchange Commission, all of which are available at www.sec.gov. SOURCE Pangaea Logistics Solutions Ltd. Related Links www.pangaeals.com
Answer: | Pangaea Logistics Solutions Ltd. Reports Financial Results for the Quarter Ended June 30, 2020 | NEWPORT, R.I., Aug. 12, 2020 /PRNewswire/ -- Pangaea Logistics Solutions Ltd. ("Pangaea" or the "Company") (NASDAQ: PANL), a global provider of comprehensive maritime logistics solutions, announced today its results for the three months ended June30, 2020. 2nd Quarter Highlights Net income attributable to Pangaea Logistics Solutions Ltd. was $3.0 million for three months ended June 30, 2020 as compared to $4.0 million of net income for the same period of 2019. Non-GAAP adjusted net income attributable to Pangaea Logistics Solutions Ltd. of $3.7 million as compared to $3.8 million for the three months ended June 30, 2019. Net income per share was $0.07 for three months ended June 30, 2020 as compared to earnings per share of $0.09 for the same period of 2019. Pangaea's TCE rates were $10,733 for the three months ended June 30, 2020 and $12,933 for the three months ended June 30, 2019. The market average for the second quarter of 2020 was approximately $5,548, giving the Company an overall average premium over market rates of approximately $5,185 or 93%. Adjusted EBITDA of $10.7 million for the three months ended June 30, 2020. Total revenue decreased to $70.4 million for the three months ended June 30, 2020, from $83.3 million for the three months ended June 30, 2019 due to a decrease in market hire and freight rates. At the end of the quarter, Pangaea had $49.5 million in cash, restricted cash and cash equivalents. Ed Coll, Chief Executive Officer of Pangaea Logistics Solutions, commented: "Our strong second quarter results outperformed in a challenging dry bulk market that tested historic lows in April and May. Adhering to our strategy in turbulent markets, we limited our exposure by adjusting our fleet composition, redelivering chartered vessels back to their owners over the last several months and replacing them when needed at lower cost. Second quarter 2020 operating income of $6.1 million, before non-cash impairment charges, is a remarkable turnaround from our first quarter of 2020 operating loss of $2.3 million. Our achieved TCE rate of $10,733 per day represented an outperformance of $5,548, or 93% premium over the average market rates. Mr. Coll added, "Looking forward we move into our seasonally strong summer ice season in a strong position. Although the market has recovered somewhat since June, we are watching global economic output and the disruptions caused by COVID-19, from changes to our working environment to rotating crews aboard our vessels. We sincerely empathize with the hardships our people and their familiars are facing, ashore and aboard our vessels. Our results are encouraging, but we expect, and will prepare for, continued uncertainty and turbulence in our markets over the next few quarters." Results for the three months ended June30, 2020 and 2019 Total revenue was $70.4 million for the three months ended June 30, 2020, compared with $83.3 million for the three months ended June 30, 2019. The 15% decrease in revenues was mainly attributed to the decrease in the average time charter rates achieved by our vessels during the second quarter of 2020 compared to the same period in 2019. Time Charter Equivalent rate (TCE) was $10,733 per day for the three months ended June 30, 2020, compared to an average of $12,933 per day for the same period in 2019. However, the achieved premium over the average market increased by $5,185 per day or 93% for the three months ended June 30, 2020. The total number of shipping days remained relatively consistent with a 1% increase to 3,600 days in the three months ended June 30, 2020, compared to 3,562 for the same period in 2019, predominantly due to the increase in voyage days. Liquidity and Cash Flows Cash, restricted cash and cash equivalents were $49.5 million as of June30, 2020, compared with $53.1 million on December31, 2019. At June30, 2020 and December31, 2019, the Company had working capital of $37.3 million and $37.1 million, respectively. Operating cash flows during thesixmonths endedJune30, 2020 was a net inflow of$6.9 million as compared toa net inflow of $19.6 millionduring the same period of 2019. Investing cash flows during the six months ended June30, 2020 was a net inflow of $5.8 million as compared to a net outflow of $33.5 million during the same period of2019. Financing cash flows during the six months ended June30, 2020 was a net outflow of $16.2 million as compared to net inflow of $1.5 million during the same period of 2019. The Company sold two vessels and paid off a lease obligation during the six months ended June 30, 2020. Subsequent Event On June 29, 2020, the Company entered into a memorandum of agreement to sell the Bulk Beothuk, a 2002-built Supramax vessel, to a third party for $4.6million less a broker commission payable to a third party. The vessel was delivered to its new owner on August 4, 2020. Conference Call Details The Company's management team will host a conference call to discuss the Company's financial results on August 13, 2020 at 8:00 a.m., Eastern Time (ET). To access the conference call, please dial (888) 895-3561 (domestic) or (904) 685-6494 (international) approximately ten minutes before the scheduled start time and reference ID#8947025. A supplemental slide presentation will accompany this quarter's conference call and can be found attached to the Current Report on Form 8-K that the Company filed concurrently with this press release. This document will be available at http://www.pangaeals.com/company-filings or at sec.gov. A recording of the call will also be available for two weeks and can be accessed by calling (855) 859-2056 (domestic) or (404) 537-3406 (international) and referencing ID#8947025. Pangaea Logistics Solutions Ltd. Consolidated Statements of Operations (unaudited) Three Months Ended June 30, Six Months Ended June 30, 2020 2019 2020 2019 Revenues: Voyage revenue $ 66,857,166 $ 77,430,067 $ 153,381,057 $ 143,281,414 Charter revenue 3,539,004 5,860,548 12,895,050 19,553,386 70,396,170 83,290,615 166,276,107 162,834,800 Expenses: Voyage expense 31,757,910 37,224,412 79,553,822 69,398,519 Charter hire expense 15,203,731 18,317,345 47,529,178 43,264,714 Vessel operating expense 9,325,060 11,074,547 19,258,922 20,828,922 General and administrative 3,872,388 5,358,991 7,865,631 9,392,671 Depreciation and amortization 4,345,707 4,491,327 8,587,958 8,868,515 Loss on impairment of vessels 1,801,039 1,801,039 Loss on sale of vessels 297,475 219,485 Total expenses 66,603,310 76,466,622 164,816,035 151,753,341 Income from operations 3,792,860 6,823,993 1,460,072 11,081,459 Other (expense) income: Interest expense, net (2,000,550) (2,101,052) (4,116,870) (4,308,220) Interest expense on related party debt (11,138) (38,036) Unrealized gain (loss) on derivative instruments, net 1,404,317 215,171 (1,512,777) 2,504,957 Other income 98,635 232,092 695,191 399,912 Total other (expense), net (497,598) (1,664,927) (4,934,456) (1,441,387) Net income (loss) 3,295,262 5,159,066 (3,474,384) 9,640,072 Income attributable to non-controlling interests (290,086) (1,126,565) (315,815) (1,905,017) Net income (loss) attributable to Pangaea Logistics Solutions Ltd. $ 3,005,176 $ 4,032,501 $ (3,790,199) $ 7,735,055 Earnings per common share: Basic $ 0.07 $ 0.09 $ (0.09) $ 0.18 Diluted $ 0.07 $ 0.09 $ (0.09) $ 0.18 Weighted average shares used to compute earnings per common share: Basic 43,445,789 42,767,785 43,442,773 42,684,966 Diluted 43,445,789 43,293,022 43,442,773 43,202,187 Pangaea Logistics Solutions Ltd. Consolidated Balance Sheets June 30, 2020 December 31, 2019 (unaudited) Assets Current assets Cash and cash equivalents $ 46,993,067 $ 50,555,091 Restricted cash 1,000,000 1,000,000 Accounts receivable (net of allowance of $1,723,510 and $1,908,841 at June 30, 2020 and December 31, 2019, respectively) 18,197,943 28,309,402 Bunker inventory 11,648,319 21,001,010 Advance hire, prepaid expenses and other current assets 15,575,442 18,770,825 Vessel held for sale 4,563,000 8,319,152 Total current assets 97,977,771 127,955,480 Restricted cash 1,500,000 1,500,000 Fixed assets, net 278,383,059 281,474,857 Investment in newbuildings in-process 15,390,634 15,357,189 Finance lease right of use assets, net 46,259,982 53,615,305 Total assets $ 439,511,446 $ 479,902,831 Liabilities and stockholders' equity Current liabilities Accounts payable, accrued expenses and other current liabilities $ 26,528,278 $ 39,973,635 Related party debt 242,852 332,987 Deferred revenue 5,343,392 14,376,394 Current portion of secured long-term debt 21,490,674 22,990,674 Current portion of finance lease liabilities 6,927,362 12,549,208 Dividend payable 95,500 631,961 Total current liabilities 60,628,058 90,854,859 Secured long-term debt, net 78,779,452 83,649,717 Finance lease liabilities, net 54,028,493 57,498,217 Long-term liabilities - other 5,108,793 4,828,364 Commitments and contingencies Stockholders' equity: Preferred stock, $0.0001 par value, 1,000,000 shares authorized and no shares issued or outstanding Common stock, $0.0001 par value, 100,000,000 shares authorized; 45,065,662 shares issued and outstanding at June 30, 2020; 44,886,122 shares issued and outstanding at December 31, 2019 4,507 4,489 Additional paid-in capital 158,874,237 157,504,895 Retained earnings 8,946,381 12,736,580 Total Pangaea Logistics Solutions Ltd. equity 167,825,125 170,245,964 Non-controlling interests 73,141,525 72,825,710 Total stockholders' equity 240,966,650 243,071,674 Total liabilities and stockholders' equity $ 439,511,446 $ 479,902,831 Pangaea Logistics Solutions Ltd. Consolidated Statements of Cash Flows (unaudited) Six Months Ended June 30, 2020 2019 Operating activities Net (loss) income $ (3,474,384) $ 9,640,072 Adjustments to reconcile net income to net cash (used in) provided by operations: Depreciation and amortization expense 8,587,958 8,868,515 Amortization of deferred financing costs 346,985 365,564 Amortization of prepaid rent 61,136 59,299 Unrealized loss (gain) on derivative instruments 1,512,777 (2,504,957) Gain from equity method investee (795,988) (247,312) Earnings attributable to non-controlling interest recorded as interest expense 28,166 (Recovery) provision for doubtful accounts (185,331) 320,491 Loss on impairment of vessels 1,801,039 Loss on sale of vessel 219,485 Drydocking costs (2,882,109) (1,545,094) Share-based compensation 1,523,486 1,045,507 Change in operating assets and liabilities: Accounts receivable 10,296,790 7,984,657 Bunker inventory 9,352,691 1,775,598 Advance hire, prepaid expenses and other current assets 3,991,371 (1,821,751) Accounts payable, accrued expenses and other current liabilities (14,444,003) 1,546,305 Deferred revenue (9,033,002) (5,902,610) Net cash provided by operating activities 6,907,067 19,584,284 Investing activities Purchase of vessels and vessel improvements (1,652,366) (25,557,060) Investment in newbuildings in-process (33,445) (7,657,000) Purchase of fixed assets and equipment (7,801) (281,011) Proceeds from sale of vessels 8,099,667 Purchase of derivative instrument (628,000) Net cash provided by (used in) investing activities 5,778,055 (33,495,071) Financing activities Proceeds from long-term debt 14,000,000 Payments of related party debt (1,691,964) Payments of financing fees and issuance costs (149,118) (277,577) Payments of long-term debt (6,568,134) (12,242,949) Proceeds from finance leases 13,000,000 Dividends paid to non-controlling interests (4,666,665) Payments of finance lease obligations (9,091,570) (2,908,693) Accrued common stock dividends paid (536,461) (3,754,985) Cash paid for incentive compensation shares relinquished (154,126) Contributions from non-controlling interest recorded as long-term liability 322,750 Payments to non-controlling interest recorded as long-term liability (70,487) Net cash (used in) provided by financing activities (16,247,146) 1,457,167 Net decrease in cash, cash equivalents and restricted cash (3,562,024) (12,453,620) Cash, cash equivalents and restricted cash at beginning of period 53,055,091 56,114,735 Cash, cash equivalents and restricted cash at end of period $ 49,493,067 $ 43,661,115 Supplemental cash flow information Cash and cash equivalents $ 46,993,067 $ 41,161,115 Restricted cash 2,500,000 2,500,000 $ 49,493,067 $ 43,661,115 Pangaea Logistics Solutions Ltd. Reconciliation of Non-GAAP Measures (unaudited) Three Months Ended June 30, Six Months Ended June 30, 2020 2019 2020 2019 Net Transportation and Service Revenue Gross Profit 9,781,061 12,218,543 11,409,632 20,545,840 Add: Vessel Depreciation and Amortization 4,328,408 4,455,768 8,524,553 8,796,805 Net transportation and service revenue $ 14,109,469 $ 16,674,311 $ 19,934,185 $ 29,342,645 Adjusted EBITDA Income from operations $ 3,792,860 $ 6,823,993 $ 1,460,072 $ 11,081,459 Depreciation and amortization 4,345,707 4,491,327 8,587,958 8,868,515 Loss on impairment of vessels 1,801,039 1,801,039 Loss on sale of vessel 297,475 219,485 Share-based compensation 420,717 370,908 1,523,486 1,045,507 Adjusted EBITDA $ 10,657,798 $ 11,686,228 $ 13,592,040 $ 20,995,481 Earnings Per Common Share Net income (loss) attributable to Pangaea Logistics Solutions Ltd. $ 3,005,176 $ 4,032,501 $ (3,790,199) $ 7,735,055 Weighted average number of common shares outstanding - basic 43,445,789 42,767,785 43,442,773 42,684,966 Weighted average number of common shares outstanding - diluted 43,445,789 43,293,022 43,442,773 43,202,187 Earnings per common share - basic $ 0.07 $ 0.09 $ (0.09) $ 0.18 Earnings per common share - diluted $ 0.07 $ 0.09 $ (0.09) $ 0.18 Adjusted EPS Net Income attributable to Pangaea Logistics Solutions Ltd. $ 3,005,176 $ 4,032,501 $ (3,790,199) $ 7,735,055 Non-GAAP Add: loss on sale of vessels 297,475 219,485 Loss on impairment of vessels 1,801,039 1,801,039 Unrealized (gain) loss on derivative instruments (1,404,317) (215,171) 1,512,777 (2,504,957) Non-GAAP adjusted net income (loss) attributable to Pangaea Logistics Solutions Ltd. $ 3,699,373 $ 3,817,330 $ (256,898) $ 5,230,098 Weighted average number of common shares - basic 43,445,789 42,767,785 43,442,773 42,684,966 Weighted average number of common shares - diluted 43,445,789 43,293,022 43,442,773 43,202,187 Adjusted EPS - basic $ 0.09 $ 0.09 $ (0.01) $ 0.12 Adjusted EPS - diluted $ 0.09 $ 0.09 $ (0.01) $ 0.12 INFORMATION ABOUT NON-GAAP FINANCIAL MEASURES. As used herein, "GAAP" refers to accounting principles generally accepted in the United States of America. To supplement our consolidated financial statements prepared and presented in accordance with GAAP, this earnings release discusses non-GAAP financial measures, including non-GAAP net revenue and non-GAAP adjusted EBITDA. This is considered a non-GAAP financial measure as defined in Rule 101 of Regulation G promulgated by the Securities and Exchange Commission. Generally, a non-GAAP financial measure is a numerical measure of a company's historical or future performance, financial position, or cash flows that either excludes or includes amounts that are not normally excluded or included in the most directly comparable measure calculated and presented in accordance with GAAP. The presentation of this non-GAAP financial information is not intended to be considered in isolation or as a substitute for, or superior to, the financial information prepared and presented in accordance with GAAP. We use non-GAAP financial measures for internal financial and operational decision making purposes and as a means to evaluate period-to-period comparisons of the performance and results of operations of our core business. Our management believes that non-GAAP financial measures provide meaningful supplemental information regarding the performance of our core business by excluding charges that are not incurred in the normal course of business. Non-GAAP financial measures also facilitate management's internal planning and comparisons to our historical performance and liquidity. We believe certain non-GAAP financial measures are useful to investors as they allow for greater transparency with respect to key metrics used by management in its financial and operational decision making and are used by our institutional investors and the analyst community to help them analyze the performance and operational results of our core business. Net transportation and service revenue.Net transportation and service revenue represents total revenue less the total direct costs of transportation and services, which includes charter hire, voyage and vessel operating expenses. Net transportation and service revenue is included because it is used by management and certain investors to measure performance by comparison to other logistic service providers. Net transportation and service revenue is not an item recognized by the generally accepted accounting principles in the United States of America, or U.S. GAAP, and should not be considered as an alternative to net income, operating income, or any other indicator of a company's operating performance required by U.S. GAAP. Pangaea's definition of net transportation and service revenue used here may not be comparable to an operating measure used by other companies. Adjusted EBITDA and adjusted EPS. Adjusted EBITDA represents income or loss from operations before depreciation, amortization and, when applicable, loss on sale and leaseback of vessel, loss on impairment of vessels, stock-based compensation and certain non-recurring charges. Earnings per share represents net income divided by the weighted average number of common shares outstanding. Adjusted earnings per share represents net income attributable to Pangaea Logistics Solutions Ltd. plus, when applicable, loss on sale of vessel, loss on sale and leaseback of vessel, loss on impairment of vessel, unrealized gains and losses on derivative instruments, and certain non-recurring charges, divided by the weighted average number of shares of common stock. There are limitations related to the use of net revenue versus income from operations, adjusted EBITDA versus income from operations, and adjusted EPS versus EPS calculated in accordance with GAAP. In particular, Pangaea's definition of adjusted EBITDA used here are not comparable to EBITDA. The table set forth above provides a reconciliation of the non-GAAP financial measures presented during the period to the most directly comparable financial measures prepared in accordance with GAAP. About Pangaea Logistics Solutions Ltd. Pangaea Logistics Solutions Ltd. (NASDAQ: PANL) provides logistics services to a broad base of industrial customers who require the transportation of a wide variety of dry bulk cargoes, including grains, pig iron, hot briquetted iron, bauxite, alumina, cement clinker, dolomite, and limestone. The Company addresses the transportation needs of its customers with a comprehensive set of services and activities, including cargo loading, cargo discharge, vessel chartering, and voyage planning. Learn more at www.pangaeals.com. Investor Relations Contacts Gianni Del Signore Tiya Gulanikar Chief Financial Officer Prosek Partners 401-846-7790 646-818-9288 [emailprotected] [emailprotected] Forward-Looking Statements Certain statements in this press release are "forward-looking statements" within the meaning of the Private Securities Litigation Act of 1995. These forward-looking statements are based on our current expectations and beliefs and are subject to a number of risk factors and uncertainties that could cause actual results to differ materially from those described in the forward-looking statements. The Company disclaims any obligation to publicly update or revise these statements whether as a result of new information, future events or otherwise, except as required by law. Such risks and uncertainties include, without limitation, the strength of world economies and currencies, general market conditions, including fluctuations in charter rates and vessel values, changes in demand for dry bulk shipping capacity, changes in our operating expenses, including bunker prices, dry-docking and insurance costs, the market for our vessels, availability of financing and refinancing, charter counterparty performance, ability to obtain financing and comply with covenants in such financing arrangements, changes in governmental rules and regulations or actions taken by regulatory authorities, potential liability from pending or future litigation, general domestic and international political conditions, potential disruption of shipping routes due to accidents or political events, vessels breakdowns and instances of off-hires and other factors, as well as other risks that have been included in filings with the Securities and Exchange Commission, all of which are available at www.sec.gov. SOURCE Pangaea Logistics Solutions Ltd. Related Links www.pangaeals.com |
edtsum2120 | You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text.
Text: BOSTON--(BUSINESS WIRE)--Early Black Friday AT&T Wireless deals have landed. Review the best savings on best-selling smartphones from popular brands like Apple, Samsung, LG and Motorola. Find the full selection of deals listed below. Best AT&T iPhone Deals: Best AT&T Apple Watch & iPad Deals: Best AT&T Galaxy & Pixel Phone Deals: More AT&T Deals: Want some more deals? We recommend checking Walmarts Black Friday Deals for Days sale and Amazons latest Black Friday-worthy deals to compare more discounts at the moment. Deal Tomato earns commissions from purchases made using the links provided. AT&T, one of Americas leading telecom companies, have phone deals that new and existing customers will surely love. For example, AT&T Wireless customers can get an iPhone 12 at zero fees. Other Apple iPhone models from iPhone 7 to 11 are also available in their list of available phones. AT&T also has interesting promos for the latest smartphone models from brands like Samsung, LG, and Motorola. Aside from phone deals, the company also gives rewards to customers of their TV and Fiber Internet plans. About Deal Tomato: Deal Tomato reports on popular sales events. As an Amazon Associate and affiliate Deal Tomato earns from qualifying purchases.
Answer: | AT&T Black Friday Deals 2020: Early AT&T iPhone Savings Reviewed by Deal Tomato Round-up of all the best early AT&T phone deals for Black Friday, including sales on Samsung, Motorola, LG and Apple iPhones | BOSTON--(BUSINESS WIRE)--Early Black Friday AT&T Wireless deals have landed. Review the best savings on best-selling smartphones from popular brands like Apple, Samsung, LG and Motorola. Find the full selection of deals listed below. Best AT&T iPhone Deals: Best AT&T Apple Watch & iPad Deals: Best AT&T Galaxy & Pixel Phone Deals: More AT&T Deals: Want some more deals? We recommend checking Walmarts Black Friday Deals for Days sale and Amazons latest Black Friday-worthy deals to compare more discounts at the moment. Deal Tomato earns commissions from purchases made using the links provided. AT&T, one of Americas leading telecom companies, have phone deals that new and existing customers will surely love. For example, AT&T Wireless customers can get an iPhone 12 at zero fees. Other Apple iPhone models from iPhone 7 to 11 are also available in their list of available phones. AT&T also has interesting promos for the latest smartphone models from brands like Samsung, LG, and Motorola. Aside from phone deals, the company also gives rewards to customers of their TV and Fiber Internet plans. About Deal Tomato: Deal Tomato reports on popular sales events. As an Amazon Associate and affiliate Deal Tomato earns from qualifying purchases. |
edtsum2124 | You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text.
Text: BOSTON--(BUSINESS WIRE)--Compare the top Bose soundbar & speaker deals for Black Friday 2020, featuring all the latest Bose soundbar 700, 500 and more deals. Links to the best deals are listed below. Best Bose Speaker & Soundbar Deals: Looking for more deals? Click here to compare the entire range of deals at Walmarts Black Friday sale and click here to shop Amazons live Black Friday deals. The Consumer Post earns commissions from purchases made using the links provided. About The Consumer Post: The Consumer Post shares news for online shoppers. As an Amazon Associate and affiliate The Consumer Post earns from qualifying purchases.
Answer: | Bose Soundbar & Speaker Black Friday Deals 2020: Best Soundbar 700, 500, 300 & More Bose Speaker & Soundbar Deals Compiled by The Consumer Post The latest Bose soundbar & speaker deals for Black Friday 2020, including wireless portable speakers & soundbar sales | BOSTON--(BUSINESS WIRE)--Compare the top Bose soundbar & speaker deals for Black Friday 2020, featuring all the latest Bose soundbar 700, 500 and more deals. Links to the best deals are listed below. Best Bose Speaker & Soundbar Deals: Looking for more deals? Click here to compare the entire range of deals at Walmarts Black Friday sale and click here to shop Amazons live Black Friday deals. The Consumer Post earns commissions from purchases made using the links provided. About The Consumer Post: The Consumer Post shares news for online shoppers. As an Amazon Associate and affiliate The Consumer Post earns from qualifying purchases. |
edtsum2125 | You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text.
Text: SECAUCUS, N.J., Jan. 18, 2021 /PRNewswire/ -- A new Quest Diagnostics Health Trends study finds that Black and Hispanic/Latinx Americans are nearly two times as likely as White Americans to say their access to COVID-19 vaccines, treatments and healthcare, once available, is worse than other racial/ethnic groups. The study, titledCOVID-19: MagnifyingRacial Disparitiesin U.S. Healthcare, is based on a nationally representative survey conducted online by The Harris Poll on behalf of Quest Diagnostics (NYSE: DGX). View PDF Quest Diagnostics Health Trends: COVID-19 and Racial Disparities in Healthcare "COVID-19 has exacerbated long-standing inequities in healthcare, particularly among communities of color.Our new Health Trends research reveals people perceive, trust and engage with the healthcare system for COVID-19 differently depending on race and ethnicity,"saidHarvey W. Kaufman, M.D.,Senior Medical Director, Head of the Health Trends Research Program for Quest Diagnostics."Importantly, it also reveals they expect America's COVID-19 experience will lead to meaningful change in healthcare. Policy makers and providers should take these insights to heart, particularly as our country embarks on an unprecedented vaccination campaign." COVID-19: MagnifyingRacial DisparitiesinU.S.Healthcarereveals racial dividesin perceptions of access to healthcare andtrust during the pandemic.Select findingsbelow:Blackand Hispanic/Latinx Americanslackconfidence inaccess to COVID-19 vaccines, therapeutics and diagnostics Black and Hispanic/Latinx Americans are nearly two times as likely to say their access to COVID-19 vaccines, once available, is worse than other racial/ethnic groups, compared to White Americans (Black, 21%; Hispanic/Latinx, 17%; White 9%). In addition, a larger proportion of Black and Hispanic/Latinx Americans felt access to COVID testing (15%, Black; 17%, Hispanic/Latinx vs. 8% White), COVID therapeutics (22%; 19% vs. 10%), quality preventative care during COVID (23%; 17% vs. 9%) and quality COVID-19 care (20%; 15% vs. 9%) is inferior to access for people of other races. Fewer Black and Hispanic/Latinx Americans trust they would receiveequitable life-savingCOVID-19care A much higher percentage of White Americans (84%) are confident that they would receive the same life-saving care as people of other races or ethnicities if they contracted COVID-19. Conversely, only 67% of Hispanic/Latinx Americans and 64% of Black Americans share this confidence. Fewer Black Americans (79%) and Hispanic/Latinx Americans (71%) trust their doctors would do everything possible to save their life if diagnosed with COVID-19 than White Americans (85%). The survey found that 42% of Black Americans are more scared of getting COVID-19 than a delayed diagnosis for cancer, compared to only 33% of White Americans. Lack ofpreventativecaremayfuel concern in undiagnosed conditions One in two Black Americans (49%) are concerned they currently have an undiagnosed health condition, compared to only 39% of White Americans. A majority of Americans (60%) have skipped or delayed some in-person medical treatments or appointments during the COVID-19 pandemic, especially Hispanic/Latinx Americans (67%, compared to White and Black Americans at 59% and 58%, respectively). The study also found that52% of Americans expectactions will be takento address racial disparities in healthcare in the wake of COVID-19."Our society is at an inflection point in terms of publicly and openly acknowledging, accepting and acting to eliminate racial disparities in healthcare,"said Gary A.Puckrein, Ph.D., President and Chief Executive Officer of theNational Minority Quality Forum."ThisQuest Diagnostics researchunderscores the lack of trust and access to healthcare in minority communities. It's vital for organizations both public and private to step off the sidelines and get into the game to take steps to build a more equitable healthcare system for all Americans. By sharing data and insights that demonstrate the depth and breadth of racial disparities, Quest Diagnostics is taking meaningful action to help solve the larger population health crisis that COVID-19 has further exposed."The analysis follows aHealth Trends reportissued last month that found that a majority of all Americans(74%)have avoided or delayed getting a diagnostic COVID-19 test when they believed they needed one (Black, 72%; Hispanic/Latinx, 83%; White 72%).AddressingRacialDisparities inHealth"2021 provides a moment to illuminate pathways forward to addressing inequities so people can access quality COVID-19 care and other services regardless of race or ethnicity," said Harvey W. Kaufman, M.D., Senior Medical Director, Head of the Health Trends Research Program for Quest Diagnostics. "COVID-19 has increased the moral imperative and urgency to address racial and ethnic disparities in healthcare,including issues of access and bias."To help address disparities now and in the future, Quest Diagnostics is working immediately to improve the equitable allocation of diagnostic testing. One of these strategies involves tailoring outreach through collaborations to encourage vulnerable communities to get back to care, in part to help better control the chronic conditions that increase risk for severe illness due to COVID-19. Insights from this study have informed additional steps Quest Diagnostics will take to improve health equity, reduce racial bias in healthcare and build trust with communities of color.In August 2020, Quest DiagnosticsannouncedQuest for Health Equity, a national initiative to address and reduce health disparities in underserved communities, including those impacted by COVID-19. The multi-year initiative involves a commitment of more than $100 million in resources by Quest Diagnostics and the Quest Diagnostics Foundation for a combination of testing services, education programs,collaborations, and direct financial support.The initiative builds on the company's relationships withfederally qualified health centers (FQHCs),through which it provides COVID-19 testing and otherlaboratory services to underserved communitiesacross the United States.In addition,inresponse toinequities highlighted by COVID-19, the company's Health Trends team haspublishedpeer-reviewedresearch, based on the company's de-identified laboratory data,on racial/ethnic differences in COVID-19testingresults.This includes a recent study thatfoundthatlargelyBlack non-Hispanic and Hispanic populationsin the United Stateshave the highest COVID-19 test positivity rates."COVID-19 highlightedexistinghealth disparities and the enormity of the problem.Too many Americansfrom ourmost vulnerable communities aredisproportionately impactedand too many lack access to care andCOVID-19 and otherdiagnostic testingamidst a pandemic,"saidRuth Clements, Vice President and General Manager of Infectious DiseasesandImmunology and leader for Quest for Health Equity at Quest Diagnostics."At Quest, we believe in equal access to COVID-19 testing andimportant preventative diagnosticservices. Through ourcommunitycollaborationslike Choose Healthy Life with the Black clergyand FQHCswe are striving to bring health equity to populations in need."MethodologyOn behalf of QuestDiagnostics, The Harris Poll conducted an online survey of 2,050 adults 18 years and older across the United States from November 10-12, 2020. The survey sample included 337 Hispanic/Latinx, 265 Black and 1,278 White adults.Figures for age by sex, region, education, household size, marital status and household incomewere weightedby race/ethnicity where necessary to make them representative of their actual proportions in the population. The Harris Poll is one of the longest running surveys in the U.S. tracking public opinion, motivations and social sentiment since 1963 that is now part of Harris Insights & Analytics, a global consulting and market research firm that delivers social intelligence for transformational times.About Quest Diagnostics Health TrendsQuest Diagnostics Health Trends is a series of scientific reports that provide insights into health topics, based on analysis of objective clinical laboratory data, to empower better patient care, population health management and public health policy. The reports are based on the Quest Diagnostics database of 48 billion de-identified laboratory test results, believed to be the largest of its kind in healthcare. Health Trends has yielded novel insights to aid the management of allergies and asthma, prescription drug monitoring, diabetes, Lyme disease, heart disease, influenza and workplace wellness. Quest Diagnostics also produces theDrug Testing Index (DTI), a series of reports on national workplace drug positivity trends based on the company's employer workplace drug testing data. www.QuestDiagnostics.com/HealthTrendsAbout COVID-19Testing at Quest DiagnosticsQuest Diagnostics empowers people to take action to improve health outcomes. Derived from the world's largest database of clinical lab results, our diagnostic insights reveal new avenues to identify and treat disease, inspire healthy behaviors and improve health care management. Quest annually serves one in three adult Americans and half the physicians and hospitals intheUnited States, and our 47,000 employees understand that, in the right hands and with the right context, our diagnostic insights can inspire actions that transform lives. For the latest developments with our COVID-19 testing, visit: newsroom.questdiagnostics.com/COVIDTestingUpdatesAbout Quest DiagnosticsQuest Diagnostics empowers people to take action to improve health outcomes. Derived from the world's largest database of clinical lab results, our diagnostic insights reveal new avenues to identify and treat disease, inspire healthy behaviors and improve health care management. Quest annually serves one in three adult Americans and half the physicians and hospitals intheUnited States, and our 47,000 employees understand that, in the right hands and with the right context, our diagnostic insights can inspire actions that transform lives.www.QuestDiagnostics.comFollow us on social media:Linkedin,Twitter,FacebookandInstagram.SOURCE Quest Diagnostics
Answer: | Black and Hispanic/Latinx Americans Less Confident in Ability to Access COVID-19 Vaccines, Treatments and Healthcare than White Americans, Finds Quest Diagnostics Health Trends Analysis | SECAUCUS, N.J., Jan. 18, 2021 /PRNewswire/ -- A new Quest Diagnostics Health Trends study finds that Black and Hispanic/Latinx Americans are nearly two times as likely as White Americans to say their access to COVID-19 vaccines, treatments and healthcare, once available, is worse than other racial/ethnic groups. The study, titledCOVID-19: MagnifyingRacial Disparitiesin U.S. Healthcare, is based on a nationally representative survey conducted online by The Harris Poll on behalf of Quest Diagnostics (NYSE: DGX). View PDF Quest Diagnostics Health Trends: COVID-19 and Racial Disparities in Healthcare "COVID-19 has exacerbated long-standing inequities in healthcare, particularly among communities of color.Our new Health Trends research reveals people perceive, trust and engage with the healthcare system for COVID-19 differently depending on race and ethnicity,"saidHarvey W. Kaufman, M.D.,Senior Medical Director, Head of the Health Trends Research Program for Quest Diagnostics."Importantly, it also reveals they expect America's COVID-19 experience will lead to meaningful change in healthcare. Policy makers and providers should take these insights to heart, particularly as our country embarks on an unprecedented vaccination campaign." COVID-19: MagnifyingRacial DisparitiesinU.S.Healthcarereveals racial dividesin perceptions of access to healthcare andtrust during the pandemic.Select findingsbelow:Blackand Hispanic/Latinx Americanslackconfidence inaccess to COVID-19 vaccines, therapeutics and diagnostics Black and Hispanic/Latinx Americans are nearly two times as likely to say their access to COVID-19 vaccines, once available, is worse than other racial/ethnic groups, compared to White Americans (Black, 21%; Hispanic/Latinx, 17%; White 9%). In addition, a larger proportion of Black and Hispanic/Latinx Americans felt access to COVID testing (15%, Black; 17%, Hispanic/Latinx vs. 8% White), COVID therapeutics (22%; 19% vs. 10%), quality preventative care during COVID (23%; 17% vs. 9%) and quality COVID-19 care (20%; 15% vs. 9%) is inferior to access for people of other races. Fewer Black and Hispanic/Latinx Americans trust they would receiveequitable life-savingCOVID-19care A much higher percentage of White Americans (84%) are confident that they would receive the same life-saving care as people of other races or ethnicities if they contracted COVID-19. Conversely, only 67% of Hispanic/Latinx Americans and 64% of Black Americans share this confidence. Fewer Black Americans (79%) and Hispanic/Latinx Americans (71%) trust their doctors would do everything possible to save their life if diagnosed with COVID-19 than White Americans (85%). The survey found that 42% of Black Americans are more scared of getting COVID-19 than a delayed diagnosis for cancer, compared to only 33% of White Americans. Lack ofpreventativecaremayfuel concern in undiagnosed conditions One in two Black Americans (49%) are concerned they currently have an undiagnosed health condition, compared to only 39% of White Americans. A majority of Americans (60%) have skipped or delayed some in-person medical treatments or appointments during the COVID-19 pandemic, especially Hispanic/Latinx Americans (67%, compared to White and Black Americans at 59% and 58%, respectively). The study also found that52% of Americans expectactions will be takento address racial disparities in healthcare in the wake of COVID-19."Our society is at an inflection point in terms of publicly and openly acknowledging, accepting and acting to eliminate racial disparities in healthcare,"said Gary A.Puckrein, Ph.D., President and Chief Executive Officer of theNational Minority Quality Forum."ThisQuest Diagnostics researchunderscores the lack of trust and access to healthcare in minority communities. It's vital for organizations both public and private to step off the sidelines and get into the game to take steps to build a more equitable healthcare system for all Americans. By sharing data and insights that demonstrate the depth and breadth of racial disparities, Quest Diagnostics is taking meaningful action to help solve the larger population health crisis that COVID-19 has further exposed."The analysis follows aHealth Trends reportissued last month that found that a majority of all Americans(74%)have avoided or delayed getting a diagnostic COVID-19 test when they believed they needed one (Black, 72%; Hispanic/Latinx, 83%; White 72%).AddressingRacialDisparities inHealth"2021 provides a moment to illuminate pathways forward to addressing inequities so people can access quality COVID-19 care and other services regardless of race or ethnicity," said Harvey W. Kaufman, M.D., Senior Medical Director, Head of the Health Trends Research Program for Quest Diagnostics. "COVID-19 has increased the moral imperative and urgency to address racial and ethnic disparities in healthcare,including issues of access and bias."To help address disparities now and in the future, Quest Diagnostics is working immediately to improve the equitable allocation of diagnostic testing. One of these strategies involves tailoring outreach through collaborations to encourage vulnerable communities to get back to care, in part to help better control the chronic conditions that increase risk for severe illness due to COVID-19. Insights from this study have informed additional steps Quest Diagnostics will take to improve health equity, reduce racial bias in healthcare and build trust with communities of color.In August 2020, Quest DiagnosticsannouncedQuest for Health Equity, a national initiative to address and reduce health disparities in underserved communities, including those impacted by COVID-19. The multi-year initiative involves a commitment of more than $100 million in resources by Quest Diagnostics and the Quest Diagnostics Foundation for a combination of testing services, education programs,collaborations, and direct financial support.The initiative builds on the company's relationships withfederally qualified health centers (FQHCs),through which it provides COVID-19 testing and otherlaboratory services to underserved communitiesacross the United States.In addition,inresponse toinequities highlighted by COVID-19, the company's Health Trends team haspublishedpeer-reviewedresearch, based on the company's de-identified laboratory data,on racial/ethnic differences in COVID-19testingresults.This includes a recent study thatfoundthatlargelyBlack non-Hispanic and Hispanic populationsin the United Stateshave the highest COVID-19 test positivity rates."COVID-19 highlightedexistinghealth disparities and the enormity of the problem.Too many Americansfrom ourmost vulnerable communities aredisproportionately impactedand too many lack access to care andCOVID-19 and otherdiagnostic testingamidst a pandemic,"saidRuth Clements, Vice President and General Manager of Infectious DiseasesandImmunology and leader for Quest for Health Equity at Quest Diagnostics."At Quest, we believe in equal access to COVID-19 testing andimportant preventative diagnosticservices. Through ourcommunitycollaborationslike Choose Healthy Life with the Black clergyand FQHCswe are striving to bring health equity to populations in need."MethodologyOn behalf of QuestDiagnostics, The Harris Poll conducted an online survey of 2,050 adults 18 years and older across the United States from November 10-12, 2020. The survey sample included 337 Hispanic/Latinx, 265 Black and 1,278 White adults.Figures for age by sex, region, education, household size, marital status and household incomewere weightedby race/ethnicity where necessary to make them representative of their actual proportions in the population. The Harris Poll is one of the longest running surveys in the U.S. tracking public opinion, motivations and social sentiment since 1963 that is now part of Harris Insights & Analytics, a global consulting and market research firm that delivers social intelligence for transformational times.About Quest Diagnostics Health TrendsQuest Diagnostics Health Trends is a series of scientific reports that provide insights into health topics, based on analysis of objective clinical laboratory data, to empower better patient care, population health management and public health policy. The reports are based on the Quest Diagnostics database of 48 billion de-identified laboratory test results, believed to be the largest of its kind in healthcare. Health Trends has yielded novel insights to aid the management of allergies and asthma, prescription drug monitoring, diabetes, Lyme disease, heart disease, influenza and workplace wellness. Quest Diagnostics also produces theDrug Testing Index (DTI), a series of reports on national workplace drug positivity trends based on the company's employer workplace drug testing data. www.QuestDiagnostics.com/HealthTrendsAbout COVID-19Testing at Quest DiagnosticsQuest Diagnostics empowers people to take action to improve health outcomes. Derived from the world's largest database of clinical lab results, our diagnostic insights reveal new avenues to identify and treat disease, inspire healthy behaviors and improve health care management. Quest annually serves one in three adult Americans and half the physicians and hospitals intheUnited States, and our 47,000 employees understand that, in the right hands and with the right context, our diagnostic insights can inspire actions that transform lives. For the latest developments with our COVID-19 testing, visit: newsroom.questdiagnostics.com/COVIDTestingUpdatesAbout Quest DiagnosticsQuest Diagnostics empowers people to take action to improve health outcomes. Derived from the world's largest database of clinical lab results, our diagnostic insights reveal new avenues to identify and treat disease, inspire healthy behaviors and improve health care management. Quest annually serves one in three adult Americans and half the physicians and hospitals intheUnited States, and our 47,000 employees understand that, in the right hands and with the right context, our diagnostic insights can inspire actions that transform lives.www.QuestDiagnostics.comFollow us on social media:Linkedin,Twitter,FacebookandInstagram.SOURCE Quest Diagnostics |
edtsum2127 | You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text.
Text: OAKLAND, Calif., Jan. 25, 2021 /PRNewswire/ --Primergy Solar, LLC ('Primergy') announced today that it has expanded its executive leadership team while growing its project pipeline, as it prepares for significant growth in the coming year and beyond. "We have brought in what we believe are some of the most experienced and talented people in the US renewables industry, while demonstrating that our commitments to diversity and inclusion aren't just simple words," said CEO Ty Daul. "We're growing our business while trying to ensure that our core commitment is to a customer and partner experience that is very open, collaborative and actually enjoyablewhich we believe is immediately setting us apart in the marketplace." Primergy, a portfolio company of Quinbrook Infrastructure Partners, acquires, develops, owns and operates distributed and utility scale solar PV and battery storage projects across North America. It recently started operating its 15 MWdc portfolio of solar and storage projects serving Illinois public schools and invested in 35 MWdc of solar projects destined for numerous customers across four states. In addition, work started earlier this month at the Gemini Project, a 690 MWac solar plus 1,400 MWhr battery energy storage project, with the construction of 27 miles of protective fencing for the desert tortoise around portions of the project site in Clark County, Nevada. Gemini is part of the 3 GW Valley of Fire solar and battery storage development portfolio in the Western US, managed by Primergy. "Executing our business plan across multiple regions and markets in North America requires a broad depth of knowledge and expertise and I couldn't be more excited about the team we've pulled together, including recognized industry professionals in the solar plus energy storage arena" said Daul. "Our team has the full complement ofin-house capabilities right across the project value chain from origination and project development, through financing, construction and long-term asset operation of solar PV and battery storage assets." Leadership additions:Primergy's new executive and leadership team members include Chief Development Officer Emily Cohen, Vice President of Development Lisa Leipzig, General Counsel Ben McReynolds, Senior Vice President of Origination Christen Blum, Senior Vice President of M&A, Anthony Sibilia and Director of Finance, Dareem David, who will handle all tax equity and debt financing. Combined, these leaders have more than a century of renewable industry experience, direct involvement with more than 12 GW of operating renewables projects, and the passion to apply that experience to Primergy's creative approaches. Management of largest US solar project under construction: Primergy's cornerstone project to date is the $1.1 billion Gemini Project, a 690 MWac solar + battery energy storage projectlocated on federal land in Clark County, Nevada, 25 miles north of Las Vegas. Believed to be the largest US solar PV and battery energy storage project under construction this year, Gemini is designed to be capable of storing more than 1,400 megawatt hours of solar power once completed in 2023 and is expected to feature more than 2.5 million solar modules installed on more than 7,100 acres of federal lands. Workstarted earlier this month on the construction of 27 miles of fencing around portions of the site for the protection of the desert tortoise after gaining approvals from the U.S. Department of the Interior and the Bureau of Land Management. Gemini will dedicate all of its renewable power output under a 25-year power purchase agreement with NV Energy. The project is part of the Valley of Fire solar and battery storage portfolio, developed in conjunction with the team from Arevia Power. About Primergy Solar Primergy Solar, LLC (https://www.primergysolar.com) is a developer, owner and operator focused on both distributed and utility scale solar PV and battery storage projects with headquarters and home offices mainly located along the West Coast. It's the primary investment platform for Quinbrook Infrastructure Partners' solar and solar plus energy storage activities in North America. About Quinbrook Infrastructure Partners Quinbrook Infrastructure Partners (www.quinbrook.com) is a specialist investment manager focused exclusively on lower carbon and renewable energy infrastructure investment and operational asset management in the US, UK and Australia. Quinbrook is led and managed by a senior team of power industry professionals who have collectively invested over $8 billion of equity in energy infrastructure assets since the early 1990's, representing a total enterprise value of $28.7 billion or 19.5 GW of power supply capacity. Quinbrook's investment and asset management team has offices in Houston, London, Jersey, and the Gold Coast of Australia. Quinbrook has completed a diverse range of direct investments in both utility and distributed scale wind power, solar PV, peaking power and grid support, biomass, battery storage and 'micro-grid' installations in the US, UK and Australia. Media Contact: Art Sasse [emailprotected] 503-453-0051 SOURCE Primergy Solar Related Links https://www.primergysolar.com
Answer: | Primergy Solar Poised for Significant Growth, Expands Leadership Team and Renewables Portfolio | OAKLAND, Calif., Jan. 25, 2021 /PRNewswire/ --Primergy Solar, LLC ('Primergy') announced today that it has expanded its executive leadership team while growing its project pipeline, as it prepares for significant growth in the coming year and beyond. "We have brought in what we believe are some of the most experienced and talented people in the US renewables industry, while demonstrating that our commitments to diversity and inclusion aren't just simple words," said CEO Ty Daul. "We're growing our business while trying to ensure that our core commitment is to a customer and partner experience that is very open, collaborative and actually enjoyablewhich we believe is immediately setting us apart in the marketplace." Primergy, a portfolio company of Quinbrook Infrastructure Partners, acquires, develops, owns and operates distributed and utility scale solar PV and battery storage projects across North America. It recently started operating its 15 MWdc portfolio of solar and storage projects serving Illinois public schools and invested in 35 MWdc of solar projects destined for numerous customers across four states. In addition, work started earlier this month at the Gemini Project, a 690 MWac solar plus 1,400 MWhr battery energy storage project, with the construction of 27 miles of protective fencing for the desert tortoise around portions of the project site in Clark County, Nevada. Gemini is part of the 3 GW Valley of Fire solar and battery storage development portfolio in the Western US, managed by Primergy. "Executing our business plan across multiple regions and markets in North America requires a broad depth of knowledge and expertise and I couldn't be more excited about the team we've pulled together, including recognized industry professionals in the solar plus energy storage arena" said Daul. "Our team has the full complement ofin-house capabilities right across the project value chain from origination and project development, through financing, construction and long-term asset operation of solar PV and battery storage assets." Leadership additions:Primergy's new executive and leadership team members include Chief Development Officer Emily Cohen, Vice President of Development Lisa Leipzig, General Counsel Ben McReynolds, Senior Vice President of Origination Christen Blum, Senior Vice President of M&A, Anthony Sibilia and Director of Finance, Dareem David, who will handle all tax equity and debt financing. Combined, these leaders have more than a century of renewable industry experience, direct involvement with more than 12 GW of operating renewables projects, and the passion to apply that experience to Primergy's creative approaches. Management of largest US solar project under construction: Primergy's cornerstone project to date is the $1.1 billion Gemini Project, a 690 MWac solar + battery energy storage projectlocated on federal land in Clark County, Nevada, 25 miles north of Las Vegas. Believed to be the largest US solar PV and battery energy storage project under construction this year, Gemini is designed to be capable of storing more than 1,400 megawatt hours of solar power once completed in 2023 and is expected to feature more than 2.5 million solar modules installed on more than 7,100 acres of federal lands. Workstarted earlier this month on the construction of 27 miles of fencing around portions of the site for the protection of the desert tortoise after gaining approvals from the U.S. Department of the Interior and the Bureau of Land Management. Gemini will dedicate all of its renewable power output under a 25-year power purchase agreement with NV Energy. The project is part of the Valley of Fire solar and battery storage portfolio, developed in conjunction with the team from Arevia Power. About Primergy Solar Primergy Solar, LLC (https://www.primergysolar.com) is a developer, owner and operator focused on both distributed and utility scale solar PV and battery storage projects with headquarters and home offices mainly located along the West Coast. It's the primary investment platform for Quinbrook Infrastructure Partners' solar and solar plus energy storage activities in North America. About Quinbrook Infrastructure Partners Quinbrook Infrastructure Partners (www.quinbrook.com) is a specialist investment manager focused exclusively on lower carbon and renewable energy infrastructure investment and operational asset management in the US, UK and Australia. Quinbrook is led and managed by a senior team of power industry professionals who have collectively invested over $8 billion of equity in energy infrastructure assets since the early 1990's, representing a total enterprise value of $28.7 billion or 19.5 GW of power supply capacity. Quinbrook's investment and asset management team has offices in Houston, London, Jersey, and the Gold Coast of Australia. Quinbrook has completed a diverse range of direct investments in both utility and distributed scale wind power, solar PV, peaking power and grid support, biomass, battery storage and 'micro-grid' installations in the US, UK and Australia. Media Contact: Art Sasse [emailprotected] 503-453-0051 SOURCE Primergy Solar Related Links https://www.primergysolar.com |
edtsum2129 | You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text.
Text: MIAMI, March 27, 2020 /PRNewswire/ -- According to several sources, the White House Office of Legislative Affairs sent a message to the Senate last week requesting that they pass H.R. 4018 "as soon as possible." H.R. 4018, a bill introduced by Congressman Ted Deutch, is designed to fix the calculation under the Elderly Home Confinement Program (EHC), which is part of the First Step Act, according to Squire Law Group. The White House email urges that "[o]lder inmates are at a unique risk to be affected by the Coronavirus. [ ] A congressional fix to allow older inmates to be placed in home confinement can help reduce the risk of community spread in a crowded environment." On Thursday, Attorney General William Barr also issued a directive to release federal inmates at heightened risk from COVID-19. The Trump administration's effort to push for H.R. 4018 is a vital step during this crisis. Criminal justice reform has long been recognized as being beneficial to more than the prison population. Extensive research has shown that credit-earning prison programs reduce the chances for felons to reoffend and reduce costs to the government. It is a win-win for our society. Time magazine reported in 2016 that "approximately 39% of the nationwide prison population [ ] is behind bars with little public safety rationale." Releasing non-violent, lower-level offenders better served by alternatives to incarceration "would save $20 billion annually, enough to employ 270,000 new police officers, 360,000 probation officers, or 327,000 school teachers." The aging prison population, which is causing the biggest healthcare cost to the American taxpayer, is the least likely group of inmates to pose a danger to society, and is now most vulnerable to COVID-19. Some conservatives ignorantly call prisons the "ultimate quarantine." In truth, prisons are quickly turning into death chambers when staff brings in the novel coronavirus. The White House email, sent on Saturday, has been criticized by a small group of conservatives. A portion of the email originally appeared in the Conservative Review, which purports "[t]o cut through the talking points and the smoke and mirrors." But earned credits, such as good time credits, have long been a salutary part of our criminal justice system. Disregarding all earned credits from the EHC calculation would defy Congress' intent for nonviolent elderly inmates to spend the last third portion of their sentence in home confinement. Studieshave shown that crimes are not deterred by a draconian criminal justice system. President Trump's flagship criminal justice reform is finally a step toward improvement. The Trump administration should not be forced to walk on eggshells as a result of misinformation in taking vital steps toward saving lives and benefiting society as a whole.To find out more about Squire Law Group, visitsquirelawgroup.comSOURCE Squire Law Group
Answer: | Trump Efforts to Save Lives and Unburden Taxpayers in COVID-19 Crisis Distorted by Conservative Media, According to Squire Law Group | MIAMI, March 27, 2020 /PRNewswire/ -- According to several sources, the White House Office of Legislative Affairs sent a message to the Senate last week requesting that they pass H.R. 4018 "as soon as possible." H.R. 4018, a bill introduced by Congressman Ted Deutch, is designed to fix the calculation under the Elderly Home Confinement Program (EHC), which is part of the First Step Act, according to Squire Law Group. The White House email urges that "[o]lder inmates are at a unique risk to be affected by the Coronavirus. [ ] A congressional fix to allow older inmates to be placed in home confinement can help reduce the risk of community spread in a crowded environment." On Thursday, Attorney General William Barr also issued a directive to release federal inmates at heightened risk from COVID-19. The Trump administration's effort to push for H.R. 4018 is a vital step during this crisis. Criminal justice reform has long been recognized as being beneficial to more than the prison population. Extensive research has shown that credit-earning prison programs reduce the chances for felons to reoffend and reduce costs to the government. It is a win-win for our society. Time magazine reported in 2016 that "approximately 39% of the nationwide prison population [ ] is behind bars with little public safety rationale." Releasing non-violent, lower-level offenders better served by alternatives to incarceration "would save $20 billion annually, enough to employ 270,000 new police officers, 360,000 probation officers, or 327,000 school teachers." The aging prison population, which is causing the biggest healthcare cost to the American taxpayer, is the least likely group of inmates to pose a danger to society, and is now most vulnerable to COVID-19. Some conservatives ignorantly call prisons the "ultimate quarantine." In truth, prisons are quickly turning into death chambers when staff brings in the novel coronavirus. The White House email, sent on Saturday, has been criticized by a small group of conservatives. A portion of the email originally appeared in the Conservative Review, which purports "[t]o cut through the talking points and the smoke and mirrors." But earned credits, such as good time credits, have long been a salutary part of our criminal justice system. Disregarding all earned credits from the EHC calculation would defy Congress' intent for nonviolent elderly inmates to spend the last third portion of their sentence in home confinement. Studieshave shown that crimes are not deterred by a draconian criminal justice system. President Trump's flagship criminal justice reform is finally a step toward improvement. The Trump administration should not be forced to walk on eggshells as a result of misinformation in taking vital steps toward saving lives and benefiting society as a whole.To find out more about Squire Law Group, visitsquirelawgroup.comSOURCE Squire Law Group |
edtsum2130 | You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text.
Text: BALTIMORE, Oct. 14, 2020 /PRNewswire/ -- Derrick Johnson, president and CEO of the NAACP, issued the following statement today in opposition to the nomination of Amy Coney Barrett to serve as Associate Justice on the Supreme Court of the United States: "Today, the NAACP submitteda letter to the Senate Judiciary Committeestrongly opposing the nomination of Amy Coney Barrett to the Supreme Court. Coming in the middle of a presidential election in which over seven million people have already voted, the Barrett nomination is as illegitimate as it is corrupt. Instead of forcing a nomination onto our highest court, the Senate should address the harms of the global pandemic raging across the country and disproportionately affecting the lives and livelihoods of African Americans. Under the "advice and consent" clause of the Constitution, the Senate must rigorously and meticulously scrutinize a Supreme Court nomination. Weeks and even months are necessary to fulfill this solemn duty. The Senate's timetable here is designed to fail. Fast-tracking this nominationeven as individual Senators have contracted coronaviruswill deprive the American people of the public, exacting review that should be afforded to a lifetime appointment to the Court. The next president should decide who sits on the Court. We have reviewed Amy Coney Barrett's record on civil rights, including her writings as a law professor and her three years as an appellate court judge. On issue after issue, we have found her to be stunningly hostile to civil rights. Her aggressive view of when past decisions should be overruled, combined with her reactionary positions on what rights the Constitution protects, will jeopardize our hard-fought wins in the Court. Her scholarship questions even foundational principles such as whether the Fourteenth Amendment was properly adopted and whetherBrown v. Board of Educationremains viable authority. Her repeated endorsement of discrimination in the workplaceincluding the stunning conclusions that separate can be equal when it comes to race and that the use of racial epithets does not necessarily create a hostile work environmentmark a clear willingness to jettison longstanding civil rights precedents. Sometimes it is difficult to discern the consequences of a confirmation from a nominee's past writings and rulings, but not with Judge Barrett. And the stakes could not be higher. The rights of African Americans to fully participate in democracy and in every facet of social and economic life, on an equal basis, lie in the balance. The NAACP has fought to protect the Supreme Court since 1930, when we helped to defeat a Herbert Hoover nominee to the Supreme Court. We will fight this illegitimate Trump nomination with everything we have because of the danger it poses to our civil rights and to the future of our democracy. At the same time, we emphatically encourage all Americans to vote. As the Supreme Court battle demonstrates, the consequences of this election could not be greater. Our voices must be heard." NOTE: The Legal Defense Fund also referred to as the NAACP-LDF was founded in 1940 as a part of the NAACP, but separated in 1957 to become a completely separate entity. It is recognized as the nation's first civil and human rights law organization, and shares our commitment to equal rights. SOURCE NAACP Empowerment Programs, Inc.
Answer: | NAACP Opposes Nomination of Amy Coney Barrett to Supreme Court As Illegitimate and Grave Threat to Civil Rights | BALTIMORE, Oct. 14, 2020 /PRNewswire/ -- Derrick Johnson, president and CEO of the NAACP, issued the following statement today in opposition to the nomination of Amy Coney Barrett to serve as Associate Justice on the Supreme Court of the United States: "Today, the NAACP submitteda letter to the Senate Judiciary Committeestrongly opposing the nomination of Amy Coney Barrett to the Supreme Court. Coming in the middle of a presidential election in which over seven million people have already voted, the Barrett nomination is as illegitimate as it is corrupt. Instead of forcing a nomination onto our highest court, the Senate should address the harms of the global pandemic raging across the country and disproportionately affecting the lives and livelihoods of African Americans. Under the "advice and consent" clause of the Constitution, the Senate must rigorously and meticulously scrutinize a Supreme Court nomination. Weeks and even months are necessary to fulfill this solemn duty. The Senate's timetable here is designed to fail. Fast-tracking this nominationeven as individual Senators have contracted coronaviruswill deprive the American people of the public, exacting review that should be afforded to a lifetime appointment to the Court. The next president should decide who sits on the Court. We have reviewed Amy Coney Barrett's record on civil rights, including her writings as a law professor and her three years as an appellate court judge. On issue after issue, we have found her to be stunningly hostile to civil rights. Her aggressive view of when past decisions should be overruled, combined with her reactionary positions on what rights the Constitution protects, will jeopardize our hard-fought wins in the Court. Her scholarship questions even foundational principles such as whether the Fourteenth Amendment was properly adopted and whetherBrown v. Board of Educationremains viable authority. Her repeated endorsement of discrimination in the workplaceincluding the stunning conclusions that separate can be equal when it comes to race and that the use of racial epithets does not necessarily create a hostile work environmentmark a clear willingness to jettison longstanding civil rights precedents. Sometimes it is difficult to discern the consequences of a confirmation from a nominee's past writings and rulings, but not with Judge Barrett. And the stakes could not be higher. The rights of African Americans to fully participate in democracy and in every facet of social and economic life, on an equal basis, lie in the balance. The NAACP has fought to protect the Supreme Court since 1930, when we helped to defeat a Herbert Hoover nominee to the Supreme Court. We will fight this illegitimate Trump nomination with everything we have because of the danger it poses to our civil rights and to the future of our democracy. At the same time, we emphatically encourage all Americans to vote. As the Supreme Court battle demonstrates, the consequences of this election could not be greater. Our voices must be heard." NOTE: The Legal Defense Fund also referred to as the NAACP-LDF was founded in 1940 as a part of the NAACP, but separated in 1957 to become a completely separate entity. It is recognized as the nation's first civil and human rights law organization, and shares our commitment to equal rights. SOURCE NAACP Empowerment Programs, Inc. |
edtsum2133 | You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text.
Text: OVERLAND PARK, Kan.--(BUSINESS WIRE)--Waddell & Reed, Inc. today announced it has appointed 20-year financial industry veteran Cory McCruden as Senior Vice President, Advisor & Client Experience. In this new role, she will be a member of the wealth management leadership team and report to Shawn Mihal, President of Waddell & Reed, Inc. Waddell & Reed, Inc., the wealth management subsidiary of Waddell & Reed Financial, Inc. (NYSE: WDR), in recent years has executed upon a strategic evolution of the wealth management business, focused on improving its advisor and client experience through technological enhancements, product expansion and broadening support. McCrudens role will further that progress through collaboration with key stakeholders across the business to improve advisor and client journeys, create new, innovative experiences, increasing loyalty and driving advocacy. She will develop and lead strategies in support of best-in-class client and advisor experience processes and procedures while acting on opportunities for innovative investment, growth and expansion. This includes multi-year roadmaps and execution plans. Were extremely pleased to gain an executive with Corys experience across client and advisor journey mapping, digital transformation and growth strategy, said Mihal. As our wealth management business continues to grow and transform, we must provide a seamless, transparent, and frictionless experience that sustains growth and deepens trust and loyalty. Cory is well positioned to lead our team devoted to this effort. McCruden previously was with Royal Bank of Canada (RBC), with her most recent role as Head of Digital Client Experience & Strategy, where she led development of the strategy, product vision, and new customer segmentation to enhance client and advisor experience within Business Banking. Prior to that role, she led Strategy and Innovation, where she and her team were responsible for driving product innovation and partnership strategies, contributing to a 20% increase in client net promoter score, and developing and implementing a proprietary wealth management advisory value proposition that was introduced to over 2,000 advisors. Prior to RBC, she held several wealth management leadership roles at BNY Mellon, including in sales, analytics, and strategy. Our industry is constantly changing, bringing financial advisors and clients a range of choices and options. We must continually be ready to adapt and excel, said Mihal. With Corys leadership, well continue to foster a client- and advisor-centric culture across our organization to drive an optimum experience for affiliated advisors and their clients. About Waddell & Reed Founded in 1937, Waddell & Reed, Inc. is one of the oldest financial planning firms in the U.S., providing total planning services to clients throughout the United States through a network of independent financial advisors. It is a subsidiary of Waddell & Reed Financial, Inc. (NYSE: WDR).
Answer: | Waddell & Reed, Inc. Appoints Industry Veteran to Lead Advisor & Client Experience New role leads strategy and innovation supporting wealth management experience capabilities | OVERLAND PARK, Kan.--(BUSINESS WIRE)--Waddell & Reed, Inc. today announced it has appointed 20-year financial industry veteran Cory McCruden as Senior Vice President, Advisor & Client Experience. In this new role, she will be a member of the wealth management leadership team and report to Shawn Mihal, President of Waddell & Reed, Inc. Waddell & Reed, Inc., the wealth management subsidiary of Waddell & Reed Financial, Inc. (NYSE: WDR), in recent years has executed upon a strategic evolution of the wealth management business, focused on improving its advisor and client experience through technological enhancements, product expansion and broadening support. McCrudens role will further that progress through collaboration with key stakeholders across the business to improve advisor and client journeys, create new, innovative experiences, increasing loyalty and driving advocacy. She will develop and lead strategies in support of best-in-class client and advisor experience processes and procedures while acting on opportunities for innovative investment, growth and expansion. This includes multi-year roadmaps and execution plans. Were extremely pleased to gain an executive with Corys experience across client and advisor journey mapping, digital transformation and growth strategy, said Mihal. As our wealth management business continues to grow and transform, we must provide a seamless, transparent, and frictionless experience that sustains growth and deepens trust and loyalty. Cory is well positioned to lead our team devoted to this effort. McCruden previously was with Royal Bank of Canada (RBC), with her most recent role as Head of Digital Client Experience & Strategy, where she led development of the strategy, product vision, and new customer segmentation to enhance client and advisor experience within Business Banking. Prior to that role, she led Strategy and Innovation, where she and her team were responsible for driving product innovation and partnership strategies, contributing to a 20% increase in client net promoter score, and developing and implementing a proprietary wealth management advisory value proposition that was introduced to over 2,000 advisors. Prior to RBC, she held several wealth management leadership roles at BNY Mellon, including in sales, analytics, and strategy. Our industry is constantly changing, bringing financial advisors and clients a range of choices and options. We must continually be ready to adapt and excel, said Mihal. With Corys leadership, well continue to foster a client- and advisor-centric culture across our organization to drive an optimum experience for affiliated advisors and their clients. About Waddell & Reed Founded in 1937, Waddell & Reed, Inc. is one of the oldest financial planning firms in the U.S., providing total planning services to clients throughout the United States through a network of independent financial advisors. It is a subsidiary of Waddell & Reed Financial, Inc. (NYSE: WDR). |
edtsum2143 | You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text.
Text: ADDISON, Texas--(BUSINESS WIRE)--Securonix, Inc., a leader in Next-Gen SIEM, today announced it has signed M.Tech, a leading cybersecurity and network performance value-added distributor, as its preferred distributor in the Australia New Zealand region. The partnership further strengthens Securonixs investments in infrastructure and personnel in Asia-Pacific following 100% year over year revenue growth in the region. Securonix UEBA capabilities and Next-Gen SIEM are designed to be cloud-first. With many organizations in ANZ now moving from on-premises to cloud environments, were ideally positioned as a best-in-class platform thats easy to deploy and replace legacy solutions during cloud migration, said Simon Carney, Director of Global Alliances at Securonix. As we focus on expansion in the region, signing with M.Tech means were working with a top distributor, known for successfully bringing market leading solutions like Securonix to its partners. M.Tech is headquartered in Singapore and has a network of 32 offices in 16 countries in the Asia-Pacific region. Its regional presence allows M.Tech to provide strong on-site sales, technical, logistics and marketing support to its reseller partners. M.Techs reach and prestige makes it an ideal partner for Securonix as it advances rapidly in the Asia-Pacific region. The Securonix Next-Gen SIEM platform strengthens M.Techs growing portfolio of established market-leading products and solutions that meet every critical IT need. The Securonix platform incorporates machine learning capabilities that go beyond the capabilities of legacy SIEM providers, which we believe is a strong reason that it was named as a leader in a recent analyst report, said Yong Foo, General Manager at M.Tech. Adding Securonix to our network of established market-leading vendors fills key use cases and cybersecurity needs for our partners across the board. Delivering analytics driven SIEM, SOAR and NTA with UEBA at its core, the Securonix Next-Gen SIEM platform helps automate security operations while reducing noise and identifying internal and external threats. The cloud solution serves five of the Global Fortune 10 and its customer base is growing rapidly across industry verticals and geographies. Over the past 12 months, Securonix has achieved 250% YoY SaaS bookings growth, a 105% net dollar retention rate, and onboarded 30+ MSSPs and 100+ logos. About M.Tech M.Tech is a leading cyber security and network performance solutions provider. From providing integrated end-to-end cyber security to enhancing network infrastructure, M.Tech optimizes organizations operations and effectiveness. Partnering with a strong network of established vendors, we have an unparalleled portfolio of best-of-breed products and solutions that meet every critical IT need from cloud access security, advanced threat prevention and data-centric security to network system management, monitoring and optimization. We also have a specialized technical team providing a host of comprehensive professional services and 24/7 technical service and support, ensuring your organizations seamless operation. At M.Tech, we constantly stay ahead in the ever-changing IT environment, to be the leading cyber security and network performance solutions provider. To learn more, visit www.mtechpro.com or follow us on LinkedIn. About Securonix Securonix is redefining SIEM for todays hybrid cloud, data-driven enterprise. Built on big data architecture, Securonix delivers SIEM, UEBA, SOAR, Security Data Lake, NTA and vertical-specific applications as a pure SaaS solution with unlimited scalability and no infrastructure cost. Securonix reduces noise and prioritizes high fidelity alerts with behavioral analytics technology that pioneered the UEBA category. To learn more, visit www.securonix.com or follow us on LinkedIn, Facebook and Twitter.
Answer: | Securonix Announces Distribution Partnership with M.Tech, Fueling Further Growth in Australia and New Zealand Securonix Bolsters Recent Asia-Pacific Expansion, Partnering with Leading Cybersecurity and Network Performance Solutions Value-Added Distributor | ADDISON, Texas--(BUSINESS WIRE)--Securonix, Inc., a leader in Next-Gen SIEM, today announced it has signed M.Tech, a leading cybersecurity and network performance value-added distributor, as its preferred distributor in the Australia New Zealand region. The partnership further strengthens Securonixs investments in infrastructure and personnel in Asia-Pacific following 100% year over year revenue growth in the region. Securonix UEBA capabilities and Next-Gen SIEM are designed to be cloud-first. With many organizations in ANZ now moving from on-premises to cloud environments, were ideally positioned as a best-in-class platform thats easy to deploy and replace legacy solutions during cloud migration, said Simon Carney, Director of Global Alliances at Securonix. As we focus on expansion in the region, signing with M.Tech means were working with a top distributor, known for successfully bringing market leading solutions like Securonix to its partners. M.Tech is headquartered in Singapore and has a network of 32 offices in 16 countries in the Asia-Pacific region. Its regional presence allows M.Tech to provide strong on-site sales, technical, logistics and marketing support to its reseller partners. M.Techs reach and prestige makes it an ideal partner for Securonix as it advances rapidly in the Asia-Pacific region. The Securonix Next-Gen SIEM platform strengthens M.Techs growing portfolio of established market-leading products and solutions that meet every critical IT need. The Securonix platform incorporates machine learning capabilities that go beyond the capabilities of legacy SIEM providers, which we believe is a strong reason that it was named as a leader in a recent analyst report, said Yong Foo, General Manager at M.Tech. Adding Securonix to our network of established market-leading vendors fills key use cases and cybersecurity needs for our partners across the board. Delivering analytics driven SIEM, SOAR and NTA with UEBA at its core, the Securonix Next-Gen SIEM platform helps automate security operations while reducing noise and identifying internal and external threats. The cloud solution serves five of the Global Fortune 10 and its customer base is growing rapidly across industry verticals and geographies. Over the past 12 months, Securonix has achieved 250% YoY SaaS bookings growth, a 105% net dollar retention rate, and onboarded 30+ MSSPs and 100+ logos. About M.Tech M.Tech is a leading cyber security and network performance solutions provider. From providing integrated end-to-end cyber security to enhancing network infrastructure, M.Tech optimizes organizations operations and effectiveness. Partnering with a strong network of established vendors, we have an unparalleled portfolio of best-of-breed products and solutions that meet every critical IT need from cloud access security, advanced threat prevention and data-centric security to network system management, monitoring and optimization. We also have a specialized technical team providing a host of comprehensive professional services and 24/7 technical service and support, ensuring your organizations seamless operation. At M.Tech, we constantly stay ahead in the ever-changing IT environment, to be the leading cyber security and network performance solutions provider. To learn more, visit www.mtechpro.com or follow us on LinkedIn. About Securonix Securonix is redefining SIEM for todays hybrid cloud, data-driven enterprise. Built on big data architecture, Securonix delivers SIEM, UEBA, SOAR, Security Data Lake, NTA and vertical-specific applications as a pure SaaS solution with unlimited scalability and no infrastructure cost. Securonix reduces noise and prioritizes high fidelity alerts with behavioral analytics technology that pioneered the UEBA category. To learn more, visit www.securonix.com or follow us on LinkedIn, Facebook and Twitter. |
edtsum2148 | You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text.
Text: REHOBOTH BEACH, Del., March 30, 2020 /PRNewswire/ -- Schell brothers, a new home builder in Rehoboth Beach, DE, along with their happiness movement, Project Kudos, have announced plans to give back to the local Delaware community as it is affected by the COVID-19 pandemic. Exterior of The Project Kudos Bus The Project Kudos Bus, a refurbished bus created in order to support Project Kudos mission of spreading positive vibes, will be doing exactly that in the coming weeks. The bus will be stocked with groceries for in-need families. Delaware based chicken farm, Mountaire, has graciously partnered with Schell Brothers to provide chicken for families as well. Families will receive reusable giveaway packs stocked with essentials like rice, beans, soup, cereal, and other much needed supplies. All items have been safely packed for distribution and the bus will be on the road with limited persons handing out food directly to neighborhoods in both the Indian River and Cape Henlopen School District. In addition to a week's supply of food, the bags will also contain chalk, coloring books, Project Kudos notebooks and pencils in an effort to help entertain school-aged children who will be out of school through May 15th. Chris Schell, owner of Schell Brothers comments, "We have always been and continue to be committed to our community. During these trying times, we hope that this food will help feed families who have been deeply affected by the current coronavirus pandemic."Michele Murphy, Community Education Coordinator at Indian River School District adds, "On behalf of all of our district staff & families, I want to sincerely thank Schell Brothers and Mountaire for reaching out to help our students. It is through these most difficult & trying times that we truly experience the best of humanity and the support from our local community!"Launched in 2018, Project Kudos was born through Schell Brothers' mission to give kudos to their employees, as well as spread good vibes and happiness throughout the community. Over the past year and a half, The Kudos Bus visited schools, festivals and businesses to support the Project Kudos mission: to spread positive vibes. Project Kudos and Schell Brothers will provide an updated list of neighborhood visits on their Facebook Page and the Project Kudos website. For more information about the bus and the Project Kudos mission: Facebook: Project Kudos, @givekudosInstagram: @ProjectKudosWebsite: ProjectKudos.comFor more information about Schell Brothers:Facebook: Schell Brothers, @schellbrothershomesInstagram: @SchellBrothersWebsite: SchellBrothers.comDirect questions to: [emailprotected]SOURCE Schell Brothers Related Links http://www.schellbrothers.com
Answer: | Schell Brothers Give Back To Communities In Time Of Crisis | REHOBOTH BEACH, Del., March 30, 2020 /PRNewswire/ -- Schell brothers, a new home builder in Rehoboth Beach, DE, along with their happiness movement, Project Kudos, have announced plans to give back to the local Delaware community as it is affected by the COVID-19 pandemic. Exterior of The Project Kudos Bus The Project Kudos Bus, a refurbished bus created in order to support Project Kudos mission of spreading positive vibes, will be doing exactly that in the coming weeks. The bus will be stocked with groceries for in-need families. Delaware based chicken farm, Mountaire, has graciously partnered with Schell Brothers to provide chicken for families as well. Families will receive reusable giveaway packs stocked with essentials like rice, beans, soup, cereal, and other much needed supplies. All items have been safely packed for distribution and the bus will be on the road with limited persons handing out food directly to neighborhoods in both the Indian River and Cape Henlopen School District. In addition to a week's supply of food, the bags will also contain chalk, coloring books, Project Kudos notebooks and pencils in an effort to help entertain school-aged children who will be out of school through May 15th. Chris Schell, owner of Schell Brothers comments, "We have always been and continue to be committed to our community. During these trying times, we hope that this food will help feed families who have been deeply affected by the current coronavirus pandemic."Michele Murphy, Community Education Coordinator at Indian River School District adds, "On behalf of all of our district staff & families, I want to sincerely thank Schell Brothers and Mountaire for reaching out to help our students. It is through these most difficult & trying times that we truly experience the best of humanity and the support from our local community!"Launched in 2018, Project Kudos was born through Schell Brothers' mission to give kudos to their employees, as well as spread good vibes and happiness throughout the community. Over the past year and a half, The Kudos Bus visited schools, festivals and businesses to support the Project Kudos mission: to spread positive vibes. Project Kudos and Schell Brothers will provide an updated list of neighborhood visits on their Facebook Page and the Project Kudos website. For more information about the bus and the Project Kudos mission: Facebook: Project Kudos, @givekudosInstagram: @ProjectKudosWebsite: ProjectKudos.comFor more information about Schell Brothers:Facebook: Schell Brothers, @schellbrothershomesInstagram: @SchellBrothersWebsite: SchellBrothers.comDirect questions to: [emailprotected]SOURCE Schell Brothers Related Links http://www.schellbrothers.com |
edtsum2151 | You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text.
Text: DULLES, Va., July 29, 2020 /PRNewswire/ -- Unison, the leading provider of software and insight to government agencies, program offices, and contractors, today announced that as a subcontractor it is helping the U.S. Department of Commerce (DOC) modernize its core business systems with the Acquisitions Management solution as a component of the DOC's Business Applications Solution (BAS) program. The BAS program is a top Departmental priority at DOC and the Unison solution will help with its goals of modernizing business systems, reducing operation redundancies and simplifying administrative functions in service to the overall mission of creating the conditions for economic growth and opportunity. "We're honored to expand the ways in which Unison serves the Department of Commerce," said Reid H. Jackson, President and Chief Executive Officer, Unison. "Supporting the BAS modernization initiative, PRISM will help streamline acquisitions and ensure compliance." PRISM is a cloud-based, secure, FedRAMP-authorized solution for acquisitions management. PRISM will enable the DOC to efficiently and effectively complete federal acquisition tasks while fully complying with FAR and agency-specific regulations. Unison PRISM accelerates the acquisition process by engaging program leaders and contracts teams with collaborative workflows and an easy to use interface. DOC will be able to process, track, and report on data from Acquisition Planning through Contract Closeout. Unison is partnering with Accenture Federal Services, the prime contractor on the $341 million contract. The contract will run for one base year, with 19 option years.About UnisonUnison's secure cloud and on-premise software, marketplace, and information products support more than 200,000 users in all cabinet-level agencies, major DoD programs, and leading prime contractors. All software development and support are done within the USA.For over 30 years, Unison has continually advanced software and insight solutions to help federal programs efficiently achieve their missions. Unison is headquartered in Dulles, VA, with offices in Tysons Corner, VA, Clearfield, UT, San Diego, CA, and Los Angeles, CA. For more information, visit www.UnisonGlobal.com.SOURCE Unison
Answer: | Unison's PRISM included in $341 Million Contract with The Department of Commerce | DULLES, Va., July 29, 2020 /PRNewswire/ -- Unison, the leading provider of software and insight to government agencies, program offices, and contractors, today announced that as a subcontractor it is helping the U.S. Department of Commerce (DOC) modernize its core business systems with the Acquisitions Management solution as a component of the DOC's Business Applications Solution (BAS) program. The BAS program is a top Departmental priority at DOC and the Unison solution will help with its goals of modernizing business systems, reducing operation redundancies and simplifying administrative functions in service to the overall mission of creating the conditions for economic growth and opportunity. "We're honored to expand the ways in which Unison serves the Department of Commerce," said Reid H. Jackson, President and Chief Executive Officer, Unison. "Supporting the BAS modernization initiative, PRISM will help streamline acquisitions and ensure compliance." PRISM is a cloud-based, secure, FedRAMP-authorized solution for acquisitions management. PRISM will enable the DOC to efficiently and effectively complete federal acquisition tasks while fully complying with FAR and agency-specific regulations. Unison PRISM accelerates the acquisition process by engaging program leaders and contracts teams with collaborative workflows and an easy to use interface. DOC will be able to process, track, and report on data from Acquisition Planning through Contract Closeout. Unison is partnering with Accenture Federal Services, the prime contractor on the $341 million contract. The contract will run for one base year, with 19 option years.About UnisonUnison's secure cloud and on-premise software, marketplace, and information products support more than 200,000 users in all cabinet-level agencies, major DoD programs, and leading prime contractors. All software development and support are done within the USA.For over 30 years, Unison has continually advanced software and insight solutions to help federal programs efficiently achieve their missions. Unison is headquartered in Dulles, VA, with offices in Tysons Corner, VA, Clearfield, UT, San Diego, CA, and Los Angeles, CA. For more information, visit www.UnisonGlobal.com.SOURCE Unison |
edtsum2158 | You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text.
Text: HOFFMAN ESTATES, Ill., April 13, 2021 /PRNewswire/ -- Transformco announced that the Kenmore brand has been named a 2021 ENERGY STARPartner of the Year for Sustained Excellence winner for the fourth year in a row. The highest honor among ENERGY STAR awards, the ENERGY STAR Partner of the Year for Sustained Excellence Award is presented by the EPA to recognize ENERGY STAR partners who demonstrate exemplary commitment and dedication to leadership in energy efficiency and the ENERGY STAR program for more than two consecutive years. Kenmore brand has supported ENERGY STAR since 1992 and is being honored for the following accomplishments: Mobile App - Released the Kenmore Smart 2.0 mobile app, including the ENERGY STAR Rebate Finder. New Products In total, the Kenmore brand offered 177 ENERGY STAR certified models in 2020, 63% of the total product assortment. In-store training Kenmore provided training on ENERGY STAR products to thousands of Home Appliance associates across its store locations in 2020, reaching more than 90 percent of current and new associates. ENERGY STAR Promotional Program The Kenmore brand provided ENERGY STAR certified products as store giveaways across the U.S. The brand also partnered with BobVila.com on a laundry giveaway. External Channel Promotion The Kenmore brand promotes ENERGY STAR across its digital platform, Kenmore.com, but has now expanded to external retail channels: Amazon.com/kenmore Howards.com/kenmore "ENERGY STAR award-winning partners are showing the world that delivering real climate solutions makes good business sense and promotes job growth," said EPA Administrator Michael S. Regan. "Many of them have been doing it for years, inspiring all of us who are committed to tackling the climate crisis and leading the way to a clean energy economy." For a complete list of 2020 winners and more information about ENERGY STAR's awards program, visitenergystar.gov/awardwinners. About the KenmoreBrandThe Kenmore Brand is an industry leader in delivering trusted performance in the home with smart and stylish appliance innovations that help consumers do things quicker, easier and better. Recognized as a top appliance brand for over 100 years, the Kenmore brand continues to give consumers more time, efficiency and improved results for better living, with industry-leading products across small and larger appliance categories. For more information, visitwww.kenmore.com,https://www.kenmore.com/press-kit/orwww.facebook.com/kenmore. About ENERGY STARENERGY STAR is the government-backed symbol for energy efficiency, providing simple, credible, and unbiased information that consumers and businesses rely on to make well-informed decisions. Thousands of industrial, commercial, utility, state, and local organizationsincluding more than 40 percent of the Fortune 500rely on their partnership with the U.S. Environmental Protection Agency (EPA) to deliver cost-saving energy efficiency solutions. Since 1992, ENERGY STAR and its partners helped American families and businesses avoid more than $450 billion in energy costs and achieve 4 billion metric tons of greenhouse gas reductions. More background information about ENERGY STAR can be found at: https://www.energystar.gov/aboutand https://www.energystar.gov/about/origins_mission/energy_star_numbers SOURCE Transformco Related Links http://www.kenmore.com
Answer: | Kenmore Brand Earns 2021 ENERGY STAR Partner of the Year Award for Sustained Excellence | HOFFMAN ESTATES, Ill., April 13, 2021 /PRNewswire/ -- Transformco announced that the Kenmore brand has been named a 2021 ENERGY STARPartner of the Year for Sustained Excellence winner for the fourth year in a row. The highest honor among ENERGY STAR awards, the ENERGY STAR Partner of the Year for Sustained Excellence Award is presented by the EPA to recognize ENERGY STAR partners who demonstrate exemplary commitment and dedication to leadership in energy efficiency and the ENERGY STAR program for more than two consecutive years. Kenmore brand has supported ENERGY STAR since 1992 and is being honored for the following accomplishments: Mobile App - Released the Kenmore Smart 2.0 mobile app, including the ENERGY STAR Rebate Finder. New Products In total, the Kenmore brand offered 177 ENERGY STAR certified models in 2020, 63% of the total product assortment. In-store training Kenmore provided training on ENERGY STAR products to thousands of Home Appliance associates across its store locations in 2020, reaching more than 90 percent of current and new associates. ENERGY STAR Promotional Program The Kenmore brand provided ENERGY STAR certified products as store giveaways across the U.S. The brand also partnered with BobVila.com on a laundry giveaway. External Channel Promotion The Kenmore brand promotes ENERGY STAR across its digital platform, Kenmore.com, but has now expanded to external retail channels: Amazon.com/kenmore Howards.com/kenmore "ENERGY STAR award-winning partners are showing the world that delivering real climate solutions makes good business sense and promotes job growth," said EPA Administrator Michael S. Regan. "Many of them have been doing it for years, inspiring all of us who are committed to tackling the climate crisis and leading the way to a clean energy economy." For a complete list of 2020 winners and more information about ENERGY STAR's awards program, visitenergystar.gov/awardwinners. About the KenmoreBrandThe Kenmore Brand is an industry leader in delivering trusted performance in the home with smart and stylish appliance innovations that help consumers do things quicker, easier and better. Recognized as a top appliance brand for over 100 years, the Kenmore brand continues to give consumers more time, efficiency and improved results for better living, with industry-leading products across small and larger appliance categories. For more information, visitwww.kenmore.com,https://www.kenmore.com/press-kit/orwww.facebook.com/kenmore. About ENERGY STARENERGY STAR is the government-backed symbol for energy efficiency, providing simple, credible, and unbiased information that consumers and businesses rely on to make well-informed decisions. Thousands of industrial, commercial, utility, state, and local organizationsincluding more than 40 percent of the Fortune 500rely on their partnership with the U.S. Environmental Protection Agency (EPA) to deliver cost-saving energy efficiency solutions. Since 1992, ENERGY STAR and its partners helped American families and businesses avoid more than $450 billion in energy costs and achieve 4 billion metric tons of greenhouse gas reductions. More background information about ENERGY STAR can be found at: https://www.energystar.gov/aboutand https://www.energystar.gov/about/origins_mission/energy_star_numbers SOURCE Transformco Related Links http://www.kenmore.com |
edtsum2159 | You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text.
Text: LOS ANGELES, March 3, 2021 /PRNewswire/ --Colin Sapire, founder of the NutriBullet*and innovator behind personal blending products for more than a decade, announces the launch of wellness brand Beast Health, and the debut of its design-forward personal blender and hydration system the B10+. Beautiful, functional design meets powerful performance. The Beast B10 Health Blender uses an innovative 12-rib blending vessel with leak-resistant seal to create the smoothest blends, and comes standard with a drinking lid and carry cap that fits the blending vessel to take your smoothie on-the-go. It is available in 3 stunning shades of black, grey or white. Visit www.thebeast.com for more info. Level up your hydration on-the-go or at home. The Beast Health Hydration System is designed to serve as an extension of the Beast B10 Health Blender, and comes as part of the B10+ product configuration. Simply pulse together a variety of fruits, vegetables or herbs in your Beast B10, transfer to the infusion chamber to enhance the flavor of your water and add more nutrients to your day. Visit www.thebeast.com for more info. Meet the Beast B10 Health Blender. Thoughtfully designed, front-to-back. This best-in-class blender was meticulously engineered to effortlessly create smooth, delicious, and healthy blends packed with nutrients to boost immunity and increase hydration. Visit www.thebeast.com for more info. Beast Health is on a mission to empower users to become Strong Inside. Beast Health's flagship B10 Health Blender is a revolution in personal blending, combining incomparable elegance and high-performance technology; and providing the perfect solution for those looking to elevate their nutrition and hydration game. The B10 Health Blender balances artful design with best-in-class technology to produce the smoothest, nutrient-rich blends imaginable. "The Beast is unlike any other personal blender," said Sapire. "Not only is it a beautifully designed countertop display piece, but its next-generation components make it one of the most elegant, effective and efficient personal blenders ever created. From the electronic interlock blade system to the thermal safety sensor and innovative 12-rib vessel design, our B10 Health Blender was engineered to elevate our customer experience; reducing spills and noise, while maximizing safety and blending efficiency." The B10 Health Blender is extremely versatile, blending up smoothies, health elixirs and cocktails, and pulsing dips, salsas, sauces or even nut butter to perfection in seconds. The Beast B10 Health Blender retails for $138. The more comprehensive Beast B10+ Health Blender and Hydration System retails for $168, and includes an innovative hydration system designed to be used in tandem with the blender to create hydration infusions. The included portable borosilicate glass drinking vessel contains a uniquely constructed infusion chamber for an entirely new hydration experience. Both of these products can be purchased at www.thebeast.com.Media contacts: Allie Yaldezian: [emailprotected] Ryan Croy: [emailprotected]About Beast Health: Beast Health was founded on the simple premise that whole foods are nature's greatest gift to us. Using innovative design and technology, we hope to enable and empower our community to strengthen their immunity and to attain their nutrition and wellness goals. As an all-encompassing wellness brand, Beast Health plans to introduce additional innovative appliances and related products for discerning, health-focused consumers across the globe and to focus on meaningful community-minded initiatives.For more information, visit www.thebeast.com.*NutriBulletis a trademark of Capbrand Holdings, LLC. There is no affiliation between Beast Health, LLC and Capbrand Holdings, LLC.SOURCE Beast Health Related Links https://thebeast.com
Answer: | Founder of NutriBullet* Launches Wellness Brand - Beast Health - and its Design-Forward Blender and Hydration System Groundbreaking Product is First of Several Planned Launches from Beast Health, LLC | LOS ANGELES, March 3, 2021 /PRNewswire/ --Colin Sapire, founder of the NutriBullet*and innovator behind personal blending products for more than a decade, announces the launch of wellness brand Beast Health, and the debut of its design-forward personal blender and hydration system the B10+. Beautiful, functional design meets powerful performance. The Beast B10 Health Blender uses an innovative 12-rib blending vessel with leak-resistant seal to create the smoothest blends, and comes standard with a drinking lid and carry cap that fits the blending vessel to take your smoothie on-the-go. It is available in 3 stunning shades of black, grey or white. Visit www.thebeast.com for more info. Level up your hydration on-the-go or at home. The Beast Health Hydration System is designed to serve as an extension of the Beast B10 Health Blender, and comes as part of the B10+ product configuration. Simply pulse together a variety of fruits, vegetables or herbs in your Beast B10, transfer to the infusion chamber to enhance the flavor of your water and add more nutrients to your day. Visit www.thebeast.com for more info. Meet the Beast B10 Health Blender. Thoughtfully designed, front-to-back. This best-in-class blender was meticulously engineered to effortlessly create smooth, delicious, and healthy blends packed with nutrients to boost immunity and increase hydration. Visit www.thebeast.com for more info. Beast Health is on a mission to empower users to become Strong Inside. Beast Health's flagship B10 Health Blender is a revolution in personal blending, combining incomparable elegance and high-performance technology; and providing the perfect solution for those looking to elevate their nutrition and hydration game. The B10 Health Blender balances artful design with best-in-class technology to produce the smoothest, nutrient-rich blends imaginable. "The Beast is unlike any other personal blender," said Sapire. "Not only is it a beautifully designed countertop display piece, but its next-generation components make it one of the most elegant, effective and efficient personal blenders ever created. From the electronic interlock blade system to the thermal safety sensor and innovative 12-rib vessel design, our B10 Health Blender was engineered to elevate our customer experience; reducing spills and noise, while maximizing safety and blending efficiency." The B10 Health Blender is extremely versatile, blending up smoothies, health elixirs and cocktails, and pulsing dips, salsas, sauces or even nut butter to perfection in seconds. The Beast B10 Health Blender retails for $138. The more comprehensive Beast B10+ Health Blender and Hydration System retails for $168, and includes an innovative hydration system designed to be used in tandem with the blender to create hydration infusions. The included portable borosilicate glass drinking vessel contains a uniquely constructed infusion chamber for an entirely new hydration experience. Both of these products can be purchased at www.thebeast.com.Media contacts: Allie Yaldezian: [emailprotected] Ryan Croy: [emailprotected]About Beast Health: Beast Health was founded on the simple premise that whole foods are nature's greatest gift to us. Using innovative design and technology, we hope to enable and empower our community to strengthen their immunity and to attain their nutrition and wellness goals. As an all-encompassing wellness brand, Beast Health plans to introduce additional innovative appliances and related products for discerning, health-focused consumers across the globe and to focus on meaningful community-minded initiatives.For more information, visit www.thebeast.com.*NutriBulletis a trademark of Capbrand Holdings, LLC. There is no affiliation between Beast Health, LLC and Capbrand Holdings, LLC.SOURCE Beast Health Related Links https://thebeast.com |
edtsum2160 | You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text.
Text: DUBLIN--(BUSINESS WIRE)--The "Global Neonatal & Prenatal Care Market By Equipment (Prenatal, Neonatal, Phototherapy equipment, Hearing and vision screening instrument, pulse oximetry), By Application, By End User, By Region, Competition, Forecast & Opportunities, 2025" report has been added to ResearchAndMarkets.com's offering. The Global Neonatal & Prenatal Care Market size was valued at USD 6 billion in 2019 and projected to grow at a steady CAGR during the forecast period. The key factor responsible for the growth of the neonatal & prenatal care market is rapid innovations regarding technology as well as infrastructural developments in the healthcare sector. Additionally, growing investments by the governing bodies and healthcare providers is another major factor that is anticipated to bode well for the growth of the neonatal & prenatal care market across the globe in the coming years. Moreover, high birth rate in emerging nations is further anticipated to bolster the market growth through 2025. The Global Neonatal & Prenatal Care Market is segmented based on equipment, application, end-user and region. Based on end-user, the market can be segmented into hospitals, pediatric & neonatal clinics and nursing homes. Out of which, the hospitals segment dominated the market in terms of largest market share until 2019 and is further anticipated to be the fastest-growing application segment of the neonatal & prenatal care market during the forecast period as well. This growth can be accredited to presence of modern & technologically advanced medical equipment in the hospitals to ensure enhanced patient care. Along with that, abundance of specialists in a hospital is another factor which is further boosting the growth of the segment across the globe. Companies Mentioned Objective of the Study: Key Topics Covered: 1. Product Overview 2. Research Methodology 3. Executive Summary 4. Global Neonatal & Prenatal Care Market Outlook 4.1. Market Size & Forecast 4.1.1. By Value & Volume 4.2. Market Share & Forecast 4.2.1. By Equipment (Prenatal {Fetal Doppler, Fetal MRI, Fetal Monitor, Fetal Pulse oximetry and others}, Neonatal {Incubators, Neonatal monitoring device {Apnea,Blood pressure, cardio} Phototherapy equipment, Hearing and vision screening instrument, pulse oximetry}) 4.2.2. By Application (ENT, Cardiovascular, Respiratory and others) 4.2.3. By End User (Hospitals, Pediatric and Neonatal Clinics , Nursing homes) 4.2.4. By Company (2019) 4.2.5. By Region 4.3. Market Attractiveness Index 5. Asia-Pacific Neonatal & Prenatal Care Market Outlook 5.1. Market Size & Forecast 5.2. Market Share & Forecast 5.3. Market Attractiveness Index 5.4. Asia-Pacific: Country Analysis 6. Europe Neonatal & Prenatal Care Market Outlook 6.1. Market Size & Forecast 6.2. Market Share & Forecast 6.3. Market Attractiveness Index 6.4. Europe: Country Analysis 7. North America Neonatal & Prenatal Care Market Outlook 7.1. Market Size & Forecast 7.2. Market Share & Forecast 7.3. Market Attractiveness Index 7.4. North America: Country Analysis 8. South America Neonatal & Prenatal Care Market Outlook 8.1. Market Size & Forecast 8.2. Market Share & Forecast 8.3. Market Attractiveness Index 8.4. South America: Country Analysis 9. Middle East and Africa Neonatal & Prenatal Care Market Outlook 9.1. Market Size & Forecast 9.2. Market Share & Forecast 9.3. Market Attractiveness Index 9.4. MEA: Country Analysis 10. Market Dynamics 10.1. Drivers 10.2. Challenges 11. Market Trends & Developments 12. Competitive Landscape 12.1. Competition Outlook 12.2. Players Profiled (Leading Companies) 13. Strategic Recommendations 14. About the author & Disclaimer For more information about this report visit https://www.researchandmarkets.com/r/xurcup
Answer: | Global Neonatal & Prenatal Care Market (2020 to 2025) - by Equipment, Application, End-user and Region - ResearchAndMarkets.com | DUBLIN--(BUSINESS WIRE)--The "Global Neonatal & Prenatal Care Market By Equipment (Prenatal, Neonatal, Phototherapy equipment, Hearing and vision screening instrument, pulse oximetry), By Application, By End User, By Region, Competition, Forecast & Opportunities, 2025" report has been added to ResearchAndMarkets.com's offering. The Global Neonatal & Prenatal Care Market size was valued at USD 6 billion in 2019 and projected to grow at a steady CAGR during the forecast period. The key factor responsible for the growth of the neonatal & prenatal care market is rapid innovations regarding technology as well as infrastructural developments in the healthcare sector. Additionally, growing investments by the governing bodies and healthcare providers is another major factor that is anticipated to bode well for the growth of the neonatal & prenatal care market across the globe in the coming years. Moreover, high birth rate in emerging nations is further anticipated to bolster the market growth through 2025. The Global Neonatal & Prenatal Care Market is segmented based on equipment, application, end-user and region. Based on end-user, the market can be segmented into hospitals, pediatric & neonatal clinics and nursing homes. Out of which, the hospitals segment dominated the market in terms of largest market share until 2019 and is further anticipated to be the fastest-growing application segment of the neonatal & prenatal care market during the forecast period as well. This growth can be accredited to presence of modern & technologically advanced medical equipment in the hospitals to ensure enhanced patient care. Along with that, abundance of specialists in a hospital is another factor which is further boosting the growth of the segment across the globe. Companies Mentioned Objective of the Study: Key Topics Covered: 1. Product Overview 2. Research Methodology 3. Executive Summary 4. Global Neonatal & Prenatal Care Market Outlook 4.1. Market Size & Forecast 4.1.1. By Value & Volume 4.2. Market Share & Forecast 4.2.1. By Equipment (Prenatal {Fetal Doppler, Fetal MRI, Fetal Monitor, Fetal Pulse oximetry and others}, Neonatal {Incubators, Neonatal monitoring device {Apnea,Blood pressure, cardio} Phototherapy equipment, Hearing and vision screening instrument, pulse oximetry}) 4.2.2. By Application (ENT, Cardiovascular, Respiratory and others) 4.2.3. By End User (Hospitals, Pediatric and Neonatal Clinics , Nursing homes) 4.2.4. By Company (2019) 4.2.5. By Region 4.3. Market Attractiveness Index 5. Asia-Pacific Neonatal & Prenatal Care Market Outlook 5.1. Market Size & Forecast 5.2. Market Share & Forecast 5.3. Market Attractiveness Index 5.4. Asia-Pacific: Country Analysis 6. Europe Neonatal & Prenatal Care Market Outlook 6.1. Market Size & Forecast 6.2. Market Share & Forecast 6.3. Market Attractiveness Index 6.4. Europe: Country Analysis 7. North America Neonatal & Prenatal Care Market Outlook 7.1. Market Size & Forecast 7.2. Market Share & Forecast 7.3. Market Attractiveness Index 7.4. North America: Country Analysis 8. South America Neonatal & Prenatal Care Market Outlook 8.1. Market Size & Forecast 8.2. Market Share & Forecast 8.3. Market Attractiveness Index 8.4. South America: Country Analysis 9. Middle East and Africa Neonatal & Prenatal Care Market Outlook 9.1. Market Size & Forecast 9.2. Market Share & Forecast 9.3. Market Attractiveness Index 9.4. MEA: Country Analysis 10. Market Dynamics 10.1. Drivers 10.2. Challenges 11. Market Trends & Developments 12. Competitive Landscape 12.1. Competition Outlook 12.2. Players Profiled (Leading Companies) 13. Strategic Recommendations 14. About the author & Disclaimer For more information about this report visit https://www.researchandmarkets.com/r/xurcup |
edtsum2161 | You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text.
Text: ORLANDO, Fla.--(BUSINESS WIRE)--Hannover Life Reassurance Company of America (Hannover Re US) announces the promotions of Tiffany Norman to Senior Vice President, Head of Annuity Solutions; Aaron Kinakin to Senior Vice President, Head of Structuring; and Thomas Porter, Senior Vice President, Head of Financial Reporting and Valuation. Tiffany Norman joined Hannover Re in 2006 as an actuarial assistant. She has since progressed through various roles in the company, developing significant expertise on reinsurance and the underlying insurance products. After significant growth in the US annuity market, the Annuity Solutions business unit was formalized in 2019 to continue serving the needs of US annuity writers, and Tiffany was appointed Vice President, Head of Annuity Solutions. Under her leadership, the business unit has expanded Hannover Res core offerings to include customized solutions that enable annuity clients to achieve their risk management and financial objectives across all annuity lines, as well as product development and consulting services. In her role as Senior Vice President, Head of Annuity Solutions, Tiffany will continue to be responsible for the growth and management of annuity reinsurance for Hannover Re in the US. Aaron Kinakin joined Hannover Re in 2014 and has successfully led a variety of significant transactions for clients spanning the life, health and annuity product lines. Leveraging his actuarial, investment and capital markets expertise, Aaron has played a pivotal role in expanding Hannover Res offers of structured solutions to all parts of the life, health and annuity industry. In Aarons role as Senior Vice President, Head of Structuring, he will continue to develop new and innovative win-win solutions for clients and advance Hannover Res customer-centric approach as the market leader of structured solutions in the US. Thomas Porter joined Hannover Re in 2005 and after moving through multiple actuarial rotations, was promoted to Vice President in 2015. During his career with Hannover Re US, Thomas has led the due diligence pricing efforts for multiple successful life transactions that added significant value for both our clients and Hannover Re. Thereafter moving to a finance role, he has been instrumental in the development of best practices on inforce management and financial reporting for life and annuity financial reinsurance transactions. In his role as Head of Financial Reporting and Valuation, Thomas will oversee all technical accounting, actuarial valuation and financial reporting functions for all life, health and annuity business for Hannover Re US. His leadership will be instrumental as Hannover Re moves into the IFRS17 framework. Hannover Re has become a leader in the fixed indexed annuity reinsurance market in recent years, adding to the breadth of experience we have developing solutions for our clients across all life, health and annuity product lines, said Pete Schaefer, President and CEO of Hannover Re US. We are excited to announce these key leadership appointments as we continue to serve our clients needs with innovative reinsurance solutions. About Hannover Re US Hannover Life Reassurance Company of America (Hannover Re US), which is licensed and/or accredited in all 50 states, the District of Columbia and Puerto Rico, is one of the North American life and health reinsurance subsidiaries of the Hannover Re Group. Hannover Re Group, with gross premium of more than EUR 22 billion, is the third-largest reinsurer in the world. It transacts all lines of property & casualty and life & health reinsurance and is present on all continents with more than 3,000 staff and a network of more than 150 subsidiaries, branches and representative offices. The rating agencies most relevant to the insurance industry have awarded Hannover Re very strong insurer financial strength ratings (Standard & Poor's AA- "Very Strong" and A.M. Best A+ "Superior"). For more information, visit www.hlramerica.com.
Answer: | Hannover Re US Announces Promotions to Strengthen Offerings across the Life and Health Markets, and Continue Expansion into the Annuity Market | ORLANDO, Fla.--(BUSINESS WIRE)--Hannover Life Reassurance Company of America (Hannover Re US) announces the promotions of Tiffany Norman to Senior Vice President, Head of Annuity Solutions; Aaron Kinakin to Senior Vice President, Head of Structuring; and Thomas Porter, Senior Vice President, Head of Financial Reporting and Valuation. Tiffany Norman joined Hannover Re in 2006 as an actuarial assistant. She has since progressed through various roles in the company, developing significant expertise on reinsurance and the underlying insurance products. After significant growth in the US annuity market, the Annuity Solutions business unit was formalized in 2019 to continue serving the needs of US annuity writers, and Tiffany was appointed Vice President, Head of Annuity Solutions. Under her leadership, the business unit has expanded Hannover Res core offerings to include customized solutions that enable annuity clients to achieve their risk management and financial objectives across all annuity lines, as well as product development and consulting services. In her role as Senior Vice President, Head of Annuity Solutions, Tiffany will continue to be responsible for the growth and management of annuity reinsurance for Hannover Re in the US. Aaron Kinakin joined Hannover Re in 2014 and has successfully led a variety of significant transactions for clients spanning the life, health and annuity product lines. Leveraging his actuarial, investment and capital markets expertise, Aaron has played a pivotal role in expanding Hannover Res offers of structured solutions to all parts of the life, health and annuity industry. In Aarons role as Senior Vice President, Head of Structuring, he will continue to develop new and innovative win-win solutions for clients and advance Hannover Res customer-centric approach as the market leader of structured solutions in the US. Thomas Porter joined Hannover Re in 2005 and after moving through multiple actuarial rotations, was promoted to Vice President in 2015. During his career with Hannover Re US, Thomas has led the due diligence pricing efforts for multiple successful life transactions that added significant value for both our clients and Hannover Re. Thereafter moving to a finance role, he has been instrumental in the development of best practices on inforce management and financial reporting for life and annuity financial reinsurance transactions. In his role as Head of Financial Reporting and Valuation, Thomas will oversee all technical accounting, actuarial valuation and financial reporting functions for all life, health and annuity business for Hannover Re US. His leadership will be instrumental as Hannover Re moves into the IFRS17 framework. Hannover Re has become a leader in the fixed indexed annuity reinsurance market in recent years, adding to the breadth of experience we have developing solutions for our clients across all life, health and annuity product lines, said Pete Schaefer, President and CEO of Hannover Re US. We are excited to announce these key leadership appointments as we continue to serve our clients needs with innovative reinsurance solutions. About Hannover Re US Hannover Life Reassurance Company of America (Hannover Re US), which is licensed and/or accredited in all 50 states, the District of Columbia and Puerto Rico, is one of the North American life and health reinsurance subsidiaries of the Hannover Re Group. Hannover Re Group, with gross premium of more than EUR 22 billion, is the third-largest reinsurer in the world. It transacts all lines of property & casualty and life & health reinsurance and is present on all continents with more than 3,000 staff and a network of more than 150 subsidiaries, branches and representative offices. The rating agencies most relevant to the insurance industry have awarded Hannover Re very strong insurer financial strength ratings (Standard & Poor's AA- "Very Strong" and A.M. Best A+ "Superior"). For more information, visit www.hlramerica.com. |
edtsum2163 | You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text.
Text: MINNEAPOLIS--(BUSINESS WIRE)--Avtex, a customer experience (CX) consulting and technology company, announced their partnership with CU NextGen, a Credit Union Service Organization (CUSO) focused on delivering next-generation technology to credit unions. Avtex will be the exclusive direct sales partner in the United States, leveraging their relationships with credit unions to further their mission of delivering exceptional experiences. In todays competitive financial services market, consumers expect their needs to be met quickly and efficiently; its crucial for credit unions to effectively manage complex member relationships. However, many credit unions have unintegrated systems that create information silos, making it nearly impossible to see the full details of a members relationship with a credit union in one place, much less take action on all of a members needs. CU NextGen helps credit unions improve the service delivered to their members, the daily experiences of their staff members and the efficiency of their operations. CU NextGen was formed through a strategic partnership between Members Development Company (MDC), a progressive and future-focused network of the leading credit unions in the country, and ClaySys Technologies, a Charlotte based technology company with core technical operations based in India, with products and expertise in automation, no-code app development, artificial intelligence, and enterprise IT consulting services. CU NextGens core competencies center on the technologies of no-code development, robotic process automation (RPA) and artificial intelligence, which form the foundation of its flagship offering, the Member Relationship Management platform (MRM). The MRM platform is a software suite that allows credit unions to design experiences for their employees and their members. The MRM platform reduces the need for manual data entry caused by a lack of integration between different credit union systems, and instead allows credit union staff to execute complex processes on members at the click of a button from within a single dashboard. According to Kent Zimmer, CEO of CU NextGen, Our goal is to give credit unions complete control over their member-facing and employee-facing experiences. By leveraging our technology and skills, and the expertise and reach of the Avtex team, we can eliminate many of the challenges facing credit unions today. As the exclusive direct sales partner, Avtex is positioned to offer their credit union clients the ability to enhance their member experience and increase operational efficiency. The combination of CX strategy and technology innovation services offered by Avtex, alongside the powerful functionality of CU NextGens MRM platform, will help credit unions effectively manage complex member relationships. The robust capabilities of the CU NextGen technology, along with the power of our member interaction technologies, can provide credit unions with an integrated member experience platform that is unlike any in the industry. says Kurt Schroeder, Chief Experience Officer at Avtex. We are excited to bring CU NextGen to our 120+ credit union clients and help them deliver exceptional experiences to their members. About Avtex Avtex is a full-service Customer Experience (CX) consulting and solution provider focused on helping organizations build meaningful connections with their customers, members and constituents. Avtex offers a wide range of solutions to support CX transformation planning and orchestration of experiences for clients. Avtex has offices across the U.S., with headquarters in Minneapolis. Avtex is recognized as a gold partner of both Microsoft and Genesys, leveraging their world class platforms as the foundation for customer engagements and digital transformation. Visit www.avtex.com for more information. About CU NextGen CU NextGen CUSO, LLC is a progressive organization with a mission to give credit unions control of their employee- and member-facing experiences. CU NextGen delivers innovative solutions using three integrated and strategic technology platforms: no-code development, robotic process automation, and artificial intelligence. The best-in-class Member Relationship Management (MRM) suite provides solutions for process automation, CRM, and more. CU NextGen currently serves credit unions nationwide through next-generation technology and on-demand consulting services, all designed to meet the unique needs of the credit union industry. Learn more at www.cunextgen.com.
Answer: | Avtex and CU NextGen Announce Partnership | MINNEAPOLIS--(BUSINESS WIRE)--Avtex, a customer experience (CX) consulting and technology company, announced their partnership with CU NextGen, a Credit Union Service Organization (CUSO) focused on delivering next-generation technology to credit unions. Avtex will be the exclusive direct sales partner in the United States, leveraging their relationships with credit unions to further their mission of delivering exceptional experiences. In todays competitive financial services market, consumers expect their needs to be met quickly and efficiently; its crucial for credit unions to effectively manage complex member relationships. However, many credit unions have unintegrated systems that create information silos, making it nearly impossible to see the full details of a members relationship with a credit union in one place, much less take action on all of a members needs. CU NextGen helps credit unions improve the service delivered to their members, the daily experiences of their staff members and the efficiency of their operations. CU NextGen was formed through a strategic partnership between Members Development Company (MDC), a progressive and future-focused network of the leading credit unions in the country, and ClaySys Technologies, a Charlotte based technology company with core technical operations based in India, with products and expertise in automation, no-code app development, artificial intelligence, and enterprise IT consulting services. CU NextGens core competencies center on the technologies of no-code development, robotic process automation (RPA) and artificial intelligence, which form the foundation of its flagship offering, the Member Relationship Management platform (MRM). The MRM platform is a software suite that allows credit unions to design experiences for their employees and their members. The MRM platform reduces the need for manual data entry caused by a lack of integration between different credit union systems, and instead allows credit union staff to execute complex processes on members at the click of a button from within a single dashboard. According to Kent Zimmer, CEO of CU NextGen, Our goal is to give credit unions complete control over their member-facing and employee-facing experiences. By leveraging our technology and skills, and the expertise and reach of the Avtex team, we can eliminate many of the challenges facing credit unions today. As the exclusive direct sales partner, Avtex is positioned to offer their credit union clients the ability to enhance their member experience and increase operational efficiency. The combination of CX strategy and technology innovation services offered by Avtex, alongside the powerful functionality of CU NextGens MRM platform, will help credit unions effectively manage complex member relationships. The robust capabilities of the CU NextGen technology, along with the power of our member interaction technologies, can provide credit unions with an integrated member experience platform that is unlike any in the industry. says Kurt Schroeder, Chief Experience Officer at Avtex. We are excited to bring CU NextGen to our 120+ credit union clients and help them deliver exceptional experiences to their members. About Avtex Avtex is a full-service Customer Experience (CX) consulting and solution provider focused on helping organizations build meaningful connections with their customers, members and constituents. Avtex offers a wide range of solutions to support CX transformation planning and orchestration of experiences for clients. Avtex has offices across the U.S., with headquarters in Minneapolis. Avtex is recognized as a gold partner of both Microsoft and Genesys, leveraging their world class platforms as the foundation for customer engagements and digital transformation. Visit www.avtex.com for more information. About CU NextGen CU NextGen CUSO, LLC is a progressive organization with a mission to give credit unions control of their employee- and member-facing experiences. CU NextGen delivers innovative solutions using three integrated and strategic technology platforms: no-code development, robotic process automation, and artificial intelligence. The best-in-class Member Relationship Management (MRM) suite provides solutions for process automation, CRM, and more. CU NextGen currently serves credit unions nationwide through next-generation technology and on-demand consulting services, all designed to meet the unique needs of the credit union industry. Learn more at www.cunextgen.com. |
edtsum2164 | You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text.
Text: NEW YORK, Oct. 13, 2020 /PRNewswire/ --Bernstein Liebhard, a nationally acclaimed investor rights law firm, reminds investors of the deadline to file a lead plaintiff motion in a securities class action that has been filed on behalf of investors that purchased or acquired the common stock of Wrap Technologies, Inc ("Wrap" or the "Company") (NASDAQ: WRTC) between July 31, 2020, and September 23, 2020 (the "Class Period"). The lawsuit filed in the United States District Court for the Central District of California alleges violations of the Securities Exchange Act of 1934. If you purchased Wrap securities, and/or would like to discuss your legal rights and options please visit Wrap Shareholder Class Action Lawsuit or contact Matthew E. Guarnero toll free at (877) 779-1414 or [emailprotected]. The Complaint alleges that throughout the Class Period, Defendants made materially false and misleading statements regarding the Company's business, operations and prospects. Specifically, Defendants misrepresented and/or failed to disclose to investors that: (1) the Company had concealed the results of the LAPD BolaWrap pilot program, which demonstrated that the BolaWrap was ineffective, expensive, and sparingly used in the field; and (2) as a result, Defendants' public statements were materially false and/or misleading at all relevant times. On September 23, 2020, White Diamond Research published a report entitled "Wrap Technologies: Disastrous LAPD BolaWrap Pilot Program Results, No Evidence These Have Been Communicated To Investors" alleging, among other things, that the Company's trial pilot program with the LAPD was a disaster, and that the Company had not disclosed the results to investors. On this news, securities of Wrap fell $2.07 per share, or 25.43% to close at $6.07 per share on September 23, 2020. If you wish to serve as lead plaintiff, you must move the Court no later than November 23, 2020. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation. Your ability to share in any recovery doesn't require that you serve as lead plaintiff. If you choose to take no action, you may remain an absent class member. If you purchased Wrap securities, and/or would like to discuss your legal rights and options please visit https://www.bernlieb.com/cases/wraptechnologiesinc-wrtc-shareholder-class-action-lawsuit-stock-fraud-314/apply/ or contact Matthew E. Guarnero toll free at (877) 779-1414 or [emailprotected]. Since 1993, Bernstein Liebhard LLP has recovered over $3.5 billion for its clients. In addition to representing individual investors, the Firm has been retained by some of the largest public and private pension funds in the country to monitor their assets and pursue litigation on their behalf. As a result of its success litigating hundreds of lawsuits and class actions, the Firm has been named toThe National Law Journal's"Plaintiffs' Hot List" thirteen times and listed inThe Legal 500for ten consecutive years. ATTORNEY ADVERTISING. 2020 Bernstein Liebhard LLP. The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, (212) 779-1414. The lawyer responsible for this advertisement in the State of Connecticut is Michael S. Bigin. Prior results do not guarantee or predict a similar outcome with respect to any future matter. Contact Information Matthew E. GuarneroBernstein Liebhard LLPhttps://www.bernlieb.com(877) 779-1414[emailprotected] SOURCE Bernstein Liebhard LLP Related Links http://www.bernlieb.com
Answer: | WRTC CLASS ACTION DEADLINE: Bernstein Liebhard Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against Wrap Technologies Inc | NEW YORK, Oct. 13, 2020 /PRNewswire/ --Bernstein Liebhard, a nationally acclaimed investor rights law firm, reminds investors of the deadline to file a lead plaintiff motion in a securities class action that has been filed on behalf of investors that purchased or acquired the common stock of Wrap Technologies, Inc ("Wrap" or the "Company") (NASDAQ: WRTC) between July 31, 2020, and September 23, 2020 (the "Class Period"). The lawsuit filed in the United States District Court for the Central District of California alleges violations of the Securities Exchange Act of 1934. If you purchased Wrap securities, and/or would like to discuss your legal rights and options please visit Wrap Shareholder Class Action Lawsuit or contact Matthew E. Guarnero toll free at (877) 779-1414 or [emailprotected]. The Complaint alleges that throughout the Class Period, Defendants made materially false and misleading statements regarding the Company's business, operations and prospects. Specifically, Defendants misrepresented and/or failed to disclose to investors that: (1) the Company had concealed the results of the LAPD BolaWrap pilot program, which demonstrated that the BolaWrap was ineffective, expensive, and sparingly used in the field; and (2) as a result, Defendants' public statements were materially false and/or misleading at all relevant times. On September 23, 2020, White Diamond Research published a report entitled "Wrap Technologies: Disastrous LAPD BolaWrap Pilot Program Results, No Evidence These Have Been Communicated To Investors" alleging, among other things, that the Company's trial pilot program with the LAPD was a disaster, and that the Company had not disclosed the results to investors. On this news, securities of Wrap fell $2.07 per share, or 25.43% to close at $6.07 per share on September 23, 2020. If you wish to serve as lead plaintiff, you must move the Court no later than November 23, 2020. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation. Your ability to share in any recovery doesn't require that you serve as lead plaintiff. If you choose to take no action, you may remain an absent class member. If you purchased Wrap securities, and/or would like to discuss your legal rights and options please visit https://www.bernlieb.com/cases/wraptechnologiesinc-wrtc-shareholder-class-action-lawsuit-stock-fraud-314/apply/ or contact Matthew E. Guarnero toll free at (877) 779-1414 or [emailprotected]. Since 1993, Bernstein Liebhard LLP has recovered over $3.5 billion for its clients. In addition to representing individual investors, the Firm has been retained by some of the largest public and private pension funds in the country to monitor their assets and pursue litigation on their behalf. As a result of its success litigating hundreds of lawsuits and class actions, the Firm has been named toThe National Law Journal's"Plaintiffs' Hot List" thirteen times and listed inThe Legal 500for ten consecutive years. ATTORNEY ADVERTISING. 2020 Bernstein Liebhard LLP. The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, (212) 779-1414. The lawyer responsible for this advertisement in the State of Connecticut is Michael S. Bigin. Prior results do not guarantee or predict a similar outcome with respect to any future matter. Contact Information Matthew E. GuarneroBernstein Liebhard LLPhttps://www.bernlieb.com(877) 779-1414[emailprotected] SOURCE Bernstein Liebhard LLP Related Links http://www.bernlieb.com |
edtsum2177 | You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text.
Text: NASHVILLE, Tenn.--(BUSINESS WIRE)--Churchill Mortgage, a leader in the mortgage industry providing conventional, FHA, VA and USDA residential mortgages across 46 states, has expanded across the state of Florida, led by Jim McQuaig, Senior Vice President, and Cory Alexander, Florida Market Director of Churchill Mortgage. Churchill Mortgage has seen record growth this year with volume increasing by 116% for January through June of this year compared to last year. To keep pace with the substantial increase in volume, the company has grown its workforce by 187 employees and 24 new branches in 2020. This growth has brought Churchill Mortgage to further expand into Florida. Floridas housing market has seen an uptick as mortgage rates reach a record low. According to Chief Economist Brad O'Connor of the Florida Association of Realtors, new pending sales of single-family homes were up 23.2% statewide year-over-year. Alexander has helped grow Churchills Florida team to support local consumers as they navigate Floridas competitive housing market. The top Florida markets for the Churchill team are Jacksonville, Orlando and Tampa. Alexander has been in the mortgage industry for nearly two decades with experience ranging from originating in bank branch models to full retail with direct lenders. For the last seven years, Alexander has focused on growing strategic markets in the Southeast United States with various companies such as JP Morgan Chase, Atlantic Bay Mortgage Group, New Penn Financial, and Equity Resources. In March 2020, Alexander joined Churchill Mortgage as the Florida Market Director and has been recruiting to grow the team so that clients can be supported in untapped residential lending markets. Our mission at Churchill Mortgage is to help consumers achieve debt-free homeownership while providing support to create a smooth homebuying experience, said Mike Hardwick, president and CEO of Churchill Mortgage. We recognize that buying a home is one of the biggest financial decisions a person can make, and we strive to help borrowers make thoughtful decisions, especially in competitive markets like Florida. Corys comprehensive experience in the mortgage industry has proven to be a valuable asset as he develops Churchills presence in Florida, said Jim McQuaig, Senior Vice President. With his help, we can ensure each customer is guided in accordance with their financial goals. I look forward to continuing to see the Florida teams success statewide. Churchill is actively seeking talented, driven mortgage professionals for its expansion efforts. For more information, visit our careers page. To learn more about the Florida team, visit our blog. About Churchill Mortgage Founded in 1992, Churchill Mortgage is a privately-owned company by its more than 600 employees. A full-service and financially sound leader in the mortgage industry, the company provides conventional, FHA, VA and USDA residential mortgages across 46 states. As heard on personal finance expert and author Dave Ramseys nationally syndicated radio show, the lenders mission is to help borrowers achieve debt-free homeownership and build wealth through a smarter mortgage plan, regardless of their starting point. Churchill Mortgage is a wholly owned subsidiary of Churchill Holdings, Inc. Churchill Mortgages notable achievements include recognitions as a Top Lender by Scotsman Guide: Residential, an eight-time Top Workplace by The Tennessean, one of the Best Mortgage Companies to Work For by National Mortgage News and a Top 100 Private Company and Best in Business by the Nashville Business Journal. For more information about Churchill Mortgage, visit www.churchillmortgage.com or follow the company on LinkedIn, Twitter @ChurchillMtg, Instagram, Pinterest and Facebook.
Answer: | Churchill Mortgage Expands Footprint Throughout Florida | NASHVILLE, Tenn.--(BUSINESS WIRE)--Churchill Mortgage, a leader in the mortgage industry providing conventional, FHA, VA and USDA residential mortgages across 46 states, has expanded across the state of Florida, led by Jim McQuaig, Senior Vice President, and Cory Alexander, Florida Market Director of Churchill Mortgage. Churchill Mortgage has seen record growth this year with volume increasing by 116% for January through June of this year compared to last year. To keep pace with the substantial increase in volume, the company has grown its workforce by 187 employees and 24 new branches in 2020. This growth has brought Churchill Mortgage to further expand into Florida. Floridas housing market has seen an uptick as mortgage rates reach a record low. According to Chief Economist Brad O'Connor of the Florida Association of Realtors, new pending sales of single-family homes were up 23.2% statewide year-over-year. Alexander has helped grow Churchills Florida team to support local consumers as they navigate Floridas competitive housing market. The top Florida markets for the Churchill team are Jacksonville, Orlando and Tampa. Alexander has been in the mortgage industry for nearly two decades with experience ranging from originating in bank branch models to full retail with direct lenders. For the last seven years, Alexander has focused on growing strategic markets in the Southeast United States with various companies such as JP Morgan Chase, Atlantic Bay Mortgage Group, New Penn Financial, and Equity Resources. In March 2020, Alexander joined Churchill Mortgage as the Florida Market Director and has been recruiting to grow the team so that clients can be supported in untapped residential lending markets. Our mission at Churchill Mortgage is to help consumers achieve debt-free homeownership while providing support to create a smooth homebuying experience, said Mike Hardwick, president and CEO of Churchill Mortgage. We recognize that buying a home is one of the biggest financial decisions a person can make, and we strive to help borrowers make thoughtful decisions, especially in competitive markets like Florida. Corys comprehensive experience in the mortgage industry has proven to be a valuable asset as he develops Churchills presence in Florida, said Jim McQuaig, Senior Vice President. With his help, we can ensure each customer is guided in accordance with their financial goals. I look forward to continuing to see the Florida teams success statewide. Churchill is actively seeking talented, driven mortgage professionals for its expansion efforts. For more information, visit our careers page. To learn more about the Florida team, visit our blog. About Churchill Mortgage Founded in 1992, Churchill Mortgage is a privately-owned company by its more than 600 employees. A full-service and financially sound leader in the mortgage industry, the company provides conventional, FHA, VA and USDA residential mortgages across 46 states. As heard on personal finance expert and author Dave Ramseys nationally syndicated radio show, the lenders mission is to help borrowers achieve debt-free homeownership and build wealth through a smarter mortgage plan, regardless of their starting point. Churchill Mortgage is a wholly owned subsidiary of Churchill Holdings, Inc. Churchill Mortgages notable achievements include recognitions as a Top Lender by Scotsman Guide: Residential, an eight-time Top Workplace by The Tennessean, one of the Best Mortgage Companies to Work For by National Mortgage News and a Top 100 Private Company and Best in Business by the Nashville Business Journal. For more information about Churchill Mortgage, visit www.churchillmortgage.com or follow the company on LinkedIn, Twitter @ChurchillMtg, Instagram, Pinterest and Facebook. |
edtsum2178 | You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text.
Text: MILWAUKEE, July 13, 2020 /PRNewswire/ -- Directors of A. O. Smith Corporation(NYSE:AOS) today declared a regular quarterly cash dividend of $.24 per share on the company's Common Stock and Class A Common Stock. The dividend is payable on August 17 to shareholders of record July 31, 2020. About A. O. SmithA. O. Smith Corporation, with headquarters in Milwaukee, Wis., is a global leader applying innovative technology and energy-efficient solutions to products manufactured and marketed worldwide. Listed on the New York Stock Exchange (NYSE), the company is one of the world's leading manufacturers of residential and commercial water heating equipment and boilers, as well as a manufacturer of water treatment and air purification products. For more information, visit www.aosmith.com. SOURCE A. O. Smith Corporation Related Links http://www.aosmith.com
Answer: | A. O. Smith declares quarterly dividend | MILWAUKEE, July 13, 2020 /PRNewswire/ -- Directors of A. O. Smith Corporation(NYSE:AOS) today declared a regular quarterly cash dividend of $.24 per share on the company's Common Stock and Class A Common Stock. The dividend is payable on August 17 to shareholders of record July 31, 2020. About A. O. SmithA. O. Smith Corporation, with headquarters in Milwaukee, Wis., is a global leader applying innovative technology and energy-efficient solutions to products manufactured and marketed worldwide. Listed on the New York Stock Exchange (NYSE), the company is one of the world's leading manufacturers of residential and commercial water heating equipment and boilers, as well as a manufacturer of water treatment and air purification products. For more information, visit www.aosmith.com. SOURCE A. O. Smith Corporation Related Links http://www.aosmith.com |
edtsum2179 | You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text.
Text: CHELMSFORD, Mass., Aug. 4, 2020 /PRNewswire/ -- Brooks Automation, Inc. (Nasdaq:BRKS) announced today that company management will participate in the Needham Virtual SemiCap and Electronic Design Automation Conference on Thursday, August 13, 2020 at 9:30 a.m. ET. The 40-minute session will be webcast live via the Brooks investor relations website at www.brooks.investorroom.com/events. About Brooks AutomationBrooks (Nasdaq: BRKS) is a leading provider of life science sample-based solutions and semiconductor manufacturing solutions worldwide. The Company's Life Sciences business provides a full suite of products and services for reliable cold-chain sample management and genomic analysis supporting areas such as drug development, clinical research and advanced cell therapies for the industry's top pharmaceutical, biotech, academic and healthcare institutions globally. With over 40 years as a partner to the semiconductor manufacturing industry, Brooks is a provider of industry-leading precision vacuum robotics, integrated automation systems and contamination control solutions to the world's leading semiconductor chip makers and equipment manufacturers. Brooks is headquartered in Chelmsford, MA, with operations in North America, Europe and Asia. For more information, visit www.brooks.com. INVESTOR CONTACTS: Mark NamaroffDirector, Investor RelationsBrooks Automation 978.262.2635[emailprotected] Sherry DinsmoreBrooks Automation978.262.2400[emailprotected] SOURCE Brooks Automation Related Links http://www.brooks.com
Answer: | Brooks to Participate in the Needham Virtual SemiCap and EDA Investor Conference | CHELMSFORD, Mass., Aug. 4, 2020 /PRNewswire/ -- Brooks Automation, Inc. (Nasdaq:BRKS) announced today that company management will participate in the Needham Virtual SemiCap and Electronic Design Automation Conference on Thursday, August 13, 2020 at 9:30 a.m. ET. The 40-minute session will be webcast live via the Brooks investor relations website at www.brooks.investorroom.com/events. About Brooks AutomationBrooks (Nasdaq: BRKS) is a leading provider of life science sample-based solutions and semiconductor manufacturing solutions worldwide. The Company's Life Sciences business provides a full suite of products and services for reliable cold-chain sample management and genomic analysis supporting areas such as drug development, clinical research and advanced cell therapies for the industry's top pharmaceutical, biotech, academic and healthcare institutions globally. With over 40 years as a partner to the semiconductor manufacturing industry, Brooks is a provider of industry-leading precision vacuum robotics, integrated automation systems and contamination control solutions to the world's leading semiconductor chip makers and equipment manufacturers. Brooks is headquartered in Chelmsford, MA, with operations in North America, Europe and Asia. For more information, visit www.brooks.com. INVESTOR CONTACTS: Mark NamaroffDirector, Investor RelationsBrooks Automation 978.262.2635[emailprotected] Sherry DinsmoreBrooks Automation978.262.2400[emailprotected] SOURCE Brooks Automation Related Links http://www.brooks.com |
edtsum2180 | You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text.
Text: DUBLIN, Dec. 10, 2020 /PRNewswire/ -- The "Innovative Cloud-based SaaS Business Models Driving the GCC Connected Trucks Telematics Market, 2022" report has been added to ResearchAndMarkets.com's offering. The connected trucks telematics market in the Gulf Cooperation Council (GCC) region is poised for slow growth due to perilous economic conditions. The market - in an economy hit by the double impact of the ongoing Coronavirus 2019 (COVID-19) pandemic and the slump in oil prices - is dominated by local aftermarket participants, while OEM suppliers are trying to catch up. Telematics technology by itself is expected to grow only gradually as the awareness about vehicle tracking and monitoring of various user-based parameters increases among the user community. Technological advancements such as real-time tracking, video safety, and advanced driver assistance systems (ADAS) are changing the current driving experience. The penetration of such features in mid-and high-range vehicles is expected to expand the market for vehicle telematics. Additionally, fluctuations in oil prices are a concern for stakeholders, especially with the growth in the number of vehicles that necessitate the adoption of telematics and fleet management solutions. Key telematics service providers (TSPs) covered in this study include Gurtam, Teltonika, Mix Telematics, and Location Solutions. Notable OEMs covered include MAN, Volvo, Daimler, and Scania. These vendors have employed various strategies to expand their product and application offerings and augment their market share. Many global companies/TSPs are attempting to enter the GCC market; however, they face major challenges. TSPs need to forge deep relationships by establishing a local presence through mergers or acquisitions, partnerships, or joint ventures with local players. Being a price-sensitive market, companies should build efficient and cost-effective solutions to address end-user requirements. The market also holds sizable opportunities for new entrants. Research Highlights This research primarily focuses on issues and challenges faced by telematics vendors and OEMs in the GCC market, highlights key market trends, profiles TSPs and OEMs operating in the market, analyses market share and pricing strategies based on hardware/solutions, and identifies available growth opportunities. Key statistics for this research are obtained from major TSPs and OEM suppliers through primary and secondary interviews. The objective of this study is to highlight developments in the telematics industry in the GCC. The market is fragmented due to the presence of many large and small vendors. This report discusses key vendors but does not detail the market share of all participants. Total telematics penetration in the GCC is expected to reach more than 1 million units by the end of 2022, registering a growth rate of over 7%. Key trends driving this adoption will be driver & vehicle safety, video safety systems, and big data analytics. Participating in the GCC connected truck telematics market will be a promising venture for new and existing TSPs. Growth in this region will be positive due to its vast geographic spread, impending regulations, and key projects in the oil & gas, transport & logistics, construction & mining, and energy & utility sectors. Key Topics Covered: 1. Strategic Imperatives Why is it Increasingly Difficult to Grow? The Strategic Imperative Impact of the Top Three Strategic Imperatives on the GCC Telematics Industry Growth Opportunities Fuel the Growth Pipeline Engine 2. Executive Summary Key Findings Roadmap of Connected Trucks Telematics Market Market Engineering Measurements PESTLE Analysis Connected Truck Telematics Market Outlook Current and Future Outlook 3. Research Scope Scope Key Questions this Study will Answer 4. Segmentation and Overview Vehicle Segmentation Fleet Size and Distance-driven Segmentation Solution Types Key Telematics Services - Overview 5. Market Outlook Market Engineering Measurements Key Economic Indicators - GCC, 2019-2022 Top Market Issues and Challenges - GCC Key Future Market Trends - GCC Connected Truck Market - Installed Base Forecast Key TSPs Operating in GCC Key OEMs Operating in GCC Ecosystem Partners and Local Partnerships 6. Country-wise Analysis Country Analysis - Saudi Arabia Country Analysis - UAE Country Analysis - Kuwait Country Analysis - Oman Country Analysis - Qatar 7. Pricing and Competitive Scenario Telematics Product Type Range Telematics Product Package Range Competitive Force Analysis Competitive Force Analysis - OEMs Vs. TSPs 8. Market Share Analysis GCC Telematics - Installed Base by Contributions Installed Base - Forecast Market Share Analysis 9. Market Opportunity Analysis Opportunity by Hardware Type Opportunity by Package Type Opportunities by Services - Top 3 Short-term Key Services Opportunity by Vehicle Type Opportunity by Fleet Type Opportunity by Industry Type Opportunity by Solution Type Key Opportunity Regions 10. Growth Opportunities and Companies to Action Growth Opportunity - Compliance with Regulations and a Strategy to Build New Business Models will Maximise Business Output Strategic Imperatives for Success and Growth 11. Conclusions Key Conclusions and Future Outlook The Last Word - 3 Big Predictions 12. Next Steps Companies Mentioned Daimler Gurtam Location Solutions MAN Mix Telematics Scania Teltonika Volvo For more information about this report visit https://www.researchandmarkets.com/r/5mq22x Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research. Media Contact: Research and Markets Laura Wood, Senior Manager [emailprotected] For E.S.T Office Hours Call +1-917-300-0470 For U.S./CAN Toll Free Call +1-800-526-8630 For GMT Office Hours Call +353-1-416-8900 U.S. Fax: 646-607-1907 Fax (outside U.S.): +353-1-481-1716 SOURCE Research and Markets Related Links http://www.researchandmarkets.com
Answer: | GCC Connected Trucks Telematics Market Report 2020: Issues and Challenges Faced by Telematics Vendors and OEMs in the market - Forecast to 2022 | DUBLIN, Dec. 10, 2020 /PRNewswire/ -- The "Innovative Cloud-based SaaS Business Models Driving the GCC Connected Trucks Telematics Market, 2022" report has been added to ResearchAndMarkets.com's offering. The connected trucks telematics market in the Gulf Cooperation Council (GCC) region is poised for slow growth due to perilous economic conditions. The market - in an economy hit by the double impact of the ongoing Coronavirus 2019 (COVID-19) pandemic and the slump in oil prices - is dominated by local aftermarket participants, while OEM suppliers are trying to catch up. Telematics technology by itself is expected to grow only gradually as the awareness about vehicle tracking and monitoring of various user-based parameters increases among the user community. Technological advancements such as real-time tracking, video safety, and advanced driver assistance systems (ADAS) are changing the current driving experience. The penetration of such features in mid-and high-range vehicles is expected to expand the market for vehicle telematics. Additionally, fluctuations in oil prices are a concern for stakeholders, especially with the growth in the number of vehicles that necessitate the adoption of telematics and fleet management solutions. Key telematics service providers (TSPs) covered in this study include Gurtam, Teltonika, Mix Telematics, and Location Solutions. Notable OEMs covered include MAN, Volvo, Daimler, and Scania. These vendors have employed various strategies to expand their product and application offerings and augment their market share. Many global companies/TSPs are attempting to enter the GCC market; however, they face major challenges. TSPs need to forge deep relationships by establishing a local presence through mergers or acquisitions, partnerships, or joint ventures with local players. Being a price-sensitive market, companies should build efficient and cost-effective solutions to address end-user requirements. The market also holds sizable opportunities for new entrants. Research Highlights This research primarily focuses on issues and challenges faced by telematics vendors and OEMs in the GCC market, highlights key market trends, profiles TSPs and OEMs operating in the market, analyses market share and pricing strategies based on hardware/solutions, and identifies available growth opportunities. Key statistics for this research are obtained from major TSPs and OEM suppliers through primary and secondary interviews. The objective of this study is to highlight developments in the telematics industry in the GCC. The market is fragmented due to the presence of many large and small vendors. This report discusses key vendors but does not detail the market share of all participants. Total telematics penetration in the GCC is expected to reach more than 1 million units by the end of 2022, registering a growth rate of over 7%. Key trends driving this adoption will be driver & vehicle safety, video safety systems, and big data analytics. Participating in the GCC connected truck telematics market will be a promising venture for new and existing TSPs. Growth in this region will be positive due to its vast geographic spread, impending regulations, and key projects in the oil & gas, transport & logistics, construction & mining, and energy & utility sectors. Key Topics Covered: 1. Strategic Imperatives Why is it Increasingly Difficult to Grow? The Strategic Imperative Impact of the Top Three Strategic Imperatives on the GCC Telematics Industry Growth Opportunities Fuel the Growth Pipeline Engine 2. Executive Summary Key Findings Roadmap of Connected Trucks Telematics Market Market Engineering Measurements PESTLE Analysis Connected Truck Telematics Market Outlook Current and Future Outlook 3. Research Scope Scope Key Questions this Study will Answer 4. Segmentation and Overview Vehicle Segmentation Fleet Size and Distance-driven Segmentation Solution Types Key Telematics Services - Overview 5. Market Outlook Market Engineering Measurements Key Economic Indicators - GCC, 2019-2022 Top Market Issues and Challenges - GCC Key Future Market Trends - GCC Connected Truck Market - Installed Base Forecast Key TSPs Operating in GCC Key OEMs Operating in GCC Ecosystem Partners and Local Partnerships 6. Country-wise Analysis Country Analysis - Saudi Arabia Country Analysis - UAE Country Analysis - Kuwait Country Analysis - Oman Country Analysis - Qatar 7. Pricing and Competitive Scenario Telematics Product Type Range Telematics Product Package Range Competitive Force Analysis Competitive Force Analysis - OEMs Vs. TSPs 8. Market Share Analysis GCC Telematics - Installed Base by Contributions Installed Base - Forecast Market Share Analysis 9. Market Opportunity Analysis Opportunity by Hardware Type Opportunity by Package Type Opportunities by Services - Top 3 Short-term Key Services Opportunity by Vehicle Type Opportunity by Fleet Type Opportunity by Industry Type Opportunity by Solution Type Key Opportunity Regions 10. Growth Opportunities and Companies to Action Growth Opportunity - Compliance with Regulations and a Strategy to Build New Business Models will Maximise Business Output Strategic Imperatives for Success and Growth 11. Conclusions Key Conclusions and Future Outlook The Last Word - 3 Big Predictions 12. Next Steps Companies Mentioned Daimler Gurtam Location Solutions MAN Mix Telematics Scania Teltonika Volvo For more information about this report visit https://www.researchandmarkets.com/r/5mq22x Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research. Media Contact: Research and Markets Laura Wood, Senior Manager [emailprotected] For E.S.T Office Hours Call +1-917-300-0470 For U.S./CAN Toll Free Call +1-800-526-8630 For GMT Office Hours Call +353-1-416-8900 U.S. Fax: 646-607-1907 Fax (outside U.S.): +353-1-481-1716 SOURCE Research and Markets Related Links http://www.researchandmarkets.com |
edtsum2181 | You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text.
Text: DUBLIN, May 1, 2020 /PRNewswire/ -- The "Global Classroom Management Systems Market 2020-2024" report has been added to ResearchAndMarkets.com's offering. This report on the global classroom management market examines market size and looks at forecasts, trends, growth drivers and challenges for the market. It provides comprehensive vendor analysis on key industry players.The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment. The market is driven by increasing emphasis on collaborative learning tools. In addition, the growing adoption of gamification is anticipated to boost the market growth.The global classroom management systems market is segmented as below:Deployment On-premise Cloud-based End-user Higher education K-12 Geographic segmentation North America APAC Europe South America MEA The report provides a detailed analysis of key vendors operating in the classroom management systems market, including APLAF Inc., Blackboard Inc., ClassDojo Inc., Dell Technologies Inc., Faronics Corp., HP Inc., Impero Solutions Ltd., Lenovo Group Ltd., Netop Solutions AS and NetSupport Ltd.The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.Key Topics Covered: Executive Summary Market Overview Market Landscape Market ecosystem Value chain analysis Market Sizing Market definition Market segment analysis Market size 2019 Market outlook: Forecast for 2019 - 2024 Five Forces Analysis Five Forces Summary Bargaining power of buyers Bargaining power of suppliers Threat of new entrants Threat of substitutes Threat of rivalry Market condition Market Segmentation by End-user Market segments Comparison by End user placement Higher education - Market size and forecast 2019-2024 K-12 - Market size and forecast 2019-2024 Market opportunity by End user Market Segmentation by Deployment Market segments Comparison by Deployment placement On-premise deployment - Market size and forecast 2019-2024 Cloud-based deployment - Market size and forecast 2019-2024 Market opportunity by Deployment Customer landscape Overview Geographic Landscape Geographic segmentation Geographic comparison North America - Market size and forecast 2019-2024 Europe - Market size and forecast 2019-2024 APAC - Market size and forecast 2019-2024 South America - Market size and forecast 2019-2024 MEA - Market size and forecast 2019-2024 Key leading countries Market opportunity by geography Drivers, Challenges, and Trends Market drivers Volume driver - Demand led growth Volume driver - Supply led growth Volume driver - External factors Volume driver - Demand shift in adjacent markets Price driver - Inflation Price driver - Shift from lower to higher priced units Market challenges Market trends Vendor Landscape Overview Vendor landscape Landscape disruption Vendor Analysis Vendors covered Market positioning of vendors Appendix Scope of the report Currency conversion rates for US$ Research methodology List of abbreviations Companies Mentioned APLAF Inc. Blackboard Inc. ClassDojo Inc. Dell Technologies Inc. Faronics Corp. HP Inc. Impero Solutions Ltd. Lenovo Group Ltd. Netop Solutions AS NetSupport Ltd. For more information about this report visit https://www.researchandmarkets.com/r/52rhil About ResearchAndMarkets.comResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends. Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research. Media Contact: Research and Markets Laura Wood, Senior Manager [emailprotected] For E.S.T Office Hours Call +1-917-300-0470 For U.S./CAN Toll Free Call +1-800-526-8630 For GMT Office Hours Call +353-1-416-8900 U.S. Fax: 646-607-1907 Fax (outside U.S.): +353-1-481-1716 SOURCE Research and Markets Related Links http://www.researchandmarkets.com
Answer: | World Market for Classroom Management Systems Report, Featuring Company Analysis of Key Players Including Blackboard, ClassDojo and HP | DUBLIN, May 1, 2020 /PRNewswire/ -- The "Global Classroom Management Systems Market 2020-2024" report has been added to ResearchAndMarkets.com's offering. This report on the global classroom management market examines market size and looks at forecasts, trends, growth drivers and challenges for the market. It provides comprehensive vendor analysis on key industry players.The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment. The market is driven by increasing emphasis on collaborative learning tools. In addition, the growing adoption of gamification is anticipated to boost the market growth.The global classroom management systems market is segmented as below:Deployment On-premise Cloud-based End-user Higher education K-12 Geographic segmentation North America APAC Europe South America MEA The report provides a detailed analysis of key vendors operating in the classroom management systems market, including APLAF Inc., Blackboard Inc., ClassDojo Inc., Dell Technologies Inc., Faronics Corp., HP Inc., Impero Solutions Ltd., Lenovo Group Ltd., Netop Solutions AS and NetSupport Ltd.The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.Key Topics Covered: Executive Summary Market Overview Market Landscape Market ecosystem Value chain analysis Market Sizing Market definition Market segment analysis Market size 2019 Market outlook: Forecast for 2019 - 2024 Five Forces Analysis Five Forces Summary Bargaining power of buyers Bargaining power of suppliers Threat of new entrants Threat of substitutes Threat of rivalry Market condition Market Segmentation by End-user Market segments Comparison by End user placement Higher education - Market size and forecast 2019-2024 K-12 - Market size and forecast 2019-2024 Market opportunity by End user Market Segmentation by Deployment Market segments Comparison by Deployment placement On-premise deployment - Market size and forecast 2019-2024 Cloud-based deployment - Market size and forecast 2019-2024 Market opportunity by Deployment Customer landscape Overview Geographic Landscape Geographic segmentation Geographic comparison North America - Market size and forecast 2019-2024 Europe - Market size and forecast 2019-2024 APAC - Market size and forecast 2019-2024 South America - Market size and forecast 2019-2024 MEA - Market size and forecast 2019-2024 Key leading countries Market opportunity by geography Drivers, Challenges, and Trends Market drivers Volume driver - Demand led growth Volume driver - Supply led growth Volume driver - External factors Volume driver - Demand shift in adjacent markets Price driver - Inflation Price driver - Shift from lower to higher priced units Market challenges Market trends Vendor Landscape Overview Vendor landscape Landscape disruption Vendor Analysis Vendors covered Market positioning of vendors Appendix Scope of the report Currency conversion rates for US$ Research methodology List of abbreviations Companies Mentioned APLAF Inc. Blackboard Inc. ClassDojo Inc. Dell Technologies Inc. Faronics Corp. HP Inc. Impero Solutions Ltd. Lenovo Group Ltd. Netop Solutions AS NetSupport Ltd. For more information about this report visit https://www.researchandmarkets.com/r/52rhil About ResearchAndMarkets.comResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends. Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research. Media Contact: Research and Markets Laura Wood, Senior Manager [emailprotected] For E.S.T Office Hours Call +1-917-300-0470 For U.S./CAN Toll Free Call +1-800-526-8630 For GMT Office Hours Call +353-1-416-8900 U.S. Fax: 646-607-1907 Fax (outside U.S.): +353-1-481-1716 SOURCE Research and Markets Related Links http://www.researchandmarkets.com |
edtsum2182 | You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text.
Text: PLYMOUTH MEETING, Pa., Feb. 22, 2021 /PRNewswire/ --A collaborative of national health IT safety experts has released new guidance aimed at improving patient safety by reducing the overwhelming number of alert notifications from computerized ordering systems in healthcare. While alerts can facilitate patient safety, they may also contribute to alert fatigue and clinician burden, says ECRI, the nation's most trusted voice in healthcare. ECRI's Partnership for Health IT Patient Safety, a multi-stakeholder collaborative that sets priorities in health IT safety, established a six-month virtual workgroup last year focused on finding ways to reduce alert fatigue associated with Computerized Physician Order Entry (CPOE) systems. Their just-released white paper, Safe Practices to Reduce CPOE Alert Fatigue through Monitoring, Analysis, and Optimization, outlines the workgroup's processes and key recommendations that provider organizations can take to improve safety now and in the future. While alerts can facilitate patient safety, they may also contribute to alert fatigue and clinician burden. Tweet this "Alert fatigue is a common occurrence for physicians and healthcare professionals and in extreme cases, can be linked to unintended consequences," says Marcus Schabacker, MD, PhD, president and chief executive officer, ECRI. "Clearly, clinicians are under enormous stress in this era of COVID-19 and we expect that these new safe practice recommendations will help keep patients safer." The multi-stakeholder workgroup, chaired by John D. McGreevey III, MD, at Penn Medicine and Adam Wright, PhD, at Vanderbilt University, set out to fulfill two goals: (1) Promote patient safety by optimizing necessary, clinically important alerts and (2) Promote clinician wellness and health IT safety. "In order to narrow the scope of the project, we looked at alerts associated with CPOE because these are the most common alerts that clinicians experience. CPOE alerts can include drug interactions, drug dosing alerts, diagnostic and treatment alerts, and alerts based on disease or condition," says Penn Medicine's McGreevey. "These alerts serve as prompts or reminders that can advise clinicians about safety considerations in the care of the patient."The white paper outlines the workgroup's four safe practice recommendations, strategies to address these recommendations, and actions for their implementation. The safe practices include the following: GovernanceIdentify, develop, and execute a Clinical Decision Support (CDS) and knowledge base governance plan MonitoringGather data and information using CDS-specific metrics and other tools to identify real-time or near real-time CDS alert functioning and impact AnalysisRegularly assess, evaluate, and interpret metrics, functionalities, usability, and impact to determine effectiveness and value while balancing and minimizing burden OptimizationMaximize the use of technology and various tools to create and promote effective, targeted, relevant, and routinely updated alerts Theworkgroupdrew on the expertise of its members and external subject matter experts, an ECRI-conducted evidence-based literature review, and analysis of pertinent patient safety data submitted to the ECRI and the Institute for Safe Medication Practices Patient Safety Organization (PSO) and partner PSOs between January 2019 and February 2020."For a majority of the PSO events we analyzed, the alert did not function as expected," says workgroup co-chair Robert Giannini, NHA, CHTS-IM/CP, patient safety analyst and consultant, ECRI. "An alert that isn't as effective as intended puts patients at risk and contributes to clinician burden."ECRI's Partnership for Health IT Patient Safety, funded in part with financial support from The Gordon and Betty Moore Foundation, was founded in 2013 and wrapped up in December 2020. All of the Partnership's findings and safe practice recommendations and toolkits are available on ECRI's websiteand atwww.hitsafety.org. Social Sharing[NEWS] @ECRI_Org & #healthIT safety experts issue white paper on reducing alert fatigue & clinical burden from #CPOE notifications @PennMedicine @VanderbiltU @ISMP_OrgAbout ECRI| ECRI is an independent, nonprofit organization improving the safety, quality, and cost-effectiveness of care across all healthcare settings. With a focus on patient safety, evidence-based medicine, and health technology decision solutions, ECRI is respected and trusted by healthcare leaders and agencies worldwide. Over the past fifty years, ECRI has built its reputation on integrity and disciplined rigor, with an unwavering commitment to independence and strict conflict-of-interest rules. ECRI is the only organization worldwide to conduct independent medical device evaluations, with labs located in North America and Asia Pacific. ECRI is designated an Evidence-based Practice Center by the U.S. Agency for Healthcare Research and Quality. ECRI and the Institute for Safe Medication Practices PSO is a federally certified Patient Safety Organization as designated by the U.S. Department of Health and Human Services. The Institute for Safe Medication Practices (ISMP) formally became an ECRI Affiliate in 2020. Visit www.ecri.org and follow @ECRI_OrgSOURCE ECRI Related Links www.ecri.org
Answer: | ECRI and Health IT Safety Experts Team up to Tackle Alert Fatigue ECRI's Partnership for Health IT Patient Safety issues safe practice recommendations to reduce overrides, missed notifications, interruptions from Computerized Provider Order Entry (CPOE) | PLYMOUTH MEETING, Pa., Feb. 22, 2021 /PRNewswire/ --A collaborative of national health IT safety experts has released new guidance aimed at improving patient safety by reducing the overwhelming number of alert notifications from computerized ordering systems in healthcare. While alerts can facilitate patient safety, they may also contribute to alert fatigue and clinician burden, says ECRI, the nation's most trusted voice in healthcare. ECRI's Partnership for Health IT Patient Safety, a multi-stakeholder collaborative that sets priorities in health IT safety, established a six-month virtual workgroup last year focused on finding ways to reduce alert fatigue associated with Computerized Physician Order Entry (CPOE) systems. Their just-released white paper, Safe Practices to Reduce CPOE Alert Fatigue through Monitoring, Analysis, and Optimization, outlines the workgroup's processes and key recommendations that provider organizations can take to improve safety now and in the future. While alerts can facilitate patient safety, they may also contribute to alert fatigue and clinician burden. Tweet this "Alert fatigue is a common occurrence for physicians and healthcare professionals and in extreme cases, can be linked to unintended consequences," says Marcus Schabacker, MD, PhD, president and chief executive officer, ECRI. "Clearly, clinicians are under enormous stress in this era of COVID-19 and we expect that these new safe practice recommendations will help keep patients safer." The multi-stakeholder workgroup, chaired by John D. McGreevey III, MD, at Penn Medicine and Adam Wright, PhD, at Vanderbilt University, set out to fulfill two goals: (1) Promote patient safety by optimizing necessary, clinically important alerts and (2) Promote clinician wellness and health IT safety. "In order to narrow the scope of the project, we looked at alerts associated with CPOE because these are the most common alerts that clinicians experience. CPOE alerts can include drug interactions, drug dosing alerts, diagnostic and treatment alerts, and alerts based on disease or condition," says Penn Medicine's McGreevey. "These alerts serve as prompts or reminders that can advise clinicians about safety considerations in the care of the patient."The white paper outlines the workgroup's four safe practice recommendations, strategies to address these recommendations, and actions for their implementation. The safe practices include the following: GovernanceIdentify, develop, and execute a Clinical Decision Support (CDS) and knowledge base governance plan MonitoringGather data and information using CDS-specific metrics and other tools to identify real-time or near real-time CDS alert functioning and impact AnalysisRegularly assess, evaluate, and interpret metrics, functionalities, usability, and impact to determine effectiveness and value while balancing and minimizing burden OptimizationMaximize the use of technology and various tools to create and promote effective, targeted, relevant, and routinely updated alerts Theworkgroupdrew on the expertise of its members and external subject matter experts, an ECRI-conducted evidence-based literature review, and analysis of pertinent patient safety data submitted to the ECRI and the Institute for Safe Medication Practices Patient Safety Organization (PSO) and partner PSOs between January 2019 and February 2020."For a majority of the PSO events we analyzed, the alert did not function as expected," says workgroup co-chair Robert Giannini, NHA, CHTS-IM/CP, patient safety analyst and consultant, ECRI. "An alert that isn't as effective as intended puts patients at risk and contributes to clinician burden."ECRI's Partnership for Health IT Patient Safety, funded in part with financial support from The Gordon and Betty Moore Foundation, was founded in 2013 and wrapped up in December 2020. All of the Partnership's findings and safe practice recommendations and toolkits are available on ECRI's websiteand atwww.hitsafety.org. Social Sharing[NEWS] @ECRI_Org & #healthIT safety experts issue white paper on reducing alert fatigue & clinical burden from #CPOE notifications @PennMedicine @VanderbiltU @ISMP_OrgAbout ECRI| ECRI is an independent, nonprofit organization improving the safety, quality, and cost-effectiveness of care across all healthcare settings. With a focus on patient safety, evidence-based medicine, and health technology decision solutions, ECRI is respected and trusted by healthcare leaders and agencies worldwide. Over the past fifty years, ECRI has built its reputation on integrity and disciplined rigor, with an unwavering commitment to independence and strict conflict-of-interest rules. ECRI is the only organization worldwide to conduct independent medical device evaluations, with labs located in North America and Asia Pacific. ECRI is designated an Evidence-based Practice Center by the U.S. Agency for Healthcare Research and Quality. ECRI and the Institute for Safe Medication Practices PSO is a federally certified Patient Safety Organization as designated by the U.S. Department of Health and Human Services. The Institute for Safe Medication Practices (ISMP) formally became an ECRI Affiliate in 2020. Visit www.ecri.org and follow @ECRI_OrgSOURCE ECRI Related Links www.ecri.org |
edtsum2183 | You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text.
Text: DALLAS, Nov. 18, 2020 /PRNewswire/ --Ranger Investment Management, L.P. (Ranger Investments), a boutique manager specializing in small- and micro-cap U.S. growth strategies, today announced its management is acquiring a controlling interest in the firm previously held by Ranger Capital Group. Kudu Investment Management, LLC (Kudu), an independent provider of permanent capital solutions to asset and wealth managers worldwide, financed the transaction and will have a passive, minority interest in Ranger Investments. Financial terms were not disclosed, and the transaction is subject to customary approvals. Dallas-based Ranger Investments manages approximately $1.6 billion in discretionary and $400 million in non-discretionary assets. Upon closing, Ranger Investments will be led and controlled by its management team. Established in 2003, the firm serves clients including pension funds, endowments, foundations and family offices. It offers two mutual fundsRanger Small Cap Fund (RFISX) and the Ranger Micro Cap Fund (RFIMX). "This transformative transaction consolidates our management team's ownership of Ranger Investments and helps ensure long-term and multi-generational stability," said W. Conrad Doenges, the firm's chief investment officer. "Each investment team partner now owns a greater personal share in the firm, strengthening our alignment with and commitment to clients." "Kudu is delighted to partner with Conrad and the firm's management team," said Rob Jakacki, Kudu's CEO. "With a long-term capital commitment from Kudu, we believe a boutique firm like Ranger Investments can produce better outcomes for clients when it has full control of its own destiny." In addition to Doenges, Ranger Investments' management committee consists of current principals Andrew Hill, president and portfolio manager; Joseph LaBate, managing director and portfolio manager; and Brown McCullough, director and sector manager. Ranger Investments will retain key back office personnel and operations and administration will continue unchanged through a service agreement with Ranger Capital Group. "We are grateful for the support over the past 17 years from the partners at Ranger Capital.Their willingness to allow the management of Ranger Investments to increase our ownership in the business is a testimony to the working partnership we've had," said Doenges. Winstead PC served as legal advisor to Ranger Investments and Seward & Kissel LLP provided legal counsel to Kudu. ABOUT RANGER INVESTMENT MANAGEMENT Ranger Investment Management, L.P. is a boutique equity investment manager that offers U.S. small- and micro-cap growth strategies. Formed in 2003, Ranger Investments is an SEC-registered investment adviser, owned and controlled by employees. The firm's strategies aim to preserve and grow capital by utilizing a bottom-up, fundamental research process to identify growing, high quality companies that can be purchased at attractive valuations. For more information, please visit: https://www.rangerinvestments.com. ABOUT KUDU INVESTMENT MANAGEMENT Kudu Investment Management provides long-term capital solutionsincluding generational ownership transfers, management buyouts, acquisition and growth finance, as well as liquidity for legacy partnersto asset and wealth managers. Kudu was founded in 2015 and is backed by capital partner White Mountains Insurance Group, Ltd. (NYSE:WTM). For more information, please visit Kudu'swebsite. SOURCE Kudu Investment Management, LLC Related Links kuduinvestment.com
Answer: | Ranger Investment Management Consolidates Ownership Interest With Capital From Kudu Investment Management | DALLAS, Nov. 18, 2020 /PRNewswire/ --Ranger Investment Management, L.P. (Ranger Investments), a boutique manager specializing in small- and micro-cap U.S. growth strategies, today announced its management is acquiring a controlling interest in the firm previously held by Ranger Capital Group. Kudu Investment Management, LLC (Kudu), an independent provider of permanent capital solutions to asset and wealth managers worldwide, financed the transaction and will have a passive, minority interest in Ranger Investments. Financial terms were not disclosed, and the transaction is subject to customary approvals. Dallas-based Ranger Investments manages approximately $1.6 billion in discretionary and $400 million in non-discretionary assets. Upon closing, Ranger Investments will be led and controlled by its management team. Established in 2003, the firm serves clients including pension funds, endowments, foundations and family offices. It offers two mutual fundsRanger Small Cap Fund (RFISX) and the Ranger Micro Cap Fund (RFIMX). "This transformative transaction consolidates our management team's ownership of Ranger Investments and helps ensure long-term and multi-generational stability," said W. Conrad Doenges, the firm's chief investment officer. "Each investment team partner now owns a greater personal share in the firm, strengthening our alignment with and commitment to clients." "Kudu is delighted to partner with Conrad and the firm's management team," said Rob Jakacki, Kudu's CEO. "With a long-term capital commitment from Kudu, we believe a boutique firm like Ranger Investments can produce better outcomes for clients when it has full control of its own destiny." In addition to Doenges, Ranger Investments' management committee consists of current principals Andrew Hill, president and portfolio manager; Joseph LaBate, managing director and portfolio manager; and Brown McCullough, director and sector manager. Ranger Investments will retain key back office personnel and operations and administration will continue unchanged through a service agreement with Ranger Capital Group. "We are grateful for the support over the past 17 years from the partners at Ranger Capital.Their willingness to allow the management of Ranger Investments to increase our ownership in the business is a testimony to the working partnership we've had," said Doenges. Winstead PC served as legal advisor to Ranger Investments and Seward & Kissel LLP provided legal counsel to Kudu. ABOUT RANGER INVESTMENT MANAGEMENT Ranger Investment Management, L.P. is a boutique equity investment manager that offers U.S. small- and micro-cap growth strategies. Formed in 2003, Ranger Investments is an SEC-registered investment adviser, owned and controlled by employees. The firm's strategies aim to preserve and grow capital by utilizing a bottom-up, fundamental research process to identify growing, high quality companies that can be purchased at attractive valuations. For more information, please visit: https://www.rangerinvestments.com. ABOUT KUDU INVESTMENT MANAGEMENT Kudu Investment Management provides long-term capital solutionsincluding generational ownership transfers, management buyouts, acquisition and growth finance, as well as liquidity for legacy partnersto asset and wealth managers. Kudu was founded in 2015 and is backed by capital partner White Mountains Insurance Group, Ltd. (NYSE:WTM). For more information, please visit Kudu'swebsite. SOURCE Kudu Investment Management, LLC Related Links kuduinvestment.com |
edtsum2196 | You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text.
Text: TAIPEI, Taiwan--(BUSINESS WIRE)--EZconn Corporation recently defeated a patent challenge brought by PCT International, Inc., a former customer with whom EZconn has done no business since March 2014. In an April 2019 press release, PCT noted that it had filed an action with the Taiwan Intellectual Property Office to cancel EZconns Patent No. M416249, which PCT claimed "copied the significant features and claims of a prior PCT patent" and was "based on the misuse of PCTs trade secrets." In a recent decision, the TIPO upheld EZconn's patent and dismissed PCT's invalidation action. PCT has been in bankruptcy proceedings in the United States since November 2019. PCT's debts to EZconn arise from prior lawsuits in which PCT alleged that EZconn copied PCT's technology and misused PCT's confidential information. After reviewing PCT's allegations and evidence, the court not only entered judgment for EZconn but also awarded EZconns attorneys fees incurred to defend against PCTs claims, which the court held lacked merit and were not tenable. The court also awarded more than US $9.4 million to EZconn for product that PCT had ordered and accepted but did not pay for. EZconns judgments were upheld on appeal. Allen Chuang, spokesperson and CFO of EZconn, said, "PCT's patent invalidation action was just another baseless effort to falsely accuse EZconn and deflect attention from PCT's self-imposed business failures. We are gratified that the Taiwan Intellectual Property Office sustained the validity of EZconn's patent and rejected PCT's arguments, just as the United States court rejected them. Rather than squandering resources on relitigating meritless allegations against EZconn, PCT should focus on turning its business around and paying its creditors." EZconn continues its collection efforts and remains hopeful that PCT, operating under oversight of the bankruptcy court, will satisfy its obligations to EZconn and its other creditors. About EZconn Corporation is headquartered in, and organized under the laws of, Taiwan. EZconn is publicly traded on the Taiwan Stock Exchange (6442.TW). It operates manufacturing facilities in Taiwan, China, and Philippines, as well as research and development facilities in Taiwan and the Czech Republic. EZconn manufactures a variety of advanced RF and fiber optics communications products. Its innovations are protected by more than 130 patents in Taiwan, the United States, and other countries. To learn more, visit http://www.ezconn.com/.
Answer: | EZconn Corporation Defeats PCT Internationals Patent Challenge | TAIPEI, Taiwan--(BUSINESS WIRE)--EZconn Corporation recently defeated a patent challenge brought by PCT International, Inc., a former customer with whom EZconn has done no business since March 2014. In an April 2019 press release, PCT noted that it had filed an action with the Taiwan Intellectual Property Office to cancel EZconns Patent No. M416249, which PCT claimed "copied the significant features and claims of a prior PCT patent" and was "based on the misuse of PCTs trade secrets." In a recent decision, the TIPO upheld EZconn's patent and dismissed PCT's invalidation action. PCT has been in bankruptcy proceedings in the United States since November 2019. PCT's debts to EZconn arise from prior lawsuits in which PCT alleged that EZconn copied PCT's technology and misused PCT's confidential information. After reviewing PCT's allegations and evidence, the court not only entered judgment for EZconn but also awarded EZconns attorneys fees incurred to defend against PCTs claims, which the court held lacked merit and were not tenable. The court also awarded more than US $9.4 million to EZconn for product that PCT had ordered and accepted but did not pay for. EZconns judgments were upheld on appeal. Allen Chuang, spokesperson and CFO of EZconn, said, "PCT's patent invalidation action was just another baseless effort to falsely accuse EZconn and deflect attention from PCT's self-imposed business failures. We are gratified that the Taiwan Intellectual Property Office sustained the validity of EZconn's patent and rejected PCT's arguments, just as the United States court rejected them. Rather than squandering resources on relitigating meritless allegations against EZconn, PCT should focus on turning its business around and paying its creditors." EZconn continues its collection efforts and remains hopeful that PCT, operating under oversight of the bankruptcy court, will satisfy its obligations to EZconn and its other creditors. About EZconn Corporation is headquartered in, and organized under the laws of, Taiwan. EZconn is publicly traded on the Taiwan Stock Exchange (6442.TW). It operates manufacturing facilities in Taiwan, China, and Philippines, as well as research and development facilities in Taiwan and the Czech Republic. EZconn manufactures a variety of advanced RF and fiber optics communications products. Its innovations are protected by more than 130 patents in Taiwan, the United States, and other countries. To learn more, visit http://www.ezconn.com/. |
edtsum2204 | You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text.
Text: SHELTON, Conn. and CLICHY, France, Dec. 17, 2020 /PRNewswire/ --BIC today announced it will partner with Exane BNP Paribas to launch the first European ESG Impact Share Buyback Program, allocating funds to J-PAL, the global research center working to reduce poverty, and to the BIC Corporate Foundation for Education. This innovative program is part of BIC's Capital Allocation policy to fund profitable growth and create value for all stakeholders. The ESG component is consistent with BIC's values, vision and mission to act as a responsible corporate citizen. Part of the funds will be allocated to the Abdul Latif Jameel Poverty Action Lab (J-PAL),the global research center led by professors Abhijit Banerjee, Esther Duflo, and Ben Olken. The projects will focus on education, including reducing school dropout, promoting soft skills, and reducing inequalities. Fundswill also be allocated to further support the BIC Corporate Foundation for Education. "Since its creation, BIC has maintained a strong commitment to Education throughout the world, including our Writing the Future, Together commitment to improve lives through education, and the BIC Corporate Foundation for Education. We are proud to pioneer this Impact Share Buyback program with Exane BNP Paribas in support of the work of J-PAL. In an environment where long-term sustainability and corporate purpose become increasingly meaningful for companies, this innovative program is a catalyst to genuine long-term stakeholder value creation," said Gonzalve Bich, BIC's Chief Executive Officer. "This generous contribution will allow us to extend the progress we have made in evaluating the relative effectiveness of different measures for promoting skills development and high-quality education opportunities for all," said J-PAL co-founder and co-director Esther Duflo. "This Impact Share Buyback illustrates BNP Paribas' willingness to help its clients innovate and develop in a sustainable manner, across all BNP Paribas activities, including Strategic Equity," said Barbara Genicot, Head of Strategic Equity Corporate Sales France, Benelux & Switzerland at BNP Paribas. "We are proud to be able to accompany BIC and to support the research work of the J-PAL lab" added Benedicte Thibord, Head of Corporate Broking and Business Development at Exane BNP Paribas. Approved by BIC's Board of Directors, the program will be executed in 2021, depending on market conditions. It is consistent with BIC's Capital Allocation Policy announced on 10 November 2020, which is comprised of: investment into operations to sustain organic growth targeted acquisitions to strengthen existing activities and develop in adjacent categories, Sustainable return to Shareholders, with an objective of ordinary dividend pay-out ratio in the range of 40% to 50% of Normalized EPS, and regular share buybacks. This share buyback will be executed under the authorization given by SOCIETE BIC Annual Shareholder Meeting on 20 May 2020. The outperformance1 in purchasing the shares will be allocated to J-PAL, and the BIC Corporation Foundation for Education. More details on the size and the duration of the share buyback program will be provided in early 2021. ABOUT BIC BICis a world leader in stationery, lighters, and shavers. For more than 75 years, the Company has honored the tradition of providing high-quality, affordable products to consumers everywhere. Through this unwavering dedication, BIC has become one of the most recognized brands and is a trademark registered worldwide. Today, BIC products are sold in more than 160 countries around the world and feature iconic brands such as Cello, Cont, BIC Flex, Lucky Stationery, Made For YOU, Soleil, Tipp-Ex, Wite-Out, and more. In 2019, BIC Net Sales were 1,949.4 million euros. The Company is listed on "Euronext Paris," is part of the SBF120 and CAC Mid 60 indexes and is recognized for its commitment to sustainable development and education. It received an A- Leadership score from CDP. For more, visit www.bicworld.comor follow us on LinkedIn, Instagram, Twitter, or YouTube. Born of BIC's desire to promote and structure its philanthropic approach, the BIC Corporate Foundation for Educationsupports inspiring and innovative projects focused on providing quality educationfor all. The Foundation focuses on three pillars: fight against school dropout, access to education for women and girls, environmental education. Since its inception in 2016, the Foundation has supported 42 projects around the world. ABOUT J-PAL The Abdul Latif Jameel Poverty Action Lab (J-PAL)is a global research center working to reduce poverty by ensuring that policy is informed by scientific evidence. Anchored by a network of 227 affiliated professors at universities around the world, J-PAL conducts randomized impact evaluations to answer critical questions in the fight against poverty. J-PAL's network of seven regional offices is hosted at leading universities in Africa, Europe, Latin America & the Caribbean, the Middle East & North Africa, North America, South Asia, and Southeast Asia. ABOUT Exane BNP Paribas Exane BNP Paribas is a leading European equities business. We offer a high-quality execution platform with full electronic trading capability. Our Research product is renowned for its depth and quality and is reinforced by experienced, top-ranked Sales & Specialist Sales teams as well as a dedicated corporate access service Exane BNPP Corporate Broking team is active in market intelligence, liquidity agreements, share buy-backs and management of listed stakes. Sophie Palliez-Capian V.P., Corporate Stakeholder Engagement Investor Relations Press Sophie Palliez-Capian + 33 6 87 89 33 51 [emailprotected] Michele Ventura +33 1 45 19 52 98 [emailprotected] Albane de La Tour d'Artaise + 33 7 85 88 19 48 [emailprotected] Isabelle de Segonzac : + 33 6 89 87 61 39 [emailprotected] 1The outperformance is the difference between the purchase price and the average VWAP over the execution period. SOURCE BIC Corporation Related Links http://www.bicworld.com
Answer: | BIC and Exane BNP Paribas pioneer the first European Environmental Social and Governance (ESG) Impact Share Buyback Program | SHELTON, Conn. and CLICHY, France, Dec. 17, 2020 /PRNewswire/ --BIC today announced it will partner with Exane BNP Paribas to launch the first European ESG Impact Share Buyback Program, allocating funds to J-PAL, the global research center working to reduce poverty, and to the BIC Corporate Foundation for Education. This innovative program is part of BIC's Capital Allocation policy to fund profitable growth and create value for all stakeholders. The ESG component is consistent with BIC's values, vision and mission to act as a responsible corporate citizen. Part of the funds will be allocated to the Abdul Latif Jameel Poverty Action Lab (J-PAL),the global research center led by professors Abhijit Banerjee, Esther Duflo, and Ben Olken. The projects will focus on education, including reducing school dropout, promoting soft skills, and reducing inequalities. Fundswill also be allocated to further support the BIC Corporate Foundation for Education. "Since its creation, BIC has maintained a strong commitment to Education throughout the world, including our Writing the Future, Together commitment to improve lives through education, and the BIC Corporate Foundation for Education. We are proud to pioneer this Impact Share Buyback program with Exane BNP Paribas in support of the work of J-PAL. In an environment where long-term sustainability and corporate purpose become increasingly meaningful for companies, this innovative program is a catalyst to genuine long-term stakeholder value creation," said Gonzalve Bich, BIC's Chief Executive Officer. "This generous contribution will allow us to extend the progress we have made in evaluating the relative effectiveness of different measures for promoting skills development and high-quality education opportunities for all," said J-PAL co-founder and co-director Esther Duflo. "This Impact Share Buyback illustrates BNP Paribas' willingness to help its clients innovate and develop in a sustainable manner, across all BNP Paribas activities, including Strategic Equity," said Barbara Genicot, Head of Strategic Equity Corporate Sales France, Benelux & Switzerland at BNP Paribas. "We are proud to be able to accompany BIC and to support the research work of the J-PAL lab" added Benedicte Thibord, Head of Corporate Broking and Business Development at Exane BNP Paribas. Approved by BIC's Board of Directors, the program will be executed in 2021, depending on market conditions. It is consistent with BIC's Capital Allocation Policy announced on 10 November 2020, which is comprised of: investment into operations to sustain organic growth targeted acquisitions to strengthen existing activities and develop in adjacent categories, Sustainable return to Shareholders, with an objective of ordinary dividend pay-out ratio in the range of 40% to 50% of Normalized EPS, and regular share buybacks. This share buyback will be executed under the authorization given by SOCIETE BIC Annual Shareholder Meeting on 20 May 2020. The outperformance1 in purchasing the shares will be allocated to J-PAL, and the BIC Corporation Foundation for Education. More details on the size and the duration of the share buyback program will be provided in early 2021. ABOUT BIC BICis a world leader in stationery, lighters, and shavers. For more than 75 years, the Company has honored the tradition of providing high-quality, affordable products to consumers everywhere. Through this unwavering dedication, BIC has become one of the most recognized brands and is a trademark registered worldwide. Today, BIC products are sold in more than 160 countries around the world and feature iconic brands such as Cello, Cont, BIC Flex, Lucky Stationery, Made For YOU, Soleil, Tipp-Ex, Wite-Out, and more. In 2019, BIC Net Sales were 1,949.4 million euros. The Company is listed on "Euronext Paris," is part of the SBF120 and CAC Mid 60 indexes and is recognized for its commitment to sustainable development and education. It received an A- Leadership score from CDP. For more, visit www.bicworld.comor follow us on LinkedIn, Instagram, Twitter, or YouTube. Born of BIC's desire to promote and structure its philanthropic approach, the BIC Corporate Foundation for Educationsupports inspiring and innovative projects focused on providing quality educationfor all. The Foundation focuses on three pillars: fight against school dropout, access to education for women and girls, environmental education. Since its inception in 2016, the Foundation has supported 42 projects around the world. ABOUT J-PAL The Abdul Latif Jameel Poverty Action Lab (J-PAL)is a global research center working to reduce poverty by ensuring that policy is informed by scientific evidence. Anchored by a network of 227 affiliated professors at universities around the world, J-PAL conducts randomized impact evaluations to answer critical questions in the fight against poverty. J-PAL's network of seven regional offices is hosted at leading universities in Africa, Europe, Latin America & the Caribbean, the Middle East & North Africa, North America, South Asia, and Southeast Asia. ABOUT Exane BNP Paribas Exane BNP Paribas is a leading European equities business. We offer a high-quality execution platform with full electronic trading capability. Our Research product is renowned for its depth and quality and is reinforced by experienced, top-ranked Sales & Specialist Sales teams as well as a dedicated corporate access service Exane BNPP Corporate Broking team is active in market intelligence, liquidity agreements, share buy-backs and management of listed stakes. Sophie Palliez-Capian V.P., Corporate Stakeholder Engagement Investor Relations Press Sophie Palliez-Capian + 33 6 87 89 33 51 [emailprotected] Michele Ventura +33 1 45 19 52 98 [emailprotected] Albane de La Tour d'Artaise + 33 7 85 88 19 48 [emailprotected] Isabelle de Segonzac : + 33 6 89 87 61 39 [emailprotected] 1The outperformance is the difference between the purchase price and the average VWAP over the execution period. SOURCE BIC Corporation Related Links http://www.bicworld.com |
edtsum2213 | You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text.
Text: NEW YORK, April 14, 2020 /PRNewswire/ -- Computer Vision Market Research Report by Component (Hardware, Services, and Software), by Application (Automotive & Transportation, Consumer Goods & Retail, Gaming, Sports & Entertainments, Healthcare, and Industrial Automation) - Global Forecast to 2025 (Cumulative Impact of COVID-19)Read the full report: https://www.reportlinker.com/p05881721/?utm_source=PRN The Global Computer Vision Market is expected to grow from USD 11,981.88 Million in 2019 to USD 19,398.97 Million by the end of 2025 at a Compound Annual Growth Rate (CAGR) of 8.36%.Market Segmentation & Coverage:This research report categorizes the Computer Vision to forecast the revenues and analyze the trends in each of the following sub-markets:"The Services is projected to witness the highest growth during the forecast period"On the basis of Component, the Computer Vision Market is studied across Hardware, Services, and Software. The Hardware commanded the largest size in the Computer Vision Market in 2019. On the other hand, the Services is expected to grow at the fastest CAGR during the forecast period."The Automotive & Transportation is projected to witness the highest growth during the forecast period"On the basis of Application, the Computer Vision Market is studied across Automotive & Transportation, Consumer Goods & Retail, Gaming, Sports & Entertainments, Healthcare, Industrial Automation, and Security & Surveillance. The Industrial Automation commanded the largest size in the Computer Vision Market in 2019. On the other hand, the Automotive & Transportation is expected to grow at the fastest CAGR during the forecast period."The Asia-Pacific is projected to witness the highest growth during the forecast period"On the basis of Geography, the Computer Vision Market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas region is studied across Argentina, Brazil, Canada, Mexico, and United States. The Asia-Pacific region is studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, South Korea, and Thailand. The Europe, Middle East & Africa region is studied across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom. The Americas commanded the largest size in the Computer Vision Market in 2019. On the other hand, the Asia-Pacific is expected to grow at the fastest CAGR during the forecast period.Company Usability Profiles:The report deeply explores the recent significant developments by the leading vendors and innovation profiles in the Global Computer Vision Market including Allied Vision Technologies GmbH, Basler AG, Blipper, Cisco Systems, Cortexica Vision Systems Ltd, Daimler AG, DATAIKU, Denso Corporation, Facebook Inc., GENERAL ELECTRIC, Image Metrics Inc., Image Sensing Systems, Inc., Infineon Technologies AG, Intel Corporation, Microsoft Corporation, Mobileye NV, NVIDIA Corporation, Occipital, Inc., Orbital Insight, Rethink Robotics, and Unity Technologies. FPNV Positioning Matrix:The FPNV Positioning Matrix evaluates and categorizes the vendors in the Computer Vision Market on the basis of Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.Competitive Strategic Window:The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies. The Competitive Strategic Window helps the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. During a forecast period, it defines the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth.The report provides insights on the following pointers:1. Market Penetration: Provides comprehensive information on sulfuric acid offered by the key players2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes the markets3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, and manufacturing capabilities of the leading players5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and new product developmentsThe report answers questions such as:1. What is the market size and forecast of the Global Computer Vision Market?2. What are the inhibiting factors and their impact analysis shaping the Global Computer Vision Market during the forecast period?3. What is the competitive position if vendors in the Global Computer Vision Market?4. How Porters Five Forces define the Global Computer Vision Market landscape?5. What are the technology trends and regulatory frameworks in the Global Computer Vision Market?6. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Computer Vision Market?7. What is the competitive strategic window for opportunities in the Global Computer Vision Market?8. What are the modes and strategic moves considered suitable for entering the Global Computer Vision Market?Read the full report: https://www.reportlinker.com/p05881721/?utm_source=PRN About Reportlinker ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place. __________________________ Contact Clare: [emailprotected]US: (339)-368-6001 Intl: +1 339-368-6001 SOURCE Reportlinker Related Links www.reportlinker.com
Answer: | The Global Computer Vision Market is expected to grow from USD 11,981.88 Million in 2019 to USD 19,398.97 Million by the end of 2025 at a Compound Annual Growth Rate (CAGR) of 8.36% | NEW YORK, April 14, 2020 /PRNewswire/ -- Computer Vision Market Research Report by Component (Hardware, Services, and Software), by Application (Automotive & Transportation, Consumer Goods & Retail, Gaming, Sports & Entertainments, Healthcare, and Industrial Automation) - Global Forecast to 2025 (Cumulative Impact of COVID-19)Read the full report: https://www.reportlinker.com/p05881721/?utm_source=PRN The Global Computer Vision Market is expected to grow from USD 11,981.88 Million in 2019 to USD 19,398.97 Million by the end of 2025 at a Compound Annual Growth Rate (CAGR) of 8.36%.Market Segmentation & Coverage:This research report categorizes the Computer Vision to forecast the revenues and analyze the trends in each of the following sub-markets:"The Services is projected to witness the highest growth during the forecast period"On the basis of Component, the Computer Vision Market is studied across Hardware, Services, and Software. The Hardware commanded the largest size in the Computer Vision Market in 2019. On the other hand, the Services is expected to grow at the fastest CAGR during the forecast period."The Automotive & Transportation is projected to witness the highest growth during the forecast period"On the basis of Application, the Computer Vision Market is studied across Automotive & Transportation, Consumer Goods & Retail, Gaming, Sports & Entertainments, Healthcare, Industrial Automation, and Security & Surveillance. The Industrial Automation commanded the largest size in the Computer Vision Market in 2019. On the other hand, the Automotive & Transportation is expected to grow at the fastest CAGR during the forecast period."The Asia-Pacific is projected to witness the highest growth during the forecast period"On the basis of Geography, the Computer Vision Market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas region is studied across Argentina, Brazil, Canada, Mexico, and United States. The Asia-Pacific region is studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, South Korea, and Thailand. The Europe, Middle East & Africa region is studied across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom. The Americas commanded the largest size in the Computer Vision Market in 2019. On the other hand, the Asia-Pacific is expected to grow at the fastest CAGR during the forecast period.Company Usability Profiles:The report deeply explores the recent significant developments by the leading vendors and innovation profiles in the Global Computer Vision Market including Allied Vision Technologies GmbH, Basler AG, Blipper, Cisco Systems, Cortexica Vision Systems Ltd, Daimler AG, DATAIKU, Denso Corporation, Facebook Inc., GENERAL ELECTRIC, Image Metrics Inc., Image Sensing Systems, Inc., Infineon Technologies AG, Intel Corporation, Microsoft Corporation, Mobileye NV, NVIDIA Corporation, Occipital, Inc., Orbital Insight, Rethink Robotics, and Unity Technologies. FPNV Positioning Matrix:The FPNV Positioning Matrix evaluates and categorizes the vendors in the Computer Vision Market on the basis of Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.Competitive Strategic Window:The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies. The Competitive Strategic Window helps the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. During a forecast period, it defines the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth.The report provides insights on the following pointers:1. Market Penetration: Provides comprehensive information on sulfuric acid offered by the key players2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes the markets3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, and manufacturing capabilities of the leading players5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and new product developmentsThe report answers questions such as:1. What is the market size and forecast of the Global Computer Vision Market?2. What are the inhibiting factors and their impact analysis shaping the Global Computer Vision Market during the forecast period?3. What is the competitive position if vendors in the Global Computer Vision Market?4. How Porters Five Forces define the Global Computer Vision Market landscape?5. What are the technology trends and regulatory frameworks in the Global Computer Vision Market?6. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Computer Vision Market?7. What is the competitive strategic window for opportunities in the Global Computer Vision Market?8. What are the modes and strategic moves considered suitable for entering the Global Computer Vision Market?Read the full report: https://www.reportlinker.com/p05881721/?utm_source=PRN About Reportlinker ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place. __________________________ Contact Clare: [emailprotected]US: (339)-368-6001 Intl: +1 339-368-6001 SOURCE Reportlinker Related Links www.reportlinker.com |
edtsum2215 | You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text.
Text: LONDON, March24, 2021 /PRNewswire/ --Huobi Group, the world's leading blockchain company, recently reaffirmed its commitment to regulatory compliance during the GDF Asia 2021 Conference held online and hosted by Global Digital Finance Ltd. Mariah Zhao, COO of Huobi Technology, and Elain Sun, Compliance Director of Huobi Technology, participated in discussions on the importance of regulatory compliance and spoke about Huobi's global compliance strategy. As Bitcoin and other digital assets begin to gain recognition worldwide, traditional institutions are beginning to embrace digital assets and even invest in digital asset-related infrastructure. However, the boom in interest has also brought to light concerns regarding the high volatility of the market and the difficulties in achieving regulatory compliance. Speaking at the conference, Mariah Zhao commented that there is growing demand from traditional asset managers to add digital assets such as bitcoin to its portfolio, and that more and more traditional capital have started to allocate to entry-level digital asset products as a way to understand this emerging asset class. However, Zhao cautioned that while digital asset adoption is accelerating globally, the high volatility and regulatory uncertainty of digital assets still prevent traditional institutions from entering the market on a large scale. To address these concerns, Huobi has adopted a compliance-focused approach which has helped it provide millions of users globally with safe, secure and regulated trading services. To navigate the evolving market and ensure the security of all assets under Huobi, the company has implemented a global compliance strategy across several countries and regions. In Hong Kong, Huobi acquired License No. 4 (for advising on securities), License No. 9 (for providing asset management), and the Hong Kong Trust and Company Service Provider License. Huobi also acquired the Nevada Trust License in December 2020. Today, Huobi Group possesses licenses to operate legally in Japan, South Korea, Thailand, Gibraltar, and more regions. "If regulatory compliance is the future of digital assets, we need all industry players to act in a compliant manner," said Elaine Sun, Compliance Director of Huobi Technology. "As one of the leaders in this emerging industry, we see it as our responsibility to pave that path toward compliance for others by fully embracing digital asset regulations." Most recently, Huobi Capital Management, a wholly-owned subsidiary of HKSE-listed Huobi Technology, received regulatory approval to launch three regulated funds, a BTC tracker fund, an ETH tracker fund, and a multi-strategy digital asset fund, all consisting entirely of virtual assets. Moving forward, Huobi plans to continue evolving its operations to meet the requirements of the regulatory environment as part of its global expansion strategy. Sun added, "The next stage of the digital asset industry will require all of us to build trust with the market and ensure the safety of users and their assets through regulatory compliance. We encourage others to invest in thor regulatory efforts so we can collectively propel the industry forward." About Huobi Group Huobi Group is the world's leading blockchain and cryptocurrency infrastructure provider with a financial product suite that includes the largest digital asset exchange by liquidity and real-trading volume. Trusted by users over 170 countries, the Huobi platform is dedicated to improving the freedom of money for users, and features an unmatched portfolio of crypto products and offerings, including: trading and finance, cryptocurrency finance infrastructure solutions, education, data and research, social welfare, investment and incubation, and many more. For more information, visit https://blog.hbg.com/. SOURCE Huobi Technology
Answer: | Huobi Reaffirms Commitment to Regulatory Compliance as Digital Assets Approach Mainstream Adoption | LONDON, March24, 2021 /PRNewswire/ --Huobi Group, the world's leading blockchain company, recently reaffirmed its commitment to regulatory compliance during the GDF Asia 2021 Conference held online and hosted by Global Digital Finance Ltd. Mariah Zhao, COO of Huobi Technology, and Elain Sun, Compliance Director of Huobi Technology, participated in discussions on the importance of regulatory compliance and spoke about Huobi's global compliance strategy. As Bitcoin and other digital assets begin to gain recognition worldwide, traditional institutions are beginning to embrace digital assets and even invest in digital asset-related infrastructure. However, the boom in interest has also brought to light concerns regarding the high volatility of the market and the difficulties in achieving regulatory compliance. Speaking at the conference, Mariah Zhao commented that there is growing demand from traditional asset managers to add digital assets such as bitcoin to its portfolio, and that more and more traditional capital have started to allocate to entry-level digital asset products as a way to understand this emerging asset class. However, Zhao cautioned that while digital asset adoption is accelerating globally, the high volatility and regulatory uncertainty of digital assets still prevent traditional institutions from entering the market on a large scale. To address these concerns, Huobi has adopted a compliance-focused approach which has helped it provide millions of users globally with safe, secure and regulated trading services. To navigate the evolving market and ensure the security of all assets under Huobi, the company has implemented a global compliance strategy across several countries and regions. In Hong Kong, Huobi acquired License No. 4 (for advising on securities), License No. 9 (for providing asset management), and the Hong Kong Trust and Company Service Provider License. Huobi also acquired the Nevada Trust License in December 2020. Today, Huobi Group possesses licenses to operate legally in Japan, South Korea, Thailand, Gibraltar, and more regions. "If regulatory compliance is the future of digital assets, we need all industry players to act in a compliant manner," said Elaine Sun, Compliance Director of Huobi Technology. "As one of the leaders in this emerging industry, we see it as our responsibility to pave that path toward compliance for others by fully embracing digital asset regulations." Most recently, Huobi Capital Management, a wholly-owned subsidiary of HKSE-listed Huobi Technology, received regulatory approval to launch three regulated funds, a BTC tracker fund, an ETH tracker fund, and a multi-strategy digital asset fund, all consisting entirely of virtual assets. Moving forward, Huobi plans to continue evolving its operations to meet the requirements of the regulatory environment as part of its global expansion strategy. Sun added, "The next stage of the digital asset industry will require all of us to build trust with the market and ensure the safety of users and their assets through regulatory compliance. We encourage others to invest in thor regulatory efforts so we can collectively propel the industry forward." About Huobi Group Huobi Group is the world's leading blockchain and cryptocurrency infrastructure provider with a financial product suite that includes the largest digital asset exchange by liquidity and real-trading volume. Trusted by users over 170 countries, the Huobi platform is dedicated to improving the freedom of money for users, and features an unmatched portfolio of crypto products and offerings, including: trading and finance, cryptocurrency finance infrastructure solutions, education, data and research, social welfare, investment and incubation, and many more. For more information, visit https://blog.hbg.com/. SOURCE Huobi Technology |
edtsum2223 | You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text.
Text: DUBLIN--(BUSINESS WIRE)--The "Asia-Pacific Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Market 2020-2030 by Category, Service Type (CMO, CRO), Therapeutic Application, End User, and Country" report has been added to ResearchAndMarkets.com's offering. Asia-Pacific's pharmaceutical CDMO market will grow by 8.3% annually with a total addressable market cap of $725.2 billion over 2020-2030 owing to the rising demand for biological therapies and specialty medicines, rising demand for cost control in drug development, and rising healthcare expenditures. Highlighted with 44 tables and 53 figures, this 136-page report "Asia-Pacific Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Market 2020-2030 by Category, Service Type (CMO, CRO), Therapeutic Application, End User, and Country" is based on comprehensive research of the entire Asia-Pacific pharmaceutical CDMO market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies of the period 2015-2019 and provides a forecast from 2020 till 2030 with 2019 as the base year. In-depth qualitative analyses include identification and investigation of the following aspects: The trend and outlook of Asia-Pacific market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19. The balanced (most likely) projection is used to quantify Asia-Pacific pharmaceutical CDMO market in every aspect of the classification from perspectives of Category, Service Type, Therapeutic Application, End User, and Country. Key Players Company Profiles of CMO: Company Profiles of CRO: Key Topics Covered: 1 Introduction 2 Market Overview and Dynamics 2.1 Market Size and Forecast 2.1.1 Impact of COVID-19 on World Economy 2.1.2 Impact of COVID-19 on the Market 2.2 Major Growth Drivers 2.3 Market Restraints and Challenges 2.4 Emerging Opportunities and Market Trends 2.5 Porter's Fiver Forces Analysis 3 Segmentation of Asia-Pacific Market by Category 3.1 Market Overview by Category 3.2 Pharmaceutical Industry 3.3 Biopharmaceutical Industry 4 Segmentation of Asia-Pacific Market by Service Type 4.1 Market Overview by Service Type 4.2 Pharmaceutical Contract Manufacturing Organization (CMO) 4.2.1 Active Pharmaceutical Ingredients (API) 4.2.2 Finished Dosage Formulations (FDF) 4.2.3 Secondary Packaging 4.3 Pharmaceutical Contract Research Organization (CRO) 4.3.1 CRO for Pre-clinical Development 4.3.2 CRO for Phase I Trials 4.3.3 CRO for Phase II Trials 4.3.4 CRO for Phase III Trials 4.3.5 CRO for Phase IV Trials 4.3.6 Laboratory Services 4.3.7 Consulting Services 4.3.8 Data Management Services 5 Segmentation of Asia-Pacific Market by Therapeutic Application 5.1 Market Overview by Therapeutic Application 5.2 Infectious Diseases 5.3 Oncology 5.4 Metabolic Disorders 5.5 Cardiovascular Disorders 5.6 Central Nervous System 5.7 Pulmonary Disorders 5.8 Gastrointestinal Disorders 5.9 Other Therapeutic Applications 6 Segmentation of Asia-Pacific Market by End User 6.1 Market Overview by End User 6.2 Pharmaceutical & Biopharmaceutical Companies 6.3 Medical Device Companies 6.4 Academic Institutes 7 Asia-Pacific Market 2019-2030 by Country 7.1 Overview of Asia-Pacific Market 7.2 Japan 7.3 China 7.4 Australia 7.5 India 7.6 South Korea 7.7 Rest of APAC Region 8 Competitive Landscape 8.1 Overview of Key Vendors 8.2 New Product Launch, Partnership, Investment, and M&A 8.3 Company Profiles 8.3.1 Company Profiles of CMO 8.3.2 Company Profiles of CRO 9 Investing in Asia-Pacific Market: Risk Assessment and Management 9.1 Risk Evaluation of Asia-Pacific Market 9.2 Critical Success Factors (CSFs) For more information about this report visit https://www.researchandmarkets.com/r/hy7xd0
Answer: | Asia-Pacific Pharmaceutical Contract Development and Manufacturing Organization Market (2020 to 2030) - by Category, Service Type, Therapeutic Application, End-user, and Country - ResearchAndMarkets.com | DUBLIN--(BUSINESS WIRE)--The "Asia-Pacific Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Market 2020-2030 by Category, Service Type (CMO, CRO), Therapeutic Application, End User, and Country" report has been added to ResearchAndMarkets.com's offering. Asia-Pacific's pharmaceutical CDMO market will grow by 8.3% annually with a total addressable market cap of $725.2 billion over 2020-2030 owing to the rising demand for biological therapies and specialty medicines, rising demand for cost control in drug development, and rising healthcare expenditures. Highlighted with 44 tables and 53 figures, this 136-page report "Asia-Pacific Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Market 2020-2030 by Category, Service Type (CMO, CRO), Therapeutic Application, End User, and Country" is based on comprehensive research of the entire Asia-Pacific pharmaceutical CDMO market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies of the period 2015-2019 and provides a forecast from 2020 till 2030 with 2019 as the base year. In-depth qualitative analyses include identification and investigation of the following aspects: The trend and outlook of Asia-Pacific market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19. The balanced (most likely) projection is used to quantify Asia-Pacific pharmaceutical CDMO market in every aspect of the classification from perspectives of Category, Service Type, Therapeutic Application, End User, and Country. Key Players Company Profiles of CMO: Company Profiles of CRO: Key Topics Covered: 1 Introduction 2 Market Overview and Dynamics 2.1 Market Size and Forecast 2.1.1 Impact of COVID-19 on World Economy 2.1.2 Impact of COVID-19 on the Market 2.2 Major Growth Drivers 2.3 Market Restraints and Challenges 2.4 Emerging Opportunities and Market Trends 2.5 Porter's Fiver Forces Analysis 3 Segmentation of Asia-Pacific Market by Category 3.1 Market Overview by Category 3.2 Pharmaceutical Industry 3.3 Biopharmaceutical Industry 4 Segmentation of Asia-Pacific Market by Service Type 4.1 Market Overview by Service Type 4.2 Pharmaceutical Contract Manufacturing Organization (CMO) 4.2.1 Active Pharmaceutical Ingredients (API) 4.2.2 Finished Dosage Formulations (FDF) 4.2.3 Secondary Packaging 4.3 Pharmaceutical Contract Research Organization (CRO) 4.3.1 CRO for Pre-clinical Development 4.3.2 CRO for Phase I Trials 4.3.3 CRO for Phase II Trials 4.3.4 CRO for Phase III Trials 4.3.5 CRO for Phase IV Trials 4.3.6 Laboratory Services 4.3.7 Consulting Services 4.3.8 Data Management Services 5 Segmentation of Asia-Pacific Market by Therapeutic Application 5.1 Market Overview by Therapeutic Application 5.2 Infectious Diseases 5.3 Oncology 5.4 Metabolic Disorders 5.5 Cardiovascular Disorders 5.6 Central Nervous System 5.7 Pulmonary Disorders 5.8 Gastrointestinal Disorders 5.9 Other Therapeutic Applications 6 Segmentation of Asia-Pacific Market by End User 6.1 Market Overview by End User 6.2 Pharmaceutical & Biopharmaceutical Companies 6.3 Medical Device Companies 6.4 Academic Institutes 7 Asia-Pacific Market 2019-2030 by Country 7.1 Overview of Asia-Pacific Market 7.2 Japan 7.3 China 7.4 Australia 7.5 India 7.6 South Korea 7.7 Rest of APAC Region 8 Competitive Landscape 8.1 Overview of Key Vendors 8.2 New Product Launch, Partnership, Investment, and M&A 8.3 Company Profiles 8.3.1 Company Profiles of CMO 8.3.2 Company Profiles of CRO 9 Investing in Asia-Pacific Market: Risk Assessment and Management 9.1 Risk Evaluation of Asia-Pacific Market 9.2 Critical Success Factors (CSFs) For more information about this report visit https://www.researchandmarkets.com/r/hy7xd0 |
edtsum2227 | You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text.
Text: DUBLIN--(BUSINESS WIRE)--The "Personalized Nutrition Market Size, Share & Analysis, By Type, By Application, And By Channel, Forecasts To 2027" report has been added to ResearchAndMarkets.com's offering. The Global Personalized Nutrition Market size is estimated to reach USD 16.6 Billion from USD 3.7 Billion in 2019, delivering a CAGR of 13.6% through 2027. The market growth is driven by rising health awareness, a paradigm shift towards a personalized approach towards nutrition, and growing demand for customized diet plans specific to personal requirements. The growing prevalence of lifestyle diseases, expansion of the geriatric population base, and growing awareness regarding the health benefits of diet modification are propelling market growth. A personalized nutrition approach is based on nutrition advice for making dietary changes in order to improve health, along with lowering the risk of conditions like type 2 diabetes, heart diseases, and obesity. With the rapid urbanization, the lifestyle of the common man is changing and becoming more sedentary. Consumers are relying heavily on ready-to-eat food, which is leading to hampered nutrition. However, the growing health awareness among consumers is leading to increased consumption of dietary supplements. For instance, A Consumer Survey on Dietary Supplements in 2017 estimated that 76% of U.S. adults take dietary supplements. A similar trend is poised to bolster personalized nutrition market growth through 2027. The ongoing breakthroughs and growth in personalized nutrition are resulting in a greater appreciation for healthier foods and better fitness, increased demand for customized health experiences, and a high adoption rate of wearable solutions to track health data on a daily basis. The increasing consumer inclination towards science-based and data-driven nutritional solutions tailored to reach specific health goals is likely to foster personalized nutrition market share through 2027. Further key findings from the report suggest Key Topics Covered: Chapter 1. Market Synopsis Chapter 2. Executive Summary 2.1. Summary Snapshot, 2019-2027 Chapter 3. Indicative Metrics Chapter 4. Personalized nutrition Market Segmentation & Impact Analysis 4.1. Personalized nutrition Market Material Segmentation Analysis 4.2. Industrial Outlook 4.2.1. Market indicators analysis 4.2.2. Market drivers analysis 4.2.2.1. Change in consumer preference due to rising aging population 4.2.2.2. The growing trend towards digital healthcare 4.2.3. Market restraints analysis 4.2.3.1. High Cost associated with Dietary Supplements and Nutrition Plans 4.3. Technological Insights 4.4. Regulatory Framework 4.5. ETOP Analysis 4.6. Porter's Five Forces Analysis 4.7. Competitive Metric Space Analysis 4.8. Price trend Analysis 4.9. Customer Mapping 4.10. Covid-19 Impact Analysis 4.11. Global Recession Influence Chapter 5. Personalized nutrition Market By Type Insights & Trends 5.1. Type Dynamics & Market Share, 2019 & 2027 5.2. Nutrition 5.2.1. Market estimates and forecast, 2017 - 2027 (USD Billion) 5.2.2. Market estimates and forecast, By Region, 2017 - 2027 (USD Billion) 5.2.3. Active measurement tools 5.2.4. Services Chapter 6. Personalized nutrition Market By Channel Insights & Trends 6.1. Channel Dynamics & Market Share, 2019 & 2027 6.2. Direct to consumer 6.3. Wellness & Fitness Centres 6.4. Hospitals & Clinics Chapter 7. Personalized nutrition Market By Application Insights & Trends 7.1. Application Dynamics & Market Share, 2019 & 2027 7.2. General Health 7.3. Medical 7.4. Sports Chapter 8. Personalized nutrition Market Regional Outlook Chapter 9. Competitive Landscape 9.1. Market Revenue Share By Manufacturers 9.2. Manufacturing Cost Breakdown Analysis 9.3. Mergers & Acquisitions 9.4. Market positioning 9.5. Strategy Benchmarking 9.6. Vendor Landscape Chapter 10. Company Profiles For more information about this report visit https://www.researchandmarkets.com/r/c7pogw
Answer: | $16.6 Billion Personalized Nutrition Market - Global Size, Share & Analysis by Type, Application, Channel Forecasts to 2027 - ResearchAndMarkets.com | DUBLIN--(BUSINESS WIRE)--The "Personalized Nutrition Market Size, Share & Analysis, By Type, By Application, And By Channel, Forecasts To 2027" report has been added to ResearchAndMarkets.com's offering. The Global Personalized Nutrition Market size is estimated to reach USD 16.6 Billion from USD 3.7 Billion in 2019, delivering a CAGR of 13.6% through 2027. The market growth is driven by rising health awareness, a paradigm shift towards a personalized approach towards nutrition, and growing demand for customized diet plans specific to personal requirements. The growing prevalence of lifestyle diseases, expansion of the geriatric population base, and growing awareness regarding the health benefits of diet modification are propelling market growth. A personalized nutrition approach is based on nutrition advice for making dietary changes in order to improve health, along with lowering the risk of conditions like type 2 diabetes, heart diseases, and obesity. With the rapid urbanization, the lifestyle of the common man is changing and becoming more sedentary. Consumers are relying heavily on ready-to-eat food, which is leading to hampered nutrition. However, the growing health awareness among consumers is leading to increased consumption of dietary supplements. For instance, A Consumer Survey on Dietary Supplements in 2017 estimated that 76% of U.S. adults take dietary supplements. A similar trend is poised to bolster personalized nutrition market growth through 2027. The ongoing breakthroughs and growth in personalized nutrition are resulting in a greater appreciation for healthier foods and better fitness, increased demand for customized health experiences, and a high adoption rate of wearable solutions to track health data on a daily basis. The increasing consumer inclination towards science-based and data-driven nutritional solutions tailored to reach specific health goals is likely to foster personalized nutrition market share through 2027. Further key findings from the report suggest Key Topics Covered: Chapter 1. Market Synopsis Chapter 2. Executive Summary 2.1. Summary Snapshot, 2019-2027 Chapter 3. Indicative Metrics Chapter 4. Personalized nutrition Market Segmentation & Impact Analysis 4.1. Personalized nutrition Market Material Segmentation Analysis 4.2. Industrial Outlook 4.2.1. Market indicators analysis 4.2.2. Market drivers analysis 4.2.2.1. Change in consumer preference due to rising aging population 4.2.2.2. The growing trend towards digital healthcare 4.2.3. Market restraints analysis 4.2.3.1. High Cost associated with Dietary Supplements and Nutrition Plans 4.3. Technological Insights 4.4. Regulatory Framework 4.5. ETOP Analysis 4.6. Porter's Five Forces Analysis 4.7. Competitive Metric Space Analysis 4.8. Price trend Analysis 4.9. Customer Mapping 4.10. Covid-19 Impact Analysis 4.11. Global Recession Influence Chapter 5. Personalized nutrition Market By Type Insights & Trends 5.1. Type Dynamics & Market Share, 2019 & 2027 5.2. Nutrition 5.2.1. Market estimates and forecast, 2017 - 2027 (USD Billion) 5.2.2. Market estimates and forecast, By Region, 2017 - 2027 (USD Billion) 5.2.3. Active measurement tools 5.2.4. Services Chapter 6. Personalized nutrition Market By Channel Insights & Trends 6.1. Channel Dynamics & Market Share, 2019 & 2027 6.2. Direct to consumer 6.3. Wellness & Fitness Centres 6.4. Hospitals & Clinics Chapter 7. Personalized nutrition Market By Application Insights & Trends 7.1. Application Dynamics & Market Share, 2019 & 2027 7.2. General Health 7.3. Medical 7.4. Sports Chapter 8. Personalized nutrition Market Regional Outlook Chapter 9. Competitive Landscape 9.1. Market Revenue Share By Manufacturers 9.2. Manufacturing Cost Breakdown Analysis 9.3. Mergers & Acquisitions 9.4. Market positioning 9.5. Strategy Benchmarking 9.6. Vendor Landscape Chapter 10. Company Profiles For more information about this report visit https://www.researchandmarkets.com/r/c7pogw |
edtsum2233 | You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text.
Text: SCHLIEREN, Switzerland, April 17, 2020 /PRNewswire/ --In 2020, the year that the Smart Home Market is expected to boom, Europe's powerline smart home technology leader Aizo Group (CH) takes big steps towards global expansion. Even more companies see powerline technology as the future for smart homes which makes the recent merge with other Swiss powerline innovator eSMART Technologies a logical next step to bring together the best technology available. On top of this Aizo Group chooses to shift up a gear by currently raising 20 to 30 million euros to fuel its expansion in Asia; and by welcoming one of the world's leading technology executives as its new board member. Welcome Aglaia Kong. As a former CTO at Google and Cisco, Aglaia Kong has a broad experience in smart homes, smart buildings and IOT. But most of all, Ms. Kong comes with a plan: "As the current CTO of Henderson Land Developments, my mission is to globally select the best smart home technology for both our existing and future building portfolio. That brought me to the Swiss Aizo Group team. I was really impressed with their powerline technology, their international project portfolio and their vision," says Ms. Kong. Powerline technology as the future of smart homes Aizo Group is the result of the merger between three European leaders in powerline smart home solutions: digitalSTROM (CH), eSMART Technologies (CH and recent merge in 2020) and ONE Smart Control (BE and merge in 2018). The group, based in Switzerland, is currently the European leader in low speed powerline technology for smart home technology, with more than 16 000 homes installed and over 650 000 connected devices. Through its powerline technology, Aizo is able to upgrade existing electrical wires in a building to a smart data network. That way, the Aizo solution connects and controls both analogue and smart devices, making them all part of a single smart home universe, simple to install and easy to use. Mrs. Kong adds: "The prospect of integrating open source CPU technology like RISC-V, that my team has been developing optimized IOT SOC for, in the powerline solution of Aizo Group creates a compelling smart home solution. This solution will support most common sensor protocols such as wifi, BLE via RISC-V based SOC, and will have super reliable connectivity with powerline communication, so that people can be worry free that their smart home solutions work efficiently. This will be a winner for everyone that wants to save energy and have guaranteed connectivity. This partnership will create interesting global growth perspectives for both of us. I am very happy I can support this exciting company with my experience." Aizo Group's CEO and co-founder of eSMART Technologies Fabrizio Lo Conte, puts it this way:"With our technology, we offer an attractive smart home experience for residents, and at the same time a valuable smart building solution for building operators. That combination is unique: inhabitants get comfort and security, operators get energy efficiency and operational excellence. And both in terms of reliability and cost our solutions leave the competition behind definitely in existing buildings." The company has achieved significant growth over the past years, organically as well as through merger and acquisitions. Its current core markets are Switzerland, Germany and Benelux but they are sold in more than 10 countries and Aizo was able to validate its technology in around 30 countries globally. SOURCE Aizo Group Related Links https://www.aizogroup.com
Answer: | Aizo Group and Leading Tech Executive Aglaia Kong Join Forces European leader in powerline smart home technology aims for global expansion with Aglaia Kong joining the board and merger eSMART Technologies | SCHLIEREN, Switzerland, April 17, 2020 /PRNewswire/ --In 2020, the year that the Smart Home Market is expected to boom, Europe's powerline smart home technology leader Aizo Group (CH) takes big steps towards global expansion. Even more companies see powerline technology as the future for smart homes which makes the recent merge with other Swiss powerline innovator eSMART Technologies a logical next step to bring together the best technology available. On top of this Aizo Group chooses to shift up a gear by currently raising 20 to 30 million euros to fuel its expansion in Asia; and by welcoming one of the world's leading technology executives as its new board member. Welcome Aglaia Kong. As a former CTO at Google and Cisco, Aglaia Kong has a broad experience in smart homes, smart buildings and IOT. But most of all, Ms. Kong comes with a plan: "As the current CTO of Henderson Land Developments, my mission is to globally select the best smart home technology for both our existing and future building portfolio. That brought me to the Swiss Aizo Group team. I was really impressed with their powerline technology, their international project portfolio and their vision," says Ms. Kong. Powerline technology as the future of smart homes Aizo Group is the result of the merger between three European leaders in powerline smart home solutions: digitalSTROM (CH), eSMART Technologies (CH and recent merge in 2020) and ONE Smart Control (BE and merge in 2018). The group, based in Switzerland, is currently the European leader in low speed powerline technology for smart home technology, with more than 16 000 homes installed and over 650 000 connected devices. Through its powerline technology, Aizo is able to upgrade existing electrical wires in a building to a smart data network. That way, the Aizo solution connects and controls both analogue and smart devices, making them all part of a single smart home universe, simple to install and easy to use. Mrs. Kong adds: "The prospect of integrating open source CPU technology like RISC-V, that my team has been developing optimized IOT SOC for, in the powerline solution of Aizo Group creates a compelling smart home solution. This solution will support most common sensor protocols such as wifi, BLE via RISC-V based SOC, and will have super reliable connectivity with powerline communication, so that people can be worry free that their smart home solutions work efficiently. This will be a winner for everyone that wants to save energy and have guaranteed connectivity. This partnership will create interesting global growth perspectives for both of us. I am very happy I can support this exciting company with my experience." Aizo Group's CEO and co-founder of eSMART Technologies Fabrizio Lo Conte, puts it this way:"With our technology, we offer an attractive smart home experience for residents, and at the same time a valuable smart building solution for building operators. That combination is unique: inhabitants get comfort and security, operators get energy efficiency and operational excellence. And both in terms of reliability and cost our solutions leave the competition behind definitely in existing buildings." The company has achieved significant growth over the past years, organically as well as through merger and acquisitions. Its current core markets are Switzerland, Germany and Benelux but they are sold in more than 10 countries and Aizo was able to validate its technology in around 30 countries globally. SOURCE Aizo Group Related Links https://www.aizogroup.com |
edtsum2246 | You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text.
Text: ATLANTA--(BUSINESS WIRE)--Angel Oak Dynamic Financial Strategies Income Term Trust (the Fund), a closed-end fund traded on the New York Stock Exchange under the symbol DYFN, today declared a distribution of $0.1228 per share for the month of February 2021. The record date for the distribution is February 12, 2021, and the payable date is February 26, 2021. The Fund will trade ex-distribution on February 11, 2021. The Fund seeks to pay a distribution at a rate that reflects net investment income actually earned. A portion of each distribution may be treated as paid from sources other than net investment income, including but not limited to short-term capital gain, long-term capital gain, or return of capital. As required by Section 19(a) of the Investment Company Act of 1940, a notice will be distributed to shareholders in the event that a portion of a monthly distribution is derived from sources other than undistributed net investment income. The final determination of the source and tax characteristics of these distributions will depend upon the Funds investment experience during its fiscal year and will be made after the Funds year end. The Fund will send to investors a Form 1099-DIV for the calendar year that will define how to report these distributions for federal income tax purposes. ABOUT DYFN Led by Angel Oaks experienced financial services team, DYFN invests predominantly in U.S. financial sector debt as well as selective opportunities across financial sector preferred and common equity. Under normal circumstances, at least 80% of DYFNs portfolio will be publicly rated investment grade or, if unrated, judged to be of investment grade quality by Angel Oak. ABOUT ANGEL OAK CAPITAL ADVISORS, LLC Angel Oak Capital Advisors is an investment management firm focused on providing compelling fixed-income investment solutions to its clients. Backed by a value-driven approach, Angel Oak Capital Advisors seeks to deliver attractive, risk-adjusted returns through a combination of stable current income and price appreciation. Its experienced investment team seeks the best opportunities in fixed income, with a specialization in mortgage-backed securities and other areas of structured credit. Information regarding the Fund and Angel Oak Capital Advisors can be found at www.angeloakcapital.com. Past performance is neither indicative nor a guarantee of future results. Investors should consider the investment objective and policies, risk considerations, charges and ongoing expenses of an investment carefully before investing. For more information please contact your investment representative or Destra Capital Advisors LLC at 877.855.3434. 2021 Angel Oak Capital Advisors, which is the investment adviser to the Angel Oak Dynamic Financial Strategies Income Term Trust.
Answer: | Angel Oak Dynamic Financial Strategies Income Term Trust Declares February 2021 Distribution | ATLANTA--(BUSINESS WIRE)--Angel Oak Dynamic Financial Strategies Income Term Trust (the Fund), a closed-end fund traded on the New York Stock Exchange under the symbol DYFN, today declared a distribution of $0.1228 per share for the month of February 2021. The record date for the distribution is February 12, 2021, and the payable date is February 26, 2021. The Fund will trade ex-distribution on February 11, 2021. The Fund seeks to pay a distribution at a rate that reflects net investment income actually earned. A portion of each distribution may be treated as paid from sources other than net investment income, including but not limited to short-term capital gain, long-term capital gain, or return of capital. As required by Section 19(a) of the Investment Company Act of 1940, a notice will be distributed to shareholders in the event that a portion of a monthly distribution is derived from sources other than undistributed net investment income. The final determination of the source and tax characteristics of these distributions will depend upon the Funds investment experience during its fiscal year and will be made after the Funds year end. The Fund will send to investors a Form 1099-DIV for the calendar year that will define how to report these distributions for federal income tax purposes. ABOUT DYFN Led by Angel Oaks experienced financial services team, DYFN invests predominantly in U.S. financial sector debt as well as selective opportunities across financial sector preferred and common equity. Under normal circumstances, at least 80% of DYFNs portfolio will be publicly rated investment grade or, if unrated, judged to be of investment grade quality by Angel Oak. ABOUT ANGEL OAK CAPITAL ADVISORS, LLC Angel Oak Capital Advisors is an investment management firm focused on providing compelling fixed-income investment solutions to its clients. Backed by a value-driven approach, Angel Oak Capital Advisors seeks to deliver attractive, risk-adjusted returns through a combination of stable current income and price appreciation. Its experienced investment team seeks the best opportunities in fixed income, with a specialization in mortgage-backed securities and other areas of structured credit. Information regarding the Fund and Angel Oak Capital Advisors can be found at www.angeloakcapital.com. Past performance is neither indicative nor a guarantee of future results. Investors should consider the investment objective and policies, risk considerations, charges and ongoing expenses of an investment carefully before investing. For more information please contact your investment representative or Destra Capital Advisors LLC at 877.855.3434. 2021 Angel Oak Capital Advisors, which is the investment adviser to the Angel Oak Dynamic Financial Strategies Income Term Trust. |
edtsum2256 | You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text.
Text: DUBAI, United Arab Emirates, July 5, 2020 /PRNewswire/ -- FINCASA VENTURES, UAE-based venture capital and advisor to Multi-Royal-Family Fund Houses, announces Investment summit with objective to syndicate USD1.0Bn investment in potential companies and start-ups during and post COVID-19 through its stellar consortium of international and domestic investors led by Family Offices, Angels, Funds.This summit invites top industry experts/speakers/panelists and investors from all over the globe with the purpose to identify potential start-ups for investments. FINCASA ANNOUNCES GLOBAL ONLINE INVESTMENT SUMMIT "NEXT GENERATION VISIONARIES" L-R - Dr. Nilesh Patil, Varis Sayed, Rahul Pawar, Dr. Roshan Patil It will be live streaming via major social media channels, organized in association with Strategic Swiss Partners (SSP), Switzerland and JW-Prime Management Consultancy, Philippines. Fincasa Ventures is a promising global venture capital led by Founder and Group CEO Varis Sayed, Entrepreneur, Co-Founder and Mentor for various companies globally from start-ups to private equity. He is specializing in cross border international businesses and investments. Fincasa Ventures recent investment announcement:Varis Sayed affirmed that he has invested50 million USD in MediSponsor.Inc - USA incorporated company, which offers easy-to-use XAAS-based innovative yet Integrated Healthcare Cloud CRM Solution along with Payment Gateway.MediSponsor is a camel of health-tech industry for investors. It will bring value proposition on COVID-19 Pandemic through its Visual Analytics technology as well as impact in healthcare service delivery. Fincasa invites global investors for second round of funding to align Phase II R&D plans. Varis Sayed informed that Rahul Pawar, Founder & CEO of MediSponsor, was appointed as Advisory Head Global Start-up Hub in Fincasa Ventures to shortlist start-ups across the globe for investments. Due to his ideation and solution architecting capabilities Varis Sayed is calling Rahul Pawar as Steve Jobs from India and supports his vision for MediSponsor - from Navi Mumbai to NASDAQ.Recent investment by Fincasa would enable MediSponsor to capitalize and position a company in the healthcare sector of Africa, Middle East, South America & South Asia through care model innovation and digital market transformation.MediSponsor leadership team includes "A perfect blend of Healthcare & Management domain"- co-founders Dr. Roshan Patil and Dr. Nilesh Patil from the Indian Institutes of Management, which is ranked among the best globally for its various management programs. MediSponsor Head Quarters in Dubai, UAE gives the company a world-class business environment for speedy growth. Fincasa investment along with strategic partnership will help MediSponsor to achieve its vision of being the most valued brand in Healthcare Technology.SOURCE Fincasa Ventures
Answer: | Fincasa Announces Global Online Investment Summit "Next Generation Visionaries" English English etina Franais | DUBAI, United Arab Emirates, July 5, 2020 /PRNewswire/ -- FINCASA VENTURES, UAE-based venture capital and advisor to Multi-Royal-Family Fund Houses, announces Investment summit with objective to syndicate USD1.0Bn investment in potential companies and start-ups during and post COVID-19 through its stellar consortium of international and domestic investors led by Family Offices, Angels, Funds.This summit invites top industry experts/speakers/panelists and investors from all over the globe with the purpose to identify potential start-ups for investments. FINCASA ANNOUNCES GLOBAL ONLINE INVESTMENT SUMMIT "NEXT GENERATION VISIONARIES" L-R - Dr. Nilesh Patil, Varis Sayed, Rahul Pawar, Dr. Roshan Patil It will be live streaming via major social media channels, organized in association with Strategic Swiss Partners (SSP), Switzerland and JW-Prime Management Consultancy, Philippines. Fincasa Ventures is a promising global venture capital led by Founder and Group CEO Varis Sayed, Entrepreneur, Co-Founder and Mentor for various companies globally from start-ups to private equity. He is specializing in cross border international businesses and investments. Fincasa Ventures recent investment announcement:Varis Sayed affirmed that he has invested50 million USD in MediSponsor.Inc - USA incorporated company, which offers easy-to-use XAAS-based innovative yet Integrated Healthcare Cloud CRM Solution along with Payment Gateway.MediSponsor is a camel of health-tech industry for investors. It will bring value proposition on COVID-19 Pandemic through its Visual Analytics technology as well as impact in healthcare service delivery. Fincasa invites global investors for second round of funding to align Phase II R&D plans. Varis Sayed informed that Rahul Pawar, Founder & CEO of MediSponsor, was appointed as Advisory Head Global Start-up Hub in Fincasa Ventures to shortlist start-ups across the globe for investments. Due to his ideation and solution architecting capabilities Varis Sayed is calling Rahul Pawar as Steve Jobs from India and supports his vision for MediSponsor - from Navi Mumbai to NASDAQ.Recent investment by Fincasa would enable MediSponsor to capitalize and position a company in the healthcare sector of Africa, Middle East, South America & South Asia through care model innovation and digital market transformation.MediSponsor leadership team includes "A perfect blend of Healthcare & Management domain"- co-founders Dr. Roshan Patil and Dr. Nilesh Patil from the Indian Institutes of Management, which is ranked among the best globally for its various management programs. MediSponsor Head Quarters in Dubai, UAE gives the company a world-class business environment for speedy growth. Fincasa investment along with strategic partnership will help MediSponsor to achieve its vision of being the most valued brand in Healthcare Technology.SOURCE Fincasa Ventures |
edtsum2272 | You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text.
Text: GUANGZHOU, China, May 18, 2020 /PRNewswire/ -- With support from the Recitation Association of Guangdong Radio and Television and many other social organizations, LIZHI INC. ("LIZHI" or the "LIZHI App") (NASDAQ: LIZI), a leading online UGC audio community and interactive audio entertainment platform in China, worked in partnership with ZAKER to launch an online reading and recitation campaign on China's Youth Day, honoring the memory of May 4th movement of 1919 by inviting young audiences to revisit this significant historic event once again with their voices. As a vibrant audio community beloved by Generation Z, LIZHI aims to take young readers on a journey through each book's universe on this year's National Youth Day allowing them to immerse in the art of storytelling and poetry recitation performed by the big namesin voice acting, broadcasting and Chinese literature. Within a week, more than 100,000 participants joined the campaign. "We are proud to initiate this campaign as a new way to connect with Chinese young audiences and readers in purveying the values and spirit of the May 4th movement, a historical turning point that spurred China to advance and continue to drive this nation forward", said Marco Lai, Founder and CEO of LIZHI. "Through this online event marking the symbolic moment in Chinese history, LIZHI App aims to bring a host of edifying, life-enlightening and informative listening experiences to a new generation in China, allowing them to read together with iconic Chinese voices and enjoy the joy and strength brought by science, poetry and classic literature", Marco added. Recently, LIZHI App also rolled out a series of podcasts for book recommendations covering history, literature, science and more: Emotion management shared by psychologist and interpersonal relationship analyst Qing Yin helped the audience unlock their skills for boosting resilience in the time of uncertainty and stress; Wildlife biologist Ran Jingcheng brought to life the stories of South China tigers and the awe-inspiring animal ecosystem through his vivid narration; Big audio stars introduced and interpreted their favorite novels and poems, offering readers fresh perspectives on the wisdom buried between the lines. Launched in 2013, LIZHI envisions a global audio community -- a place where everyone not only can enjoy high-quality user-generated audio content and audio entertainment features, but also create, share and connect through voices across and cultures and continents. With a simple and convenient user interface, LIZHI App offers a mobile audio platform with many interactive features that allows everyone to showcase their vocal talent. Every user can record, generate and upload their own audio content to share with the community with simple and intuitive audio-producing tools developed by LIZHI. In the fourth quarter of 2019, LIZHI has attracted 51.9 million monthly active users and 5.9 million monthly active creators who have generated a total of 178 million podcasts, making it one of the top online UGC audio communities in China. Connecting with the young, LIZHI seeks to bring support to all levels of communities and, in particular, offer help and care to children, the old and vulnerable with the power of voice. Since 2018, LIZHI has brought heart-warming stories into children's hospitals in partnership with charity organizations. Through emotional therapy storytelling initiatives for children with serious illness, LIZHI encourages users to use their voice and unique stories to provide patients and their families with the strength and courage to cope with critical illnesses. AboutLIZHI INC. LIZHI INC. is a leading online UGC audio community and interactive audio entertainment platform in China, with a mission to enable everyone to showcase vocal talent. The Company is aiming to bring people closer together through voices. Since launching LIZHI APPin 2013, LIZHI has cultivated a vibrant and growing community encouraging audio content creation and sharing. Now LIZHI is an audio wonderland offering a wide range of podcasts and audio social entertainment products and features, including audio live streaming and various interactive audio products, empowering users to enjoy an immersive and diversified entertainment experience through audio. SOURCE Lizhi Inc Related Links http://ir.lizhi.fm/
Answer: | LIZHI App Launches Online Reading and Recitation Campaign to Honor the Spirit of China's Youth Day | GUANGZHOU, China, May 18, 2020 /PRNewswire/ -- With support from the Recitation Association of Guangdong Radio and Television and many other social organizations, LIZHI INC. ("LIZHI" or the "LIZHI App") (NASDAQ: LIZI), a leading online UGC audio community and interactive audio entertainment platform in China, worked in partnership with ZAKER to launch an online reading and recitation campaign on China's Youth Day, honoring the memory of May 4th movement of 1919 by inviting young audiences to revisit this significant historic event once again with their voices. As a vibrant audio community beloved by Generation Z, LIZHI aims to take young readers on a journey through each book's universe on this year's National Youth Day allowing them to immerse in the art of storytelling and poetry recitation performed by the big namesin voice acting, broadcasting and Chinese literature. Within a week, more than 100,000 participants joined the campaign. "We are proud to initiate this campaign as a new way to connect with Chinese young audiences and readers in purveying the values and spirit of the May 4th movement, a historical turning point that spurred China to advance and continue to drive this nation forward", said Marco Lai, Founder and CEO of LIZHI. "Through this online event marking the symbolic moment in Chinese history, LIZHI App aims to bring a host of edifying, life-enlightening and informative listening experiences to a new generation in China, allowing them to read together with iconic Chinese voices and enjoy the joy and strength brought by science, poetry and classic literature", Marco added. Recently, LIZHI App also rolled out a series of podcasts for book recommendations covering history, literature, science and more: Emotion management shared by psychologist and interpersonal relationship analyst Qing Yin helped the audience unlock their skills for boosting resilience in the time of uncertainty and stress; Wildlife biologist Ran Jingcheng brought to life the stories of South China tigers and the awe-inspiring animal ecosystem through his vivid narration; Big audio stars introduced and interpreted their favorite novels and poems, offering readers fresh perspectives on the wisdom buried between the lines. Launched in 2013, LIZHI envisions a global audio community -- a place where everyone not only can enjoy high-quality user-generated audio content and audio entertainment features, but also create, share and connect through voices across and cultures and continents. With a simple and convenient user interface, LIZHI App offers a mobile audio platform with many interactive features that allows everyone to showcase their vocal talent. Every user can record, generate and upload their own audio content to share with the community with simple and intuitive audio-producing tools developed by LIZHI. In the fourth quarter of 2019, LIZHI has attracted 51.9 million monthly active users and 5.9 million monthly active creators who have generated a total of 178 million podcasts, making it one of the top online UGC audio communities in China. Connecting with the young, LIZHI seeks to bring support to all levels of communities and, in particular, offer help and care to children, the old and vulnerable with the power of voice. Since 2018, LIZHI has brought heart-warming stories into children's hospitals in partnership with charity organizations. Through emotional therapy storytelling initiatives for children with serious illness, LIZHI encourages users to use their voice and unique stories to provide patients and their families with the strength and courage to cope with critical illnesses. AboutLIZHI INC. LIZHI INC. is a leading online UGC audio community and interactive audio entertainment platform in China, with a mission to enable everyone to showcase vocal talent. The Company is aiming to bring people closer together through voices. Since launching LIZHI APPin 2013, LIZHI has cultivated a vibrant and growing community encouraging audio content creation and sharing. Now LIZHI is an audio wonderland offering a wide range of podcasts and audio social entertainment products and features, including audio live streaming and various interactive audio products, empowering users to enjoy an immersive and diversified entertainment experience through audio. SOURCE Lizhi Inc Related Links http://ir.lizhi.fm/ |
edtsum2274 | You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text.
Text: COLUMBIA, Miss., May 18, 2020 /PRNewswire/ --Beautiful Belligerence is a first-person dark comedy based on real events. In 2013 four friends decided to plan a trip to a Kansas City Chiefs game. What ensued was a wild tale of experience, exuberance, excess, fate, and friendship played out across Kansas City, MO. Set to the backdrop of an emotional undoing, this first person narrative tells the story of a weekend where four friends left their inhibitions to the wind and decided to live free for the sake of their friendship. Continue Reading Beautiful Belligerence Cover Brent Beamer Pic "Beautiful Belligerence is a story for anyone who has experienced hard times and laughed with friends. It is a story of becoming. It is rambling, nonsensical, radical, ridiculous, and hilarious. It's the truth. One of the major themes in Beautiful Belligerence is the constant battle between being locked in your own head full of negative thoughts versus the outside world that your friends help you experience. Love and laughter can conquer all if they are embraced. I find the honesty in this book to be refreshing. I focused on presenting the characters, as well as myself in all of our glory. I had three friends who were there for me in a tough time. My friends kept my mind off of the negativity for the most part. They made me laugh. This book is in honor of them." Brent Beamer "Honest. Ridiculous. Hysterical. Beautiful Belligerence knows how to party!" Aaron Warbritton Beautiful Belligerence is self-published by Brent Beamer. RRP $9.99 ISBN978-0578674223 Available on Amazon and Kindle. Soon to be available on Audible in audiobook format. About The AuthorBrent Beameris a self-published author as well as a self-released indie music artist. Brent's writing is largely inspired by the wild country and characters of Northeastern Missouri where he grew up. Brent tends to approach writing with a realisticperspective, blending in a fair share of wit and humor into his honest interpretations of modern life ethos. Brent counts among his many influences to be John Steinbeck, Mark Twain,Hunter S. Thompson and Bob Dylan.www.BrentBeamer.com Media Inquiries: Please Contact Brent 573-356-3292 [emailprotected] Follow on social @brentbeamer SOURCE Brent Beamer
Answer: | Newly Published Book, Beautiful Belligerence by Brent Beamer, Now Available Inspired by the real events of a wild weekend in Kansas City where four best friends came together to celebrate life as they knew it. Surrounded by darkness laughter unfolded an endless carnival of sorts. | COLUMBIA, Miss., May 18, 2020 /PRNewswire/ --Beautiful Belligerence is a first-person dark comedy based on real events. In 2013 four friends decided to plan a trip to a Kansas City Chiefs game. What ensued was a wild tale of experience, exuberance, excess, fate, and friendship played out across Kansas City, MO. Set to the backdrop of an emotional undoing, this first person narrative tells the story of a weekend where four friends left their inhibitions to the wind and decided to live free for the sake of their friendship. Continue Reading Beautiful Belligerence Cover Brent Beamer Pic "Beautiful Belligerence is a story for anyone who has experienced hard times and laughed with friends. It is a story of becoming. It is rambling, nonsensical, radical, ridiculous, and hilarious. It's the truth. One of the major themes in Beautiful Belligerence is the constant battle between being locked in your own head full of negative thoughts versus the outside world that your friends help you experience. Love and laughter can conquer all if they are embraced. I find the honesty in this book to be refreshing. I focused on presenting the characters, as well as myself in all of our glory. I had three friends who were there for me in a tough time. My friends kept my mind off of the negativity for the most part. They made me laugh. This book is in honor of them." Brent Beamer "Honest. Ridiculous. Hysterical. Beautiful Belligerence knows how to party!" Aaron Warbritton Beautiful Belligerence is self-published by Brent Beamer. RRP $9.99 ISBN978-0578674223 Available on Amazon and Kindle. Soon to be available on Audible in audiobook format. About The AuthorBrent Beameris a self-published author as well as a self-released indie music artist. Brent's writing is largely inspired by the wild country and characters of Northeastern Missouri where he grew up. Brent tends to approach writing with a realisticperspective, blending in a fair share of wit and humor into his honest interpretations of modern life ethos. Brent counts among his many influences to be John Steinbeck, Mark Twain,Hunter S. Thompson and Bob Dylan.www.BrentBeamer.com Media Inquiries: Please Contact Brent 573-356-3292 [emailprotected] Follow on social @brentbeamer SOURCE Brent Beamer |
edtsum2287 | You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text.
Text: DUBLIN--(BUSINESS WIRE)--The "Industry Convergence Impacting the Global Compressor Market, 2020" report has been added to ResearchAndMarkets.com's offering. This study identifies, analyzes, and evaluates the existing and upcoming trends impacting the global compressors market. Amid uncertain economic conditions exuberated by the COVID-19 pandemic and small pockets of opportunities in some end-user industries, such as food and beverages, water and wastewater, and life sciences. It seeks to provide insights into the growth prospects for compressor manufacturers for the year 2020. It discusses the product, market, and technology-based growth opportunities impacting the industry's future. The regions covered include North America, Latin America, Europe, the Middle East, Africa, and Asia-Pacific. IIoT is a major trend affecting compressor manufacturers, as end-users continue to focus on improving plant maintenance and curb operational expenditure (OPEX). The current dynamic environment has uncertain economic conditions, trade wars, price volatility, production slowdowns, and intense market competition. Manufacturers are striving to improve operational efficiency in their existing plants and are keen to decrease maintenance and operational costs occurring due to unexpected failure and asset downtime. Realizing that the future of manufacturing is likely to be driven by IIoT, companies have concerns about data ownership, security, integration with existing infrastructure, and return on investment (ROI) achieved from these solutions. For the study, a specific methodology comprised of discussions with the senior management of compressor manufacturers, supported by secondary research, has been followed. The study sheds light on the industry convergence of three major trends: sustainability; technology such as industry 4.0; and the shift from capital expenditure to operating expenditure (CAPEX to OPEX): The following key growth opportunities are analyzed in the study: Key Topics Covered: 1. Growth Environment 2. Growth Opportunities 3. List of Exhibits For more information about this report visit https://www.researchandmarkets.com/r/pjrw1v
Answer: | Global Compressor Market Report 2020: Industry 4.0, Sustainability, and New Business Models Drive New Growth Opportunities - ResearchAndMarkets.com | DUBLIN--(BUSINESS WIRE)--The "Industry Convergence Impacting the Global Compressor Market, 2020" report has been added to ResearchAndMarkets.com's offering. This study identifies, analyzes, and evaluates the existing and upcoming trends impacting the global compressors market. Amid uncertain economic conditions exuberated by the COVID-19 pandemic and small pockets of opportunities in some end-user industries, such as food and beverages, water and wastewater, and life sciences. It seeks to provide insights into the growth prospects for compressor manufacturers for the year 2020. It discusses the product, market, and technology-based growth opportunities impacting the industry's future. The regions covered include North America, Latin America, Europe, the Middle East, Africa, and Asia-Pacific. IIoT is a major trend affecting compressor manufacturers, as end-users continue to focus on improving plant maintenance and curb operational expenditure (OPEX). The current dynamic environment has uncertain economic conditions, trade wars, price volatility, production slowdowns, and intense market competition. Manufacturers are striving to improve operational efficiency in their existing plants and are keen to decrease maintenance and operational costs occurring due to unexpected failure and asset downtime. Realizing that the future of manufacturing is likely to be driven by IIoT, companies have concerns about data ownership, security, integration with existing infrastructure, and return on investment (ROI) achieved from these solutions. For the study, a specific methodology comprised of discussions with the senior management of compressor manufacturers, supported by secondary research, has been followed. The study sheds light on the industry convergence of three major trends: sustainability; technology such as industry 4.0; and the shift from capital expenditure to operating expenditure (CAPEX to OPEX): The following key growth opportunities are analyzed in the study: Key Topics Covered: 1. Growth Environment 2. Growth Opportunities 3. List of Exhibits For more information about this report visit https://www.researchandmarkets.com/r/pjrw1v |
edtsum2293 | You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text.
Text: MILFORD, Conn., Jan. 5, 2021 /PRNewswire/ --NFL Veteran Marshawn Lynch is partnering with Subway restaurants to help guests 'Go Pro' and make better choices in the New Year. Lynch is featured in television commercials, social and digital advertising promoting new protein-packed choices and helping aspiring pros through the Subway Pro Teen Awards. Subway guests can now 'Go Pro' at participating restaurants with NEW! Protein Bowls or $2*double protein upgrades to Footlongs and Protein Bowls. The new offerings are the latest examples of how Subway continues to evolve its menu with more freshly-made options. From the Sweet Onion Chicken Teriyaki to the Chicken and Bacon Protein Bowls, guests can build any Footlong into a Protein Bowl, with the same portion of protein, vegetables, cheese and sauce, just without the bread.** Guests can 'Go Pro' when ordering in-restaurant, through the Subway App, online or for Contactless Curbside pick-up at participating restaurants. Think you have what it takes to 'Go Pro' like Marshawn Lynch? Enter The Subway Pro Teen Awards! Subway and Lynch are also teaming up on a new national contest, geared towards high school athletes who had to forgo their football season due to the ongoing pandemic. Subway, with the help of NFL stars Marshawn Lynch and Keenan Allen, is launching the Subway Pro Teen Awards to celebrate future pros working to achieve their athletic dreams. Beginning January 15, high school football players can submit a video of their best pro moves, craziest catches, hardest tackles and longest throws or kicks here for a chance to be one of 20 winning players.***High school athletes are encouraged to submit entries, but coaches, teachers, parents, teammates and friends can submit entries on the high school athletes' behalf. Winners will receive a personalized video from Lynch, an invitation to attend a virtual awards event with Allen, and a $1,500 scholarship from Subway. Pro Teen winners will be judged by Lynch and Allen, along with public voting, and selected based on a three-part scoring system: 30% of score based on the number of votes on their video. 10% on how well the entry meets the contest theme. 60% based on judges' scoring (Lynch & Allen) of video entries based on skill/creativity captured in the video. "Subway helps you power up and 'Go Pro' on and off the field with their new Protein Bowls and their Pro Teen Awards," saidLynch. "2020 was a year like we've never seen before, with many players having to sacrifice their season and slow down their hustle. I'm excitedto be part of Subway's Pro Teen Awards and give high school athletes another chance to achieve their goals and celebrate the game.So check it out, and let's fuel up and get back out there together with Subway!" For more information and official rules, visit http://www.Subway.com/ProTeen. Subway is an Official Sponsor of the NFL. Subway kicked off Footlong Season in 2020 as part of a three-year sponsorship. The brand continues to roll out campaigns and promotions to keep fans fueled all season long. *Double protein based on meat only. Limited time only at participating restaurants. Extras/Add-ons addt'l. Plus tax. No addt'l discounts/coupons.**Excludes Veggie Delite. At participating restaurants. Extras/Add-ons addt'l. Plus tax.*** NO PURCHASE NECESSARY TO ENTER OR WIN. Nominations open to legal residents of the 50 United States and D.C., who are full time High School students with demonstrated Football skill. Nominations begin at 12:00:01 a.m. ET on 1/15/21 and ends at 11:59:59 p.m. ET 2/6/21. See full terms & conditions here. About Subway Restaurants The Subway restaurant chain continues to evolve the dining experience, offering guests in more than 100 countries quality ingredients, as well as robust flavor combinations while serving over 6 million made-to-order sandwiches created each day. All Subway restaurants are owned and operated by more than 20,000 Franchise Owners, who employ many people in their communities. The Subway experience is also delivered online atSubway.com, throughSubway.com/Delivers, and the Subway App. Subway is a Registered Trademark of Subway IP LLC. 2020 Subway IP LLC SOURCE Subway Restaurants Related Links http://www.subway.com
Answer: | Eat Like NFL Pro Marshawn Lynch by Doubling Up on Protein at Subway 'Go Pro' in the New Year with NEW! Protein Bowls, $2 double protein upgrades and Subway Pro Teen Awards | MILFORD, Conn., Jan. 5, 2021 /PRNewswire/ --NFL Veteran Marshawn Lynch is partnering with Subway restaurants to help guests 'Go Pro' and make better choices in the New Year. Lynch is featured in television commercials, social and digital advertising promoting new protein-packed choices and helping aspiring pros through the Subway Pro Teen Awards. Subway guests can now 'Go Pro' at participating restaurants with NEW! Protein Bowls or $2*double protein upgrades to Footlongs and Protein Bowls. The new offerings are the latest examples of how Subway continues to evolve its menu with more freshly-made options. From the Sweet Onion Chicken Teriyaki to the Chicken and Bacon Protein Bowls, guests can build any Footlong into a Protein Bowl, with the same portion of protein, vegetables, cheese and sauce, just without the bread.** Guests can 'Go Pro' when ordering in-restaurant, through the Subway App, online or for Contactless Curbside pick-up at participating restaurants. Think you have what it takes to 'Go Pro' like Marshawn Lynch? Enter The Subway Pro Teen Awards! Subway and Lynch are also teaming up on a new national contest, geared towards high school athletes who had to forgo their football season due to the ongoing pandemic. Subway, with the help of NFL stars Marshawn Lynch and Keenan Allen, is launching the Subway Pro Teen Awards to celebrate future pros working to achieve their athletic dreams. Beginning January 15, high school football players can submit a video of their best pro moves, craziest catches, hardest tackles and longest throws or kicks here for a chance to be one of 20 winning players.***High school athletes are encouraged to submit entries, but coaches, teachers, parents, teammates and friends can submit entries on the high school athletes' behalf. Winners will receive a personalized video from Lynch, an invitation to attend a virtual awards event with Allen, and a $1,500 scholarship from Subway. Pro Teen winners will be judged by Lynch and Allen, along with public voting, and selected based on a three-part scoring system: 30% of score based on the number of votes on their video. 10% on how well the entry meets the contest theme. 60% based on judges' scoring (Lynch & Allen) of video entries based on skill/creativity captured in the video. "Subway helps you power up and 'Go Pro' on and off the field with their new Protein Bowls and their Pro Teen Awards," saidLynch. "2020 was a year like we've never seen before, with many players having to sacrifice their season and slow down their hustle. I'm excitedto be part of Subway's Pro Teen Awards and give high school athletes another chance to achieve their goals and celebrate the game.So check it out, and let's fuel up and get back out there together with Subway!" For more information and official rules, visit http://www.Subway.com/ProTeen. Subway is an Official Sponsor of the NFL. Subway kicked off Footlong Season in 2020 as part of a three-year sponsorship. The brand continues to roll out campaigns and promotions to keep fans fueled all season long. *Double protein based on meat only. Limited time only at participating restaurants. Extras/Add-ons addt'l. Plus tax. No addt'l discounts/coupons.**Excludes Veggie Delite. At participating restaurants. Extras/Add-ons addt'l. Plus tax.*** NO PURCHASE NECESSARY TO ENTER OR WIN. Nominations open to legal residents of the 50 United States and D.C., who are full time High School students with demonstrated Football skill. Nominations begin at 12:00:01 a.m. ET on 1/15/21 and ends at 11:59:59 p.m. ET 2/6/21. See full terms & conditions here. About Subway Restaurants The Subway restaurant chain continues to evolve the dining experience, offering guests in more than 100 countries quality ingredients, as well as robust flavor combinations while serving over 6 million made-to-order sandwiches created each day. All Subway restaurants are owned and operated by more than 20,000 Franchise Owners, who employ many people in their communities. The Subway experience is also delivered online atSubway.com, throughSubway.com/Delivers, and the Subway App. Subway is a Registered Trademark of Subway IP LLC. 2020 Subway IP LLC SOURCE Subway Restaurants Related Links http://www.subway.com |
edtsum2295 | You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text.
Text: SAN FRANCISCO & REDWOOD CITY, Calif.--(BUSINESS WIRE)--Zuora, Inc. (NYSE: ZUO) a leading subscription management platform provider, today announced a strategic partnership with Stripe to accelerate the growth of the Subscription Economy. A new product integration will enable Zuora customers -- including Carbar, Intercom and Seiko Epson -- to enhance their subscription experience with advanced payment capabilities. IDC predicts that, by 2023, the global economy will reach a point of digital supremacy, whereby products and services from digitally determined organizations will make up over 50% of the global GDP. "Digitally determined" enterprises will be far more proactive than their peers in building out new partner ecosystems required to monetize and deliver digital services and consuming monetized digital services delivered through the partner ecosystems.1 "Winning subscription companies want to use the best technologies to build a competitive advantage, said Chris Battles, Chief Product Officer at Zuora. Were thrilled to work with Stripe in an ecosystem of new world partners that helps to optimize and automate processes throughout our customers journey in the Subscription Economy. Stripes Chief Business Officer Billy Alvarado, said, "Stripe's mission is to grow the GDP of the internet, and this partnership with Zuora extends that goal by giving Zuora users access to the full capabilities of Stripe payments. With the internet powering a rapidly growing portion of the global economy, it's never been more important to provide subscription businesses with the economic infrastructure they need." Zuora customers will gain access to Stripe's industry-leading payment capabilities within their existing Zuora subscription management integration, with key benefits like: (1) Advanced payments, fully integrated. Zuora customers will be able to take full advantage of Stripes advanced payment processing capabilities integrated with the Zuora platform, including fraud detection, artificial intelligence-enhanced payment retries, and payment processing capabilities - ability to pass L2 and L3 data to issuers - that reduce transaction processing costs. Stripes direct connections to global card networks and non-card payment methods, such as ACH, SEPA Debit and Bacs enables businesses to easily expand into new markets. Intercom leverages the integration between Zuora and Stripe to extend the full value of Stripes global payments infrastructure to users around the world. Kevin Kooi, Senior Director, FP&A said, "Our customers want seamless, secure transactions in any country. Zuoras partnership with Stripe will enable Intercom to access the latest payments features across dozens of countries to offer a best-in-class customer experience." (2) Payment flexibility across subscriber experiences. Companies in the Subscription Economy succeed when they deliver compelling subscription experiences that evolve with customer needs. Zuora provides the agility and automation needed to price, package, and bill in countless combinations, and now Stripe adds additional payments flexibility so subscribers can pay when, where, and how they choose. Carbar, a subscription car company in Australia, uses Stripe and Zuora to create a more seamless subscription experience. Co-founder and CEO Desmond Hang said, Together, the Zuora and Stripe APIs give us the ability to seamlessly integrate and scale the entire order to revenue process. The latest integration will not only provide a solid foundation for us to continue pioneering the growth of car subscriptions in Australia, but will enable us to truly focus on innovating the end-to-end subscriber experience. (3) Future-proofed architecture. Stripe and Zuora are working together as part of a modern ecosystem for digital subscriptions and commerce to create solutions that support global businesses. The partnership gives customers the access and ability to use an architecture specific to their unique needs. Multi-billion dollar manufacturer Seiko Epson Corp.s Executive Officer, Junkichi Yoshida said, As a global organization operating in countless regions, it's critical for us to ensure seamless, reliable payment and billing processes that can scale when needed. Having experienced the benefits of Stripe and Zuora alone, the latest integration will enable us to truly optimize our ReadyPrint subscription offering, which has been deployed in nine countries so far, keep expanding, while increasing the overall success of subscription-based transactions. IDC Research Director Mark Thomason, responsible for the Digital Business Models and Monetization practice, said, The Zuora and Stripe partnership brings together two leading payment and billing companies to help their customers succeed in this new digital era by combining shared insight and strategy. For more on the Stripe and Zuora integration, visit: https://www.zuora.com/stripe-partnership About Stripe Stripe is a global technology company that builds economic infrastructure for the internet. Millions of businesses of every sizefrom new startups to large enterprises like Salesforce, Amazon, and Slackuse Stripe to manage their online finance and treasury functions, from accepting payments to issuing credit cards to sending international payouts and growing subscription revenue. By removing complexity for users, Stripe enables companies to be adaptive to ever-changing customer behavior and participate fully in the online economy in more than 140 countries worldwide. About Zuora, Inc. Zuora provides the leading cloud-based subscription management platform that functions as a system of record for subscription businesses across all industries. Powering the Subscription Economy, the Zuora platform was architected specifically for dynamic, recurring subscription business models and acts as an intelligent subscription management hub that automates and orchestrates the entire subscription order-to-revenue process seamlessly across billing and revenue recognition. Zuora serves more than 1,000 companies around the world, including Box, Ford, Penske Media Corporation, Schneider Electric, Siemens, Xplornet, and Zoom. Headquartered in Silicon Valley, Zuora also operates offices around the world in the U.S., EMEA and APAC. To learn more about the Zuora platform, please visit www.zuora.com. 2020 Zuora, Inc. All Rights Reserved. Zuora, Subscribed, Subscription Economy, Powering the Subscription Economy, and Subscription Economy Index are trademarks or registered trademarks of Zuora, Inc. Third party trademarks mentioned above are owned by their respective companies. Nothing in this press release should be construed to the contrary, or as an approval, endorsement or sponsorship by any third parties of Zuora, Inc. or any aspect of this press release. 1 IDC FutureScape: Worldwide Monetization 2021 Predictions, Mark Thomason, October 2020, IDC #US46246920 SOURCE: Zuora Financial
Answer: | Zuora and Stripe Partner to Accelerate the Growth of the Subscription Economy | SAN FRANCISCO & REDWOOD CITY, Calif.--(BUSINESS WIRE)--Zuora, Inc. (NYSE: ZUO) a leading subscription management platform provider, today announced a strategic partnership with Stripe to accelerate the growth of the Subscription Economy. A new product integration will enable Zuora customers -- including Carbar, Intercom and Seiko Epson -- to enhance their subscription experience with advanced payment capabilities. IDC predicts that, by 2023, the global economy will reach a point of digital supremacy, whereby products and services from digitally determined organizations will make up over 50% of the global GDP. "Digitally determined" enterprises will be far more proactive than their peers in building out new partner ecosystems required to monetize and deliver digital services and consuming monetized digital services delivered through the partner ecosystems.1 "Winning subscription companies want to use the best technologies to build a competitive advantage, said Chris Battles, Chief Product Officer at Zuora. Were thrilled to work with Stripe in an ecosystem of new world partners that helps to optimize and automate processes throughout our customers journey in the Subscription Economy. Stripes Chief Business Officer Billy Alvarado, said, "Stripe's mission is to grow the GDP of the internet, and this partnership with Zuora extends that goal by giving Zuora users access to the full capabilities of Stripe payments. With the internet powering a rapidly growing portion of the global economy, it's never been more important to provide subscription businesses with the economic infrastructure they need." Zuora customers will gain access to Stripe's industry-leading payment capabilities within their existing Zuora subscription management integration, with key benefits like: (1) Advanced payments, fully integrated. Zuora customers will be able to take full advantage of Stripes advanced payment processing capabilities integrated with the Zuora platform, including fraud detection, artificial intelligence-enhanced payment retries, and payment processing capabilities - ability to pass L2 and L3 data to issuers - that reduce transaction processing costs. Stripes direct connections to global card networks and non-card payment methods, such as ACH, SEPA Debit and Bacs enables businesses to easily expand into new markets. Intercom leverages the integration between Zuora and Stripe to extend the full value of Stripes global payments infrastructure to users around the world. Kevin Kooi, Senior Director, FP&A said, "Our customers want seamless, secure transactions in any country. Zuoras partnership with Stripe will enable Intercom to access the latest payments features across dozens of countries to offer a best-in-class customer experience." (2) Payment flexibility across subscriber experiences. Companies in the Subscription Economy succeed when they deliver compelling subscription experiences that evolve with customer needs. Zuora provides the agility and automation needed to price, package, and bill in countless combinations, and now Stripe adds additional payments flexibility so subscribers can pay when, where, and how they choose. Carbar, a subscription car company in Australia, uses Stripe and Zuora to create a more seamless subscription experience. Co-founder and CEO Desmond Hang said, Together, the Zuora and Stripe APIs give us the ability to seamlessly integrate and scale the entire order to revenue process. The latest integration will not only provide a solid foundation for us to continue pioneering the growth of car subscriptions in Australia, but will enable us to truly focus on innovating the end-to-end subscriber experience. (3) Future-proofed architecture. Stripe and Zuora are working together as part of a modern ecosystem for digital subscriptions and commerce to create solutions that support global businesses. The partnership gives customers the access and ability to use an architecture specific to their unique needs. Multi-billion dollar manufacturer Seiko Epson Corp.s Executive Officer, Junkichi Yoshida said, As a global organization operating in countless regions, it's critical for us to ensure seamless, reliable payment and billing processes that can scale when needed. Having experienced the benefits of Stripe and Zuora alone, the latest integration will enable us to truly optimize our ReadyPrint subscription offering, which has been deployed in nine countries so far, keep expanding, while increasing the overall success of subscription-based transactions. IDC Research Director Mark Thomason, responsible for the Digital Business Models and Monetization practice, said, The Zuora and Stripe partnership brings together two leading payment and billing companies to help their customers succeed in this new digital era by combining shared insight and strategy. For more on the Stripe and Zuora integration, visit: https://www.zuora.com/stripe-partnership About Stripe Stripe is a global technology company that builds economic infrastructure for the internet. Millions of businesses of every sizefrom new startups to large enterprises like Salesforce, Amazon, and Slackuse Stripe to manage their online finance and treasury functions, from accepting payments to issuing credit cards to sending international payouts and growing subscription revenue. By removing complexity for users, Stripe enables companies to be adaptive to ever-changing customer behavior and participate fully in the online economy in more than 140 countries worldwide. About Zuora, Inc. Zuora provides the leading cloud-based subscription management platform that functions as a system of record for subscription businesses across all industries. Powering the Subscription Economy, the Zuora platform was architected specifically for dynamic, recurring subscription business models and acts as an intelligent subscription management hub that automates and orchestrates the entire subscription order-to-revenue process seamlessly across billing and revenue recognition. Zuora serves more than 1,000 companies around the world, including Box, Ford, Penske Media Corporation, Schneider Electric, Siemens, Xplornet, and Zoom. Headquartered in Silicon Valley, Zuora also operates offices around the world in the U.S., EMEA and APAC. To learn more about the Zuora platform, please visit www.zuora.com. 2020 Zuora, Inc. All Rights Reserved. Zuora, Subscribed, Subscription Economy, Powering the Subscription Economy, and Subscription Economy Index are trademarks or registered trademarks of Zuora, Inc. Third party trademarks mentioned above are owned by their respective companies. Nothing in this press release should be construed to the contrary, or as an approval, endorsement or sponsorship by any third parties of Zuora, Inc. or any aspect of this press release. 1 IDC FutureScape: Worldwide Monetization 2021 Predictions, Mark Thomason, October 2020, IDC #US46246920 SOURCE: Zuora Financial |
edtsum2297 | You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text.
Text: BOSTON, April 1, 2021 /PRNewswire/ -- Whilst relatively light on technical content, an interesting point during Volkswagen's recent Power Day referred to their long-term strategy of employing high-manganese cathodes for their 'volume segment' a prominent role for a chemistry not currently in widespread use. Improvements to energy density are unlikely using high-manganese cathodes, with motivation for developing these materials instead stemming from a desire to reduce cost and eliminate cobalt consumption. But what does 'high-manganese' refer to, and how do they compare to other cathode materials? Continue Reading Comparison between NMC 811 and three high-manganese cathodes (LMFP, Li-Mn-rich, LNMO). Source: IDTechEx (PRNewsfoto/IDTechEx) 'High-manganese' cathodes could refer to several different materials, and so it is unclear as to the specific material Volkswagen were referring to. The options for high-manganese cathodes include LMO (lithium-manganese oxide), LNMO (lithium-nickel-manganese oxide), Li-Mn-rich (also abbreviated as LMR-NMC), and LMP (lithium manganese phosphate) or LMFP (lithium-manganese-iron phosphate). A comparison between NMC 811 and three high-manganese cathodes (LMFP, Li-Mn-rich, LNMO) shows that trade-offs in performance are always involved. Delving deeper into each option can help provide some insight into what specific material might be being developed for use. LMO (LiMn2O4) firstly, commercially available high-manganese cathodes already exist in the form of the lithium-manganese oxide spinel, which was used for the 1st generation Nissan Leaf cars. However, it suffers from accelerated degradation at elevated temperatures, which leads to poor cycle life, hence the replacement of LMO with NMC in subsequent Nissan Leaf generations. With a theoretical capacity of only 148 mAh/g and an average discharge voltage of approximately 4.0-4.1 V, this cathode would lead to lower energy densities compared to cells using current state-of-the-art NMC or NCA layered oxides. LMP (LiMnPO4) and LMFP (LiMnxFe1-xPO4) - LMP shares the same olivine crystal structure as LFP but operates at a more positive voltage, increasing energy density. Cycle life tends to be low, due to the high manganese content, while the material has poor electronic and ionic conductivity, meaning that reasonable capacities are generally only measured at low charge/discharge rates. The addition of Fe to form LMFP can improve conductivity and cycle life but lowers the average voltage. LMFP may bridge the gap between LFP and NMC/NCA but the reversible capacities of LMP and LMFP are too low to reach the cell-level energy densities of cells using NMC/NCA.Li-Mn-rich (xLi2MnO3(1 x)LiMO3 where M = Ni, Mn, Co) the lithium-manganese rich, layered-oxide cathode is one of only a few options, alongside conversion type cathodes, that offer a capacity improvement over current state-of-the-art NMC and NCA materials. However, stability and cycle life are poor and require considerable improvement before commercialization can be expected. BASF's high manganese cathode, NCM 217, may refer to a Li-Mn-rich type material.This leaves LNMO as the most likely cathode VW were referring to. The high-voltage LNMO spinel (LiNi0.5Mn1.5O4) operates at a voltage of approximately 4.7 V vs. Li/Li+ and also holds potential as a high-power cathode due to its three-dimensional structure (improving Li diffusion pathways). However, its theoretical specific capacity is only 147 mAh/g, meaning it will not offer any advantage to specific energy or energy density over high-Ni NMC or NCA cathodes. Furthermore, key issues with LNMO revolve around its low cycle life and poor stability, especially at elevated temperatures, whilst its high voltage also necessitates developments to electrolytes. As outlined by Volkswagen themselves, the use of high-manganese cathodes represents a long-term strategy. Nevertheless, there is some commercial development of LNMO from the likes of Haldor Topsoe, NEI Corporation, and Targray. The potential for cost reduction that the material holds, without significantly reducing energy density, added to the possibility of eliminating cobalt consumption, suggests there is a future for this chemistry. Given the trade-off between cost and different performance metrics from different Li-ion cathodes, a range of cathode materials will have to be employed by the Li-ion industry. Further detail and analysis of Li-ion technology trends, and their impact on battery material demand forecasts, can be explored in IDTechEx's reports "Li-ion Batteries 2020-2030" and "Materials for Electric Vehicle Battery Cells and Packs 2021-2031" or via an IDTechEx Market Intelligence Subscription. For more information on the subscription service, please contact [emailprotected]. For the full portfolio of Energy Storageresearch available fromIDTechEx,please visit www.IDTechEx.com/Research/ES. About IDTechExIDTechEx guides your strategic business decisions through its Research, Subscription and Consultancy products, helping you profit from emerging technologies. For more information, contact [emailprotected]or visit www.IDTechEx.com.Images download:https://www.dropbox.com/sh/u0q5nbtig03999t/AADDYOZIHzgsFXnxBrhWlWmga?dl=0Media Contact:Natalie MoretonDigital Marketing Manager[emailprotected]+44(0)1223 812300Social Media Links:Twitter: https://www.twitter.com/IDTechExLinkedIn: https://www.linkedin.com/company/idtechex/Facebook: https://www.facebook.com/IDTechExResearchPhoto: https://mma.prnewswire.com/media/1479640/IDTechEx.jpg Logo: https://mma.prnewswire.com/media/478371/IDTechEx_Logo.jpg SOURCE IDTechEx
Answer: | IDTechEx Commentary on Volkswagen's Long-term, High-Manganese Cathode Strategy | BOSTON, April 1, 2021 /PRNewswire/ -- Whilst relatively light on technical content, an interesting point during Volkswagen's recent Power Day referred to their long-term strategy of employing high-manganese cathodes for their 'volume segment' a prominent role for a chemistry not currently in widespread use. Improvements to energy density are unlikely using high-manganese cathodes, with motivation for developing these materials instead stemming from a desire to reduce cost and eliminate cobalt consumption. But what does 'high-manganese' refer to, and how do they compare to other cathode materials? Continue Reading Comparison between NMC 811 and three high-manganese cathodes (LMFP, Li-Mn-rich, LNMO). Source: IDTechEx (PRNewsfoto/IDTechEx) 'High-manganese' cathodes could refer to several different materials, and so it is unclear as to the specific material Volkswagen were referring to. The options for high-manganese cathodes include LMO (lithium-manganese oxide), LNMO (lithium-nickel-manganese oxide), Li-Mn-rich (also abbreviated as LMR-NMC), and LMP (lithium manganese phosphate) or LMFP (lithium-manganese-iron phosphate). A comparison between NMC 811 and three high-manganese cathodes (LMFP, Li-Mn-rich, LNMO) shows that trade-offs in performance are always involved. Delving deeper into each option can help provide some insight into what specific material might be being developed for use. LMO (LiMn2O4) firstly, commercially available high-manganese cathodes already exist in the form of the lithium-manganese oxide spinel, which was used for the 1st generation Nissan Leaf cars. However, it suffers from accelerated degradation at elevated temperatures, which leads to poor cycle life, hence the replacement of LMO with NMC in subsequent Nissan Leaf generations. With a theoretical capacity of only 148 mAh/g and an average discharge voltage of approximately 4.0-4.1 V, this cathode would lead to lower energy densities compared to cells using current state-of-the-art NMC or NCA layered oxides. LMP (LiMnPO4) and LMFP (LiMnxFe1-xPO4) - LMP shares the same olivine crystal structure as LFP but operates at a more positive voltage, increasing energy density. Cycle life tends to be low, due to the high manganese content, while the material has poor electronic and ionic conductivity, meaning that reasonable capacities are generally only measured at low charge/discharge rates. The addition of Fe to form LMFP can improve conductivity and cycle life but lowers the average voltage. LMFP may bridge the gap between LFP and NMC/NCA but the reversible capacities of LMP and LMFP are too low to reach the cell-level energy densities of cells using NMC/NCA.Li-Mn-rich (xLi2MnO3(1 x)LiMO3 where M = Ni, Mn, Co) the lithium-manganese rich, layered-oxide cathode is one of only a few options, alongside conversion type cathodes, that offer a capacity improvement over current state-of-the-art NMC and NCA materials. However, stability and cycle life are poor and require considerable improvement before commercialization can be expected. BASF's high manganese cathode, NCM 217, may refer to a Li-Mn-rich type material.This leaves LNMO as the most likely cathode VW were referring to. The high-voltage LNMO spinel (LiNi0.5Mn1.5O4) operates at a voltage of approximately 4.7 V vs. Li/Li+ and also holds potential as a high-power cathode due to its three-dimensional structure (improving Li diffusion pathways). However, its theoretical specific capacity is only 147 mAh/g, meaning it will not offer any advantage to specific energy or energy density over high-Ni NMC or NCA cathodes. Furthermore, key issues with LNMO revolve around its low cycle life and poor stability, especially at elevated temperatures, whilst its high voltage also necessitates developments to electrolytes. As outlined by Volkswagen themselves, the use of high-manganese cathodes represents a long-term strategy. Nevertheless, there is some commercial development of LNMO from the likes of Haldor Topsoe, NEI Corporation, and Targray. The potential for cost reduction that the material holds, without significantly reducing energy density, added to the possibility of eliminating cobalt consumption, suggests there is a future for this chemistry. Given the trade-off between cost and different performance metrics from different Li-ion cathodes, a range of cathode materials will have to be employed by the Li-ion industry. Further detail and analysis of Li-ion technology trends, and their impact on battery material demand forecasts, can be explored in IDTechEx's reports "Li-ion Batteries 2020-2030" and "Materials for Electric Vehicle Battery Cells and Packs 2021-2031" or via an IDTechEx Market Intelligence Subscription. For more information on the subscription service, please contact [emailprotected]. For the full portfolio of Energy Storageresearch available fromIDTechEx,please visit www.IDTechEx.com/Research/ES. About IDTechExIDTechEx guides your strategic business decisions through its Research, Subscription and Consultancy products, helping you profit from emerging technologies. For more information, contact [emailprotected]or visit www.IDTechEx.com.Images download:https://www.dropbox.com/sh/u0q5nbtig03999t/AADDYOZIHzgsFXnxBrhWlWmga?dl=0Media Contact:Natalie MoretonDigital Marketing Manager[emailprotected]+44(0)1223 812300Social Media Links:Twitter: https://www.twitter.com/IDTechExLinkedIn: https://www.linkedin.com/company/idtechex/Facebook: https://www.facebook.com/IDTechExResearchPhoto: https://mma.prnewswire.com/media/1479640/IDTechEx.jpg Logo: https://mma.prnewswire.com/media/478371/IDTechEx_Logo.jpg SOURCE IDTechEx |
edtsum2300 | You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text.
Text: CEO of social good software leader voluntarily forgoes paycheck; releases free resources to customers; gives donation to fight virus; expands employee matching gift program CHARLESTON, S.C., March 30, 2020 /PRNewswire/ -- Blackbaud(NASDAQ: BLKB), the world's leading cloud software company powering social good, announced new measures to support its customers and the broader social economy as many organizations are thrown into crisis mode in the wake of the COVID-19 pandemic. As the COVID-19 crisis evolves around the globe, social good organizations are experiencing unprecedented challenges, and even disruptions to their operations. The need for funding, support and resources is significant as organizations work to pivot their models, activate supporters and minimize disruptions to their services and work. When addressing Blackbaud's global workforce this morning, president and CEO Mike Gianoni outlined a series of measures to support customers, fuel critical innovation and help employees. Among the measures outlined, Gianoni announced he would stop taking a paycheck until the business stabilizes. "At Blackbaud, we believe the world will be a better place when good takes over," said Gianoni. "And, that higher purpose has taken on entirely new meaning and importance during this unprecedented time. We are taking measures to ensure business continuity while remaining critically focused on the success of our customers. We want to empower them to not only survive this pandemic, but to thrive. We also want to do our part to help bring the global economy back to a powerful place. And, most importantly, we want to do our part to help save lives." Blackbaud is seeing the needs and impact of COVID-19 manifest in many ways for its customers depending on the organization type. Many private K12 schools across the U.S. are benefitting from Blackbaud's cloud solutions by being able to swiftly move classes online. Food banks are receiving record high donations through Blackbaud Merchant Services up more than 500% year-over-year. Meanwhile, other nonprofits like arts and cultural organizations face entirely different challenges, which Blackbaud is working diligently to support through resources and guidance. Blackbaud is helping churches recapture weekly offering by quickly setting up virtual platforms. Blackbaud solutions support virtual events, so as organizations around the world are having to cancel important in-person eventseven marathonsthey're able to quickly move fundraising aspects online and recapture revenue. For example, Blackbaud's JustGiving platform is experiencing a rise in COVID-19-related virtual events, individual crowdfunding and direct donations from charities, individuals and celebrities. In support of this, Blackbaud's team is working hands-on with organizations and redeploying resources to accelerate the "go live" of all COVID-19 campaigns. Below are some of the announcements that Blackbaud made today to further support its customers. Blackbaud to Now Offer Customers Free, Universal Access to All Recorded eLearning ResourcesMany social good organizationsnonprofits, higher education institutions, K12 schools, healthcare organizations, faith communities, arts and cultural organizations, foundations and companiesare relying on software in an unprecedented way to fuel communications, fundraising and more during this crisis. To make it easier for its customers to get the training and education they need, the company announced free universal access to its entire curriculum of recorded eLearning resources through Blackbaud University. Customers can learn more here. Blackbaud Releases More than 100 New Resources at No Cost to the Social Good CommunitySocial good organizations are seeking best practices and advice on how to operate and pivot amidst the unforeseen challenges of COVID-19. To help arm these organizations with the knowledge and resources they seek, Blackbaud created new webinars, virtual user groups, community forums, podcasts, e-books and more over the last two weeks; making them available at no cost. Topics include change management, managing a global remote workforce, virtual fundraising, financial management, donor communications and more. Blackbaud's resource library is being continually updated and can be accessed at Blackbaud.com/COVID-19-Resources. Additionally, Blackbaud launched job boards and a COVID-19 discussion thread as part of its Blackbaud Communities platform to help customers further connect and share best practices with each other during this time. Blackbaud Donates to World Health Organization and UN Foundation's COVID-19 Solidarity Response FundBlackbaud's mission is to empower and connect people through technology to drive impact for social good, which is especially critical during these times. Throughout all major disasters, Blackbaud is on the frontlines with its customers and supporting the social good community globally. Blackbaud will be making a donation to the World Health Organization and the UN Foundation's COVID-19 Solidarity Response Fund to put technology in place to fight the spread of the virus. This technology will help track the virus and provide powerful insights into how it is spreading, ensuring patients are getting the care they need; improving the buying and shipping of essential medical supplies; and accelerating efforts to develop a vaccine. Blackbaud Employees Empowered with New Programs and Expanded Employee Gift Matching ProgramBlackbaud's employees are committed to social good professionally and personally as evidenced by employee participation in thecompany's matching gift program being consistently more than two times the national median, according to company data. To continue to empower employees' drive to support causes they care about, Blackbaud today increased its employee matching gift program for the second time since January, bringing the increase to 30% in 2020. The company also began rolling out "virtual volunteerism" programs, which will augment the more than 100,000 hours its employees physically donate each year. Learn more about the resources and measures that Blackbaud is taking for its customers here. About BlackbaudBlackbaud(NASDAQ: BLKB) is the world's leading cloud software company powering social good. Serving the entire social good communitynonprofits, higher education institutions, K12 schools, healthcare organizations, faith communities, arts and cultural organizations, foundations, companies and individual change agentsBlackbaud connects and empowers organizations to increase their impact through cloud software, services, expertise and data intelligence. The Blackbaud portfolio is tailored to the unique needs of vertical markets, with solutions for fundraising and CRM, marketing, advocacy, peer-to-peer fundraising, corporate social responsibility, school management, ticketing, grantmaking, financial management, payment processing and analytics. Serving the industry for more than three decades, Blackbaud is headquartered in Charleston, South Carolina, and has operations in the United States, Australia, Canada, Costa Rica and the United Kingdom. For more information, visit www.blackbaud.comor follow us onTwitter, LinkedIn,Instagram andFacebook. Media Inquiries[emailprotected] Forward-looking StatementsExcept for historical information, all of the statements, expectations, and assumptions contained in this news release are forward-looking statements that involve a number of risks and uncertainties, including statements regarding expected benefits of products and product features. Although Blackbaud attempts to be accurate in making these forward-looking statements, it is possible that future circumstances might differ from the assumptions on which such statements are based. In addition, other important factors that could cause results to differ materially include the following: general economic risks; uncertainty regarding increased business and renewals from existing customers; continued success in sales growth; management of integration of acquired companies and other risks associated with acquisitions; risks associated with successful implementation of multiple integrated software products; the ability to attract and retain key personnel; risks associated with management of growth; lengthy sales and implementation cycles, particularly in larger organization; technological changes that make our products and services less competitive; and the other risk factors set forth from time to time in the SEC filings for Blackbaud, copies of which are available free of charge at the SEC's website at www.sec.gov or upon request from Blackbaud's investor relations department. All Blackbaud product names appearing herein are trademarks or registered trademarks of Blackbaud, Inc. SOURCE Blackbaud Related Links http://www.blackbaud.com
Answer: | Blackbaud Announces New Measures to Support Customers and Global Community in Response to COVID-19 Pandemic | CEO of social good software leader voluntarily forgoes paycheck; releases free resources to customers; gives donation to fight virus; expands employee matching gift program CHARLESTON, S.C., March 30, 2020 /PRNewswire/ -- Blackbaud(NASDAQ: BLKB), the world's leading cloud software company powering social good, announced new measures to support its customers and the broader social economy as many organizations are thrown into crisis mode in the wake of the COVID-19 pandemic. As the COVID-19 crisis evolves around the globe, social good organizations are experiencing unprecedented challenges, and even disruptions to their operations. The need for funding, support and resources is significant as organizations work to pivot their models, activate supporters and minimize disruptions to their services and work. When addressing Blackbaud's global workforce this morning, president and CEO Mike Gianoni outlined a series of measures to support customers, fuel critical innovation and help employees. Among the measures outlined, Gianoni announced he would stop taking a paycheck until the business stabilizes. "At Blackbaud, we believe the world will be a better place when good takes over," said Gianoni. "And, that higher purpose has taken on entirely new meaning and importance during this unprecedented time. We are taking measures to ensure business continuity while remaining critically focused on the success of our customers. We want to empower them to not only survive this pandemic, but to thrive. We also want to do our part to help bring the global economy back to a powerful place. And, most importantly, we want to do our part to help save lives." Blackbaud is seeing the needs and impact of COVID-19 manifest in many ways for its customers depending on the organization type. Many private K12 schools across the U.S. are benefitting from Blackbaud's cloud solutions by being able to swiftly move classes online. Food banks are receiving record high donations through Blackbaud Merchant Services up more than 500% year-over-year. Meanwhile, other nonprofits like arts and cultural organizations face entirely different challenges, which Blackbaud is working diligently to support through resources and guidance. Blackbaud is helping churches recapture weekly offering by quickly setting up virtual platforms. Blackbaud solutions support virtual events, so as organizations around the world are having to cancel important in-person eventseven marathonsthey're able to quickly move fundraising aspects online and recapture revenue. For example, Blackbaud's JustGiving platform is experiencing a rise in COVID-19-related virtual events, individual crowdfunding and direct donations from charities, individuals and celebrities. In support of this, Blackbaud's team is working hands-on with organizations and redeploying resources to accelerate the "go live" of all COVID-19 campaigns. Below are some of the announcements that Blackbaud made today to further support its customers. Blackbaud to Now Offer Customers Free, Universal Access to All Recorded eLearning ResourcesMany social good organizationsnonprofits, higher education institutions, K12 schools, healthcare organizations, faith communities, arts and cultural organizations, foundations and companiesare relying on software in an unprecedented way to fuel communications, fundraising and more during this crisis. To make it easier for its customers to get the training and education they need, the company announced free universal access to its entire curriculum of recorded eLearning resources through Blackbaud University. Customers can learn more here. Blackbaud Releases More than 100 New Resources at No Cost to the Social Good CommunitySocial good organizations are seeking best practices and advice on how to operate and pivot amidst the unforeseen challenges of COVID-19. To help arm these organizations with the knowledge and resources they seek, Blackbaud created new webinars, virtual user groups, community forums, podcasts, e-books and more over the last two weeks; making them available at no cost. Topics include change management, managing a global remote workforce, virtual fundraising, financial management, donor communications and more. Blackbaud's resource library is being continually updated and can be accessed at Blackbaud.com/COVID-19-Resources. Additionally, Blackbaud launched job boards and a COVID-19 discussion thread as part of its Blackbaud Communities platform to help customers further connect and share best practices with each other during this time. Blackbaud Donates to World Health Organization and UN Foundation's COVID-19 Solidarity Response FundBlackbaud's mission is to empower and connect people through technology to drive impact for social good, which is especially critical during these times. Throughout all major disasters, Blackbaud is on the frontlines with its customers and supporting the social good community globally. Blackbaud will be making a donation to the World Health Organization and the UN Foundation's COVID-19 Solidarity Response Fund to put technology in place to fight the spread of the virus. This technology will help track the virus and provide powerful insights into how it is spreading, ensuring patients are getting the care they need; improving the buying and shipping of essential medical supplies; and accelerating efforts to develop a vaccine. Blackbaud Employees Empowered with New Programs and Expanded Employee Gift Matching ProgramBlackbaud's employees are committed to social good professionally and personally as evidenced by employee participation in thecompany's matching gift program being consistently more than two times the national median, according to company data. To continue to empower employees' drive to support causes they care about, Blackbaud today increased its employee matching gift program for the second time since January, bringing the increase to 30% in 2020. The company also began rolling out "virtual volunteerism" programs, which will augment the more than 100,000 hours its employees physically donate each year. Learn more about the resources and measures that Blackbaud is taking for its customers here. About BlackbaudBlackbaud(NASDAQ: BLKB) is the world's leading cloud software company powering social good. Serving the entire social good communitynonprofits, higher education institutions, K12 schools, healthcare organizations, faith communities, arts and cultural organizations, foundations, companies and individual change agentsBlackbaud connects and empowers organizations to increase their impact through cloud software, services, expertise and data intelligence. The Blackbaud portfolio is tailored to the unique needs of vertical markets, with solutions for fundraising and CRM, marketing, advocacy, peer-to-peer fundraising, corporate social responsibility, school management, ticketing, grantmaking, financial management, payment processing and analytics. Serving the industry for more than three decades, Blackbaud is headquartered in Charleston, South Carolina, and has operations in the United States, Australia, Canada, Costa Rica and the United Kingdom. For more information, visit www.blackbaud.comor follow us onTwitter, LinkedIn,Instagram andFacebook. Media Inquiries[emailprotected] Forward-looking StatementsExcept for historical information, all of the statements, expectations, and assumptions contained in this news release are forward-looking statements that involve a number of risks and uncertainties, including statements regarding expected benefits of products and product features. Although Blackbaud attempts to be accurate in making these forward-looking statements, it is possible that future circumstances might differ from the assumptions on which such statements are based. In addition, other important factors that could cause results to differ materially include the following: general economic risks; uncertainty regarding increased business and renewals from existing customers; continued success in sales growth; management of integration of acquired companies and other risks associated with acquisitions; risks associated with successful implementation of multiple integrated software products; the ability to attract and retain key personnel; risks associated with management of growth; lengthy sales and implementation cycles, particularly in larger organization; technological changes that make our products and services less competitive; and the other risk factors set forth from time to time in the SEC filings for Blackbaud, copies of which are available free of charge at the SEC's website at www.sec.gov or upon request from Blackbaud's investor relations department. All Blackbaud product names appearing herein are trademarks or registered trademarks of Blackbaud, Inc. SOURCE Blackbaud Related Links http://www.blackbaud.com |
edtsum2305 | You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text.
Text: STAFFORD, Va.--(BUSINESS WIRE)--BAE Systems Amphibious Combat Vehicle Family of Vehicles (ACV FOV) program has achieved its most significant milestone to date with the Marine Corps decision to move into full-rate production and award a $184 million contract for 36 vehicles. The ACV is an advanced, next generation vehicle for conducting ship-to-shore operations and effectively getting Marines into the fight. The full-rate production milestone comes shortly after the Marine Corps declared the the ACV had met the requirements for Initial Operational Capability (IOC). The IOC declaration occurred on November 13, and is also a significant milestone for the program and a demonstration of confidence in the vehicle. As the ACV enters into service it will be providing highly advanced solutions for conducting maritime-based warfare operations and will play a vital role in the Marine Corps complex and challenging missions, said John Swift, director of amphibious programs at BAE Systems. For BAE Systems, full-rate production validates years of dedication and teamwork in partnership with the Marines to introduce this capability to the warfighter and leave our adversaries on the battlefield at a marked disadvantage. We are proud of our role in the program. The ACV is a highly mobile, survivable, and adaptable platform for conducting full spectrum ship-to-shore operations and brings enhanced combat power to the battlefield. Developed with teammate IVECO Defence Vehicles, the ACV represents the optimum balance of sea and land mobility, survivability, and future growth potential. With a force protection capability three times greater than the Assault Amphibious Vehicle, the ACV is designed so Marines can complete their missions successfully. It provides substantially increased horsepower, with its six-cylinder, 690 horsepower engine, making it capable of land speeds exceeding 55 mph. Its also designed to provide Marines the flexibility to address additional mission roles and future technologies through its modular design. This first lot of full-rate production is planned to grow to 72 vehicles in early 2021, with the options calling for 80 vehicles annually over five years. BAE Systems is currently under a $67 million contract modification awarded in June 2019 to develop new variants for the ACV Family of Vehicles program to enhance battlefield situational awareness and firepower. The contract calls for the design and development of the command (ACV-C) and the 30mm medium caliber cannon (ACV-30) variants. Design and development efforts have begun on both. ACV production and support is taking place at BAE Systems locations in Stafford, Virginia; San Jose, California; Sterling Heights, Michigan; Aiken, South Carolina; and York, Pennsylvania.
Answer: | U.S. Marine Corps Awards $184 Million Contract for Full-Rate Production of the Amphibious Combat Vehicle Following IOC Declaration | STAFFORD, Va.--(BUSINESS WIRE)--BAE Systems Amphibious Combat Vehicle Family of Vehicles (ACV FOV) program has achieved its most significant milestone to date with the Marine Corps decision to move into full-rate production and award a $184 million contract for 36 vehicles. The ACV is an advanced, next generation vehicle for conducting ship-to-shore operations and effectively getting Marines into the fight. The full-rate production milestone comes shortly after the Marine Corps declared the the ACV had met the requirements for Initial Operational Capability (IOC). The IOC declaration occurred on November 13, and is also a significant milestone for the program and a demonstration of confidence in the vehicle. As the ACV enters into service it will be providing highly advanced solutions for conducting maritime-based warfare operations and will play a vital role in the Marine Corps complex and challenging missions, said John Swift, director of amphibious programs at BAE Systems. For BAE Systems, full-rate production validates years of dedication and teamwork in partnership with the Marines to introduce this capability to the warfighter and leave our adversaries on the battlefield at a marked disadvantage. We are proud of our role in the program. The ACV is a highly mobile, survivable, and adaptable platform for conducting full spectrum ship-to-shore operations and brings enhanced combat power to the battlefield. Developed with teammate IVECO Defence Vehicles, the ACV represents the optimum balance of sea and land mobility, survivability, and future growth potential. With a force protection capability three times greater than the Assault Amphibious Vehicle, the ACV is designed so Marines can complete their missions successfully. It provides substantially increased horsepower, with its six-cylinder, 690 horsepower engine, making it capable of land speeds exceeding 55 mph. Its also designed to provide Marines the flexibility to address additional mission roles and future technologies through its modular design. This first lot of full-rate production is planned to grow to 72 vehicles in early 2021, with the options calling for 80 vehicles annually over five years. BAE Systems is currently under a $67 million contract modification awarded in June 2019 to develop new variants for the ACV Family of Vehicles program to enhance battlefield situational awareness and firepower. The contract calls for the design and development of the command (ACV-C) and the 30mm medium caliber cannon (ACV-30) variants. Design and development efforts have begun on both. ACV production and support is taking place at BAE Systems locations in Stafford, Virginia; San Jose, California; Sterling Heights, Michigan; Aiken, South Carolina; and York, Pennsylvania. |
edtsum2307 | You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text.
Text: WASHINGTON, Aug. 7, 2020 /PRNewswire/ -- Girl Scouts from across the nation will pose questions next week to NASA astronaut Chris Cassidyaboard the International Space Station. The educational downlink event will air live at 10:55 a.m. EDT Tuesday, Aug. 11, on NASA Television and the agency's website. Cassidy will answer prerecorded questions selected from the 1.7 million girls who are members of the Girl Scouts of the United States of America. Girl Scouts works to provide girls in grades K-12 with engaging opportunities that increase their interest in STEM, including space science badges, training, and events that inspire them to explore space science. Linking students directly to astronauts aboard the space station provides unique, authentic experiences designed to enhance student learning, performance and interest in science, technology, engineering and mathematics. Astronauts living in space on the orbiting laboratory communicate with NASA's Mission Control Center in Houston 24 hours a day through the Space Network's Tracking and Data Relay Satellites (TDRS). For nearly 20 years, astronauts have continuously lived and work on the space station, testing technologies, performing science and developing the skills needed to explore farther from Earth. Through NASA's Artemis program, the agency will send astronauts to the Moon by 2024, with eventual human exploration of Mars. Inspiring the next generation of explorers the Artemis Generation ensures America will continue to lead in space exploration and discovery. Follow America's Moon to Mars exploration at: https://www.nasa.gov/topics/moon-to-mars Follow NASA astronauts on social media at: https://www.twitter.com/NASA_astronauts See videos and lesson plans highlighting research on the International Space Station at: https://www.nasa.gov/stemonstation SOURCE NASA Related Links http://www.nasa.gov
Answer: | NASA Astronaut Aboard Space Station to Answer Girl Scouts' Questions | WASHINGTON, Aug. 7, 2020 /PRNewswire/ -- Girl Scouts from across the nation will pose questions next week to NASA astronaut Chris Cassidyaboard the International Space Station. The educational downlink event will air live at 10:55 a.m. EDT Tuesday, Aug. 11, on NASA Television and the agency's website. Cassidy will answer prerecorded questions selected from the 1.7 million girls who are members of the Girl Scouts of the United States of America. Girl Scouts works to provide girls in grades K-12 with engaging opportunities that increase their interest in STEM, including space science badges, training, and events that inspire them to explore space science. Linking students directly to astronauts aboard the space station provides unique, authentic experiences designed to enhance student learning, performance and interest in science, technology, engineering and mathematics. Astronauts living in space on the orbiting laboratory communicate with NASA's Mission Control Center in Houston 24 hours a day through the Space Network's Tracking and Data Relay Satellites (TDRS). For nearly 20 years, astronauts have continuously lived and work on the space station, testing technologies, performing science and developing the skills needed to explore farther from Earth. Through NASA's Artemis program, the agency will send astronauts to the Moon by 2024, with eventual human exploration of Mars. Inspiring the next generation of explorers the Artemis Generation ensures America will continue to lead in space exploration and discovery. Follow America's Moon to Mars exploration at: https://www.nasa.gov/topics/moon-to-mars Follow NASA astronauts on social media at: https://www.twitter.com/NASA_astronauts See videos and lesson plans highlighting research on the International Space Station at: https://www.nasa.gov/stemonstation SOURCE NASA Related Links http://www.nasa.gov |
edtsum2310 | You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text.
Text: PITTSBURGH, March 19, 2021 /PRNewswire/ --"My 12-year-old grandson inspired me with this invention," said an inventor from Pine Grove, Pa. "This led me to develop a means to protect the interior of vehicles from overheating." He developed THE RYDER AUTO SAFETY FAN to provide enhanced safety and peace of mind by automatically ventilating and cooling the vehicle's interior. This invention could prevent the interior of the vehicle from overheating to reduce the incidence of children and pets suffering hyperthermia and possibly dying. It could also eliminate burns from hot seat belt buckles, steering wheel rims or leather seats. Additionally, it could provide enhanced comfort when entering a vehicle in warm weather. The original design was submitted to the Lancaster sales office of InventHelp. It is currently patent-pending and is available for licensing or sale to manufacturers or marketers. For more information, write Dept. 19-LCC-5135, InventHelp, 217 Ninth Street, Pittsburgh, PA 15222, or call (412) 288-1300 ext. 1368. Learn more about InventHelp's Invention Submission Services at http://www.InventHelp.com. SOURCE InventHelp Related Links http://www.inventhelp.com
Answer: | InventHelp Inventor Develops Cooling Safety System (LCC-5135) | PITTSBURGH, March 19, 2021 /PRNewswire/ --"My 12-year-old grandson inspired me with this invention," said an inventor from Pine Grove, Pa. "This led me to develop a means to protect the interior of vehicles from overheating." He developed THE RYDER AUTO SAFETY FAN to provide enhanced safety and peace of mind by automatically ventilating and cooling the vehicle's interior. This invention could prevent the interior of the vehicle from overheating to reduce the incidence of children and pets suffering hyperthermia and possibly dying. It could also eliminate burns from hot seat belt buckles, steering wheel rims or leather seats. Additionally, it could provide enhanced comfort when entering a vehicle in warm weather. The original design was submitted to the Lancaster sales office of InventHelp. It is currently patent-pending and is available for licensing or sale to manufacturers or marketers. For more information, write Dept. 19-LCC-5135, InventHelp, 217 Ninth Street, Pittsburgh, PA 15222, or call (412) 288-1300 ext. 1368. Learn more about InventHelp's Invention Submission Services at http://www.InventHelp.com. SOURCE InventHelp Related Links http://www.inventhelp.com |
edtsum2313 | You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text.
Text: SAN DIEGO, Oct. 23, 2020 /PRNewswire/ -- Qualcomm Incorporated (NASDAQ: QCOM) today announced that it will publish the Company's financial results for its fourth quarter and fiscal 2020 on Wednesday, November 4, 2020, after the close of the market on the Company's Investor Relations website, at https://investor.qualcomm.com/financial-information. The earnings release will also be furnished to the Securities and Exchange Commission (SEC) on a Form 8-K, which will be available on the SEC website at http://www.sec.gov. Qualcomm will host a conference call to discuss its fourth quarter and fiscal 2020 results which will be broadcast live on November 4, 2020, beginning at 1:45 p.m. Pacific Time (PT) at https://investor.qualcomm.com/news-events/events. An audio replay will be available at https://investor.qualcomm.com/news-events/events and via telephone following the live call for 30 days thereafter. To listen to the replay via telephone, U.S. callers may dial (877) 660-6853 and international callers may dial (201) 612-7415. Callers should use reservation number 13711766. About Qualcomm Qualcomm is the world's leading wireless technology innovator and the driving force behind the development, launch, and expansion of 5G. When we connected the phone to the internet, the mobile revolution was born. Today, our foundational technologies enable the mobile ecosystem and are found in every 3G, 4G and 5G smartphone. We bring the benefits of mobile to new industries, including automotive, the internet of things, and computing, and are leading the way to a world where everything and everyone can communicate and interact seamlessly. Qualcomm Incorporated includes our licensing business, QTL, and the vast majority of our patent portfolio. Qualcomm Technologies, Inc., a subsidiary of Qualcomm Incorporated, operates, along with its subsidiaries, substantially all of our engineering, research and development functions, and substantially all of our products and services businesses, including our QCT semiconductor business. For more information, visit www.qualcomm.com. Qualcomm Contact: Mauricio Lopez-HodoyanVice President, Investor Relations Phone: (858) 658-4813Email: [emailprotected] SOURCE Qualcomm Incorporated Related Links http://www.qualcomm.com
Answer: | Qualcomm Schedules Fourth Quarter and Fiscal 2020 Earnings Release and Conference Call | SAN DIEGO, Oct. 23, 2020 /PRNewswire/ -- Qualcomm Incorporated (NASDAQ: QCOM) today announced that it will publish the Company's financial results for its fourth quarter and fiscal 2020 on Wednesday, November 4, 2020, after the close of the market on the Company's Investor Relations website, at https://investor.qualcomm.com/financial-information. The earnings release will also be furnished to the Securities and Exchange Commission (SEC) on a Form 8-K, which will be available on the SEC website at http://www.sec.gov. Qualcomm will host a conference call to discuss its fourth quarter and fiscal 2020 results which will be broadcast live on November 4, 2020, beginning at 1:45 p.m. Pacific Time (PT) at https://investor.qualcomm.com/news-events/events. An audio replay will be available at https://investor.qualcomm.com/news-events/events and via telephone following the live call for 30 days thereafter. To listen to the replay via telephone, U.S. callers may dial (877) 660-6853 and international callers may dial (201) 612-7415. Callers should use reservation number 13711766. About Qualcomm Qualcomm is the world's leading wireless technology innovator and the driving force behind the development, launch, and expansion of 5G. When we connected the phone to the internet, the mobile revolution was born. Today, our foundational technologies enable the mobile ecosystem and are found in every 3G, 4G and 5G smartphone. We bring the benefits of mobile to new industries, including automotive, the internet of things, and computing, and are leading the way to a world where everything and everyone can communicate and interact seamlessly. Qualcomm Incorporated includes our licensing business, QTL, and the vast majority of our patent portfolio. Qualcomm Technologies, Inc., a subsidiary of Qualcomm Incorporated, operates, along with its subsidiaries, substantially all of our engineering, research and development functions, and substantially all of our products and services businesses, including our QCT semiconductor business. For more information, visit www.qualcomm.com. Qualcomm Contact: Mauricio Lopez-HodoyanVice President, Investor Relations Phone: (858) 658-4813Email: [emailprotected] SOURCE Qualcomm Incorporated Related Links http://www.qualcomm.com |
Subsets and Splits